18712290-619	Purification, characterization, and preliminary X-ray diffraction analysis of a <compound-id="294,6134,84571,440995">lactose</compound-id>-specific <protein-id="P02871,P02873,P02874,P02875,P07386,P16108,P16349,P16351,P16352,P33888,P38662,P42088,P83410,P83511,P84987,Q41114">lectin</protein-id> from Cymbosema roseum seeds.	lactose__lectin__interaction
18712290-620	Here, we report the purification, partial primary structure, carbohydrate affinity characterization, crystallization, and preliminary X-ray diffraction analysis of a <compound-id="294,6134,84571,440995">lactose</compound-id>-specific <protein-id="P02871,P02873,P02874,P02875,P07386,P16108,P16349,P16351,P16352,P33888,P38662,P42088,P83410,P83511,P84987,Q41114">lectin</protein-id> from Cymbosema roseum seeds (CRLII).	lactose__lectin__interaction
18712361-637	Effects on haemolytic activity of single <compound-id="614,8988,145742">proline</compound-id> substitutions in the Bordetella pertussis <protein-id="P00936,P0A1A7,P0A1A8,P15318,P19485,P40127,P40134,P40137,P59739,P98009,Q57506,Q8FBP0,Q8XAP1,Q9WXC3">CyaA</protein-id> pore-forming fragment.	proline__CyaA__interaction
18712381-639	Associations between the uptake of 111In-<compound-id="3053">DTPA</compound-id>-trastuzumab, <protein-id="P04626">HER2</protein-id> density and response to trastuzumab (Herceptin) in athymic mice bearing subcutaneous human tumour xenografts.	DTPA__HER2__interaction
18712381-640	The purpose of the study was to investigate the associations between uptake of (111)In-<compound-id="3053">DTPA</compound-id>-trastuzumab, tumour <protein-id="P04626">HER2</protein-id> density and response to trastuzumab (Herceptin) of human breast cancer (BC) xenografts in athymic mice.	DTPA__HER2__interaction
18712598-674	The <compound-id="60961">adenosine</compound-id> (the final product of ATP hydrolysis by <protein-id="P29240">ectonucleotidases</protein-id>), have a recognized neuroprotective actions in the central nervous system (CNS) in pathological conditions.	adenosine__ectonucleotidases__interaction
18712838-744	To this end, the cultured fibroblasts were analyzed for very <compound-id="284">long chain fatty acid</compound-id> (VLCFA) concentrations, peroxisomal beta- and alpha-oxidation, <protein-id="O15228,P98192,Q9ES71">dihydroxyacetone-phosphate acyltransferase</protein-id> (<protein-id="O15228">DHAPAT</protein-id>) activity, peroxisomal <protein-id="Q6L8K7">thiolase</protein-id>, and <protein-id="O24339,O52762,O62839,O68146,O77229,O93662,O97492,P00432,P04040,P04762,P07145,P0A323,P0A324,P0A325,P0A326,P0A327,P11934,P17336,P24168,P24270,P25890,P29422,P30265,P30266,P32290,P42321,P44390,P45737,P45739,P55304,P55306,P55310,P55311,P55313,P77872,P81138,P90682,Q27710,Q49XC1,Q4L643,Q59296,Q59337,Q59602,Q59714,Q5HG86,Q5HPK8,Q5RF10,Q64405,Q6G9M4,Q6GH72,Q7A5T2,Q8CPD0,Q8FWU0,Q8NWV5,Q8X1P0,Q8Y3P9,Q926X0,Q99UE2,Q9AXH0,Q9KW19,Q9L4S1,Q9M5L6,Q9PT92,Q9PWF7,Q9Z598,Q9ZKX5,Q9ZN99">catalase</protein-id> immunofluorescence.	long chain fatty acid__dihydroxyacetone-phosphate acyltransferase__no_interaction	long chain fatty acid__catalase__no_interaction	long chain fatty acid__DHAPAT__no_interaction	long chain fatty acid__thiolase__no_interaction
18713274-881	Also, <protein-id="O19114,O46660,O54705,O62699,P29477,P35228,P79290,Q06518,Q27995,Q28314,Q90703,Q92037,Q92091">iNOS</protein-id> induction and concomitant <compound-id="145068">nitric oxide</compound-id> generation appear to participate in the cytotoxicity of excessive portal pressure after extended hepatectomy.	nitric oxide__iNOS__interaction
18713277-882	<protein-id="O50258">Superoxide dismutase</protein-id> (<protein-id="O12933,O22668,O75007,P24705,P51547,P93258,Q01137,Q27666,Q9SM64">SOD</protein-id>), <protein-id="O32770,O59858,Q00277,Q9CFV1">glutathione peroxidase</protein-id> (GSH-Px), <protein-id="O24339,O52762,O62839,O68146,O77229,O93662,O97492,P00432,P04040,P04762,P07145,P0A323,P0A324,P0A325,P0A326,P0A327,P11934,P17336,P24168,P24270,P25890,P29422,P30265,P30266,P32290,P42321,P44390,P45737,P45739,P55304,P55306,P55310,P55311,P55313,P77872,P81138,P90682,Q27710,Q49XC1,Q4L643,Q59296,Q59337,Q59602,Q59714,Q5HG86,Q5HPK8,Q5RF10,Q64405,Q6G9M4,Q6GH72,Q7A5T2,Q8CPD0,Q8FWU0,Q8NWV5,Q8X1P0,Q8Y3P9,Q926X0,Q99UE2,Q9AXH0,Q9KW19,Q9L4S1,Q9M5L6,Q9PT92,Q9PWF7,Q9Z598,Q9ZKX5,Q9ZN99">catalase</protein-id> (<protein-id="O62839,O97492,P00432,P00485,P00486,P00487,P04040,P06135,P07641,P11504,P20074,P22782,P25309,P25819,P26825,P26826,P32796,P36882,P36883,P43155,P47934,P49417,P52826,P58777,P62577,P62578,P62579,P62580,P90682,Q00614,Q02736,Q03058,Q5RF10,Q64405,Q704S8,Q9M5L6,Q9PWF7">CAT</protein-id>) enzyme activities, antioxidant potential (AOP) value, <compound-id="10964">malondialdehyde</compound-id> (MDA), <compound-id="304,5997,6432564,11025495">cholesterol</compound-id> and triglyceride levels in the liver tissues and total <compound-id="304,5997,6432564,11025495">cholesterol</compound-id> and triglyceride levels in serum samples were measured.	cholesterol__glutathione peroxidase__no_interaction	cholesterol__catalase__no_interaction	cholesterol__CAT__no_interaction	malondialdehyde__SOD__no_interaction	malondialdehyde__glutathione peroxidase__no_interaction	cholesterol__Superoxide dismutase__no_interaction	malondialdehyde__CAT__no_interaction	malondialdehyde__Superoxide dismutase__no_interaction	cholesterol__SOD__no_interaction	malondialdehyde__catalase__no_interaction
18714161-1109	Inhibition of apoptotic signaling and neointimal hyperplasia by <compound-id="137994">tempol</compound-id> and <protein-id="O61309,O61608,Q27571,Q9I9M2">nitric oxide synthase</protein-id> following vascular injury.	tempol__nitric oxide synthase__no_interaction
18715145-1378	Forced cytoplasmic overexpression of <protein-id="P14904">APE1</protein-id> profoundly attenuated the upregulation of <protein-id="P07156,P09429,P10103,P12682,P36194,Q4R844,Q6YKA4">HMGB1</protein-id>-mediated reactive <compound-id="977">oxygen</compound-id> species generation, cytokine secretion, and <protein-id="O02768,O19183,O62698,O62725,P27607,P35354,P35355,P70682,P79208,Q05769">cyclooxygenase-2</protein-id> expression by primary monocytes and macrophage-like THP-1 cell lines.	oxygen__cyclooxygenase-2__no_interaction	oxygen__APE1__interaction	oxygen__HMGB1__interaction
18715148-1380	NO, a gas, is produced from L-<compound-id="232,4367,6322">arginine</compound-id> by different isoforms of <protein-id="O61309,O61608,Q27571,Q9I9M2">nitric oxide synthase</protein-id> (<protein-id="O54705,O61309,O61608,Q26240,Q28969,Q9I9M2">NOS</protein-id>) and serves many normal physiologic purposes, such as promoting vasodilation of blood vessels and mediating communication between nervous system cells.	arginine__nitric oxide synthase__interaction	arginine__NOS__interaction
18715149-1381	As one of the very few repair systems for oxidized proteins, <protein-id="O25011,O26635,O69761,O83641,P0A081,P0A082,P0A083,P0A084,P0A085,P0A086,P0A3Q9,P0A3R0,P0A5L0,P0A5L1,P0A744,P0A745,P23212,P47648,P54154,P65443,P65444,P75188,Q4J9L3,Q53W34,Q576P8,Q5HG58,Q5HVD4,Q5PJ81,Q5XDH1,Q66F89,Q6D151,Q6L2S4,Q6LV65,Q6LYY1,Q6NEL2,Q71YF6,Q746G0,Q7MYW1,Q87D27,Q87SW6,Q88AI5,Q88QZ8,Q899M3,Q8DE84,Q8DSY4,Q8DYH1,Q8E434,Q8FAG4,Q8FLU6,Q8FUZ0,Q8NLL5,Q8P272,Q8PCA6,Q8PNY8,Q8PUD6,Q8TQV6,Q8VS50,Q8XCG3,Q8XH97,Q8Y1C6,Q8Y640,Q8YDE7,Q8Z150,Q8ZB94,Q8ZK71,Q92AE8,Q93KF3,Q93S39,Q97MV3,Q97Y45,Q98PE5,Q99YT1,Q9A149,Q9AJF7,Q9APY4,Q9CCZ3,Q9CN40,Q9EWF7,Q9HQG0,Q9HUF1,Q9KAN8,Q9KP30,Q9LAM9,Q9PC45,Q9PQK2,Q9RTB6,Q9ZEQ8,Q9ZMK8">MsrA</protein-id> and <protein-id="O26807,P0A087,P0A088,P0A746,P0A747,P0A748,P47686,P54155,P65447,P65448,P65449,P65450,P65451,P75129,P99065,Q49XN4,Q4L6D3,Q5HPB4,Q5WH73,Q5XCD0,Q66AP6,Q6D4P7,Q6G9D8,Q6GGY4,Q71YF7,Q72NN2,Q7MMC4,Q83L66,Q87AJ9,Q87MS5,Q885Q1,Q88LQ6,Q88W33,Q89EM9,Q8CSK6,Q8D849,Q8DJK9,Q8E026,Q8E5Q9,Q8F7W8,Q8K7M6,Q8P172,Q8UGX7,Q8XJZ6,Q8XYL1,Q8Y641,Q8ZEK7,Q92AE9,Q97IU0,Q99ZV6,Q9A6B1,Q9CJ17,Q9CMB1,Q9I016,Q9KCX2,Q9KQK0,Q9PF29,Q9RUK6,Q9XB39,Q9ZNJ9">MsrB</protein-id> enzymes play a major role in protein homeostasis during aging and have also been involved in cellular defenses against oxidative stress, by scavenging reactive <compound-id="977">oxygen</compound-id> species.	oxygen__MsrA__interaction	oxygen__MsrB__interaction
18715284-1402	<protein-id="P81182">High density lipoprotein</protein-id>-<compound-id="304,5997,6432564,11025495">cholesterol</compound-id> levels increase with age in American women but not in Hong Kong Chinese women.	cholesterol__High density lipoprotein__interaction
18715284-1403	<protein-id="P81182">High-density lipoprotein</protein-id> (HDL) <compound-id="304,5997,6432564,11025495">cholesterol</compound-id> is a powerful cardiovascular risk factor.	cholesterol__High-density lipoprotein__interaction
18715643-1517	Repeated injections of arsenic trioxide induced oxidative stress and hepatotoxicity in mice as revealed from elevated levels of glutamate oxaloacetate transaminases, glutamate pyruvate transaminases, acid and <protein-id="O60109,P81800,P83456">alkaline phosphatases</protein-id>, lipid peroxidation along with reduction of <protein-id="O50258">superoxide dismutase</protein-id>, <protein-id="O24339,O52762,O62839,O68146,O77229,O93662,O97492,P00432,P04040,P04762,P07145,P0A323,P0A324,P0A325,P0A326,P0A327,P11934,P17336,P24168,P24270,P25890,P29422,P30265,P30266,P32290,P42321,P44390,P45737,P45739,P55304,P55306,P55310,P55311,P55313,P77872,P81138,P90682,Q27710,Q49XC1,Q4L643,Q59296,Q59337,Q59602,Q59714,Q5HG86,Q5HPK8,Q5RF10,Q64405,Q6G9M4,Q6GH72,Q7A5T2,Q8CPD0,Q8FWU0,Q8NWV5,Q8X1P0,Q8Y3P9,Q926X0,Q99UE2,Q9AXH0,Q9KW19,Q9L4S1,Q9M5L6,Q9PT92,Q9PWF7,Q9Z598,Q9ZKX5,Q9ZN99">catalase</protein-id>, <compound-id="124886">reduced glutathione</compound-id> content, <protein-id="O15770,P06715,P11804,P23189,P41921,P43783,P48638,P48639,P70619,P78965,Q60151,Q6BPI1,Q6C5H4,Q6FRV2,Q6HA23,Q74ZK4,Q873E8,Q94655">glutathione reductase</protein-id> and succinate dehydrogenase activities.	reduced glutathione__superoxide dismutase__no_interaction	reduced glutathione__alkaline phosphatases__no_interaction	reduced glutathione__catalase__no_interaction	reduced glutathione__glutathione reductase__no_interaction
18715643-1518	Hepatoprotective potential of vitamin C was indicated by its ability to restore <compound-id="124886">GSH</compound-id>, <protein-id="O12933,O22668,O75007,P24705,P51547,P93258,Q01137,Q27666,Q9SM64">SOD</protein-id>, <protein-id="O62839,O97492,P00432,P00485,P00486,P00487,P04040,P06135,P07641,P11504,P20074,P22782,P25309,P25819,P26825,P26826,P32796,P36882,P36883,P43155,P47934,P49417,P52826,P58777,P62577,P62578,P62579,P62580,P90682,Q00614,Q02736,Q03058,Q5RF10,Q64405,Q704S8,Q9M5L6,Q9PWF7">CAT</protein-id>, <protein-id="P56544">AcP</protein-id>, AlkP and <protein-id="Q24352">GRD</protein-id> levels towards near normal.	GSH__CAT__no_interaction	GSH__SOD__no_interaction	GSH__AcP__no_interaction	GSH__GRD__no_interaction
18715823-1582	The interaction of <compound-id="5280343">quercetin</compound-id>, which is a <compound-id="5280805">bioflavonoid</compound-id>, with bovine <protein-id="P21847,P83517">serum albumin</protein-id> (<protein-id="P02769">BSA</protein-id>) was investigated under pseudo-physiological conditions by the application of UV-vis spectrometry, spectrofluorimetry and cyclic voltammetry (CV).	bioflavonoid__serum albumin__no_interaction	quercetin__serum albumin__interaction	bioflavonoid__BSA__no_interaction	quercetin__BSA__interaction
18715823-1585	1x10(-5) mol L(-1)), most of the site marker reacted with the quercetin-<protein-id="P02769">BSA</protein-id>, but free <compound-id="54678486">warfarin</compound-id> was present at higher concentrations.	warfarin__BSA__no_interaction
18715824-1587	Under optimum conditions, the fluorescence intensity of <protein-id="P02769">BSA</protein-id>-GNPs is linearly proportional to <compound-id="935">nickel</compound-id> concentration from 6.0x10(-8)mol/L to 8.0x10(-6)mol/L with a detection limit of 1.0x10(-8)mol/L.	nickel__BSA__interaction
18716315-1771	C18 and C20Gb(3) were, in mixtures without <compound-id="446804">C24</compound-id> :1Gb(3), dominant negative for <protein-id="O12164,O41803,O70902,O89292,O91086,P03375,P03377,P03378,P04577,P04578,P04579,P04580,P04581,P04582,P04583,P04624,P05877,P05878,P05879,P05880,P05881,P05882,P05883,P05884,P05885,P05886,P08810,P11267,P12449,P12487,P12488,P12489,P12490,P12491,P12492,P15831,P17281,P17755,P18040,P18094,P18799,P19503,P19549,P19550,P19551,P20871,P20872,P20888,P22380,P24105,P27757,P27977,P31819,P31872,P32536,P35961,Q02837,Q1A243,Q1A261,Q70626,Q73372,Q74126,Q75008,Q76638,Q77377,Q79670,Q89607,Q8AIH5,Q9IDV2,Q9Q714,Q9QBY2,Q9QBZ0,Q9QBZ4,Q9QBZ8,Q9QSQ7,Q9WC60,Q9WC69">gp120</protein-id> vesicle binding.	C24__gp120__no_interaction
18716315-1772	<protein-id="O12164,O41803,O70902,O89292,O91086,P03375,P03377,P03378,P04577,P04578,P04579,P04580,P04581,P04582,P04583,P04624,P05877,P05878,P05879,P05880,P05881,P05882,P05883,P05884,P05885,P05886,P08810,P11267,P12449,P12487,P12488,P12489,P12490,P12491,P12492,P15831,P17281,P17755,P18040,P18094,P18799,P19503,P19549,P19550,P19551,P20871,P20872,P20888,P22380,P24105,P27757,P27977,P31819,P31872,P32536,P35961,Q02837,Q1A243,Q1A261,Q70626,Q73372,Q74126,Q75008,Q76638,Q77377,Q79670,Q89607,Q8AIH5,Q9IDV2,Q9Q714,Q9QBY2,Q9QBZ0,Q9QBZ4,Q9QBZ8,Q9QSQ7,Q9WC60,Q9WC69">Gp120</protein-id>/VT1bound C18 and <compound-id="446804">C24</compound-id> :1Gb(3) mixtures, although neither isoform bound alone.	C24__Gp120__interaction
18716315-1773	Monolayer surface pressure measurement showed VT1, but not VT2, bound <compound-id="5353448">Gb(3</compound-id>) at cellular DRM surface pressures, and confirmed loss of VT1 and <protein-id="O12164,O41803,O70902,O89292,O91086,P03375,P03377,P03378,P04577,P04578,P04579,P04580,P04581,P04582,P04583,P04624,P05877,P05878,P05879,P05880,P05881,P05882,P05883,P05884,P05885,P05886,P08810,P11267,P12449,P12487,P12488,P12489,P12490,P12491,P12492,P15831,P17281,P17755,P18040,P18094,P18799,P19503,P19549,P19550,P19551,P20871,P20872,P20888,P22380,P24105,P27757,P27977,P31819,P31872,P32536,P35961,Q02837,Q1A243,Q1A261,Q70626,Q73372,Q74126,Q75008,Q76638,Q77377,Q79670,Q89607,Q8AIH5,Q9IDV2,Q9Q714,Q9QBY2,Q9QBZ0,Q9QBZ4,Q9QBZ8,Q9QSQ7,Q9WC60,Q9WC69">gp120</protein-id> (but not VT2) specific C18Gb(3) binding.	Gb(3__gp120__no_interaction
18716607-1835	<protein-id="P32749,P32750,P32751,P32752,P32753,P81908">Cholinesterase</protein-id> inhibition in chlorpyrifos workers: Characterization of biomarkers of exposure and response in relation to urinary <compound-id="62764">TCPy</compound-id>.	TCPy__Cholinesterase__no_interaction
18716607-1836	The objective of this study was to evaluate the quantitative relation between measured red blood cell <protein-id="Q867X2,Q867X3,Q86GC9,Q92081">acetylcholinesterase</protein-id> (RBC AChE) and plasma butyrylcholinesterase (BuChE) activities with exposure to <compound-id="2730">chlorpyrifos</compound-id> (CPF) as assessed by measurement of urinary <compound-id="23017">3,5,6-trichloro-2-pyridinol</compound-id> (<compound-id="62764">TCPy</compound-id>) in a study group of workers occupationally exposed in the manufacture of CPF and a referent group of chemical manufacturing workers.	chlorpyrifos__acetylcholinesterase__interaction	TCPy__acetylcholinesterase__interaction	3,5,6-trichloro-2-pyridinol__acetylcholinesterase__interaction
18716756-1877	Immunofluorescence analysis revealed that two known virulence-associated <protein-id="O12164,O41803,O42043,O56861,O70902,O71037,O89292,O91086,P03374,P03375,P03377,P03378,P03379,P03380,P03381,P03383,P03385,P03386,P03387,P03388,P03390,P03391,P03392,P03395,P03396,P03397,P03399,P04027,P04502,P04577,P04578,P04579,P04580,P04581,P04582,P04583,P04624,P05877,P05878,P05879,P05880,P05881,P05882,P05883,P05884,P05885,P05886,P06445,P06751,P06752,P07575,P08359,P08360,P08810,P0C212,P10259,P10267,P10269,P11261,P11267,P11268,P11306,P12449,P12487,P12488,P12489,P12492,P14075,P14351,P15073,P15831,P16082,P16090,P16899,P17281,P17755,P18040,P18094,P18799,P19030,P19503,P19549,P19550,P19551,P19556,P19557,P20871,P20872,P20888,P21412,P21415,P21436,P21443,P21444,P21445,P22380,P22427,P22428,P22429,P22430,P23064,P23073,P23422,P23423,P24105,P25057,P25504,P25505,P25506,P25507,P26803,P26804,P27399,P27757,P27977,P31621,P31626,P31627,P31789,P31791,P31794,P31796,P31819,P31872,P32536,P32541,P33498,P35954,P35961,P51515,P51519,P51520,P60507,P60508,P60608,P61549,P61550,P61552,P61553,P61554,P61555,P61556,P61557,P61558,P61559,P61561,P61562,P61563,P61564,P61565,P61566,P61567,P61570,Q02076,Q02077,Q02282,Q02837,Q03804,Q03816,Q03817,Q04993,Q04995,Q05312,Q09SZ7,Q0R5Q9,Q14264,Q1A243,Q1A261,Q69384,Q70626,Q73372,Q74126,Q75008,Q76638,Q77377,Q79670,Q85646,Q89607,Q8AIH5,Q8MIB6,Q902F8,Q902F9,Q96L62,Q9IDV2,Q9N2J8,Q9N2J9,Q9N2K0,Q9NX77,Q9Q714,Q9QBY2,Q9QBZ0,Q9QBZ4,Q9QBZ8,Q9QSQ7,Q9TTC0,Q9UKH3,Q9UQF0,Q9WC60,Q9WC69">surface proteins</protein-id> featuring <compound-id="3977067">Leu-Pro</compound-id>-X-Thr-<compound-id="750,5460845">Gly</compound-id> motif, <protein-id="O64362,O80288,O80292,P00720,P03706,P07540,P09963,P10439,P11187,P15057,P19385,P19386,P27359,P33486,P51728,P51771,P62692,P62693,P68920,P68921,P76159,P78285,Q37875,Q37896,Q9T1T5,Q9T1X2,Q9ZXB7">muramidase</protein-id>-released protein and surface antigen one, were absent in the DeltasrtA.	Leu-Pro__muramidase__no_interaction	Leu-Pro__surface proteins__interaction	Gly__surface proteins__interaction	Gly__muramidase__no_interaction
18716761-1880	In addition, neuronal <protein-id="O61309,O61608,Q27571,Q9I9M2">nitric oxide synthase</protein-id>, another component of the <compound-id="22880">NMDA</compound-id>/<compound-id="145068">nitric oxide</compound-id>/<compound-id="24316">cGMP</compound-id> intracellular pathway, has been reported to be dysregulated in schizophrenia patients.	nitric oxide__nitric oxide synthase__interaction	NMDA__nitric oxide synthase__interaction	cGMP__nitric oxide synthase__interaction
18716776-1883	Vitamin K deficiency amplifies anticoagulation response to <compound-id="9574101">ximelagatran</compound-id> : possible implications for direct <protein-id="P82354">thrombin inhibitors</protein-id> and their clinical safety.	ximelagatran__thrombin inhibitors__no_interaction
18716776-1884	This study examined whether vitamin K insufficiency affected anticoagulation response to the direct <protein-id="P82354">thrombin inhibitor</protein-id>, <compound-id="9574101">ximelagatran</compound-id>.	ximelagatran__thrombin inhibitor__interaction
18716782-1887	A role for <protein-id="P28374">natriuretic peptide</protein-id> in <compound-id="11970143">lipopolysaccharide</compound-id>-induced fever in Pekin ducks (Anas platyrhynchos): is <protein-id="P28374">natriuretic peptide</protein-id> an endogenous antipyretic in birds.	lipopolysaccharide__natriuretic peptide__no_interaction
18716782-1888	We induced fever in Pekin ducks with <compound-id="11970143">lipopolysaccharide</compound-id> and, at the same time, treated the animals with <protein-id="P28374">natriuretic peptide</protein-id> antiserum at a dose that effectively inhibited the known renal actions of endogenously secreted <protein-id="P28374">natriuretic peptide</protein-id>.	lipopolysaccharide__natriuretic peptide__no_interaction
18716808-1894	Among the Gram-negative bacteria, 100% of the Escherichia coli isolates (including extended spectrum <protein-id="P80298,P80545,P81173">beta-lactamase</protein-id> [ESBL]-producers) were <compound-id="54686904">tigecycline</compound-id>-susceptible, while about 10% of the Enterobacter cloacae and Klebsiella pneumoniae isolates were resistant.	tigecycline__beta-lactamase__no_interaction
18716858-1921	Sequencing of the 5'-upstream region of the <protein-id="O01739,O35078,P00371,P14920,P18894,P19801,P22942,P24552,P36633,P80324,Q19564,Q8JZQ5,Q99042,Q9TRC7,Q9Z1M5,Q9Z302">DAO</protein-id> gene revealed the deletion of one triplet in the 15 <compound-id="2723949">TAA</compound-id> repeats approximately 700-bp upstream of the transcription start point.	TAA__DAO__interaction
18716864-1923	The data presented here show that NH4Cl (5 mM) mediates astroglial cell swelling, and that treatment with NH4Cl or <compound-id="612">lactate</compound-id> (25 mM) causes rearrangements of <protein-id="O00937,O13419,O16808,O17320,O65314,O65315,O65316,O74258,O81221,P02577,P10365,P10989,P11426,P13363,P14235,P17128,P20904,P24902,P26182,P26183,P30161,P45520,P45521,P48465,P50138,P51775,P53455,P53476,P53477,P53491,P53498,P53499,P53500,P53502,P53689,P60009,P60010,P60011,P68555,P78711,P80709,P81085,P90689,P91754,Q05214,Q11212,Q24733,Q2U7A3,Q39596,Q39758,Q6TCF2,Q75D00,Q8SWN8,Q8X119,Q92192,Q92193,Q99023,Q9P4D1,Q9UVF3,Q9UVX4,Q9UVZ8">actin</protein-id> filaments and reduces astroglial glutamate uptake capacity.	lactate__actin__interaction
18716881-1939	<protein-id="Q80U72">Lap4</protein-id>, a <protein-id="P14904">vacuolar aminopeptidase I</protein-id>, is involved in <compound-id="23973">cadmium</compound-id>-glutathione metabolism.	cadmium__Lap4__interaction	cadmium__vacuolar aminopeptidase I__no_interaction
18716881-1940	Here, we proposed that <protein-id="Q80U72">Lap4</protein-id>, a vacuolar amino peptidase, is involved in glutathione catabolism under <compound-id="23973">cadmium</compound-id> stress.	cadmium__Lap4__interaction
18716881-1941	Saccharomyces cerevisiae cells deficient in <protein-id="Q80U72">Lap4</protein-id> absorbed almost 3-fold as much cadmium as the wild-type strain (wt), probably due to the lower rate of cadmium-<compound-id="124886">glutathione</compound-id> complex synthesis in the cytoplasm.	glutathione__Lap4__no_interaction
18716881-1942	Thus, under <compound-id="23973">cadmium</compound-id> stress, <protein-id="Q80U72">Lap4</protein-id> and gamma-glutamyl transferase seem to work together to assure an efficient <compound-id="124886">glutathione</compound-id> turnover stored in the vacuole.	glutathione__Lap4__interaction	cadmium__Lap4__no_interaction
18716920-1959	In this research, the effects of pH, temperature, and <compound-id="977">oxygen</compound-id> on growth kinetics of a newly isolated strain of Bacillus circulans from the Amazon and their correlations with <protein-id="P40746,P52183,P81453,Q819L3,Q81MS1,Q8GR90,Q9K5W7">transglutaminase</protein-id> (<protein-id="P40746,P81453,Q05187,Q819L3,Q81MS1,Q8GR90,Q9K5W7">TGase</protein-id>) production and cell sporulation were investigated.	oxygen__transglutaminase__interaction	oxygen__TGase__interaction
18717617-2177	No relationships were observed among <compound-id="23931">mercury</compound-id>, <compound-id="6326970">selenium</compound-id>, and several other neurochemical biomarkers (<compound-id="681">dopamine</compound-id>-2, <compound-id="119">gamma-aminobutyric acid</compound-id> type A, muscarinic cholinergic, and nicotinic cholinergic receptors; <protein-id="P32749,P32750,P32751,P32752,P32753,P81908">cholinesterase</protein-id> and <protein-id="P49253">monoamine oxidase</protein-id> enzymes).	gamma-aminobutyric acid__cholinesterase__no_interaction	selenium__cholinesterase__no_interaction	dopamine__cholinesterase__no_interaction	selenium__monoamine oxidase__no_interaction	dopamine__monoamine oxidase__no_interaction	gamma-aminobutyric acid__monoamine oxidase__no_interaction	mercury__monoamine oxidase__no_interaction	mercury__cholinesterase__no_interaction
18717625-2181	Despite responsive antioxidative defense (increased activities of <protein-id="O50258">superoxide dismutase</protein-id>, ascorbate <protein-id="P15984,P16147,P84714">peroxidase</protein-id>, and pyrogallol <protein-id="P15984,P16147,P84714">peroxidase</protein-id>), <compound-id="105005">Tl</compound-id>+ caused oxidative damage to lipids and proteins as evaluated by malondialdehyde and carbonyl group levels, and induced DNA strand breaks.	Tl__peroxidase__no_interaction	Tl__superoxide dismutase__no_interaction
18717627-2182	However, Ref-1 inhibition followed by H2O2 treatment extensively induced the level of intracellular reactive <compound-id="977">oxygen</compound-id> species (ROS) through activation of the components of NADPH oxidase, like <protein-id="O75935,P03304,P11691,P15961,P16342,P17593,P17594,P19751,P23169,P24102,P50629,P50630,P50631,P50632,P50633,P50634,P82796,Q05903,Q66198,Q8V439,Q8V6W7,Q91A29,Q9PYA3">p22</protein-id> (phox), <protein-id="O10300,P08567,P26642,P34051,Q12802,Q91375,Q9SZB9,Q9Y240">p47</protein-id> (phox), and <protein-id="Q924V1,Q9JHI8">Nox4</protein-id>.	oxygen__p47__interaction	oxygen__p22__interaction	oxygen__Nox4__interaction
18717628-2183	We conclude that mitochondrial dysfunction can induce <protein-id="O55042,P37377,P37840,P61138,P61139,P61140,P61141,P61142,P61143,P61144,P61145,P61146,P61147,Q3I5G7,Q3T0G8,Q91448">alpha-synuclein</protein-id> oligomerization via <compound-id="5957">ATP</compound-id> depletion-driven microtubule depolymerization and via ROS increase-driven protein oxidation.	ATP__alpha-synuclein__interaction
18717715-2195	Decreased expression of <protein-id="Q02563,Q9JIS5">synaptic vesicle protein 2A</protein-id>, the binding site for <compound-id="5284583">levetiracetam</compound-id>, during epileptogenesis and chronic epilepsy.	levetiracetam__synaptic vesicle protein 2A__interaction
18717715-2196	We previously showed that gene expression of <protein-id="Q02563,Q9JIS5">synaptic vesicle protein 2A</protein-id> (<protein-id="Q29397,Q4R4X3,Q5R4L9,Q7L0J3">SV2A</protein-id>), the binding site for the antiepileptic drug <compound-id="5284583">levetiracetam</compound-id>, is reduced during epileptogenesis in the rat.	levetiracetam__synaptic vesicle protein 2A__interaction	levetiracetam__SV2A__interaction
18718483-1342	The pharmacological profile of AL-38022A suggests that it could be a useful tool in defining <protein-id="O46635,P14842,P18599,P28223,P35363,P35382,P50128,P50129,Q5R4Q6,Q75Z89">5-HT2</protein-id> receptor signaling and receptor characterization where <compound-id="5202">5-HT</compound-id> may function as a neurotransmitter.	5-HT__5-HT2__interaction
18718549-2503	We also demonstrated that the deletion of the <protein-id="P20166,P37439,P42015,P47315,P57437,P69786,P69787,P69788,P75569,Q45298,Q46072,Q89AG6,Q8K9J0">ptsG</protein-id> gene doubled ATP-driven <compound-id="124886">glutathione</compound-id> synthesis and increased cellular ATP synthetic activity.	glutathione__ptsG__interaction
18718551-2505	Selenocystine induces caspase-independent apoptosis in MCF-7 human breast carcinoma cells with involvement of <protein-id="O09185,O12946,O57538,O93379,P02340,P04637,P10361,P19558,P19559,P56423,P56424,P61260,P79820,P79892,Q29537,Q42578,Q8SPZ3,Q92143,Q9TTA1,Q9TUB2,Q9W678,Q9W679">p53</protein-id> phosphorylation and reactive <compound-id="977">oxygen</compound-id> species generation.	oxygen__p53__no_interaction
18718551-2506	In the present study, we showed that selenocystine (SeC), a naturally occurring selenoamino acid, induced caspase-independent apoptosis in MCF-7 breast carcinoma cells, which was accompanied by poly(<protein-id="P02783">ADP</protein-id>-ribose) polymerase (<protein-id="O50017,P08469,P14043,P31669,P35875,P55057,Q08824,Q11208">PARP</protein-id>) cleavage, caspase activation, DNA fragmentation, <compound-id="445141,6323481,44147587">phosphatidylserine</compound-id> exposure and nuclear condensation.	phosphatidylserine__PARP__no_interaction	phosphatidylserine__ADP__no_interaction
18718551-2507	Silencing and attenuating of <protein-id="O09185,O12946,O57538,O93379,P02340,P04637,P10361,P19558,P19559,P56423,P56424,P61260,P79820,P79892,Q29537,Q42578,Q8SPZ3,Q92143,Q9TTA1,Q9TUB2,Q9W678,Q9W679">p53</protein-id> activation with RNA interference and <compound-id="4817">pifithrin-alpha</compound-id> treatment, respectively, partially suppressed SeC-induced cell apoptosis.	pifithrin-alpha__p53__interaction
18718660-2524	Activation of c-<protein-id="P05627,P17325,P18289">Jun</protein-id> N-terminal kinase is essential for oxidative stress-induced Jurkat cell apoptosis by <compound-id="25423">monochloramine</compound-id>.	monochloramine__Jun__interaction
18718660-2525	Within 10min of NH(2) <compound-id="312">Cl</compound-id> treatment, c-<protein-id="P05627,P17325,P18289">Jun</protein-id> N-terminal kinase (<protein-id="P92208,Q966Y3">JNK</protein-id>) activation and elevation of cytosolic <compound-id="271">Ca(2</compound-id>+) were observed.	Ca(2__JNK__no_interaction	Cl__JNK__interaction	Ca(2__Jun__no_interaction	Cl__Jun__interaction
18718713-2535	Induction in the activity of <protein-id="P06181,P11542,P11543,P20010,P20011,P20012,P20013,P21764,P31837,P31838,P49012,P50622">lignin peroxidase</protein-id> and <protein-id="P05982,P15559,Q5RD31,Q64669,Q8CHK7">azoreductase</protein-id> was observed during decolorization of <compound-id="6093247">Reactive Red 2</compound-id> in the batch culture, which represented their role in degradation.	Reactive Red 2__lignin peroxidase__interaction	Reactive Red 2__azoreductase__interaction
18718986-79	Inhibition of radiographic progression with combination <protein-id="P20333">etanercept</protein-id> and <compound-id="126941">methotrexate</compound-id> in patients with moderately active rheumatoid arthritis previously treated with monotherapy.	methotrexate__etanercept__no_interaction
18718986-80	To determine the effect of changing from <protein-id="P20333">etanercept</protein-id> or <compound-id="126941">methotrexate</compound-id> monotherapy to <protein-id="P20333">etanercept</protein-id> plus <compound-id="126941">methotrexate</compound-id> combination therapy on radiographic progression in rheumatoid arthritis (RA) patients.	methotrexate__etanercept__no_interaction
18719855-2110	Treatment with <compound-id="100017">nimbolide</compound-id> resulted in dose- and time-dependent inhibition of growth of BeWo cells with IC(50) values of 2.01 and 1.19 microM for 7 and 24 h respectively, accompanied by downregulation of <protein-id="O01377,O02115,O16852,O82134,O82797,P04961,P12004,P15873,P17070,P17917,P17918,P18248,P22177,P24314,P31008,P53358,P57761,P61074,P61258,Q00268,Q03392,Q43124,Q43266,Q6B6N4,Q9DDF1,Q9DEA3,Q9MAY3,Q9PTP1,Q9W644">proliferating cell nuclear antigen</protein-id>.	nimbolide__proliferating cell nuclear antigen__interaction
18719891-434	In all cases, the phenotype of SVQ524 was nearly overcome by the addition of <compound-id="876,6137">methionine</compound-id> or <compound-id="3034082,6713940,25243974">cobalamin</compound-id> to the plant growth media or by the presence of a copy of the <protein-id="P29930">cobO</protein-id> gene in cosmid pMUS756.	methionine__cobO__no_interaction	cobalamin__cobO__no_interaction
18719894-435	Ameliorating prefrontal cortical dysfunction in mental illness: inhibition of phosphotidyl <compound-id="892">inositol</compound-id>-<protein-id="P13678,Q25378">protein kinase C</protein-id> signaling.	inositol__protein kinase C__interaction
18719894-436	DISCUSSION: Recent genetic and biochemical studies have also linked these illnesses to disinhibition of phosphotidyl <compound-id="892">inositol</compound-id>-<protein-id="P13678,Q25378">protein kinase C</protein-id> signaling.	inositol__protein kinase C__interaction
18719894-437	Animal studies have shown that high levels of phosphotidyl <compound-id="892">inositol</compound-id>-<protein-id="P13678,Q25378">protein kinase C</protein-id> signaling in the PFC markedly impair PFC function at the behavioral and cellular levels.	inositol__protein kinase C__interaction
18719969-461	Obesity increases <protein-id="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7">insulin</protein-id> resistance and <compound-id="206,5793,64689,79025">glucose</compound-id> intolerance and also exacerbates metabolic abnormalities present in type 2 diabetes.	glucose__insulin__no_interaction
18720192-531	Inhibition of <protein-id="O08328,O66935,O84804,P05416,P0A6U8,P0A6U9,P0A6V0,P39125,P45179,P58395,Q21BQ1,Q221N9,Q255S3,Q28MN0,Q2A4U4,Q2G7S7,Q2IM81,Q2J308,Q2K485,Q2P9F6,Q2RH55,Q2RS50,Q2T6R2,Q2W5G0,Q2YB48,Q30Z13,Q31BS5,Q31IB5,Q31VJ4,Q32AV6,Q3A0B8,Q3AKK1,Q3APL6,Q3AVF9,Q3B6C3,Q3BYI1,Q3K1K2,Q3KD65,Q3KKP3,Q3SH79,Q3YW96,Q46LU1,Q47IJ4,Q48JG9,Q4KCP0,Q4QK70,Q4UZL8,Q4ZS46,Q57IU1,Q5DZC1,Q5FL65,Q5H6Q4,Q5L562,Q5N1P1,Q5NHN2,Q5NXZ7,Q5PM09,Q5SMC5,Q632H4,Q65FS7,Q65TI3,Q664I5,Q6CZK3,Q6HC18,Q6KHP2,Q6LKA1,Q6MAS9,Q6NCT7,Q729V4,Q72G68,Q72YJ6,Q73MC7,Q7MJ50,Q7NM37,Q7U7I2,Q7UPY2,Q7V275,Q7V8F0,Q7VBP0,Q7W6L5,Q7WIJ0,Q816G8,Q81K85,Q821W4,Q82SP3,Q83PV4,Q87QX5,Q880M9,Q88FN9,Q890I8,Q8CWX0,Q8DAR0,Q8DKU2,Q8DPS3,Q8E079,Q8E5V5,Q8ET54,Q8KAY6,Q8PDD2,Q8PQA3,Q8RF65,Q8XPA1,Q8XT73,Q8Z232,Q8ZA78,Q935Y7,Q97GX6,Q97QS5,Q985P2,Q9CHM9,Q9CN91,Q9EUT5,Q9I1V0,Q9KDX6,Q9KRB6,Q9PLC3,Q9RNH6,Q9RWS1,Q9WZZ7,Q9Z6V8">glycogen synthase</protein-id> kinase by <compound-id="969516">curcumin</compound-id> : Investigation by simulated molecular docking and subsequent in vitro/in vivo evaluation.	curcumin__glycogen synthase__interaction
18720192-532	The investigation included simulated docking experiments to fit <compound-id="969516">curcumin</compound-id> within the binding pocket of <protein-id="P18266,P49841,Q5YJC2,Q9WV60">GSK-3beta</protein-id> followed by experimental in vitro and in vivo validations.	curcumin__GSK-3beta__interaction
18720192-533	<compound-id="969516">Curcumin</compound-id> was found to optimally fit within the binding pocket of <protein-id="P18266,P49841,Q5YJC2,Q9WV60">GSK-3beta</protein-id> via several attractive interactions with key amino acids.	Curcumin__GSK-3beta__interaction
18720446-603	A sample preparation protocol applying a binary matrix-assisted laser desorption/ionization(MALDI) matrix containing alpha-cyano-4-hydroxy cinnamic acid (<compound-id="5328791">CHCA</compound-id>) and 2,5-dihydroxy <compound-id="243,167551">benzoic acid</compound-id> (<compound-id="9882105">DHB</compound-id>) on <compound-id="6422">trifluoro acetic acid</compound-id> (<protein-id="Q27203">TFA</protein-id>) etched latex glove surfaces allowed the direct determination (exact molecular weight) of <protein-id="P02877">Hevein</protein-id>, <protein-id="P15252,P45951">REF</protein-id> and a truncated form of <protein-id="P15252,P45951">REF</protein-id> (tREF) within nine different brands of natural latex gloves by means of MALDI-TOF-MS in the linear mode.	benzoic acid__REF__no_interaction	trifluoro acetic acid__REF__no_interaction	trifluoro acetic acid__Hevein__no_interaction	DHB__TFA__no_interaction	CHCA__REF__no_interaction	CHCA__Hevein__no_interaction	benzoic acid__Hevein__no_interaction	trifluoro acetic acid__TFA__no_interaction	CHCA__TFA__no_interaction	benzoic acid__TFA__no_interaction	DHB__REF__no_interaction	DHB__Hevein__no_interaction
18721130-774	Increased <compound-id="1153,6057,5460803">tyrosine</compound-id> phosphorylation of <protein-id="P31016,P78352,Q62108,Q6R005">PSD-95</protein-id> by <protein-id="P05480,Q9WUD9">Src</protein-id> family kinases after brain ischaemia.	tyrosine__Src__interaction	tyrosine__PSD-95__interaction
18721130-776	The present study demonstrates that brain ischaemia and reperfusion increase the <compound-id="1153,6057,5460803">tyrosine</compound-id> phosphorylation of <protein-id="P31016,P78352,Q62108,Q6R005">PSD-95</protein-id> in the rat hippocampus.	tyrosine__PSD-95__interaction
18721130-777	Thus the present study reveals an additional mechanism for the regulation of <protein-id="P31016,P78352,Q62108,Q6R005">PSD-95</protein-id> by <compound-id="1153,6057,5460803">tyrosine</compound-id> phosphorylation.	tyrosine__PSD-95__interaction
18721153-786	Pathological role of <protein-id="P14745,P16070,P20944,Q05078,Q28284,Q29423,Q60522">CD44</protein-id> on NKT cells in <compound-id="5943">carbon tetrachloride</compound-id>-mediated liver injury.	carbon tetrachloride__CD44__no_interaction
18721153-787	Methods: We injected <protein-id="P14745,P16070,P20944,Q05078,Q28284,Q29423,Q60522">CD44</protein-id> knock out (KO) or wild type mice with <compound-id="5943">carbon tetrachloride</compound-id> (CCl(4)) and examined the difference of liver injury by immunological or histological analysis.	carbon tetrachloride__CD44__no_interaction
18721245-809	Studies using 1-<compound-id="98112">methyl-tryptophan</compound-id> (<compound-id="98112">1-MT</compound-id>), the specific inhibitor of IDO, showed that this enzyme is important in <protein-id="Q9TTB0">interferon-gamma</protein-id> (<protein-id="O35497,O35735,O57571,O57603,O57608,O73915,O77763,P01579,P01580,P01581,P07353,P17773,P17803,P28333,P28341,P30123,P42160,P42161,P42162,P46402,P49708,P63309,P63310,P63311,P79154,Q1WM28,Q25BC0,Q2PE75,Q4ZH68,Q5CCK0,Q5I6S9,Q62574,Q647G2,Q7TSP4,Q865W6,Q865X1,Q865Y4,Q866Y6,Q8MKF5,Q8SPW9,Q9QXX2,Q9TTB0,Q9TV67,Q9YGB9">IFN-gamma</protein-id>)-dependent inhibition of allergic inflammation in the respiratory airway during immunotherapy.	methyl-tryptophan__interferon-gamma__no_interaction	1-MT__IFN-gamma__no_interaction	methyl-tryptophan__IFN-gamma__no_interaction	1-MT__interferon-gamma__no_interaction
18721829-966	We examined the substrates of cannabinoid-mediated inhibition of both the emetic phases via immunolabeling for <compound-id="5202">serotonin</compound-id>, <protein-id="P01289,P06767,P19850,P20366,P28498,P28499,P41333,P41539,P41540,P67932,P67933,Q60541">Substance P</protein-id>, <protein-id="O02777,P20272,P21554,P47746,P56971,Q333S9,Q5IS73,Q71SP5,Q801M1,Q9PUI7">cannabinoid receptors 1</protein-id> and 2 (CB(1), CB(2)), and the neuronal activation marker <protein-id="P01101,P12841,Q56415">Fos</protein-id> in the least shrew (Cryptotis parva).	serotonin__Fos__no_interaction	serotonin__Substance P__no_interaction	serotonin__cannabinoid receptors 1__no_interaction
18722097-1040	To observe the inhibitory effects of <protein-id="P11032,Q28178">TSP-1</protein-id> functional fragments, critical for <protein-id="P16671,P26201,P70110">CD36</protein-id> binding, on the activation of L-<protein-id="O19011,O93449,P01137,P04202,P07200,P09531,P09533,P16176,P17246,P18341,P50414,P54831,Q38HS2,Q9PTQ2,Q9Z1Y6">TGF-beta1</protein-id>, we isolated alveolar macrophages from Wistar rat lungs 7 days after <compound-id="456190,5360373,5460769">bleomycin</compound-id> administration (5mg/kg body weight) and cultured the cells with or without <protein-id="P11032,Q28178">TSP-1</protein-id> functional or control fragments.	bleomycin__CD36__no_interaction	bleomycin__TSP-1__no_interaction	bleomycin__TGF-beta1__no_interaction
18722104-1045	The pEREGFP9 vector was delivered to a single MCF-7 using a nanoneedle and the effect of <compound-id="104741">ICI 182,780</compound-id>, which is an antagonist of estrogen, was observed using the <protein-id="P42212">GFP</protein-id> expression level.	ICI 182,780__GFP__interaction
18722104-1046	By <compound-id="104741">ICI 182,780</compound-id> treatment, the fluorescence intensity of the <protein-id="P42212">GFP</protein-id> was decreased by 30-50% within 24h.	ICI 182,780__GFP__interaction
18722114-1051	Effect of different <protein-id="P07981,P07982,P07983,P10474,P10475,P10476,P13933,P15329,P15704,P16216,P17974,P18126,P18336,P19487,P21833,P21834,P22533,P22669,P22699,P23548,P23549,P23665,P27035,P29019,P37651,P37696,P45699,P46236,P46237,P46239,P58599,P58935,P81190,P82186,P84194,P84196,Q05622,Q12622,Q12714,Q8RSY9,Q8X5L9,Q8Z289,Q8ZLB7">cellulase</protein-id> dosages on cell viability and <compound-id="702">ethanol</compound-id> production by Kluyveromyces marxianus in SSF processes.	ethanol__cellulase__interaction
18722114-1052	This study was aimed to study the effect of commercial <protein-id="P07981,P07982,P07983,P10474,P10475,P10476,P13933,P15329,P15704,P16216,P17974,P18126,P18336,P19487,P21833,P21834,P22533,P22669,P22699,P23548,P23549,P23665,P27035,P29019,P37651,P37696,P45699,P46236,P46237,P46239,P58599,P58935,P81190,P82186,P84194,P84196,Q05622,Q12622,Q12714,Q8RSY9,Q8X5L9,Q8Z289,Q8ZLB7">cellulases</protein-id> (Celluclast 1.5 LFG) on Kluyveromyces marxianus CECT 10875 growth and <compound-id="702">ethanol</compound-id> production in SSF processes.	ethanol__cellulases__interaction
18722394-1736	We examined both basal and stress-induced <protein-id="P01189,P01190,P01191,P01192,P01193,P01194,P01196,P01197,P01201,P06297,P06298,P06299,P10000,P11280,P11885,P19402,P21252,P22923,P68000,P68001,P87352,Q04617,Q04618,Q91082,Q9YGK2,Q9YGK4,Q9YGK5">ACTH</protein-id> and <compound-id="5753">corticosterone</compound-id> (CORT) release in two stress contexts thought to differ in intensity: novel environment ('mild') and restraint ('intense').	corticosterone__ACTH__no_interaction
18722490-1167	<protein-id="O77220,P14944,P30814,P55845,P56687,P59685,P81032,P83800,Q25588,Q25589,Q25683,Q26181">Crustacean hyperglycemic hormone</protein-id> (<protein-id="O77220,P14944,P30814,P55845,P56687,P59685,P81032,P83800,Q25588,Q25589,Q25683,Q26181">CHH</protein-id>) not only plays an important role in the modulation of hemolymph <compound-id="206,5793,64689,79025">glucose</compound-id> level but also functions in other biological events including molting, reproduction and stress response.	glucose__CHH__interaction	glucose__Crustacean hyperglycemic hormone__interaction
18722763-1249	As a proof-of-concept, <protein-id="P81460,P81461">Concanavalin A</protein-id>-coated QDs (<protein-id="P02866,P14894,P81460,P81461">ConA</protein-id>-QDs) and <compound-id="4125253,5460037">dextran</compound-id>-coated AuNPs (Dex-AuNPs) were used to detect the mannosylated proteins.	dextran__Concanavalin A__no_interaction	dextran__ConA__no_interaction
18722763-1250	As a result, the PL intensity of QDs was found to be linearly correlated with the concentration and the number of <compound-id="871">glycan</compound-id> moiety of the <protein-id="P08163">glycoprotein</protein-id>.	glycan__glycoprotein__interaction
18723022-1306	We demonstrate for the first time that several developmental stages of the human parasite Schistosoma mansoni express <protein-id="O49046,P00812,P0A2X9,P0A2Y0,P0A2Y1,P14012,P33280,P37818,P39138,P40906,P46637,P53608,P60086,P60087,P60088,Q10066,Q12611,Q1E180,Q6G7E9,Q6GER3,Q74ZW4,Q7M0Z3,Q8NVE3">arginase</protein-id>, which is responsible for the hydrolysis of l-<compound-id="232,4367,6322">arginine</compound-id> to <compound-id="6262">l-ornithine</compound-id> and <compound-id="1176,265993">urea</compound-id>.	arginine__arginase__interaction	urea__arginase__interaction	l-ornithine__arginase__interaction
18723107-1332	To overcome this limitation we turned to the yeast Pichia stipitis, which naturally produces <compound-id="6912">xylitol</compound-id>, as a source of <protein-id="O75191,P09099,P12867,P21939,P26909,P27155,P27156,P29444,P35850,P39211,P42826,P44401,P54271,Q3MIF4,Q3SYZ6,Q3TNA1,Q5R830,Q9CFG8,Q9RK00">xylulokinase</protein-id> (Xyl3).	xylitol__xylulokinase__interaction
18723107-1333	We examined the effects of plasmid-based expression of Xyl3 versus <protein-id="O30360,P09099,P12867,P21939,P26909,P27155,P27156,P29444,P35850,P39211,P39849,P44401,P45982,P54271,Q5HL88,Q8CR47,Q9CFG8,Q9RK00">XylB</protein-id> on growth and <compound-id="6912">xylitol</compound-id> production by engineered E. coli strains.	xylitol__XylB__interaction
18723121-1340	Behavioral and biochemical responses including filtering rates, key phase I, II and antioxidant enzymes and levels of <protein-id="O02033,O13257,O18842,O42152,O93571,P02807,P04358,P07216,P08002,P23038,P25127,P25128,P30331,P30565,P51902,P52723,P52725,P52726,P52728,P55945,P55946,P55948,P55951,P55952,P55953,P68494,P68495,P68497,P68498,P68499,P80367,P80593,P84865,Q05890,Q6J1T3,Q6S4N8,Q6XUW5,Q708T3,Q7ZZP9,Q800D3,Q8UVY1,Q94550,Q9IB50,Q9U568">metallothioneins</protein-id>, <compound-id="124886">glutathione</compound-id>, lipid peroxidation and DNA strand breaks were determined in digestive glands of mussels after being exposed to sublethal levels of mercury chloride, methyl mercury, cadmium and Aroclor 1260 during 5 days.	glutathione__metallothioneins__no_interaction
18723336-870	In this study, a representative FRET system (<protein-id="P27918,Q5RBP8,Q64181">CFP</protein-id> donor and <protein-id="P21578">YFP</protein-id> acceptor) is compared with the BRET(2) system (Renilla <protein-id="P08659,P13129,Q01158,Q26304,Q27757">luciferase</protein-id> donor, <protein-id="P42212">green fluorescent protein</protein-id> (2) (<protein-id="P42212">GFP</protein-id> (2)) acceptor and <compound-id="22832089">coelenterazine 400a</compound-id> substrate).	coelenterazine 400a__CFP__no_interaction	coelenterazine 400a__GFP__interaction	coelenterazine 400a__luciferase__interaction	coelenterazine 400a__YFP__no_interaction	coelenterazine 400a__green fluorescent protein__interaction
18723342-981	If no pretreatment applied, hydrolyses of the textiles by <protein-id="P07981,P07982,P07983,P10474,P10475,P10476,P13933,P15329,P15704,P16216,P17974,P18126,P18336,P19487,P21833,P21834,P22533,P22669,P22699,P23548,P23549,P23665,P27035,P29019,P37651,P37696,P45699,P46236,P46237,P46239,P58599,P58935,P81190,P82186,P84194,P84196,Q05622,Q12622,Q12714,Q8RSY9,Q8X5L9,Q8Z289,Q8ZLB7">cellulase</protein-id> and <protein-id="P12614,P15885,P27034,P29091,P40740,Q03506,Q46684">beta-glucosidase</protein-id> for 24 h followed by simultaneous saccharification and fermentation (SSF) in 4 days, resulted in 0.140-0.145 g <compound-id="702">ethanol</compound-id>/g textiles, which was 25-26% of the corresponding theoretical yield.	ethanol__beta-glucosidase__interaction	ethanol__cellulase__interaction
18723440-1394	In cystic fibrosis, this equilibrium is disrupted by mutations in the <protein-id="P13569,P26361,P26362,P26363,P34158,P35071,Q00552,Q00553,Q00554,Q00555,Q07DV2,Q07DW5,Q07DX5,Q07DY5,Q07DZ6,Q07E16,Q07E42,Q09YH0,Q09YJ4,Q09YK5,Q108U0,Q2IBA1,Q2IBB3,Q2IBE4,Q2IBF6,Q2QL74,Q2QL83,Q2QLA3,Q2QLB4,Q2QLC5,Q2QLE5,Q2QLF9,Q2QLH0,Q5D1Z7,Q5U820,Q6PQZ2,Q7JII7,Q7JII8,Q9TSP5,Q9TUQ2">cystic fibrosis transmembrane conductance regulator</protein-id> (<protein-id="P13569,P26361,P26362,P26363,P34158,P35071,Q00552,Q00553,Q00554,Q00555,Q07DV2,Q07DW5,Q07DX5,Q07DY5,Q07DZ6,Q07E16,Q07E42,Q09YH0,Q09YJ4,Q09YK5,Q108U0,Q2IBA1,Q2IBB3,Q2IBE4,Q2IBF6,Q2QL74,Q2QL83,Q2QLA3,Q2QLB4,Q2QLC5,Q2QLE5,Q2QLF9,Q2QLH0,Q5D1Z7,Q5U820,Q6PQZ2,Q7JII7,Q7JII8,Q9TSP5,Q9TUQ2">CFTR</protein-id>) gene resulting in the absence of functional <protein-id="P13569,P26361,P26362,P26363,P34158,P35071,Q00552,Q00553,Q00554,Q00555,Q07DV2,Q07DW5,Q07DX5,Q07DY5,Q07DZ6,Q07E16,Q07E42,Q09YH0,Q09YJ4,Q09YK5,Q108U0,Q2IBA1,Q2IBB3,Q2IBE4,Q2IBF6,Q2QL74,Q2QL83,Q2QLA3,Q2QLB4,Q2QLC5,Q2QLE5,Q2QLF9,Q2QLH0,Q5D1Z7,Q5U820,Q6PQZ2,Q7JII7,Q7JII8,Q9TSP5,Q9TUQ2">CFTR</protein-id> protein, which in turn results in deficient <compound-id="6076">cAMP</compound-id>-dependent <compound-id="312">Cl</compound-id> (-) secretion and predominant <compound-id="923,373840">Na</compound-id> (+) absorption.	Na__CFTR__interaction	cAMP__CFTR__interaction	Na__cystic fibrosis transmembrane conductance regulator__interaction	cAMP__cystic fibrosis transmembrane conductance regulator__interaction	Cl__CFTR__interaction	Cl__cystic fibrosis transmembrane conductance regulator__interaction
18723471-1399	Two patients presented a heterozygous T-to-G transversion in exon 2 (c.518T&gt;G) of the <protein-id="Q8NFJ6,Q8SPN1">PROKR2</protein-id>, which results in a <compound-id="857,6106,439524">leucine</compound-id>-to-<compound-id="232,4367,6322">arginine</compound-id> substitution at codon 173.	arginine__PROKR2__interaction	leucine__PROKR2__interaction
18723570-1420	<compound-id="446541">Mycophenolic acid</compound-id> inhibits the autocrine PDGF-B synthesis and PDGF-BB-induced mRNA expression of <protein-id="P08046">Egr-1</protein-id> in rat mesangial cells.	Mycophenolic acid__Egr-1__interaction
18723579-1422	<protein-id="P01015,P01016,P01017,P01019,P11859,P20757,P67885,P67886,Q9GLN8,Q9GLP6,Q9TSZ0">Angiotensin II</protein-id> (<protein-id="P01015,P01016,P01017,P01019,P11859,P20757,P67885,P67886,Q9GLN8,Q9GLP6,Q9TSZ0">AngII</protein-id>) stimulation of water and <compound-id="5234">NaCl</compound-id> intake is a classic model of the behavioural effects of hormones.	NaCl__AngII__interaction	NaCl__Angiotensin II__interaction
18723579-1423	Previous studies support the hypotheses that <protein-id="P05130,P13677,P13678,P34722">PKC</protein-id> is involved in AngII-induced water, but not <compound-id="5234">NaCl</compound-id> intake and that MAP kinase plays a role in <compound-id="5234">NaCl</compound-id> consumption, but not water intake, after injection of AngII.	NaCl__PKC__no_interaction
18723579-1424	Pretreatment with the PKC inhibitor <compound-id="2703,411938">chelerythrine</compound-id> attenuated <protein-id="P01015,P01016,P01017,P01019,P11859,P20757,P67885,P67886,Q9GLN8,Q9GLP6,Q9TSZ0">AngII</protein-id>-induced water intake, but <compound-id="5234">NaCl</compound-id> intake was unaffected.	NaCl__AngII__interaction	chelerythrine__AngII__interaction
18723579-1425	In contrast, pretreatment with U0126, a MAP kinase inhibitor, had no effect on <protein-id="P01015,P01016,P01017,P01019,P11859,P20757,P67885,P67886,Q9GLN8,Q9GLP6,Q9TSZ0">AngII</protein-id>-induced water intake, but attenuated <compound-id="5234">NaCl</compound-id> intake.	NaCl__AngII__interaction
18723580-1427	<compound-id="5957">Adenosine triphosphate</compound-id>, <protein-id="P30880,P30881,P31888">calcitonin gene-related peptide</protein-id> and <protein-id="P01289,P06767,P19850,P20366,P28498,P28499,P41333,P41539,P41540,P67932,P67933,Q60541">substance P</protein-id> coexist in some sensory-motor nerves.	Adenosine triphosphate__calcitonin gene-related peptide__no_interaction	Adenosine triphosphate__substance P__no_interaction
18723580-1428	Three cotransmitters are involved, namely ATP, <compound-id="145068">nitric oxide</compound-id> and <protein-id="P01282,P01283,P01284,P04566,P09684,P09685,P32648,P32649,P39089,P45644,P48142,P48143,P63289,P63290,P63291,P81016,P81401,P84488,P84771,P84772">vasoactive intestinal polypeptide</protein-id>.	nitric oxide__vasoactive intestinal polypeptide__no_interaction
18724397-1741	The prevalence rates of elevated blood pressure and hypertriglyceridemia were significantly higher among HCT recipients than among controls, but the prevalence rates of abdominal obesity, elevated blood <compound-id="206,5793,64689,79025">glucose</compound-id> and low <protein-id="P81182">high-density lipoprotein</protein-id> <compound-id="304,5997,6432564,11025495">cholesterol</compound-id> were not.	glucose__high-density lipoprotein__no_interaction	cholesterol__high-density lipoprotein__interaction
18725236-2014	Specific neurochemical elements in these structures include not only decreases in reward neurotransmission, such as decreases in <compound-id="681">dopamine</compound-id> and opioid peptide function in the ventral striatum, but also recruitment of brain stress systems, such as <protein-id="P01142,P01143,P06296,P06850,P49188,P49926,Q8CIT0,Q95MI6,Q9PTS1">corticotropin-releasing factor</protein-id> (<protein-id="O75973,P01142,P01143,P06296,P06850,P49188,P49926,Q8CIT0,Q95MI6,Q9PTS1">CRF</protein-id>), in the extended amygdala.	dopamine__CRF__interaction	dopamine__corticotropin-releasing factor__interaction
18726068-972	Neither enzymatic activity of transaminases (<protein-id="P0AE37,P0AE38,P80357,P80358,Q0TH83,Q1C8B0,Q1RB46,Q321N9,Q32G89,Q3Z294,Q5PHB9,Q66B20,Q7N2G8,Q83L52,Q8FH00,Q8Z6G0,Q8ZPV1,Q9NRA2,Q9ZC67">AST</protein-id> and ALT) nor <compound-id="1176,265993">urea</compound-id> levels were significantly altered.	urea__AST__no_interaction
18726117-2302	On other hand, <protein-id="P00533,P13387,P55245">EGFR</protein-id> gene mutations at kinase domain in non-small cell lung cancer (NSCLC) have been examined for their ability to predict sensitivity to <compound-id="123631">gefitinib</compound-id> or <compound-id="176870">erlotinib</compound-id>.	gefitinib__EGFR__interaction	erlotinib__EGFR__interaction
18726675-2476	Although the TO2 hamster heart exhibits normal function at 1 month of age (presymptomatic stage), elevated levels of myeloperoxidase, <protein-id="P10148,P13500,P14844,P28292,P42831,P52203,P61274,P61275,Q08782,Q9TTQ3">monocyte chemotactic protein-1</protein-id>, <compound-id="10964">malondialdehyde</compound-id>, osteopontin, and <protein-id="O60109,P81800,P83456">alkaline phosphatase</protein-id> were evident, indicating the presence of inflammation, oxidative stress, and osteogenic phenotype.	malondialdehyde__alkaline phosphatase__no_interaction	malondialdehyde__monocyte chemotactic protein-1__no_interaction
18726677-2477	Transitions in the <compound-id="1148,6305,9060,5460840">tryptophan</compound-id> microenvironment and secondary structure of two monocot <protein-id="P02871,P02873,P02874,P02875,P07386,P16108,P16349,P16351,P16352,P33888,P38662,P42088,P83410,P83511,P84987,Q41114">lectins</protein-id> from Sauromatum guttatum and Arisaema tortuosum under different denaturing conditions were studied by steady state and time resolved fluorescence and CD spectroscopy.	tryptophan__lectins__interaction
18726677-2478	The <protein-id="P02871,P02873,P02874,P02875,P07386,P16108,P16349,P16351,P16352,P33888,P38662,P42088,P83410,P83511,P84987,Q41114">lectins</protein-id> exist as tetramers with a single <compound-id="1148,6305,9060,5460840">tryptophan</compound-id> residue estimated per monomer, present in a polar environment.	tryptophan__lectins__interaction
18726677-2479	Similarly, both the <protein-id="P02871,P02873,P02874,P02875,P07386,P16108,P16349,P16351,P16352,P33888,P38662,P42088,P83410,P83511,P84987,Q41114">lectins</protein-id> showed a drastic loss of secondary structure in 5 M <compound-id="97535">Gdn</compound-id>-<compound-id="313">HCl</compound-id> or 6 M <compound-id="1176,265993">Urea</compound-id> or at pH 2.0 and below.	HCl__lectins__interaction	Urea__lectins__interaction	Gdn__lectins__interaction
18726687-2490	In order to determine the possible effects of hemolysate on brain microvascular endothelial cells (BMECs), we examined the effects of hemolysate on the expression of intercellular adhesion molecule-1 (<protein-id="P05362,P13597,P33729,Q00238,Q28806,Q5NKV4,Q5NKV6,Q5NKV9,Q95132">ICAM-1</protein-id>) and <protein-id="P10148,P13500,P14844,P28292,P42831,P52203,P61274,P61275,Q08782,Q9TTQ3">monocyte chemoattractant protein-1</protein-id> (<protein-id="P10148,P13500,P14844,P28291,P28292,P42831,P52203,P61274,P61275,Q08782,Q9TTQ3">MCP-1</protein-id>), generation of reactive <compound-id="977">oxygen</compound-id> species (ROS), and NF-kappaB activation in rat BMECs.	oxygen__monocyte chemoattractant protein-1__no_interaction	oxygen__ICAM-1__no_interaction	oxygen__MCP-1__no_interaction
18726998-19	We examined <compound-id="5280453">1,25 dihydroxyvitamin D</compound-id> (1,25(OH)(2)D(3))-induced expression of 25-hydroxyvitamin D(3) 24-hydroxylase (<protein-id="Q07973">CYP24</protein-id>) and apical calcium channel (<protein-id="Q9H1D0">TRPV6</protein-id>) mRNA levels in 2-, 9-, and 15-day cultures Caco-2 cells that model proliferating, post-proliferative, and differentiated enterocytes.	1,25 dihydroxyvitamin D__TRPV6__interaction	1,25 dihydroxyvitamin D__CYP24__interaction
18727009-26	Here, we tested the hypothesis that interactions with <protein-id="P38086">DNA-topoisomerases</protein-id> play a role in the DNA-damaging properties of <compound-id="5359485">AOH</compound-id>.	AOH__DNA-topoisomerases__interaction
18727009-27	Next, we selected <compound-id="5359485">AOH</compound-id> as the most DNA-damaging Alternaria metabolite for further studies of interactions with <protein-id="P38086">DNA topoisomerases</protein-id>.	AOH__DNA topoisomerases__interaction
18727009-28	Stabilisation of covalent <protein-id="O29238,O51934,O58530,O67037,O67226,P74759,P95479,Q08582,Q58907,Q6F598,Q8R979,Q8ZXT5,Q971T7,Q975P6,Q97ZF5,Q97ZZ8,Q9UZ86,Q9YC75,Q9YCB6">topoisomerase</protein-id> II-DNA intermediates by <compound-id="5359485">AOH</compound-id> was also detectable in cell culture, and here, the IIalpha isoform was preferentially targeted.	AOH__topoisomerase__interaction
18727113-70	Bone formation and maturation processes were evaluated by double staining for <protein-id="O60109,P81800,P83456">alkaline phosphatase</protein-id> and tartrate-resistant acid <protein-id="P06961,P45269,Q57JQ5,Q5E2K7,Q5F8K9,Q5P3T0,Q5PC82,Q5WT58,Q5X1E5,Q5ZRX9,Q60CQ4,Q62EU1,Q63YC3,Q65Q41,Q665U9,Q6D160,Q6FA38,Q6LV05,Q7M7K5,Q7MAZ9,Q7MBF4,Q821A6,Q82U82,Q87DS9,Q87SK9,Q88A53,Q88QU2,Q8CWL6,Q8CXX6,Q8P5D4,Q8PPG9,Q8XBL4,Q8Y395,Q8Z3M9,Q8ZI64,Q8ZLY4,Q9CP21,Q9I5V3,Q9JUB2,Q9JZ88,Q9KPC6,Q9L7A3,Q9PDL7">phosphatase</protein-id>, immunohistochemistry for bone <protein-id="O12705,O18559,O57299,O89341,P03314,P03344,P03419,P03426,P03519,P04876,P04888,P05769,P06157,P06166,P06446,P06502,P06503,P06935,P06942,P06943,P07564,P07720,P07873,P08325,P08671,P09732,P09866,P11206,P12446,P12823,P13616,P13844,P14335,P14336,P14340,P14403,P15200,P16287,P16628,P16629,P17748,P17763,P18356,P18611,P19110,P19692,P19718,P22046,P22338,P24266,P24615,P25058,P25182,P25223,P25224,P26034,P27019,P27020,P27287,P27395,P27663,P27910,P27912,P27913,P27915,P29165,P29837,P29838,P29983,P29984,P29990,P29991,P30026,P31035,P31620,P32886,P33478,P33482,P33515,P35947,P35976,P36355,P36356,P41358,P52637,P62683,P62684,P62685,P62689,P62690,P63117,P63126,P63128,P63130,P63145,P87577,P87889,Q01299,Q01427,Q04538,Q074N0,Q1X880,Q1X881,Q66112,Q6DV88,Q6J3P1,Q7LDI9,Q84131,Q88266,Q88428,Q89277,Q91B74,Q96PI4,Q98803,Q9HDB9,Q9IK90,Q9JAF2,Q9NRZ4,Q9UKH8,Q9YNA8,Q9YRV3">matrix proteins</protein-id>, vital staining with <compound-id="65079">calcein</compound-id>, and elemental mapping with an electron probe microanalyzer.	calcein__phosphatase__no_interaction	calcein__matrix proteins__no_interaction	calcein__alkaline phosphatase__no_interaction
18728222-493	Phosphorylation of <protein-id="Q28516">insulin receptor</protein-id> substrate (<protein-id="P41252,Q8BU30,Q9XTN2">IRS</protein-id>) proteins on <compound-id="5951">serine</compound-id> residues has emerged as a key step in these control processes under both physiological and pathological conditions.	serine__IRS__interaction	serine__insulin receptor__interaction
18728345-519	In contrast, <protein-id="Q14703,Q9WTZ2,Q9WTZ3,Q9Z2A8">SKI-1</protein-id> (<protein-id="Q14703,Q9Z2A8">S1P</protein-id> or site-1) is a membrane-bound <protein-id="P83290">serine protease</protein-id> inhibitable by <compound-id="1701">AEBSF</compound-id>.	AEBSF__S1P__interaction	AEBSF__SKI-1__interaction	AEBSF__serine protease__no_interaction
18728347-520	The progressive ankylosis gene (<protein-id="P58366,Q9JHZ2">ank</protein-id>) is a <protein-id="O12164,O41803,O42043,O56861,O70902,O71037,O89292,O91086,P03374,P03375,P03377,P03378,P03379,P03380,P03381,P03383,P03384,P03385,P03386,P03387,P03388,P03390,P03391,P03392,P03396,P03397,P03398,P03399,P04027,P04502,P04577,P04578,P04579,P04580,P04581,P04582,P04583,P04624,P05877,P05878,P05879,P05880,P05881,P05882,P05883,P05884,P05885,P05886,P06445,P06751,P06752,P07575,P08359,P08360,P08810,P0C212,P10259,P10267,P10269,P11261,P11267,P11268,P11306,P12449,P12487,P12488,P12489,P12492,P14075,P14351,P15073,P15831,P16082,P16090,P16899,P17281,P17755,P18040,P18094,P18799,P19030,P19503,P19549,P19550,P19551,P19556,P19557,P20871,P20872,P20888,P21412,P21415,P21436,P21443,P21445,P22380,P22427,P22428,P22429,P22430,P23064,P23073,P23422,P23423,P24105,P25057,P25504,P25505,P25506,P25507,P26803,P26804,P27399,P27757,P27977,P31621,P31626,P31627,P31789,P31791,P31794,P31796,P31819,P31872,P32536,P32541,P33498,P35954,P35961,P51515,P51519,P51520,P60507,P60508,P61550,P61552,P61553,P61554,P61555,P61556,P61557,P61558,P61559,P61561,P61562,P61563,P61564,P61565,P61566,P61567,P61570,Q02076,Q02077,Q02282,Q02837,Q03804,Q03816,Q03817,Q04993,Q04995,Q05312,Q09SZ7,Q0R5Q9,Q14264,Q1A243,Q1A261,Q69384,Q70626,Q73372,Q74126,Q75008,Q76638,Q77377,Q79670,Q85646,Q89607,Q8AIH5,Q8MIB6,Q902F8,Q902F9,Q96L62,Q9IDV2,Q9N2J8,Q9N2J9,Q9N2K0,Q9NX77,Q9Q714,Q9QBY2,Q9QBZ0,Q9QBZ4,Q9QBZ8,Q9QSQ7,Q9TTC0,Q9UKH3,Q9UQF0,Q9WC60,Q9WC69">transmembrane protein</protein-id> that transports intracellular <compound-id="644102">pyrophosphate</compound-id> to the extracellular milieu.	pyrophosphate__ank__interaction	pyrophosphate__transmembrane protein__no_interaction
18728678-624	<protein-id="Q8JFG3">Tumor necrosis factor</protein-id> receptor-1 is essential for LPS-induced sensitization and tolerance to <compound-id="977">oxygen</compound-id>-<compound-id="206,5793,64689,79025">glucose</compound-id> deprivation in murine neonatal organotypic hippocampal slices.	oxygen__Tumor necrosis factor__interaction	glucose__Tumor necrosis factor__interaction
18728678-625	The role of <protein-id="Q8JFG3">tumor necrosis factor</protein-id> (<protein-id="O35734,O77510,O77764,P01375,P04924,P13296,P19101,P23383,P23563,P29553,P33620,P36939,P48094,P51435,P51742,P51743,P59684,P59693,P59694,P59695,P79337,P79374,Q06599,Q19LH4,Q1G1A2,Q1WM27,Q2MH05,Q539C2,Q75N23,Q8HZD9,Q8JFG3,Q8MKG8,Q8WNR1,Q9BEA1">TNF</protein-id>) receptors 1 and 2 in <compound-id="11970143">lipopolysaccharide</compound-id> (LPS)-induced sensitization and tolerance to <compound-id="977">oxygen</compound-id>-<compound-id="206,5793,64689,79025">glucose</compound-id> deprivation (OGD) was evaluated in neonatal murine hippocampal organotypic slices.	glucose__tumor necrosis factor__interaction	oxygen__tumor necrosis factor__interaction	lipopolysaccharide__TNF__interaction	oxygen__TNF__interaction	glucose__TNF__interaction	lipopolysaccharide__tumor necrosis factor__interaction
18729103-711	The immunoblot, ELISA and EMSA analysis demonstrated that the treatment of HCT116 cells with <compound-id="128853">delphinidin</compound-id> resulted in the inhibition of (i) <protein-id="O15111,Q60680">IKKalpha</protein-id>, (ii) phosphorylation and degradation of <protein-id="P25963,Q08353,Q63746,Q91974,Q9Z1E3">IkappaBalpha</protein-id>, (iii) phosphorylation of NF-kappaB/<protein-id="P16342,P19751,P21521,P21579,P21707,P41823,P46096,P47191,P48018,P53663,P54963,Q42920,Q49539,Q66198,Q8V439,Q8V6W7,Q91A29,Q9FJR1,Q9PYA3">p65</protein-id> at Ser (536), (iv) nuclear translocation of NF-kappaB/<protein-id="P16342,P19751,P21521,P21579,P21707,P41823,P46096,P47191,P48018,P53663,P54963,Q42920,Q49539,Q66198,Q8V439,Q8V6W7,Q91A29,Q9FJR1,Q9PYA3">p65</protein-id>, (v) NF-kappaB/<protein-id="P16342,P19751,P21521,P21579,P21707,P41823,P46096,P47191,P48018,P53663,P54963,Q42920,Q49539,Q66198,Q8V439,Q8V6W7,Q91A29,Q9FJR1,Q9PYA3">p65</protein-id> DNA binding activity, and (vi) transcriptional activation of NF-kappaB.	delphinidin__p65__interaction	delphinidin__IKKalpha__interaction	delphinidin__IkappaBalpha__interaction
18729824-936	Accommodation of <compound-id="5983,14107712">physostigmine</compound-id> and its analogues by <protein-id="Q867X2,Q867X3,Q86GC9,Q92081">acetylcholinesterase</protein-id> is dominated by hydrophobic interactions.	physostigmine__acetylcholinesterase__interaction
18729824-937	The role of the functional architecture of the HuAChE (human <protein-id="Q867X2,Q867X3,Q86GC9,Q92081">acetylcholinesterase</protein-id>) in reactivity toward the carbamates <compound-id="4991">pyridostigmine</compound-id>, <compound-id="77991">rivastigmine</compound-id> and several analogues of <compound-id="5983,14107712">physostigmine</compound-id>, that are currently used or considered for use as drugs for Alzheimer's disease, was analysed using over 20 mutants of residues that constitute the interaction subsites in the active centre.	rivastigmine__acetylcholinesterase__interaction	physostigmine__acetylcholinesterase__interaction	pyridostigmine__acetylcholinesterase__interaction
18751681-68	Cells were grown for 24 h with <compound-id="1983">APAP</compound-id> in the presence or absence of 4-methylpyrazole (4MP), <compound-id="550788">L-arginine methyl ester</compound-id> (L-NAME), <protein-id="O50258">superoxide dismutase</protein-id> (<protein-id="O12933,O22668,O75007,P24705,P51547,P93258,Q01137,Q27666,Q9SM64">SOD</protein-id>), or <compound-id="23950">ruthenium</compound-id> red (<compound-id="4971">RuR</compound-id>).	ruthenium__superoxide dismutase__no_interaction	ruthenium__SOD__no_interaction	RuR__superoxide dismutase__no_interaction	L-arginine methyl ester__SOD__no_interaction	RuR__SOD__no_interaction	APAP__superoxide dismutase__no_interaction	L-arginine methyl ester__superoxide dismutase__no_interaction	APAP__SOD__no_interaction
18751889-128	Synaptic vesicle-bound <protein-id="O05118,O06134,O08309,O44006,O51323,O62619,O94122,P19680,P22360,P30614,P31865,P32044,P34038,P43924,P46614,P47458,P51181,P51182,P57404,P70789,P78031,P80885,P81344,P94685,P94939,Q02499,Q04668,Q07637,Q10208,Q12669,Q27686,Q27788,Q44473,Q46078,Q46289,Q56301,Q57572,Q6BS75,Q759A9,Q7RVA8,Q875M9,Q875S4,Q875Z9,Q89AI8,Q8FP04,Q8K9M3,Q9PK61,Q9Z984">pyruvate kinase</protein-id> can support vesicular <compound-id="611,23327,33032">glutamate</compound-id> uptake.	glutamate__pyruvate kinase__interaction
18751889-129	We present evidence that ATP generated by synaptic vesicle-associated <protein-id="O05118,O06134,O08309,O44006,O51323,O62619,O94122,P19680,P22360,P30614,P31865,P32044,P34038,P43924,P46614,P47458,P51181,P51182,P57404,P70789,P78031,P80885,P81344,P94685,P94939,Q02499,Q04668,Q07637,Q10208,Q12669,Q27686,Q27788,Q44473,Q46078,Q46289,Q56301,Q57572,Q6BS75,Q759A9,Q7RVA8,Q875M9,Q875S4,Q875Z9,Q89AI8,Q8FP04,Q8K9M3,Q9PK61,Q9Z984">pyruvate kinase</protein-id> is harnessed to transport <compound-id="611,23327,33032">glutamate</compound-id> into synaptic vesicles.	glutamate__pyruvate kinase__no_interaction
18751891-135	We examined the expression of <protein-id="O08651,Q61753">Phgdh</protein-id> and <protein-id="O35874,P43007">ASCT1</protein-id> in <compound-id="10255">kainic acid</compound-id> (KA)-induced neurodegeneration of the mouse hippocampus using immunohistochemistry and Western blots.	kainic acid__Phgdh__interaction	kainic acid__ASCT1__interaction
18751892-136	In the present study the effect of the convulsant drug <compound-id="6514">3-mercaptopropionic acid</compound-id> (MP) repetitive administration (4-7 days) on the hippocampal <protein-id="Q00960,Q01097,Q13224">NR2B</protein-id> subunit was studied.	3-mercaptopropionic acid__NR2B__no_interaction
18751892-137	A significant decrease in <protein-id="Q00960,Q01097,Q13224">NR2B</protein-id> in the whole hippocampus was observed after MP4 with a tendency to recover to normal values in <compound-id="49766501">MP7</compound-id> by western blot assay.	MP7__NR2B__interaction
18751894-139	Heart glycogen represents a store of glucosyl residues which are mobilized by the catalysis of <protein-id="O66932,O84250,P06738,P0AC86,P0AC87,P39123,P45180,P73511,Q10639,Q7U078,Q9CN90,Q9PKE6,Q9XTL9,Q9Z8N1">glycogen phosphorylase</protein-id> (GP) and are mainly destined to serve as substrates for the generation of <compound-id="5957">ATP</compound-id>.	ATP__glycogen phosphorylase__no_interaction
18752001-187	However, <compound-id="8249">phenformin</compound-id> was equally effective in AMPKalpha1(-/-) and wild-type animals, suggesting additional <protein-id="P54646,Q09136,Q9Y478">AMPK</protein-id>-independent action of <compound-id="8249">phenformin</compound-id>.	phenformin__AMPK__no_interaction
18752070-205	The relationship between <protein-id="P10765,P22393,P33089,P33090,P33091,P43001">prolactin</protein-id> (<protein-id="O62781,O62819,O93337,P01236,P01237,P01238,P01239,P01240,P06879,P09585,P10765,P12420,P14676,P17572,P21993,P22393,P29234,P29235,P33089,P33090,P33091,P33096,P34181,P35395,P37884,P40424,P43001,P43299,P46403,P48096,P48249,P51904,P55151,P87495,Q28318,Q28632,Q3Y4G6,Q6UC74,Q7ZZV3,Q8HXS1,Q9QZL1,Q9YGV6">PRL</protein-id>), <protein-id="O02750,O93416,Q28603,Q95189,Q95234">leptin</protein-id>, <compound-id="145068">nitric oxide</compound-id> (NO), and cytokines in patients with hyperprolactinemia.	nitric oxide__PRL__interaction	nitric oxide__prolactin__interaction	nitric oxide__leptin__interaction
18752070-206	The aim of this study was to determine the changes in serum <protein-id="O02750,O93416,Q28603,Q95189,Q95234">leptin</protein-id>, <protein-id="Q8JFG3">tumor necrosis factor</protein-id>-alpha (<protein-id="O35734,O77510,O77764,P01375,P04924,P06804,P13296,P16599,P19101,P23383,P23563,P29553,P33620,P36939,P48094,P51435,P51742,P51743,P59684,P59693,P59694,P59695,P79337,P79374,Q06599,Q19LH4,Q1G1A2,Q1WM27,Q2MH05,Q539C2,Q75N23,Q8HZD9,Q8JFG3,Q8MKG8,Q8WNR1,Q9BEA1">TNF-alpha</protein-id>), <protein-id="P41693">interleukin-6</protein-id> (<protein-id="O35736,P05231,P08505,P20607,P26892,P26893,P29455,P41323,P41683,P41693,P46650,P51494,P79341,Q25BC2,Q28319,Q28747,Q28819,Q2MH06,Q5I6E3,Q6V919,Q865W7,Q865X6,Q8MKH0,Q95181,Q9MZR1,Q9XT80">IL-6</protein-id>), <compound-id="145068">nitric oxide</compound-id> (NO) levels in patients with hyperprolactinemia.	nitric oxide__leptin__no_interaction	nitric oxide__IL-6__no_interaction	nitric oxide__tumor necrosis factor__no_interaction	nitric oxide__TNF-alpha__no_interaction	nitric oxide__interleukin-6__no_interaction
18752089-210	Joint analysis of individual participants' data from 17 studies on the association of the <protein-id="O35736,P05231,P26892,P26893,P29455,P41323,P41683,P41693,P46650,P51494,P79341,Q25BC2,Q28319,Q28747,Q28819,Q2MH06,Q5I6E3,Q6V919,Q865W7,Q865X6,Q8MKH0,Q95181,Q9MZR1,Q9XT80">IL6</protein-id> variant-174G&gt;C with circulating <compound-id="206,5793,64689,79025">glucose</compound-id> levels, <protein-id="P41693">interleukin-6</protein-id> levels, and body mass index.	glucose__interleukin-6__no_interaction	glucose__IL6__no_interaction
18752284-283	Effect of <protein-id="P20815,P80056">cytochrome P450 3A5</protein-id> *3 genotype on the stereoselective pharmacokinetics of <compound-id="2162">amlodipine</compound-id> in healthy subjects.	amlodipine__cytochrome P450 3A5__interaction
18752284-286	In conclusion, the present study showed that despite the evidence that <compound-id="2162">amlodipine</compound-id> is stereoselectively metabolized, <protein-id="P20815">CYP3A5</protein-id> *3 genotype did not affect stereoselective disposition of <compound-id="2162">amlodipine</compound-id>.	amlodipine__CYP3A5__no_interaction
18752284-287	It provides the evidence that <protein-id="P20815">CYP3A5</protein-id> *3genotype plays a minor role in the interindividual variability of stereoselective disposition of <compound-id="2162">amlodipine</compound-id> in humans.	amlodipine__CYP3A5__interaction
18752291-293	Tissues were stained for <compound-id="6035">BrdU</compound-id>, <protein-id="P47239">Pax-7</protein-id>, <protein-id="P02543,P02544,P08670,P09654,P20152,P31000,P48616,P48670,P48674,P84198,Q4R4X4,Q5R1W8,Q92155,Q9MZA9">vimentin</protein-id>, and <compound-id="442514">haematoxylin</compound-id> and eosin staining.	haematoxylin__Pax-7__no_interaction	BrdU__Pax-7__no_interaction	BrdU__vimentin__no_interaction	haematoxylin__vimentin__no_interaction
18752295-295	Differences in the expression of inwardly rectifying potassium channels (<protein-id="P49655">Kir4.1</protein-id>), glial fibrillary <protein-id="P01538,P01543,P01544,P01545,P08772,P08943,P09617,P09618,P21742,P32032,Q05806,Q42596,Q42597,Q42838,Q8H0Q5,Q8VZK8,Q9C8D6,Q9SBK8">acidic protein</protein-id> (<protein-id="P03995,P14136,P47819,Q28115">GFAP</protein-id>), and <compound-id="1123">taurine</compound-id> levels in cortical astrocytes were detected using immunohistochemical methods.	taurine__acidic protein__no_interaction	taurine__Kir4.1__no_interaction	taurine__GFAP__no_interaction
18752295-296	Immunohistochemical analysis suggests that the diverse expression of <protein-id="P49655">Kir4.1</protein-id> channels and <protein-id="P03995,P14136,P47819,Q28115">GFAP</protein-id> as well as differences in the accumulation of <compound-id="1123">taurine</compound-id> might contribute to the distinct ability of astrocytes to regulate their volume.	taurine__Kir4.1__no_interaction	taurine__GFAP__no_interaction
18752301-300	These evoked expressions at both molecular and cellular levels were significantly inhibited after TRPV(1) receptors were blocked by <compound-id="16219535">5'-iodoresiniferatoxin</compound-id> (5 microg) or <protein-id="P05130,P13677,P13678,P34722">PKC</protein-id> was inhibited by <compound-id="2703,411938">chelerythrine</compound-id> <compound-id="312">chloride</compound-id> (5 microg).	chelerythrine__PKC__interaction	5'-iodoresiniferatoxin__PKC__no_interaction	chloride__PKC__interaction
18752305-1438	Regulation of the phosphoinositide-3 kinase and <protein-id="Q00859">mitogen-activated protein kinase</protein-id> signaling pathways by <compound-id="5994">progesterone</compound-id> and its reduced metabolites in the rat brain.	progesterone__mitogen-activated protein kinase__interaction
18752305-1439	Several growth factors, such as vascular endothelial growth factor, <protein-id="P25430,P25431,P25432,Q06225">brain-derived neurotrophic factor</protein-id>, and <protein-id="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7">insulin</protein-id>-like growth factor-I are involved in the actions of <compound-id="5994">progesterone</compound-id> in the central nervous system.	progesterone__brain-derived neurotrophic factor__interaction	progesterone__insulin__interaction
18752305-1440	Significant increases in the phosphorylation of <protein-id="P29323">ERK</protein-id>, in the expression of the catalytic (<protein-id="P07566,P08563,P08564,P14907,P19725,P47825,Q6X2U1,Q6X2U3,Q8VA10,Q99IE6,Q9J6K8">p110</protein-id>) and the regulatory (<protein-id="O43439,P46655,P49846,Q14155">p85</protein-id>) subunits of <protein-id="O00329,O02697,O35904,P23727,P26450,P27986,P32871,P42336,P42337,P42338,P42347,P42348,P48736,P54673,P54674,P54675,P54676,Q63787,Q8BTI9,Q8UUU2,Q9JHG7,Q9Z1L0">PI3K</protein-id> and in the phosphorylation of <protein-id="P31750,Q8INB9">Akt</protein-id> were observed in the hypothalamus, the hippocampus, and the cerebellum 24 hr after <compound-id="5994">progesterone</compound-id> administration.	progesterone__ERK__interaction	progesterone__p85__interaction	progesterone__p110__interaction	progesterone__Akt__interaction	progesterone__PI3K__interaction
18752414-337	In addition, we used PET to evaluate the striatal dopamine transporter availability (<protein-id="P13483,P23977,P27922,Q01959,Q03614,Q61327,Q9GJT6">DAT</protein-id>) with [(11)C]d-threo-<compound-id="4158">methylphenidate</compound-id> in the patient group.	methylphenidate__DAT__interaction
18752468-361	Associated with the mitochondrial permeabilization, PdC also induced the release of <protein-id="O07091,O13393,O22642,O93863,P00002,P00003,P00004,P00007,P00008,P00011,P00012,P00013,P00014,P00017,P00018,P00019,P00020,P00021,P00022,P00024,P00025,P00027,P00028,P00029,P00030,P00031,P00032,P00035,P00036,P00037,P00038,P00039,P00040,P00041,P00042,P00043,P00046,P00047,P00048,P00049,P00051,P00052,P00053,P00054,P00055,P00056,P00057,P00058,P00059,P00060,P00061,P00062,P00063,P00064,P00065,P00066,P00067,P00068,P00069,P00070,P00071,P00072,P00073,P00074,P00075,P00076,P00077,P00078,P00079,P12831,P15451,P18822,P19681,P19974,P21665,P22342,P25400,P29380,P32556,P38091,P53698,P56205,P59218,P62772,P62773,P62894,P62895,P62896,P67881,P67882,P68096,P68097,P68098,P68099,P68100,P68517,P68518,P68519,P81280,P81459,P99998,P99999,Q41346,Q4HVX7,Q52V08,Q52V09,Q52V10,Q5RFH4,Q640U4,Q6C9Q0,Q6IQM2,Q6Q4H8,Q6QLW4,Q6WUX8,Q753F4,Q7YR71,Q96VP3">cytochrome c</protein-id>, which is sensitive to inhibition by <compound-id="439352">DTT</compound-id>.	DTT__cytochrome c__interaction
18752565-399	Toll-like receptor 4 (<protein-id="P23799">TLR</protein-id>-4)/myeloid differentiation <protein-id="P03548,P03549,P03550,P05397,P09521,P19818,Q00965,Q01087,Q02966">protein-2</protein-id> complex ligation by <compound-id="11970143">lipopolysaccharide</compound-id> induces production of pro-inflammatory cytokines and co-stimulatory molecules on antigen presenting cells.	lipopolysaccharide__TLR__interaction	lipopolysaccharide__protein-2__interaction
18752633-420	Immunohistochemistry was performed on paraffin-embedded sections, using anti-<compound-id="65040">5-methylcytosine</compound-id> (5mc) and anti-Acetyl-<protein-id="P02299,P07041,P08437,P08898,P22843,P23753,P40285,P50564,P61830,P61831,P61832,P61833,P61834,P61835,P61836,P80553,P83864,P84235,P84236,P84237,P84238,P84239,P90543,Q06196,Q2UCQ0,Q5DWI3,Q757N1,Q7XYZ0,Q98RY4,Q9HDN1,Q9P427,Q9U7D1">Histone H3</protein-id> (Lys 9).	5-methylcytosine__Histone H3__no_interaction
18752635-423	Here, the <protein-id="O43763">NCX</protein-id>-mediated (45)Ca(2+) uptake was compared in <compound-id="923,373840">Na</compound-id> (+)-loaded pig coronary artery smooth muscle and endothelial cells.	Na__NCX__no_interaction
18752635-425	The concept of a linkage between <protein-id="O43763">NCX</protein-id> and SERCA in smooth muscle was also confirmed by similar distribution of <protein-id="O43763">NCX</protein-id> and <protein-id="O46674,O55143,P11507,P11607,P16615,P20647,Q00779,Q03669">SERCA2</protein-id> proteins when detergent-treated microsomes were fractionated by flotation on <compound-id="5988">sucrose</compound-id> density gradients.	sucrose__SERCA2__no_interaction	sucrose__NCX__no_interaction
18752971-536	The recent approval of <compound-id="5329102">sunitinib</compound-id>, <compound-id="216239">sorafenib</compound-id>, <compound-id="148191,6918289,18293306,23724530,24847874,53486199,54608508">temsirolimus</compound-id> and bevacizumab in combination with <protein-id="P35849">IFN-alpha</protein-id> has revolutionized the management of renal cell carcinoma.	temsirolimus__IFN-alpha__no_interaction	sorafenib__IFN-alpha__no_interaction	sunitinib__IFN-alpha__no_interaction
18753126-578	Here we report identification of the first three in vivo non-histone protein substrates of <compound-id="866,5962">lysine</compound-id> propionylation in eukaryotic cells: <protein-id="O09185,O12946,O57538,O93379,P02340,P04637,P10361,P19558,P19559,P56423,P56424,P61260,P79820,P79892,Q29537,Q42578,Q8SPZ3,Q92143,Q9TTA1,Q9TUB2,Q9W678,Q9W679">p53</protein-id>, <protein-id="Q01705,Q09472">p300</protein-id>, and <protein-id="P45481,Q92793">CREB-binding protein</protein-id>.	lysine__CREB-binding protein__interaction	lysine__p53__interaction	lysine__p300__interaction
18753126-580	<protein-id="Q01705,Q09472">p300</protein-id> was able to perform autopropionylation on <compound-id="866,5962">lysine</compound-id> residues in cells.	lysine__p300__interaction
18753604-688	This study determined the effects of the estrous cycle, pregnancy, <compound-id="5994">progesterone</compound-id> (P4), and interferon <protein-id="P10637,P16525,P19332,P58384">tau</protein-id> (<protein-id="O46633,P28171,P28172,Q95187">IFNT</protein-id>) on expression of both facilitative (<protein-id="P11166,P13355,P20303,P27674,P46896,P79365">SLC2A1</protein-id>, <protein-id="O62787,P11169,P28568,P47842,P47843,P58352,Q5R608,Q9XSC2">SLC2A3</protein-id>, and <protein-id="P14672,Q27994,Q9XST2,Q9XT10">SLC2A4</protein-id>) and sodium-dependent (<protein-id="P11170,P13866,P26429,P53791">SLC5A1</protein-id> and SLC5A11) <protein-id="P23586">glucose transporters</protein-id> in ovine uterine endometria from Days 10 to 16 of the estrous cycle and Days 10 to 20 of pregnancy, as well as in conceptuses from Days 10 to 20 of pregnancy.	progesterone__SLC2A1__interaction	progesterone__SLC2A3__interaction	progesterone__SLC5A1__interaction	progesterone__glucose transporters__interaction	progesterone__SLC2A4__interaction	progesterone__IFNT__no_interaction	progesterone__tau__no_interaction
18753675-708	In <protein-id="P16671,P26201,P70110">CD36</protein-id>-D patients, plasma triglycerides, <protein-id="P04114">apolipoprotein B-48</protein-id> (<protein-id="P04114">apoB-48</protein-id>), free fatty acids (FFAs), and free <compound-id="753">glycerol</compound-id> levels were much higher after OFL than those of controls, along with increases in chylomicron (CM) remnants and small dense low-density lipoprotein (sdLDL) particles.	glycerol__CD36__no_interaction	glycerol__apoB-48__no_interaction	glycerol__apolipoprotein B-48__no_interaction
18753676-709	Identification of <protein-id="Q5MIZ7">SMEK2</protein-id> as a candidate gene for regulation of responsiveness to dietary <compound-id="304,5997,6432564,11025495">cholesterol</compound-id> in rats.	cholesterol__SMEK2__interaction
18753676-710	Here we narrowed Dihc2 to a region including 33 genes and predicted transcripts and identified RGD1309450_predicted, a homologous gene of <protein-id="Q5MIZ7">SMEK2</protein-id>, as a strong candidate for responsiveness to dietary <compound-id="304,5997,6432564,11025495">cholesterol</compound-id>.	cholesterol__SMEK2__interaction
18753737-733	<compound-id="6013">Testosterone</compound-id> is a strong correlate of <protein-id="Q6BEG6,Q6BEG7,Q9BDJ6,Q9BEF8,Q9EQX0,Q9GKY5,Q9QYH7,Q9UBU3">ghrelin</protein-id> levels in men and postmenopausal women.	Testosterone__ghrelin__interaction
18754081-829	Up to 72% hexose yield and 94% pentose yield were obtained using modified steam explosion with 2% <compound-id="1118">sulfuric acid</compound-id> at 140 degrees C for 30 min and enzymatic hydrolysis with <protein-id="P07981,P07982,P07983,P10474,P10475,P10476,P13933,P15329,P15704,P16216,P17974,P18126,P18336,P19487,P21833,P21834,P22533,P22669,P22699,P23548,P23549,P23665,P27035,P29019,P37651,P37696,P45699,P46236,P46237,P46239,P58599,P58935,P81190,P82186,P84194,P84196,Q05622,Q12622,Q12714,Q8RSY9,Q8X5L9,Q8Z289,Q8ZLB7">cellulase</protein-id> (15 filter per unit (FPU)/g cellulose) and <protein-id="P12614,P15885,P27034,P29091,P40740,Q03506,Q46684">beta-glucosidase</protein-id> (50 cellobiose units (CBU)/g cellulose).	sulfuric acid__beta-glucosidase__no_interaction	sulfuric acid__cellulase__no_interaction
18754092-832	<compound-id="124886">Glutathione</compound-id> (<compound-id="124886">GSH</compound-id>), <protein-id="O24339,O52762,O62839,O68146,O77229,O93662,O97492,P00432,P04040,P04762,P07145,P0A323,P0A324,P0A325,P0A326,P0A327,P11934,P17336,P24168,P24270,P25890,P29422,P30265,P30266,P32290,P42321,P44390,P45737,P45739,P55304,P55306,P55310,P55311,P55313,P77872,P81138,P90682,Q27710,Q49XC1,Q4L643,Q59296,Q59337,Q59602,Q59714,Q5HG86,Q5HPK8,Q5RF10,Q64405,Q6G9M4,Q6GH72,Q7A5T2,Q8CPD0,Q8FWU0,Q8NWV5,Q8X1P0,Q8Y3P9,Q926X0,Q99UE2,Q9AXH0,Q9KW19,Q9L4S1,Q9M5L6,Q9PT92,Q9PWF7,Q9Z598,Q9ZKX5,Q9ZN99">catalase</protein-id> (<protein-id="O62839,O97492,P00432,P00485,P00486,P00487,P04040,P06135,P07641,P11504,P20074,P22782,P25309,P25819,P26825,P26826,P32796,P36882,P36883,P43155,P47934,P49417,P52826,P58777,P62577,P62578,P62579,P62580,P90682,Q00614,Q02736,Q03058,Q5RF10,Q64405,Q704S8,Q9M5L6,Q9PWF7">CAT</protein-id>), and <compound-id="10964">malondialdehyde</compound-id> (MDA) activities in blood were measured.	Glutathione__CAT__no_interaction	GSH__CAT__no_interaction	malondialdehyde__CAT__no_interaction	GSH__catalase__no_interaction	malondialdehyde__catalase__no_interaction	Glutathione__catalase__no_interaction
18754092-833	<protein-id="O24339,O52762,O62839,O68146,O77229,O93662,O97492,P00432,P04040,P04762,P07145,P0A323,P0A324,P0A325,P0A326,P0A327,P11934,P17336,P24168,P24270,P25890,P29422,P30265,P30266,P32290,P42321,P44390,P45737,P45739,P55304,P55306,P55310,P55311,P55313,P77872,P81138,P90682,Q27710,Q49XC1,Q4L643,Q59296,Q59337,Q59602,Q59714,Q5HG86,Q5HPK8,Q5RF10,Q64405,Q6G9M4,Q6GH72,Q7A5T2,Q8CPD0,Q8FWU0,Q8NWV5,Q8X1P0,Q8Y3P9,Q926X0,Q99UE2,Q9AXH0,Q9KW19,Q9L4S1,Q9M5L6,Q9PT92,Q9PWF7,Q9Z598,Q9ZKX5,Q9ZN99">Catalase</protein-id>, myeloperoxidase (<protein-id="P05164,P11247">MPO</protein-id>), <protein-id="O32770,O59858,Q00277,Q9CFV1">glutathione peroxidase</protein-id> (GSH-Px), <protein-id="O15770,P06715,P11804,P23189,P41921,P43783,P48638,P48639,P70619,P78965,Q60151,Q6BPI1,Q6C5H4,Q6FRV2,Q6HA23,Q74ZK4,Q873E8,Q94655">glutathione reductase</protein-id> (GR), <compound-id="10964">malondialdehyde</compound-id>, and <compound-id="145068">nitric oxide</compound-id> (NO) activities were measured from tissue samples.	malondialdehyde__MPO__no_interaction	nitric oxide__glutathione reductase__no_interaction	nitric oxide__Catalase__no_interaction	malondialdehyde__glutathione peroxidase__no_interaction	nitric oxide__glutathione peroxidase__no_interaction	malondialdehyde__Catalase__no_interaction	malondialdehyde__glutathione reductase__no_interaction	nitric oxide__MPO__no_interaction
18754101-836	In this study we examined the possible antigenotoxic effect of selenium (Se) in rats chronically exposed to low levels of <compound-id="7906">methylmercury</compound-id> (<compound-id="6860">MeHg</compound-id>) and the association between <protein-id="O32770,O59858,Q00277,Q9CFV1">glutathione peroxidase</protein-id> (GSH-Px) activity and DNA lesions (via comet assay) in the same exposed animals.	methylmercury__glutathione peroxidase__no_interaction	MeHg__glutathione peroxidase__no_interaction
18754103-838	To investigate any similarities in the inhibition of <protein-id="O18963,P05181,P08682,P33266,P51581,P79383,Q6GUQ4">CYP2E1</protein-id> by quinacrine and <compound-id="3117">disulfiram</compound-id>, molecular modeling techniques were adopted and revealed that quinacrine molecule anchors inside the same binding pocket of the protein where <compound-id="3117">disulfiram</compound-id> is also attached.	disulfiram__CYP2E1__interaction
18754105-839	administered during 7 days at 20 mg/kg per day (subacute treatment), <compound-id="445154">resveratrol</compound-id> abrogated LPS-induced erythrocytes lipoperoxidation and <protein-id="O24339,O52762,O62839,O68146,O77229,O93662,O97492,P00432,P04040,P04762,P07145,P0A323,P0A324,P0A325,P0A326,P0A327,P11934,P17336,P24168,P24270,P25890,P29422,P30265,P30266,P32290,P42321,P44390,P45737,P45739,P55304,P55306,P55310,P55311,P55313,P77872,P81138,P90682,Q27710,Q49XC1,Q4L643,Q59296,Q59337,Q59602,Q59714,Q5HG86,Q5HPK8,Q5RF10,Q64405,Q6G9M4,Q6GH72,Q7A5T2,Q8CPD0,Q8FWU0,Q8NWV5,Q8X1P0,Q8Y3P9,Q926X0,Q99UE2,Q9AXH0,Q9KW19,Q9L4S1,Q9M5L6,Q9PT92,Q9PWF7,Q9Z598,Q9ZKX5,Q9ZN99">catalase</protein-id> (<protein-id="O62839,O97492,P00432,P00485,P00486,P00487,P04040,P06135,P07641,P11504,P20074,P22782,P25309,P25819,P26825,P26826,P32796,P36882,P36883,P43155,P47934,P49417,P52826,P58777,P62577,P62578,P62579,P62580,P90682,Q00614,Q02736,Q03058,Q5RF10,Q64405,Q704S8,Q9M5L6,Q9PWF7">CAT</protein-id>) activity depression to control levels.	resveratrol__CAT__interaction	resveratrol__catalase__interaction
18754702-986	H2S can be produced from <compound-id="594,5862,5360637">cysteine</compound-id> by enzymes such as <protein-id="P32232,P32582,P35520,P46794,Q58H57,Q91WT9,Q9N0V7,Q9YBL2">cystathionine beta-synthase</protein-id>.	cysteine__cystathionine beta-synthase__interaction
18754757-1000	The influence of carbon sources on rhGH (recombinant human <protein-id="O12980,O13188,O18938,O62754,O70615,O73848,O73849,O93566,P01241,P01244,P01245,P01246,P01248,P06880,P07064,P08591,P08998,P09113,P09537,P09539,P10298,P10607,P10766,P10813,P10814,P11228,P13391,P19795,P20391,P20392,P22077,P24363,P29971,P33092,P33093,P33711,P34005,P34006,P34744,P34745,P34746,P34747,P37885,P37886,P45643,P45654,P45655,P46404,P46407,P48248,P55755,P56437,P58343,P58756,P67930,P67931,P69158,P69159,P69160,P69161,P69162,P79885,P87391,Q01282,Q01283,Q05163,Q07221,Q1HFN3,Q659Q8,Q7YQB8,Q7YQD2,Q7YRR6,Q864S7,Q8HYE5,Q8MI73,Q98UF6,Q9DEV3,Q9DGG5,Q9GKA1,Q9GL60,Q9GMB2,Q9GMB3,Q9I9L5,Q9I9M4,Q9IB11,Q9IBE5,Q9JKM4,Q9PWG3,Q9W6J5,Q9W6J7,Q9W6R8">growth hormone</protein-id>) production by two Pichia pastoris strains having different <compound-id="19314">methanol</compound-id> utilization phenotypes (P. pastoris-hGH-Mut (+) and P. pastoris-hGH-Mut (s)) was investigated using batch bioreactors.	methanol__growth hormone__no_interaction
18754816-1023	The present study was undertaken to test the hypothesis that PPARalpha activator <compound-id="3339">fenofibrate</compound-id> plays a key role in left ventricular hypertrophic remodelling via the formation of c-<protein-id="P01101,P12841,Q56415">fos</protein-id>/c-<protein-id="P05627,P17325,P18289">jun</protein-id> heterodimers in spontaneous hypertensive rats (SHRs).	fenofibrate__fos__interaction	fenofibrate__jun__interaction
18755047-1448	Effects of <compound-id="446284">eicosapentaenoic acid</compound-id> <compound-id="8857">ethyl ester</compound-id> on <protein-id="P43490,Q52I78,Q80Z29,Q99KQ4">visfatin</protein-id> and <compound-id="56841713">apelin</compound-id> in lean and overweight (cafeteria diet-fed) rats.	eicosapentaenoic acid__visfatin__no_interaction	ethyl ester__visfatin__no_interaction	apelin__visfatin__no_interaction
18755051-1093	In the presence of AA (Fe:AA molar ratio of 1:20), significantly more Fe was absorbed from FeSO4 (about 303 %), <protein-id="P10961,P12850,P19875,P22121,P22813,P41154,Q02953">HSF</protein-id> (about 454 %) and P-<protein-id="P10961,P12850,P19875,P22121,P22813,P41154,Q02953">HSF</protein-id> (about 371 %) when compared with ferrous <compound-id="1117">sulfate</compound-id> or <protein-id="Q26061">ferritin</protein-id> without AA.	sulfate__HSF__no_interaction	sulfate__ferritin__no_interaction
18755266-1173	<protein-id="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7">Insulin</protein-id>-like growth factor-I (<protein-id="P05017,P07455,P08025,P10763,P16545,P17085,P17647,P18254,P33712,P51457,P51458,P51462,Q02815,Q28933,Q68LC0,Q6GUL6,Q6IVA5,Q6JLX1,Q95222">IGF-I</protein-id>) is neuroprotective against <compound-id="702">ethanol</compound-id>-related toxicity and promotes white matter production following a number of insults.	ethanol__IGF-I__interaction	ethanol__Insulin__interaction
18755266-1174	These data indicate that <protein-id="P05017,P07455,P08025,P10763,P16545,P17085,P17647,P18254,P33712,P51457,P51458,P51462,Q02815,Q28933,Q68LC0,Q6GUL6,Q6IVA5,Q6JLX1,Q95222">IGF-I</protein-id> may be a potential treatment for some of <compound-id="702">ethanol</compound-id>'s damaging effects, a finding that has important implications for children of women who drink alcohol during pregnancy.	ethanol__IGF-I__interaction
18755506-1246	This study is aimed to investigate the effects of <compound-id="7979">triethyleneglycol dimethacrylate</compound-id> (TEGDMA) and <compound-id="13360">2-hydroxyethyl methacrylate</compound-id> (HEMA) on expression of <protein-id="O02768,O19183,O62698,O62725,P27607,P35354,P35355,P70682,P79208,Q05769">cyclooxygenase-2</protein-id> (<protein-id="O02768,O19183,O62698,O62725,P27607,P35354,P35355,P70682,P79208,Q05769">COX-2</protein-id>) and inducible <protein-id="O61309,O61608,Q27571,Q9I9M2">nitric oxide synthase</protein-id> (<protein-id="O19114,O46660,O54705,O62699,P29477,P35228,P79290,Q06518,Q27995,Q28314,Q90703,Q92037,Q92091">iNOS</protein-id>) in cultured murine macrophage cell line RAW 264.7.	triethyleneglycol dimethacrylate__cyclooxygenase-2__interaction	triethyleneglycol dimethacrylate__COX-2__interaction	triethyleneglycol dimethacrylate__iNOS__interaction	2-hydroxyethyl methacrylate__nitric oxide synthase__interaction	2-hydroxyethyl methacrylate__COX-2__interaction	2-hydroxyethyl methacrylate__iNOS__interaction	triethyleneglycol dimethacrylate__nitric oxide synthase__interaction	2-hydroxyethyl methacrylate__cyclooxygenase-2__interaction
18755582-1265	SWCNT coatings were thus functionalized with poly(<compound-id="9238">adamantane</compound-id>-pyrrole) and applied to the anchoring of <protein-id="P81156">glucose oxidase</protein-id> (<protein-id="P05414,Q92452,Q9UJM8,Q9WU19">GOX</protein-id>), modified with beta-cyclodextrin.	adamantane__GOX__interaction	adamantane__glucose oxidase__interaction
18755582-1266	This allows the immobilization of <compound-id="9238">adamantane</compound-id>-tagged <protein-id="P05414,Q92452,Q9UJM8,Q9WU19">GOX</protein-id>.	adamantane__GOX__interaction
18755616-1270	<compound-id="4677798">Statin</compound-id>-induced bone <protein-id="P07580">morphogenetic protein</protein-id> (<protein-id="P35855">BMP</protein-id>) 2 expression during bone regeneration: an immunohistochemical study.	Statin__morphogenetic protein__interaction	Statin__BMP__interaction
18755616-1271	The purpose of this study was to investigate bone <protein-id="P07580">morphogenetic protein</protein-id> (<protein-id="P35855">BMP</protein-id>) 2 expression after implantation of a <compound-id="4677798">statin</compound-id> and recombinant human <protein-id="O19006,O46564,P12643,P21274,P49001,Q804S2,Q90751">BMP-2</protein-id> (rhBMP-2) and to compare the bone regeneration capability of these substances in the rabbit nasal bone using immunohistologic methods.	statin__BMP-2__no_interaction	statin__morphogenetic protein__interaction	statin__BMP__no_interaction
18755796-1307	<compound-id="6076">cAMP</compound-id>, a second messenger in LH signaling, was identified as a factor in hCG-dependent regulation of <protein-id="P48609,P49615,P51166,Q03114">Cdk5</protein-id>/<protein-id="P04083,P07150,P08160,P10107,P12723,P14087,P16342,P19619,P19751,P27920,P30047,P31354,P38626,P46193,P51662,P51948,P51949,P61809,P61810,P70552,P99025,Q03148,Q15078,Q28199,Q66198,Q80YF6,Q864V4,Q8V439,Q8V6W7,Q91A29,Q91QT2,Q92108,Q96510,Q96FF9,Q9BT76,Q9PYA3">p35</protein-id>.	cAMP__p35__interaction	cAMP__Cdk5__interaction
18755820-1310	Intracellular production of <protein-id="O35734,O77510,O77764,P01375,P04924,P06804,P13296,P16599,P19101,P23383,P23563,P29553,P33620,P36939,P48094,P51435,P51742,P51743,P59684,P59693,P59694,P59695,P79337,P79374,Q06599,Q19LH4,Q1G1A2,Q1WM27,Q2MH05,Q539C2,Q75N23,Q8HZD9,Q8JFG3,Q8MKG8,Q8WNR1,Q9BEA1">TNFalpha</protein-id> and <protein-id="O62641,O77620,O97513,P04351,P05016,P17108,P19114,P26891,P36835,P37997,P46649,P51747,P60568,P60569,P68290,P68291,Q07885,Q08081,Q08867,Q1WM29,Q25BC3,Q29416,Q29615,Q2PE47,Q2PE78,Q4U313,Q5MBA8,Q5PXD0,Q7JFM2,Q7JFM3,Q7JFM4,Q7JFM5,Q865X2,Q865Y1,Q8MKH2,Q95KP3,Q9XS38,Q9XT83,Q9XT84">IL-2</protein-id> after stimulation with <compound-id="290670,442070,24832117">phorbol</compound-id> <compound-id="11005">myristate</compound-id>/<compound-id="3733,6434517,6912226,25134244">ionomycin</compound-id> was flowcytometrically measured in CD4 (+) T cells from peripheral blood (PB) and cerebrospinal fluid (CSF) of 29 patients with multiple sclerosis (MS), and 16 with other inflammatory and 41 with other non-inflammatory neurological diseases.	ionomycin__TNFalpha__interaction	phorbol__IL-2__interaction	phorbol__TNFalpha__interaction	ionomycin__IL-2__interaction	myristate__TNFalpha__interaction	myristate__IL-2__interaction
18756496-1463	Although we reported that 8-Cl-cAMP induces growth inhibition via p38 mitogen-activated protein kinase (<protein-id="O42781,P27638,Q00859">MAPK</protein-id>) and a metabolite of 8-Cl-cAMP, 8-Cl-<compound-id="60961">adenosine</compound-id> mediates this process, the action mechanism of 8-Cl-cAMP is still uncertain.	adenosine__MAPK__interaction
18756527-1486	Certain non-steroidal anti-inflammatory drugs, e.g., the <protein-id="O02768,O19183,O62698,O62725,P27607,P35354,P35355,P70682,P79208,Q05769">cyclooxygenase 2</protein-id>-specific nonsteroidal anti-inflammatory drugs, <compound-id="2662">celecoxib</compound-id>, raise Abeta(42) levels.	celecoxib__cyclooxygenase 2__interaction
18756589-1515	This was significantly in accordance with intracellular oxidative stress levels measured by <compound-id="124886">glutathione</compound-id> depletion, <compound-id="10964">malondialdehyde</compound-id> production, <protein-id="O50258">superoxide dismutase</protein-id> inhibition as well as reactive <compound-id="977">oxygen</compound-id> species generation.	malondialdehyde__superoxide dismutase__no_interaction	oxygen__superoxide dismutase__no_interaction	glutathione__superoxide dismutase__no_interaction
18757054-1690	<compound-id="7847">Acrolein</compound-id>, <protein-id="O35736,P05231,P08505,P20607,P26892,P26893,P29455,P41323,P41683,P41693,P46650,P51494,P79341,Q25BC2,Q28319,Q28747,Q28819,Q2MH06,Q5I6E3,Q6V919,Q865W7,Q865X6,Q8MKH0,Q95181,Q9MZR1,Q9XT80">IL-6</protein-id> and <protein-id="O19062,P02741,P02742,P08462,P18151,P21291,P41964,P47875,P49254,P49262,P52753,P67966,P67967,P97315,Q07203">CRP</protein-id> as markers of silent brain infarction.	Acrolein__IL-6__no_interaction	Acrolein__CRP__no_interaction
18757054-1691	We found previously that increased levels of <protein-id="Q6QHF9,Q865R1,Q8C0L6">polyamine oxidase</protein-id> (<protein-id="O64411,Q6QHF9,Q865R1,Q9FYC2">PAO</protein-id>) [acetylpolyamine oxidase (AcPAO) plus <protein-id="Q99K82,Q9NWM0">spermine oxidase</protein-id> (<protein-id="O42224,P56726,P97698,Q99835,Q9NWM0">SMO</protein-id>)], and <compound-id="7847">acrolein</compound-id> (CH(2)CHCHO) are good markers of stroke.	acrolein__SMO__no_interaction	acrolein__PAO__no_interaction	acrolein__polyamine oxidase__no_interaction	acrolein__spermine oxidase__no_interaction
18757054-1692	We then investigated whether silent brain infarction (SBI) can be detected by measuring <compound-id="7847">acrolein</compound-id>, <protein-id="O64411,Q6QHF9,Q865R1,Q9FYC2">PAO</protein-id>, or other biomarkers.	acrolein__PAO__no_interaction
18757054-1693	It was found that the levels of protein-conjugated <compound-id="7847">acrolein</compound-id> (PC-Acro), <protein-id="P41693">interleukin-6</protein-id> (<protein-id="O35736,P05231,P08505,P20607,P26892,P26893,P29455,P41323,P41683,P41693,P46650,P51494,P79341,Q25BC2,Q28319,Q28747,Q28819,Q2MH06,Q5I6E3,Q6V919,Q865W7,Q865X6,Q8MKH0,Q95181,Q9MZR1,Q9XT80">IL-6</protein-id>) and C-reactive protein (<protein-id="O19062,P02741,P02742,P08462,P18151,P21291,P41964,P47875,P49254,P49262,P52753,P67966,P67967,P97315,Q07203">CRP</protein-id>) were significantly higher in SBI than in normal subjects.	acrolein__interleukin-6__no_interaction	acrolein__IL-6__no_interaction	acrolein__CRP__no_interaction
18757097-1716	Human skin keratinocytes HaCat attacked by Staphylococcus aureus <protein-id="P09616,P0C216,Q0TV31,Q9RF12">alpha-toxin</protein-id> showed a transient drop of cellular <compound-id="5957">ATP</compound-id> levels whereas in toxin-perforated bovine mammary epithelial cells (BMEC), the <compound-id="5957">ATP</compound-id> levels dropped more slowly.	ATP__alpha-toxin__interaction
18757185-1747	Catalepsy, serum <protein-id="P10765,P22393,P33089,P33090,P33091,P43001">prolactin</protein-id>, receptor binding profile and cortical (PFC), hippocampal (Hip) and <compound-id="681">dopamine</compound-id> (DA) levels were determined.	dopamine__prolactin__no_interaction
18757188-1748	Estrogenic effect was determined by the change of uterine weight, and oxidant effects were determined by the content of <protein-id="O12933,O22668,O75007,P24705,P51547,P93258,Q01137,Q27666,Q9SM64">SOD</protein-id>, <compound-id="124886">GSH</compound-id>-Px, <protein-id="O62839,O97492,P00432,P00485,P00486,P00487,P04040,P06135,P07641,P11504,P20074,P22782,P25309,P25819,P26825,P26826,P32796,P36882,P36883,P43155,P47934,P49417,P52826,P58777,P62577,P62578,P62579,P62580,P90682,Q00614,Q02736,Q03058,Q5RF10,Q64405,Q704S8,Q9M5L6,Q9PWF7">CAT</protein-id> and MDA.	GSH__CAT__no_interaction	GSH__SOD__no_interaction
18757188-1749	The intake of formononetin increased the uterine weight of the mice significantly as well as the content of <protein-id="O12933,O22668,O75007,P24705,P51547,P93258,Q01137,Q27666,Q9SM64">SOD</protein-id>, <compound-id="124886">GSH</compound-id>-Px, <protein-id="O62839,O97492,P00432,P00485,P00486,P00487,P04040,P06135,P07641,P11504,P20074,P22782,P25309,P25819,P26825,P26826,P32796,P36882,P36883,P43155,P47934,P49417,P52826,P58777,P62577,P62578,P62579,P62580,P90682,Q00614,Q02736,Q03058,Q5RF10,Q64405,Q704S8,Q9M5L6,Q9PWF7">CAT</protein-id>, and reduced MDA in body.	GSH__CAT__no_interaction	GSH__SOD__no_interaction
18757189-1750	A novel <compound-id="906,444885,445063">sialic acid</compound-id>-specific <protein-id="P02871,P02873,P02874,P02875,P07386,P16108,P16349,P16351,P16352,P33888,P38662,P42088,P83410,P83511,P84987,Q41114">lectin</protein-id> from Phaseolus coccineus seeds with potent antineoplastic and antifungal activities.	sialic acid__lectin__interaction
18757189-1751	A novel <protein-id="P02871,P02873,P02874,P02875,P07386,P16108,P16349,P16351,P16352,P33888,P38662,P42088,P83410,P83511,P84987,Q41114">lectin</protein-id> (PCL) with specificity towards <compound-id="906,444885,445063">sialic acid</compound-id> was purified from Phaseolus coccineus L. (P. multiflorus willd) seeds using ion exchange chromatography on CM and DEAE-Sepharose, and gel filtration on Sephacryl S-200 column.	sialic acid__lectin__interaction
18757233-1762	The characterization for the binding of calcium and <compound-id="23958">terbium</compound-id> to Euplotes octocarinatus <protein-id="P05434,P41210,P43645,P43646,P53441,P54213,Q06827,Q24956,Q27177,Q27178,Q27179">centrin</protein-id>.	terbium__centrin__interaction
18757307-1779	We have previously shown that ROS-induced <protein-id="P98088">MUC5AC</protein-id> expression in NHBE cells is dependent on <compound-id="24759">hyaluronan</compound-id> depolymerization and <protein-id="P55245">epidermal growth factor receptor</protein-id> (<protein-id="P00533,P13387,P55245">EGFR</protein-id>)/<protein-id="Q00859">mitogen-activated protein kinase</protein-id> (<protein-id="O42781,P27638,Q00859">MAPK</protein-id>) activation.	hyaluronan__MAPK__no_interaction	hyaluronan__mitogen-activated protein kinase__no_interaction	hyaluronan__MUC5AC__interaction	hyaluronan__epidermal growth factor receptor__no_interaction	hyaluronan__EGFR__no_interaction
18757495-1808	<protein-id="O60109,P81800,P83456">Alkaline phosphatase</protein-id> activity and <protein-id="O93390,P07214,P09486,P13213,P16975,P20112,P34714,P36233,P36377,P36378,P36379">osteonectin</protein-id> expression of the osteoblasts cultured on the <compound-id="36797">PLGA</compound-id> scaffolds remained stable over three weeks, whilst expression of collagen type I and osteopontin decreased.	PLGA__osteonectin__no_interaction	PLGA__Alkaline phosphatase__no_interaction
18757495-1809	The <protein-id="O60109,P81800,P83456">alkaline phosphatase</protein-id> activity of osteoblasts cultured on <compound-id="36797">PLGA</compound-id> scaffolds is comparable with that from two commercially-available scaffolds-OPLA and collagen scaffolds (Becton-Dickinson (BD) Inc., Franklin Lakes, NJ, USA).	PLGA__alkaline phosphatase__no_interaction
18757514-1816	The vasodilating effect of <compound-id="1986">acetazolamide</compound-id> and <compound-id="5284549">dorzolamide</compound-id> involves mechanisms other than <protein-id="P27134,P46281,P46510,P46511,P54212,P84537,Q54735,Q92051,Q9ZN54">carbonic anhydrase</protein-id> inhibition.	acetazolamide__carbonic anhydrase__no_interaction	dorzolamide__carbonic anhydrase__no_interaction
18757837-1932	The objective of the present study was to investigate the effects of a high-<compound-id="304,5997,6432564,11025495">cholesterol</compound-id> diet on <protein-id="P33724,P35431,P41350,P49817,P79132,Q03135,Q07DV9,Q07DX1,Q07DY2,Q07DZ2,Q07E02,Q07E25,Q07E38,Q07E49,Q09YH8,Q09YK1,Q09YN6,Q108U7,Q2IBA5,Q2IBC1,Q2IBD7,Q2IBF0,Q2IBG8,Q2QL79,Q2QL90,Q2QLB0,Q2QLC1,Q2QLF2,Q2QLG6,Q2QLH7,Q6B3Y2,Q6RVA9,Q94051,Q9YGM8">caveolin-1</protein-id> expression and IR localization and activity in the rat liver.	cholesterol__caveolin-1__interaction
18758183-2073	<protein-id="O11451,O11452,O11453,O39927,O39928,O39929,O91936,O92529,O92530,O92531,O92532,P06934,P16342,P19751,P25880,P25881,P25882,P25884,P25989,P26660,P26661,P26662,P26663,P26664,P27958,P29833,P29846,P29996,P29997,P40305,P68763,P68764,P68765,P69180,P69181,P69182,P69183,P69184,P69618,P69619,Q00269,Q43735,Q5I2N3,Q66198,Q68749,Q68798,Q68801,Q81258,Q81487,Q81495,Q81754,Q81835,Q81842,Q8V439,Q8V6W7,Q913D4,Q91A29,Q91DH7,Q91DH8,Q91DH9,Q99IB8,Q9DHD6,Q9E925,Q9PYA3,Q9QAX1,Q9WMX2">P27</protein-id> and <protein-id="O09185,O12946,O57538,O93379,P02340,P04637,P10361,P19558,P19559,P56423,P56424,P61260,P79820,P79892,Q29537,Q42578,Q8SPZ3,Q92143,Q9TTA1,Q9TUB2,Q9W678,Q9W679">P53</protein-id> play important roles in the signal transduction leading to neointimal growth inhibition and induction of apoptosis of smooth muscle cells due to <compound-id="5040,478951,5284616,5358081,5374464,5460439,5497196,6436030,16760631,17753749,44295234,53627520,54600319">rapamycin</compound-id> and <compound-id="4666,36314,441276,5352019,6713921,6915727,44155032,53313247">paclitaxel</compound-id>.	paclitaxel__P27__interaction	rapamycin__P53__interaction	rapamycin__P27__interaction	paclitaxel__P53__interaction
18758695-2200	Immobilization of <protein-id="P15160,P17724,P73925,Q03459">hemoglobin</protein-id> on the <compound-id="23985">gold colloid</compound-id> modified pretreated glassy carbon electrode for preparing a novel hydrogen peroxide biosensor.	gold colloid__hemoglobin__interaction
18758695-2201	A novel hydrogen peroxide (H2O2) biosensor was developed by immobilizing <protein-id="P15160,P17724,P73925,Q03459">hemoglobin</protein-id> on the <compound-id="23985">gold colloid</compound-id> modified electrochemical pretreated glassy carbon electrode (PGCE) via the bridging of an ethylenediamine monolayer.	gold colloid__hemoglobin__interaction
18758751-2238	Involvement of <protein-id="P05130,P13677,P13678,P34722">PKC</protein-id> in TPA-potentiated apoptosis induction during <compound-id="4971">hemin</compound-id>-mediated erythroid differentiation in K562 cells.	hemin__PKC__no_interaction
18758751-2239	To better understand the mechanisms underlying differentiation-mediated regulation of apoptosis, we have studied the effects of <protein-id="P05130,P13677,P13678,P34722">PKC</protein-id> pathway with an activator of the protein kinase C, <compound-id="27924">12-O-tetradecanoylphorbol-13-acetate</compound-id> (TPA), during <compound-id="4971">hemin</compound-id>-induced erythroid differentiation of K562 erythroleukemia cells.	hemin__PKC__no_interaction	12-O-tetradecanoylphorbol-13-acetate__PKC__interaction
18758751-2244	Taken together, our results suggested the involvement of <protein-id="P05130,P13677,P13678,P34722">PKC</protein-id> in TPA-potentiated apoptosis induction during <compound-id="4971">hemin</compound-id>-mediated erythroid differentiation in K562 cells.	hemin__PKC__no_interaction
18758757-2247	At glutamatergic synapses, increased binding to the <compound-id="750">glycine</compound-id>-B site located in the <protein-id="P35439,Q9R1M7">N-methyl-D-aspartate receptor</protein-id> (NMDAR) can enhance neurotransmission via NMDARs.	glycine__N-methyl-D-aspartate receptor__interaction
18758781-2256	The most common adverse events were mild and transient gastrointestinal disturbances, skin rash, nonprogressive transient increases in serum <compound-id="588">creatinine</compound-id> and urine <protein-id="P01885,P01886,P19341,P21612,P30442,P55077,P55078,Q03423,Q04714">beta2-microglobulin</protein-id>, and a temporary reduction of the <compound-id="588">creatinine</compound-id> clearance.	creatinine__beta2-microglobulin__no_interaction
18758819-2275	In vitro effect of radiation, antibody to <protein-id="P55245">epidermal growth factor receptor</protein-id> and <compound-id="148124">Docetaxel</compound-id> in human head and neck squamous carcinoma cells with mutant <protein-id="O09185,O12946,O57538,O93379,P02340,P04637,P10361,P19558,P19559,P56423,P56424,P61260,P79820,P79892,Q29537,Q42578,Q8SPZ3,Q92143,Q9TTA1,Q9TUB2,Q9W678,Q9W679">P53</protein-id> and over-expressed <protein-id="P00533,P13387,P55245">EGFR</protein-id>.	Docetaxel__P53__interaction	Docetaxel__EGFR__interaction	Docetaxel__epidermal growth factor receptor__no_interaction
18758925-2312	The optimal condition for the labeling of cypate to <protein-id="O25424,O34482,P06608,P26900,P30363,P43843,P50286,P63627,P63628,Q9RRX9,Q9X7E6,Q9ZLB9">L-ASNase</protein-id> was 4 h reaction duration at 4 degrees C and pH 8.5 under catalysis by <compound-id="75771">HOBt</compound-id>/<compound-id="130500">HBTU</compound-id>.	HBTU__L-ASNase__interaction	HOBt__L-ASNase__interaction
18758938-2315	Effects of <protein-id="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7">insulin</protein-id> and <compound-id="54670067,54690394">ascorbic acid</compound-id> on expression of <protein-id="P10417,P49950">Bcl-2</protein-id> family proteins and caspase-3 activity in hippocampus of diabetic rats were evaluated in this study.	ascorbic acid__Bcl-2__interaction	ascorbic acid__insulin__no_interaction
18758940-2316	Chemo-enzymatic synthesis of <compound-id="119547">poly-N-acetyllactosamine</compound-id> (poly-<compound-id="16760443">LacNAc</compound-id>) structures and their characterization for <protein-id="P20718">CGL2</protein-id>-<protein-id="Q801X7">galectin</protein-id>-mediated binding of ECM <protein-id="P08163">glycoproteins</protein-id> to biomaterial surfaces.	LacNAc__CGL2__interaction	poly-N-acetyllactosamine__galectin__interaction	LacNAc__galectin__interaction	poly-N-acetyllactosamine__CGL2__interaction	LacNAc__glycoproteins__interaction	poly-N-acetyllactosamine__glycoproteins__interaction
18758940-2317	<compound-id="119547">Poly-N-acetyllactosamine</compound-id> (poly-<compound-id="16760443">LacNAc</compound-id>) structures have been identified as important ligands for <protein-id="Q801X7">galectin</protein-id>-mediated cell adhesion to extra-cellular matrix (ECM) proteins.	Poly-N-acetyllactosamine__galectin__interaction	LacNAc__galectin__interaction
18758940-2318	We here present the biofunctionalization of surfaces with poly-<compound-id="16760443">LacNAc</compound-id> structures and subsequent binding of ECM <protein-id="P08163">glycoproteins</protein-id>.	LacNAc__glycoproteins__interaction
18758940-2319	A mixture of poly-<compound-id="16760443">LacNAc</compound-id>-structures covalently coupled to functionalized microtiter plates were identified for best binding to our model <protein-id="Q801X7">galectin</protein-id> His(6) <protein-id="P20718">CGL2</protein-id>.	LacNAc__CGL2__interaction	LacNAc__galectin__interaction
18758940-2320	We further demonstrate for the first time that these poly-<compound-id="16760443">LacNAc</compound-id> surfaces are suitable for further <protein-id="Q801X7">galectin</protein-id>-mediated binding of the <protein-id="Q13201">ECM</protein-id> <protein-id="P08163">glycoproteins</protein-id> <compound-id="44342165">laminin</compound-id> and <protein-id="P07589,P11722,Q28275,Q28377,Q28749,Q91289,Q91400">fibronectin</protein-id>.	laminin__glycoproteins__interaction	LacNAc__galectin__interaction	LacNAc__fibronectin__interaction	laminin__ECM__interaction	LacNAc__glycoproteins__interaction	laminin__fibronectin__interaction	LacNAc__ECM__interaction	laminin__galectin__interaction
18758978-2339	Seasonal variation of the metal (Zn, Fe, <compound-id="23930">Mn</compound-id>) and <protein-id="O02033,O13257,O18842,O42152,O93571,P02807,P04358,P07216,P08002,P23038,P25127,P25128,P30331,P30565,P51902,P52723,P52725,P52726,P52728,P55945,P55946,P55948,P55951,P55952,P55953,P68494,P68495,P68497,P68498,P68499,P80367,P80593,P84865,Q05890,Q6J1T3,Q6S4N8,Q6XUW5,Q708T3,Q7ZZP9,Q800D3,Q8UVY1,Q94550,Q9IB50,Q9U568">metallothionein</protein-id> concentrations in the liver cytosol of the European chub (Squalius cephalus L.).	Mn__metallothionein__no_interaction
18758978-2340	The specimens caught in the spring period had higher biometric (liver mass, condition and hepatosomatic indices) and some biochemical parameters (<protein-id="O02033,O13257,O18842,O42152,O93571,P02807,P04358,P07216,P08002,P23038,P25127,P25128,P30331,P30565,P51902,P52723,P52725,P52726,P52728,P55945,P55946,P55948,P55951,P55952,P55953,P68494,P68495,P68497,P68498,P68499,P80367,P80593,P84865,Q05890,Q6J1T3,Q6S4N8,Q6XUW5,Q708T3,Q7ZZP9,Q800D3,Q8UVY1,Q94550,Q9IB50,Q9U568">metallothionein</protein-id> (MT) and <compound-id="23930">Mn</compound-id>) that are characteristic for the reproductive period.	Mn__metallothionein__no_interaction
18758993-2343	<protein-id="O30418,P20228,P54767,Q04792,Q07346,Q9CG20">Glutamate decarboxylase</protein-id> (<protein-id="P20228,P54767,Q04792,Q07346,Q42521,Q99259,Q9CG20">GAD</protein-id>) is the rate-limiting enzyme in the synthesis of <compound-id="119">gamma-aminobutyric acid</compound-id> (<compound-id="119">GABA</compound-id>), the most important inhibitory neurotransmitter in central nervous system (CNS).	GABA__Glutamate decarboxylase__interaction	gamma-aminobutyric acid__GAD__interaction	GABA__GAD__interaction	gamma-aminobutyric acid__Glutamate decarboxylase__interaction
18758993-2344	These transcripts were predicted to synthesis of <protein-id="P20228,P54767,Q04792,Q07346,Q42521,Q99259,Q9CG20">GAD</protein-id> proteins truncated of the binding site for <compound-id="1051">pyridoxal phosphate</compound-id>, an essential cofactor, therefore cannot function as a decarboxylase.	pyridoxal phosphate__GAD__interaction
18759148-2382	Loss-of-expression of <protein-id="P30874,P34993,P34994">SSTR2</protein-id> in tumor tissues has been suggested to correlate with tumor progression and to the relatively poorer outcomes of <compound-id="16129681,16129706">somatostatin</compound-id> analog treatment in some clinical trials.	somatostatin__SSTR2__interaction
18760301-213	<compound-id="56842156">Cobra venom factor</compound-id> (CVF) is a structural and functional analog of <protein-id="P23667,P98094">complement C3</protein-id> isolated from cobra venom.	Cobra venom factor__complement C3__interaction
18760497-301	Activities of malate- and succinate-dehydrogenases (<protein-id="O24047,P20932,P33216,P46487,P52426,Q04820,Q43744">MDH</protein-id>, <protein-id="O34607,O34635,O86564,P09367,P20132,P21801,P21912,P21914,P33073,P33074,P38997,P38998,P42630,P43065,P56072,P66773,P66774,P71349,P80212,P80213,Q02912,Q09694,Q48838,Q6FU27,Q75BV4,Q7SFX6,Q870G1,Q8LGI2,Q99K67,Q9SMZ4,Q9SQT8,Q9UDR5,Q9ZMU7">SDH</protein-id>) and NADH- and succinate-<protein-id="O07091,O13393,O22642,O93863,P00002,P00003,P00004,P00007,P00008,P00011,P00012,P00013,P00014,P00017,P00018,P00019,P00020,P00021,P00022,P00024,P00025,P00027,P00028,P00029,P00030,P00031,P00032,P00035,P00036,P00037,P00038,P00039,P00040,P00041,P00042,P00043,P00046,P00047,P00048,P00049,P00051,P00052,P00053,P00054,P00055,P00056,P00057,P00058,P00059,P00060,P00061,P00062,P00063,P00064,P00065,P00066,P00067,P00068,P00069,P00070,P00071,P00072,P00073,P00074,P00075,P00076,P00077,P00078,P00079,P12831,P15451,P18822,P19681,P19974,P21665,P22342,P25400,P29380,P32556,P38091,P53698,P56205,P59218,P62772,P62773,P62894,P62895,P62896,P67881,P67882,P68096,P68097,P68098,P68099,P68100,P68517,P68518,P68519,P81280,P81459,P99998,P99999,Q41346,Q4HVX7,Q52V08,Q52V09,Q52V10,Q5RFH4,Q640U4,Q6C9Q0,Q6IQM2,Q6Q4H8,Q6QLW4,Q6WUX8,Q753F4,Q7YR71,Q96VP3">cytochrome c</protein-id> reductases (NCCR, SCCR) were rapidly inhibited, while <protein-id="O07091,O13393,O22642,O93863,P00002,P00003,P00004,P00007,P00008,P00011,P00012,P00013,P00014,P00017,P00018,P00019,P00020,P00021,P00022,P00024,P00025,P00027,P00028,P00029,P00030,P00031,P00032,P00035,P00036,P00037,P00038,P00039,P00040,P00041,P00042,P00043,P00046,P00047,P00048,P00049,P00051,P00052,P00053,P00054,P00055,P00056,P00057,P00058,P00059,P00060,P00061,P00062,P00063,P00064,P00065,P00066,P00067,P00068,P00069,P00070,P00071,P00072,P00073,P00074,P00075,P00076,P00077,P00078,P00079,P12831,P15451,P18822,P19681,P19974,P21665,P22342,P25400,P29380,P32556,P38091,P53698,P56205,P59218,P62772,P62773,P62894,P62895,P62896,P67881,P67882,P68096,P68097,P68098,P68099,P68100,P68517,P68518,P68519,P81280,P81459,P99998,P99999,Q41346,Q4HVX7,Q52V08,Q52V09,Q52V10,Q5RFH4,Q640U4,Q6C9Q0,Q6IQM2,Q6Q4H8,Q6QLW4,Q6WUX8,Q753F4,Q7YR71,Q96VP3">cytochrome c</protein-id> oxidase (CCO) was unaltered by <compound-id="23973">cadmium</compound-id> treatment.	cadmium__SDH__interaction	cadmium__cytochrome c__no_interaction	cadmium__MDH__interaction
18760497-302	However, this stimulated the NADPH-generating enzyme activities of the <compound-id="854">pentose</compound-id> phosphate pathway, glucose-6-phosphate- and 6-phosphogluconate-dehydrogenases (<protein-id="P37830,P48826">G6PDH</protein-id>, 6PGDH), as well as enzyme activity of fermentation, <protein-id="O31186,P00332,P00334,P06525,P07159,P07162,P0A9Q7,P0A9Q8,P10807,P12311,P14940,P17648,P21518,P21898,P22245,P23277,P23278,P23361,P25139,P25721,P25988,P26719,P28483,P28484,P33744,P37473,P42327,P42328,P48584,P48585,P48977,P51549,P51550,P51551,P51552,P71017,P84328,Q00669,Q00670,Q00671,Q00672,Q03384,Q05114,Q07588,Q09009,Q09010,Q24641,Q24803,Q27404,Q6LCE4,Q9GN94,Q9NAR7,Q9NG40,Q9NG42,Q9U8S9">alcohol dehydrogenase</protein-id> (<protein-id="P06525,P0A9Q7,P0A9Q8,P17648,P33744,P42327,P48977,P81786,Q04983,Q24803,Q24857,Q9NAR7">ADH</protein-id>), with concomitant inhibition in the capacity of enzyme inactivator (INADH).	pentose__alcohol dehydrogenase__no_interaction	pentose__G6PDH__no_interaction	pentose__ADH__no_interaction
18760912-456	We also examined cellular impedance responsiveness of PC 12 cells in response to phenotypic alteration especially with regard to modulation of ion fluxes using nerve growth factor (<protein-id="P21617,P34129,Q6YBR5,Q90W38">NGF</protein-id>), <compound-id="5743">dexamethasone</compound-id> and <compound-id="47936">forskolin</compound-id>.	forskolin__NGF__no_interaction	dexamethasone__NGF__no_interaction
18760952-480	This paper investigates the effect of sterilisation by gamma irradiation (dose 2.5Mrad) on the following properties of <compound-id="10401">polycaprolactone</compound-id> (PCL): (1) degradation rate (catalysed by <protein-id="Q7M4U7">lipase</protein-id>), (2) mechanical properties, (3) the ability of cells to attach and subsequently grow on its surface.	polycaprolactone__lipase__interaction
18761029-495	Specifically, animals were exposed to one of five dipsetic stimuli: (1) 24-h water deprivation, (2) replacement of drinking water with 2.5% <compound-id="5234">NaCl</compound-id>, (3) peripheral administration of hypertonic saline, (4) ICV injection of <protein-id="P01015,P01016,P01017,P01019,P11859,P20757,P67885,P67886,Q9GLN8,Q9GLP6,Q9TSZ0">angiotensin II</protein-id> (<protein-id="P01015,P01016,P01017,P01019,P11859,P20757,P67885,P67886,Q9GLN8,Q9GLP6,Q9TSZ0">AngII</protein-id>), or (5) the combination of peripheral hypertonic saline and central <protein-id="P01015,P01016,P01017,P01019,P11859,P20757,P67885,P67886,Q9GLN8,Q9GLP6,Q9TSZ0">AngII</protein-id>.	NaCl__AngII__no_interaction	NaCl__angiotensin II__no_interaction
18761103-512	We therefore propose <compound-id="23978">copper</compound-id>-dependent homodimerization to be an essential step in the regulation of <protein-id="O00244,Q9TT99,Q9XT28">ATOX1</protein-id>-dependent transcription.	copper__ATOX1__interaction
18761380-599	In order to investigate the role of spinal <protein-id="P84814">opioid peptide</protein-id> in the phenomenon of <compound-id="5284596,16395294">naloxone</compound-id>-precipitated withdrawal we examined the effect of herpes simplex virus vector-mediated overexpression of proenkephalin in lumbar dorsal root ganglia in rats with neuropathic pain treated with morphine.	naloxone__opioid peptide__interaction
18761426-612	The <protein-id="P02871,P02873,P02874,P02875,P07386,P16108,P16349,P16351,P16352,P33888,P38662,P42088,P83410,P83511,P84987,Q41114">lectins</protein-id> were isolated by <compound-id="6097028">ammonium sulphate</compound-id> treatment of crude extracts followed by chromatography on chitin.	ammonium sulphate__lectins__interaction
18761603-651	One hundred and forty-four HCV-2- and HCV-3-infected patients initiated Peg-<protein-id="P35849">IFN alpha</protein-id>-2a (180 microg/week) and <compound-id="37542">ribavirin</compound-id> (1000 or 1200 mg/day); those with viral clearance at week 4 were randomized to either Peg-<protein-id="P35849">IFN alpha</protein-id>-2a monotherapy (n = 59) or continuing combination therapy (n = 61) until week 12.	ribavirin__IFN alpha__no_interaction
18761603-652	Thus in HCV-2- and HCV-3-infected patients, withdrawal of <compound-id="37542">ribavirin</compound-id> and continuation of Peg-<protein-id="P35849">IFN alpha</protein-id>-2a monotherapy may be appropriate to attain an SVR, providing viraemia is cleared early during therapy and associated with low baseline viral load.	ribavirin__IFN alpha__no_interaction
18761779-682	The <protein-id="P02649,P02650,P05770,P08226,P10517,P18287,P18649,P18650,P23529,Q03247,Q28502,Q28995,Q7M2U7,Q7M2U8,Q9GJU3,Q9GLC0,Q9GLM6,Q9GLM7,Q9GLM8">apoE</protein-id>-deficient mouse, which develops atherosclerotic lesions rapidly when fed <compound-id="304,5997,6432564,11025495">cholesterol</compound-id>, was used to determine the ability of dried plums to reduce atherosclerosis.	cholesterol__apoE__no_interaction
18761779-683	Urinary <compound-id="2723628">thiobarbituric acid</compound-id>-reactive substances (TBARS) excretion and <protein-id="P15697,P19095,P20677">serum amyloid P-component</protein-id> (<protein-id="O19063,O60880,P02743,P07629,P12246,P19095,P20677,P23680,P24047,P35827,P49255,Q9FKH1">SAP</protein-id>) were measured as indicators of oxidative stress and inflammation, respectively.	thiobarbituric acid__SAP__no_interaction	thiobarbituric acid__serum amyloid P-component__no_interaction
18762200-801	Inhibition in the brain is dominated by the neurotransmitter <compound-id="119">gamma-aminobutyric acid</compound-id> (<compound-id="119">GABA</compound-id>); operating through <protein-id="P26714,Q08832,Q9BLY8">GABA(A) receptors</protein-id>.	gamma-aminobutyric acid__GABA(A) receptors__interaction	GABA__GABA(A) receptors__interaction
18762201-805	Thus, in keeping with the ability of neurosteroids to potentiate <compound-id="119">GABA</compound-id> currents via a broad variety of <protein-id="P26714,Q08832,Q9BLY8">GABA(A) receptor</protein-id> isoforms in neurons, the potentiation site is structurally highly conserved on this important neurotransmitter receptor family.	GABA__GABA(A) receptor__interaction
18762202-807	The 5-HT2AR response dominated the <protein-id="O42781,P27638,Q00859">MAPK</protein-id> signaling pathway when co-expressed with 5-HT1AR, and diminution of the response by the 5-HT2AR antagonist <compound-id="3822">Ketanserin</compound-id> could not be rescued by the 5-HT1AR agonist.	Ketanserin__MAPK__interaction
18762271-826	The inhibitors include mitogen-inducible gene-6 (<protein-id="P05432,Q99JZ7,Q9UJM3">Mig-6</protein-id>)/receptor-associated late transducer (RALT)/Gene 33, fibroblast growth factor receptor substrate 2beta (<protein-id="Q91WJ0">FRS2beta</protein-id>)/<protein-id="O43559,Q52RG8">suc1-associated neurotrophic factor target-2</protein-id> (<protein-id="O43559,Q52RG8">SNT-2</protein-id>)/<protein-id="O43559">FRS3</protein-id>, <protein-id="O14543,O35718,O88583,Q68AM8,Q90X67,Q9BEG9">suppressor of cytokine signaling 3</protein-id> (<protein-id="O14543,Q68AM8,Q90X67,Q9BEG9">SOCS3</protein-id>)/<protein-id="O14544,Q8WXH5">SOCS4</protein-id>/<protein-id="O75159,Q29RN6">SOCS5</protein-id>, and <compound-id="857,6106,439524">leucine</compound-id>-rich repeats and immunoglobulin-like domains 1 (<protein-id="Q96JA1">LRIG1</protein-id>).	leucine__Mig-6__no_interaction	leucine__LRIG1__no_interaction	leucine__SOCS4__no_interaction	leucine__SOCS5__no_interaction	leucine__suppressor of cytokine signaling 3__no_interaction	leucine__SNT-2__no_interaction	leucine__FRS3__no_interaction	leucine__suc1-associated neurotrophic factor target-2__no_interaction	leucine__SOCS3__no_interaction	leucine__FRS2beta__no_interaction
18762369-869	Novel homo- and hetero-nuclear <compound-id="23978">copper</compound-id> (II) complexes of tetradentate Schiff bases: synthesis, characterization, solvent-extraction and <protein-id="O24339,O52762,O62839,O68146,O77229,O93662,O97492,P00432,P04040,P04762,P07145,P0A323,P0A324,P0A325,P0A326,P0A327,P11934,P17336,P24168,P24270,P25890,P29422,P30265,P30266,P32290,P42321,P44390,P45737,P45739,P55304,P55306,P55310,P55311,P55313,P77872,P81138,P90682,Q27710,Q49XC1,Q4L643,Q59296,Q59337,Q59602,Q59714,Q5HG86,Q5HPK8,Q5RF10,Q64405,Q6G9M4,Q6GH72,Q7A5T2,Q8CPD0,Q8FWU0,Q8NWV5,Q8X1P0,Q8Y3P9,Q926X0,Q99UE2,Q9AXH0,Q9KW19,Q9L4S1,Q9M5L6,Q9PT92,Q9PWF7,Q9Z598,Q9ZKX5,Q9ZN99">catalase</protein-id>-like activity studies.	copper__catalase__no_interaction
18762913-991	In streptozotocin-nicotinamide-induced diabetic mice, ASP8497 was administered orally for 3 weeks at 1, 3, or 10 mg/kg once daily, which improved the <protein-id="Q42665">hemoglobin A</protein-id> (1c), non-fasting plasma <protein-id="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7">insulin</protein-id>, fasting blood <compound-id="206,5793,64689,79025">glucose</compound-id> levels, <compound-id="206,5793,64689,79025">glucose</compound-id> intolerance, and lipid profiles (plasma triglyceride, non-esterified fatty acid and total <compound-id="304,5997,6432564,11025495">cholesterol</compound-id>) with neutral effect on body weight.	glucose__insulin__no_interaction	glucose__hemoglobin A__no_interaction	cholesterol__hemoglobin A__no_interaction	cholesterol__insulin__no_interaction
18762977-1011	The laboratory findings of the cases were compatible with VDDR; serum calcium (Ca) 7.5+/-1.9 mg/dL, <compound-id="1061">PO4</compound-id> 4.4+/-1.3 mg/dL, <protein-id="O60109,P81800,P83456">alkaline phosphatase</protein-id> (<protein-id="P03973,P12547,P22298,P28296,P29118,P35211,P83610,P97430,Q03420,Q53GG5,Q9H0A0,Q9PU47,Q9Z1X0">ALP</protein-id>) 1,341+/-823, <compound-id="5283731,6433735">25-hydroxyvitamin D</compound-id> (25 (OH) D) 5.8+/-2.9 ng/mL, intact parathyroid hormone (iPTH) 240+/-106 pg/mL.	25-hydroxyvitamin D__ALP__no_interaction	25-hydroxyvitamin D__alkaline phosphatase__no_interaction	PO4__ALP__no_interaction	PO4__alkaline phosphatase__no_interaction
18763027-1031	There are no controlled trials comparing <protein-id="P20333">etanercept</protein-id> and <compound-id="5284513">acitretin</compound-id> efficacy and therapeutic mechanisms in psoriasis.	acitretin__etanercept__no_interaction
18763047-1035	Oral immunogenicity and protective efficacy in mice of transgenic rice plants producing a vaccine candidate antigen (<compound-id="10196533">As16</compound-id>) of Ascaris suum fused with cholera <protein-id="P01380,P18177,P25669">toxin B</protein-id> subunit.	As16__toxin B__no_interaction
18763168-1076	Inhibition of human poly(A)-specific <protein-id="P00645,P00646,P04061,P13312,P17999,P35078,P37203,P84784,P84844,P84867">ribonuclease</protein-id> (<protein-id="O95453,P69341,Q5RC51,Q9LG26">PARN</protein-id>) by <compound-id="1044">purine</compound-id> nucleotides: kinetic analysis.	purine__ribonuclease__interaction	purine__PARN__interaction
18764779-1509	The aqueous extract was found to be more effective than <compound-id="31703">doxorubicin</compound-id>, a classical anticarcinogenic drug, with respect to its action on antioxidant enzymes and <protein-id="P29038,P33571,P93052,Q27797,Q27888,Q95028,Q99289">LDH</protein-id> in the liver of mice with developing lymphomas.	doxorubicin__LDH__interaction
18764780-1510	Cu,Zn-<protein-id="O50258">superoxide dismutase</protein-id>-driven free radical modifications: <compound-id="23978">copper</compound-id>- and carbonate radical anion-initiated protein radical chemistry.	copper__superoxide dismutase__no_interaction
18764780-1511	The understanding of the mechanism, oxidant(s) involved and how and what protein radicals are produced during the reaction of wild-type <protein-id="O42724,O46412,O59924,O94178,P00441,P00442,P00443,P00445,P04178,P09212,P09670,P33431,P60052,P80566,P93258,Q42684,Q52RN5,Q5FB29,Q6C662,Q6CPE2,Q6FWL5,Q6T3B0,Q711T9,Q751L8,Q7M1R5,Q8HXP8,Q8HXP9,Q8HXQ0,Q8HXQ1,Q8HXQ2,Q8HXQ3,Q8HXQ4,Q8J0N2,Q8J0N3,Q8WNN6,Q96VL0,Q9C0N4,Q9SQL5">SOD1</protein-id> (Cu,Zn-<protein-id="O50258">superoxide dismutase</protein-id>) with <compound-id="784">H2O2</compound-id> and their fate is incomplete, but a better understanding of the role of this reaction is needed.	H2O2__SOD1__interaction	H2O2__superoxide dismutase__interaction
18764780-1512	In the absence of (bi)carbonate, site-specific radical-mediated fragmentation is produced by <protein-id="O42724,O46412,O59924,O94178,P00441,P00442,P00443,P00445,P04178,P09212,P09670,P33431,P60052,P80566,P93258,Q42684,Q52RN5,Q5FB29,Q6C662,Q6CPE2,Q6FWL5,Q6T3B0,Q711T9,Q751L8,Q7M1R5,Q8HXP8,Q8HXP9,Q8HXQ0,Q8HXQ1,Q8HXQ2,Q8HXQ3,Q8HXQ4,Q8J0N2,Q8J0N3,Q8WNN6,Q96VL0,Q9C0N4,Q9SQL5">SOD1</protein-id> active-site <compound-id="23978">copper</compound-id>.	copper__SOD1__interaction
18764780-1513	Finally, we propose a biochemical mechanism to explain CO(*-) production from CO2, enhanced protein radical formation and protection by (bi)carbonate against <compound-id="784">H2O2</compound-id>-induced fragmentation of the <protein-id="O42724,O46412,O59924,O94178,P00441,P00442,P00443,P00445,P04178,P09212,P09670,P33431,P60052,P80566,P93258,Q42684,Q52RN5,Q5FB29,Q6C662,Q6CPE2,Q6FWL5,Q6T3B0,Q711T9,Q751L8,Q7M1R5,Q8HXP8,Q8HXP9,Q8HXQ0,Q8HXQ1,Q8HXQ2,Q8HXQ3,Q8HXQ4,Q8J0N2,Q8J0N3,Q8WNN6,Q96VL0,Q9C0N4,Q9SQL5">SOD1</protein-id> active site.	H2O2__SOD1__interaction
18764784-1516	Furthermore, lysosomal integrity was disrupted after addition of <compound-id="2788">clioquinol</compound-id> and zinc to the cells, as shown by redistribution of both <compound-id="62344">Acridine Orange</compound-id> and cathepsin D. <compound-id="2788">Clioquinol</compound-id> plus zinc resulted in a cleavage of Bid (<protein-id="P55957,P70444,Q4JHS0,Q8JGM8,Q9JLT6">BH3-interacting domain death agonist</protein-id>), a hallmark of lysosome-mediated apoptotic cell death.	Clioquinol__BH3-interacting domain death agonist__no_interaction	clioquinol__BH3-interacting domain death agonist__no_interaction	Acridine Orange__BH3-interacting domain death agonist__no_interaction
18764864-1538	<compound-id="68156">Imidazoline</compound-id>-induced amplification of <compound-id="206,5793,64689,79025">glucose</compound-id>- and <compound-id="2551">carbachol</compound-id>-stimulated <protein-id="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7">insulin</protein-id> release includes a marked suppression of islet nitric oxide generation in the mouse.	carbachol__insulin__interaction	glucose__insulin__interaction	Imidazoline__insulin__interaction
18764923-1564	The picture of signalling mechanisms underlying the wound-regulated <protein-id="P46310,P48618,P48620,P48621">FAD7</protein-id> expression, and potential roles of <protein-id="P26602,P81711,Q0TA23,Q0VTA8,Q142T1,Q1BUR8,Q1C0T7,Q1CE94,Q1GXB4,Q1LIU6,Q1QE02,Q1QSG3,Q1R3P7,Q21U27,Q2L1H6,Q2NR06,Q2SZY9,Q2Y5S2,Q31DN1,Q31TU7,Q327U6,Q39E37,Q3IHW4,Q3SLJ3,Q3YUU5,Q46XB3,Q47AZ9,Q48AM0,Q48BQ6,Q4FUZ9,Q4K3M0,Q4ZLB5,Q57GZ4,Q5E206,Q5P5L9,Q5PL18,Q5QUP2,Q609A0,Q62ID2,Q63W06,Q66FH1,Q6D9I9,Q6F9N7,Q6FZ67,Q6G5M1,Q6LVS4,Q70C33,Q7MQ88,Q7MZB5,Q7VZD6,Q7WAC9,Q7WJH0,Q82TP3,Q83F94,Q83IP6,Q87KM8,Q87U40,Q88C66,Q8DD50,Q8EKG2,Q8FB35,Q8XEC3,Q8XVQ0,Q8Z1T7,Q8ZJ20,Q8ZKI0,Q9CMB5,Q9FD32,Q9HTK1,Q9KVP6">CPL</protein-id> proteins as attenuators of wound-induced <compound-id="5281166">JA</compound-id> biosynthesis, are discussed.	JA__CPL__interaction	JA__FAD7__no_interaction
18765263-1705	KiSS-1 mRNA was significantly increased by seizure activity in rats and when neuronal activity in organotypic hippocampal slice cultures was enhanced by <compound-id="10255">kainate</compound-id> or <compound-id="31304,518601,5311359,5458938,6473767,24867522,57402144">picrotoxin</compound-id>, while mRNA for <protein-id="Q6BD04,Q969F8">GPR54</protein-id> remained essentially unchanged.	picrotoxin__GPR54__no_interaction	kainate__GPR54__no_interaction
18765295-1718	In permeabilized muscle fibers, we observed, a strong inhibition of both state 3 mitochondrial respiration and functionally isolated maximal <protein-id="O07091,O13393,O22642,O93863,P00002,P00003,P00004,P00007,P00008,P00011,P00012,P00013,P00014,P00017,P00018,P00019,P00020,P00021,P00022,P00024,P00025,P00027,P00028,P00029,P00030,P00031,P00032,P00035,P00036,P00037,P00038,P00039,P00040,P00041,P00042,P00043,P00046,P00047,P00048,P00049,P00051,P00052,P00053,P00054,P00055,P00056,P00057,P00058,P00059,P00060,P00061,P00062,P00063,P00064,P00065,P00066,P00067,P00068,P00069,P00070,P00071,P00072,P00073,P00074,P00075,P00076,P00077,P00078,P00079,P12831,P15451,P18822,P19681,P19974,P21665,P22342,P25400,P29380,P32556,P38091,P53698,P56205,P59218,P62772,P62773,P62894,P62895,P62896,P67881,P67882,P68096,P68097,P68098,P68099,P68100,P68517,P68518,P68519,P81280,P81459,P99998,P99999,Q41346,Q4HVX7,Q52V08,Q52V09,Q52V10,Q5RFH4,Q640U4,Q6C9Q0,Q6IQM2,Q6Q4H8,Q6QLW4,Q6WUX8,Q753F4,Q7YR71,Q96VP3">cytochrome c</protein-id> oxidase (<protein-id="P11353,P36551,P36552,Q9UTE2,Q9V3D2">COX</protein-id>) activity after 49 days of <compound-id="6860">MeHg</compound-id> exposure.	MeHg__COX__interaction	MeHg__cytochrome c__interaction
18765678-1803	The dominant positive regulator of mTORC1 is the <compound-id="6830">GTP</compound-id>-charged form of the <protein-id="P03967,P22126,Q07152">ras</protein-id>-like GTPase <protein-id="Q62639,Q921J2,Q9VND8">Rheb</protein-id>.	GTP__ras__interaction	GTP__Rheb__interaction
18765678-1804	In contrast, amino acids, especially leucine, regulate mTORC1 by controlling the ability of <protein-id="Q62639,Q921J2,Q9VND8">Rheb</protein-id>-<compound-id="6830">GTP</compound-id> to activate mTORC1.	GTP__Rheb__interaction
18765850-1867	<compound-id="5754">Cortisol</compound-id>, hematocrit, blood urea nitrogen, total protein, albumin, <protein-id="O33822,O58489,O67781,O86459,O93744,P00509,P14909,P23034,P44425,P53001,P58661,P72173,Q4J8X2,Q55128,Q56114,Q56232,Q59228,Q60013,Q92JE7,Q972A2,Q9V0L2,Q9X0Y2,Q9ZE56">aspartate aminotransferase</protein-id> 0.05) after transport regardless of space allowance.	Cortisol__aspartate aminotransferase__no_interaction
18766172-2008	At 2 h in suspension, keratinocytes that had become committed to terminal differentiation had increased side scatter, were <compound-id="65180">7-aminoactinomycin D</compound-id> (7-<protein-id="P23670,P81336,Q01752,Q7NSA6,Q8XR10,Q9EYI7,Q9RPK1">AAD</protein-id>) positive and <protein-id="P08758,P14668,P17153,P48036,P70075,P81287,Q4R4H7,Q5R1W0">annexin V</protein-id> negative; they exhibited loss of mitochondrial membrane potential and increased cardiolipin oxidation, but with no increase in reactive oxygen species.	7-aminoactinomycin D__AAD__no_interaction	7-aminoactinomycin D__annexin V__no_interaction
18766385-2075	Iron uptake by the ubiquitous iron-storage protein <protein-id="Q26061">ferritin</protein-id> involves the oxidation of two <compound-id="27284">Fe(II</compound-id>) ions located at the highly conserved dinuclear " <protein-id="P00450,P13635,Q61147,Q9XT27">ferroxidase</protein-id> centre" in individual subunits.	Fe(II__ferroxidase__interaction	Fe(II__ferritin__interaction
18766385-2076	We have measured X-ray absorption spectra of four mutants (K86Q, K86Q/E27D, K86Q/E107D, and K86Q/E27D/E107D, involving variations of Glu to Asp on either or both sides of the dinuclear <protein-id="P00450,P13635,Q61147,Q9XT27">ferroxidase</protein-id> site) of recombinant human H-chain <protein-id="Q26061">ferritin</protein-id> (rHuHF) in their complexes with reactive <compound-id="27284">Fe(II</compound-id>) and redox-inactive <compound-id="32051">Zn(II</compound-id>).	Zn(II__ferritin__interaction	Fe(II__ferroxidase__interaction	Zn(II__ferroxidase__interaction	Fe(II__ferritin__interaction
18766955-2250	The aim of this study was to determine the effect of <compound-id="5833">spironolactone</compound-id> on endothelial function in anti-tumour necrosis factor (<protein-id="O35734,O77510,O77764,P01375,P04924,P13296,P19101,P23383,P23563,P29553,P33620,P36939,P48094,P51435,P51742,P51743,P59684,P59693,P59694,P59695,P79337,P79374,Q06599,Q19LH4,Q1G1A2,Q1WM27,Q2MH05,Q539C2,Q75N23,Q8HZD9,Q8JFG3,Q8MKG8,Q8WNR1,Q9BEA1">TNF</protein-id>)-naive RA patients.	spironolactone__TNF__interaction
18767058-2287	Compared with nonperfused constructs, flow perfused constructs demonstrated improved cells proliferation and differentiation according to cell viability, <compound-id="206,5793,64689,79025">glucose</compound-id> consumption, <protein-id="O60109,P81800,P83456">alkaline phosphatase</protein-id> activity, and osteopontin.	glucose__alkaline phosphatase__no_interaction
18767059-2288	Behavior of rat periodontal ligament cells on <protein-id="Q60487">fibroblast growth factor-2</protein-id>-immobilized <compound-id="23963">titanium</compound-id> surfaces treated by plasma modification.	titanium__fibroblast growth factor-2__interaction
18767059-2289	The aim of this study was to investigate the behavior of rat periodontal ligament (PDL) cells cultured on <protein-id="Q60487">fibroblast growth factor-2</protein-id> (<protein-id="P03969,P20003,P48800,Q60487">FGF-2</protein-id>)-immobilized <compound-id="23963">titanium</compound-id> surfaces treated by <compound-id="977">oxygen</compound-id> (<compound-id="977,5359597">O2</compound-id>) plasma.	oxygen__FGF-2__no_interaction	O2__FGF-2__no_interaction	oxygen__fibroblast growth factor-2__no_interaction	titanium__FGF-2__interaction	O2__fibroblast growth factor-2__no_interaction	titanium__fibroblast growth factor-2__interaction
18767059-2290	These were treated with <compound-id="977">oxygen</compound-id> plasma and dipped in <protein-id="P03969,P20003,P48800,Q60487">FGF-2</protein-id> solution.	oxygen__FGF-2__no_interaction
18767059-2291	Cells from fourth subculture were seeded onto the <protein-id="P03969,P20003,P48800,Q60487">FGF-2</protein-id>-immobilized <compound-id="23963">titanium</compound-id> surface.	titanium__FGF-2__interaction
18767059-2292	These findings suggest that <compound-id="977">oxygen</compound-id> plasma modification can immobilize <protein-id="P03969,P20003,P48800,Q60487">FGF-2</protein-id> onto a <compound-id="23963">titanium</compound-id> surface.	oxygen__FGF-2__interaction	titanium__FGF-2__interaction
18767063-2297	One of the best triads for bone engineering is bone marrow stromal cells, <compound-id="24441,24456,24632">calcium phosphate</compound-id> ceramics, and bone <protein-id="P07580">morphogenetic protein</protein-id> (<protein-id="P35855">BMP</protein-id>).	calcium phosphate__morphogenetic protein__no_interaction	calcium phosphate__BMP__no_interaction
18767063-2298	The cells were mixed with <compound-id="24456">beta-tricalcium phosphate</compound-id> (beta-TCP) granules followed by osteoblast induction with recombinant human <protein-id="O19006,O46564,P12643,P21274,P49001,Q804S2,Q90751">BMP-2</protein-id> (rhBMP-2) (first mixture), or were first induced with rhBMP-2 on plastic dishes and then mixed with the beta-TCP granules (last mixture) just prior to the operation.	beta-tricalcium phosphate__BMP-2__no_interaction
18767136-1171	Effect of short-time exposures to <compound-id="935">nickel</compound-id> and lead on brain <protein-id="P49253">monoamine oxidase</protein-id> from Danio rerio and Poecilia reticulata.	nickel__monoamine oxidase__no_interaction
18767136-1172	The aim of this work was to verify, in two small size freshwater teleosts Danio rerio and Poecilia reticulata, the effects of short-time exposures (24 and 72 h) to a sublethal dose (500 microg/L) of <compound-id="935">nickel</compound-id> and lead, on brain <protein-id="P49253">monoamine oxidase</protein-id> (<protein-id="P49253">MAO</protein-id>), an important neural enzyme.	nickel__MAO__no_interaction	nickel__monoamine oxidase__no_interaction
18767138-2325	<protein-id="O84081,O96553,P07245,P09440,P11586,P24186,P27653,P44313,P47259,P51696,P54382,P55818,P56467,P57557,P58688,P75096,P96050,Q05213,Q27772,Q60006,Q89A92,Q8K979,Q922D8,Q92HY4,Q9PKW1,Q9Z8K3,Q9ZD32,Q9ZLQ4">Methylenetetrahydrofolate dehydrogenase</protein-id>) <protein-id="O84081,O96553,P07245,P09440,P11586,P13995,P18155,P24186,P27653,P44313,P47259,P51696,P54382,P56467,P57557,P58688,P75096,P96050,Q04448,Q05213,Q27772,Q49135,Q5ZKA5,Q60006,Q89A92,Q8K979,Q922D8,Q92HY4,Q9PKW1,Q9Z8K3,Q9ZD32,Q9ZLQ4">methenyltetrahydrofolate cyclohydrolase</protein-id>) <protein-id="O66164,O96553,P07245,P09440,P11586,P13419,P21164,P27653,P28723,Q07064,Q27772,Q3Z8K3,Q3ZX40,Q4FL49,Q4JVW2,Q4L776,Q59925,Q5E3V8,Q5FAG1,Q5HF42,Q5HNH4,Q5LD60,Q5LNV0,Q5M083,Q5M4U2,Q5NQC7,Q5V5Y2,Q5XZD9,Q605Q9,Q63C61,Q64U80,Q65IA6,Q67JH9,Q6ABS5,Q6AL19,Q6G8J5,Q6GFX6,Q6HJK9,Q6KZM3,Q6LNJ0,Q6NH87,Q71YD9,Q72GY9,Q739F4,Q73RR6,Q74JC1,Q7A535,Q7MEE8,Q7MUZ8,Q7VLW6,Q81E87,Q81RE1,Q834D6,Q83WS0,Q87HX2,Q88W76,Q891R3,Q8A9S8,Q8CNV9,Q8D7D8,Q8DPL5,Q8DZP5,Q8E5E3,Q8EJA7,Q8EUQ1,Q8G700,Q8NW37,Q8R7L3,Q8RHF4,Q8XHL4,Q8Y624,Q922D8,Q92AD2,Q92N42,Q97CL3,Q97EB3,Q97QI2,Q98HQ4,Q99TD2,Q9CH07,Q9HI67,Q9JVY8,Q9JXY2,Q9KLX7,Q9PQS1,Q9SPK5,Q9X287">formyltetrahydrofolate synthetase</protein-id> (<protein-id="P11586">MTHFD1</protein-id>) is a trifunctional enzyme that interconverts <compound-id="91443">tetrahydrofolate</compound-id> (THF) derivatives for nucleotide synthesis.	tetrahydrofolate__methenyltetrahydrofolate cyclohydrolase__interaction	tetrahydrofolate__MTHFD1__interaction	tetrahydrofolate__Methylenetetrahydrofolate dehydrogenase__interaction	tetrahydrofolate__formyltetrahydrofolate synthetase__interaction
18767147-1187	An oncogenetic tree model was built using data on mutations of <protein-id="O09185,O12946,O36006,O57538,O93379,P04637,P10360,P13481,P25035,P41685,P51664,P56423,P56424,P61260,P67938,P67939,P79820,P79892,Q00366,Q29480,Q29537,Q64662,Q8SPZ3,Q92143,Q95330,Q9TTA1,Q9TUB2,Q9W678,Q9W679,Q9WUR6">TP53</protein-id>, <protein-id="P01116">KRAS2</protein-id>, <protein-id="P25054">APC</protein-id>, and <protein-id="P15056,P34908,Q04982">BRAF</protein-id> genes, methylation at <compound-id="6804">CpG</compound-id> sites of <protein-id="P38920,P40692">MLH1</protein-id> and TP16 genes, methylation in tumor (MINT) markers, and microsatellite instability (MSI) for 971 colon tumors from a population-based series.	CpG__BRAF__no_interaction	CpG__APC__no_interaction	CpG__MLH1__interaction	CpG__KRAS2__no_interaction	CpG__TP53__no_interaction
18767149-2331	We characterized this selenoprotein <protein-id="O25011,O26635,O69761,O83641,P0A081,P0A082,P0A083,P0A084,P0A085,P0A086,P0A3Q9,P0A3R0,P0A5L0,P0A5L1,P0A744,P0A745,P23212,P47648,P54154,P65443,P65444,P75188,Q4J9L3,Q53W34,Q576P8,Q5HG58,Q5HVD4,Q5PJ81,Q5XDH1,Q66F89,Q6D151,Q6L2S4,Q6LV65,Q6LYY1,Q6NEL2,Q71YF6,Q746G0,Q7MYW1,Q87D27,Q87SW6,Q88AI5,Q88QZ8,Q899M3,Q8DE84,Q8DSY4,Q8DYH1,Q8E434,Q8FAG4,Q8FLU6,Q8FUZ0,Q8NLL5,Q8P272,Q8PCA6,Q8PNY8,Q8PUD6,Q8TQV6,Q8VS50,Q8XCG3,Q8XH97,Q8Y1C6,Q8Y640,Q8YDE7,Q8Z150,Q8ZB94,Q8ZK71,Q92AE8,Q93KF3,Q93S39,Q97MV3,Q97Y45,Q98PE5,Q99YT1,Q9A149,Q9AJF7,Q9APY4,Q9CCZ3,Q9CN40,Q9EWF7,Q9HQG0,Q9HUF1,Q9KAN8,Q9KP30,Q9LAM9,Q9PC45,Q9PQK2,Q9RTB6,Q9ZEQ8,Q9ZMK8">MsrA</protein-id> which had a single Sec residue at the catalytic site but no <compound-id="594,5862,5360637">cysteine</compound-id> (Cys) residues in the protein sequence.	cysteine__MsrA__no_interaction
18767150-2332	Zn2+-linked dimerization of <protein-id="O54424,P0A4R7,P0A4R8,P0A664,P0A665,P18319,P42871,P42877,P44396,P69992,P69993,P72955,Q03287,Q06206,Q07403,Q09066,Q55057,Q56561,Q9ZMZ7">UreG</protein-id> from Helicobacter pylori, a chaperone involved in <compound-id="935">nickel</compound-id> trafficking and <protein-id="O00084,O13465,P07374,P08298,Q5KCQ6,Q6A3P9">urease</protein-id> activation.	nickel__UreG__interaction	nickel__urease__no_interaction
18767150-2333	The biosynthesis of the active metal-bound form of the nickel-dependent enzyme <protein-id="O00084,O13465,P07374,P08298,Q5KCQ6,Q6A3P9">urease</protein-id> involves the formation of a <compound-id="866,5962">lysine</compound-id>-<compound-id="277">carbamate</compound-id> functional group concomitantly with the delivery of two <compound-id="934">Ni(2</compound-id>+) ions into the precast active site of the apoenzyme and with GTP hydrolysis.	lysine__urease__interaction	Ni(2__urease__interaction	carbamate__urease__interaction
18767155-2335	Residue-wise conformational stability of <protein-id="P63167,P63168,P63169,P63170,Q9D0M5">DLC8</protein-id> dimer from native-state <compound-id="783">hydrogen</compound-id> exchange.	hydrogen__DLC8__interaction
18767934-15	Whereas the role of locally produced 1, <compound-id="5283731,6433735">25-dihydroxyvitamin D</compound-id> is not yet clear, it is possible that it contributes importantly to <compound-id="5280795">vitamin D</compound-id>-mediated inhibition of parathyroid cell growth, so <protein-id="O15528">CYP27B1</protein-id> can be considered a candidate parathyroid tumor suppressor gene in that its acquired inactivation in a parathyroid cell could confer a tumorigenic growth advantage.	25-dihydroxyvitamin D__CYP27B1__no_interaction	vitamin D__CYP27B1__no_interaction
18768213-91	Mechanistically, we showed EphA2 knockdown suppressed <protein-id="P84122">thrombin</protein-id>-induced <compound-id="5951">serine</compound-id> 536 phosphorylation of NFkappaB, an event critical of <protein-id="P05362,P13597,P33729,Q00238,Q28806,Q5NKV4,Q5NKV6,Q5NKV9,Q95132">ICAM-1</protein-id> transcriptional upregulation.	serine__thrombin__interaction	serine__ICAM-1__interaction
18768362-173	Total antioxidant capacity, <protein-id="O24339,O52762,O62839,O68146,O77229,O93662,O97492,P00432,P04040,P04762,P07145,P0A323,P0A324,P0A325,P0A326,P0A327,P11934,P17336,P24168,P24270,P25890,P29422,P30265,P30266,P32290,P42321,P44390,P45737,P45739,P55304,P55306,P55310,P55311,P55313,P77872,P81138,P90682,Q27710,Q49XC1,Q4L643,Q59296,Q59337,Q59602,Q59714,Q5HG86,Q5HPK8,Q5RF10,Q64405,Q6G9M4,Q6GH72,Q7A5T2,Q8CPD0,Q8FWU0,Q8NWV5,Q8X1P0,Q8Y3P9,Q926X0,Q99UE2,Q9AXH0,Q9KW19,Q9L4S1,Q9M5L6,Q9PT92,Q9PWF7,Q9Z598,Q9ZKX5,Q9ZN99">catalase</protein-id>, <compound-id="2723628">thiobarbituric acid</compound-id>-reactive substances, <protein-id="P15160,P17724,P73925,Q03459">hemoglobin</protein-id>, <protein-id="P02787,P09571,P12346,P19134,P27425,Q29443,Q921I1">transferrin</protein-id> saturation and <protein-id="Q26061">ferritin</protein-id> did not change significantly.	thiobarbituric acid__ferritin__no_interaction	thiobarbituric acid__transferrin__no_interaction	thiobarbituric acid__catalase__no_interaction	thiobarbituric acid__hemoglobin__no_interaction
18768916-385	Considering the post-cAMP sites of HA action, it is shown herein that HA markedly inhibited db-cAMP-stimulated steroidogenic acute regulatory (STAR) protein expression, as well as steps catalyzed by P450-dependent enzymes, mainly the conversion of <compound-id="304,5997,6432564,11025495">cholesterol</compound-id> to <compound-id="8955">pregnenolone</compound-id> by <protein-id="O46515,P00189,P05108,P10612,P14137,P79153,P79202,Q07217,Q28827,Q2XV99,Q92045,Q9EPT4,Q9QZ82">cholesterol side-chain cleavage enzyme</protein-id> (<protein-id="P05108,Q2XV99,Q9EPT4">CYP11A</protein-id>).	pregnenolone__CYP11A__interaction	cholesterol__cholesterol side-chain cleavage enzyme__interaction	cholesterol__CYP11A__interaction	pregnenolone__cholesterol side-chain cleavage enzyme__interaction
18768916-386	Finally, HA increased <protein-id="O61309,O61608,Q27571,Q9I9M2">nitric oxide synthase</protein-id> (NOS) activity, and the NOS inhibitor NG-nitro-<compound-id="550788">L-arginine methyl ester</compound-id> (L-NAME) markedly attenuated the effect of the amine on steroid synthesis.	L-arginine methyl ester__nitric oxide synthase__no_interaction
18769443-565	LH, FSH, 17 <compound-id="5757">beta-estradiol</compound-id>, <compound-id="5994">progesterone</compound-id>, aldosterone and <protein-id="P06703,P10977">PRA</protein-id> were assayed at the seventh, fourteenth, twenty-first and twenty-eighth days of the cycle after 30 min of recumbency.	beta-estradiol__PRA__no_interaction	progesterone__PRA__no_interaction
18769443-566	Aldosterone was positively related to <protein-id="P06703,P10977">PRA</protein-id> and <compound-id="5994">progesterone</compound-id>.	progesterone__PRA__no_interaction
18769474-571	<protein-id="O23760,O81646,O82054,P21964,P28002,P46484,Q06509,Q06528,Q43239,Q43609,Q6ZD89,Q8GU25,Q8LL87,Q8W013,Q99028,Q9FQY8,Q9SWC2">COMT</protein-id> activity and <compound-id="614,8988,145742">proline</compound-id> levels may therefore be altered in 22q11DS individuals.	proline__COMT__no_interaction
18769474-572	<protein-id="O23760,O81646,O82054,P21964,P28002,P46484,Q06509,Q06528,Q43239,Q43609,Q6ZD89,Q8GU25,Q8LL87,Q8W013,Q99028,Q9FQY8,Q9SWC2">COMT</protein-id> (158) genotype and plasma <compound-id="614,8988,145742">proline</compound-id> levels were determined in the 22q11DS children.	proline__COMT__no_interaction
18769875-666	We have investigated its antibacterial activity and binding activity to pathogenic whole cell antigens, <compound-id="11970143">lipopolysaccharide</compound-id> (LPS) and staphylococcal <protein-id="P22542">enterotoxin B</protein-id>.	lipopolysaccharide__enterotoxin B__no_interaction
18770028-698	Quinone formation is closely linked to other representative hypotheses such as mitochondrial dysfunction, inflammation, oxidative stress, and dysfunction of the <protein-id="O46543,P08565,P08618,P0C014,P0C072,P13117,P14624,P14792,P15174,P19848,P20685,P22589,P23324,P23398,P42739,P42740,P46574,P49634,P49635,P59263,P59669,P61862,P61863,P61864,P62972,P62973,P62974,P62975,P62976,P62977,P62988,P62989,P62990,P62991,P63049,P63051,P68195,P68196,P68197,P68198,P68199,P68201,P68204,P69308,P69309,P69310,P69311,P69312,P69313,P69314,P69315,P69316,P69317,P69318,P69319,P69320,P69321,P69322,P69323,P69324,P69325,P69326,P84589,Q05550,Q865C5,Q867C2,Q867C3,Q867C4,Q8MKD1,Q9Y848">ubiquitin</protein-id>-proteasome system, in the pathogenesis of neurodegenerative diseases such as Parkinson's disease and <compound-id="1206,10836,36604">methamphetamine</compound-id>-induced neurotoxicity.	methamphetamine__ubiquitin__no_interaction
18771337-1073	The effect of <compound-id="31200">fenitrothion</compound-id> exposure on birds was examined by measuring aerobic metabolism, blood <protein-id="P15160,P17724,P73925,Q03459">hemoglobin</protein-id> content, plasma <protein-id="P32749,P32750,P32751,P32752,P32753,P81908">cholinesterases</protein-id>, and body weight for up to 21 d postdose.	fenitrothion__cholinesterases__interaction	fenitrothion__hemoglobin__interaction
18771515-1111	Of the 37 E. coli isolated from diarrhoeic calves, <compound-id="49837850">K99</compound-id> (18.9%), <compound-id="760826">F41</compound-id> (18.9%), heat-stable <protein-id="P54355,P80567,P80568">enterotoxin</protein-id> a (STa) (18.9%), Shiga <protein-id="P45629">toxin 1</protein-id> (Stx1; 13.5%) and Shiga toxin 2 (<protein-id="P50279,Q00262">Stx2</protein-id> ; 5.4%) and <protein-id="O31000,P19809,P43261,P52869,Q07591">intimin</protein-id> (8.1%) genes were identified by multiplex <protein-id="O66148,O80333,P15904,Q01289,Q39617,Q41249,Q59987,Q9SDT1">PCR</protein-id>.	K99__toxin 1__no_interaction	K99__Stx2__no_interaction	F41__intimin__no_interaction	F41__toxin 1__no_interaction	K99__enterotoxin__no_interaction	F41__PCR__no_interaction	K99__PCR__no_interaction	F41__enterotoxin__no_interaction	F41__Stx2__no_interaction	K99__intimin__no_interaction
18771515-1112	Of the 18 E. coli isolated from healthy calves, <compound-id="49837850">K99</compound-id> (16.6%) and <protein-id="O31000,P19809,P43261,P52869,Q07591">intimin</protein-id> (55.5%) genes were identified by <protein-id="O66148,O80333,P15904,Q01289,Q39617,Q41249,Q59987,Q9SDT1">PCR</protein-id>.	K99__PCR__no_interaction	K99__intimin__no_interaction
18771515-1113	<compound-id="49837850">K99</compound-id>, <compound-id="760826">F41</compound-id>, STa, Stx1 and <protein-id="P50279,Q00262">Stx2</protein-id> were found as the most common virulence gene markers of E. coli strains isolated from calves with diarrhoea.	K99__Stx2__no_interaction	F41__Stx2__no_interaction
18771570-1136	These agents possess a range of physiological effects that are associated with improved glycaemic control in diabetes including stimulation of <compound-id="206,5793,64689,79025">glucose</compound-id>-dependent <protein-id="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7">insulin</protein-id> secretion, suppression of <protein-id="O12956,O42143,O42144,P01272,P01273,P01274,P01275,P04093,P05110,P06883,P07449,P09566,P09567,P09682,P09686,P0C235,P13189,P15438,P18108,P22890,P29794,P31297,P33528,P55095,P68259,P68260,P68273,P68274,P68275,P68952,P68953,P68954,P68955,P68956,P68957,P79695,P81880,Q8MJ25,Q9PRQ9">glucagon</protein-id> secretion, slowing of gastric emptying, and reduction of food intake.	glucose__insulin__interaction	glucose__glucagon__no_interaction
18771604-1158	Induction of the spliced form of <protein-id="P17861,P40489">XBP1</protein-id> as well as total <protein-id="P17861,P40489">XBP1</protein-id> by <compound-id="446378">thapsigargin</compound-id> was significantly attenuated in patients with BD.	thapsigargin__XBP1__interaction
18771604-1159	Induction of <protein-id="O18750,P08113,P08712,P14625,P41148,Q29092,Q95M18">GRP94</protein-id> by <compound-id="446378">thapsigargin</compound-id> was also decreased in the BD group.	thapsigargin__GRP94__interaction
18771683-1179	Efforts in the field of synthetic vaccine carriers are focussing on decorating the particle surface with ligands for DC receptors such as heparan <compound-id="1117">sulphate</compound-id> glycosaminoglycan structures, integrins, Siglecs, <protein-id="Q801X7">galectins</protein-id>, C-type <protein-id="P02871,P02873,P02874,P02875,P07386,P16108,P16349,P16351,P16352,P33888,P38662,P42088,P83410,P83511,P84987,Q41114">lectins</protein-id> and toll-like receptors.	sulphate__lectins__no_interaction	sulphate__galectins__no_interaction
18771795-1211	Reversal of the inhibitory effect of <compound-id="5282448">fondaparinux</compound-id> on <protein-id="P84122">thrombin</protein-id> generation by rFVIIa, aPCC and <compound-id="62529">PCC</compound-id>.	fondaparinux__thrombin__interaction	PCC__thrombin__interaction
18771857-1234	It appears that <protein-id="P09488,P16413,Q9N0V4,Q9TSM5">GSTM1</protein-id> null and <protein-id="P20135,P30711,Q2NL00">GSTT1</protein-id> null have a clear association with longer overall survival in patients with different malignancies who are treated with substrates for these <protein-id="P20432,P30104,P30106,P30107,P30108,Q04522,Q0ZS46,Q7REH6,Q8ILQ7,Q8MU52">GSTs</protein-id> (mostly alkylating agents and <compound-id="23939">platinum compounds</compound-id>).	platinum compounds__GSTs__interaction	platinum compounds__GSTT1__interaction	platinum compounds__GSTM1__interaction
18771904-1247	<compound-id="5213,31553,3086637,16211710">Silibinin</compound-id> attenuates antigen-specific IgE production through the modulation of <protein-id="Q64279,Q922L6">Th1</protein-id>/Th2 balance in ovalbumin-sensitized BALB/c mice.	Silibinin__Th1__interaction
18771904-1248	BALB/c mice were either left untreated or administered daily with vehicle (VH; saline) and/or <compound-id="5213,31553,3086637,16211710">silibinin</compound-id> (200 or 400 mg/kg) by gavage for 3 consecutive days prior to sensitization with <protein-id="O73860,P01012,P19104,Q6V115">ovalbumin</protein-id> (OVA).	silibinin__ovalbumin__no_interaction
18772236-1315	Treatment with <compound-id="23931">HG</compound-id>, but not equimolar <compound-id="6251">mannitol</compound-id> or 3-O-methyl <compound-id="206,5793,64689,79025">glucose</compound-id>, resulted in phosphorylation and activation of <protein-id="O77636,P78536,Q9Z0F8,Q9Z1K9">TNF-alpha converting enzyme</protein-id> (<protein-id="O77636,P78536">TACE</protein-id>) (<protein-id="O77636,P78536">ADAM17</protein-id>), which were attenuated by <compound-id="337359">sorbinil</compound-id> or AR-specific small interference RNA.	HG__ADAM17__interaction	mannitol__TNF-alpha converting enzyme__no_interaction	glucose__TACE__no_interaction	sorbinil__TNF-alpha converting enzyme__interaction	HG__TNF-alpha converting enzyme__interaction	mannitol__ADAM17__no_interaction	sorbinil__ADAM17__interaction	glucose__TNF-alpha converting enzyme__no_interaction	HG__TACE__interaction	sorbinil__TACE__interaction	glucose__ADAM17__no_interaction	mannitol__TACE__no_interaction
18772236-1316	These results indicate that <compound-id="23931">HG</compound-id>-induced <protein-id="O35734,O77510,O77764,P01375,P04924,P06804,P13296,P16599,P19101,P23383,P23563,P29553,P33620,P36939,P48094,P51435,P51742,P51743,P59684,P59693,P59694,P59695,P79337,P79374,Q06599,Q19LH4,Q1G1A2,Q1WM27,Q2MH05,Q539C2,Q75N23,Q8HZD9,Q8JFG3,Q8MKG8,Q8WNR1,Q9BEA1">TNF-alpha</protein-id> shedding could be attributed to <protein-id="O77636,P78536">TACE</protein-id> activation, which is regulated, in part, by <protein-id="P10829">PKC-delta</protein-id> and AR.	HG__TACE__interaction	HG__TNF-alpha__interaction	HG__PKC-delta__no_interaction
18772240-1321	We conclude that gastrocnemius, heart, and liver mitochondria of streptozotocin diabetic rats are not irrevocably altered toward excess <compound-id="5359597">superoxide</compound-id> production either by <protein-id="Q07842">complex I</protein-id> or complex III.	superoxide__complex I__interaction
18772354-1356	Consequently, the primary mechanism of resistance to <compound-id="5394">temozolomide</compound-id> is a function of the activity of the DNA repair enzyme O(6)-methylguanine DNA <protein-id="O40976,P03588,P03589,P06011,P17769,P20122,P27752,P28726,P28931,Q00020,Q66121,Q83264,Q83270">methyltransferase</protein-id> (<protein-id="O26715,O27970,O59499,O74023,O93728,P0A2U0,P0A2U1,P0A696,P0A697,P0AFH0,P0AFH1,P11742,P16455,P24528,P26186,P26187,P26188,P29177,P44687,P52982,Q4J9C6,Q58924,Q5UNU9,Q6TDU1,Q8PY44,Q8TI34,Q8TZ11,Q8TZV2,Q973C7,Q97VW7,Q9V1N7,Q9ZET8">MGMT</protein-id>).	temozolomide__methyltransferase__interaction	temozolomide__MGMT__interaction
18772483-962	Despite their inhibitory effects on inflammatory gene expression, loss of <protein-id="Q07869">PPARs</protein-id> or LXRs in macrophages did not exert major effects on obesity or <compound-id="206,5793,64689,79025">glucose</compound-id> tolerance induced by a high-fat diet.	glucose__PPARs__no_interaction
18772483-964	Our results do not exclude a contribution of macrophage <protein-id="Q07869">PPAR</protein-id> and LXR expression to systemic metabolism in certain contexts, but these factors do not appear to be dominant contributors to <compound-id="206,5793,64689,79025">glucose</compound-id> tolerance in a high-fat-fed Th1-biased bone marrow transplant model.	glucose__PPAR__no_interaction
18772488-1372	The dark side of <compound-id="6013">testosterone</compound-id> deficiency: II. Type 2 diabetes and <protein-id="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7">insulin</protein-id> resistance.	testosterone__insulin__interaction
18772488-1373	A considerable body of evidence exists suggesting a link among reduced <compound-id="6013">testosterone</compound-id> plasma levels, type 2 diabetes (T2D), and <protein-id="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7">insulin</protein-id> resistance (IR).	testosterone__insulin__interaction
18772488-1376	Androgen therapy of hypogonadal men improves <protein-id="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7">insulin</protein-id> sensitivity, fasting <compound-id="206,5793,64689,79025">glucose</compound-id>, and HbA1c levels.	glucose__insulin__no_interaction
18772894-1473	Effects of <compound-id="5280644,5282796">conjugated linoleic acid</compound-id> plus n-3 <compound-id="56842239">polyunsaturated fatty acids</compound-id> on <protein-id="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7">insulin</protein-id> secretion and estimated <protein-id="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7">insulin</protein-id> sensitivity in men.	polyunsaturated fatty acids__insulin__interaction	conjugated linoleic acid__insulin__interaction
18773149-1572	A mechanism for the bioreduction of H2PtCl6 and PtCl2 into <compound-id="23939">platinum</compound-id> nanoparticles by a <protein-id="P80509,P80510">hydrogenase</protein-id> enzyme from Fusarium oxysporum is proposed.	platinum__hydrogenase__interaction
18773198-1602	Responses of limbic and extrapyramidal <protein-id="P01289,P06767,P19850,P20366,P28498,P28499,P41333,P41539,P41540,P67932,P67933,Q60541">substance P</protein-id> systems to <compound-id="942,89594,157672">nicotine</compound-id> treatment.	nicotine__substance P__interaction
18773247-1624	Radioisotopic localization of (90) <compound-id="23993">Yttrium</compound-id>-ibritumomab tiuxetan in patients with <protein-id="P11836,Q3C2E2">CD20</protein-id>+ non-Hodgkin's lymphoma.	Yttrium__CD20__no_interaction
18773910-1819	We solved the crystal structures of Aquifex aeolicus <protein-id="P31927,P49031,P49903,Q43845,Q43876">SPS</protein-id> and its complex with adenosine 5 '-(alpha,beta-<compound-id="123164">methylene</compound-id>) triphosphate (<compound-id="92199">AMPCPP</compound-id>).	AMPCPP__SPS__interaction	methylene__SPS__interaction
18773910-1820	To identify the amino-acid residues that contribute to <protein-id="P31927,P49031,P49903,Q43845,Q43876">SPS</protein-id> activity, we prepared six mutants of <protein-id="P31927,P49031,P49903,Q43845,Q43876">SPS</protein-id> and examined their <compound-id="107674">selenide</compound-id>-dependent ATP consumption.	selenide__SPS__interaction
18773910-1821	In <protein-id="P31927,P49031,P49903,Q43845,Q43876">SPS</protein-id>. <compound-id="92199">AMPCPP</compound-id>, the N-terminal loop, including the two residues, assumes different conformations ("open" and "closed") between the two subunits.	AMPCPP__SPS__interaction
18773925-1827	The results indicated that <protein-id="O02777,P20272,P21554,P47746,P56971,Q333S9,Q5IS73,Q71SP5,Q801M1,Q9PUI7">CB1</protein-id> receptors within the nucleus accumbens are involved in the acquisition and expression of <compound-id="5288826,5479215">morphine</compound-id>-induced CPP in sensitized rats.	morphine__CB1__interaction
18773927-1828	Effect of <protein-id="Q6BEG6,Q6BEG7,Q9BDJ6,Q9BEF8,Q9EQX0,Q9GKY5,Q9UBU3">obestatin</protein-id> on <protein-id="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7">insulin</protein-id>, <protein-id="O12956,O42143,O42144,P01272,P01273,P01274,P01275,P04093,P05110,P06883,P07449,P09566,P09567,P09682,P09686,P0C235,P13189,P15438,P18108,P22890,P29794,P31297,P33528,P55095,P68259,P68260,P68273,P68274,P68275,P68952,P68953,P68954,P68955,P68956,P68957,P79695,P81880,Q8MJ25,Q9PRQ9">glucagon</protein-id> and <compound-id="16129681,16129706">somatostatin</compound-id> secretion in the perfused rat pancreas.	somatostatin__glucagon__no_interaction	somatostatin__obestatin__interaction	somatostatin__insulin__no_interaction
18773927-1829	The potentiated effect of <protein-id="Q6BEG6,Q6BEG7,Q9BDJ6,Q9BEF8,Q9EQX0,Q9GKY5,Q9UBU3">obestatin</protein-id> on <compound-id="206,5793,64689,79025">glucose</compound-id>-induced <protein-id="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7">insulin</protein-id> output was not observed in the presence of <compound-id="3019">diazoxide</compound-id>, an agent that activates ATP-dependent K(+) channels, thus suggesting that these channels might be sensitive to this peptide.	glucose__insulin__interaction	glucose__obestatin__interaction	diazoxide__insulin__interaction	diazoxide__obestatin__interaction
18773954-1841	Four brain areas (cortex, hippocampus, thalamus and hypothalamus) were analyzed for EB extravasation, water and electrolyte (<compound-id="923,373840">Na</compound-id> (+), K(+), <compound-id="312">Cl</compound-id> (-)) contents, immunostained for albumin and glial fibrillary <protein-id="P01538,P01543,P01544,P01545,P08772,P08943,P09617,P09618,P21742,P32032,Q05806,Q42596,Q42597,Q42838,Q8H0Q5,Q8VZK8,Q9C8D6,Q9SBK8">acidic protein</protein-id> (<protein-id="P03995,P14136,P47819,Q28115">GFAP</protein-id>), and examined for neuronal, glial and axonal alterations using standard light and electron microscopy.	Na__acidic protein__no_interaction	Na__GFAP__no_interaction	Cl__GFAP__no_interaction	Cl__acidic protein__no_interaction
18773955-1842	We administered <compound-id="991">parathion</compound-id> to newborn rats on postnatal days (PN) 1-4 at doses spanning the threshold for detectable <protein-id="P32749,P32750,P32751,P32752,P32753,P81908">cholinesterase</protein-id> inhibition (0.1 mg/kg/day) and the first signs of loss of viability (0.2 mg/kg/day).	parathion__cholinesterase__interaction
18774132-1889	The Arg105 in <protein-id="O95528,Q9BYW1">GLUT10</protein-id> is highly conserved across species and its replacement with <compound-id="594,5862,5360637">cysteine</compound-id> is predicted to be pathogenic.	cysteine__GLUT10__interaction
18774203-1922	<compound-id="4583,149096,452723">[Ofloxacin</compound-id> is contraindicated in case of <protein-id="O00091,O24357,O51581,O54537,O55044,O68282,O83491,O84188,P05370,P0A584,P0A585,P0A586,P0A587,P0AC53,P0AC54,P11410,P11411,P11412,P11413,P12646,P15588,P21907,P29686,P37830,P37986,P41571,P41764,P44311,P48826,P48828,P48848,P48992,P54547,P54996,P56110,P57405,P73411,P77809,P80619,P97324,Q00612,Q23711,Q24625,Q25019,Q25537,Q27464,Q27638,Q29492,Q42919,Q43793,Q43839,Q7YS37,Q89AI7,Q8K9M2,Q8XCJ6,Q9PKK8,Q9X0N9,Q9Z3S2,Q9Z8U6,Q9ZKB2">G6PD</protein-id> deficiency: is it evidenced based?].	[Ofloxacin__G6PD__no_interaction
18774319-1994	We also assess prostaglandin (<protein-id="Q29458">PGE</protein-id> (2)) and <compound-id="114873">thromboxane</compound-id> (<compound-id="9548654">TXB</compound-id> (2)) inhibition to establish the correlation between behavioural measures and the degree of selectivity for <protein-id="O62664,O97554,P05979,P22437,P23219,Q63921,Q9T0N8">COX-1</protein-id> and <protein-id="O02768,O19183,O62698,O62725,P27607,P35354,P35355,P70682,P79208,Q05769">COX-2</protein-id>.	TXB__COX-2__no_interaction	TXB__COX-1__no_interaction	thromboxane__COX-2__no_interaction	thromboxane__COX-1__no_interaction	TXB__PGE__no_interaction	thromboxane__PGE__no_interaction
18774664-2104	High-dose steroid therapy for the former symptoms of AHS, and immunoglobulin, <protein-id="P35834,Q28746">granulocyte colony-stimulating factor</protein-id>, and <compound-id="5491295">cefepime</compound-id> for the latter agranulocytosis were successfully performed.	cefepime__granulocyte colony-stimulating factor__no_interaction
18774689-2116	0.05 vs. aortic IR) plasma levels of <compound-id="10964">malondialdehyde</compound-id>, P-selectin, intercellular adhesion molecule-1 (ICAM-I), and tissue levels of <compound-id="10964">malondialdehyde</compound-id> and <protein-id="O24339,O52762,O62839,O68146,O77229,O93662,O97492,P00432,P04040,P04762,P07145,P0A323,P0A324,P0A325,P0A326,P0A327,P11934,P17336,P24168,P24270,P25890,P29422,P30265,P30266,P32290,P42321,P44390,P45737,P45739,P55304,P55306,P55310,P55311,P55313,P77872,P81138,P90682,Q27710,Q49XC1,Q4L643,Q59296,Q59337,Q59602,Q59714,Q5HG86,Q5HPK8,Q5RF10,Q64405,Q6G9M4,Q6GH72,Q7A5T2,Q8CPD0,Q8FWU0,Q8NWV5,Q8X1P0,Q8Y3P9,Q926X0,Q99UE2,Q9AXH0,Q9KW19,Q9L4S1,Q9M5L6,Q9PT92,Q9PWF7,Q9Z598,Q9ZKX5,Q9ZN99">catalase</protein-id>.	malondialdehyde__catalase__no_interaction
18774957-2175	Niemann-Pick C disease (NPC) is an autosomal recessive neurodegenerative disorder caused by the abnormal function of <protein-id="O15118,P56941">NPC1</protein-id> or <protein-id="O93388,O97763,P61916,P61917,P61918,P79345,Q12408,Q28895,Q4P580,Q52FS9,Q5A8A2,Q5KIR9,Q6BV42,Q6CHU5,Q6CNE0,Q6FNB1,Q756Q3,Q9VQ62">NPC2</protein-id> proteins, leading to an accumulation of unesterified <compound-id="304,5997,6432564,11025495">cholesterol</compound-id> and glycosphingolipids (GSLs) in the lysosomes.	cholesterol__NPC1__interaction	cholesterol__NPC2__interaction
18775028-2185	<protein-id="O49046,P00812,P0A2X9,P0A2Y0,P0A2Y1,P14012,P33280,P37818,P39138,P40906,P46637,P53608,P60086,P60087,P60088,Q10066,Q12611,Q1E180,Q6G7E9,Q6GER3,Q74ZW4,Q7M0Z3,Q8NVE3">arginase</protein-id>-diminished <compound-id="232,4367,6322">arginine</compound-id> and indolamine 2,3-dioxygenase-diminished <compound-id="1148,6305,9060,5460840">tryptophan</compound-id>) or <compound-id="145068">nitric oxide</compound-id> (NO) production.	nitric oxide__arginase__no_interaction	arginine__arginase__interaction	tryptophan__arginase__no_interaction
18775088-2206	Memory impairment in young women at increased risk of depression: influence of <compound-id="5754">cortisol</compound-id> and 5-<protein-id="P31645">HTT</protein-id> genotype.	cortisol__HTT__no_interaction
18775088-2207	The aim of the present study was to determine whether memory impairments were present in young women at increased familial risk of depression and whether memory performance was related either to <compound-id="5754">cortisol</compound-id> secretion or to allelic variation in the promoter region of the serotonin transporter gene (5-<protein-id="P31645">HTT</protein-id>).	cortisol__HTT__no_interaction
18775090-2208	The relative gene expression of <protein-id="O07091,O13393,O22642,O93863,P00002,P00003,P00004,P00007,P00008,P00011,P00012,P00013,P00014,P00017,P00018,P00019,P00020,P00021,P00022,P00024,P00025,P00027,P00028,P00029,P00030,P00031,P00032,P00035,P00036,P00037,P00038,P00039,P00040,P00041,P00042,P00043,P00046,P00047,P00048,P00049,P00051,P00052,P00053,P00054,P00055,P00056,P00057,P00058,P00059,P00060,P00061,P00062,P00063,P00064,P00065,P00066,P00067,P00068,P00069,P00070,P00071,P00072,P00073,P00074,P00075,P00076,P00077,P00078,P00079,P12831,P15451,P18822,P19681,P19974,P21665,P22342,P25400,P29380,P32556,P38091,P53698,P56205,P59218,P62772,P62773,P62894,P62895,P62896,P67881,P67882,P68096,P68097,P68098,P68099,P68100,P68517,P68518,P68519,P81280,P81459,P99998,P99999,Q41346,Q4HVX7,Q52V08,Q52V09,Q52V10,Q5RFH4,Q640U4,Q6C9Q0,Q6IQM2,Q6Q4H8,Q6QLW4,Q6WUX8,Q753F4,Q7YR71,Q96VP3">cytochrome c</protein-id> 0.05) in-<compound-id="104815">Cu</compound-id> calves compared with+ <compound-id="104815">Cu</compound-id> or-<compound-id="104815">Cu</compound-id>+Mn calves.	Cu__cytochrome c__interaction
18775100-2213	Effects of a flaxseed-derived <compound-id="261166">lignan</compound-id> supplement on C-reactive protein, <protein-id="O35736,P05231,P08505,P20607,P26892,P26893,P29455,P41323,P41683,P41693,P46650,P51494,P79341,Q25BC2,Q28319,Q28747,Q28819,Q2MH06,Q5I6E3,Q6V919,Q865W7,Q865X6,Q8MKH0,Q95181,Q9MZR1,Q9XT80">IL-6</protein-id> and retinol-binding <protein-id="P09048,P69610,P69611">protein 4</protein-id> in type 2 diabetic patients.	lignan__IL-6__interaction	lignan__protein 4__interaction
18775100-2214	The present study explored the effects of flaxseed-derived <compound-id="261166">lignan</compound-id> on inflammatory factors and <protein-id="P02753,P06912,P18902,P27485,P41263,P61641,Q28369">RBP4</protein-id> concentrations in type 2 diabetics, who have higher levels of these biomarkers.	lignan__RBP4__interaction
18775100-2215	No between-treatment differences were found with regard to <protein-id="O35736,P05231,P08505,P20607,P26892,P26893,P29455,P41323,P41683,P41693,P46650,P51494,P79341,Q25BC2,Q28319,Q28747,Q28819,Q2MH06,Q5I6E3,Q6V919,Q865W7,Q865X6,Q8MKH0,Q95181,Q9MZR1,Q9XT80">IL-6</protein-id> or <protein-id="P02753,P06912,P18902,P27485,P41263,P61641,Q28369">RBP4</protein-id> ; though <protein-id="O35736,P05231,P08505,P20607,P26892,P26893,P29455,P41323,P41683,P41693,P46650,P51494,P79341,Q25BC2,Q28319,Q28747,Q28819,Q2MH06,Q5I6E3,Q6V919,Q865W7,Q865X6,Q8MKH0,Q95181,Q9MZR1,Q9XT80">IL-6</protein-id> 0.001 following <compound-id="261166">lignan</compound-id> and placebo treatments, respectively).	lignan__RBP4__no_interaction	lignan__IL-6__no_interaction
18775460-2359	These include typical G-protein (Galphaq/11)-coupled cascades, such as activation of phospholipase C (PLC), and subsequent accumulation of inositol-(1,4,5)-triphosphate (IP3), intracellular <compound-id="271">Ca(2</compound-id>+) mobilization, and activation of <protein-id="P13678,Q25378">protein kinase C</protein-id>.	Ca(2__protein kinase C__no_interaction
18775471-2362	Here we report the discovery of a series of novel adamantyl <compound-id="713">carboxamides</compound-id> as selective inhibitors of human 11beta-HSD1 in HEK-293 cells transfected with the <protein-id="P28845,P51975,Q29608,Q6QLL4,Q6R0J2,Q7M3I4">HSD11B1</protein-id> gene.	carboxamides__HSD11B1__no_interaction
18775538-2383	Polymorphism in the <protein-id="P14417">apolipoprotein(a)</protein-id> gene, plasma lipoprotein(a), cardiovascular disease, and low-dose <compound-id="2244">aspirin</compound-id> therapy.	aspirin__apolipoprotein(a)__no_interaction
18775538-2384	We investigated whether this allele was associated with elevated <protein-id="P08519,P14417">Lp(a)</protein-id> and cardiovascular risk in the Women's Health Study, a randomized trial of low-dose <compound-id="2244">aspirin</compound-id>, and whether <compound-id="2244">aspirin</compound-id> reduced cardiovascular risk in minor allele carriers.	aspirin__Lp(a)__no_interaction
18775593-2403	The study was prompted to characterize the B-type <protein-id="P16397,P18773">esterase</protein-id> activities in the terrestrial snail Xeropicta derbentina and to evaluate its sensitivity to organophosphorus and <compound-id="277">carbamate</compound-id> pesticides.	carbamate__esterase__interaction
18775593-2404	Specific <protein-id="P32749,P32750,P32751,P32752,P32753,P81908">cholinesterase</protein-id> and carboxylesterase activities were mainly obtained with <compound-id="20544">acetylthiocholine</compound-id> (K(m)=77.2 mM; V(max)=38.2 mU/mg protein) and <compound-id="13247">1-naphthyl acetate</compound-id> (K(m)=222 mM, V(max)=1095 mU/mg protein) substrates, respectively.	acetylthiocholine__cholinesterase__interaction	1-naphthyl acetate__cholinesterase__interaction
18775733-2451	To distinguish between isoform-specific and context-dependent modulation as possible explanations for this selectivity, the effects of <compound-id="5904">penicillin</compound-id> were evaluated on recombinant <protein-id="P26714,Q08832,Q9BLY8">GABA(A) receptors</protein-id> expressed in HEK293T cells.	penicillin__GABA(A) receptors__interaction
18775745-2455	Drosophila responds to detection of diamonopimelic-type microbial <compound-id="9816401">peptidoglycan</compound-id> through activation of the immune deficiency (Imd) pathway, a signaling pathway with numerous similarities to the mammalian pro-inflammatory <protein-id="O35734,O77510,O77764,P01375,P04924,P13296,P19101,P23383,P23563,P29553,P33620,P36939,P48094,P51435,P51742,P51743,P59684,P59693,P59694,P59695,P79337,P79374,Q06599,Q19LH4,Q1G1A2,Q1WM27,Q2MH05,Q539C2,Q75N23,Q8HZD9,Q8JFG3,Q8MKG8,Q8WNR1,Q9BEA1">TNF</protein-id> pathway.	peptidoglycan__TNF__interaction
18775894-2504	We measured serum high-sensitivity C-reactive protein (hs-<protein-id="O19062,P02741,P02742,P08462,P18151,P21291,P41964,P47875,P49254,P49262,P52753,P67966,P67967,P97315,Q07203">CRP</protein-id>), <protein-id="O70159,P02765,P12763,P24090,P29699,P29700,P29701,P80191,P97515,Q9N2D0">fetuin-A</protein-id>, <protein-id="O35736,P05231,P08505,P20607,P26892,P26893,P29455,P41323,P41683,P41693,P46650,P51494,P79341,Q25BC2,Q28319,Q28747,Q28819,Q2MH06,Q5I6E3,Q6V919,Q865W7,Q865X6,Q8MKH0,Q95181,Q9MZR1,Q9XT80">IL-6</protein-id>, <protein-id="O19073,P70380,P97636,Q14116,Q3ZT29,Q5I931,Q8QFQ8,Q95M33,Q9TU73,Q9XSQ7,Q9XSR0">IL-18</protein-id>, <protein-id="O46673,O97798,P18893,P22301,P29456,P43480,P46651,P47965,P48411,P51496,P51497,P51746,P55029,P79338,Q0Z972,Q25BC1,Q28374,Q29055,Q29408,Q2PE73,Q5Q0V6,Q865X4,Q8MKG9,Q9JHK7,Q9TSJ4,Q9Z1Y5">IL-10</protein-id> (ELISA) and others (haemoglobin level, white blood cell count, serum <compound-id="24441,24456,24632">calcium, phosphate</compound-id>, <compound-id="24441,24456,24632">calcium-phosphate</compound-id> product, albumin, <protein-id="P22775,P81070">fibrinogen</protein-id>, <compound-id="304,5997,6432564,11025495">cholesterol</compound-id>, <protein-id="P81182">high-density lipoprotein</protein-id> (HDL), triglycerides and <protein-id="P01270">parathormone</protein-id>).	cholesterol__CRP__no_interaction	calcium-phosphate__IL-6__no_interaction	cholesterol__fibrinogen__no_interaction	calcium, phosphate__IL-6__no_interaction	cholesterol__fetuin-A__no_interaction	calcium-phosphate__CRP__no_interaction	calcium, phosphate__fetuin-A__no_interaction	cholesterol__IL-18__no_interaction	cholesterol__IL-6__no_interaction	calcium, phosphate__high-density lipoprotein__no_interaction	cholesterol__high-density lipoprotein__no_interaction	calcium, phosphate__IL-18__no_interaction	calcium-phosphate__fibrinogen__no_interaction	calcium-phosphate__parathormone__no_interaction	calcium-phosphate__IL-10__no_interaction	cholesterol__IL-10__no_interaction	calcium-phosphate__IL-18__no_interaction	calcium-phosphate__high-density lipoprotein__no_interaction	cholesterol__parathormone__no_interaction	calcium, phosphate__IL-10__no_interaction	calcium, phosphate__fibrinogen__no_interaction	calcium, phosphate__parathormone__no_interaction	calcium, phosphate__CRP__no_interaction	calcium-phosphate__fetuin-A__no_interaction
18775944-2518	Serum <compound-id="5283731,6433735">25-hydroxyvitamin D</compound-id> (25-OHD), calcium, <protein-id="O60109,P81800,P83456">alkaline phosphatase</protein-id> and <compound-id="24404,139579">phosphorus</compound-id> were measured.	25-hydroxyvitamin D__alkaline phosphatase__no_interaction	phosphorus__alkaline phosphatase__no_interaction
18776133-17	In the current study, we found that treatment of peripheral blood mononuclear cells with combination IL-2/IL-4 for 48 hours, but not with IL-2 or IL-4 alone, abrogated <compound-id="5743">dexamethasone</compound-id> (DEX)-induced <protein-id="O13186,O46567,O73673,P04150,P06536,P06537,P35547,P49115,P49843,P49844,P59667,P79269,P79686,Q5R9P5,Q6XLJ0,Q95267,Q9N1U3">glucocorticoid receptor</protein-id> (GCR)-alpha nuclear translocation in both <protein-id="P01730,P05542,P16003,P16004,P33705,P46630,P79184,P79185,Q08336,Q08338,Q08339,Q08340,Q29037,Q9XS78">CD4</protein-id> (+) and CD8(+) T cells.	dexamethasone__glucocorticoid receptor__interaction	dexamethasone__CD4__interaction
18776170-42	Linear regression analyses showed that <compound-id="304,5997,6432564,11025495">cholesterol</compound-id> and phospholipid efflux and cellular <protein-id="O18759,O42175,O42296,O42363,P02647,P02648,P04639,P08250,P09809,P15497,P18647,P18648,P27007,P32918,P68292,P68293,Q00623,Q91488,Q9Z2L4">apoA-I</protein-id> binding correlated significantly with the ability of <protein-id="O95477">ABCA1</protein-id> to form cell surface lipid domains.	cholesterol__ABCA1__interaction	cholesterol__apoA-I__no_interaction
18776171-43	<compound-id="5280644,5282796">Conjugated linoleic acid</compound-id>-mediated inflammation and <protein-id="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7">insulin</protein-id> resistance in human adipocytes are attenuated by <compound-id="445154">resveratrol</compound-id>.	Conjugated linoleic acid__insulin__no_interaction	resveratrol__insulin__interaction
18776171-44	Inflammation plays a role in trans-10, cis-12 (10,12)-<compound-id="5280644,5282796">conjugated linoleic acid</compound-id> (CLA)-mediated delipidation and <protein-id="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7">insulin</protein-id> resistance in adipocytes.	conjugated linoleic acid__insulin__no_interaction
18776171-45	Given the anti-inflammatory role of <compound-id="445154">resveratrol</compound-id> (RSV), we hypothesized that RSV would attenuate inflammation and <protein-id="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7">insulin</protein-id> resistance caused by 10,12 CLA in human adipocytes.	resveratrol__insulin__no_interaction
18777013-349	Near-infrared fluorescence detection of <compound-id="5957">ATP</compound-id>-<compound-id="253,171548">biotin</compound-id>-mediated <protein-id="O55778,O57285,P03421,P03422,P03520,P04859,P04860,P04877,P04878,P04879,P04880,P06162,P06163,P06747,P06940,P11208,P12579,P14156,P14251,P14252,P15198,P16072,P16073,P16286,P16380,P16595,P19717,P21299,P21738,P22044,P22363,P23055,P23056,P24567,P24698,P26033,P26668,P28054,P32530,P32531,P32532,P33454,P35939,P35945,P35974,P60166,P69479,P69480,Q00793,Q01769,Q03335,Q06427,Q83956,Q86606,Q9DUE2,Q9IK91,Q9WS39">phosphoprotein</protein-id> labeling.	ATP__phosphoprotein__interaction	biotin__phosphoprotein__interaction
18777014-352	Wheat germ <protein-id="Q7M4U7">lipase</protein-id> had a high activity and enantioselectivity only in n-hexane with a high initial water activity (alpha(w) = 0.97), especially with <compound-id="7409">1-phenylethanol</compound-id> (C 32%, E &gt; 200).	1-phenylethanol__lipase__interaction
18777087-373	We determined effects of the vasopeptidase inhibitor (VPI) <compound-id="656629">omapatrilat</compound-id> and angiotensin II type 1 receptor (AT(1)R) blocker (ARB) <compound-id="2541">candesartan</compound-id> in rats during healing between day-2 and day-21 after reperfused myocardial infarction (RMI) on left ventricular (LV) remodeling and function, and regional matrix metalloproteinase (MMP)-9, tissue inhibitor of MMP (<protein-id="P01033">TIMP</protein-id>)-3, inducible-<protein-id="O61309,O61608,Q27571,Q9I9M2">nitric-oxide-synthase</protein-id> (<protein-id="O19114,O46660,O54705,O62699,P29477,P35228,P79290,Q06518,Q27995,Q28314,Q90703,Q92037,Q92091">iNOS</protein-id>), oxidant-generating myeloperoxidase (<protein-id="P05164,P11247">MPO</protein-id>), and cytokines <protein-id="Q8JFG3">tumor-necrosis-factor</protein-id> (<protein-id="O35734,O77510,O77764,P01375,P04924,P13296,P19101,P23383,P23563,P29553,P33620,P36939,P48094,P51435,P51742,P51743,P59684,P59693,P59694,P59695,P79337,P79374,Q06599,Q19LH4,Q1G1A2,Q1WM27,Q2MH05,Q539C2,Q75N23,Q8HZD9,Q8JFG3,Q8MKG8,Q8WNR1,Q9BEA1">TNF</protein-id>)-alpha, interleukin (IL)-6 and <protein-id="O46673,O97798,P18893,P22301,P29456,P43480,P46651,P47965,P48411,P51496,P51497,P51746,P55029,P79338,Q0Z972,Q25BC1,Q28374,Q29055,Q29408,Q2PE73,Q5Q0V6,Q865X4,Q8MKG9,Q9JHK7,Q9TSJ4,Q9Z1Y5">IL-10</protein-id>, and transforming-growth-factor (TGF)-beta(1), and collagens.	candesartan__tumor-necrosis-factor__no_interaction	omapatrilat__tumor-necrosis-factor__no_interaction	omapatrilat__nitric-oxide-synthase__no_interaction	omapatrilat__iNOS__no_interaction	candesartan__MPO__no_interaction	omapatrilat__TIMP__no_interaction	candesartan__TNF__no_interaction	candesartan__iNOS__no_interaction	omapatrilat__IL-10__no_interaction	omapatrilat__MPO__no_interaction	omapatrilat__TNF__no_interaction	candesartan__TIMP__no_interaction	candesartan__IL-10__no_interaction	candesartan__nitric-oxide-synthase__no_interaction
18777087-374	The results suggest that modulation of matrix <protein-id="O41798,O89290,O89940,O91080,O93215,P03311,P03353,P03355,P03356,P03362,P03363,P03366,P03367,P03369,P03370,P04023,P04024,P04323,P04584,P04585,P04587,P04588,P04589,P05959,P05960,P05961,P05962,P07570,P0C210,P0C211,P10210,P10265,P10270,P10271,P10272,P10273,P10274,P10394,P10978,P11227,P11365,P12451,P12497,P12498,P12499,P14074,P14078,P15833,P16046,P16423,P16901,P17757,P18042,P18096,P18802,P19028,P19199,P19560,P19561,P20825,P20875,P20876,P20892,P21407,P21414,P24107,P24740,P26808,P26809,P26810,P27502,P28936,P31822,P35956,P35963,P51518,P63119,P63120,P63121,P63122,P63123,P63124,P63125,P63127,P63128,P63129,P63131,P84454,Q09SZ9,Q0R5R2,Q0R5R3,Q1A249,Q1A267,Q4U0X6,Q73368,Q74120,Q75002,Q76634,Q77373,Q79666,Q89928,Q8AII1,Q8I7P9,Q9IDV9,Q9Q720,Q9QBY3,Q9QBZ1,Q9QBZ5,Q9QSR3,Q9WC54,Q9WC63,Q9Y6I0">proteases</protein-id>, oxidants, cytokines, and NOSs with <compound-id="656629">omapatrilat</compound-id> and <compound-id="2541">candesartan</compound-id> contribute to reversal of adverse collagen and LV remodeling and attenuation of LV dysfunction during healing after RMI.	candesartan__proteases__interaction	omapatrilat__proteases__interaction
18777088-375	We recently reported <compound-id="778">homocysteine</compound-id> (Hcy)-induced <protein-id="P29323">ERK</protein-id>-phosphorylation was suppressed by pertussis toxin (PTX), which suggested the involvement of GPCRs in initiating signal transduction.	homocysteine__ERK__interaction
18777110-388	Other factors prognostic for inferior survival were <protein-id="P21847,P83517">serum albumin</protein-id> 37 g/L (HR 3.22, 95% CI 1.11-13.22, p = 0.034) and treatment with non-<compound-id="2907,9554282">cyclophosphamide</compound-id>, <compound-id="31703">doxorubicin</compound-id>, <compound-id="5978">vincristine</compound-id>, and <compound-id="5755">prednisolone</compound-id> chemotherapy (HR 4.89, 95% CI 1.67-14.36, p = 0.004).	doxorubicin__serum albumin__no_interaction	cyclophosphamide__serum albumin__no_interaction	vincristine__serum albumin__no_interaction	prednisolone__serum albumin__no_interaction
18777117-392	Association between <compound-id="107487">Val/Leu</compound-id> (247) polymorphism of <protein-id="P02749,P17690,P26644,P33703,Q01339,Q95LB0">apolipoprotein H</protein-id> and cerebral infarction in a Chinese population.	Val/Leu__apolipoprotein H__interaction
18777117-393	The purpose of this study was to identify associations between the <compound-id="107487">Val/Leu</compound-id> (247) polymorphism of <protein-id="P02749,P17690,P26644,P33703,Q01339,Q95LB0">apoH</protein-id> gene and CI in a Chinese cohort.	Val/Leu__apoH__interaction
18777136-397	We have discovered multiple genetic and biochemical differences between humans and these other hominids, in relation to <compound-id="349960">sialic acids</compound-id> and in Siglecs (Sia-recognizing Ig superfamily <protein-id="P02871,P02873,P02874,P02875,P07386,P16108,P16349,P16351,P16352,P33888,P38662,P42088,P83410,P83511,P84987,Q41114">lectins</protein-id>).	sialic acids__lectins__no_interaction
18777160-404	Possible binding site for the substrate, prostaglandin H(2) (<compound-id="445049">PGH(2</compound-id>)), was identified by systematically probing the refined molecular structure of <protein-id="Q9JM51">mPGES-1</protein-id>.	PGH(2__mPGES-1__interaction
18777180-406	We cloned the zGCAP4 gene, purified non-myristoylated and myristoylated forms of the protein after heterologous expression in Escherichia coli and studied its properties: zGCAP4 was a strong activator of membrane-bound guanylate <protein-id="O94303,P33734,Q9P4P9,Q9SZ30">cyclases</protein-id> from bovine and zebrafish retina, showing half-maximal activation at 520-570 nM free <compound-id="271">Ca(2</compound-id>+) concentration.	Ca(2__cyclases__no_interaction
18777180-408	Thus, expression and biochemical properties of zGCAP4 are in agreement with its function as an efficient <compound-id="271">Ca(2</compound-id>+)-sensitive regulator of guanylate <protein-id="O94303,P33734,Q9P4P9,Q9SZ30">cyclase</protein-id> activity in cone vision.	Ca(2__cyclase__no_interaction
18777181-411	The results of the present work show that this replacement does not considerably affect the DNA modifications by this drug, recognition of these modifications by <protein-id="P07156,P09429,P10103,P12682,P36194,Q4R844,Q6YKA4">HMGB1</protein-id> protein, their repair, and reactivity of the <compound-id="2915">platinum complex</compound-id> with <compound-id="124886">GSH</compound-id>.	platinum complex__HMGB1__no_interaction	GSH__HMGB1__no_interaction
18778244-705	However, in addition to <protein-id="P20432,P30104,P30106,P30107,P30108,Q04522,Q0ZS46,Q7REH6,Q8ILQ7,Q8MU52">GST</protein-id> activity, we discovered that EGST also possesses <compound-id="45102689">thiol</compound-id> : <protein-id="O84179,P0A6M2,P0A6M3,P44707,P59343,P59346,P59347,P63993,P63994,P94287,Q44856,Q54155,Q56578,Q7MJN7,Q7VKY2,Q822U2,Q83D55,Q87AV3,Q87N03,Q887H2,Q8ERY3,Q8GHM3,Q8PC32,Q8PNQ6,Q8XZM2,Q8ZEM1,Q9JTA9,Q9JYC6,Q9KBI6,Q9KQU6,Q9L6B3,Q9PGG2,Q9PKL7,Q9RWB5,Q9Z8V7">disulfide oxidoreductase</protein-id> activity, for which the residue Cys (10) plays an essential role.	thiol__GST__no_interaction	thiol__disulfide oxidoreductase__no_interaction
18778281-720	Anti-P mAb promoted <protein-id="O46673,O97798,P18893,P22301,P29456,P43480,P46651,P47965,P48411,P51496,P51497,P51746,P55029,P79338,Q0Z972,Q25BC1,Q28374,Q29055,Q29408,Q2PE73,Q5Q0V6,Q865X4,Q8MKG9,Q9JHK7,Q9TSJ4,Q9Z1Y5">IL-10</protein-id> overproduction in a dose- and time-dependent manner in both <compound-id="11970143">lipopolysaccharide</compound-id> (LPS)-activated RAW 264.7 cells and primary human macrophages.	lipopolysaccharide__IL-10__no_interaction
18778289-732	Increased secretion of hyperimmune antibodies following <compound-id="11970143">lipopolysaccharide</compound-id> stimulation of <protein-id="P25942,Q28203,Q3LRP1,Q3ZTK5,Q7YRL5,Q8SQ34">CD40</protein-id>-activated human B cells in vitro.	lipopolysaccharide__CD40__interaction
18778316-735	The addition of a bisecting <compound-id="24139">N-acetylglucosamine</compound-id> residue by beta(1,4)-<protein-id="Q02527,Q09327,Q10470">N-acetylglucosaminyltransferase III</protein-id> (GnTIII) is known to control the processing of N-linked glycans in mammals, for example by preventing alpha(1,6)-fucosylation of the core glycan.	N-acetylglucosamine__N-acetylglucosaminyltransferase III__interaction
18778316-736	Both CTSs targeted enhanced <protein-id="P21578">yellow fluorescent protein</protein-id> (eYFP) to a <compound-id="5287620">brefeldin A</compound-id>-sensitive compartment, indicative of Golgi localization.	brefeldin A__yellow fluorescent protein__no_interaction
18778404-750	The Solanum lycopersicum <protein-id="P93022">auxin response factor 7</protein-id> (SlARF7) regulates <compound-id="802">auxin</compound-id> signaling during tomato fruit set and development.	auxin__auxin response factor 7__interaction
18778748-865	We have investigated the pre-receptor metabolism of <compound-id="5994">progesterone</compound-id> in primary hOSE cells and an immortalised hOSE cell line, OSE-C2, focusing on transcriptional regulation of <protein-id="P19871">3beta-hydroxysteroid dehydrogenase</protein-id> (<protein-id="O46516,O57245,P14893,P21097,P26670,P27365,Q5IFP1,Q67477,Q9N119">3beta-HSD</protein-id>) by inflammatory, anti-inflammatory and apoptotic factors.	progesterone__3beta-HSD__no_interaction	progesterone__3beta-hydroxysteroid dehydrogenase__no_interaction
18778749-866	Coexpression with H6PDH potentiated <protein-id="P16232,P28845,P50172,P51975,Q29608,Q6QLL4,Q6R0J2,Q7M3I4">11beta-HSD1</protein-id> reductase activity at high <compound-id="206,5793,64689,79025">glucose</compound-id>.	glucose__11beta-HSD1__interaction
18778749-867	<protein-id="P16232,P28845,P50172,P51975,Q29608,Q6QLL4,Q6R0J2,Q7M3I4">11beta-HSD1</protein-id> dehydrogenase activity was observed in H4IIE cells only at subphysiological <compound-id="206,5793,64689,79025">glucose</compound-id> levels, indicating a highly efficient supply of substrate for H6PDH and NADPH generation in the ER-lumen.	glucose__11beta-HSD1__interaction
18778768-874	There are data to suggest that psychological intervention can influence neuroendocrine (e.g., <compound-id="5754">cortisol</compound-id>) and immune function indicators, especially lymphocyte proliferation and <protein-id="Q24134,Q8IXH7,Q9UVI4">TH1</protein-id> cytokine production.	cortisol__TH1__no_interaction
18778874-903	The proteins identified belong to the photosynthesis, carbohydrate and <compound-id="947,123329">nitrogen</compound-id> metabolism, and <protein-id="Q41112,Q9SW70">stress-related protein</protein-id> functional categories.	nitrogen__stress-related protein__no_interaction
18778892-914	In the present study, we investigated whether CD147/<protein-id="Q99PA3">basigin</protein-id> is involved, via its association with <protein-id="O35439,P53985,Q03064,Q12283">MCT1</protein-id> and 4 to transport <compound-id="612">lactate</compound-id>, in glycolysis and then contributes to the progression of A375 melanoma cells.	lactate__MCT1__interaction	lactate__basigin__interaction
18779389-1017	TCblR belongs to the <protein-id="P01131,P20063,Q28832">low-density lipoprotein receptor</protein-id> family, with 2 low-density lipoprotein receptor <protein-id="P02855">type A</protein-id> domains separated by a complement-like <compound-id="594,5862,5360637">cysteine</compound-id>-rich region.	cysteine__low-density lipoprotein receptor__interaction	cysteine__type A__interaction
18780301-1284	Variability of <protein-id="O42275,O62763,P04058,P07140,P07692,P21836,P22303,P23795,P36196,P37136,P56161,Q27677,Q29499,Q867X2,Q867X3,Q869C3,Q86GC8,Q86GC9,Q92035,Q92081,Q9DDE3">AChE</protein-id>, BChE, and <protein-id="P07668,P13222,P28329,P32738,P32756,Q03059">ChAT</protein-id> genes in the late-onset form of Alzheimer's disease and relationships with response to treatment with <compound-id="3152">Donepezil</compound-id> and <compound-id="77991">Rivastigmine</compound-id>.	Donepezil__ChAT__interaction	Rivastigmine__ChAT__interaction	Rivastigmine__AChE__interaction	Donepezil__AChE__interaction
18780328-1293	Extended-release PEG-<compound-id="5484207">luciferin</compound-id> allows for long-term imaging of firefly <protein-id="P08659,P13129,Q01158,Q26304,Q27757">luciferase</protein-id> activity in vivo.	luciferin__luciferase__interaction
18780332-1296	Spectrofluorimetric determination of vitamin B(1) using horseradish <protein-id="P15984,P16147,P84714">peroxidase</protein-id> as catalyst in the presence of <compound-id="784">hydrogen peroxide</compound-id>.	hydrogen peroxide__peroxidase__interaction
18780332-1297	In this work a new spectrofluorimetric method for the determination of vitamin B(1), based on the catalytic activity of horseradish <protein-id="P15984,P16147,P84714">peroxidase</protein-id> (<protein-id="Q08168">HRP</protein-id>) in the presence of <compound-id="784">hydrogen peroxide</compound-id> (<compound-id="784">H2O2</compound-id>), has been developed.	H2O2__HRP__interaction	H2O2__peroxidase__interaction	hydrogen peroxide__HRP__interaction	hydrogen peroxide__peroxidase__interaction
18780360-1305	Electrospun <compound-id="123833">polyglyconate</compound-id> (<compound-id="123833">Maxon</compound-id>) and its blends with proteins such as gelatin and <protein-id="P11547">elastin</protein-id>, with a spatially designed layer structure, were prepared as potential scaffolds for vascular tissue engineering.	Maxon__elastin__interaction	polyglyconate__elastin__interaction
18781168-1823	So far, in maize, three classes of mutants involved in <compound-id="890">phytic acid</compound-id> biosynthesis have been isolated: <protein-id="P61793,P61794">lpa1</protein-id>, <protein-id="Q9JL06">lpa2</protein-id> and <protein-id="Q8K5E0,Q9EQ31">lpa3</protein-id>.	phytic acid__lpa1__interaction	phytic acid__lpa2__interaction	phytic acid__lpa3__interaction
18781316-1566	Bevacizumab (Avastin), ranibizumab (Lucentis) and <compound-id="158786">pegaptanib sodium</compound-id> (<compound-id="158786">Macugen</compound-id>) are anti-<protein-id="P15691,P15692,P26617,P49151,P50412,P67964,P67965,Q99PS1,Q9GKR0,Q9MYV3">VEGF</protein-id> medications that have been used in the treatment of CNV.	Macugen__VEGF__interaction	pegaptanib sodium__VEGF__interaction
18781338-1571	Blood samples were collected to assay for biomarkers of oxidative stress (<compound-id="10964">malondialdehyde</compound-id> and carbonyl groups) and antioxidants (<protein-id="O32770,O59858,Q00277,Q9CFV1">glutathione peroxidase</protein-id>, <compound-id="124886">reduced glutathione</compound-id>, alpha-tocopherol, and beta-carotene).	reduced glutathione__glutathione peroxidase__no_interaction	malondialdehyde__glutathione peroxidase__no_interaction
18781385-1599	The low content of sphingomyelin, sulfatide and <compound-id="52949283">galactosylceramide</compound-id> is consistent with the immunohistochemical results showing that in the grey-lethal brain significant depletion and disorganization of the myelinated fibres is present, thus supporting the hypothesis that loss of function of the <protein-id="Q86WC4">OSTM1</protein-id> causes neuronal impairment and myelin deficit.	galactosylceramide__OSTM1__no_interaction
18781596-1677	Finally and most importantly, our data indicate that a decrease in AKT activity followed by a total decrease in <protein-id="O39927,O39928,O39929,O91936,O92529,O92530,O92531,O92532,P08133,P14824,P26660,P26661,P26662,P26663,P26664,P27694,P27958,P29846,P48037,P51901,P79134,Q00269,Q01588,Q24492,Q5FW17,Q5I2N3,Q5R7Q4,Q5ZJJ2,Q68749,Q68798,Q68801,Q6NY74,Q81258,Q81487,Q81495,Q81754,Q8VEE4,Q913D4,Q99IB8,Q9DHD6,Q9FMI7,Q9QAX1,Q9WMX2">p70</protein-id> (<protein-id="P23443,P67998,P67999,Q6TJY3,Q8BSK8">S6K</protein-id>) phosphorylation reflecting a decrease in <protein-id="P42345,P42346,Q9JLN9">mTOR</protein-id> activity occurs during high <compound-id="977">oxygen</compound-id> consumption, resulting from high cell density.	oxygen__S6K__interaction	oxygen__p70__interaction	oxygen__mTOR__interaction
18781650-1708	Some of the peptide derivatives inhibited <protein-id="P36836,P46059,Q8WMX5">PEPT1</protein-id>-mediated uptake of [(3)H] <compound-id="750,5460845">Gly</compound-id>-Sar.	Gly__PEPT1__interaction
18781688-1721	Effect of enzyme supplementation at moderate <protein-id="P07981,P07982,P07983,P10474,P10475,P10476,P13933,P15329,P15704,P16216,P17974,P18126,P18336,P19487,P21833,P21834,P22533,P22669,P22699,P23548,P23549,P23665,P27035,P29019,P37651,P37696,P45699,P46236,P46237,P46239,P58599,P58935,P81190,P82186,P84194,P84196,Q05622,Q12622,Q12714,Q8RSY9,Q8X5L9,Q8Z289,Q8ZLB7">cellulase</protein-id> loadings on initial <compound-id="5793">glucose</compound-id> and xylose release from corn stover solids pretreated by leading technologies.	glucose__cellulase__no_interaction
18781688-1722	For a combined mass loading of <protein-id="P07981,P07982,P07983,P10474,P10475,P10476,P13933,P15329,P15704,P16216,P17974,P18126,P18336,P19487,P21833,P21834,P22533,P22669,P22699,P23548,P23549,P23665,P27035,P29019,P37651,P37696,P45699,P46236,P46237,P46239,P58599,P58935,P81190,P82186,P84194,P84196,Q05622,Q12622,Q12714,Q8RSY9,Q8X5L9,Q8Z289,Q8ZLB7">cellulase</protein-id> and <protein-id="P12614,P15885,P27034,P29091,P40740,Q03506,Q46684">beta-glucosidase</protein-id> of 16.1 mg/g original <compound-id="5793">glucan</compound-id> (about 7.5 FPU/g), <compound-id="5793">glucose</compound-id> release from pretreated solids ranged from 50% to75% of the theoretical maximum and was greater for all pretreatments at all protein loadings compared to pure Avicel cellulose except for solids from controlled pH pretreatment and from dilute acid pretreatment by the Sunds pilot unit.	glucan__beta-glucosidase__interaction	glucose__beta-glucosidase__interaction	glucan__cellulase__interaction	glucose__cellulase__interaction
18782461-1964	PCFT/<protein-id="Q13946,Q96NT5">HCP1</protein-id> could therefore play a physiological role in Fe nutrition and the data highlight the potential for the interaction of <compound-id="6037">folate</compound-id> and haem at the level of intestinal absorption.	folate__HCP1__interaction
18782463-1965	Following an oral <compound-id="206,5793,64689,79025">glucose</compound-id> challenge, there was a weak trend for <compound-id="206,5793,64689,79025">glucose</compound-id>-stimulated <protein-id="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7">insulin</protein-id> release to be increased in the offspring of dams fed the folate-deficient diet.	glucose__insulin__interaction
18782570-2009	Association between serum retinol-binding <protein-id="P09048,P69610,P69611">protein 4</protein-id> and small dense low-density lipoprotein <compound-id="304,5997,6432564,11025495">cholesterol</compound-id> levels in young adult women.	cholesterol__protein 4__interaction
18782588-2018	Adult female X. laevis were injected three times at weekly intervals with the hapten-carrier complex, trinitrophenylated bovine <protein-id="P21847,P83517">serum albumin</protein-id> (<compound-id="5289486">TNP</compound-id>-<protein-id="P02769">BSA</protein-id>).	TNP__serum albumin__interaction	TNP__BSA__interaction
18782661-2054	By using the system, we obtained four event timing data sets (stimulation by <protein-id="P21617,P34129,Q6YBR5,Q90W38">NGF</protein-id> with and without <compound-id="5279,44259,451705,5311103,5459111,6419748,6711321,9956178,44299148">staurosporine</compound-id> at the concentrations of 0.01, 0.1, and 1 microM).	staurosporine__NGF__no_interaction
18783254-2197	Because of their critical biological roles, <protein-id="P15160,P17724,P73925,Q03459">hemoglobin</protein-id> and <protein-id="O77003,P02144,P02145,P02147,P02148,P02150,P02151,P02152,P02153,P02154,P02155,P02156,P02157,P02159,P02160,P02161,P02163,P02164,P02165,P02166,P02167,P02168,P02169,P02170,P02171,P02173,P02174,P02177,P02178,P02179,P02180,P02181,P02182,P02183,P02184,P02185,P02186,P02187,P02189,P02190,P02191,P02192,P02193,P02194,P02195,P02196,P02197,P02199,P02200,P02201,P02202,P02203,P02204,P02205,P02206,P02210,P02211,P02214,P02215,P04247,P04248,P04249,P04250,P09965,P0C227,P11343,P14393,P14396,P14397,P14398,P14399,P15160,P17724,P20856,P29287,P30562,P31331,P32428,P49672,P51535,P51537,P56208,P56532,P62734,P62735,P63113,P63114,P68080,P68081,P68082,P68083,P68084,P68085,P68086,P68189,P68190,P68276,P68277,P68278,P68279,P80721,P80722,P83682,P84997,P87497,Q01966,Q03459,Q0KIY0,Q0KIY1,Q0KIY2,Q0KIY3,Q0KIY5,Q0KIY9,Q2MJN4,Q6I7B0,Q6PL31,Q6VN46,Q701N9,Q76G09,Q7LZM1,Q7LZM2,Q7LZM3,Q7LZM4,Q7LZM5,Q7M3C1,Q7M424,Q7T044,Q9DEN8,Q9DEN9,Q9DEP0,Q9DEP1,Q9DGI8,Q9DGI9,Q9DGJ0,Q9DGJ1,Q9DGJ2,Q9QZ76">myoglobin</protein-id> are among the most extensively studied proteins in human history, while nitrite <compound-id="169814">tops</compound-id> the list of most-studied small molecules.	tops__hemoglobin__no_interaction	tops__myoglobin__no_interaction
18783254-2198	First, R-state, or allosteric, autocatalysis of nitrite reduction increases the rate of NO generation by deoxyhemoglobin and results in maximal NO production at approximately 50% <protein-id="P15160,P17724,P73925,Q03459">hemoglobin</protein-id> <compound-id="977">oxygen</compound-id> saturation, which is physiologically associated with greatest NO-dependent vasodilation.	oxygen__hemoglobin__interaction
18783311-2231	Role of <protein-id="Q924V1,Q9JHI8">Nox4</protein-id> and Nox2 in hyperoxia-induced reactive <compound-id="977">oxygen</compound-id> species generation and migration of human lung endothelial cells.	oxygen__Nox4__interaction
18783311-2234	Downregulation of <protein-id="Q924V1,Q9JHI8">Nox4</protein-id>, or pretreatment with <compound-id="12035">N-acetylcysteine</compound-id>, attenuated hyperoxia-induced cell migration and capillary tube formation, suggesting that ROS generated by <protein-id="Q924V1,Q9JHI8">Nox4</protein-id> regulate endothelial cell motility.	N-acetylcysteine__Nox4__no_interaction
18783384-2267	Using newly designed degenerate primers targeting the <protein-id="P09785,P0AFJ1,P0AFJ2,P0AFJ3,P0AFJ4,P44479,Q02419">phnA</protein-id> gene we analysed the potential for <compound-id="546">phosphonoacetate</compound-id> utilization in DNA and cDNA libraries constructed from a phytoplankton bloom in the Western English Channel during July 2006.	phosphonoacetate__phnA__interaction
18783774-2396	Low-density lipoprotein <compound-id="304,5997,6432564,11025495">cholesterol</compound-id> and non-<protein-id="P81182">high-density lipoprotein</protein-id> <compound-id="304,5997,6432564,11025495">cholesterol</compound-id> and the incidence of cardiovascular disease in an urban Japanese cohort study: The Suita study.	cholesterol__high-density lipoprotein__no_interaction
18783774-2397	Only a small number of population-based cohort studies have directly compared the predictive value of low-density lipoprotein <compound-id="304,5997,6432564,11025495">cholesterol</compound-id> (LDL-C) and non-<protein-id="P81182">high-density lipoprotein</protein-id> <compound-id="304,5997,6432564,11025495">cholesterol</compound-id> (non-HDLC) for coronary artery disease in Asian populations, such as Japan.	cholesterol__high-density lipoprotein__no_interaction
18783827-2422	Finally, we show that Vcx1 helps return cytosolic <compound-id="271">Ca(2</compound-id>+) toward resting levels after shock with high extracellular <compound-id="271">Ca(2</compound-id>+) much more effectively than <protein-id="Q9P7Y4">Pmc1</protein-id> and that calcineurin, a protein phosphatase regulator of Vcx1 and <protein-id="Q9P7Y4">Pmc1</protein-id>, had no detectable effects on these factors within the first few minutes of its activation.	Ca(2__Pmc1__no_interaction
18783828-2424	It is a serious problem that effective treatment choices to T315I, in the <protein-id="P00519,P00521,P10447,P11681,Q00022">ABL</protein-id> kinase domain that shows a strong tolerance in <compound-id="5291">imatinib</compound-id> do not exist clinically.	imatinib__ABL__interaction
18783846-2433	Moreover, diacylgycerol-dependent <protein-id="P13678,Q25378">protein kinase C</protein-id> isoenzymes and activation of extracellular signal-regulated <protein-id="P00513,P25848">protein kinase</protein-id> (<protein-id="P29323">ERK</protein-id>) are required for <compound-id="206,5793,64689,79025">glucose</compound-id>-, <compound-id="5505">tolbutamide</compound-id>- and KCl-induced <protein-id="P08046">Egr-1</protein-id> expression.	tolbutamide__ERK__interaction	glucose__protein kinase C__interaction	tolbutamide__protein kinase C__interaction	tolbutamide__Egr-1__interaction	glucose__Egr-1__interaction	glucose__ERK__interaction	glucose__protein kinase__interaction	tolbutamide__protein kinase__interaction
18784063-2498	Long-term blinded placebo-controlled study of <compound-id="3686">SNT-MC17</compound-id>/<compound-id="3686">idebenone</compound-id> in the <protein-id="O97592,P11530,P11531,P11532,P11533,Q5GN48">dystrophin</protein-id> deficient mdx mouse: cardiac protection and improved exercise performance.	idebenone__dystrophin__interaction	SNT-MC17__dystrophin__interaction
18784648-124	<protein-id="O13186,O46567,O73673,P04150,P06536,P06537,P35547,P49115,P49843,P49844,P59667,P79269,P79686,Q5R9P5,Q6XLJ0,Q95267,Q9N1U3">Glucocorticoid receptor</protein-id> blockade normalizes hippocampal alterations and cognitive impairment in <compound-id="5300,29327,6420074,6713972,7067772,45357367">streptozotocin</compound-id>-induced type 1 diabetes mice.	streptozotocin__Glucocorticoid receptor__no_interaction
18784734-168	The study aim was to determine whether urine albumin/<compound-id="588">creatinine</compound-id> ratio (UACR), high-sensitivity C-reactive protein (hsCRP) or N-terminal pro-<protein-id="P40753">brain natriuretic peptide</protein-id> (Nt-proBNP) added to risk prediction based on HeartScore and history of diabetes or cardiovascular disease.	creatinine__brain natriuretic peptide__no_interaction
18784749-176	Transgene optimization significantly improves SIN vector titers, <protein-id="O46522,P04839,P52649,Q61093,Q95L74">gp91phox</protein-id> expression and reconstitution of <compound-id="5359597">superoxide</compound-id> production in X-CGD cells.	superoxide__gp91phox__no_interaction
18784906-222	Quantitative evaluation of <protein-id="P36836,P46059,Q8WMX5">PEPT1</protein-id> contribution to oral absorption of <compound-id="27447">cephalexin</compound-id> in rats.	cephalexin__PEPT1__interaction
18784908-224	<compound-id="104815">Cu</compound-id> concentration in the liver and in plasma alanine aminotransferase (ALT) and aspartate transaminase (<protein-id="P0AE37,P0AE38,P80357,P80358,Q0TH83,Q1C8B0,Q1RB46,Q321N9,Q32G89,Q3Z294,Q5PHB9,Q66B20,Q7N2G8,Q83L52,Q8FH00,Q8Z6G0,Q8ZPV1,Q9NRA2,Q9ZC67">AST</protein-id>) activities were determined.	Cu__AST__interaction
18784908-225	In brain tissue, <compound-id="104815">Cu</compound-id> concentration, <protein-id="O50258">superoxide dismutase</protein-id> (<protein-id="O12933,O22668,O75007,P24705,P51547,P93258,Q01137,Q27666,Q9SM64">SOD</protein-id>) activities, <compound-id="10964">malondialdehyde</compound-id> (MDA) levels and glutathione (GSH) concentrations were determined.	malondialdehyde__SOD__no_interaction	malondialdehyde__superoxide dismutase__no_interaction	Cu__superoxide dismutase__no_interaction	Cu__SOD__no_interaction
18785000-243	We previously reported that inhibition of <protein-id="O51891,O67031,O83281,P03304,P0A295,P0A296,P0AG30,P0AG31,P0AG32,P0AG33,P15409,P17593,P17594,P20350,P29403,P33561,P35359,P38527,P44619,P45835,P51489,P52152,P52153,P52154,P52155,P52156,P52157,P52158,P56466,P57652,P66028,P66029,Q03222,Q06447,Q89A22,Q9ZD24,Q9ZLS9">Rho</protein-id>-kinase (ROCK) by hydroxyl <compound-id="3547">fasudil</compound-id> improves cognitive deficit and neuronal damage in rats with chronic cerebral ischemia (Huang et al., Cell Mol Neurobiol 28:757-768, 2008).	fasudil__Rho__interaction
18785000-244	Finally, in the presence of OGD and <compound-id="3547">fasudil</compound-id> mesylate, <protein-id="O50258">superoxide dismutase</protein-id> (<protein-id="O12933,O22668,O75007,P24705,P51547,P93258,Q01137,Q27666,Q9SM64">SOD</protein-id>) activity was increased by 50% for cortex and by 58% for hippocampus, compared to OGD only group.	fasudil__SOD__interaction	fasudil__superoxide dismutase__interaction
18785066-298	Na+/H+ exchanger isoform 3 (<protein-id="P26432,P26433,P48764,Q28362,Q84WG1">NHE-3</protein-id>) is responsible for net uptake of <compound-id="5234">NaCl</compound-id> and water from the gastrointestinal (GI) tract.	NaCl__NHE-3__interaction
18785206-418	<protein-id="Q07343">PDE4B</protein-id> is also important in the regulation of <compound-id="6076">cAMP</compound-id> signaling, a second messenger implicated in learning, memory, and mood.	cAMP__PDE4B__interaction
18785212-354	Elevated amounts of <protein-id="P00558,P00559,P00560,P29405,P29407,P29408,P41757,P46273,P50310,Q3T0P6,Q5NVB5,Q60HD8,Q6BLA0,Q6FKY1,Q757Q0,Q7SIB7,Q7ZA46">PGK1</protein-id>, one of the <compound-id="5957">ATP</compound-id>-generating reactions of glycolysis, in wood frog brain during freezing would enhance the glycolytic capacity of the organ and support the maintenance of cellular energetics under the ischemic conditions of the frozen state.	ATP__PGK1__interaction
18785685-518	SNs and SMs were exposed to macrophages with and without addition of <compound-id="53481793">endotoxin lipopolysaccharide</compound-id> (LPS), a positive inducer of <protein-id="Q8JFG3">tumor necrosis factor</protein-id>-alpha (<protein-id="O35734,O77510,O77764,P01375,P04924,P06804,P13296,P16599,P19101,P23383,P23563,P29553,P33620,P36939,P48094,P51435,P51742,P51743,P59684,P59693,P59694,P59695,P79337,P79374,Q06599,Q19LH4,Q1G1A2,Q1WM27,Q2MH05,Q539C2,Q75N23,Q8HZD9,Q8JFG3,Q8MKG8,Q8WNR1,Q9BEA1">TNF-alpha</protein-id>), <protein-id="P41693">interleukin 6</protein-id> (<protein-id="O35736,P05231,P08505,P20607,P26892,P26893,P29455,P41323,P41683,P41693,P46650,P51494,P79341,Q25BC2,Q28319,Q28747,Q28819,Q2MH06,Q5I6E3,Q6V919,Q865W7,Q865X6,Q8MKH0,Q95181,Q9MZR1,Q9XT80">IL-6</protein-id>), and <compound-id="145068">nitric oxide</compound-id> (NO).	endotoxin lipopolysaccharide__IL-6__interaction	nitric oxide__interleukin 6__no_interaction	nitric oxide__tumor necrosis factor__no_interaction	nitric oxide__TNF-alpha__no_interaction	endotoxin lipopolysaccharide__TNF-alpha__interaction	endotoxin lipopolysaccharide__interleukin 6__interaction	nitric oxide__IL-6__no_interaction	endotoxin lipopolysaccharide__tumor necrosis factor__interaction
18785878-575	We therefore hypothesized that a diffusible product of the <protein-id="O15886,P09194">GPI-PLC</protein-id> enzyme reaction [possibly DAG (<compound-id="6026790">diacylglycerol</compound-id>)] mediated the biological effects of the protein.	diacylglycerol__GPI-PLC__interaction
18786000-610	Silencing of <protein-id="O04111,O04220,O22586,O22652,O65872,O82144,P06515,P13114,P16107,P17818,P23569,P30078,P30079,P48385,P48389,P48405,P51075,P51080,P51089,P51090,Q9FUB7,Q9LKP7,Q9MBB1,Q9SEP2,Q9SEP4,Q9ZRR8,Q9ZRS4,Q9ZU06">chalcone synthase</protein-id>, the key entry-point enzyme for flavonoid biosynthesis led to <compound-id="10251">flavonoid</compound-id>-deficient roots.	flavonoid__chalcone synthase__interaction
18786181-656	<protein-id="P13448,P13449,P27763,P27764,P33036,P82605,P97051,P97052,Q53117,Q53118">Nitrilase</protein-id> enzymes have been characterised in plants, bacteria and fungi and are thought to be important in detoxification of nitriles, utilisation of <compound-id="947,123329">nitrogen</compound-id> and synthesis of plant hormones.	nitrogen__Nitrilase__interaction
18786181-657	In plants cyanide is converted to beta-cyano-L-alanine, which is subsequently detoxified to <compound-id="424,5960,83887">aspartic acid</compound-id> and <compound-id="222">ammonia</compound-id> by <protein-id="P46011,Q42965">NIT4</protein-id>.	ammonia__NIT4__interaction	aspartic acid__NIT4__interaction
18786182-658	The mitochondrial membrane potential (Delta psi (mit)) was also tested with <compound-id="65218">rhodamine 123</compound-id> 30 min after SI challenge, and was shown to have collapsed in the incompatible pollen tubes after exposure to <protein-id="P00669">S-RNase</protein-id>.	rhodamine 123__S-RNase__interaction
18786279-668	In conclusion, female rats undernourished in utero had normophagic obesity as adults but had an absence of <compound-id="5202">serotonin</compound-id>-induced hypophagia and low hypothalamic levels of the <protein-id="P08909,P28335,P34968,Q5IS66,Q60F97">5-HT 2C</protein-id> receptor.	serotonin__5-HT 2C__no_interaction
18786279-669	Compensatory adaptations for the functional serotonergic impairment were evidenced, such as an enhanced release of <compound-id="5202">serotonin</compound-id> in response to a meal allied to up-regulated hypothalamic <protein-id="O08892,P28222,P28286,P28334,P28564,P35404,P46636,P49144,P56496,P60020,P79250,P79399,Q588Y6,Q6XXX8,Q9N2B7">5-HT1B</protein-id> and transporter expression.	serotonin__5-HT1B__interaction
18786604-753	The proliferation of the parental cell line was most efficiently stimulated by <compound-id="10635">5alpha-dihydrotestosterone</compound-id> (<compound-id="10635">DHT</compound-id>), but the LNCaP[<protein-id="O54939,P37058,P70385">17beta-HSD3</protein-id>] cells were equally stimulated by Adione, indicating that <protein-id="O54939,P37058,P70385">17beta-HSD3</protein-id> efficiently converts Adione to T in this model.	5alpha-dihydrotestosterone__17beta-HSD3__no_interaction	DHT__17beta-HSD3__no_interaction
18786605-754	They potentiate <compound-id="206,5793,64689,79025">glucose</compound-id>-induced <protein-id="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7">insulin</protein-id> secretion and may be responsible for up to 70% of postprandial <protein-id="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7">insulin</protein-id> secretion.	glucose__insulin__interaction
18786605-755	However, in supraphysiological doses, <protein-id="O12956,P01272,P01273,P01274,P01275,P05110,P06883,P22890,P29794,P55095,P68259,Q06605,Q8MJ25">GLP-1</protein-id> administration may completely normalize beta as well as alpha cell sensitivity to <compound-id="206,5793,64689,79025">glucose</compound-id>.	glucose__GLP-1__interaction
18786649-767	The induction of signal transduction by serum and growth factors significantly increases the level of <protein-id="P23443,P67998,P67999,Q6TJY3,Q8BSK8">S6K</protein-id> ubiquitination, while the treatment of cells with UV and <compound-id="5279,44259,451705,5311103,5459111,6419748,6711321,9956178,44299148">staurosporine</compound-id> has the opposite effect.	staurosporine__S6K__interaction
18786760-796	Interaction of <compound-id="11295">malachite green</compound-id> with bovine <protein-id="P21847,P83517">serum albumin</protein-id> : determination of the binding mechanism and binding site by spectroscopic methods.	malachite green__serum albumin__interaction
18786760-797	The interaction between <compound-id="11295">malachite green</compound-id> (MG) and bovine <protein-id="P21847,P83517">serum albumin</protein-id> (<protein-id="P02769">BSA</protein-id>) under simulative physiological conditions was investigated by the methods of fluorescence spectroscopy, UV-vis absorption and circular dichroism (CD) spectroscopy.	malachite green__serum albumin__interaction	malachite green__BSA__interaction
18786760-798	The binding distance (r) between MG and the <compound-id="1148,6305,9060,5460840">tryptophan</compound-id> residue of <protein-id="P02769">BSA</protein-id> was obtained to be 4.79 nm according to Frster theory of non-radioactive energy transfer.	tryptophan__BSA__interaction
18786974-878	Unlike <compound-id="588">creatinine</compound-id>, <protein-id="P08935,P25973,P81061,P81714,Q06445">Cystatin</protein-id> C (<protein-id="O29953,O34577,P0A6J1,P0A6J2,P56858,P56861,P57497,P57702,P63889,P63890,P72940,Q5HL02,Q7MPF0,Q7UMW2,Q7UQW3,Q87SX6,Q88X60,Q8CR04,Q8DE75,Q8DJ87,Q8EB13,Q8FEJ2,Q8K9D4,Q8ZBP3,Q97MT8,Q9KP21,Q9YCR6">CysC</protein-id>) is believed to be independent of body composition in both adults and children.	creatinine__CysC__no_interaction	creatinine__Cystatin__no_interaction
18787021-886	Levels of endothelial <protein-id="O61309,O61608,Q27571,Q9I9M2">nitric oxide synthase</protein-id> and inducible <protein-id="O61309,O61608,Q27571,Q9I9M2">nitric oxide synthase</protein-id> did not differ among the groups, nor did total nitrite plus <compound-id="943">nitrate</compound-id> levels.	nitrate__nitric oxide synthase__no_interaction
18787024-887	<compound-id="79025">Glucose</compound-id> controls cytosolic Ca2+ and <protein-id="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7">insulin</protein-id> secretion in mouse islets lacking <compound-id="5957">adenosine triphosphate</compound-id>-sensitive K+ channels owing to a knockout of the pore-forming subunit Kir6.2.	Glucose__insulin__interaction	adenosine triphosphate__insulin__interaction
18787032-890	Thereafter we determined that hCG effect could be partially blocked by pharmacologic inhibition of <protein-id="O42781,P27638,Q00859">MAPK</protein-id> pathway with 50 microM <compound-id="4713">PD98059</compound-id> but not by the inhibition of the phosphatidylinositol 3-kinase pathway with 0.1 microm <compound-id="312145">wortmannin</compound-id>.	PD98059__MAPK__interaction	wortmannin__MAPK__no_interaction
18787174-941	Lung injury was assessed by measuring vascular permeability (via <compound-id="9566058">Evans blue dye</compound-id>), edema, neutrophil infiltration (via myeloperoxidase [<protein-id="P05164,P11247">MPO</protein-id>), and expression of proinflammatory cytokines.	Evans blue dye__MPO__no_interaction
18787236-950	<compound-id="304,5997,6432564,11025495">Cholesterol</compound-id> efflux from [(3)H] <compound-id="5283632">cholesterol-oleate</compound-id>-acetyl-LDL-loaded monocyte-derived macrophages to standard <protein-id="P18647">apolipoprotein A-I</protein-id> (<protein-id="O18759,O42175,O42296,O42363,P02647,P02648,P04639,P08250,P09809,P15497,P18647,P18648,P27007,P32918,P68292,P68293,Q00623,Q91488,Q9Z2L4">apoA-I</protein-id>), HDL(2), and serum was measured.	cholesterol-oleate__apoA-I__interaction	Cholesterol__apoA-I__interaction	cholesterol-oleate__apolipoprotein A-I__interaction	Cholesterol__apolipoprotein A-I__interaction
18787236-952	<compound-id="304,5997,6432564,11025495">Cholesterol</compound-id> efflux to <protein-id="O18759,O42175,O42296,O42363,P02647,P02648,P04639,P08250,P09809,P15497,P18647,P18648,P27007,P32918,P68292,P68293,Q00623,Q91488,Q9Z2L4">apoA-I</protein-id>, HDL(2), and serum from macrophage foam cells derived from low- and high-HDL subjects was similar.	Cholesterol__apoA-I__no_interaction
18787236-954	<compound-id="304,5997,6432564,11025495">Cholesterol</compound-id> efflux from THP-1 macrophages to serum from study subjects correlated with serum apoB (P = 0.033), <protein-id="O18759,O42175,O42296,O42363,P02647,P02648,P04639,P08250,P09809,P15497,P18647,P18648,P27007,P32918,P68292,P68293,Q00623,Q91488,Q9Z2L4">apoA-I</protein-id> (P = 0.004), <protein-id="P02652,P02653,P04638,P09813,P18656,P81644,P83704,Q8MIQ5">apoA-II</protein-id> 0.0001), and the percentage of <protein-id="O18759,O42175,O42296,O42363,P02647,P02648,P04639,P08250,P09809,P15497,P18647,P18648,P27007,P32918,P68292,P68293,Q00623,Q91488,Q9Z2L4">apoA-I</protein-id> present in the form of prebeta-HDL (P = 0.0001).	Cholesterol__apoA-I__interaction	Cholesterol__apoA-II__interaction
18787748-1079	In this study, the degradation of <protein-id="P31750">Rac</protein-id>- and R-<compound-id="42586,11150163">metalaxyl</compound-id> under anaerobic conditions was studied.	metalaxyl__Rac__no_interaction
18787757-1084	Regulation of muscle protein degradation, not synthesis, by dietary <compound-id="857,6106,439524">leucine</compound-id> in rats fed <protein-id="P03161,P03610,P03631,P03632,P07394,P15966,P25243,P25244,P35823,P98005">a protein</protein-id>-deficient diet.	leucine__a protein__no_interaction
18787837-1099	Studies of HeLa cells and serum- and glucocorticoid-regulated kinase 1 (SGK1) knockout mice identified <compound-id="6288">threonine</compound-id> residues in the <protein-id="Q62433,Q92597">n-myc downstream-regulated gene 1 protein</protein-id> (<protein-id="Q92597">NDRG1</protein-id>-Thr (346/356/366)) that are phosphorylated by SGK1 but not by related kinases (Murray et al., Biochem J 385:1-12, 2005).	threonine__n-myc downstream-regulated gene 1 protein__interaction	threonine__NDRG1__interaction
18787837-1100	Although G (Na) is negligible in hormone-deprived cells, these cells displayed basal <protein-id="O00141,Q9XT18">SGK1</protein-id> activity that was sensitive to <compound-id="3973">LY294002</compound-id>, an inhibitor of 3-phosphatidylinositol phosphate kinase (PI3K).	LY294002__SGK1__interaction
18787840-1103	<protein-id="P55245">Epidermal growth factor receptor</protein-id> expression analysis in chemotherapy-naive patients with advanced non-small-cell lung cancer treated with gefitinib or placebo in combination with <compound-id="23939">platinum</compound-id>-based chemotherapy.	platinum__Epidermal growth factor receptor__interaction
18787967-1145	The present investigation was carried out to assess the erythrocytic oxidative stress indices such as lipid peroxides level and activities of antioxidant enzymes such as <protein-id="O50258">superoxide dismutase</protein-id> and <protein-id="O24339,O52762,O62839,O68146,O77229,O93662,O97492,P00432,P04040,P04762,P07145,P0A323,P0A324,P0A325,P0A326,P0A327,P11934,P17336,P24168,P24270,P25890,P29422,P30265,P30266,P32290,P42321,P44390,P45737,P45739,P55304,P55306,P55310,P55311,P55313,P77872,P81138,P90682,Q27710,Q49XC1,Q4L643,Q59296,Q59337,Q59602,Q59714,Q5HG86,Q5HPK8,Q5RF10,Q64405,Q6G9M4,Q6GH72,Q7A5T2,Q8CPD0,Q8FWU0,Q8NWV5,Q8X1P0,Q8Y3P9,Q926X0,Q99UE2,Q9AXH0,Q9KW19,Q9L4S1,Q9M5L6,Q9PT92,Q9PWF7,Q9Z598,Q9ZKX5,Q9ZN99">catalase</protein-id>, and some hematological parameters after treatment of subclinically ketotic lactating cows with antioxidants, <compound-id="2116,14985,1548900,1742129">vitamin E</compound-id> and <compound-id="6326970">selenium</compound-id>, incorporated in conventional treatment regimen.	vitamin E__superoxide dismutase__no_interaction	vitamin E__catalase__no_interaction	selenium__superoxide dismutase__no_interaction	selenium__catalase__no_interaction
18787973-1149	This study was designed to determine the effect of <compound-id="4239">molsidomine</compound-id> (MO), a precursor of <compound-id="145068">nitric oxide</compound-id> (NO) donor, on hypoxia inducible factor alpha (<protein-id="O35800,Q0PGG7,Q16665,Q309Z6,Q61221,Q98SW2,Q9I8A9,Q9XTA5,Q9YIB9">HIF-1alpha</protein-id>) and Sonic hedgehog (Shh) levels considered to be involved in the development of testes ischemia/reperfusion (I-R) injury.	nitric oxide__HIF-1alpha__no_interaction	molsidomine__HIF-1alpha__interaction
18787978-1152	Candida albicans and C. tropicalis obtained from whole saliva of patients presenting signs of oral candidosis were assayed for quantification of colony forming units, exoenzyme activity (phospholipase and <protein-id="P10265,P63119,P63120,P63121,P63122,P63123,P63124,P63125,P63127,P63129,P63131,Q9Y6I0">proteinase</protein-id>) and antifungal drug sensitivity (<compound-id="5280965">amphotericin B</compound-id>, <compound-id="3365">fluconazole</compound-id> and <compound-id="3793,55283,6917738,14179013">itraconazole</compound-id>) by the reference method of the Clinical and Laboratory Standards Institute.	amphotericin B__proteinase__no_interaction	fluconazole__proteinase__no_interaction	itraconazole__proteinase__no_interaction
18788036-1175	To achieve sustained delivery of a novel bone-induced growth factor, chitosan microspheres loaded with synthetic oligopeptide (S([<compound-id="1061">PO4</compound-id>])KIPKASSVPTELSAISTLYLDDD, P24) were prepared by an emulsion-ionic cross-linking method in the presence of tripolyphosphate, with bovine <protein-id="P21847,P83517">serum albumin</protein-id> (<protein-id="P02769">BSA</protein-id>) as a control.	PO4__BSA__no_interaction	PO4__serum albumin__no_interaction
18789002-1201	Colon cancer cells maintain low levels of <compound-id="1060">pyruvate</compound-id> to avoid cell death caused by inhibition of <protein-id="P56517,P56518,Q13547,Q94517">HDAC1</protein-id>/<protein-id="O15379,P56520">HDAC3</protein-id>.	pyruvate__HDAC1__no_interaction	pyruvate__HDAC3__no_interaction
18789002-1204	This process is associated with an increase in intracellular levels of <compound-id="1060">pyruvate</compound-id>, increase in the acetylation status of <protein-id="P02309,P04914,P04915,P08436,P09322,P27996,P35057,P35059,P40287,P50566,P59259,P62776,P62777,P62778,P62779,P62780,P62781,P62782,P62783,P62784,P62787,P62788,P62789,P62790,P62791,P62792,P62793,P62794,P62795,P62796,P62797,P62798,P62799,P62800,P62801,P62802,P62803,P62804,P62805,P62806,P62887,P80738,P80739,P82888,P83865,P84040,P84041,P84042,P84043,P84044,P84045,P84046,P84047,P84048,P84049,P84050,P90516,P91849,P91882,P91890,Q27443,Q27765,Q43083,Q6LAF1,Q6LAF3,Q6PMI5,Q6V9I2,Q6WV72,Q6WV73,Q6WV74,Q6WV90,Q6WZ83,Q6ZXX3,Q71V09,Q76FD9,Q76FE7,Q76FF1,Q76FF5,Q76H85,Q76MU7,Q7K8C0,Q7KQD1,Q7LKT3,Q7M3Z5,Q8I0Y4,Q8J1L3,Q8MTV8,Q8NIG3,Q8SQP4,Q8T7J8,Q9HDF5,Q9U7D0">histone H4</protein-id>, and enhanced cell death.	pyruvate__histone H4__no_interaction
18789341-1500	The <compound-id="6076">cAMP</compound-id>/<protein-id="Q05608,Q9RI12">protein kinase A</protein-id> (PKA) signaling cascade is crucial for synaptic plasticity in a wide variety of species.	cAMP__protein kinase A__interaction
18789398-1523	Epigenetic reprogramming of breast cancer cells by <compound-id="3121">valproic acid</compound-id> occurs regardless of <protein-id="O42132,P03372,P06211,P06212,P16058,P19785,P49884,P49885,P49886,P50240,P50241,P50242,P57717,P57753,P81559,Q29040,Q53AD2,Q91250,Q91424,Q9PVZ9,Q9QZJ5,Q9TV98,Q9YH33,Q9YHT3,Q9YHZ7">estrogen receptor</protein-id> status.	valproic acid__estrogen receptor__no_interaction
18789440-1646	In the present study, we have investigated the effect of <protein-id="O35497,O35735,O57571,O57603,O57608,O73915,O77763,P01579,P01580,P01581,P07353,P17773,P17803,P28333,P28341,P30123,P42160,P42161,P42162,P46402,P49708,P63309,P63310,P63311,P79154,Q1WM28,Q25BC0,Q2PE75,Q4ZH68,Q5CCK0,Q5I6S9,Q62574,Q647G2,Q7TSP4,Q865W6,Q865X1,Q865Y4,Q866Y6,Q8MKF5,Q8SPW9,Q9QXX2,Q9TTB0,Q9TV67,Q9YGB9">IFN-gamma</protein-id> on <protein-id="O95477">ABCA1</protein-id> expression and <compound-id="304,5997,6432564,11025495">cholesterol</compound-id> efflux in THP-1 macrophage-derived foam cells.	cholesterol__IFN-gamma__interaction	cholesterol__ABCA1__no_interaction
18789466-1548	Every 12 weeks intestinal permeability (<compound-id="3872,11333,11024312,16217605,16760534">lactulose</compound-id>/<compound-id="6251">mannitol</compound-id> ratio), haemoglobin, plasma albumin, <protein-id="Q08398">alpha-1</protein-id>-acid <protein-id="P08163">glycoprotein</protein-id>, IgG and Giardia-specific IgM (GSIgM) and eggs of the three common geohelminths and G. intestinalis cysts were determined.	lactulose__glycoprotein__no_interaction	mannitol__alpha-1__no_interaction	lactulose__alpha-1__no_interaction	mannitol__glycoprotein__no_interaction
18789492-1558	As such, the aim of the present study was to investigate whether <protein-id="P11597,P22687,P25914,P47896">CETP</protein-id>-inhibition with <compound-id="6918540">JTT-705</compound-id>, a molecule distinctly different from torcetrapib, impacts on vascular function, a well-established surrogate of atherosclerotic vascular disease, as well as markers of inflammation and oxidative stress in patients with type II hyperlipidemia.	JTT-705__CETP__interaction
18789529-1570	In this review we discuss the <protein-id="P16629,P24266,P28991,Q04565,Q07252">membrane proteins</protein-id> that transport arsenic and <compound-id="6326970">selenium</compound-id> into cells, from bacteria to humans, as well as some of the efflux proteins involved in detoxification.	selenium__membrane proteins__interaction
18789530-2169	Pathways involved in the hydrolysis of nitrile pollutants (aliphatic nitriles, <compound-id="7505">benzonitrile</compound-id> analogues) and the corresponding enzymes (<protein-id="P13448,P13449,P27763,P27764,P33036,P82605,P97051,P97052,Q53117,Q53118">nitrilase</protein-id>, nitrile hydratase) are described in detail.	benzonitrile__nitrilase__interaction
18789597-659	Since stellate cells have been found to express the beta but not the alpha isoform of the <protein-id="O42132,P03372,P06211,P06212,P16058,P19785,P49884,P49885,P49886,P50240,P50241,P50242,P57717,P57753,P81559,Q29040,Q53AD2,Q91250,Q91424,Q9PVZ9,Q9QZJ5,Q9TV98,Q9YH33,Q9YHT3,Q9YHZ7">estrogen receptor</protein-id>, it can be predicted that nutritional intakes of the soy <compound-id="72304">isoflavone</compound-id> <compound-id="5280961">genistein</compound-id>-a selective agonist for ERbeta in the low nanomolar plasma concentrations achievable with these intakes-have potential for suppressing hepatic fibrosis, in both men and women.	genistein__estrogen receptor__no_interaction	isoflavone__estrogen receptor__no_interaction
18789664-1638	We report that the PP inhibition of proteolysis in young rats was mediated by the increased <protein-id="P01308,P01310,P01311,P01313,P01314,P01315,P01316,P01317,P01318,P01319,P01320,P01321,P01324,P01327,P01328,P01329,P01330,P01331,P01333,P01334,P01335,P01336,P01340,P01342,P04667,P06306,P07453,P09476,P09477,P0C236,P12703,P12704,P12705,P12708,P13190,P17715,P18109,P21563,P29335,P30406,P30407,P30410,P41522,P42633,P51463,P67968,P67969,P67970,P67971,P67972,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69045,P69046,P69047,P69048,P81025,P81423,P81881,Q62587,Q6YK33,Q8HXV2,Q91XI3,Q98TA8,Q9TQY7,Q9W7R2">INS</protein-id> secretion and resulted from a down-regulation of both lysosomal and <compound-id="271">Ca(2</compound-id>+)-dependent proteolysis.	Ca(2__INS__no_interaction
18789666-1639	Aqueous extract of cumin was tested for its antiglycating ability against <compound-id="5984">fructose</compound-id>-induced glycation of goat lens total soluble protein (<protein-id="P07996,P12528,Q9XJP3">TSP</protein-id>), alpha-crystallin from goat lens and a nonlenticular protein bovine <protein-id="P21847,P83517">serum albumin</protein-id> (<protein-id="P02769">BSA</protein-id>).	fructose__serum albumin__interaction	fructose__TSP__interaction	fructose__BSA__interaction
18789669-1641	To investigate the effects of <compound-id="6326970">selenium</compound-id> on mRNA expressions of proinflammatory cytokines and inducible <protein-id="O61309,O61608,Q27571,Q9I9M2">nitric oxide synthase</protein-id> (<protein-id="O19114,O46660,O54705,O62699,P29477,P35228,P79290,Q06518,Q27995,Q28314,Q90703,Q92037,Q92091">iNOS</protein-id>) in the pancreas of streptozotocin-induced diabetic mice, the animals were divided into three groups in this study: a normal control group, an untreated diabetes mellitus group and a <compound-id="1090">selenite</compound-id>-treated diabetes mellitus group.	selenite__iNOS__no_interaction	selenite__nitric oxide synthase__no_interaction	selenium__nitric oxide synthase__interaction	selenium__iNOS__interaction
18789669-1642	The results showed that pancreatic <compound-id="6326970">selenium</compound-id> content and <protein-id="O32770,O59858,Q00277,Q9CFV1">glutathione peroxidase</protein-id>.05), respectively, in <compound-id="1090">selenite</compound-id>-treated diabetes mellitus group compared with untreated diabetes mellitus group.	selenium__glutathione peroxidase__no_interaction	selenite__glutathione peroxidase__no_interaction
18789669-1643	Meanwhile, pancreatic mRNA expressions of proinflammatory cytokines interleukin-1beta, <protein-id="Q8JFG3">tumor necrosis factor</protein-id>-alpha and <protein-id="Q9TTB0">interferon-gamma</protein-id> ; mRNA expression and activity of <protein-id="O19114,O46660,O54705,O62699,P29477,P35228,P79290,Q06518,Q27995,Q28314,Q90703,Q92037,Q92091">iNOS</protein-id>.05), respectively, in <compound-id="1090">selenite</compound-id>-treated diabetes mellitus group compared with untreated diabetes mellitus group.	selenite__tumor necrosis factor__no_interaction	selenite__iNOS__no_interaction	selenite__interferon-gamma__no_interaction
18789733-21	Decreases in PNNs, aggrecan and <compound-id="24759,453618,3084050,24728612">hyaluronic acid</compound-id> were observed only in the terminal stages and correlated with the distribution of <protein-id="O18754,O46501,P04156,P04273,P04925,P10279,P13852,P23907,P40242,P40243,P40244,P40245,P40246,P40247,P40248,P40249,P40251,P40252,P40255,P40256,P40257,P40258,P47852,P49927,P51446,P51780,P52113,P52114,P61761,P61762,P61766,P61767,P61768,P67986,P67987,P67988,P67989,P67990,P67991,P67992,P67993,P67994,P67995,P67996,P67997,P79141,Q5UAF1,Q5UJG1,Q5UJG3,Q5UJG7,Q5UJH0,Q5UJH8,Q5UJI7,Q5XVM4,Q60468,Q60506,Q68G95,Q6EH52,Q7JIH3,Q7JIY2,Q7JK02,Q95174,Q95176,Q95211,Q95270,Q95M08,Q9Z0T3">PrP</protein-id> (BSE) and activated glial cells.	hyaluronic acid__PrP__interaction
18789733-22	This study suggests that the loss of <protein-id="P79122,P79149,Q5R5X0,Q9H307">PNNs</protein-id>, aggrecan and <compound-id="24759,453618,3084050,24728612">hyaluronic acid</compound-id> is a consequence of <protein-id="O18754,O46501,P04156,P04273,P04925,P10279,P13852,P23907,P40242,P40243,P40244,P40245,P40246,P40247,P40248,P40249,P40251,P40252,P40255,P40256,P40257,P40258,P47852,P49927,P51446,P51780,P52113,P52114,P61761,P61762,P61766,P61767,P61768,P67986,P67987,P67988,P67989,P67990,P67991,P67992,P67993,P67994,P67995,P67996,P67997,P79141,Q5UAF1,Q5UJG1,Q5UJG3,Q5UJG7,Q5UJH0,Q5UJH8,Q5UJI7,Q5XVM4,Q60468,Q60506,Q68G95,Q6EH52,Q7JIH3,Q7JIY2,Q7JK02,Q95174,Q95176,Q95211,Q95270,Q95M08,Q9Z0T3">PrP</protein-id> (BSE) accumulation.	hyaluronic acid__PrP__interaction	hyaluronic acid__PNNs__interaction
18789802-1681	Cells were exposed to native low-density lipoprotein (LDL), acetylated LDL, and LDL that had been modified by oxidation with <compound-id="23978">copper</compound-id> or <compound-id="27284">ferrous ions</compound-id> or by exposure to auto-oxidation products of <compound-id="444899">arachidonic acid</compound-id> for 16h, and <protein-id="P15691,P15692,P26617,P49151,P50412,P67964,P67965,Q99PS1,Q9GKR0,Q9MYV3">VEGF</protein-id> was then assayed in medium.	copper__VEGF__no_interaction	arachidonic acid__VEGF__no_interaction	ferrous ions__VEGF__no_interaction
18789953-507	In hypersensitive alpha4L9'A mice, injections of a low dose of <compound-id="942,89594,157672">nicotine</compound-id> (0.1 mg/kg) led to strong c-<protein-id="P01101,P12841,Q56415">fos</protein-id> expression in only the ventrolateral region of the MHb, but not in the MHb of wild-type (WT) mice.	nicotine__fos__interaction
18790021-1764	To address this issue, we have examined the effects of excitotoxic lesion of CM/Pf and of <compound-id="4624">6-hydroxydopamine</compound-id>-induced lesion of nigral dopamine neurons, separately or in association, on gene expression of markers of neuronal activity in the rat basal ganglia (striatal <protein-id="P21259">neuropeptide</protein-id> precursors, <protein-id="P14748,P48319,Q5IS68,Q99259">GAD67</protein-id>, <protein-id="P45021">cytochrome oxidase subunit I</protein-id>) by quantitative in situ hybridization histochemistry.	6-hydroxydopamine__neuropeptide__interaction	6-hydroxydopamine__cytochrome oxidase subunit I__interaction	6-hydroxydopamine__GAD67__interaction
18790083-1786	Participating in a significant fraction of the fundamental paths connecting the ligands to the phenotypes, cofactor <compound-id="6830">GTP</compound-id> and complex Gbeta/Ggamma were identified as "housekeeping" molecules, through which all pathways of <protein-id="P00533,P13387,P55245">EGFR</protein-id> network are cross-talking.	GTP__EGFR__interaction
18790533-1437	These effects were probably associated with the increase of intracellular <compound-id="5359597">superoxide</compound-id> in mitochondrial signaling pathway which attributed to the down-regulation of <protein-id="O50258">superoxide dismutase</protein-id> (<protein-id="O12933,O22668,O75007,P24705,P51547,P93258,Q01137,Q27666,Q9SM64">SOD</protein-id>).	superoxide__superoxide dismutase__interaction	superoxide__SOD__interaction
18790812-2041	This initiates a <compound-id="6076">cAMP</compound-id> signalling cascade resulting in the translocation of <protein-id="O62735,O77697,O77714,O77722,O77740,P41181,P79099,P79144,P79164,P79165,P79168,P79200,P79213,P79229,P79803">AQP2</protein-id>-bearing vesicles to the apical membrane.	cAMP__AQP2__interaction
18790996-2085	The formation and trafficking of autophagic vesicles are directed in part by associated conjugation cascades that couple the AUTOPHAGY-RELATED8 (<protein-id="P0C075,P38182,P87068,Q4P2U6,Q51MW4,Q5KN30,Q5QFG1,Q6BT31,Q6C794,Q6CMF8,Q6FXR8,Q755X2,Q8H715,Q8J282,Q8NJJ4">ATG8</protein-id>) and <protein-id="O94817,P38316,Q3T0W7,Q51P78,Q55S70,Q5AKU4,Q5R7W1,Q69NP0,Q6BU30,Q6BZZ1,Q6CUD5,Q6FMM7,Q75EB4">ATG12</protein-id> proteins to their respective targets, <compound-id="114944">phosphatidylethanolamine</compound-id> and the <protein-id="Q12380,Q3MQ04,Q3MQ24,Q525E4,Q59VY1,Q5K6S9,Q5R792,Q6BVI8,Q6C4Q6,Q6CKE2,Q6FJZ6,Q6ZGL4,Q75BY9,Q9FFI2,Q9H1Y0">ATG5</protein-id> protein.	phosphatidylethanolamine__ATG8__interaction	phosphatidylethanolamine__ATG12__interaction	phosphatidylethanolamine__ATG5__no_interaction
18790996-2086	Levels of Atg transcripts and/or the <protein-id="P0C075,P38182,P87068,Q4P2U6,Q51MW4,Q5KN30,Q5QFG1,Q6BT31,Q6C794,Q6CMF8,Q6FXR8,Q755X2,Q8H715,Q8J282,Q8NJJ4">ATG8</protein-id>-<compound-id="114944">phosphatidylethanolamine</compound-id> adduct increase during leaf senescence and nitrogen and fixed-carbon limitations, indicating that autophagy plays a key role in nutrient remobilization.	phosphatidylethanolamine__ATG8__interaction
18791141-99	This study confirmed QTL previously identified for pH except those on <protein-id="O43315,P12398,Q9BW60">SSC1</protein-id>, 11, 12, and X, and found 11 new 5% genome-wise significant QTL for <compound-id="439177">glycogen</compound-id>-related traits.	glycogen__SSC1__no_interaction
18791145-109	The objective of this study was to examine the effect of level and duration of feeding of an n-3 PUFA-enriched fish oil (<compound-id="46209,69711">FO</compound-id>) supplement in combination with soybean oil (SO) on the transcriptional regulation of <protein-id="O00767,O02858,O62849,O94523,Q12618,Q64420,Q92038,Q95MI7,Q9TT94">Delta(9)-desaturase</protein-id> gene expression in bovine muscle.	FO__Delta(9)-desaturase__interaction
18791154-2132	Whole blood and plasma were analyzed for total Se, <protein-id="O32770,O59858,Q00277,Q9CFV1">glutathione peroxidase</protein-id> activity in whole blood (<protein-id="P47236">GPX-1</protein-id>) and plasma, and thyroid hormones (<compound-id="853,5819">thyroxine</compound-id> and <compound-id="861,5920,71212">triiodothyronine</compound-id>) in plasma.	triiodothyronine__glutathione peroxidase__no_interaction	thyroxine__glutathione peroxidase__no_interaction	triiodothyronine__GPX-1__no_interaction	thyroxine__GPX-1__no_interaction
18791496-2222	Studies have shown that administration of <compound-id="5757">17beta-estradiol</compound-id> (estrogen) after trauma-hemorrhage normalized cardiac <protein-id="O35736,P05231,P08505,P20607,P26892,P26893,P29455,P41323,P41683,P41693,P46650,P51494,P79341,Q25BC2,Q28319,Q28747,Q28819,Q2MH06,Q5I6E3,Q6V919,Q865W7,Q865X6,Q8MKH0,Q95181,Q9MZR1,Q9XT80">IL-6</protein-id> levels and restored cardiac functions under those conditions.	17beta-estradiol__IL-6__interaction
18791496-2223	Vehicle, the HIF-alpha inhibitor <compound-id="5712">YC-1</compound-id> [<compound-id="5712">3-(5'-hydroxymethyl-2'-furyl)-1-benzylindazole</compound-id>, a novel activator of platelet guanylate <protein-id="O94303,P33734,Q9P4P9,Q9SZ30">cyclase</protein-id>], or estrogen was administered to trauma-hemorrhage and sham groups during resuscitation.	3-(5'-hydroxymethyl-2'-furyl)-1-benzylindazole__cyclase__interaction	YC-1__cyclase__interaction
18791811-2349	Chemopreventive potential of <compound-id="445154">resveratrol</compound-id> in mouse skin tumors through regulation of mitochondrial and <protein-id="O00329,O02697,O35904,P23727,P26450,P27986,P32871,P42336,P42337,P42338,P42347,P42348,P48736,P54673,P54674,P54675,P54676,Q63787,Q8BTI9,Q8UUU2,Q9JHG7,Q9Z1L0">PI3K</protein-id>/AKT signaling pathways.	resveratrol__PI3K__interaction
18791821-2351	<compound-id="41867">Epirubicin</compound-id> plus low-dose trastuzumab in <protein-id="P04626">HER2</protein-id> positive metastatic breast cancer.	Epirubicin__HER2__no_interaction
18791821-2352	This phase II study, evaluated the activity and cardiotoxicity of first-line <compound-id="41867">epirubicin</compound-id> plus low-dose trastuzumab (LD-T) in patients with <protein-id="P04626">HER2</protein-id> positive MBC.	epirubicin__HER2__no_interaction
18791856-2363	The roles of endothelial <protein-id="O61309,O61608,Q27571,Q9I9M2">nitric oxide synthase</protein-id> (<protein-id="P29473,P29474,P70313,P79209,P97270,Q28969,Q62600">eNOS</protein-id>), and its putative association with <protein-id="P31749,P31750,P47196,Q01314,Q8INB9">protein kinase B</protein-id> (<protein-id="P31749,P31750,P47196,Q01314,Q8INB9">PKB</protein-id>), and inducible <protein-id="O61309,O61608,Q27571,Q9I9M2">nitric oxide synthase</protein-id> (<protein-id="O19114,O46660,O54705,O62699,P29477,P35228,P79290,Q06518,Q27995,Q28314,Q90703,Q92037,Q92091">iNOS</protein-id>) are not well characterized in hypoxic cardiac cells and there is a lack of studies that measure <compound-id="145068">nitric oxide</compound-id> (NO) directly.	nitric oxide__PKB__no_interaction	nitric oxide__protein kinase B__no_interaction	nitric oxide__eNOS__no_interaction	nitric oxide__nitric oxide synthase__no_interaction	nitric oxide__iNOS__no_interaction
18791914-2380	The DEP-induced increases in peribronchial eosinophils and mucous goblet cells in the lung tissues, and of <protein-id="O02699,O08987,O77515,P04401,P05113,P46685,P48093,P52173,Q08125,Q28586,Q62575,Q95J76,Q9ESI9,Q9XT91">IL-5</protein-id> and <protein-id="P20109,P35225,P42203,P61126,Q5I6E4,Q864V6,Q865W5,Q865X3,Q95J68,Q9N0W9,Q9XSV9">IL-13</protein-id> in the BAL fluid, were significantly attenuated by the antioxidant <compound-id="12035">N-acetylcysteine</compound-id>.	N-acetylcysteine__IL-5__interaction	N-acetylcysteine__IL-13__interaction
18792056-2438	Each of the developed consortium has a <compound-id="1061,167704,644102">phosphate</compound-id> solubilizer, <compound-id="947,123329">nitrogen</compound-id> fixer, <protein-id="O12980,O13188,O18938,O62754,O70615,O73848,O73849,O93566,P01241,P01244,P01245,P01246,P01248,P06880,P07064,P08591,P08998,P09113,P09537,P09539,P10298,P10607,P10766,P10813,P10814,P11228,P13391,P19795,P20391,P20392,P22077,P24363,P29971,P33092,P33093,P33711,P34005,P34006,P34744,P34745,P34746,P34747,P37885,P37886,P45643,P45654,P45655,P46404,P46407,P48248,P55755,P56437,P58343,P58756,P67930,P67931,P69158,P69159,P69160,P69161,P69162,P79885,P87391,Q01282,Q01283,Q05163,Q07221,Q1HFN3,Q659Q8,Q7YQB8,Q7YQD2,Q7YRR6,Q864S7,Q8HYE5,Q8MI73,Q98UF6,Q9DEV3,Q9DGG5,Q9GKA1,Q9GL60,Q9GMB2,Q9GMB3,Q9I9L5,Q9I9M4,Q9IB11,Q9IBE5,Q9JKM4,Q9PWG3,Q9W6J5,Q9W6J7,Q9W6R8">growth hormone</protein-id> producer, heterotrophic member and an antagonist.	nitrogen__growth hormone__no_interaction	phosphate__growth hormone__no_interaction
18792785-89	Using cannabinoid receptor antagonists and cannabinoid receptor gene deficient mice (CB(1) (-/-) and CB(2) (-/-)), we showed that both CB(1) and CB(2) receptors were involved in the <compound-id="134740">THC</compound-id>-induced attenuation of serum IL-12 and <protein-id="O35497,O35735,O57571,O57603,O57608,O73915,O77763,P01579,P01580,P01581,P07353,P17773,P17803,P28333,P28341,P30123,P42160,P42161,P42162,P46402,P49708,P63309,P63310,P63311,P79154,Q1WM28,Q25BC0,Q2PE75,Q4ZH68,Q5CCK0,Q5I6S9,Q62574,Q647G2,Q7TSP4,Q865W6,Q865X1,Q865Y4,Q866Y6,Q8MKF5,Q8SPW9,Q9QXX2,Q9TTB0,Q9TV67,Q9YGB9">IFNgamma</protein-id>.	THC__IFNgamma__no_interaction
18792801-694	Promoter analysis of the <protein-id="P11464">PSG1</protein-id>, 4, and 11 genes in HeLa cells did not reveal a cis-regulatory element responsive to <compound-id="6035">5-bromodeoxyuridine</compound-id> in their 5'-flanking sequences.	5-bromodeoxyuridine__PSG1__no_interaction
18792915-162	<protein-id="O62618">p38-MAPK</protein-id>- and caspase-3-mediated superoxide-induced apoptosis of rat hepatic stellate cells: reversal by <compound-id="444795">retinoic acid</compound-id>.	retinoic acid__p38-MAPK__interaction
18793216-256	In vivo administration of a synthetic phospholipid, named hereafter phospho-ceramide analogue-1 (PCERA-1), was previously found to suppress <compound-id="11970143">lipopolysaccharide</compound-id> (LPS)-induced <protein-id="O35734,O77510,O77764,P01375,P04924,P06804,P13296,P16599,P19101,P23383,P23563,P29553,P33620,P36939,P48094,P51435,P51742,P51743,P59684,P59693,P59694,P59695,P79337,P79374,Q06599,Q19LH4,Q1G1A2,Q1WM27,Q2MH05,Q539C2,Q75N23,Q8HZD9,Q8JFG3,Q8MKG8,Q8WNR1,Q9BEA1">TNF-alpha</protein-id> blood levels.	lipopolysaccharide__TNF-alpha__interaction
18793216-258	In conclusion, the anti-inflammatory activity of PCERA-1 seems to be mediated by a cell membrane receptor, upstream of <compound-id="6076">cAMP</compound-id> production, and eventually <protein-id="O35734,O77510,O77764,P01375,P04924,P06804,P13296,P16599,P19101,P23383,P23563,P29553,P33620,P36939,P48094,P51435,P51742,P51743,P59684,P59693,P59694,P59695,P79337,P79374,Q06599,Q19LH4,Q1G1A2,Q1WM27,Q2MH05,Q539C2,Q75N23,Q8HZD9,Q8JFG3,Q8MKG8,Q8WNR1,Q9BEA1">TNF-alpha</protein-id> suppression and <protein-id="O46673,O97798,P18893,P22301,P29456,P43480,P46651,P47965,P48411,P51496,P51497,P51746,P55029,P79338,Q0Z972,Q25BC1,Q28374,Q29055,Q29408,Q2PE73,Q5Q0V6,Q865X4,Q8MKG9,Q9JHK7,Q9TSJ4,Q9Z1Y5">IL-10</protein-id> induction.	cAMP__IL-10__no_interaction	cAMP__TNF-alpha__no_interaction
18793341-327	Acylated <protein-id="Q6BEG6,Q6BEG7,Q9BDJ6,Q9BEF8,Q9EQX0,Q9GKY5,Q9QYH7,Q9UBU3">ghrelin</protein-id> and <protein-id="O35734,O77510,O77764,P01375,P04924,P13296,P19101,P23383,P23563,P29553,P33620,P36939,P48094,P51435,P51742,P51743,P59684,P59693,P59694,P59695,P79337,P79374,Q06599,Q19LH4,Q1G1A2,Q1WM27,Q2MH05,Q539C2,Q75N23,Q8HZD9,Q8JFG3,Q8MKG8,Q8WNR1,Q9BEA1">TNF</protein-id> , <protein-id="P28172,P51526">IFN</protein-id> , IL-1 and <protein-id="O35736,P05231,P08505,P20607,P26892,P26893,P29455,P41323,P41683,P41693,P46650,P51494,P79341,Q25BC2,Q28319,Q28747,Q28819,Q2MH06,Q5I6E3,Q6V919,Q865W7,Q865X6,Q8MKH0,Q95181,Q9MZR1,Q9XT80">IL-6</protein-id> were measured with <compound-id="636403">bioplex</compound-id>.	bioplex__IFN__interaction	bioplex__TNF__interaction	bioplex__ghrelin__interaction	bioplex__IL-6__interaction
18793347-2512	Pre-gravid physical activity and reduced risk of <compound-id="206,5793,64689,79025">glucose</compound-id> intolerance in pregnancy : the role of <protein-id="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7">insulin</protein-id> sensitivity.	glucose__insulin__interaction
18793347-2513	Thus, we sought to study the relationships between types of pre-gravid physical activity and metabolic parameters in pregnancy, including <compound-id="206,5793,64689,79025">glucose</compound-id> tolerance, <protein-id="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7">insulin</protein-id> sensitivity and beta-cell function.	glucose__insulin__no_interaction
18793351-330	Inhibition of autophagy by treating rats with <compound-id="312145">Wortmannin</compound-id> (15 microg/kg; intraperitoneally) abolished the ischaemic adaptation-induced induction of <protein-id="P82160">LC3</protein-id>-II, <protein-id="O88597,Q14457,Q4A1L4,Q4A1L5">Beclin-1</protein-id>, <protein-id="Q60739,Q99933">BAG-1</protein-id> and cardioprotection.	Wortmannin__LC3__interaction	Wortmannin__BAG-1__interaction	Wortmannin__Beclin-1__interaction
18793654-448	Mutations within the glycine-binding site of the GlyR <protein-id="Q08398">alpha1</protein-id> subunit reduced the inhibitory potency of Cu2+ and led to an up to 4-fold potentiation of <compound-id="750">glycine</compound-id>-elicited currents by Cu2+.	glycine__alpha1__interaction
18793694-459	When myosin molecules work as an aggregate, the sliding movement of a myosin filament driven by the power strokes of some myosin heads makes other myosin heads that have completed their power strokes detach from the <protein-id="O00937,O13419,O16808,O17320,O65314,O65315,O65316,O74258,O81221,P02577,P10365,P10989,P11426,P13363,P14235,P17128,P20904,P24902,P26182,P26183,P30161,P45520,P45521,P48465,P50138,P51775,P53455,P53476,P53477,P53491,P53498,P53499,P53500,P53502,P53689,P60009,P60010,P60011,P68555,P78711,P80709,P81085,P90689,P91754,Q05214,Q11212,Q24733,Q2U7A3,Q39596,Q39758,Q6TCF2,Q75D00,Q8SWN8,Q8X119,Q92192,Q92193,Q99023,Q9P4D1,Q9UVF3,Q9UVX4,Q9UVZ8">actin</protein-id> without consuming <compound-id="5957">ATP</compound-id>.	ATP__actin__no_interaction
18793694-460	A critical requirement for this mechanism is that <compound-id="5957">ATP</compound-id> must preferentially facilitate the detachment of myosins that have completed their power strokes, but are still strongly attached to the <protein-id="O00937,O13419,O16808,O17320,O65314,O65315,O65316,O74258,O81221,P02577,P10365,P10989,P11426,P13363,P14235,P17128,P20904,P24902,P26182,P26183,P30161,P45520,P45521,P48465,P50138,P51775,P53455,P53476,P53477,P53491,P53498,P53499,P53500,P53502,P53689,P60009,P60010,P60011,P68555,P78711,P80709,P81085,P90689,P91754,Q05214,Q11212,Q24733,Q2U7A3,Q39596,Q39758,Q6TCF2,Q75D00,Q8SWN8,Q8X119,Q92192,Q92193,Q99023,Q9P4D1,Q9UVF3,Q9UVX4,Q9UVZ8">actin</protein-id>.	ATP__actin__no_interaction
18793801-496	Urinary <protein-id="P54802">NAG</protein-id> (N-acetyl-beta-glucosaminidase), a kidney function test, blood <compound-id="206,5793,64689,79025">glucose</compound-id>, triglyceride, <compound-id="304,5997,6432564,11025495">cholesterol</compound-id>, high density lipid and low density lipid were measured.	cholesterol__NAG__no_interaction	glucose__NAG__no_interaction
18794178-604	Efficacy, safety and patient-reported outcomes of combination <protein-id="P20333">etanercept</protein-id> and <compound-id="5353980,5359476,5384001">sulfasalazine</compound-id> versus <protein-id="P20333">etanercept</protein-id> alone in patients with rheumatoid arthritis: a double-blind randomised 2-year study.	sulfasalazine__etanercept__no_interaction
18794178-605	To determine the efficacy and safety of <protein-id="P20333">etanercept</protein-id> and <protein-id="P20333">etanercept</protein-id> plus <compound-id="5353980,5359476,5384001">sulfasalazine</compound-id> versus <compound-id="5353980,5359476,5384001">sulfasalazine</compound-id> in patients with rheumatoid arthritis (RA) despite <compound-id="5353980,5359476,5384001">sulfasalazine</compound-id> therapy.	sulfasalazine__etanercept__no_interaction
18794865-1914	A randomized trial of <compound-id="3310,36462,439525,5284558,6419930,6610299,11758093,45356822,50989217">etoposide</compound-id> and <protein-id="O02708,O02837,P09919,P09920,P35833,P35834,Q28746">G-CSF</protein-id> with or without rituximab for PBSC mobilization in B-cell non-Hodgkin's lymphoma.	etoposide__G-CSF__no_interaction
18794865-1915	Twenty seven patients were mobilized with <compound-id="3310,36462,439525,5284558,6419930,6610299,11758093,45356822,50989217">etoposide</compound-id> and <protein-id="O02708,O02837,P09919,P09920,P35833,P35834,Q28746">G-CSF</protein-id> and 28 with <compound-id="3310,36462,439525,5284558,6419930,6610299,11758093,45356822,50989217">etoposide</compound-id>, <protein-id="O02708,O02837,P09919,P09920,P35833,P35834,Q28746">G-CSF</protein-id> and rituximab.	etoposide__G-CSF__no_interaction
18795231-893	Aberrant methylation of the <protein-id="O26715,O27970,O59499,O74023,O93728,P0A2U0,P0A2U1,P0A696,P0A697,P0AFH0,P0AFH1,P11742,P16455,P24528,P26186,P26187,P26188,P29177,P44687,P52982,Q4J9C6,Q58924,Q5UNU9,Q6TDU1,Q8PY44,Q8TI34,Q8TZ11,Q8TZV2,Q973C7,Q97VW7,Q9V1N7,Q9ZET8">MGMT</protein-id> (O6-methylguanine-DNA <protein-id="O40976,P03588,P03589,P06011,P17769,P20122,P27752,P28726,P28931,Q00020,Q66121,Q83264,Q83270">methyltransferase</protein-id>) DNA-repair gene is a predictive marker for the response to chemotherapy with alkylating agents (e.g., <compound-id="5394">temozolomide</compound-id>) in malignant gliomas.	temozolomide__methyltransferase__interaction	temozolomide__MGMT__interaction
18795240-896	This work describes the influence of two polar lipids, Sn-1/3 and Sn-<compound-id="123409">2 monopalmitin</compound-id>, on the activity of <protein-id="Q7M4U7">lipase</protein-id> in biphasic systems and in microemulsions.	2 monopalmitin__lipase__interaction
18795240-897	In previous communications, we have shown that Sn-<compound-id="17756737">2 monoglycerides</compound-id> can replace Sn-1,3 regiospecific <protein-id="Q7M4U7">lipases</protein-id> at the oil-water interface, causing a drastically reduced rate of lipolysis.	2 monoglycerides__lipases__interaction
18795263-905	Depletion of tungsten and/or molybdenum, however, did not affect the growth of the pure culture of S. fumaroxidans on <compound-id="1032">propionate</compound-id> plus <compound-id="444972">fumarate</compound-id> significantly, although the specific activities of <protein-id="P80509,P80510">hydrogenase</protein-id> and especially <protein-id="P33160,P33677,Q07103">formate dehydrogenase</protein-id> were influenced by the absence of Mo and W. This indicates that the organism has a low W or Mo requirement under these conditions.	propionate__hydrogenase__no_interaction	propionate__formate dehydrogenase__no_interaction	fumarate__hydrogenase__no_interaction	fumarate__formate dehydrogenase__no_interaction
18795263-906	Our results suggest a more prominent role for H2 as electron carrier in the syntrophic conversion of <compound-id="1032">propionate</compound-id>, when the essential trace metals W and Mo for the functioning of <protein-id="P33160,P33677,Q07103">formate dehydrogenase</protein-id> are depleted.	propionate__formate dehydrogenase__interaction
18795264-907	Previous studies have demonstrated an association between genetic polymorphisms of the mu opioid receptor gene (<protein-id="P35372,P79350,P97266,Q5IS39,Q5IS84,Q95247,Q95M54,Q9MYW9">OPRM1</protein-id>) and response to <compound-id="5360515">naltrexone</compound-id> treatment.	naltrexone__OPRM1__interaction
18795290-925	Based on the preclinical evidence of <protein-id="O29238,O51934,O58530,O67037,O67226,P74759,P95479,Q08582,Q58907,Q6F598,Q8R979,Q8ZXT5,Q971T7,Q975P6,Q97ZF5,Q97ZZ8,Q9UZ86,Q9YC75,Q9YCB6">topoisomerase</protein-id> I (Topo-1) upregulation by <compound-id="5746">mitomycin C</compound-id> (MMC) and decreased NF-kappaB activation by celecoxib, we evaluated combinations of irinotecan/MMC and irinotecan/MMC/celecoxib in patients with advanced solid malignancies.	mitomycin C__topoisomerase__interaction
18795320-932	The cells expressed <protein-id="P29972,P29975,P47865,P53386,P56401,P61837,P61838,Q02013,Q5R819,Q6PQZ1,Q9N2J4">aquaporin-1</protein-id> sensitive to <compound-id="24182">HgCl</compound-id> (2) and decreased by siRNA, which both reduced fast volume changes.	HgCl__aquaporin-1__interaction
18795889-1063	Two conserved <compound-id="857,6106,439524">leucine</compound-id> repeats within the COMM domain were found to be critically required for <protein-id="P98170">XIAP</protein-id> binding.	leucine__XIAP__interaction
18795892-1064	Functional analysis of rat liver <protein-id="P0AE74,P0AE75">citrate carrier</protein-id> promoter: differential responsiveness to <compound-id="56842239">polyunsaturated fatty acids</compound-id>.	polyunsaturated fatty acids__citrate carrier__interaction
18795918-1074	Wet-wrap treatment using dilutions of <compound-id="5372,445643,445647,6426916,6436007,6473866,6536850,9940643,23581796,54611630">tacrolimus</compound-id> ointment and <compound-id="444036">fluticasone propionate</compound-id> cream in human <protein-id="P02654,P18657,P33047,P34929,P56595,Q9XSN5">APOC1</protein-id> (+/+) mice with atopic dermatitis.	tacrolimus__APOC1__no_interaction	fluticasone propionate__APOC1__no_interaction
18795969-1090	The use of low-dose COCs is preferable in PCOS, especially among patients with <compound-id="206,5793,64689,79025">glucose</compound-id> intolerance, <protein-id="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7">insulin</protein-id> resistance and uncomplicated diabetes mellitus.	glucose__insulin__no_interaction
18796314-1192	Due to its faculty to protect <protein-id="P32749,P32750,P32751,P32752,P32753,P81908">cholinesterase</protein-id> (ChE) activity against irreversible inactivation by OP, <compound-id="4991">pyridostigmine bromide</compound-id> (PB) was used as a prophylaxis treatment during the first Persian Gulf War.	pyridostigmine bromide__cholinesterase__no_interaction
18796403-1220	Mice lacking Niemann-Pick C1-Like 1 (<protein-id="Q9UHC9">NPC1L1</protein-id>) (<protein-id="Q9UHC9">NPC1L1</protein-id> (-/-)mice) exhibit a defect in intestinal absorption of cholesterol and <compound-id="12303662">phytosterols</compound-id>.	phytosterols__NPC1L1__interaction
18796403-1222	In this study, we examined the role of <protein-id="Q9UHC9">NPC1L1</protein-id> in <compound-id="222284,457801">phytosterol</compound-id> and cholesterol trafficking in mice lacking ATP-binding cassette (ABC) transporters G5 and G8 (G5/G8(-/-) mice).	phytosterol__NPC1L1__interaction
18796403-1223	We found that mice lacking <protein-id="Q9H222">ABCG5</protein-id>/G8 and <protein-id="Q9UHC9">NPC1L1</protein-id> [triple knockout (TKO) mice] did not accumulate <compound-id="12303662">phytosterols</compound-id> in plasma and the liver.	phytosterols__NPC1L1__interaction	phytosterols__ABCG5__interaction
18796403-1224	In conclusion, <protein-id="Q9UHC9">NPC1L1</protein-id> is essential for <compound-id="12303662">phytosterols</compound-id> to enter the body in mice.	phytosterols__NPC1L1__interaction
18796561-1268	The slow BSO-induced <compound-id="124886">GSH</compound-id> depletion allows separation of two redox-related phases, namely, early thiol disequilibrium and late frank oxidative stress; each phase contributes to the progressive activation of a <protein-id="P23061,P38644,P83939,Q05894,Q28618,Q43731">p50</protein-id>-<protein-id="P23061,P38644,P83939,Q05894,Q28618,Q43731">p50</protein-id> homodimer.	GSH__p50__no_interaction
18796623-1276	In contrast, Notch-signaling inhibition by the <compound-id="16760646">gamma-secretase inhibitor I</compound-id> (GSI ; z-Leu-Leu-Nle-CHO) and the specific <protein-id="O35516,Q9QW30">Notch2</protein-id> down-regulation by small-interfering RNA accelerate spontaneous B-CLL cell apoptosis.	gamma-secretase inhibitor I__Notch2__no_interaction
18797825-1625	Effects of exhaustion and calcium supplementation on <protein-id="P01189,P01190,P01191,P01192,P01193,P01194,P01196,P01197,P01201,P06297,P06298,P06299,P10000,P11280,P11885,P19402,P21252,P22923,P68000,P68001,P87352,Q04617,Q04618,Q91082,Q9YGK2,Q9YGK4,Q9YGK5">adrenocorticotropic hormone</protein-id> and <compound-id="5754">cortisol</compound-id> levels in athletes.	cortisol__adrenocorticotropic hormone__no_interaction
18797825-1626	The present study was performed to investigate the effects of strenuous exercise and calcium supplementation on <compound-id="5754">cortisol</compound-id> and <protein-id="P01189,P01190,P01191,P01192,P01193,P01194,P01196,P01197,P01201,P06297,P06298,P06299,P10000,P11280,P11885,P19402,P21252,P22923,P68000,P68001,P87352,Q04617,Q04618,Q91082,Q9YGK2,Q9YGK4,Q9YGK5">adrenocorticotropic hormone</protein-id> levels in athletes at rest and exhaustion.	cortisol__adrenocorticotropic hormone__no_interaction
18797825-1627	One-month supplementation with calcium does not influence the <compound-id="5754">cortisol</compound-id> and <protein-id="P01189,P01190,P01191,P01192,P01193,P01194,P01196,P01197,P01201,P06297,P06298,P06299,P10000,P11280,P11885,P19402,P21252,P22923,P68000,P68001,P87352,Q04617,Q04618,Q91082,Q9YGK2,Q9YGK4,Q9YGK5">adrenocorticotropic hormone</protein-id> 0.05).	cortisol__adrenocorticotropic hormone__no_interaction
18797870-1649	Effects of nonspecific targeting of <protein-id="P36888">FLT3</protein-id> were evaluated with addition of imatinib (<compound-id="5291">Gleevec</compound-id>) to cell cultures.	Gleevec__FLT3__no_interaction
18797914-1664	In the pericentral necrotic zone after <compound-id="5943">CCl4</compound-id>-treatment, no induction of <protein-id="P01830,P01831">Thy-1</protein-id> was found.	CCl4__Thy-1__no_interaction
18797943-1672	Sixty-one percent of the isolates were <protein-id="P80298,P80545,P81173">beta-lactamase</protein-id> producers, which explains the poor activity of <compound-id="5904">penicillin</compound-id>.	penicillin__beta-lactamase__interaction
18798087-1724	Since the discovery of <compound-id="5280754,5284373,5497195,6435893,24883466,25246316">cyclosporine</compound-id> in 1971, <protein-id="O88480,Q9Y6J0">calcineurin inhibitors</protein-id> have played a critical role in the therapeutic suppression of the immune response.	cyclosporine__calcineurin inhibitors__interaction
18798087-1725	With the introduction of <compound-id="5372,445643,445647,6426916,6436007,6473866,6536850,9940643,23581796,54611630">tacrolimus</compound-id>, a more potent <protein-id="O88480,Q9Y6J0">calcineurin inhibitor</protein-id>, clinical outcomes of transplants have continued to improve; however, little improvement has been noted in lung transplantation.	tacrolimus__calcineurin inhibitor__interaction
18798281-1790	In contrast, chelating intracellular calcium ([<compound-id="271">Ca(2</compound-id>+)](i)) by <compound-id="2293">BAPTA-AM</compound-id> abolished <protein-id="O18752,O18753,O18755,O70183,O97759,P14082,P21237,P23363,P23560,P25429,P25430,P25431,P25432,Q02193,Q06225,Q3SAT7,Q4L0Y3,Q5IS78,Q6LCI5,Q7YRB4,Q90322,Q95106,Q9TST3">BDNF</protein-id>-mediated Arc up-regulation.	BAPTA-AM__BDNF__interaction	Ca(2__BDNF__interaction
18798281-1791	These data suggested novel functions of [<compound-id="271">Ca(2</compound-id>+)](i) and <protein-id="O02367,O16305,O60041,O82018,O94739,O96102,O97341,P02594,P02595,P02598,P02599,P04352,P04353,P04464,P05933,P05934,P05935,P06787,P07463,P11118,P11120,P11121,P15094,P17928,P18061,P21251,P23286,P24044,P27161,P27165,P27166,P41040,P41041,P48976,P60204,P60205,P60206,P61859,P61860,P61861,P62144,P62145,P62149,P62151,P62152,P62154,P62155,P62156,P62157,P62158,P62160,P62161,P62162,P62184,P62201,P62202,P62203,P62204,P69097,P69098,P84339,P93087,P93171,Q00168,Q05055,Q39752,Q40302,Q5EHV7,Q5RAD2,Q6IT78,Q6PI52,Q6R520,Q6YNX6,Q71UH5,Q71UH6,Q7T3T2,Q7Y052,Q8STF0,Q8X187,Q95NI4,Q95NR9,Q9GRJ1,Q9HFY6,Q9U6D3,Q9UWF0">CaM</protein-id> in <protein-id="O18752,O18753,O18755,O70183,O97759,P14082,P21237,P23363,P23560,P25429,P25430,P25431,P25432,Q02193,Q06225,Q3SAT7,Q4L0Y3,Q5IS78,Q6LCI5,Q7YRB4,Q90322,Q95106,Q9TST3">BDNF</protein-id> signaling.	Ca(2__BDNF__interaction	Ca(2__CaM__interaction
18798281-1792	Comparison of the Arc transcription profiles between <compound-id="271">Ca(2</compound-id>+)-stimulated and <protein-id="O18752,O18753,O18755,O70183,O97759,P14082,P21237,P23363,P23560,P25429,P25430,P25431,P25432,Q02193,Q06225,Q3SAT7,Q4L0Y3,Q5IS78,Q6LCI5,Q7YRB4,Q90322,Q95106,Q9TST3">BDNF</protein-id>-stimulated neurons demonstrated that the regulatory mechanisms were distinctively tailored to the complex features of neuronal activity.	Ca(2__BDNF__no_interaction
18798567-1853	Bark of elderberry (Sambucus nigra) contains a <compound-id="6036,439353,439357">galactose</compound-id> (Gal)/<compound-id="899,35717,84265,439174">N-acetylgalactosamine</compound-id> (<compound-id="35717,84265">GalNAc</compound-id>)-specific <protein-id="P02871,P02873,P02874,P02875,P07386,P16108,P16349,P16351,P16352,P33888,P38662,P42088,P83410,P83511,P84987,Q41114">lectin</protein-id> (SNA-II) corresponding to slightly truncated B-chains of a genuine Type-II <protein-id="P10297,P21326,P23339,P24475,P24476,P24477,P80750,Q03464,Q40772">ribosome-inactivating protein</protein-id> (Type-II <protein-id="P24817,P52594,P56626,Q13546,Q2TA45,Q86UA6">RIPs</protein-id>, SNA-V), found in the same species.	galactose__RIPs__no_interaction	N-acetylgalactosamine__lectin__interaction	galactose__lectin__interaction	GalNAc__lectin__interaction	galactose__ribosome-inactivating protein__no_interaction	N-acetylgalactosamine__ribosome-inactivating protein__no_interaction	N-acetylgalactosamine__RIPs__no_interaction	GalNAc__RIPs__no_interaction	GalNAc__ribosome-inactivating protein__no_interaction
18798730-1896	Infusion of each receptor antagonist alone similarly reduced basal unstressed volume and blood flow in <protein-id="Q9P8W3">ACEI</protein-id>-treated CHF patients, but not in healthy volunteers or <compound-id="439764">ARB</compound-id>-treated CHF patients.	ARB__ACEI__no_interaction
18798730-1897	In <compound-id="439764">ARB</compound-id>-treated heart failure, venous responses to <protein-id="O08677,P01042,P01044,P01045,P08934,P83055,P83060,P83856,P83857,P84697,P84825,P84895,Q7T3L1,Q90W88,Q90WZ1">bradykinin</protein-id> are preserved but arterial responses are reduced compared with healthy controls.	ARB__bradykinin__no_interaction
18798833-1679	Later-onset congenital central hypoventilation syndrome due to a heterozygous 24-<compound-id="5950">polyalanine</compound-id> repeat expansion mutation in the <protein-id="Q99453">PHOX2B</protein-id> gene.	polyalanine__PHOX2B__interaction
18798833-1680	to describe a family with later onset congenital central hypoventilation syndrome (LO-CCHS) and heterozygosity for a 24-<compound-id="5950">polyalanine</compound-id> repeat expansion mutation in the <protein-id="Q99453">PHOX2B</protein-id> gene, rendered phenotypically apparent with exposure to anesthetics.	polyalanine__PHOX2B__interaction
18798864-1974	Effects of <compound-id="5035">raloxifene</compound-id> on breast cancer cell migration and invasion through the <protein-id="O00937,O13419,O16808,O17320,O65314,O65315,O65316,O74258,O81221,P02577,P10365,P10989,P11426,P13363,P14235,P17128,P20904,P24902,P26182,P26183,P30161,P45520,P45521,P48465,P50138,P51775,P53455,P53476,P53477,P53491,P53498,P53499,P53500,P53502,P53689,P60009,P60010,P60011,P68555,P78711,P80709,P81085,P90689,P91754,Q05214,Q11212,Q24733,Q2U7A3,Q39596,Q39758,Q6TCF2,Q75D00,Q8SWN8,Q8X119,Q92192,Q92193,Q99023,Q9P4D1,Q9UVF3,Q9UVX4,Q9UVZ8">actin</protein-id> cytoskeleton.	raloxifene__actin__interaction
18798867-1982	High <compound-id="206,5793,64689,79025">glucose</compound-id> attenuates <protein-id="P15691,P15692,P26617,P49151,P50412,P67964,P67965,Q99PS1,Q9GKR0,Q9MYV3">VEGF</protein-id> expression in rat multipotent adult progenitor cells in association with inhibition of <protein-id="O60674">JAK2</protein-id>/<protein-id="P40763,P61635">STAT3</protein-id> signalling.	glucose__STAT3__interaction	glucose__JAK2__interaction	glucose__VEGF__interaction
18798867-1983	This study was to investigate the effect of high <compound-id="206,5793,64689,79025">glucose</compound-id> (<compound-id="23931">HG</compound-id>) on vascular endothelial growth factor (<protein-id="P15691,P15692,P26617,P49151,P50412,P67964,P67965,Q99PS1,Q9GKR0,Q9MYV3">VEGF</protein-id>) expression in bone marrow stem cells and <protein-id="O60674">JAK2</protein-id>/<protein-id="P08457,P35610,Q7QDU4">STAT</protein-id>-3 signalling.	glucose__STAT__interaction	glucose__JAK2__interaction	HG__VEGF__interaction	HG__JAK2__interaction	HG__STAT__interaction	glucose__VEGF__interaction
18798873-1986	In this study, a calcineurin B-like (<protein-id="P06721,P0A4K2,P0A4K3,P18949,P22681,P23256,P43623,P44527,P53101,P53780,Q07703,Q52811">CBL</protein-id>)-interacting <protein-id="P00513,P25848">protein kinase</protein-id> (CIPK) gene, CIPK8, was found to be involved in early <compound-id="943">nitrate</compound-id> signaling.	nitrate__CBL__no_interaction	nitrate__protein kinase__interaction
18798873-1988	Taken together, our results indicate that <protein-id="P06721,P0A4K2,P0A4K3,P18949,P22681,P23256,P43623,P44527,P53101,P53780,Q07703,Q52811">CBL</protein-id>-CIPK networks are responsible not only for stress responses and potassium shortage, but also for <compound-id="943">nitrate</compound-id> sensing.	nitrate__CBL__interaction
18799187-2083	Hepatic stellate cell activation in focal nodular hyperplasia with a central scar was accompanied by the expression of <compound-id="73318">8-hydroxy-2'-deoxyguanosine</compound-id> and inducible <protein-id="O61309,O61608,Q27571,Q9I9M2">nitric oxide synthase</protein-id> in the liver.	8-hydroxy-2'-deoxyguanosine__nitric oxide synthase__no_interaction
18799187-2084	Expression of <compound-id="73318">8-hydroxy-2'-deoxyguanosine</compound-id> and inducible <protein-id="O61309,O61608,Q27571,Q9I9M2">nitric oxide synthase</protein-id> was rarely seen in focal nodular hyperplasia without a central scar, focal nodular hyperplasia-like nodules, or nodular regenerative hyperplasia.	8-hydroxy-2'-deoxyguanosine__nitric oxide synthase__no_interaction
18799201-2087	The main purpose of this study was to evaluate the regional distribution pattern and relative frequency of some endocrine cells in the three portions of the gastrointestinal tract (GIT)--the proventriculus, gizzard and duodenum-of the rufous-collared sparrow (Zonotrichia capensis subtorquata), by immunohistochemical methods using six types of polyclonal antisera, specific for <compound-id="5202">serotonin</compound-id> (<compound-id="5202">5-HT</compound-id>), <compound-id="16129681,16129706">somatostatin</compound-id> (D cells), <protein-id="O12956,O42143,O42144,P01272,P01273,P01274,P01275,P04093,P05110,P06883,P07449,P09566,P09567,P09682,P09686,P0C235,P13189,P15438,P18108,P22890,P29794,P31297,P33528,P55095,P68259,P68260,P68273,P68274,P68275,P68952,P68953,P68954,P68955,P68956,P68957,P79695,P81880,Q8MJ25,Q9PRQ9">glucagon</protein-id>, <protein-id="O18811,O18845,O46617,O62820,P01307,P12872,P19863,P27114,Q99MP5,Q9PRP6,Q9XSE2">motilin</protein-id>, polypeptide YY (<protein-id="P09641,P10082,P10631,P29203,P29204,P29205,P29206,P48098,P51694,P68004,P68005,P69092,P69093,P69094,P69095,P69096,P81028,Q76CL2,Q9EPS2,Q9PT99,Q9TR93">PYY</protein-id>) and <protein-id="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7">insulin</protein-id>.	somatostatin__PYY__no_interaction	serotonin__glucagon__no_interaction	5-HT__insulin__no_interaction	serotonin__motilin__no_interaction	5-HT__motilin__no_interaction	somatostatin__glucagon__no_interaction	serotonin__insulin__no_interaction	serotonin__PYY__no_interaction	5-HT__glucagon__no_interaction	somatostatin__insulin__no_interaction	5-HT__PYY__no_interaction	somatostatin__motilin__no_interaction
18799201-2088	In the gizzard, endocrine cells secreting <compound-id="16129681,16129706">somatostatin</compound-id>, <compound-id="5202">5-HT</compound-id> and <protein-id="P09641,P10082,P10631,P29203,P29204,P29205,P29206,P48098,P51694,P68004,P68005,P69092,P69093,P69094,P69095,P69096,P81028,Q76CL2,Q9EPS2,Q9PT99,Q9TR93">PYY</protein-id> were detected, while those secreting <protein-id="O12956,O42143,O42144,P01272,P01273,P01274,P01275,P04093,P05110,P06883,P07449,P09566,P09567,P09682,P09686,P0C235,P13189,P15438,P18108,P22890,P29794,P31297,P33528,P55095,P68259,P68260,P68273,P68274,P68275,P68952,P68953,P68954,P68955,P68956,P68957,P79695,P81880,Q8MJ25,Q9PRQ9">glucagon</protein-id> and <protein-id="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7">insulin</protein-id> were not.	somatostatin__PYY__no_interaction	5-HT__insulin__no_interaction	somatostatin__glucagon__no_interaction	5-HT__glucagon__no_interaction	5-HT__PYY__no_interaction	somatostatin__insulin__no_interaction
18799201-2089	In the final part of the gizzard, endocrine cells secreting <compound-id="5202">5-HT</compound-id> were more frequent, and cells secreting <compound-id="16129681,16129706">somatostatin</compound-id> and <protein-id="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7">insulin</protein-id> were not detected.	5-HT__insulin__no_interaction	somatostatin__insulin__no_interaction
18799634-2193	Cell fractionation by <compound-id="5988">sucrose</compound-id> gradient and differential centrifugation demonstrated that in bradykinin-stimulated cells, <protein-id="Q96QT4">TRPM7</protein-id> localized in fractions corresponding to caveolae.	sucrose__TRPM7__no_interaction
18799753-2260	However, there are conflicting data regarding the role of Gpr30 as an <protein-id="O42132,P03372,P06211,P06212,P16058,P19785,P49884,P49885,P49886,P50240,P50241,P50242,P57717,P57753,P81559,Q29040,Q53AD2,Q91250,Q91424,Q9PVZ9,Q9QZJ5,Q9TV98,Q9YH33,Q9YHT3,Q9YHZ7">estrogen receptor</protein-id> (ER): several laboratories were unable to demonstrate <compound-id="5757">estradiol</compound-id> binding to GPR30 or <compound-id="5757">estradiol</compound-id>-activated signal transduction in Gpr30-expressing cells.	estradiol__estrogen receptor__no_interaction
18799753-2261	Our data demonstrate that in vivo <protein-id="O08878,Q8BMP4">Gpr30</protein-id> is dispensable for the mediation of <compound-id="5757">estradiol</compound-id> effects in reproductive organs.	estradiol__Gpr30__interaction
18799757-2262	<compound-id="5780">Sorbitol</compound-id> can fuel mouse sperm motility and protein <compound-id="1153,6057,5460803">tyrosine</compound-id> phosphorylation via <protein-id="P07846,P27867,Q00796,Q02912,Q06004,Q29318,Q4R639,Q58D31,Q59787,Q64442,Q9Z9U1">sorbitol dehydrogenase</protein-id>.	tyrosine__sorbitol dehydrogenase__interaction	Sorbitol__sorbitol dehydrogenase__interaction
18799757-2263	Here we characterize <protein-id="P27867,Q64442">Sord</protein-id> mRNA and <protein-id="P07846,Q00796,Q29318,Q4R639,Q58D31">SORD</protein-id> expression during mouse spermatogenesis and examine the ability of <compound-id="5780">sorbitol</compound-id> to support epididymal sperm motility and <compound-id="1153,6057,5460803">tyrosine</compound-id> phosphorylation.	sorbitol__Sord__no_interaction	sorbitol__SORD__no_interaction	tyrosine__SORD__no_interaction	tyrosine__Sord__no_interaction
18800037-1366	Increase in <compound-id="5212">sildenafil</compound-id> clearance in the early postnatal period likely reflects maturation of <protein-id="P21568,P21569,P24525,P34887,Q26551">CYP</protein-id>-mediated N-demethylation.	sildenafil__CYP__interaction
18800064-2365	<compound-id="2995">Desipramine</compound-id> modulation of alpha-, <protein-id="O76070,Q2PFW6,Q63544,Q9NZ50,Q9Z0F7">gamma-synuclein</protein-id>, and the <protein-id="O55192,P23975,P51143">norepinephrine transporter</protein-id> in an animal model of depression.	Desipramine__gamma-synuclein__interaction	Desipramine__norepinephrine transporter__interaction
18800064-2366	The <protein-id="O55192,P23975,P41970,P51143,P54762">NET</protein-id>-selective antidepressant <compound-id="2995">desipramine</compound-id> (DMI) was chronically administered for 14 days to WKY rats and the strain from which it was outbred that does not show depressive-like behavior, the Wistar rat.	desipramine__NET__interaction
18800198-2413	The present study was designed to evaluate the impact of zinc status before burn on the recovery of injury with focus on plasma <protein-id="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7">insulin</protein-id> and <compound-id="206,5793,64689,79025">glucose</compound-id> levels.	glucose__insulin__no_interaction
18800198-2414	Blood and tissue samples were collected 3, 6, and 24 h after injury in order to study biochemical parameters and the <compound-id="206,5793,64689,79025">glucose</compound-id>/<protein-id="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7">insulin</protein-id> response in relation with the zinc status.	glucose__insulin__no_interaction
18800198-2415	In addition, the burn-induced <protein-id="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7">insulin</protein-id> resistance, leading to protein catabolism, was emphasized, with higher plasma <protein-id="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7">insulin</protein-id>, <compound-id="206,5793,64689,79025">glucose</compound-id>, and <protein-id="O02750,O93416,Q28603,Q95189,Q95234">leptin</protein-id> levels in zinc-deficient animals versus normal-fed rats.	glucose__leptin__no_interaction	glucose__insulin__no_interaction
18800204-2418	methoxyphenoxy)benzyl) <compound-id="8083">morpholine</compound-id>) is a positron emission tomography (PET) radioligand recently applied in clinical studies of <protein-id="O55192,P23975,P51143">norepinephrine transporters</protein-id> (<protein-id="O55192,P23975,P41970,P51143,P54762">NETs</protein-id>) in the human brain in vivo.	morpholine__NETs__interaction	morpholine__norepinephrine transporters__interaction
18800231-631	The most predictive model of <protein-id="P01588,P07865,P11678,P33707,P33708,P33709,P48617,P49157,P49290,P80550,Q28513,Q6H8S9,Q6H8T1,Q6H8T2,Q867B1,Q9GKA2">EPO</protein-id> response for the pediatric cohort had, as the major variables, <compound-id="1176,265993">urea</compound-id> clearance x dialysis duration/total body water (Kt/V), <compound-id="1176,265993">urea</compound-id> reduction ratio (URR), intact parathyroid hormone (iPTH), blood loss, normalized protein catabolic rates (nPCR) and indices of malnutrition and inflammation, whereas adults had iron and <compound-id="6037">folate</compound-id> deficiencies as the dominant variables.	urea__EPO__interaction	folate__EPO__interaction
18800231-632	In summary <protein-id="P01588,P07865,P11678,P33707,P33708,P33709,P48617,P49157,P49290,P80550,Q28513,Q6H8S9,Q6H8T1,Q6H8T2,Q867B1,Q9GKA2">EPO</protein-id> resistance in the pediatric dialysis cohort was predicted by nutritional deficits, inflammation, poor dialysis, and hyperparathyroidism, while iron and <compound-id="6037">folate</compound-id> deficits were the major determinants in adults.	folate__EPO__interaction
18800270-2444	<protein-id="O14463,O17486,O22022,O30974,O51088,O51890,O83889,O84544,O96952,O97508,O97680,P00276,P08058,P08628,P08629,P09857,P0A0K4,P0A0K5,P0A0K6,P0A4L3,P0A4L4,P0A616,P0A617,P10472,P10473,P10599,P10639,P11232,P14930,P14949,P21609,P21610,P29429,P29451,P33791,P34723,P37395,P42115,P43785,P46843,P47370,P50254,P50338,P50413,P51225,P52227,P52230,P52231,P52233,P57653,P59527,P66928,P66929,P75512,P80579,P81108,P81109,P81110,P82460,P96132,P99122,P99505,Q05739,Q57755,Q5HGT9,Q5HQ29,Q5R9M3,Q6GA69,Q6GHU0,Q7KQL8,Q7M1B9,Q8CPL5,Q92JR5,Q98PL5,Q98TX1,Q9BDJ3,Q9CM49,Q9DGI3,Q9JWM8,Q9K1N8,Q9PJK3,Q9R6P9,Q9UW02,Q9X2T1,Q9Z7P5,Q9ZEE0">Thioredoxin</protein-id> (<protein-id="O17486,O30974,O51088,O51890,O83889,O84544,P08058,P09857,P0A0K4,P0A0K5,P0A0K6,P0A616,P0A617,P0AA25,P0AA26,P0AA27,P0AA28,P0AA29,P0AA30,P10472,P10473,P10599,P14949,P21609,P21610,P33791,P43785,P52227,P52230,P52231,P52233,P57653,P59527,P66928,P66929,P75512,P80579,P81108,P81109,P81110,P96132,P99122,Q05739,Q5HGT9,Q5HQ29,Q6GA69,Q6GHU0,Q7M1B9,Q8CPL5,Q92JR5,Q98PL5,Q9BDJ3,Q9CM49,Q9DGI3,Q9PJK3,Q9X2T1,Q9Z7P5,Q9ZEE0">TRX</protein-id>) is a redox protein that scavenges reactive <compound-id="977">oxygen</compound-id> species (ROS).	oxygen__TRX__interaction	oxygen__Thioredoxin__interaction
18800351-2001	<compound-id="16315">Diallyl trisulfide</compound-id> selectively causes <protein-id="P27297,Q07813,Q63690">Bax</protein-id>- and <protein-id="O08734">Bak</protein-id>-mediated apoptosis in human lung cancer cells.	Diallyl trisulfide__Bak__interaction	Diallyl trisulfide__Bax__interaction
18800351-2002	The <compound-id="75552">DATS</compound-id>-mediated G2-M phase cell cycle arrest was explained by down-regulation of <protein-id="P06493,P11440,P13863,P39951,P48734,P51958,Q5RCH1,Q9DG98,Q9DGA2,Q9DGA5,Q9DGD3">cyclin-dependent kinase 1</protein-id> (<protein-id="P34556">Cdk1</protein-id>) and cell division cycle 25C protein expression leading to accumulation of Tyr15 phosphorylated (inactive) <protein-id="P34556">Cdk1</protein-id>.	DATS__Cdk1__interaction	DATS__cyclin-dependent kinase 1__interaction
18800351-2003	Knockdown of <protein-id="P27297,Q07813,Q63690">Bax</protein-id> and <protein-id="O08734">Bak</protein-id> proteins conferred significant protection against <compound-id="75552">DATS</compound-id>-induced apoptotic cytoplasmic histone-associated DNA fragmentation.	DATS__Bak__interaction	DATS__Bax__interaction
18800985-2514	In the present work, we showed for the first time that synthetic oligodeoxynucleotides containing unmethylated <compound-id="597">cytosine</compound-id> <compound-id="764">guanine</compound-id> motifs (<compound-id="6804">CpG</compound-id>) are able to stimulate, in the presence of <protein-id="Q9TTB0">interferon-gamma</protein-id> (<protein-id="O35497,O35735,O57571,O57603,O57608,O73915,O77763,P01579,P01580,P01581,P07353,P17773,P17803,P28333,P28341,P30123,P42160,P42161,P42162,P46402,P49708,P63309,P63310,P63311,P79154,Q1WM28,Q25BC0,Q2PE75,Q4ZH68,Q5CCK0,Q5I6S9,Q62574,Q647G2,Q7TSP4,Q865W6,Q865X1,Q865Y4,Q866Y6,Q8MKF5,Q8SPW9,Q9QXX2,Q9TTB0,Q9TV67,Q9YGB9">IFN-gamma</protein-id>), both <protein-id="O49046,P00812,P0A2X9,P0A2Y0,P0A2Y1,P14012,P33280,P37818,P39138,P40906,P46637,P53608,P60086,P60087,P60088,Q10066,Q12611,Q1E180,Q6G7E9,Q6GER3,Q74ZW4,Q7M0Z3,Q8NVE3">arginase</protein-id> and inducible <protein-id="O61309,O61608,Q27571,Q9I9M2">nitric oxide synthase</protein-id> (<protein-id="O19114,O46660,O54705,O62699,P29477,P35228,P79290,Q06518,Q27995,Q28314,Q90703,Q92037,Q92091">iNOS</protein-id>) in murine Mphi.	guanine__iNOS__interaction	guanine__IFN-gamma__interaction	cytosine__interferon-gamma__interaction	cytosine__nitric oxide synthase__interaction	CpG__IFN-gamma__interaction	CpG__arginase__interaction	guanine__interferon-gamma__interaction	CpG__interferon-gamma__interaction	cytosine__arginase__interaction	guanine__arginase__interaction	CpG__nitric oxide synthase__interaction	guanine__nitric oxide synthase__interaction	cytosine__iNOS__interaction	cytosine__IFN-gamma__interaction	CpG__iNOS__interaction
18800985-2515	A significant increase in <protein-id="O49046,P00812,P0A2X9,P0A2Y0,P0A2Y1,P14012,P33280,P37818,P39138,P40906,P46637,P53608,P60086,P60087,P60088,Q10066,Q12611,Q1E180,Q6G7E9,Q6GER3,Q74ZW4,Q7M0Z3,Q8NVE3">arginase</protein-id> activity was observed upon a short pre-incubation (1 hr) with <protein-id="O35497,O35735,O57571,O57603,O57608,O73915,O77763,P01579,P01580,P01581,P07353,P17773,P17803,P28333,P28341,P30123,P42160,P42161,P42162,P46402,P49708,P63309,P63310,P63311,P79154,Q1WM28,Q25BC0,Q2PE75,Q4ZH68,Q5CCK0,Q5I6S9,Q62574,Q647G2,Q7TSP4,Q865W6,Q865X1,Q865Y4,Q866Y6,Q8MKF5,Q8SPW9,Q9QXX2,Q9TTB0,Q9TV67,Q9YGB9">IFN-gamma</protein-id> and subsequent <compound-id="6804">CpG</compound-id> stimulation.	CpG__arginase__interaction	CpG__IFN-gamma__no_interaction
18800985-2516	Therefore, a very interesting observation of this study was that the <compound-id="6804">CpG</compound-id>-mediated <protein-id="O49046,P00812,P0A2X9,P0A2Y0,P0A2Y1,P14012,P33280,P37818,P39138,P40906,P46637,P53608,P60086,P60087,P60088,Q10066,Q12611,Q1E180,Q6G7E9,Q6GER3,Q74ZW4,Q7M0Z3,Q8NVE3">arginase</protein-id> activity is dependent on <protein-id="O35497,O35735,O57571,O57603,O57608,O73915,O77763,P01579,P01580,P01581,P07353,P17773,P17803,P28333,P28341,P30123,P42160,P42161,P42162,P46402,P49708,P63309,P63310,P63311,P79154,Q1WM28,Q25BC0,Q2PE75,Q4ZH68,Q5CCK0,Q5I6S9,Q62574,Q647G2,Q7TSP4,Q865W6,Q865X1,Q865Y4,Q866Y6,Q8MKF5,Q8SPW9,Q9QXX2,Q9TTB0,Q9TV67,Q9YGB9">IFN-gamma</protein-id> priming.	CpG__IFN-gamma__interaction	CpG__arginase__interaction
18800985-2517	This report reveals a singular effect of the combination of <compound-id="6804">CpG</compound-id> and <protein-id="O35497,O35735,O57571,O57603,O57608,O73915,O77763,P01579,P01580,P01581,P07353,P17773,P17803,P28333,P28341,P30123,P42160,P42161,P42162,P46402,P49708,P63309,P63310,P63311,P79154,Q1WM28,Q25BC0,Q2PE75,Q4ZH68,Q5CCK0,Q5I6S9,Q62574,Q647G2,Q7TSP4,Q865W6,Q865X1,Q865Y4,Q866Y6,Q8MKF5,Q8SPW9,Q9QXX2,Q9TTB0,Q9TV67,Q9YGB9">IFN-gamma</protein-id>, one of the mayor cytokines produced in response to <compound-id="6804">CpG</compound-id> administration in vivo.	CpG__IFN-gamma__interaction
18801207-197	<compound-id="5321439,5468522">Bakuchiol</compound-id> has a three-fold higher binding affinity for <protein-id="O42132,P03372,P06211,P06212,P16058,P19785,P49884,P49885,P49886,P50240,P50241,P50242,P57717,P57753,P81559,Q29040,Q53AD2,Q91250,Q91424,Q9PVZ9,Q9QZJ5,Q9TV98,Q9YH33,Q9YHT3,Q9YHZ7">ERalpha</protein-id> than for <protein-id="O08537,O13012,O93511,P57781,P57782,Q62986,Q92731,Q95171,Q9IAK1,Q9PTU5,Q9PVE2,Q9TTE5,Q9TU15,Q9W6M2,Q9XSB5,Q9XSW2,Q9YH32">ERbeta</protein-id>.	Bakuchiol__ERbeta__interaction	Bakuchiol__ERalpha__interaction
18801387-245	While rtTA mRNA levels were high in developmental and adult tissues, <protein-id="P06956,P16961">Cre</protein-id> <protein-id="P22877">recombinase</protein-id> mRNA levels remained low after <compound-id="54671203">doxycycline</compound-id> treatment.	doxycycline__recombinase__interaction	doxycycline__Cre__interaction
18801483-309	In the present study, we examined the effect of <compound-id="3475">gliclazide</compound-id>, a second generation <compound-id="104818">sulfonylurea</compound-id> with antioxidant properties, on <protein-id="O70156,P78380,P79391,Q9EQ09,Q9TTK7,Q9XTA8">LOX-1</protein-id> expression and <protein-id="O70156,P78380,P79391,Q9EQ09,Q9TTK7,Q9XTA8">LOX-1</protein-id>-mediated <protein-id="O18733,P14780,P41245,P41246,P50282,P52176">MMP-9</protein-id> expression and apoptosis in oxLDL-treated human aortic endothelial cells (HAECs).	sulfonylurea__MMP-9__no_interaction	gliclazide__MMP-9__interaction	gliclazide__LOX-1__interaction	sulfonylurea__LOX-1__no_interaction
18801573-338	The phenolics: <compound-id="145858">anthocyanin</compound-id> (ATH), sinapoyl esters and activity of antioxidant enzymes: <protein-id="O50258">superoxide dismutase</protein-id> (<protein-id="O12933,O22668,O75007,P24705,P51547,P93258,Q01137,Q27666,Q9SM64">SOD</protein-id>), <protein-id="O24339,O52762,O62839,O68146,O77229,O93662,O97492,P00432,P04040,P04762,P07145,P0A323,P0A324,P0A325,P0A326,P0A327,P11934,P17336,P24168,P24270,P25890,P29422,P30265,P30266,P32290,P42321,P44390,P45737,P45739,P55304,P55306,P55310,P55311,P55313,P77872,P81138,P90682,Q27710,Q49XC1,Q4L643,Q59296,Q59337,Q59602,Q59714,Q5HG86,Q5HPK8,Q5RF10,Q64405,Q6G9M4,Q6GH72,Q7A5T2,Q8CPD0,Q8FWU0,Q8NWV5,Q8X1P0,Q8Y3P9,Q926X0,Q99UE2,Q9AXH0,Q9KW19,Q9L4S1,Q9M5L6,Q9PT92,Q9PWF7,Q9Z598,Q9ZKX5,Q9ZN99">catalase</protein-id> (<protein-id="O62839,O97492,P00432,P00485,P00486,P00487,P04040,P06135,P07641,P11504,P20074,P22782,P25309,P25819,P26825,P26826,P32796,P36882,P36883,P43155,P47934,P49417,P52826,P58777,P62577,P62578,P62579,P62580,P90682,Q00614,Q02736,Q03058,Q5RF10,Q64405,Q704S8,Q9M5L6,Q9PWF7">CAT</protein-id>), guaiacol <protein-id="P15984,P16147,P84714">peroxidase</protein-id> (<protein-id="P07003,P37063,P92983,Q54970">POX</protein-id>), ascorbate <protein-id="P15984,P16147,P84714">peroxidase</protein-id> (<protein-id="P27695,Q01613,Q42564">APX</protein-id>), <protein-id="O32770,O59858,Q00277,Q9CFV1">glutathione peroxidase</protein-id> (<protein-id="O77834,P83564,Q00277">GPX</protein-id>) and <protein-id="O15770,P06715,P11804,P23189,P41921,P43783,P48638,P48639,P70619,P78965,Q60151,Q6BPI1,Q6C5H4,Q6FRV2,Q6HA23,Q74ZK4,Q873E8,Q94655">glutathione reductase</protein-id> (GR), in red cabbage seedlings subjected to Cu2+ stress were investigated.	anthocyanin__POX__no_interaction	anthocyanin__catalase__no_interaction	anthocyanin__CAT__no_interaction	anthocyanin__GPX__no_interaction	anthocyanin__glutathione reductase__no_interaction	anthocyanin__glutathione peroxidase__no_interaction	anthocyanin__SOD__no_interaction	anthocyanin__APX__no_interaction	anthocyanin__superoxide dismutase__no_interaction	anthocyanin__peroxidase__no_interaction
18801573-339	It could results from the fact that phenolic compounds (<compound-id="444567">PhC</compound-id>), which could be also substrates for different <protein-id="P15984,P16147,P84714">peroxidases</protein-id>, were the first line of defence against metal stress.	PhC__peroxidases__interaction
18801652-367	The affinity characteristics of developed immunosensors were investigated in reaction with <compound-id="445434,6437057">microcystin-LR</compound-id>, and <protein-id="P07288,P10658,P33619,P55786,Q11011,Q6DT45,Q9Y617">PSA</protein-id>.	microcystin-LR__PSA__no_interaction
18801652-368	The detection limit for <compound-id="445434,6437057">microcystin-LR</compound-id> was 10 ngmL(-1) and for <protein-id="P07288,P10658,P33619,P55786,Q11011,Q6DT45,Q9Y617">PSA</protein-id> 0.01 ngmL(-1).	microcystin-LR__PSA__no_interaction
18801682-382	This was achieved by (1) direct comparison of the sensitivity of <protein-id="P55926,P78348,Q7T1N4">ASIC1</protein-id>, <protein-id="Q16515">ASIC2</protein-id>, <protein-id="O35240,Q6X1Y6,Q9UHC3">ASIC3</protein-id> and <protein-id="Q697L1,Q8NER1">TRPV1</protein-id> knockout mice versus wildtype littermates to acute thermal and mechanical noxious stimuli and (2) studying the behavioural responses of each transgenic strain to hind paw inflammation with either complete Freund's adjuvant (CFA) or <compound-id="712">formalin</compound-id>.	formalin__ASIC3__no_interaction	formalin__ASIC2__no_interaction	formalin__ASIC1__no_interaction	formalin__TRPV1__no_interaction
18801682-383	Following <compound-id="712">formalin</compound-id> injection, <protein-id="P55926,P78348,Q7T1N4">ASIC1</protein-id> (-/-) and <protein-id="Q16515">ASIC2</protein-id> (-/-), but not <protein-id="O35240,Q6X1Y6,Q9UHC3">ASIC3</protein-id> (-/-) or <protein-id="Q697L1,Q8NER1">TRPV1</protein-id> (-/-), mice showed enhanced pain behaviour, predominantly in the second phase of the test.	formalin__ASIC3__no_interaction	formalin__ASIC2__interaction	formalin__TRPV1__no_interaction	formalin__ASIC1__interaction
18801894-463	The biochemical parameters studied are: albumin (<protein-id="O35090,P02768,P02769,P08835,P14639,P19121,P21847,P35747,P49064,P49065,P49822,Q28522,Q5XLE4">ALB</protein-id>), alanine aminotransferase (ALT), amylase (<protein-id="Q9BXS0">AMY</protein-id>), total <compound-id="5280352">bilirubin</compound-id> (TBI), blood urea nitrogen (BUN), <compound-id="588">creatinine</compound-id> (CRE), <compound-id="206,5793,64689,79025">glucose</compound-id>, globulin, total proteins (TP), and the ions calcium, <compound-id="24404,139579">phosphorus</compound-id>, sodium, and potassium.	bilirubin__AMY__no_interaction	phosphorus__AMY__no_interaction	bilirubin__ALB__no_interaction	phosphorus__ALB__no_interaction	creatinine__AMY__no_interaction	glucose__ALB__no_interaction	creatinine__ALB__no_interaction	glucose__AMY__no_interaction
18801899-465	In addition, serum levels of <compound-id="206,5793,64689,79025">glucose</compound-id>, adiponectin, and <protein-id="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7">insulin</protein-id> were measured.	glucose__insulin__no_interaction
18801899-466	In addition, <compound-id="6083">adenosine monophosphate</compound-id>-activated <protein-id="P00513,P25848">protein kinase</protein-id> levels were high during fasting and low during HF diet.	adenosine monophosphate__protein kinase__interaction
18801901-901	This action of <protein-id="P05017,P07455,P08025,P10763,P16545,P17085,P17647,P18254,P33712,P51457,P51458,P51462,Q02815,Q28933,Q68LC0,Q6GUL6,Q6IVA5,Q6JLX1,Q95222">IGF-I</protein-id> was abolished by SB 212090 but not by <compound-id="312145">wortmannin</compound-id>.	wortmannin__IGF-I__no_interaction
18801905-473	After 7 d central <protein-id="O02750,O93416,Q28603,Q95189,Q95234">leptin</protein-id> treatment, the total content of <compound-id="5283565">ceramides</compound-id> was analyzed by quantitative shotgun lipidomics mass spectrometry.	ceramides__leptin__no_interaction
18801908-476	Previously we have shown that <compound-id="77999">rosiglitazone</compound-id> has antiinflammatory actions not explicable by activation of <protein-id="O18924,O18971,O19052,O62807,O88275,P37231,P37234,P37238,P57797,Q4U3Q4">PPARgamma</protein-id>,but possibly by the <protein-id="O13186,O46567,O73673,P04150,P06536,P06537,P35547,P49115,P49843,P49844,P59667,P79269,P79686,Q5R9P5,Q6XLJ0,Q95267,Q9N1U3">glucocorticoid receptor</protein-id> (GR).	rosiglitazone__PPARgamma__no_interaction	rosiglitazone__glucocorticoid receptor__interaction
18801908-477	<compound-id="77999">Rosiglitazone</compound-id> drives <protein-id="P08659,P13129,Q01158,Q26304,Q27757">luciferase</protein-id> expression from a simple glucocorticoid-response element containing reporter gene in a GR-dependent manner (EC50 4 microm), with a similar amplitude response to the partial GR agonist RU486.	Rosiglitazone__luciferase__interaction
18801909-478	To begin to understand the mechanisms for the development of acute <protein-id="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7">insulin</protein-id> resistance, <compound-id="5951">serine</compound-id> phosphorylation of <protein-id="Q28516">insulin receptor</protein-id> substrate (<protein-id="P41252,Q8BU30,Q9XTN2">IRS</protein-id>)-1 and c-<protein-id="P05627,P17325,P18289">Jun</protein-id> N-terminal kinase phosphorylation/activation was investigated.	serine__IRS__interaction	serine__insulin__no_interaction	serine__Jun__no_interaction	serine__insulin receptor__interaction
18802196-558	Circulating oxidized LDL (oxLDL) levels are strongly correlated to LDL-<compound-id="304,5997,6432564,11025495">cholesterol</compound-id> (LDL-c) and apolipoprotein-B100 (<protein-id="P04114">apoB100</protein-id>), making it difficult to disentangle their independent contributions to cardiovascular risk.	cholesterol__apoB100__no_interaction
18802196-559	FMD of the brachial artery and plasma concentrations of oxLDL, LDL-<compound-id="304,5997,6432564,11025495">cholesterol</compound-id>, and <protein-id="P04114">apoB100</protein-id> were measured in 624 men and women (age range 50 to 87 years), participating in a population-based cohort study.	cholesterol__apoB100__no_interaction
18802196-560	After adjustment for age, sex, <compound-id="206,5793,64689,79025">glucose</compound-id> tolerance status, and Framingham risk score, the oxLDL/<protein-id="P04114">apoB100</protein-id> ratio was negatively related to FMD (P = 0.017).	glucose__apoB100__no_interaction
18802325-593	The <protein-id="O81439">fibrillin-1</protein-id> isolated from the youngest group had the highest capacity to form <compound-id="20484">fructosamine</compound-id> and AGEs under glycation in vitro.	fructosamine__fibrillin-1__interaction
18802724-681	The patterns of nerves immunoreactive (IR) to antibodies towards <compound-id="5202">serotonin</compound-id> (<compound-id="5202">5-HT</compound-id>) and the invertebrate <protein-id="P21259">neuropeptide</protein-id> <protein-id="P08020,P08021,P08022,P69145,P69146,P69147,P69148">FMRFamide</protein-id> are described in relation to the musculature.	5-HT__neuropeptide__no_interaction	serotonin__FMRFamide__no_interaction	serotonin__neuropeptide__no_interaction	5-HT__FMRFamide__no_interaction
18802750-687	Based on these results we analyzed the expression of either M1 receptors or <protein-id="O18752,O18753,O18755,O70183,O97759,P14082,P21237,P23363,P23560,P25429,P25430,P25431,P25432,Q02193,Q06225,Q3SAT7,Q4L0Y3,Q5IS78,Q6LCI5,Q7YRB4,Q90322,Q95106,Q9TST3">BDNF</protein-id> following <compound-id="27924,122634,22833501">PMA</compound-id> treatment of retinal cell cultures.	PMA__BDNF__interaction
18802816-701	Immunotoxicity of perfluorooctanoic acid and perfluorooctane <compound-id="1099">sulfonate</compound-id> and the role of <protein-id="O35507,P23204,P37230,P37232,Q07869,Q8HYL6,Q95N78">peroxisome proliferator-activated receptor alpha</protein-id>.	sulfonate__peroxisome proliferator-activated receptor alpha__no_interaction
18803227-822	Inhibitory activities of Cassia tora and its <compound-id="6780">anthraquinone</compound-id> constituents on <protein-id="Q10751">angiotensin-converting enzyme</protein-id>.	anthraquinone__angiotensin-converting enzyme__interaction
18803284-847	The results obtained from the <compound-id="104978">Fluo-3</compound-id> image experiments showed that <protein-id="P15691,P15692,P26617,P49151,P50412,P67964,P67965,Q99PS1,Q9GKR0,Q9MYV3">VEGF</protein-id> pretreatment of cultured neurons at a final concentration of 50, 100, or 200 ng/ml acutely and dose dependently attenuated the <compound-id="271">Ca(2</compound-id>+) influx induced by application of KCl (60 mM) or glutamate (50 microM).	Ca(2__VEGF__interaction	Fluo-3__VEGF__interaction
18803286-849	<compound-id="6035">5-Bromo-2'-deoxyuridine (BrdU</compound-id>) was injected into pregnant mice 3 hr after the <protein-id="P59275,P80958,Q99523">NT3</protein-id> administration to label the neural progenitor cells.	5-Bromo-2'-deoxyuridine (BrdU__NT3__no_interaction
18803297-852	A vitreous fraction showing <protein-id="Q02011">growth-promoting activity</protein-id> 1000 Da, consistent with <compound-id="54670067,54690394">ascorbic acid</compound-id>.	ascorbic acid__growth-promoting activity__no_interaction
18803462-1385	The secretion of endorphins, <compound-id="5994">progesterone</compound-id> (P(4)), human chorionic gonadotropin, <compound-id="5757">17beta-estradiol</compound-id>, and <protein-id="P27429">gonadotropin-releasing hormone</protein-id> by trophoblasts that lie adjacent to the embryoblast in the blastocyst suggests that these pregnancy-associated factors may directly signal the growth and development of the embryoblast.	progesterone__gonadotropin-releasing hormone__no_interaction	17beta-estradiol__gonadotropin-releasing hormone__no_interaction
18803582-1273	A specific <compound-id="15478">digoxigenin</compound-id>-labelled probe, obtained by PCR amplification of a 270-bp fragment of the gene coding the LCDV <protein-id="O39163,O39164,P03226,P03530,P03531,P04509,P04535,P06491,P08035,P09245,P14162,P16487,P16488,P16592,P16593,P16729,P17499,P17500,P17887,P18162,P18610,P22166,P22176,P22535,P22776,P26596,P28920,P30328,P35840,P51720,P52347,P69481,P69482,P69483,Q00705,Q00734,Q00999,Q04754,Q04755,Q05815,Q06386,Q38055,Q67473,Q6S6S9,Q91QZ8,Q9ZXI0">major capsid protein</protein-id>, was used for ISH.	digoxigenin__major capsid protein__interaction
18803655-955	In particular, a Cimicifuga heracleifolia extract (CHE) was reported to inhibit the formation of <compound-id="611,23327,33032">glutamate</compound-id> and the <protein-id="O52310,O59650,O74024,P28270,P52596,P80319,P93541,P94598,P96110,Q09115,Q43260,Q47950,Q47951,Q56304,Q9YC65">glutamate dehydrogenase</protein-id> activity in cultured rat islet.	glutamate__glutamate dehydrogenase__no_interaction
18804292-1116	No differences in <compound-id="5757">estradiol</compound-id>, <compound-id="6013">testosterone</compound-id>, or <protein-id="P19615">vitellogenin</protein-id> plasma concentrations were observed in exposed males or females compared to controls.	testosterone__vitellogenin__no_interaction	estradiol__vitellogenin__no_interaction
18804314-557	Macrophages located in the media differentiate into giant cells and/or produce reactive <compound-id="977">oxygen</compound-id> species, <compound-id="145068">nitric oxide</compound-id> and matrix metallo-<protein-id="P10265,P63119,P63120,P63121,P63122,P63123,P63124,P63125,P63127,P63129,P63131,Q9Y6I0">proteinases</protein-id>.	nitric oxide__proteinases__no_interaction	oxygen__proteinases__no_interaction
18804365-1156	Having compared four kinds of antibody immobilizations on Au surface, an optimized mAb 8G3 was immobilized onto the Au electrode with <protein-id="P02810,P03064,P07602,P18164,P26779,Q66929,Q96631,Q992J0,Q993M1,Q9DIC5,Q9IMM4,Q9J7Z2,Q9QAZ8">protein A</protein-id> on a mixed self-assembled monolayer (SAM) of <compound-id="543502">11-mercaptoundecanoic acid</compound-id> (11-<compound-id="108714">MUA</compound-id>) and <compound-id="560126">6-mercaptohexan-1-ol</compound-id> (6-<compound-id="10062737">MHO</compound-id>) as adhesive layer.	11-mercaptoundecanoic acid__protein A__no_interaction	MUA__protein A__no_interaction	MHO__protein A__no_interaction	6-mercaptohexan-1-ol__protein A__no_interaction
18804521-2419	<compound-id="2462,40000,63006,3033890,5281004,5702148,24867460">Budesonide</compound-id> is a potent glucocorticoid with high affinity for the <protein-id="O13186,O46567,O73673,P04150,P06536,P06537,P35547,P49115,P49843,P49844,P59667,P79269,P79686,Q5R9P5,Q6XLJ0,Q95267,Q9N1U3">glucocorticoid receptor</protein-id>, which is now used for the treatment of inflammatory bowel diseases.	Budesonide__glucocorticoid receptor__interaction
18804525-2139	Studies on the antioxidant effect and interaction of <compound-id="15460">diphenyl diselenide</compound-id> and dicholesteroyl diselenide with hepatic <protein-id="O26839,O28305,O33357,O42768,O67876,O84638,P05373,P06214,P0ACB2,P0ACB3,P0C1R9,P10518,P13716,P30950,P42504,P43087,P45622,P46723,P54919,P56074,P64333,P64334,P64335,P77923,P77969,P78974,Q02250,Q2FXR3,Q59295,Q59334,Q59643,Q5HFA4,Q5HNN5,Q5R971,Q60178,Q60HH9,Q6G8Q7,Q6GG37,Q750E0,Q8CNZ0,Q8KCJ0,Q9K8G2,Q9PLU4,Q9Z7G1,Q9ZMR8">delta-aminolevulinic acid dehydratase</protein-id> and isoforms of lactate dehydrogenase.	diphenyl diselenide__delta-aminolevulinic acid dehydratase__interaction
18804525-2140	Studies on the interaction of dicholesteroyl diselenide (DCDS) and <compound-id="15460">diphenyl diselenide</compound-id> (DPDS) with hepatic <protein-id="O26839,O28305,O33357,O42768,O67876,O84638,P05373,P06214,P0ACB2,P0ACB3,P0C1R9,P10518,P13716,P30950,P42504,P43087,P45622,P46723,P54919,P56074,P64333,P64334,P64335,P77923,P77969,P78974,Q02250,Q2FXR3,Q59295,Q59334,Q59643,Q5HFA4,Q5HNN5,Q5R971,Q60178,Q60HH9,Q6G8Q7,Q6GG37,Q750E0,Q8CNZ0,Q8KCJ0,Q9K8G2,Q9PLU4,Q9Z7G1,Q9ZMR8">delta-aminolevulinic acid dehydratase</protein-id> (ALA-D) and different isoforms of lactate dehydrogenase (<protein-id="P29038,P33571,P93052,Q27797,Q27888,Q95028,Q99289">LDH</protein-id>) from different tissues were investigated.	diphenyl diselenide__delta-aminolevulinic acid dehydratase__interaction	diphenyl diselenide__LDH__interaction
18804848-1280	A single <compound-id="6802">guanosine</compound-id> insertion/deletion (4G/<compound-id="2763225">5G</compound-id>) polymorphism in the promoter region of the <protein-id="P05121,P13909,P20961,P22777,P50449,P79335">PAI-1</protein-id> gene, may play an important role in the regulation of <protein-id="P05121,P13909,P20961,P22777,P50449,P79335">PAI-1</protein-id> expression.	guanosine__PAI-1__interaction	5G__PAI-1__interaction
18804908-377	<compound-id="18897,439213,441477,445621,45933887">Glucosamine</compound-id> is an effective chemo-sensitizer via <protein-id="P08587,P21980,P21981,P51176,P52181,Q01841">transglutaminase 2</protein-id> inhibition.	Glucosamine__transglutaminase 2__interaction
18804908-379	<compound-id="18897,439213,441477,445621,45933887">Glucosamine</compound-id> also recovered the depletion of <protein-id="P25963,Q08353,Q63746,Q91974,Q9Z1E3">I-kappaBalpha</protein-id> via <protein-id="P40746,P81453,Q05187,Q819L3,Q81MS1,Q8GR90,Q9K5W7">TGase</protein-id> 2 inhibition, which resulted in a decrease of NF-kappaB activity in EcR293/TG cells.	Glucosamine__TGase__interaction	Glucosamine__I-kappaBalpha__interaction
18804927-1300	Influence of <protein-id="P05017,P07455,P08025,P10763,P16545,P17085,P17647,P18254,P33712,P51457,P51458,P51462,Q02815,Q28933,Q68LC0,Q6GUL6,Q6IVA5,Q6JLX1,Q95222">IGF-I</protein-id> on buffalo (Bubalus bubalis) spermatozoa motility, membrane integrity, lipid peroxidation and <compound-id="5984">fructose</compound-id> uptake in vitro.	fructose__IGF-I__interaction
18804927-1301	The objective of the present experiment was to examine the influence of mean physiological concentration of <protein-id="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7">insulin</protein-id>-like growth factor-I (<protein-id="P05017,P07455,P08025,P10763,P16545,P17085,P17647,P18254,P33712,P51457,P51458,P51462,Q02815,Q28933,Q68LC0,Q6GUL6,Q6IVA5,Q6JLX1,Q95222">IGF-I</protein-id>) on frozen-thawed Surti buffalo (Bubalus bubalis) spermatozoa functional parameters, i.e., motility, plasmalemma integrity, acrosomal integrity, functional membrane integrity, lipid peroxidation and <compound-id="5984">fructose</compound-id> uptake in vitro.	fructose__insulin__interaction	fructose__IGF-I__interaction
18804927-1302	Frozen-thawed semen samples (n=6) were washed in <compound-id="6503">tris buffer</compound-id> and divided into two equal parts (control and <protein-id="P05017,P07455,P08025,P10763,P16545,P17085,P17647,P18254,P33712,P51457,P51458,P51462,Q02815,Q28933,Q68LC0,Q6GUL6,Q6IVA5,Q6JLX1,Q95222">IGF-I</protein-id> groups).	tris buffer__IGF-I__no_interaction
18804927-1303	<compound-id="5984">Fructose</compound-id> utilization was significantly higher in <protein-id="P05017,P07455,P08025,P10763,P16545,P17085,P17647,P18254,P33712,P51457,P51458,P51462,Q02815,Q28933,Q68LC0,Q6GUL6,Q6IVA5,Q6JLX1,Q95222">IGF-I</protein-id> 0.01) of incubation.	Fructose__IGF-I__interaction
18804950-1309	This diagnosis was confirmed by genetic testing, which revealed a novel point mutation in the <protein-id="P02461,P04258,P12105">COL3A1</protein-id> gene, c.2545G--&gt;C, leading to a codon encoding for <compound-id="232,4367,6322">arginine</compound-id> instead of <compound-id="750">glycine</compound-id> (p.Gly849Arg).	arginine__COL3A1__interaction	glycine__COL3A1__interaction
18804984-1311	Animal studies show that ecosapentaenoic acid (EPA) and <compound-id="445580">docosahexaenoic acid</compound-id> (DHA) are effective for the prevention and treatment of <protein-id="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7">insulin</protein-id> resistance (IR).	docosahexaenoic acid__insulin__interaction
18805402-1407	Signaling involving <compound-id="6076">cAMP</compound-id> is organized in subcellular compartments and a distinct <compound-id="6076">cAMP</compound-id> compartment might be required for proper <protein-id="O02747,P35869,Q95LD9">AHR</protein-id> mobility and function.	cAMP__AHR__interaction
18805433-1411	We also found an inhibitory effect of <compound-id="216326">lenalidomide</compound-id> on the associations between cadherin 5, <protein-id="P26233,P35222,P35223,P35224,Q02248,Q9WU82">beta-catenin</protein-id> and CD31, adherens junction proteins whose interaction is critical for endothelial cell cord formation.	lenalidomide__beta-catenin__interaction
18805433-1412	We also found a strong inhibitory effect of <compound-id="216326">lenalidomide</compound-id> on hypoxia-induced endothelial cell formation of cords and <protein-id="O35800,Q0PGG7,Q16665,Q309Z6,Q61221,Q98SW2,Q9I8A9,Q9XTA5,Q9YIB9">HIF-1 alpha</protein-id> expression, the main mediator of hypoxia-mediated effects and a key driver of angiogenesis and metastasis.	lenalidomide__HIF-1 alpha__interaction
18805442-1416	Differential effects of <protein-id="P08909,P28335,P34968,Q5IS66,Q60F97">5-HT2C</protein-id> receptor activation by WAY 161503 on <compound-id="942,89594,157672">nicotine</compound-id>-induced place conditioning and locomotor activity in rats.	nicotine__5-HT2C__no_interaction
18805484-1419	Control <compound-id="3955">loperamide</compound-id>-loaded <protein-id="P24807,Q07490">HSA</protein-id> nanoparticles with IgG2a antibodies yielded only marginal effects.	loperamide__HSA__interaction
18805505-1370	Engineered <compound-id="6326970">selenium</compound-id>-containing <protein-id="O81187,P00276,P45242,P55142,P55143,Q9HU55,Q9JVU9,Q9JY15,Q9KSW0,Q9ZDW1,Q9ZR41">glutaredoxin</protein-id> displays strong <protein-id="O32770,O59858,Q00277,Q9CFV1">glutathione peroxidase</protein-id> activity rivaling natural enzyme.	selenium__glutathione peroxidase__no_interaction	selenium__glutaredoxin__interaction
18805505-1371	The use of a common thioredoxin fold with a high affinity for <compound-id="124886">glutathione</compound-id> in <protein-id="O81187,P00276,P45242,P55142,P55143,Q9HU55,Q9JVU9,Q9JY15,Q9KSW0,Q9ZDW1,Q9ZR41">glutaredoxin</protein-id> (Grx) and <protein-id="O32770,O59858,Q00277,Q9CFV1">glutathione peroxidase</protein-id> (GPx) suggests a possibility of engineering Grx into GPx and vice versa.	glutathione__glutathione peroxidase__interaction	glutathione__glutaredoxin__interaction
18805508-1434	The potassium channels blockade by either <compound-id="5413">tetraethylammonium</compound-id> or <protein-id="P13487">charybdotoxin</protein-id> also resulted in a potent inhibition of HEDS-induced aortic relaxation, whereas <compound-id="16129677">apamine</compound-id> only slightly reduced it.	tetraethylammonium__charybdotoxin__no_interaction	apamine__charybdotoxin__no_interaction
18805632-1457	ROS activated almost immediately in a time- and concentration-dependent manner the <protein-id="O42781,P27638,Q00859">MAPK</protein-id> pathways <protein-id="O24473,O75791,O95433,O97628,P46108,P80350,P82869,Q01552,Q04929,Q63768,Q64010,Q9LDA4,Q9Y2S7">p38</protein-id>, <protein-id="P29323">ERK</protein-id> and <protein-id="P92208,Q966Y3">JNK</protein-id> (their activation was abrogated by the antioxidant <compound-id="12035">N-acetylcysteine</compound-id>).	N-acetylcysteine__JNK__interaction	N-acetylcysteine__ERK__interaction	N-acetylcysteine__MAPK__no_interaction	N-acetylcysteine__p38__interaction
18805639-1461	Multiple linear regression (MLR), radial basis network (RB), and multilayer perceptron (MLP) neural network (NN) models have been explored for the estimation of toxicity of <compound-id="223">ammonium</compound-id>, <compound-id="795">imidazolium</compound-id>, <compound-id="8083">morpholinium</compound-id>, <compound-id="5460504">phosphonium</compound-id>, <compound-id="8082">piperidinium</compound-id>, <compound-id="1049">pyridinium</compound-id>, <compound-id="31268">pyrrolidinium</compound-id> and <compound-id="7047">quinolinium</compound-id> ionic liquid salts in the Leukemia Rat Cell Line (IPC-81) and <protein-id="Q867X2,Q867X3,Q86GC9,Q92081">Acetylcholinesterase</protein-id> (<protein-id="O42275,O62763,P04058,P07140,P07692,P21836,P22303,P23795,P36196,P37136,P56161,Q27677,Q29499,Q867X2,Q867X3,Q869C3,Q86GC8,Q86GC9,Q92035,Q92081,Q9DDE3">AChE</protein-id>) using only their empirical formulas (elemental composition) and molecular weights.	pyridinium__AChE__interaction	ammonium__AChE__interaction	pyrrolidinium__Acetylcholinesterase__interaction	phosphonium__Acetylcholinesterase__interaction	phosphonium__AChE__interaction	piperidinium__AChE__interaction	piperidinium__Acetylcholinesterase__interaction	imidazolium__Acetylcholinesterase__interaction	quinolinium__Acetylcholinesterase__interaction	ammonium__Acetylcholinesterase__interaction	morpholinium__AChE__interaction	pyrrolidinium__AChE__interaction	morpholinium__Acetylcholinesterase__interaction	pyridinium__Acetylcholinesterase__interaction	quinolinium__AChE__interaction	imidazolium__AChE__interaction
18805685-1489	The beneficial effect of DHA on the treatment groups was accompanied by decreases in blood-brain barrier disruption, brain edema, <compound-id="10964">malondialdehyde</compound-id> (MDA) production, inflammatory cell infiltration, <protein-id="P41693">interleukin-6</protein-id> (<protein-id="O35736,P05231,P08505,P20607,P26892,P26893,P29455,P41323,P41683,P41693,P46650,P51494,P79341,Q25BC2,Q28319,Q28747,Q28819,Q2MH06,Q5I6E3,Q6V919,Q865W7,Q865X6,Q8MKH0,Q95181,Q9MZR1,Q9XT80">IL-6</protein-id>) expression and caspase-3 activity.	malondialdehyde__IL-6__no_interaction	malondialdehyde__interleukin-6__no_interaction
18805685-1490	Elevation of antioxidative capacity, as evidenced by decreased MDA level and increased <protein-id="O50258">superoxide dismutase</protein-id> activity and <compound-id="124886">glutathione</compound-id> level, was detected only in the chronic daily-administration group.	glutathione__superoxide dismutase__no_interaction
18806218-232	<protein-id="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7">Insulin</protein-id> secretion is highly sensitive to desorption of plasma membrane <compound-id="304,5997,6432564,11025495">cholesterol</compound-id>.	cholesterol__Insulin__interaction
18806218-233	<compound-id="304,5997,6432564,11025495">Cholesterol</compound-id>-rich clusters of SNARE (<protein-id="Q23983">soluble NSF attachment protein</protein-id> receptor) proteins have been implicated as being important for exocytosis.	Cholesterol__soluble NSF attachment protein__interaction
18806296-1733	Suppression of retinal <protein-id="O18924,O18971,O19052,O62807,O88275,P37231,P37234,P37238,P57797,Q4U3Q4">peroxisome proliferator-activated receptor gamma</protein-id> in experimental diabetes and <compound-id="977">oxygen</compound-id>-induced retinopathy: role of NADPH oxidase.	oxygen__peroxisome proliferator-activated receptor gamma__no_interaction
18806930-1949	TKTL 1 was highest expressed in cell lines derived from more invasive tumors but the expression level was not strongly correlated to proliferation rate, to <protein-id="P79365">GLUT-1</protein-id> expression or to the response to <compound-id="8682">oxythiamine</compound-id>.	oxythiamine__GLUT-1__no_interaction
18806932-1906	<compound-id="5462224">Magnesium</compound-id> (Mg), <protein-id="P10145">interleukin 8</protein-id> (<protein-id="O62812,P08317,P10145,P19874,P26894,P36925,P41324,P46653,P49113,P67813,P67814,P79255,Q102R3,Q7YRB5,Q9XSX5">IL-8</protein-id>), and <compound-id="10964">malondialdehyde</compound-id> levels were analyzed in blood, while edema, neutrophil infiltration, eosinophilia, loss of striation, and nucleolization were evaluated in histopathological examination.	malondialdehyde__interleukin 8__no_interaction	malondialdehyde__IL-8__no_interaction	Magnesium__interleukin 8__no_interaction	Magnesium__IL-8__no_interaction
18807018-1954	Study of multiple binding constants of <compound-id="5743">dexamethasone</compound-id> with human <protein-id="P21847,P83517">serum albumin</protein-id> by capillary electrophoresis-frontal analysis and multivariate regression.	dexamethasone__serum albumin__interaction
18807018-1955	In this paper, to evaluate the pharmacokinetic and pharmacodynamic properties of <compound-id="5743">dexamethasone</compound-id> (DXM), the interaction between DXM and <protein-id="P24807,Q07490">HSA</protein-id> was studied by capillary electrophoresis-frontal analysis (CE-FA).	dexamethasone__HSA__interaction
18807050-1745	Arthropod <protein-id="P80888">hemocyanins</protein-id> transport and store <compound-id="977">oxygen</compound-id> and are composed of six subunits, or multiples thereof depending on the species.	oxygen__hemocyanins__no_interaction
18807050-1746	The protein is insensitive to lactate, but affected by urate which markedly increased <protein-id="P80888">hemocyanin</protein-id>-<compound-id="977">oxygen</compound-id> affinity, acting as the physiological major positive effector.	oxygen__hemocyanin__interaction
18807177-2028	The estrogen-induced increase in <protein-id="O62747,P25930,P56491,P56498,P61072,P61073,P79394,Q28474,Q28553,Q3LSL6,Q764M9,Q7YS92,Q8HZU0,Q8HZU1,Q9TSQ8">CXCR4</protein-id> protein in MCF-7-HER2 cells was abrogated by the antiestrogen <compound-id="104741">ICI 182780</compound-id> and by <compound-id="123631">gefitinib</compound-id> (<compound-id="123631">Iressa</compound-id> ; a phospho-tyrosine kinase inhibitor), indicating an ER-mediated effect and confirming involvement of receptor tyrosine kinases, respectively.	Iressa__CXCR4__interaction	gefitinib__CXCR4__interaction	ICI 182780__CXCR4__interaction
18807200-2046	Enzymatic activities of an H(2)O(2) independent oxidase along with <protein-id="Q12570">laccase</protein-id> and an <protein-id="P05982,P15559,Q5RD31,Q64669,Q8CHK7">azoreductase</protein-id> suggest their prominent role during the decolorization of reactive yellow <compound-id="24180624">84A</compound-id>.	84A__laccase__interaction	84A__azoreductase__interaction
18807200-2047	<protein-id="P05982,P15559,Q5RD31,Q64669,Q8CHK7">Azoreductase</protein-id> activity was prominent in presence of cofactors <compound-id="439153">NADH</compound-id> and <compound-id="5886">NADP</compound-id> in mineral salt medium.	NADH__Azoreductase__interaction	NADP__Azoreductase__interaction
18807214-2051	The increase of <compound-id="977">oxygen</compound-id> availability caused the induction of the antioxidant enzyme <protein-id="O50258">superoxide dismutase</protein-id>, which indicates that the defensive mechanisms of the cells against oxidative stress were effective and cells could cope with increased pressure.	oxygen__superoxide dismutase__interaction
18808217-2356	Concentrations of aqueous-phase perfluorooctanoic acid (PFOA), a representative perfluorinated aliphatic (PFA) compound, are shown to be reduced effectively via reaction with horseradish <protein-id="P15984,P16147,P84714">peroxidase</protein-id> (<protein-id="Q08168">HRP</protein-id>), <compound-id="784">hydrogen peroxide</compound-id>, and a phenolic cosubstrate (<compound-id="9015">4-methoxyphenol</compound-id>).	4-methoxyphenol__HRP__interaction	4-methoxyphenol__peroxidase__interaction	hydrogen peroxide__peroxidase__interaction	hydrogen peroxide__HRP__interaction
18808217-2357	Approximately 68% depletion of the parent compound and 98% depletion of its related acute aquatic toxicity are achieved in 6 h. Because no PFOA removal is observed in the absence of cosubstrate and/or following consumption thereof, we conclude that radical intermediate species generated during reaction between <protein-id="Q08168">HRP</protein-id> and <compound-id="9015">4-methoxyphenol</compound-id> mediate nonspecific depletion of PFOA and that these intermediates may be sufficiently reactive to sever the extremely stable C-F bonds of PFOA.	4-methoxyphenol__HRP__interaction
18808365-2406	In the present study, the mRNA expression and promoter <compound-id="6804">CpG</compound-id> methylation of <protein-id="O42132,P03372,P06211,P06212,P16058,P19785,P49884,P49885,P49886,P50240,P50241,P50242,P57717,P57753,P81559,Q29040,Q53AD2,Q91250,Q91424,Q9PVZ9,Q9QZJ5,Q9TV98,Q9YH33,Q9YHT3,Q9YHZ7">ERalpha</protein-id> isoforms (i.e.	CpG__ERalpha__interaction
18808365-2407	The present study is the first report that demonstrates selective inactivation of <protein-id="O42132,P03372,P06211,P06212,P16058,P19785,P49884,P49885,P49886,P50240,P50241,P50242,P57717,P57753,P81559,Q29040,Q53AD2,Q91250,Q91424,Q9PVZ9,Q9QZJ5,Q9TV98,Q9YH33,Q9YHT3,Q9YHZ7">ERalpha</protein-id> isoforms through the promoter <compound-id="6804">CpG</compound-id> methylation pathway in leukaemias.	CpG__ERalpha__interaction
18808455-2441	<protein-id="P02854">Type-B</protein-id> monogalactosyldiacylglycerol synthases are involved in <compound-id="1061,167704,644102">phosphate</compound-id> starvation-induced lipid remodeling, and are crucial for low-<compound-id="1061,167704,644102">phosphate</compound-id> adaptation.	phosphate__Type-B__interaction
18809244-141	This study was performed to evaluate the effects of <compound-id="5291">imatinib</compound-id> on breast cancer cell lines with respect to the activity of <protein-id="P05622,P09619,P79749,Q05030,Q6QNF3">PDGFR beta</protein-id> and <protein-id="P31750,Q8INB9">Akt</protein-id> : a downstream modulator of cell growth and survival.	imatinib__PDGFR beta__interaction	imatinib__Akt__interaction
18809262-150	The mechanisms may include the recently revealed anti-inflammatory effects of <protein-id="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7">insulin</protein-id> as well as its conventional <compound-id="206,5793,64689,79025">glucose</compound-id> and free fatty acids lowering effects, and possibly may also include changes in body fat distribution and plasma adiponectin level.	glucose__insulin__interaction
18809347-188	Recently, we reported stimulatory effect of <protein-id="Q6BEG6,Q6BEG7,Q9BDJ6,Q9BEF8,Q9EQX0,Q9GKY5,Q9QYH7,Q9UBU3">ghrelin</protein-id> alone and in combination with <protein-id="O12980,O13188,O18938,O62754,O70615,O73848,O73849,O93566,P01241,P01244,P01245,P01246,P01248,P06880,P07064,P08591,P08998,P09113,P09537,P09539,P10298,P10607,P10766,P10813,P10814,P11228,P13391,P19795,P20391,P20392,P22077,P24363,P29971,P33092,P33093,P33711,P34005,P34006,P34744,P34745,P34746,P34747,P37885,P37886,P45643,P45654,P45655,P46404,P46407,P48248,P55755,P56437,P58343,P58756,P67930,P67931,P69158,P69159,P69160,P69161,P69162,P79885,P87391,Q01282,Q01283,Q05163,Q07221,Q1HFN3,Q659Q8,Q7YQB8,Q7YQD2,Q7YRR6,Q864S7,Q8HYE5,Q8MI73,Q98UF6,Q9DEV3,Q9DGG5,Q9GKA1,Q9GL60,Q9GMB2,Q9GMB3,Q9I9L5,Q9I9M4,Q9IB11,Q9IBE5,Q9JKM4,Q9PWG3,Q9W6J5,Q9W6J7,Q9W6R8">growth hormone</protein-id> (GH) on <compound-id="5757">estradiol</compound-id> secretion, <protein-id="O42145,O46512,P11511,P19098,P22443,P28649,P46194,P70091,P79304,P79430,P79699,Q29605,Q29624,Q5QQX7,Q69FB6,Q6QHT9,Q6YI21,Q92087,Q92111,Q92112,Q95M61,Q9XS28">aromatase</protein-id> activity in parallel with inhibitory effect on cell apoptosis.	estradiol__aromatase__no_interaction	estradiol__growth hormone__interaction	estradiol__ghrelin__interaction
18809347-189	In cultures treated together <protein-id="Q6BEG6,Q6BEG7,Q9BDJ6,Q9BEF8,Q9EQX0,Q9GKY5,Q9QYH7,Q9UBU3">ghrelin</protein-id> and (D-Lys-3)-GHRP-6, <compound-id="5757">estradiol</compound-id> secretion, <protein-id="O42145,O46512,P11511,P19098,P22443,P28649,P46194,P70091,P79304,P79430,P79699,Q29605,Q29624,Q5QQX7,Q69FB6,Q6QHT9,Q6YI21,Q92087,Q92111,Q92112,Q95M61,Q9XS28">aromatase</protein-id> activity and cell proliferation returned to control levels.	estradiol__aromatase__no_interaction	estradiol__ghrelin__interaction
18809364-192	Expression levels of the functional activities (albumin secretion and <compound-id="222">ammonia</compound-id> removal) and the cell-cell adhesion molecules (cadherin and <protein-id="O18968,P08033,P08034,P28230,Q60HF7,Q6WGK6">connexin-32</protein-id>) were higher in the hepatocytes that formed spheroids compared to those which assumed a monolayer configuration, and these levels were maintained for at least 10 days.	ammonia__connexin-32__no_interaction
18809367-193	Nevertheless, certain clinical cases manifest themselves with the onset of acute renal failure bought upon by the administration of blockers of the rennin-<protein-id="Q10757">angiotensin</protein-id>-<compound-id="5839">aldosterone</compound-id> system, or by some other causes responsible for a sudden drop in renal plasma flow (e.g., thrombosis of the renal artery).	aldosterone__angiotensin__no_interaction
18809432-1105	The function of rhamnose-binding <protein-id="P02871,P02873,P02874,P02875,P07386,P16108,P16349,P16351,P16352,P33888,P38662,P42088,P83410,P83511,P84987,Q41114">lectin</protein-id> in innate immunity by restricted binding to <compound-id="11963508">Gb3</compound-id>.	Gb3__lectin__interaction
18809432-1106	This is the first finding that <compound-id="11963508">Gb3</compound-id> plays a role in innate immunity by cooperating with natural ligands, <protein-id="Q9PVW8">RBLs</protein-id>.	Gb3__RBLs__interaction
18809481-220	Effect of polyols on the solubility of bovine <protein-id="P21847,P83517">serum albumin</protein-id> (<protein-id="P02769">BSA</protein-id>) in the presence of <compound-id="6325">polyethylene</compound-id> glycols (PEGs) was investigated in order to strengthen the understanding of the observed effects of polyols and PEGs on protein properties in solution.	polyethylene__BSA__no_interaction	polyethylene__serum albumin__no_interaction
18810331-544	After 2 and 6 weeks of treatment, parotid gland was removed and total protein and <compound-id="906,444885,445063">sialic acid</compound-id> (free and total) concentration and amylase and <protein-id="P15984,P16147,P84714">peroxidase</protein-id> activities were determined.	sialic acid__peroxidase__no_interaction
18810331-545	At week 2 of the study, parotid gland of diabetic rats presented a reduction of total protein concentration (55%) and an increase of amylase (120%) and <protein-id="P15984,P16147,P84714">peroxidase</protein-id> (160%) activities, free (150%) and total (170%) <compound-id="906,444885,445063">sialic acid</compound-id> concentration.	sialic acid__peroxidase__no_interaction
18810466-577	To investigate the change pattern of <protein-id="P01289,P06767,P19850,P20366,P28498,P28499,P41333,P41539,P41540,P67932,P67933,Q60541">substance P</protein-id> (SP) and <compound-id="145068">nitric oxide</compound-id> (NO) in the portal vein during the recto-anal inhibitory reflex (RAIR), and its physiological significance; the influence of external splanchnic nerve (ESN) of rectum and anus to the RAIR.	nitric oxide__substance P__no_interaction
18810510-591	Considering the common metabolic pathway and synergism between dopamine and <compound-id="5202">serotonin</compound-id>, the role of dopamine transporter (<protein-id="P27922,Q01959,Q9GJT6">SLC6A3</protein-id>, <protein-id="P13483,P23977,P27922,Q01959,Q03614,Q61327,Q9GJT6">DAT</protein-id>) and <protein-id="P49253">monoamine oxidase</protein-id> A (<protein-id="O18851,P21397,P21398,P58027,Q5NU32,Q5RE60,Q6Q2J0">MAOA</protein-id>) genes in SIDS and stillbirth (sudden intrauterine unexplained death, SIUD) was investigated.	serotonin__monoamine oxidase__no_interaction	serotonin__MAOA__no_interaction	serotonin__SLC6A3__no_interaction	serotonin__DAT__no_interaction
18810517-648	A <protein-id="Q7M4U7">lipase</protein-id> (F2) and <protein-id="Q7M4U7">lipase</protein-id>-like materials (F1) were purified from the culture supernatant of P. monteilii TKU009 with soybean powder as the sole carbon/<compound-id="947,123329">nitrogen</compound-id> source.	nitrogen__lipase__no_interaction
18810712-643	DHEA, <compound-id="12594">DHEA-S</compound-id>, <compound-id="10635">dihydrotestosterone</compound-id>, total <compound-id="6013">testosterone</compound-id>, free <compound-id="6013">testosterone</compound-id>, sex hormone-binding globulin, <compound-id="5870">estrone</compound-id>, <compound-id="5757">estradiol</compound-id>, <compound-id="5754">cortisol</compound-id>, <protein-id="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7">insulin</protein-id>, <protein-id="Q95222">IGF-1</protein-id>, <protein-id="P08833,P21743,P24591,P47876,Q6Q484,Q75ZP3">IGFBP-1</protein-id>, <protein-id="P15473,P16611,P17936,P20959,P47878">IGFBP-3</protein-id>, and adiponectin in plasma or serum were measured.	dihydrotestosterone__IGF-1__no_interaction	estrone__IGF-1__no_interaction	cortisol__IGFBP-3__no_interaction	testosterone__IGFBP-3__no_interaction	DHEA-S__IGF-1__no_interaction	DHEA-S__insulin__no_interaction	dihydrotestosterone__insulin__no_interaction	cortisol__insulin__no_interaction	estradiol__IGFBP-1__no_interaction	testosterone__IGF-1__no_interaction	DHEA-S__IGFBP-3__no_interaction	estradiol__insulin__no_interaction	estradiol__IGF-1__no_interaction	DHEA-S__IGFBP-1__no_interaction	cortisol__IGFBP-1__no_interaction	estrone__insulin__no_interaction	dihydrotestosterone__IGFBP-1__no_interaction	testosterone__insulin__no_interaction	dihydrotestosterone__IGFBP-3__no_interaction	testosterone__IGFBP-1__no_interaction	estrone__IGFBP-1__no_interaction	cortisol__IGF-1__no_interaction	estradiol__IGFBP-3__no_interaction	estrone__IGFBP-3__no_interaction
18812013-984	Our data indicate that genetic differences in <protein-id="P02638,P04271,Q6YNR6">S100B</protein-id> gene expression may predispose individual differences in the responsivity to repeated intake of <compound-id="1615">MDMA</compound-id>.	MDMA__S100B__interaction
18812209-396	<protein-id="P01015,P01016,P01017,P01019,P11859,P20757,P67885,P67886,Q9GLN8,Q9GLP6,Q9TSZ0">Angiotensin II</protein-id> (<protein-id="P01015,P01016,P01017,P01019,P11859,P20757,P67885,P67886,Q9GLN8,Q9GLP6,Q9TSZ0">Ang II</protein-id>) is the key <protein-id="P81626">peptide hormone</protein-id> in the renin-<protein-id="Q10757">angiotensin</protein-id>-<compound-id="5839">aldosterone</compound-id> system (RAAS).	aldosterone__Ang II__interaction	aldosterone__peptide hormone__interaction	aldosterone__angiotensin__interaction	aldosterone__Angiotensin II__interaction
18812225-1232	The enzyme responsible for D-<compound-id="5951">serine</compound-id> biosynthesis, <protein-id="Q9GZT4,Q9QZX7">serine racemase</protein-id> (SR), is therefore a promising target for treatment of neuropathologies related to glutamate receptor excitotoxicity, such as stroke or Alzheimer's disease.	serine__serine racemase__interaction
18812229-1054	Hepatocyte apoptosis was estimated morphologically using <protein-id="P08758,P14668,P17153,P48036,P70075,P81287,Q4R4H7,Q5R1W0">Annexin-V</protein-id> combined with <compound-id="4939">propidium iodide</compound-id>, or <compound-id="7084">toluidine blue</compound-id> staining.	propidium iodide__Annexin-V__no_interaction	toluidine blue__Annexin-V__no_interaction
18812233-1056	To investigate the metabolism of <compound-id="5282105">NADA</compound-id> through the <protein-id="O08469">cytochrome P450</protein-id> (CYP450) metabolic pathway, we studied the in vitro rat liver microsomal production of hydroxylated metabolites and their activity at recombinant human TRPV(1) receptors.	NADA__cytochrome P450__interaction
18812596-1164	The FFA fractions elicited pro-inflammatory responses inducing <protein-id="O35734,O77510,O77764,P01375,P04924,P06804,P13296,P16599,P19101,P23383,P23563,P29553,P33620,P36939,P48094,P51435,P51742,P51743,P59684,P59693,P59694,P59695,P79337,P79374,Q06599,Q19LH4,Q1G1A2,Q1WM27,Q2MH05,Q539C2,Q75N23,Q8HZD9,Q8JFG3,Q8MKG8,Q8WNR1,Q9BEA1">TNFalpha</protein-id> and intracellular adhesion molecule expression and reactive <compound-id="977">oxygen</compound-id> species (ROS) production in human aortic endothelial cells (HAECs).	oxygen__TNFalpha__no_interaction
18812689-1190	<protein-id="P08183,P13568,P16875,P28873,P53258,Q06034,Q9LJX0,Q9ZR72">MDR1</protein-id> single nucleotide polymorphism G2677T/A and haplotype are correlated with response to <compound-id="148124">docetaxel</compound-id>-cisplatin chemotherapy in patients with non-small-cell lung cancer.	docetaxel__MDR1__interaction
18814142-2252	Functional expression of <protein-id="O70431,P04274,P07550,P10608,P18762,P54833,Q28044,Q28509,Q28997,Q4KWL2,Q8UUY8,Q9TST5">beta2 adrenergic receptors</protein-id> responsible for protection against oxidative stress through promotion of <compound-id="124886">glutathione</compound-id> synthesis after <protein-id="O54968,Q60795">Nrf2</protein-id> upregulation in undifferentiated mesenchymal C3H10T1/2 stem cells.	glutathione__beta2 adrenergic receptors__interaction	glutathione__Nrf2__no_interaction
18814142-2253	Exposure to adrenaline not only increased cAMP formation, phosphorylation of cAMP responsive element (CRE) binding protein (<protein-id="P15337,P16220,P27925,P51984,P51985,Q01147">CREB</protein-id>) on serine133 and CRE reporter activity in a manner sensitive to <compound-id="4946,21138,91536">propranolol</compound-id>, but also rendered C3H10T1/2 cells resistant to the cytotoxicity of <compound-id="784">hydrogen peroxide</compound-id>, but not of either 2,4-dinitirophenol or tunicamycin.	propranolol__CREB__interaction	hydrogen peroxide__CREB__interaction
18814142-2254	These results suggest that adrenaline may selectively protect mesenchymal C3H10T1/2 cells from oxidative stress through a mechanism related to the promoted biosynthesis of <compound-id="124886">glutathione</compound-id> in association with transient <protein-id="O54968,Q60795">Nrf2</protein-id> expression after activation of beta(2)AdR.	glutathione__Nrf2__no_interaction
18814181-1610	Two principal signaling pathways that regulate proliferation are <protein-id="O00329,O02697,O35904,P23727,P26450,P27986,P32871,P42336,P42337,P42338,P42347,P42348,P48736,P54673,P54674,P54675,P54676,Q63787,Q8BTI9,Q8UUU2,Q9JHG7,Q9Z1L0">PI3K</protein-id>/<compound-id="643963">PI(3,4,5)P3</compound-id>/<protein-id="P31750,Q8INB9">Akt</protein-id> and <protein-id="P33247,P33990,P54924,P55348,P98083">Shc</protein-id>/<protein-id="P03967,P22126,Q07152">Ras</protein-id>/<protein-id="P27361,P28869,P42525,Q07176">ERK1</protein-id>/2.	PI(3,4,5)P3__Shc__no_interaction	PI(3,4,5)P3__Ras__no_interaction	PI(3,4,5)P3__PI3K__interaction	PI(3,4,5)P3__Akt__interaction	PI(3,4,5)P3__ERK1__no_interaction
18814266-2509	However, <compound-id="53232">lovastatin</compound-id> treatment resulted in intracellular accumulation of <protein-id="P04116,P13085,P22858,P23289,P23294,P30044,P47789,P47790,P60201,P60202,P60203,P79826,P80145,P99029,Q8HXW7,Q96GD0,Q9R063">PLP</protein-id> and prevented its translocation to the cell surface.	lovastatin__PLP__interaction
18814279-1660	<compound-id="5291">Imatinib mesylate</compound-id> (<compound-id="5291">imatinib</compound-id>) is a potent and selective inhibitor of the tyrosine kinases, <protein-id="P28246,P45123">Bcr</protein-id>-<protein-id="P00520,P00522">Abl</protein-id>, <protein-id="O97799,P05532,P10721,P43481,Q08156,Q28317,Q28889,Q2HWD6,Q76II0,Q8AXC6">c-Kit</protein-id> and platelet-derived growth factor receptors (PDGFRs).	Imatinib mesylate__c-Kit__interaction	imatinib__Abl__interaction	Imatinib mesylate__Bcr__interaction	imatinib__c-Kit__interaction	imatinib__Bcr__interaction	Imatinib mesylate__Abl__interaction
18814300-1665	The large and diverse family of <protein-id="O08469">cytochrome P450</protein-id> monooxygenases (<protein-id="P21568,P21569,P24525,P34887,Q26551">CYPs</protein-id>) was systematically analyzed to identify selectivity- and specificity-determining residues in the substrate recognition site 5, which is located in close vicinity to the <compound-id="4971">heme</compound-id> center.	heme__cytochrome P450__no_interaction	heme__CYPs__no_interaction
18814300-1666	In 98.4% of all <protein-id="P21568,P21569,P24525,P34887,Q26551">CYP</protein-id> sequences a preferentially hydrophobic residue is located at position 5 after the ExxR motif that is predicted to point close to the <compound-id="4971">heme</compound-id> center.	heme__CYP__no_interaction
18814316-53	We report the interaction of a potent synthetic derivative of <compound-id="969516">curcumin</compound-id>, isoxazolcurcumin (<compound-id="446240">IOC</compound-id>) with human <protein-id="P21847,P83517">serum albumin</protein-id> (<protein-id="P24807,Q07490">HSA</protein-id>) using various biophysical methods.	curcumin__HSA__interaction	IOC__serum albumin__interaction	curcumin__serum albumin__interaction	IOC__HSA__interaction
18814316-54	The observed fluorescence quenching of <protein-id="P24807,Q07490">HSA</protein-id> by <compound-id="446240">IOC</compound-id> is due to a complex formation by a static quenching process with a quenching constant of the order of 10(5) M(-1).	IOC__HSA__interaction
18814316-55	From the observed Frster-type fluorescence resonance energy transfer (FRET), the donor (Trp 214 in <protein-id="P24807,Q07490">HSA</protein-id>) to acceptor (<compound-id="446240">IOC</compound-id>) distance is calculated to be 3.2 nm.	IOC__HSA__interaction
18814316-56	The preferred binding site of <compound-id="446240">IOC</compound-id> was analyzed by ligand displacement experiments with <compound-id="1369">1-anilino-8-naphthalenesulfonate</compound-id> (ANS) and <compound-id="54678486">warfarin</compound-id>-bound <protein-id="P24807,Q07490">HSA</protein-id>.	warfarin__HSA__interaction	1-anilino-8-naphthalenesulfonate__HSA__interaction	IOC__HSA__interaction
18814864-1818	A number of site-specific modifications of the nucleosome core histones-including the trimethylated forms of <protein-id="P02299,P07041,P08437,P08898,P22843,P23753,P40285,P50564,P61830,P61831,P61832,P61833,P61834,P61835,P61836,P80553,P83864,P84235,P84236,P84237,P84238,P84239,P90543,Q06196,Q2UCQ0,Q5DWI3,Q757N1,Q7XYZ0,Q98RY4,Q9HDN1,Q9P427,Q9U7D1">histone H3</protein-id> lysines K4, K9, and <compound-id="5492535">K27</compound-id>-are of particular interest for postmortem research, because these marks differentiate between active and inactive chromatin and seem to remain relatively stable during tissue autolysis.	K27__histone H3__interaction
18814910-1833	We here demonstrate that <protein-id="O75762">TRPA1</protein-id> confers a sensitivity towards near ultraviolet (UVA) light, which rapidly causes <compound-id="271">Ca(2</compound-id>+) entry.	Ca(2__TRPA1__interaction
18814910-1834	In the presence of the photosensitising agents <compound-id="62344">acridine orange</compound-id> (100 nM) or <compound-id="5281051">hypericin</compound-id> (10 nM), the sensitivity of light-induced <protein-id="O75762">TRPA1</protein-id> activation was increased and extended towards the visible spectrum.	acridine orange__TRPA1__interaction	hypericin__TRPA1__interaction
18814934-1845	To verify the possible involvement of lipids and several other compounds including <compound-id="784">hydrogen peroxide</compound-id> (H(2)O(2)) and <protein-id="O01360,O13507,O27090,O28542,O32755,O42259,O52631,O57479,O57672,O59494,O59841,O67161,O83816,P00355,P00356,P00357,P00361,P00362,P04406,P04797,P08439,P09316,P09317,P0A1P0,P0A1P1,P0C0G6,P0C0G7,P10096,P10618,P15115,P16858,P17244,P17721,P19089,P19314,P19315,P20287,P20445,P23722,P24163,P24164,P24166,P24746,P24748,P24749,P24750,P24751,P24753,P26988,P27726,P28844,P29497,P32637,P32638,P34783,P35143,P39460,P44304,P46406,P46713,P46795,P46796,P47543,P48812,P51009,P51469,P51640,P52694,P52987,P53430,P54117,P54118,P54226,P55070,P55071,P55971,P56649,P57384,P58839,P61879,P61880,P64178,P64179,P68777,P70685,P75358,P83601,P87197,P94915,Q00301,Q00584,Q00640,Q01597,Q01651,Q01982,Q05025,Q07234,Q12552,Q1DTF9,Q27652,Q28259,Q28554,Q2NEN0,Q3IUT3,Q46450,Q48335,Q4J940,Q4KYY3,Q58546,Q59199,Q59309,Q59800,Q59906,Q5JHB5,Q5R2J2,Q5RAB4,Q5V061,Q5XDW3,Q6BMK0,Q6CCU7,Q6L125,Q6M0E6,Q757I2,Q89AK1,Q8J1H3,Q8K8M9,Q8NK47,Q8PTD3,Q8TFJ2,Q8WZN0,Q8X1X3,Q8ZWK7,Q92211,Q92243,Q92263,Q94469,Q96US8,Q971K2,Q97BJ8,Q9HFX1,Q9HGY7,Q9HJ69,Q9HSS7,Q9N2D5,Q9N655,Q9P8C0,Q9PJN6,Q9UR38,Q9UVC0,Q9UW96,Q9V1P1,Q9Y796,Q9Y8E9,Q9YFS9,Q9Z518,Q9Z7T0,Q9ZKT0">glyceraldehyde-3-phosphate dehydrogenase</protein-id> (<protein-id="P51640,Q28554">G3PDH</protein-id>) in the response of Hordeum vulgare to early potassium deprivation, plants were grown in hydroponic conditions for 30d with a modified Hewitt nutrient solution containing 3mM K(+).	hydrogen peroxide__G3PDH__no_interaction	hydrogen peroxide__glyceraldehyde-3-phosphate dehydrogenase__no_interaction
18815024-1868	A new biosensor for trehalose determination has been realized by means of a flow system, based on a reactor in which the trehalase enzyme catalyses its hydrolysis into two <compound-id="206,79025">alpha,d-glucose</compound-id> molecules, and a <protein-id="P13006,P81156,Q92452">GOD</protein-id> (<protein-id="P81156">glucose oxidase</protein-id>) amperometric biosensor is employed for the <compound-id="206,64689,79025">glucose</compound-id> determination.	alpha,d-glucose__glucose oxidase__no_interaction	glucose__glucose oxidase__no_interaction	glucose__GOD__no_interaction	alpha,d-glucose__GOD__no_interaction
18815084-1886	The angiogenic potential of vascular endothelial growth factor (<protein-id="P15691,P15692,P26617,P49151,P50412,P67964,P67965,Q99PS1,Q9GKR0,Q9MYV3">VEGF</protein-id>) and its <compound-id="977">oxygen</compound-id> pressure-dependent regulation suggest a strong connection between this growth factor and the 'delay phenomenon'.	oxygen__VEGF__interaction
18815123-1901	Quantitative proteomics analysis of macrophage rafts reveals compartmentalized activation of the proteasome and of proteasome-mediated <protein-id="P29323">ERK</protein-id> activation in response to <compound-id="11970143">lipopolysaccharide</compound-id>.	lipopolysaccharide__ERK__interaction
18815141-1912	<compound-id="7906">Methylmercury</compound-id> toxicity and <protein-id="O54968,Q60795">Nrf2</protein-id>-dependent detoxification in astrocytes.	Methylmercury__Nrf2__interaction
18815243-1973	After serum <compound-id="588">creatinine</compound-id> reached a stable nadir in the transplant recipients, <protein-id="Q92565">GFR</protein-id> and its hemodynamic determinants were evaluated and the whole allograft K(f) was computed.	creatinine__GFR__no_interaction
18815356-1953	Lower expression of <protein-id="P08833,P24591,Q6Q484,Q75ZP3">IGFBP1</protein-id> and <protein-id="P10765,P22393,P33089,P33090,P33091,P43001">prolactin</protein-id> mRNA and protein was observed in hESF from women with vs. those without endometriosis in response to <compound-id="32014">8-Br-cAMP</compound-id>, but not P4, suggesting a blunted response of these decidual biomarkers to activation of the PKA pathway in eutopic endometrium in women with disease.	8-Br-cAMP__prolactin__interaction	8-Br-cAMP__IGFBP1__interaction
18815358-2022	Furthermore, constitutive expression of an <compound-id="977">oxygen</compound-id>-insensitive, active form of <protein-id="Q0PGG7,Q16665,Q309Z6,Q98SW2,Q9XTA5,Q9YIB9">HIF1A</protein-id> protein mimicked the effects of low <compound-id="977">oxygen</compound-id>, inhibiting the differentiation of trophoblast giant cells.	oxygen__HIF1A__no_interaction
18815782-2147	Finally, the results showed that the <protein-id="Q7M4U7">lipase</protein-id> covalently attached onto <compound-id="169944">epoxy resin</compound-id> exhibited the highest enantioselectivity and operational stability.	epoxy resin__lipase__interaction
18815831-2150	Effect of the inoculum size on carbapenem susceptibilities of <protein-id="P80298,P80545,P81173">beta-lactamase</protein-id>-negative, <compound-id="6249">ampicillin</compound-id>-resistant Haemophilus influenzae.	ampicillin__beta-lactamase__no_interaction
18815831-2151	However, the effect of inoculum size of <protein-id="P80298,P80545,P81173">beta-lactamase</protein-id>-negative, <compound-id="6249">ampicillin</compound-id>-resistant H. influenzae (BLNAR) on MICs for carbapenems has not been investigated.	ampicillin__beta-lactamase__no_interaction
18815849-2155	It has been proposed that there is improvement in <compound-id="206,5793,64689,79025">glucose</compound-id> and <protein-id="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7">insulin</protein-id> metabolism after weight loss in patients who underwent diet restriction and bariatric surgery.	glucose__insulin__no_interaction
18815869-2158	<compound-id="6037">Folate</compound-id> deficiency due to the <protein-id="P42898,Q5I598,Q60HE5,Q9WU20">methylenetetrahydrofolate reductase</protein-id> (<protein-id="P42898,Q5I598,Q60HE5">MTHFR</protein-id>) and <protein-id="O26869,O33259,O33465,O58816,P13009,P37586,P55299,P57704,Q49775,Q4JAI4,Q4JIJ3,Q55786,Q58868,Q5E814,Q5JH51,Q7MHB1,Q87L95,Q8DCJ7,Q8TH63,Q975N4,Q979L4,Q980A9,Q99707,Q9AJQ8,Q9KUW9,Q9V085,Q9YA91">methionine synthase</protein-id> (MS) variants leads to carcinogenesis by affecting DNA synthesis, repair, and methylation.	Folate__MTHFR__interaction	Folate__methionine synthase__interaction	Folate__methylenetetrahydrofolate reductase__interaction
18815881-2160	<compound-id="2733526">Tamoxifen</compound-id> has been the mainstay of endocrine therapy for <protein-id="O42132,P03372,P06211,P06212,P16058,P19785,P49884,P49885,P49886,P50240,P50241,P50242,P57717,P57753,P81559,Q29040,Q53AD2,Q91250,Q91424,Q9PVZ9,Q9QZJ5,Q9TV98,Q9YH33,Q9YHT3,Q9YHZ7">estrogen receptor</protein-id>-positive breast cancer.	Tamoxifen__estrogen receptor__interaction
18815882-2164	The bifunctional enzyme <protein-id="O35826,P27828,P39131,P52642,Q7TQ49,Q8XAR8,Q8Z388,Q8ZAE3,Q91WG8,Q9L6R5,Q9Y223">UDP-N-acetylglucosamine 2-epimerase</protein-id>/N-acetylmannosamine kinase (<protein-id="Q7TQ49,Q9Y223">GNE</protein-id>) is the key enzyme for the biosynthesis of <compound-id="349960">sialic acids</compound-id>, terminal components of glycoconjugates associated with a variety of physiological and pathological processes.	sialic acids__UDP-N-acetylglucosamine 2-epimerase__interaction	sialic acids__GNE__interaction
18816186-2283	A subthreshold stimulation by acute pathological threatening conditions (e.g., global ischemia subthreshold for cell death) enhances neuronal <protein-id="O54851,O70610,Q866T7,Q9UKL4">Cx36</protein-id> and glial <protein-id="O57474,P08050,P14154,P16863,P17302,P18246,P23242,Q29101,Q6S9C0">Cx43</protein-id> hemichannel activity, favoring <compound-id="5957">ATP</compound-id> release and generation of preconditioning.	ATP__Cx36__interaction	ATP__Cx43__interaction
18816698-2452	A study of rituximab and <compound-id="3690,9588020">ifosfamide</compound-id>, <compound-id="2568">carboplatin</compound-id>, and <compound-id="3310,36462,439525,5284558,6419930,6610299,11758093,45356822,50989217">etoposide</compound-id> chemotherapy in children with recurrent/refractory B-cell (<protein-id="P11836,Q3C2E2">CD20</protein-id>+) non-Hodgkin lymphoma and mature B-cell acute lymphoblastic leukemia: a report from the Children's Oncology Group.	etoposide__CD20__interaction	carboplatin__CD20__interaction	ifosfamide__CD20__interaction
18816790-2482	4) PKA regulates neurotransmission without <protein-id="P05130,P13677,P13678,P34722">PKC</protein-id> involvement because, after <compound-id="27924,122634,22833501">PMA</compound-id> or CaC modulation of the <protein-id="P05130,P13677,P13678,P34722">PKC</protein-id> activity, coupling to the ACh release of PKA can normally be stimulated with Sp-8-BrcAMP or inhibited with H-89.	PMA__PKC__no_interaction
18816790-2483	5) After PKA inhibition with H-89, <protein-id="P05130,P13677,P13678,P34722">PKC</protein-id> stimulation with <compound-id="27924,122634,22833501">PMA</compound-id> (or inhibition with CaC) does not lead to any change in evoked ACh release.	PMA__PKC__interaction
18816790-2484	In contrast, PKA inhibition prevent <protein-id="P05130,P13677,P13678,P34722">PKC</protein-id> stimulation (with the <compound-id="27924,22833501">phorbol ester</compound-id>) and coupling to ACh output.	phorbol ester__PKC__interaction
18817778-252	The inhibition of female rabbit sexual behavior by <compound-id="5994">progesterone</compound-id> : <protein-id="P06186,P06401,P07812,P79373,Q00175,Q28590,Q63449,Q8AYI2,Q9GLW0">progesterone receptor</protein-id>-dependent and-independent effects.	progesterone__progesterone receptor__interaction
18817795-259	Reproductive experience alters <compound-id="5753">corticosterone</compound-id> and <protein-id="P08185,P23775,P31211,P49920,P50451,Q06770,Q5R9E3,Q5RF65,Q60543,Q9H227">CBG</protein-id> levels in the rat dam.	corticosterone__CBG__no_interaction
18817795-260	The present study investigated whether the levels of circulating <compound-id="5753">corticosterone</compound-id> and its binding protein, <protein-id="P23775">corticosteroid binding globulin</protein-id> (<protein-id="P08185,P23775,P31211,P49920,P50451,Q06770,Q5R9E3,Q5RF65,Q60543,Q9H227">CBG</protein-id>), are altered with reproductive experience and pup-exposure during late pregnancy and the postpartum.	corticosterone__corticosteroid binding globulin__interaction	corticosterone__CBG__interaction
18817795-261	Total serum <compound-id="5753">corticosterone</compound-id> and <protein-id="P08185,P23775,P31211,P49920,P50451,Q06770,Q5R9E3,Q5RF65,Q60543,Q9H227">CBG</protein-id> were assayed from five groups; multiparous, primiparous, nulliparous, primip-no-pups, and sensitized rats during gestation (days 14 and 19) and the postpartum period (days 1, 5, 14, 21, and 35).	corticosterone__CBG__no_interaction
18817797-263	The influence of <compound-id="54454,4677798">simvastatin</compound-id>, <compound-id="60823">atorvastatin</compound-id> and high-cholesterol diet on <protein-id="Q867X2,Q867X3,Q86GC9,Q92081">acetylcholinesterase</protein-id> activity, amyloid beta and cholesterol synthesis in rat brain.	simvastatin__acetylcholinesterase__interaction	atorvastatin__acetylcholinesterase__interaction
18817816-1059	The expressions of <protein-id="Q17239,Q25190,Q25414">serotonin receptors</protein-id> (<protein-id="O46635,Q17239,Q25190,Q25414">5-hydroxytryptamine receptor</protein-id>), <protein-id="P01142,P01143,P06296,P06850,P49188,P49926,Q8CIT0,Q95MI6,Q9PTS1">corticotropin-releasing hormone</protein-id> (<protein-id="P01142,P06296,P06850,P49926,Q95MI6,Q9PTS1">CRH</protein-id>) and <compound-id="8230,644077,44285245">arginine vasopressin</compound-id> (AVP) mRNA in the hypothalamus were detected by real time PCR.	arginine vasopressin__CRH__no_interaction	arginine vasopressin__corticotropin-releasing hormone__no_interaction	arginine vasopressin__5-hydroxytryptamine receptor__no_interaction	arginine vasopressin__serotonin receptors__no_interaction
18817841-391	After incubation with 4- androstene-3,17-dione (4-dione), there are no estrogens, <compound-id="5870">estrone</compound-id> (E1) and <compound-id="5757">estradiol</compound-id> (E2), detected suggesting that the pathway of <protein-id="O42145,O46512,P11511,P19098,P22443,P28649,P46194,P70091,P79304,P79430,P79699,Q29605,Q29624,Q5QQX7,Q69FB6,Q6QHT9,Q6YI21,Q92087,Q92111,Q92112,Q95M61,Q9XS28">aromatase</protein-id> is not important in these cell lines.	estradiol__aromatase__no_interaction	estrone__aromatase__no_interaction
18817845-305	The aim of this study was to investigate the effects of acute and chronic exercise on <compound-id="2723628">thiobarbituric acid</compound-id> reactive substances, as an indicator of lipid peroxidation, in the hippocampus, which has a high concentration of <protein-id="O13186,O46567,O73673,P04150,P06536,P06537,P35547,P49115,P49843,P49844,P59667,P79269,P79686,Q5R9P5,Q6XLJ0,Q95267,Q9N1U3">glucocorticoid receptors</protein-id>, and prefrontal cortex and striatum, which have high <compound-id="681">dopamine</compound-id> content.	thiobarbituric acid__glucocorticoid receptors__no_interaction	dopamine__glucocorticoid receptors__no_interaction
18817845-306	Additionally we examined antioxidant enzyme activities, <protein-id="O50258">superoxide dismutase</protein-id> and <protein-id="O32770,O59858,Q00277,Q9CFV1">glutathione peroxidase</protein-id> and nitrite-<compound-id="943">nitrate</compound-id> levels to assess the effects of reactive oxygen and nitrogen species.	nitrate__superoxide dismutase__no_interaction	nitrate__glutathione peroxidase__no_interaction
18818063-283	Oral administration of (PhSe)(2) in rats did not change plasma alanine and <protein-id="O33822,O58489,O67781,O86459,O93744,P00509,P14909,P23034,P44425,P53001,P58661,P72173,Q4J8X2,Q55128,Q56114,Q56232,Q59228,Q60013,Q92JE7,Q972A2,Q9V0L2,Q9X0Y2,Q9ZE56">aspartate aminotransferase</protein-id> activities (<protein-id="P0AE37,P0AE38,P80357,P80358,Q0TH83,Q1C8B0,Q1RB46,Q321N9,Q32G89,Q3Z294,Q5PHB9,Q66B20,Q7N2G8,Q83L52,Q8FH00,Q8Z6G0,Q8ZPV1,Q9NRA2,Q9ZC67">AST</protein-id> and ALT) as well as <compound-id="1176,265993">urea</compound-id> and <compound-id="588">creatinine</compound-id> levels.	urea__aspartate aminotransferase__no_interaction	urea__AST__no_interaction	creatinine__aspartate aminotransferase__no_interaction	creatinine__AST__no_interaction
18818229-311	Total plasma <compound-id="778">homocysteine</compound-id> level, <protein-id="P42898,Q5I598,Q60HE5">MTHFR</protein-id> C677T polymorphism, inherited abnormalities of the natural anticoagulant system as well as plasma <compound-id="6037">folate</compound-id> and <compound-id="3034082,6713940,25243974">cobalamin</compound-id> levels were determined.	homocysteine__MTHFR__no_interaction	cobalamin__MTHFR__no_interaction	folate__MTHFR__no_interaction
18818289-2648	Immunohistochemical colabeling for nesfatin-1 and <protein-id="Q6BEG6,Q6BEG7,Q9BDJ6,Q9BEF8,Q9EQX0,Q9GKY5,Q9QYH7,Q9UBU3">ghrelin</protein-id>, <protein-id="P05034,P16453,P19113,P23738,P28577,P28578,P54772,P95477,Q05733,Q56581,Q5EA83,Q8L0Z4,Q98A07">histidine decarboxylase</protein-id>, or <compound-id="16129681,16129706">somatostatin</compound-id> revealed two subtypes of nesfatin-1-positive endocrine cells.	somatostatin__ghrelin__no_interaction	somatostatin__histidine decarboxylase__no_interaction
18818289-2649	Cells in the midportion of the glands coexpressed nesfatin-1 and <protein-id="Q6BEG6,Q6BEG7,Q9BDJ6,Q9BEF8,Q9EQX0,Q9GKY5,Q9QYH7,Q9UBU3">ghrelin</protein-id>, whereas few cells in the glandular base coexpressed nesfatin-1 and <compound-id="16129681,16129706">somatostatin</compound-id> or <protein-id="P05034,P16453,P19113,P23738,P28577,P28578,P54772,P95477,Q05733,Q56581,Q5EA83,Q8L0Z4,Q98A07">histidine decarboxylase</protein-id>.	somatostatin__ghrelin__no_interaction	somatostatin__histidine decarboxylase__no_interaction
18818294-345	Importantly, <protein-id="P00750,P11214,P19637,Q28198">tPA</protein-id> and <protein-id="P05121,P13909,P20961,P22777,P50449,P79335">PAI-1</protein-id> proteins and <protein-id="P00750,P11214,P19637,Q28198">tPA</protein-id> activity were low/nondetectable in granulosa cells obtained after treatment with hCG and the PG synthesis inhibitor <compound-id="2662">celecoxib</compound-id>.	celecoxib__tPA__interaction	celecoxib__PAI-1__interaction
18818294-346	To determine whether hCG stimulation of <protein-id="P00750,P11214,P19637,Q28198">tPA</protein-id> and <protein-id="P05121,P13909,P20961,P22777,P50449,P79335">PAI-1</protein-id> requires PGE2, granulosa cells obtained at 0 h were cultured with hCG plus <compound-id="3715">indomethacin</compound-id> to inhibit PG production; some cells also received PGE2 or an agonist selective for one PGE2 receptor (EP).	indomethacin__PAI-1__no_interaction	indomethacin__tPA__no_interaction
18818299-354	The role of <compound-id="164676">tanshinone IIA</compound-id> in the treatment of obesity through <protein-id="O18924,O18971,O19052,O62807,O88275,P37231,P37234,P37238,P57797,Q4U3Q4">peroxisome proliferator-activated receptor gamma</protein-id> antagonism.	tanshinone IIA__peroxisome proliferator-activated receptor gamma__interaction
18818375-367	In conclusion, the enhanced H(2)O(2) contraction in resistance arteries from SHRs seems to be mediated by increased TXA(2) release from <protein-id="O62664,O97554,P05979,P22437,P23219,Q63921,Q9T0N8">COX-1</protein-id> followed by elevations in vascular smooth muscle [<compound-id="271">Ca(2</compound-id>+)](i) levels and O(2)(.	Ca(2__COX-1__no_interaction
18818396-379	The <protein-id="P01103,P06876,P10242,P46200">c-myb</protein-id> proto-oncogene and microRNA-<compound-id="10036366">15a</compound-id> comprise an active autoregulatory feedback loop in human hematopoietic cells.	15a__c-myb__interaction
18818396-380	Herein we show that <protein-id="P01103,P06876,P10242,P46200">c-Myb</protein-id> expression is subject to posttranscriptional regulation by microRNA (miRNA)-<compound-id="10036366">15a</compound-id>.	15a__c-Myb__interaction
18818396-381	Exogenous expression of <protein-id="P01103,P06876,P10242,P46200">c-myb</protein-id> mRNA lacking the 3'-UTR partially rescued the miR-<compound-id="10036366">15a</compound-id> induced cell-cycle block.	15a__c-myb__interaction
18818396-382	Occupancy of one canonical <protein-id="P01103,P06876,P10242,P46200">c-Myb</protein-id> binding site was demonstrated by chromatin immunoprecipitation analysis and shown to be required for miR-<compound-id="10036366">15a</compound-id> expression in K562 cells.	15a__c-Myb__interaction
18818396-384	In aggregate, these findings suggest the presence of a <protein-id="P01103,P06876,P10242,P46200">c-Myb</protein-id>-miR-<compound-id="10036366">15a</compound-id> autoregulatory feedback loop of potential importance in human hematopoiesis.	15a__c-Myb__interaction
18818486-396	The central homeostasis is characterized by increased cerebrocortical synaptosomal T(3) content, deiodinase type II (<protein-id="P0C187,Q2RSB3">DII</protein-id>) activity, and <compound-id="6076">cAMP</compound-id> content.	cAMP__DII__no_interaction
18818687-454	This review provides an introduction to epigenetic concepts for renal investigators and an overview of our work detailing an epigenetic pathway for <compound-id="5839">aldosterone</compound-id> signaling and the control of epithelial <protein-id="P02719">Na(+) channel</protein-id>-alpha (ENaCalpha) subunit gene expression in the collecting duct.	aldosterone__Na(+) channel__no_interaction
18818710-2729	We aim to evaluate whether an E1A, E1B double-restricted oncolytic adenovirus, AxdAdB-3, can improve the efficacy for gallbladder cancers (GBCs) of the replication-deficient adenovirus-based herpes simplex virus <protein-id="O50519,O52951,O57203,O81263,O96720,P03176,P03177,P04363,P04364,P04407,P04408,P06478,P06479,P07605,P08333,P09250,P0A3L9,P0A3M0,P0C0E5,P0C0E6,P0C0E7,P10052,P13157,P13159,P13300,P14342,P14343,P16600,P17402,P17653,P18555,P21293,P22649,P23331,P23335,P23983,P24096,P24424,P24425,P25987,P27363,P28851,P28852,P28855,P33802,P36226,P44309,P47280,P47848,P57926,P65230,P65231,P68563,P68564,P69185,P69186,P75070,Q03221,Q05879,Q05880,Q21Q74,Q28M21,Q2A3U3,Q2FF09,Q2G5F0,Q2K5N6,Q2NIM1,Q2P902,Q2RZH4,Q2SSX9,Q2YUN4,Q31ZS8,Q32GW8,Q38WJ3,Q3BM98,Q3IBU5,Q3K118,Q3Z0V3,Q483R5,Q48TL1,Q492N1,Q49Z66,Q4A7B8,Q4A977,Q4L800,Q4QN19,Q4UNV0,Q57NR0,Q5E4F2,Q5FKZ1,Q5H6C5,Q5HE81,Q5HMA3,Q5JGT7,Q5KUH1,Q5LHP5,Q5LUY8,Q5M0B8,Q5M4W5,Q5NH50,Q5NQ29,Q5PCT4,Q5QWC7,Q5UP25,Q5WB52,Q5WYR3,Q5X7B5,Q5XC70,Q5ZXU5,Q5ZZT0,Q630R8,Q64YL9,Q65DU6,Q65RN9,Q66AM8,Q6A8W6,Q6D4R3,Q6F0I2,Q6G7J1,Q6GEV6,Q6HAV3,Q6KH30,Q6LT81,Q6MHW4,Q6YRB1,Q71WN4,Q72XC1,Q74K26,Q7CQF3,Q7CXF9,Q7MLR4,Q7MVV7,Q7N457,Q7NVK0,Q7UFR1,Q7VLH2,Q7VQZ6,Q814U0,Q81JX0,Q82KI9,Q831F5,Q83A42,Q878R8,Q87QJ8,Q88UT1,Q898Y8,Q8A5G4,Q8CRM9,Q8D8R2,Q8DPZ6,Q8DU63,Q8DZM3,Q8E5C2,Q8ECK0,Q8EM59,Q8EU99,Q8FHX4,Q8NVG5,Q8P126,Q8P3C8,Q8PEQ8,Q8RDA1,Q8RLE0,Q8VVL0,Q8XFQ8,Q8Y4A7,Q8ZEJ1,Q8ZV53,Q90029,Q90033,Q927U9,Q92N38,Q97F65,Q97R22,Q98HR4,Q99ZP6,Q9CHX5,Q9HPQ9,Q9JFB7,Q9K6F0,Q9KST9,Q9PPP5,Q9Q8N6,Q9QNF7,Q9RSY5,Q9WYN2,Q9ZIG2">thymidine kinase</protein-id> (HSVtk)/<compound-id="3454">ganciclovir</compound-id> (<compound-id="445994">GCV</compound-id>) therapy directed by the <protein-id="P06731">carcinoembryonic antigen</protein-id> (<protein-id="P06731">CEA</protein-id>) promoter.	ganciclovir__carcinoembryonic antigen__interaction	GCV__CEA__interaction	ganciclovir__CEA__interaction	GCV__thymidine kinase__interaction	GCV__carcinoembryonic antigen__interaction	ganciclovir__thymidine kinase__interaction
18818710-2730	Cytopathic effects of AxdAdB-3 plus AxCEAprTK (an adenovirus expressing HSVtk directed by <protein-id="P06731">CEA</protein-id> promoter) or AxCAHSVtk (an adenovirus expressing HSVtk directed by a nonspecific <protein-id="Q00398">CAG</protein-id> promoter) with <compound-id="445994">GCV</compound-id> administration were examined in several GBC lines and normal cells.	GCV__CAG__no_interaction	GCV__CEA__no_interaction
18818914-538	Low-temperature (77 K) steady-state fluorescence emission spectroscopy and dynamic light scattering were applied to the main <compound-id="5351507,5459387,6326752,6433193,6914133,9600410">chlorophyll a</compound-id>/<protein-id="P03168">b protein</protein-id> light harvesting complex of photosystem II (LHC II) in different aggregation states to elucidate the mechanism of fluorescence quenching within LHC II oligomers.	chlorophyll a__b protein__interaction
18818946-557	This mutation in the <protein-id="O95528">SLC2A10</protein-id> gene replaces a <compound-id="594,5862,5360637">cysteine</compound-id> encoding codon with a stop signal.	cysteine__SLC2A10__interaction
18819019-595	<protein-id="O53021,P0AFL3,P0AFL4,P0AFL5,P10111,P14851,P17742,P62935,P62936,P62937,P62938,P62940,P62941,Q0ZQK3,Q0ZQK6,Q0ZQK7,Q0ZQK8,Q0ZQL0,Q0ZQL1,Q0ZQL2,Q59641,Q5R8S7,Q6DTV9,Q8HXS3,Q9TTC6">Cyclophilin A</protein-id> (<protein-id="O08469">CypA</protein-id>), a receptor for the immunosuppressive agent <compound-id="2909,5280754,5284373,5458585,5497195,6435893,24883466,49867938">cyclosporin A</compound-id> (CsA), is a cis-trans peptidyl-prolyl isomerase (<protein-id="O00060,O00845,O04287,O07046,O08437,O22870,O25748,O25982,O42123,O46638,O49886,O52980,O54998,O60046,O66105,O74191,O75344,O83369,O94746,O95302,P0A9K9,P0A9L0,P0A9L1,P0A9L2,P0A9L3,P0A9L4,P0ABZ6,P0ABZ7,P0ABZ8,P0ABZ9,P0AEM0,P0AEM1,P0AEM2,P0AEM3,P0C196,P0C1B0,P0C1I4,P0C1I5,P0C1I6,P0C1J1,P0C1J3,P0C1J4,P0C1J5,P0C1J6,P0C1J7,P10255,P14088,P14832,P15425,P18203,P18253,P21568,P21569,P21863,P22011,P23284,P23285,P24367,P24368,P24369,P24525,P25007,P25334,P25719,P26623,P26882,P26883,P26884,P26885,P27124,P28517,P28870,P29117,P29820,P30404,P30405,P30412,P30416,P30417,P31106,P32472,P34887,P35176,P35627,P38911,P42693,P44760,P44830,P45523,P45877,P45878,P47103,P48375,P51752,P52009,P52010,P52011,P52012,P52013,P52014,P52015,P52016,P52017,P52018,P53605,P53691,P53728,P54397,P54985,P57599,P59024,P59724,P62942,P62943,P65764,P65765,P69059,P72704,P73789,P80311,P81104,P81531,P82536,P84342,P84343,P91791,Q00688,Q01490,Q02790,Q06205,Q08752,Q09637,Q09734,Q10175,Q11004,Q13356,Q13451,Q26486,Q26551,Q26565,Q2KJC8,Q2U256,Q2U316,Q2U5W8,Q2U6U0,Q2UN37,Q2UPT7,Q38931,Q38935,Q38936,Q39613,Q41649,Q41651,Q43207,Q4HZB8,Q4I1Y1,Q4IBK5,Q4IE79,Q4IN00,Q4INZ9,Q4IPB8,Q4P555,Q4PCH8,Q4PIN7,Q4W9R2,Q4WAQ9,Q4WCR3,Q4WHX4,Q4WLV6,Q4WMB6,Q4WMV5,Q4WVU5,Q57726,Q58235,Q59VR3,Q5ARI5,Q5ASQ0,Q5ATN7,Q5AXD5,Q5AXT6,Q5BAH7,Q5E992,Q5KAW8,Q5KGT9,Q5KHA8,Q5KIJ5,Q5KKX7,Q5KMG3,Q5KNY5,Q5R941,Q5RET2,Q5RF88,Q5UP71,Q5ZLV2,Q5ZXE0,Q61576,Q62446,Q62658,Q64378,Q66H94,Q6BP84,Q6BSE7,Q6BX45,Q6C4C9,Q6CF41,Q6CGG3,Q6CUZ8,Q6CWE8,Q6CX30,Q6DGG0,Q6FK71,Q6FKH7,Q6FMA3,Q6FSC1,Q6KBA8,Q6M981,Q6MWS8,Q754K8,Q756V1,Q7DMA9,Q7RXA6,Q7SCN0,Q7SF72,Q812D3,Q86ZF2,Q871A4,Q89A61,Q8K943,Q8LGG0,Q8WUA2,Q8X191,Q91XW8,Q96AY3,Q99KR7,Q9CR16,Q9CXG3,Q9D0W5,Q9D1M7,Q9D6L8,Q9D787,Q9H2H8,Q9LDC0,Q9LM71,Q9NWM8,Q9NYL4,Q9P3X9,Q9PJK1,Q9QVC8,Q9SCY2,Q9SCY3,Q9TRY0,Q9VL78,Q9Y3C6,Q9Y680,Q9Z247,Q9Z7P3,Q9ZJH5,Q9ZK89">PPIase</protein-id>) which accelerates the cis-trans isomerization of prolyl-peptide bonds, interacts with a variety of proteins and therefore regulates their activities.	cyclosporin A__PPIase__no_interaction	cyclosporin A__CypA__interaction	cyclosporin A__Cyclophilin A__interaction
18819053-613	While studies have shown that <compound-id="443872">eplerenone</compound-id> does not exhibit nonspecific actions on <protein-id="O97775,O97776,O97952,O97960,P10275,P15207,P19091,P49699,Q6QT55,Q7T1K4,Q8MIK0,Q9GKL7,Q9TT90">androgen receptor</protein-id>, its effects on steroid hormone production have not been reported.	eplerenone__androgen receptor__no_interaction
18819705-825	New treatments for type 2 diabetes mellitus are needed to retain <protein-id="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7">insulin</protein-id>-<compound-id="206,5793,64689,79025">glucose</compound-id> coupling and lower the risk of weight gain and hypoglycaemia.	glucose__insulin__interaction
18819713-827	The parameters measured in E. albidus whole body were: lipid peroxidation (LPO), total <compound-id="124886">glutathione</compound-id> (TG), as well as the enzymatic activities of <protein-id="O50258">superoxide dismutase</protein-id> (<protein-id="O12933,O22668,O75007,P24705,P51547,P93258,Q01137,Q27666,Q9SM64">SOD</protein-id>), <protein-id="O24339,O52762,O62839,O68146,O77229,O93662,O97492,P00432,P04040,P04762,P07145,P0A323,P0A324,P0A325,P0A326,P0A327,P11934,P17336,P24168,P24270,P25890,P29422,P30265,P30266,P32290,P42321,P44390,P45737,P45739,P55304,P55306,P55310,P55311,P55313,P77872,P81138,P90682,Q27710,Q49XC1,Q4L643,Q59296,Q59337,Q59602,Q59714,Q5HG86,Q5HPK8,Q5RF10,Q64405,Q6G9M4,Q6GH72,Q7A5T2,Q8CPD0,Q8FWU0,Q8NWV5,Q8X1P0,Q8Y3P9,Q926X0,Q99UE2,Q9AXH0,Q9KW19,Q9L4S1,Q9M5L6,Q9PT92,Q9PWF7,Q9Z598,Q9ZKX5,Q9ZN99">catalase</protein-id> (<protein-id="O62839,O97492,P00432,P00485,P00486,P00487,P04040,P06135,P07641,P11504,P20074,P22782,P25309,P25819,P26825,P26826,P32796,P36882,P36883,P43155,P47934,P49417,P52826,P58777,P62577,P62578,P62579,P62580,P90682,Q00614,Q02736,Q03058,Q5RF10,Q64405,Q704S8,Q9M5L6,Q9PWF7">CAT</protein-id>), <protein-id="O15770,P06715,P11804,P23189,P41921,P43783,P48638,P48639,P70619,P78965,Q60151,Q6BPI1,Q6C5H4,Q6FRV2,Q6HA23,Q74ZK4,Q873E8,Q94655">glutathione reductase</protein-id> (GR), <protein-id="O32770,O59858,Q00277,Q9CFV1">glutathione peroxidase</protein-id> (GPx) and <protein-id="O04437,O18598,P0A9D2,P0A9D3,P30116,P44521,P46088,P46419,P46423,P46426,P46428,P46437,P48438,P80894,P81065,P82996,P82997,P82998,P82999,P83000,P83001,P83246,Q04522,Q08392,Q08393,Q0ZS46,Q7REH6,Q8ILQ7,Q8MU52,Q96324">glutathione S-transferase</protein-id> (<protein-id="P20432,P30104,P30106,P30107,P30108,Q04522,Q0ZS46,Q7REH6,Q8ILQ7,Q8MU52">GST</protein-id>).	glutathione__CAT__no_interaction	glutathione__GST__no_interaction	glutathione__SOD__no_interaction	glutathione__glutathione S-transferase__no_interaction	glutathione__superoxide dismutase__no_interaction	glutathione__glutathione reductase__no_interaction	glutathione__glutathione peroxidase__no_interaction	glutathione__catalase__no_interaction
18819820-872	Augmentation of antibody responses by <compound-id="444795">retinoic acid</compound-id> and <protein-id="Q5ZPR3,Q7TPB4,Q8VE98">costimulatory molecules</protein-id>.	retinoic acid__costimulatory molecules__no_interaction
18820127-944	In accord with published results, we could show that treatment with <compound-id="6440175">17AAG</compound-id> resulted in depletion of <protein-id="O35280,P34208,Q6DE87,Q91ZN7">Chk1</protein-id>, a known <protein-id="P40292,P41887,Q90474">Hsp90</protein-id> client protein.	17AAG__Chk1__interaction	17AAG__Hsp90__no_interaction
18820127-945	In addition, we observed a time- and dose-dependent decrease in <protein-id="P07527,P47810,Q63802">Wee1</protein-id> kinase level, a negative regulator of mitosis, after <compound-id="6440175">17AAG</compound-id> treatment in gastrointestinal cancer cells.	17AAG__Wee1__interaction
18820134-953	<protein-id="Q8JFG3">Tumor necrosis factor</protein-id> alpha is a proximal mediator of synergistic hepatotoxicity from <compound-id="62959">trovafloxacin</compound-id>/lipopolysaccharide coexposure.	trovafloxacin__Tumor necrosis factor__interaction
18820153-959	A small cytoplasmic protein, <protein-id="Q8N668,Q8WMD0">MURR1</protein-id>, has been identified in human hepatic tissue, but its role in <compound-id="104815">Cu</compound-id> metabolism is unknown.	Cu__MURR1__no_interaction
18820153-962	As with <protein-id="O14618,Q42435,Q6PWT7,Q9SEA0">CCS</protein-id>, they are involved in making <compound-id="104815">Cu</compound-id> available to apo-enzymes inside the cell.	Cu__CCS__interaction
18820175-973	BrdU proliferation assays showed that in vivo proliferation of CD8+ T cells was reduced in <compound-id="702">ethanol</compound-id>-fed mice, and <protein-id="O62641,O77620,O97513,P04351,P05016,P17108,P19114,P26891,P36835,P37997,P46649,P51747,P60568,P60569,P68290,P68291,Q07885,Q08081,Q08867,Q1WM29,Q25BC3,Q29416,Q29615,Q2PE47,Q2PE78,Q4U313,Q5MBA8,Q5PXD0,Q7JFM2,Q7JFM3,Q7JFM4,Q7JFM5,Q865X2,Q865Y1,Q8MKH2,Q95KP3,Q9XS38,Q9XT83,Q9XT84">IL-2</protein-id>-dependent in vitro proliferation of naive CD8+ T cells was also reduced.	ethanol__IL-2__no_interaction
18820241-987	Multiple studies suggest increased conversion of <compound-id="304,5997,6432564,11025495">cholesterol</compound-id> to bile acids by <protein-id="O46491,P18125,P22680,P46634,P51542,Q64505">cholesterol 7alpha-hydroxylase</protein-id> (<protein-id="O46491,P22680,P46634,P51542">CYP7A1</protein-id>) protects against dyslipidemia and atherosclerosis.	cholesterol__cholesterol 7alpha-hydroxylase__interaction	cholesterol__CYP7A1__interaction
18820279-997	Therefore, we queried whether <compound-id="446157">rosuvastatin</compound-id> is prosurvival in podocytes through a <protein-id="O19002,O39927,O39928,O39929,O91936,O92529,O92530,O92531,O92532,P26660,P26661,P26662,P26663,P26664,P27954,P27955,P27956,P27957,P27958,P27959,P27960,P27961,P29846,P38936,P39689,P61585,P63028,Q00269,Q01403,Q01404,Q07828,Q11118,Q42580,Q5EG65,Q5I2N3,Q62092,Q68749,Q68798,Q68801,Q81258,Q81487,Q81495,Q81754,Q913D4,Q99IB8,Q9DHD6,Q9QAX1,Q9WMX2">p21</protein-id>-dependent pathway.	rosuvastatin__p21__interaction
18820825-2189	Treatment with pioglitazone, associated with <compound-id="4091">metformin</compound-id>, showed a reduction of <protein-id="O35736,P05231,P08505,P20607,P26892,P26893,P29455,P41323,P41683,P41693,P46650,P51494,P79341,Q25BC2,Q28319,Q28747,Q28819,Q2MH06,Q5I6E3,Q6V919,Q865W7,Q865X6,Q8MKH0,Q95181,Q9MZR1,Q9XT80">IL-6</protein-id> monocyte production after their in vitro activation with LPS.	metformin__IL-6__interaction
18820838-1229	Regulation of T-type <protein-id="P51637,P51638">Cav3</protein-id>.1 channels expression by synthetic glucocorticoid <compound-id="5743">dexamethasone</compound-id> in neonatal cardiac myocytes.	dexamethasone__Cav3__interaction
18820905-1243	The supernatant of the majority of the strains did not release the aglycone from <compound-id="107971,1023571,4183640,11992452,44257214">daidzin</compound-id>, suggesting that cell-associated <protein-id="P12614,P15885,P27034,P29091,P40740,Q03506,Q46684">beta-glucosidases</protein-id> (beta-<protein-id="P00864">Glu</protein-id>) are mainly responsible for the metabolism of soybean glyco-conjugates.	daidzin__Glu__no_interaction	daidzin__beta-glucosidases__no_interaction
18820913-1250	Role of <protein-id="Q9UNQ0">BCRP</protein-id> as a biomarker for predicting resistance to <compound-id="3385">5-fluorouracil</compound-id> in breast cancer.	5-fluorouracil__BCRP__interaction
18821018-1286	Acute regulation is mediated by the <protein-id="P58864,Q9DG08">steroidogenic acute regulatory protein</protein-id> (<protein-id="O46689,P49675,P51557,P58864,P70114,P79245,P97826,Q28918,Q28996,Q9DE06,Q9DEB4,Q9DG08,Q9DG09,Q9DG10">StAR</protein-id>), which facilitates the rapid influx of <compound-id="304,5997,6432564,11025495">cholesterol</compound-id> into mitochondria, where P450scc resides.	cholesterol__steroidogenic acute regulatory protein__interaction	cholesterol__StAR__interaction
18821018-1287	In the absence of <protein-id="O57525,O73853,P05093,P05185,P11715,P12394,P19100,P27786,P30437,P70085,P70687,Q29497,Q2XVA1,Q64410,Q8HYM9,Q8HYN0,Q8HYN1,Q91Z85,Q92113,Q95328,Q9GLD2,Q9GMC7,Q9GMC8,Q9N0U7">P450c17</protein-id> in the zona glomerulosa, C21 deoxy steroids are produced, leading to the mineralocorticoid, <compound-id="5839">aldosterone</compound-id>.	aldosterone__P450c17__interaction
18821018-1288	In the presence of the 17alpha-hydroxylase but not the 17,20 lyase activity of <protein-id="O57525,O73853,P05093,P05185,P11715,P12394,P19100,P27786,P30437,P70085,P70687,Q29497,Q2XVA1,Q64410,Q8HYM9,Q8HYN0,Q8HYN1,Q91Z85,Q92113,Q95328,Q9GLD2,Q9GMC7,Q9GMC8,Q9N0U7">P450c17</protein-id> in the zona fasciculata, C21, 17-hydroxy steroids are produced, leading to the glucocorticoid, <compound-id="5754">cortisol</compound-id>.	cortisol__P450c17__interaction
18821018-1289	When both the 17alpha-hydroxylase and 17,20 lyase activities of <protein-id="O57525,O73853,P05093,P05185,P11715,P12394,P19100,P27786,P30437,P70085,P70687,Q29497,Q2XVA1,Q64410,Q8HYM9,Q8HYN0,Q8HYN1,Q91Z85,Q92113,Q95328,Q9GLD2,Q9GMC7,Q9GMC8,Q9N0U7">P450c17</protein-id> are present in the zona reticularis, the androgen precursor <compound-id="5881">DHEA</compound-id> is produced.	DHEA__P450c17__interaction
18821018-1291	In the adrenal zona reticularis, the abundant expression of P450 oxidoreductase and <protein-id="O04354,P00167,P00168,P00169,P00170,P00171,P00172,P00173,P00174,P40312,P40934,P49096,P49097,P49098,P49100,P56395,Q874I5,Q9HFV1,Q9V4N3,Q9Y706">cytochrome b5</protein-id>, and the low expression of <protein-id="P19871">3beta-hydroxysteroid dehydrogenase</protein-id> (<protein-id="P26439,Q64421">HSD3B2</protein-id>) result in the production of the large amounts of <compound-id="5881">DHEA</compound-id> that characterize adrenarche.	DHEA__3beta-hydroxysteroid dehydrogenase__interaction	DHEA__cytochrome b5__interaction	DHEA__HSD3B2__interaction
18821058-2709	These were mutated in onion <protein-id="O24509,P29000,P29001,Q43857">vacuolar invertase</protein-id> (acINV) according to the residue in festuca <compound-id="5988">sucrose</compound-id> : <protein-id="P49175">sucrose 1</protein-id>-fructosyltransferase (saSST) and vice versa.	sucrose__vacuolar invertase__no_interaction	sucrose__sucrose 1__no_interaction
18821074-2737	<compound-id="24632">Calcium pyrophosphate</compound-id> dihydrate (CPPD) crystals are known to accumulate as substrates of <protein-id="P05186,P08289,P09242">TNSALP</protein-id> in tissues and joints of patients with HP.	Calcium pyrophosphate__TNSALP__interaction
18821127-1366	Optimization of chitosan succinate and chitosan <compound-id="1017">phthalate</compound-id> microspheres for oral delivery of <protein-id="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7">insulin</protein-id> using response surface methodology.	phthalate__insulin__interaction
18821127-1367	The relative pharmacological efficacy for chitosan <compound-id="1017">phthalate</compound-id> and chitosan succinate microspheres (18.66+/-3.84%, 16.24+/-4%) was almost three-fold higher than the efficacy of the oral <protein-id="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7">insulin</protein-id> administration (4.68+/-1.52%).	phthalate__insulin__no_interaction
18821579-1511	Induction of autophagy in malignant rhabdoid tumor cells by the histone deacetylase inhibitor <compound-id="5352062">FK228</compound-id> through <protein-id="O95831">AIF</protein-id> translocation.	FK228__AIF__interaction
18821579-1513	<compound-id="5352062">FK228</compound-id> converted unconjugated microtubule-associated protein light <protein-id="Q00285">chain 3</protein-id> (<protein-id="P82160">LC3</protein-id>-I) to conjugated light <protein-id="Q00285">chain 3</protein-id> (<protein-id="P82160">LC3</protein-id>-II) and induced localization of <protein-id="P82160">LC3</protein-id> to autophagosomes.	FK228__chain 3__interaction	FK228__LC3__interaction
18821579-1514	<protein-id="O95831,Q9JM53,Q9Z0X1">Apoptosis inducing factor</protein-id> (<protein-id="O95831">AIF</protein-id>), which plays a role in caspase-independent cell death, translocated to the nucleus in response to <compound-id="5352062">FK228</compound-id> treatment.	FK228__Apoptosis inducing factor__interaction	FK228__AIF__interaction
18821853-1612	Furthermore, the effect of <compound-id="445228">HBO</compound-id> on <protein-id="P89113,Q16832">DDR2</protein-id> has not been reported previously.	HBO__DDR2__interaction
18821853-1613	In the present study, we investigated the cellular and molecular mechanisms of <protein-id="P89113,Q16832">DDR2</protein-id> regulation by <compound-id="445228">HBO</compound-id> in VSMCs (vascular SMCs).	HBO__DDR2__interaction
18822097-1667	This <protein-id="P13807,P13834,Q8MJ26">GYS1</protein-id> point mutation appears to cause a gain-of-function of the enzyme and to result in the accumulation of a <compound-id="439177">glycogen</compound-id>-like, less-branched polysaccharide in skeletal muscle.	glycogen__GYS1__interaction
18822097-1668	The aim of this work was to test for possible associations between genetic polymorphisms in four candidate genes of the <compound-id="439177">glycogen</compound-id> pathway or the <protein-id="P13807,P13834,Q8MJ26">GYS1</protein-id> mutation in Cob Normand draught horses diagnosed with PSSM by muscle biopsy.	glycogen__GYS1__no_interaction
18822099-1671	The objective of this study was to examine the impact of polymorphisms in the acyl-CoA:diacylglycerol <protein-id="P05521,P19197,P21309,P23148,P41302,Q06878,Q7N576,Q9AJA7,Q9S3Z2">acyltransferase</protein-id> (<protein-id="O75907,Q8MK44,Q9GMF1">DGAT1</protein-id>), <protein-id="O02750,O93416,Q28603,Q95189,Q95234">leptin</protein-id> and <protein-id="O12980,O13188,O18938,O62754,O70615,O73848,O73849,O93566,P01241,P01244,P01245,P01246,P01248,P06880,P07064,P08591,P08998,P09113,P09537,P09539,P10298,P10607,P10766,P10813,P10814,P11228,P13391,P19795,P20391,P20392,P22077,P24363,P29971,P33092,P33093,P33711,P34005,P34006,P34744,P34745,P34746,P34747,P37885,P37886,P45643,P45654,P45655,P46404,P46407,P48248,P55755,P56437,P58343,P58756,P67930,P67931,P69158,P69159,P69160,P69161,P69162,P79885,P87391,Q01282,Q01283,Q05163,Q07221,Q1HFN3,Q659Q8,Q7YQB8,Q7YQD2,Q7YRR6,Q864S7,Q8HYE5,Q8MI73,Q98UF6,Q9DEV3,Q9DGG5,Q9GKA1,Q9GL60,Q9GMB2,Q9GMB3,Q9I9L5,Q9I9M4,Q9IB11,Q9IBE5,Q9JKM4,Q9PWG3,Q9W6J5,Q9W6J7,Q9W6R8">growth hormone</protein-id> receptor genes on body energy (body condition score, total body energy content and cumulative effective energy balance) and blood metabolic traits (levels of <compound-id="441">beta-hydroxybutyrate</compound-id>, <compound-id="206,5793,64689,79025">glucose</compound-id> and non-esterified fatty acids), measured once before the first calving and then repeatedly throughout first lactation in 497 Holstein cows.	beta-hydroxybutyrate__leptin__no_interaction	beta-hydroxybutyrate__DGAT1__no_interaction	glucose__growth hormone__no_interaction	glucose__leptin__no_interaction	beta-hydroxybutyrate__acyltransferase__no_interaction	glucose__DGAT1__no_interaction	glucose__acyltransferase__no_interaction	beta-hydroxybutyrate__growth hormone__no_interaction
18822105-1672	Pretransplant conditioning consisted of <compound-id="657237">fludarabine</compound-id>, l-<protein-id="O75592,P10731,P14925,P19021,P83388,P97467">PAM</protein-id> and TBI (2 Gy).	fludarabine__PAM__no_interaction
18822107-1673	Despite pre- and post-operative PP and immunosuppressive treatment consisting of steroids, <protein-id="P00083,P00090,P00091,P00094,P00096,P00149,P00154,P04164,P0AAE0,P0AAE1,P0C0X8,P0C189,P38091,P42426,P43302,P56205,Q2RVM4,Q3J164,Q45233,Q57142,Q5SME3,Q9RQB9">CycA</protein-id>, daclizumab, and <protein-id="P15513">MMF</protein-id>, daily protein excretion and serum <compound-id="588">creatinine</compound-id> increased.	creatinine__MMF__no_interaction	creatinine__CycA__no_interaction
18822278-1745	Inhibition of <protein-id="O14313,O22711,O30973,O32823,O43099,O66790,O69777,O83790,O84101,P0A9P4,P0A9P5,P0AE52,P0AE53,P0AE54,P0AE55,P14292,P14293,P21762,P26830,P30044,P34227,P39916,P40553,P43496,P43788,P44411,P44758,P46843,P47348,P49537,P50971,P51272,P51978,P52213,P52214,P52215,P55979,P56431,P56577,P56578,P56876,P57279,P57399,P61076,P65688,P65689,P66010,P66011,P73728,P75531,P80880,P80892,P81433,P94284,P99029,P99101,Q01116,Q05741,Q25861,Q53212,Q55624,Q5HHQ4,Q5HQW4,Q6BIS1,Q6C7L4,Q6FR39,Q6GB66,Q6GIM7,Q75CM8,Q7Z7S3,Q89AJ2,Q89AS1,Q8CPY8,Q8J0U0,Q8K9W0,Q8T6Z1,Q92375,Q928B5,Q92I02,Q98PK9,Q9BGI1,Q9GLW7,Q9GLW9,Q9KSS4,Q9M7T0,Q9PKT7,Q9PR71,Q9R063,Q9Z8M4,Q9ZD97,Q9ZHF0,Q9ZL18,Q9ZMU4">thioredoxin reductase</protein-id> by <compound-id="94304">mansonone F</compound-id> analogues: Implications for anticancer activity.	mansonone F__thioredoxin reductase__interaction
18822413-1812	<protein-id="P81182">High-density-lipoproteins</protein-id>-<compound-id="304,5997,6432564,11025495">cholesterol</compound-id> (HDL-C) is invertedly related to the incidence of cardiovascular events.	cholesterol__High-density-lipoproteins__interaction
18823071-2096	An isocratic fluorescence HPLC assay for the monitoring of <protein-id="O88202,P26900,P30363,P50286,Q9U518">l-asparaginase</protein-id> activity and l-<compound-id="236,6267,342043,439600">asparagine</compound-id> depletion in children receiving E. colil-asparaginase for the treatment of acute lymphoblastic leukaemia.	asparagine__l-asparaginase__no_interaction
18823430-2181	Effects of <protein-id="P33261">CYP2C19</protein-id> and <protein-id="P08183,P13568,P16875,P28873,P53258,Q06034,Q9LJX0,Q9ZR72">MDR1</protein-id> genotype on the eradication rate of Helicobacter pylori infection by triple therapy with pantoprazole, amoxycillin and <compound-id="54688,84029,4663848,5284534,5311050,6426662,11969952,13048687,44629879">clarithromycin</compound-id>.	clarithromycin__MDR1__interaction	clarithromycin__CYP2C19__interaction
18823436-2183	Anti-gastric cancer effects of <compound-id="2662">celecoxib</compound-id>, a selective COX-2 inhibitor, through inhibition of <protein-id="P31750,Q8INB9">Akt</protein-id> signaling.	celecoxib__Akt__interaction
18823687-2243	Effect of renin-angiotensin-<compound-id="5839">aldosterone</compound-id> system inhibition, dietary sodium restriction, and/or diuretics on urinary <protein-id="O54947">kidney injury molecule 1</protein-id> excretion in nondiabetic proteinuric kidney disease: a post hoc analysis of a randomized controlled trial.	aldosterone__kidney injury molecule 1__interaction
18823722-2255	Among the R-Nx strains, a substitution of <compound-id="750,5460845">Gly</compound-id> to Cys at position 81 (Gly81 Cys) of the <protein-id="O33149,O33926,O50628,O51396,O67108,O83051,O84192,P05653,P0AES4,P0AES5,P0C0Q9,P0C0R0,P14829,P20831,P21557,P22446,P34030,P35810,P35885,P37411,P41080,P41513,P43700,P47235,P47250,P47719,P48354,P48369,P48370,P48371,P48372,P50071,P57277,P72065,P72524,P94605,Q03470,Q07702,Q2FKQ0,Q2G2Q0,Q49166,Q49467,Q49608,Q55738,Q57532,Q5HJZ0,Q5HK04,Q5XC58,Q6GD84,Q6GKT9,Q89AS3,Q8DPM2,Q8K7H2,Q8K9W2,Q8NKW8,Q8P116,Q92IZ6,Q932M0,Q99XG5,Q9L7Q5,Q9PKK4,Q9PR63,Q9Z8R4,Q9ZLD9">gyrA</protein-id> gene in 10 strains isolated from wild birds and ovine foetuses, and of Asp to Tyr at position 87 (Asp87 Tyr) in one strain isolated from ewe faeces, were revealed by sequencing the gene.	Gly__gyrA__interaction
18823727-2261	Expansion of the first <compound-id="5950">polyalanine</compound-id> tract of the <protein-id="O42115,Q96QS3">ARX</protein-id> gene in a boy presenting with generalized dystonia in the absence of infantile spasms.	polyalanine__ARX__interaction
18823727-2262	Gene sequencing detected an additional seven GCG repeats in the first <compound-id="5950">polyalanine</compound-id> tract of the <protein-id="O42115,Q96QS3">ARX</protein-id> gene, a mutation which leads to an expansion of the normal 16 <compound-id="602,4580,5950,71080">alanine</compound-id> residues to 23.	alanine__ARX__interaction	polyalanine__ARX__interaction
18823739-2263	Vascular endothelial dysfunction (VED) results in reduced activation of endothelial <protein-id="O61309,O61608,Q27571,Q9I9M2">nitric oxide synthase</protein-id> (<protein-id="P29473,P29474,P70313,P79209,P97270,Q28969,Q62600">eNOS</protein-id>), reduced generation and bioavailability of <compound-id="145068">nitric oxide</compound-id> (NO) and increased production of reactive oxygen species (ROS).	nitric oxide__eNOS__no_interaction	nitric oxide__nitric oxide synthase__no_interaction
18823877-2298	Emerging evidence that both <protein-id="P25430,P25431,P25432,Q06225">brain-derived neurotrophic factor</protein-id> (<protein-id="O18752,O18753,O18755,O70183,O97759,P14082,P21237,P23363,P23560,P25429,P25430,P25431,P25432,Q02193,Q06225,Q3SAT7,Q4L0Y3,Q5IS78,Q6LCI5,Q7YRB4,Q90322,Q95106,Q9TST3">BDNF</protein-id>) and <compound-id="28486,3028194">lithium</compound-id> suppress FoxO activity suggests a potential role of FoxOs in regulating mood-relevant behavior.	lithium__brain-derived neurotrophic factor__no_interaction	lithium__BDNF__no_interaction
18823890-2301	We determined the plasma concentrations of <compound-id="1148,6305,9060,5460840">tryptophan</compound-id> (TRP), <compound-id="161166">KYN</compound-id>, <compound-id="89">3-hydroxykynurenine</compound-id> (3-HKYN); two distinct SOX markers: Cu/Zn <protein-id="O50258">superoxide dismutase</protein-id> (Cu/Zn <protein-id="O12933,O22668,O75007,P24705,P51547,P93258,Q01137,Q27666,Q9SM64">SOD</protein-id>) and total <compound-id="784">peroxide</compound-id> ; and high sensitivity C-reactive protein (hs <protein-id="O19062,P02741,P02742,P08462,P18151,P21291,P41964,P47875,P49254,P49262,P52753,P67966,P67967,P97315,Q07203">CRP</protein-id>) as a indicator of inflammation in 146 ESRD patients and healthy controls.	KYN__superoxide dismutase__no_interaction	tryptophan__SOD__no_interaction	tryptophan__superoxide dismutase__no_interaction	KYN__CRP__no_interaction	peroxide__CRP__no_interaction	3-hydroxykynurenine__SOD__no_interaction	KYN__SOD__no_interaction	3-hydroxykynurenine__superoxide dismutase__no_interaction	tryptophan__CRP__no_interaction	peroxide__superoxide dismutase__no_interaction	peroxide__SOD__no_interaction	3-hydroxykynurenine__CRP__no_interaction
18823890-2304	ESRD patients showed a significant increase in Cu/Zn <protein-id="O12933,O22668,O75007,P24705,P51547,P93258,Q01137,Q27666,Q9SM64">SOD</protein-id>, total <compound-id="784">peroxide</compound-id> and hs <protein-id="O19062,P02741,P02742,P08462,P18151,P21291,P41964,P47875,P49254,P49262,P52753,P67966,P67967,P97315,Q07203">CRP</protein-id> levels between controls and all patients group.	peroxide__SOD__no_interaction	peroxide__CRP__no_interaction
18823964-2330	Diabetes is characterized by elevated fasting blood <compound-id="206,5793,64689,79025">glucose</compound-id> (FBG) resulting from improper <protein-id="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7">insulin</protein-id> regulation and/or <protein-id="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7">insulin</protein-id> resistance.	glucose__insulin__interaction
18823964-2332	THII significantly diminished these changes in <compound-id="206,5793,64689,79025">glucose</compound-id> and <protein-id="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7">insulin</protein-id>.	glucose__insulin__no_interaction
18824011-260	Using HPLC techniques we evaluated the electrical field stimulation-evoked overflow of <compound-id="951,439260">noradrenaline</compound-id> (<compound-id="923,373840">NA</compound-id>), adenosine 5 '-triphosphate (ATP), and <compound-id="5893">beta-nicotinamide adenine dinucleotide</compound-id> (<compound-id="5893">beta-NAD</compound-id>) in the presence of low nanomolar concentrations of omega-<protein-id="P83301,P83390">conotoxin</protein-id> GVIA or <protein-id="P30288">omega-agatoxin IVA</protein-id> in the canine mesenteric arteries and veins.	beta-nicotinamide adenine dinucleotide__omega-agatoxin IVA__interaction	NA__conotoxin__interaction	beta-NAD__conotoxin__interaction	NA__omega-agatoxin IVA__interaction	beta-nicotinamide adenine dinucleotide__conotoxin__interaction	noradrenaline__conotoxin__interaction	noradrenaline__omega-agatoxin IVA__interaction	beta-NAD__omega-agatoxin IVA__interaction
18824106-2403	An extensive kinetic profile towards a plethora of purines and mutational analyses have established models on how <protein-id="Q07307">UapA</protein-id> recognizes the <compound-id="1044">purine ring</compound-id> and revealed specific amino acid residues involved in proper folding, topogenesis, function and specificity.	purine ring__UapA__interaction
18824106-2404	The present work describes for the first time the purification of the <protein-id="Q07307">UapA</protein-id> transporter of A. nidulans through overexpression via the strong, <compound-id="702">ethanol</compound-id>-inducible, <compound-id="206,5793,64689,79025">glucose</compound-id>-repressible, <protein-id="P08843,P65199,P65200,Q44740">alcA</protein-id> promoter.	ethanol__UapA__interaction	glucose__UapA__interaction	ethanol__alcA__interaction	glucose__alcA__interaction
18824121-2411	Three enzymes function in biosynthesis of <compound-id="8977">GDP</compound-id>-<compound-id="18950">mannose</compound-id> from the glycolytic intermediate <compound-id="69507">fructose 6-phosphate</compound-id> : <protein-id="O66954,P00946,P07874,P25081,P29951,P29952,P29954,P29956,P34650,P34948,P34949,P39841,P59785,Q3SZI0,Q44407,Q4JCA7,Q59935,Q66WM4,Q68FX1,Q75AB5,Q76IQ2,Q83KZ1,Q870Y1,Q887Q9,Q88ND5,Q8HXX2,Q8J093,Q8ZWV0,Q924M7,Q96YC2,Q978F3,Q97WE5,Q9GP38,Q9HFU4,Q9HIC2,Q9YE01">phosphomannose isomerase</protein-id> (<protein-id="O66954,P00946,P07874,P25081,P29951,P29952,P29954,P29956,P34650,P34948,P34949,P39841,P59785,Q3SZI0,Q44407,Q4JCA7,Q59935,Q66WM4,Q68FX1,Q75AB5,Q76IQ2,Q83KZ1,Q870Y1,Q887Q9,Q88ND5,Q8HXX2,Q8J093,Q8ZWV0,Q924M7,Q96YC2,Q978F3,Q97WE5,Q9GP38,Q9HFU4,Q9HIC2,Q9YE01">PMI</protein-id>), <protein-id="O43976,O85343,P07283,P24175,P26341,P26405,P29955,P31353,P37742,P37755,P45632,P47299,P47723,P55356,P75050,Q00330,Q01411,Q06951,Q48463,Q9UTJ2">phosphomannomutase</protein-id> (<protein-id="O43976,O80840,O85343,P07283,P18159,P24175,P26341,P26405,P29955,P31353,P37742,P37755,P45632,P47299,P47723,P55356,P75050,Q00330,Q01411,Q06951,Q48463,Q57290,Q57842,Q9UTJ2,Q9VTZ6,Q9XUE6">PMM</protein-id>) and <protein-id="O74484,O74624,O85342,O93827,P07874,P24174,P26340,P26404,P29956,P37741,P37753,P37820,P41940,P55357,P59785,Q00473,Q01410,Q07024,Q2UJU5,Q48462,Q4I1Y5,Q4U3E8,Q5B1J4,Q5KKH2,Q6BN12,Q6CCU3,Q70SJ2,Q752H4,Q7RVR8,Q887Q9,Q88ND5,Q9P8N0">GDP-mannose pyrophosphorylase</protein-id> (GMPP).	GDP__PMI__interaction	fructose 6-phosphate__GDP-mannose pyrophosphorylase__interaction	GDP__PMM__interaction	fructose 6-phosphate__phosphomannomutase__interaction	fructose 6-phosphate__phosphomannose isomerase__interaction	mannose__phosphomannose isomerase__interaction	mannose__PMM__interaction	mannose__GDP-mannose pyrophosphorylase__interaction	GDP__phosphomannomutase__interaction	GDP__phosphomannose isomerase__interaction	fructose 6-phosphate__PMI__interaction	fructose 6-phosphate__PMM__interaction	mannose__PMI__interaction	mannose__phosphomannomutase__interaction	GDP__GDP-mannose pyrophosphorylase__interaction
18824121-2412	Synthesis of <compound-id="8977">GDP</compound-id>-<compound-id="18950">mannose</compound-id> from exogenous <compound-id="18950">mannose</compound-id> requires <protein-id="P33284,P50506,P80581,Q02155,Q26609,Q969A8">hexokinase</protein-id> or phosphotransferase enzymes together with <protein-id="O43976,O80840,O85343,P07283,P18159,P24175,P26341,P26405,P29955,P31353,P37742,P37755,P45632,P47299,P47723,P55356,P75050,Q00330,Q01411,Q06951,Q48463,Q57290,Q57842,Q9UTJ2,Q9VTZ6,Q9XUE6">PMM</protein-id> and GMPP.	GDP__PMM__interaction	mannose__hexokinase__interaction	GDP__hexokinase__interaction	mannose__PMM__interaction
18824341-1648	Preincubation of airway epithelial cells with <compound-id="446925">lycopene</compound-id> (dissolved in <compound-id="8028">tetrahydrofuran</compound-id>) delivered <compound-id="446925">lycopene</compound-id> into the cells and resulted in a 24% reduction in <protein-id="P41693">interleukin-6</protein-id> after rhinovirus-1B infection, 31% reduction in <protein-id="P02778,P17515,P48973">IP-10</protein-id> after rhinovirus-43 infection and 85% reduction in rhinovirus-1B replication.	lycopene__IP-10__interaction	tetrahydrofuran__IP-10__interaction	lycopene__interleukin-6__interaction	tetrahydrofuran__interleukin-6__interaction
18824415-2564	<protein-id="P84122">Thrombin</protein-id>, vascular endothelial growth factor, and <compound-id="784">hydrogen peroxide</compound-id> increased EC permeability, disrupted cell junctions, and induced stress fiber formation.	hydrogen peroxide__Thrombin__interaction
18824476-2583	Clarified glycomic and protemic information combined with publicly available microarray data sets allowed us to identify <protein-id="P08699,P16110,P17931,P38486,P47845,P47953">galectin-3</protein-id> as a receptor of <compound-id="16219440">Galalpha1-3Gal</compound-id> epitope.	Galalpha1-3Gal__galectin-3__interaction
18824496-2592	Spinal and bulbar muscular atrophy (SBMA) is a motor neuron disease caused by <compound-id="5961">polyglutamine</compound-id> expansion mutation in the <protein-id="O97775,O97776,O97952,O97960,P10275,P15207,P19091,P49699,Q6QT55,Q7T1K4,Q8MIK0,Q9GKL7,Q9TT90">androgen receptor</protein-id> (AR).	polyglutamine__androgen receptor__interaction
18824518-2598	Also, our previous studies implicated the SphK1/<protein-id="Q14703,Q9Z2A8">S1P</protein-id> pathway in the induction of the <compound-id="444899">arachidonic acid</compound-id> cascade, a major inflammatory pathway involved in colon carcinogenesis.	arachidonic acid__S1P__interaction
18824518-2599	In the <compound-id="33184">azoxymethane</compound-id> (<compound-id="33184">AOM</compound-id>) murine model of colon cancer, SphK1 and <protein-id="Q14703,Q9Z2A8">S1P</protein-id> were significantly elevated in colon cancer tissues compared to normal mucosa.	AOM__S1P__interaction	azoxymethane__S1P__interaction
18824524-2604	Uptake of <compound-id="60846">valsartan</compound-id>, <compound-id="3961">losartan</compound-id>, and <compound-id="47965">cefadroxil</compound-id> was quantified in HeLa cells after heterologous expression of human <protein-id="P36836,P46059,Q8WMX5">PEPT1</protein-id> (hPEPT1).	valsartan__PEPT1__interaction	losartan__PEPT1__interaction	cefadroxil__PEPT1__interaction
18824524-2605	In contrast to <compound-id="47965">cefadroxil</compound-id>, no <protein-id="P36836,P46059,Q8WMX5">PEPT1</protein-id>-specific uptake of <compound-id="60846">valsartan</compound-id> and <compound-id="3961">losartan</compound-id> was found.	valsartan__PEPT1__no_interaction	losartan__PEPT1__no_interaction	cefadroxil__PEPT1__interaction
18824527-2607	The 2-(acylamino)-3-thiophenecarboxylates suppressed <protein-id="P13569,P26361,P26362,P26363,P34158,P35071,Q00552,Q00553,Q00554,Q00555,Q07DV2,Q07DW5,Q07DX5,Q07DY5,Q07DZ6,Q07E16,Q07E42,Q09YH0,Q09YJ4,Q09YK5,Q108U0,Q2IBA1,Q2IBB3,Q2IBE4,Q2IBF6,Q2QL74,Q2QL83,Q2QLA3,Q2QLB4,Q2QLC5,Q2QLE5,Q2QLF9,Q2QLH0,Q5D1Z7,Q5U820,Q6PQZ2,Q7JII7,Q7JII8,Q9TSP5,Q9TUQ2">CFTR</protein-id>-mediated <compound-id="312">Cl</compound-id> (-) current in T84 colonic cells in response to cholera and Escherichia coli (STa) toxins, and prevented intestinal fluid accumulation in a closed-loop mouse model of secretory diarrhea.	Cl__CFTR__interaction
18824596-2638	We investigated the hypothesis that modulation of EPC biology and attenuation of allograft vasculopathy by increased <protein-id="P81182">high-density lipoprotein</protein-id> <compound-id="304,5997,6432564,11025495">cholesterol</compound-id> after human apo A-I (AdA-I) transfer requires scavenger receptor (SR)-BI expression in bone marrow-derived EPCs.	cholesterol__high-density lipoprotein__interaction
18824635-2654	<protein-id="P15304,P16386,P54310,Q05469,Q68J42,Q9R101">Hormone-sensitive lipase</protein-id> (<protein-id="P15304,P16386,P54310,Q05469,Q68J42,Q9R101">HSL</protein-id>) is a key regulator of <compound-id="304,5997,6432564,11025495">cholesterol</compound-id> esters metabolism.	cholesterol__HSL__interaction	cholesterol__Hormone-sensitive lipase__interaction
18825162-2817	We found associations between the <compound-id="4192">midazolam</compound-id> phenotype and age, diagnosis of hypertension and one htSNP (141689) located upstream of <protein-id="P08684">CYP3A4</protein-id>.	midazolam__CYP3A4__no_interaction
18825163-2818	<protein-id="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7">Insulin</protein-id> and free <compound-id="5757">oestradiol</compound-id> are independent risk factors for benign prostatic hyperplasia.	oestradiol__Insulin__no_interaction
18825163-2819	The objective of the present study was to test the <protein-id="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7">insulin</protein-id>, <compound-id="5757">oestradiol</compound-id> and metabolic syndrome hypotheses as promoters of BPH.	oestradiol__insulin__no_interaction
18825163-2820	Using a multivariate analysis, BPH as measured by the total prostate gland volume correlated statistically significantly with fasting serum <protein-id="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7">insulin</protein-id> (beta=0.200, P=0.028), free <compound-id="5757">oestradiol</compound-id> (beta=0.233, P=0.008) and lean body mass (beta=0.257, P=0.034).	oestradiol__insulin__no_interaction
18825163-2821	<protein-id="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7">Insulin</protein-id> and free <compound-id="5757">oestradiol</compound-id> appear to be independent risk factors for BPH, confirming both the <protein-id="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7">insulin</protein-id> and the <compound-id="5757">oestradiol</compound-id> hypotheses.	oestradiol__Insulin__no_interaction	oestradiol__insulin__no_interaction
18825302-18	<compound-id="65981">Repaglinide</compound-id> plus single-dose <protein-id="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7">insulin</protein-id> glargine: a safe regimen for low-risk type 2 diabetic patients who insist on fasting in Ramadan.	Repaglinide__insulin__no_interaction
18825335-25	Much interest has been directed to the study of the <protein-id="Q697L1,Q8NER1">TRPV1</protein-id>, because <compound-id="1548943">capsaicin</compound-id> has been instrumental in discovering the unique role of a subset of primary sensory neurons in causing nociceptive responses, in activating reflex pathways including cough, and in producing neurogenic inflammation.	capsaicin__TRPV1__no_interaction
18825368-41	To evaluate <compound-id="8230,644077,44285245">arginine vasopressin</compound-id> (AVP) and <protein-id="P01180,P01181,P01183,P01185,P01186,P10769,P35455">copeptin</protein-id> plasma concentrations in patients with vasodilatory shock after cardiac surgery.	arginine vasopressin__copeptin__no_interaction
18825380-47	In this study, we report a novel <protein-id="P13224,P56400,Q04785">GPIbbeta</protein-id> defect in a Tunisian family, in which <compound-id="5951">Serine</compound-id> 23 is substituted by a Stop codon causing a premature termination of translation.	Serine__GPIbbeta__interaction
18825527-114	Eight newly synthesized carbacylamidophosphates with the general formula RC(O) <compound-id="1702">NHP</compound-id> (O) Cl2 with R = pCl-C6H4 1a, <compound-id="11852">pBr</compound-id>-C6H4 2a, C6H5 3a, and <compound-id="134601">pMe</compound-id>-C6H4 4a and RC(O) <compound-id="1702">NHP</compound-id> (O)(NC4H8O)2 R = pCl-C6H4 1b, <compound-id="11852">pBr</compound-id>-C6H4 2b, C6H5 3b, <compound-id="134601">pMe</compound-id>-C6H4 4b, were selected to compare the inhibition kinetic parameters, IC50, Ki, kp and KD, on human erythrocyte <protein-id="Q867X2,Q867X3,Q86GC9,Q92081">acetylcholinesterase</protein-id> (hAChE) and bovine serum butyrylcholinesterase (BuChE), Also, the in vivo inhibition potency of <compound-id="398803">compound 2a</compound-id>, 2b and 3a, were studied.	compound 2a__acetylcholinesterase__no_interaction	NHP__acetylcholinesterase__no_interaction	pBr__acetylcholinesterase__no_interaction	pMe__acetylcholinesterase__no_interaction
18825528-117	The presented study is aimed at reactivation of <compound-id="5853">trichlorfon</compound-id>-inhibited butyrylcholinesterase since this enzyme play an important role in Alzheimer's disease as deputy for <protein-id="Q867X2,Q867X3,Q86GC9,Q92081">acetylcholinesterase</protein-id> and furthermore it could be applied as a scavenger in case of overdosing.	trichlorfon__acetylcholinesterase__no_interaction
18825531-118	Among them, <compound-id="5858639">compound 3</compound-id> and 5 had significant <protein-id="P27730">calpain</protein-id> inhibitory activities.	compound 3__calpain__interaction
18825537-122	Here we report the docking study of four <compound-id="4630">green tea</compound-id> catechins and four alkylating anticancer drugs into the <protein-id="P80031">GST P1-1</protein-id> model, as <protein-id="P20432,P30104,P30106,P30107,P30108,Q04522,Q0ZS46,Q7REH6,Q8ILQ7,Q8MU52">GSTs</protein-id> were found to be affected by tea catechins.	green tea__GST P1-1__interaction	green tea__GSTs__interaction
18825553-139	The protein glycation inhibitory activity of ethanolic extract of Lawsonia inermis (henna) plant tissues was evaluated in vitro using the model system of bovine <protein-id="P21847,P83517">serum albumin</protein-id> and <compound-id="206,5793,64689,79025">glucose</compound-id>.	glucose__serum albumin__no_interaction
18825555-141	In vitro effects of <compound-id="104806">peroxynitrite</compound-id> treatment on fish liver <protein-id="O24339,O52762,O62839,O68146,O77229,O93662,O97492,P00432,P04040,P04762,P07145,P0A323,P0A324,P0A325,P0A326,P0A327,P11934,P17336,P24168,P24270,P25890,P29422,P30265,P30266,P32290,P42321,P44390,P45737,P45739,P55304,P55306,P55310,P55311,P55313,P77872,P81138,P90682,Q27710,Q49XC1,Q4L643,Q59296,Q59337,Q59602,Q59714,Q5HG86,Q5HPK8,Q5RF10,Q64405,Q6G9M4,Q6GH72,Q7A5T2,Q8CPD0,Q8FWU0,Q8NWV5,Q8X1P0,Q8Y3P9,Q926X0,Q99UE2,Q9AXH0,Q9KW19,Q9L4S1,Q9M5L6,Q9PT92,Q9PWF7,Q9Z598,Q9ZKX5,Q9ZN99">catalase</protein-id> activity.	peroxynitrite__catalase__interaction
18825555-142	The effect of <compound-id="104806">peroxynitrite</compound-id> (PN), a highly toxic agent, on <protein-id="O24339,O52762,O62839,O68146,O77229,O93662,O97492,P00432,P04040,P04762,P07145,P0A323,P0A324,P0A325,P0A326,P0A327,P11934,P17336,P24168,P24270,P25890,P29422,P30265,P30266,P32290,P42321,P44390,P45737,P45739,P55304,P55306,P55310,P55311,P55313,P77872,P81138,P90682,Q27710,Q49XC1,Q4L643,Q59296,Q59337,Q59602,Q59714,Q5HG86,Q5HPK8,Q5RF10,Q64405,Q6G9M4,Q6GH72,Q7A5T2,Q8CPD0,Q8FWU0,Q8NWV5,Q8X1P0,Q8Y3P9,Q926X0,Q99UE2,Q9AXH0,Q9KW19,Q9L4S1,Q9M5L6,Q9PT92,Q9PWF7,Q9Z598,Q9ZKX5,Q9ZN99">catalase</protein-id> (<protein-id="O62839,O97492,P00432,P00485,P00486,P00487,P04040,P06135,P07641,P11504,P20074,P22782,P25309,P25819,P26825,P26826,P32796,P36882,P36883,P43155,P47934,P49417,P52826,P58777,P62577,P62578,P62579,P62580,P90682,Q00614,Q02736,Q03058,Q5RF10,Q64405,Q704S8,Q9M5L6,Q9PWF7">CAT</protein-id>) activity in fish liver microsomal homogenates was determined.	peroxynitrite__catalase__interaction	peroxynitrite__CAT__interaction
18825778-209	NMR-derived <compound-id="6037">folate</compound-id>-bound structure of <protein-id="Q5V3R2">dihydrofolate reductase 1</protein-id> from the halophile Haloferax volcanii.	folate__dihydrofolate reductase 1__interaction
18826375-301	<compound-id="773,6274">Histidine</compound-id>-regulated activity of <protein-id="O00602,O70165,Q9WTS8">M-ficolin</protein-id>.	Histidine__M-ficolin__interaction
18826375-305	The biological roles of the <compound-id="773,6274">histidine</compound-id>-regulated conformational equilibrium of <protein-id="O00602,O70165,Q9WTS8">M-ficolin</protein-id> are discussed in terms of the self and non-self discrimination mechanism.	histidine__M-ficolin__interaction
18826425-314	The Iowa Gambling Task (IGT) was used to examine (i) social decision-making in women with borderline personality disorder (BPD), and (ii) the relationship between impaired decision-making and the tryptophan hydroxylase-1 (<protein-id="P90697">TPH-1</protein-id>) gene, involved in <compound-id="5202">serotonin</compound-id> synthesis.	serotonin__TPH-1__interaction
18826485-2656	These results underscore the differential regulation of <protein-id="O77834,P83564,Q00277">GPX</protein-id> expression in response to cadmium, <compound-id="5359268">aluminium</compound-id> and <compound-id="145068">nitric oxide</compound-id>, and strongly support a role for <protein-id="O48646,P59796,Q96SL4">GPX6</protein-id> and possibly other <protein-id="O77834,P83564,Q00277">GPX</protein-id> genes in stress and/or metabolic signalling.	nitric oxide__GPX6__interaction	aluminium__GPX__interaction	aluminium__GPX6__interaction	nitric oxide__GPX__interaction
18827283-620	Effects of acceptor composition and mechanism of <protein-id="P45844">ABCG1</protein-id>-mediated cellular free <compound-id="304,5997,6432564,11025495">cholesterol</compound-id> efflux.	cholesterol__ABCG1__interaction
18827283-621	Among the known mechanisms of reverse cholesterol transport (RCT), ATP binding cassette transporter G1 (<protein-id="P45844">ABCG1</protein-id>)-mediated free <compound-id="304,5997,6432564,11025495">cholesterol</compound-id> (FC) transport is the most recent and least studied.	cholesterol__ABCG1__interaction
18827283-622	Here, we have characterized the efficiencies of different acceptors using baby hamster kidney (BHK) cells transfected with human <protein-id="P45844">ABCG1</protein-id> cDNA, which is inducible upon treatment with <compound-id="55245">mifepristone</compound-id>.	mifepristone__ABCG1__interaction
18827741-766	<compound-id="3961">Losartan</compound-id> treatment significantly attenuated <protein-id="O35734,O77510,O77764,P01375,P04924,P06804,P13296,P16599,P19101,P23383,P23563,P29553,P33620,P36939,P48094,P51435,P51742,P51743,P59684,P59693,P59694,P59695,P79337,P79374,Q06599,Q19LH4,Q1G1A2,Q1WM27,Q2MH05,Q539C2,Q75N23,Q8HZD9,Q8JFG3,Q8MKG8,Q8WNR1,Q9BEA1">TNF-alpha</protein-id>, <protein-id="O35736,P05231,P08505,P20607,P26892,P26893,P29455,P41323,P41683,P41693,P46650,P51494,P79341,Q25BC2,Q28319,Q28747,Q28819,Q2MH06,Q5I6E3,Q6V919,Q865W7,Q865X6,Q8MKH0,Q95181,Q9MZR1,Q9XT80">IL-6</protein-id>, and <protein-id="P01584,P09428,P10749,P14628,P21621,P26889,P41687,P46648,P48090,P51493,P51745,P79162,P79182,Q28292,Q28386,Q2HZH0,Q2MH07,Q63264,Q6PUD2,Q6R2X3,Q865X8,Q8WNR2,Q9WVG1,Q9XS77">IL-1beta</protein-id> 6 h after CLP.	Losartan__IL-1beta__interaction	Losartan__IL-6__interaction	Losartan__TNF-alpha__interaction
18827742-767	<protein-id="P15160,P17724,P73925,Q03459">Hemoglobin</protein-id> vesicles and red blood cells as carriers of <compound-id="281">carbon monoxide</compound-id> prior to <compound-id="977">oxygen</compound-id> for resuscitation after hemorrhagic shock in a rat model.	carbon monoxide__Hemoglobin__interaction	oxygen__Hemoglobin__interaction
18827746-775	Reduced responses of <protein-id="P01189,P01190,P01191,P01192,P01193,P01194,P01196,P01197,P01201,P06297,P06298,P06299,P10000,P11280,P11885,P19402,P21252,P22923,P41589,P61280,P61281,P68000,P68001,P87352,Q91082,Q9YGK2,Q9YGK4,Q9YGK5">alpha-MSH</protein-id> or <protein-id="O26279,O30024,O59193,P0C0K9,Q01631,Q08597,Q47005,Q4J6D8,Q57728,Q5JGB7,Q5V5C9,Q6L1N3,Q6M0I0,Q8PVF0,Q8TSA1,Q8TWS7,Q8U0P1,Q96YI2,Q97CI3,Q9HI94,Q9HS36,Q9V0Z2,Q9YFQ1">Nac</protein-id>-beta-END IRM to <protein-id="P01142,P06296,P06850,P49926,Q95MI6,Q9PTS1">CRH</protein-id> and the invalid suppression by <compound-id="5743">dexamethasone</compound-id> reflect a state of dysfunction of the melanotroph-type <protein-id="P01189,P01190,P01191,P01192,P01193,P01194,P01196,P01201,P06297,P10000,P11280,P11885,P19402,P21252,P22923,P68000,P68001,P87352,Q91082,Q9YGK2">POMC</protein-id> system in nonsurvivors.	dexamethasone__Nac__no_interaction	dexamethasone__POMC__no_interaction	dexamethasone__CRH__no_interaction	dexamethasone__alpha-MSH__no_interaction
18827747-776	Systemic, hepatosplanchnic, and renal hemodynamics; <compound-id="977">oxygen</compound-id> exchange; energy metabolism (<compound-id="612">lactate</compound-id>/<compound-id="1060">pyruvate</compound-id> and ketone body ratios); ileal mucosal and renal cortex microcirculation; systemic inflammation (<protein-id="O35734,O77510,O77764,P01375,P04924,P06804,P13296,P16599,P19101,P23383,P23563,P29553,P33620,P36939,P48094,P51435,P51742,P51743,P59684,P59693,P59694,P59695,P79337,P79374,Q06599,Q19LH4,Q1G1A2,Q1WM27,Q2MH05,Q539C2,Q75N23,Q8HZD9,Q8JFG3,Q8MKG8,Q8WNR1,Q9BEA1">TNF-alpha</protein-id>, <protein-id="O35736,P05231,P08505,P20607,P26892,P26893,P29455,P41323,P41683,P41693,P46650,P51494,P79341,Q25BC2,Q28319,Q28747,Q28819,Q2MH06,Q5I6E3,Q6V919,Q865W7,Q865X6,Q8MKH0,Q95181,Q9MZR1,Q9XT80">IL-6</protein-id>); nitrosative/oxidative stress (<compound-id="2723628">thiobarbituric acid</compound-id> reactive species, nitrates+ nitrites); and endothelial/coagulation dysfunction (<compound-id="123831">asymmetric dimethylarginine</compound-id>, <protein-id="Q62935">von Willebrand factor</protein-id>, <protein-id="P84122">thrombin</protein-id>-antithrombin complexes, platelet count) were assessed before and 12, 18, and 22 h of peritonitis.	thiobarbituric acid__TNF-alpha__no_interaction	oxygen__von Willebrand factor__no_interaction	thiobarbituric acid__IL-6__no_interaction	pyruvate__IL-6__no_interaction	lactate__von Willebrand factor__no_interaction	pyruvate__thrombin__no_interaction	pyruvate__von Willebrand factor__no_interaction	oxygen__IL-6__no_interaction	thiobarbituric acid__thrombin__no_interaction	oxygen__TNF-alpha__no_interaction	asymmetric dimethylarginine__thrombin__no_interaction	lactate__thrombin__no_interaction	lactate__TNF-alpha__no_interaction	asymmetric dimethylarginine__von Willebrand factor__no_interaction	asymmetric dimethylarginine__TNF-alpha__no_interaction	thiobarbituric acid__von Willebrand factor__no_interaction	asymmetric dimethylarginine__IL-6__no_interaction	lactate__IL-6__no_interaction	pyruvate__TNF-alpha__no_interaction	oxygen__thrombin__no_interaction
18827975-862	The purpose of this retrospective study was to compare the effects of <protein-id="P01050">lepirudin</protein-id> and <compound-id="2232,92722,152951,440542,445156">argatroban</compound-id> in the management of HIT.	argatroban__lepirudin__no_interaction
18828007-864	The outer membrane <protein-id="P02930,Q54001,Q9K2Y1">TolC</protein-id> is involved in <compound-id="594,5862,5360637">cysteine</compound-id> tolerance and overproduction in Escherichia coli.	cysteine__TolC__interaction
18828007-866	Gene expression analysis revealed that the <protein-id="P02930,Q54001,Q9K2Y1">tolC</protein-id> gene encoding the outer membrane channel is essential for <compound-id="581,5862,5460838">L-cysteine</compound-id> tolerance in E. coli cells.	L-cysteine__tolC__interaction
18828019-168	The present study was performed to elucidate the relationship between the expression of <protein-id="P08183,P21448">ABCB1</protein-id>/<protein-id="P08183,P13568,P16875,P28873,P53258,Q06034,Q9LJX0,Q9ZR72">MDR1</protein-id> and <protein-id="P33527,Q5F364">ABCC1</protein-id>/<protein-id="P10662,P20585,P33527,Q5F364,Q6UR05,Q864R9,Q8HXQ5,Q9C8G9">MRP1</protein-id> with resistance to either <compound-id="108150,44584244">ET-743</compound-id> or PM00104.	ET-743__MRP1__interaction	ET-743__ABCC1__interaction	ET-743__ABCB1__interaction	ET-743__MDR1__interaction
18828793-1124	The previous <compound-id="5280965">amphotericin B</compound-id>, <protein-id="P35834,Q28746">granulocyte colony-stimulating factor</protein-id>, hyperbaric <compound-id="977">oxygen</compound-id> and nasal and left maxillary sinus surgical debridement therapy was ineffective in stopping the progression of the infection to the brain.	oxygen__granulocyte colony-stimulating factor__no_interaction	amphotericin B__granulocyte colony-stimulating factor__no_interaction
18829006-1222	<protein-id="O04437,O18598,P0A9D2,P0A9D3,P30116,P44521,P46088,P46419,P46423,P46426,P46428,P46437,P48438,P80894,P81065,P82996,P82997,P82998,P82999,P83000,P83001,P83246,Q04522,Q08392,Q08393,Q0ZS46,Q7REH6,Q8ILQ7,Q8MU52,Q96324">Glutathione S-transferase</protein-id> (<protein-id="P09488,P16413,Q9N0V4,Q9TSM5">GSTM1</protein-id>) plays an important role in the excretion of <compound-id="289,9064,73160">catechol</compound-id> estrogens and is therefore a candidate marker for fibroids.	catechol__GSTM1__interaction	catechol__Glutathione S-transferase__interaction
18829132-1261	Bacterial strains differed in their ability to synthesize <compound-id="802">auxin</compound-id> and <compound-id="768">hydrogen cyanide</compound-id> compounds, as well as in their <protein-id="O57809,P30297,Q00740,Q51813,Q5KMX3,Q5PWZ8,Q62CE3,Q63KN7,Q6J256,Q7M523,Q87YW7,Q89XR6,Q8U4R3,Q8XS35,Q93AG0,Q98AM7,Q9AHF0,Q9URX3,Q9V2L2,Q9WY68,Q9ZHW3">ACC deaminase</protein-id> activity.	auxin__ACC deaminase__no_interaction	hydrogen cyanide__ACC deaminase__no_interaction
18829266-1329	Toll-like receptor (<protein-id="P23799">TLR</protein-id>) 4 is a critical receptor and signal transducer for <compound-id="11970143">lipopolysaccharide</compound-id> (LPS), a major component of Gram-negative bacteria.	lipopolysaccharide__TLR__interaction
18829281-1345	Postprandial <compound-id="206,5793,64689,79025">glucose</compound-id> and <protein-id="O19062,P02741,P02742,P08462,P18151,P21291,P41964,P47875,P49254,P49262,P52753,P67966,P67967,P97315,Q07203">CRP</protein-id>.05) in HTAG.	glucose__CRP__no_interaction
18829286-1353	Colonization of germ-free (GF) mice has been shown to induce the gastrointestinal form of the <compound-id="6326970">selenium</compound-id>-dependent <protein-id="O32770,O59858,Q00277,Q9CFV1">glutathione peroxidases</protein-id>, <protein-id="P18283,P83645,Q4AEH7,Q4AEH8,Q4AEH9,Q4AEI0,Q9JHC0">GPx2</protein-id>.	selenium__GPx2__interaction	selenium__glutathione peroxidases__interaction
18829287-2771	The purpose of this study was to investigate whether or not the role of <compound-id="445580">docosahexaenoic acid</compound-id> (DHA) supplementation on cognitive capability was related with <protein-id="P25430,P25431,P25432,Q06225">brain-derived neurotrophic factor</protein-id> (<protein-id="O18752,O18753,O18755,O70183,O97759,P14082,P21237,P23363,P23560,P25429,P25430,P25431,P25432,Q02193,Q06225,Q3SAT7,Q4L0Y3,Q5IS78,Q6LCI5,Q7YRB4,Q90322,Q95106,Q9TST3">BDNF</protein-id>), <compound-id="145068">nitric oxide</compound-id> (NO) and <compound-id="681">dopamine</compound-id> (DA) in aged mice.	nitric oxide__BDNF__no_interaction	dopamine__brain-derived neurotrophic factor__no_interaction	docosahexaenoic acid__BDNF__interaction	nitric oxide__brain-derived neurotrophic factor__no_interaction	docosahexaenoic acid__brain-derived neurotrophic factor__interaction	dopamine__BDNF__no_interaction
18829372-151	Model analysis of local <compound-id="977">oxygen</compound-id> delivery with liposome-encapsulated <protein-id="P15160,P17724,P73925,Q03459">hemoglobin</protein-id>.	oxygen__hemoglobin__interaction
18829372-152	Liposome-encapsulated <protein-id="P15160,P17724,P73925,Q03459">hemoglobins</protein-id> (LHs) are comparable to red blood cells (RBCs) in terms of <compound-id="977">oxygen</compound-id> (O(2))-carrying capacity.	oxygen__hemoglobins__interaction
18829677-1475	Moreover, both lung and plasma concentrations of the pro-inflammatory cytokines tumour necrosis factor-alpha and <protein-id="Q9TTB0">interferon-gamma</protein-id> were higher in <compound-id="942,89594,157672">nicotine</compound-id>-treated animals at this time-point.	nicotine__interferon-gamma__interaction
18829704-1495	The role of <compound-id="26623">Hg(2</compound-id>+)-insensitive <protein-id="O14520">AQP7</protein-id>, if any, in sperm volume regulation was studied in transgenic mice.	Hg(2__AQP7__no_interaction
18829704-1496	Therefore, the <compound-id="26623">Hg(2</compound-id>+)-sensitive <protein-id="O94778,Q5I4F8">AQP8</protein-id>, which was localized in elongated spermatids and spermatozoa, is a likely candidate for a water channel responsible for physiological sperm volume regulation crucial to in vivo fertilization.	Hg(2__AQP8__interaction
18829979-1580	Increased intrahepatic vascular tone in cirrhosis has been attributed to a decrease of hepatic <compound-id="145068">nitric oxide</compound-id> (NO) secondary to disturbances in the post-translational regulation of the enzyme <protein-id="P29473,P29474,P70313,P79209,P97270,Q28969,Q62600">eNOS</protein-id>.	nitric oxide__eNOS__no_interaction
18830228-1650	<protein-id="O27580,O28041,O58582,O60105,O66856,P0AB89,P0AB90,P12047,P21265,P30566,P44797,P52201,P54822,P56468,P57351,P72478,P74384,Q05911,Q21774,Q2FFI7,Q2G2S0,Q2YU66,Q49YV3,Q4L7M3,Q58339,Q5HEL4,Q5HN26,Q60Q90,Q6G825,Q6GFE9,Q7A0G9,Q7A4Q3,Q89AM3,Q8CRT6,Q8HXY5,Q8K9Q7,Q99SX9,Q9RSE6,Q9UZ99,Q9X0I0,Q9ZKA2">Adenylosuccinate lyase</protein-id> deficiency is a rare autosomal disorder of de novo <compound-id="1044">purine</compound-id> synthesis, which results in the accumulation of succinylpurines in body fluids.	purine__Adenylosuccinate lyase__interaction
18830228-1651	Both patients had an increased <compound-id="165243,20849086">succinyladenosine</compound-id>/SAICAr ratio of 1.6, and exhibited a novel homozygous missense mutation (c.674T&gt;C; p.Met225Thr) in the exon 6 of the <protein-id="P21265,P30566,Q8HXY5">ADSL</protein-id> gene.	succinyladenosine__ADSL__interaction
18830381-1696	The profile of global DNA and <protein-id="O42132,P03372,P06211,P06212,P16058,P19785,P49884,P49885,P49886,P50240,P50241,P50242,P57717,P57753,P81559,Q29040,Q53AD2,Q91250,Q91424,Q9PVZ9,Q9QZJ5,Q9TV98,Q9YH33,Q9YHT3,Q9YHZ7">estrogen receptor</protein-id> (ER)-alpha gene methylation during cancer development was determined by analysis of <compound-id="65040">5-methylcytosine</compound-id> (5-<compound-id="448166">MeC</compound-id>) using immunohistochemical (IHC) staining, dot blot analysis or a quantitative gene methylation assay (QGMA).	5-methylcytosine__estrogen receptor__interaction	MeC__estrogen receptor__interaction
18830594-1807	Zebularine suppresses the apoptotic potential of <compound-id="3385">5-fluorouracil</compound-id> via <compound-id="6076">cAMP</compound-id>/PKA/<protein-id="P15337,P16220,P27925,P51984,P51985,Q01147">CREB</protein-id> pathway against human oral squamous cell carcinoma cells.	5-fluorouracil__CREB__no_interaction	cAMP__CREB__no_interaction
18830620-1813	Complex modulation of L-type <compound-id="271">Ca(2</compound-id>+) current inactivation by <protein-id="P05044,P30626,Q5R4U9,Q6P069,Q94743">sorcin</protein-id> in isolated rabbit cardiomyocytes.	Ca(2__sorcin__interaction
18830680-1821	Donor testicular cells were prepared from heterozygous chicken <protein-id="O18840,O42161,O93400,P15475,P29751,P48975,P60706,P60707,P60708,P60709,P60710,P60711,P60712,P60713,P68143,P79818,P83750,P83751,P84336,P84856,Q0PGG4,Q4L0Y2,Q5R1X3,Q711N9,Q71FK5,Q76N69,Q91ZK5,Q9Y702">beta actin</protein-id> (<protein-id="Q00398">CAG</protein-id>)/enhanced <protein-id="P42212">green fluorescent protein</protein-id> (EGFP)-transgenic rats (EGFP Tg rats) during the second week after birth and injected into the seminiferous tubules of the MT-myc Tg rats (line-A and-B; both subfertile) or rats pretreated with <compound-id="2478">busulfan</compound-id> to remove endogenous spermatogonia.	busulfan__green fluorescent protein__no_interaction	busulfan__CAG__no_interaction	busulfan__beta actin__no_interaction
18830721-1832	Models of noncoupled dinuclear <compound-id="23978">copper</compound-id> centers in <protein-id="P00279,P00281,P00283,P00284,P00285,P00286,P34097,P80546">azurin</protein-id>.	copper__azurin__interaction
18830721-1833	Toward this goal, models of the noncoupled <compound-id="23978">copper</compound-id> centers found in the enzymes peptidyl alpha-hydroxylating monooxygenase (<protein-id="P10731,P14925,P19021,P83388,P97467,Q95XM2">PHM</protein-id>), <protein-id="P09172,P15101,Q05754,Q64237">dopamine beta-monooxygenase</protein-id> (DBM), and nitrite reductase (<protein-id="Q39161,Q43090">NiR</protein-id>) were designed into the small soluble protein <protein-id="P00279,P00281,P00283,P00284,P00285,P00286,P34097,P80546">azurin</protein-id>.	copper__PHM__interaction	copper__azurin__interaction	copper__NiR__interaction	copper__dopamine beta-monooxygenase__interaction
18830721-1834	The models are significant because they maintain the existing type 1 (T1) <compound-id="23978">copper</compound-id>, electron transfer site of <protein-id="P00279,P00281,P00283,P00284,P00285,P00286,P34097,P80546">azurin</protein-id> while including the second designed type 2 (T2) <compound-id="23978">copper</compound-id> center that mimics the T2 catalytic sites in the target enzymes.	copper__azurin__interaction
18830722-1835	Intraprotein electron transfer (IET) from <compound-id="710,8965,643976">flavin mononucleotide</compound-id> (<compound-id="710,8965,643976">FMN</compound-id>) to <compound-id="4971">heme</compound-id> is essential in NO synthesis by NO synthase (<protein-id="O54705,O61309,O61608,Q26240,Q28969,Q9I9M2">NOS</protein-id>).	flavin mononucleotide__NOS__interaction	heme__NOS__interaction	FMN__NOS__interaction
18830729-1841	The <protein-id="P16397,P18773">esterase</protein-id> and <protein-id="Q7M4U7">lipase</protein-id> activities were determined by the hydrolysis of pNPB and <compound-id="378">pNPP</compound-id>, respectively.	pNPP__lipase__interaction	pNPP__esterase__interaction
18830730-1843	In the present work, the activity of the enzymes <protein-id="P38715">xylose reductase</protein-id> (XR); <protein-id="P22144,P83049,Q59545,Q8U7Y1,Q92MT4,Q98D10">xylitol dehydrogenase</protein-id> (XD); and glucose-6-phosphate dehydrogenase (<protein-id="O00091,O24357,O51581,O54537,O55044,O68282,O83491,O84188,P05370,P0A584,P0A585,P0A586,P0A587,P0AC53,P0AC54,P11410,P11411,P11412,P11413,P12646,P15588,P21907,P29686,P37830,P37986,P41571,P41764,P44311,P48826,P48828,P48848,P48992,P54547,P54996,P56110,P57405,P73411,P77809,P80619,P97324,Q00612,Q23711,Q24625,Q25019,Q25537,Q27464,Q27638,Q29492,Q42919,Q43793,Q43839,Q7YS37,Q89AI7,Q8K9M2,Q8XCJ6,Q9PKK8,Q9X0N9,Q9Z3S2,Q9Z8U6,Q9ZKB2">G6PD</protein-id>) during cultivation of Candida guilliermondii on rice straw hemicellulosic hydrolysate was measured and correlated with <compound-id="6912">xylitol</compound-id> production under different pH values (around 4.5 and 7.5) and initial xylose concentration (around 30 and 70 g l(-1)).	xylitol__G6PD__interaction	xylitol__xylose reductase__interaction	xylitol__xylitol dehydrogenase__interaction
18830873-1896	QSAR studies for the inhibition of the transmembrane <protein-id="P27134,P46281,P46510,P46511,P54212,P84537,Q54735,Q92051,Q9ZN54">carbonic anhydrase</protein-id> isozyme XIV with <compound-id="12145736">sulfonamides</compound-id> using PRECLAV software.	sulfonamides__carbonic anhydrase__interaction
18830873-1897	QSAR studies for the inhibition of isozyme XIV of human <protein-id="P27134,P46281,P46510,P46511,P54212,P84537,Q54735,Q92051,Q9ZN54">carbonic anhydrase</protein-id> (CA, EC 4.2.1.1) by a series of <compound-id="12145736">sulfonamides</compound-id> including clinically used derivatives (acetazolamide, methazolamide, ethoxzolamide, dichlorophenamide, dorzolamide, brinzolamide, benzolamide, and zonisamide) are presented.	sulfonamides__carbonic anhydrase__interaction
18830874-1898	Inhibition of human <protein-id="P13929,P15429,P21550,P25704">muscle-specific enolase</protein-id> by <compound-id="880">methylglyoxal</compound-id> and irreversible formation of advanced glycation end products.	methylglyoxal__muscle-specific enolase__interaction
18830874-1900	The affinity of <protein-id="O02654,O26149,O29133,O30885,O32513,O51312,O52191,O59605,O66778,O69174,O74286,O84591,O85348,P0A6P9,P0A6Q0,P0A6Q1,P0A6Q2,P15007,P25696,P26300,P29201,P31683,P33675,P33676,P37869,P42040,P42448,P42848,P42894,P42896,P42897,P43806,P47647,P48285,P56252,P57492,P57975,P59566,P64074,P64075,P64076,P64077,P64078,P64079,P64080,P64081,P69949,P69950,P69951,P74934,P75189,P77972,P84208,P84541,P96377,P99088,Q12560,Q27527,Q27655,Q27727,Q27877,Q42971,Q43130,Q43321,Q4J920,Q5E326,Q5F8Z2,Q5FKM6,Q5FNN5,Q5GYK4,Q5HHP1,Q5HQV0,Q5HSC1,Q5JEV6,Q5KVE7,Q5LQL4,Q5M0M5,Q5M561,Q5N3P4,Q5NGW8,Q5NZ69,Q5PEH4,Q5R143,Q5SME1,Q5WDK9,Q5WV02,Q5X3L4,Q5XD01,Q5YQ30,Q5ZTX1,Q60173,Q601S2,Q62J10,Q631M2,Q63SQ0,Q65VZ7,Q661T0,Q66ED8,Q67SV9,Q6AAB8,Q6ADR6,Q6AM97,Q6C1F3,Q6D182,Q6F0Z7,Q6FAT9,Q6G173,Q6GB54,Q6GIL4,Q6HBF3,Q6KIB0,Q6LMT1,Q6M075,Q6MEY2,Q6MPQ2,Q6MTZ2,Q6N5U6,Q6NI61,Q6RG04,Q6W3C0,Q6YQT9,Q70CP7,Q71WX1,Q72F92,Q72H85,Q72QZ8,Q72XY5,Q73HQ2,Q73P50,Q741U7,Q74AR6,Q756H2,Q76KF9,Q7M8Q0,Q7MHQ1,Q7MTV8,Q7N835,Q7NAY0,Q7NIR1,Q7RA60,Q7RV85,Q7U0U6,Q7U3T1,Q7UIR2,Q7V377,Q7V483,Q7VDY0,Q7VIH4,Q7VNM6,Q7VQH3,Q7VW79,Q7W5N9,Q7WD75,Q815K8,Q81X78,Q821H7,Q82HH5,Q83B44,Q83FF7,Q83H73,Q870B9,Q87DY6,Q87LQ0,Q88MF9,Q898R0,Q89KV6,Q89Z05,Q8CPY3,Q8D2K1,Q8DC62,Q8DL40,Q8DPS0,Q8DTS9,Q8EBR0,Q8ENP5,Q8EW32,Q8F4T8,Q8FQS7,Q8G0G3,Q8G5I9,Q8GE63,Q8GR70,Q8IJN7,Q8K9E0,Q8KNX9,Q8L202,Q8NRS1,Q8P9Z3,Q8PLS0,Q8PT81,Q8R967,Q8RI55,Q8TQ79,Q8TUV6,Q8U477,Q8UFH1,Q8XKU4,Q8Y0B5,Q8YHF0,Q8YRB0,Q8ZBN2,Q8ZYE7,Q92Q98,Q967Y8,Q96VP4,Q96X30,Q96X46,Q972B6,Q979Z9,Q97L52,Q97QS2,Q97ZJ3,Q98MZ3,Q98Q50,Q9A7J9,Q9CD42,Q9HDT3,Q9HJT1,Q9HQI9,Q9HXZ5,Q9JU46,Q9JZ53,Q9K596,Q9K717,Q9KPC5,Q9PDT8,Q9PJF3,Q9PQV9,Q9RR60,Q9U615,Q9UAL5,Q9UXZ0,Q9XDS7,Q9Y927,Q9Z7A6,Q9ZMS6">enolase</protein-id> for gluconeogenic substrate <compound-id="1005">phosphoenolpyruvate</compound-id> altered after preincubation with MG in the same manner, but less intensively.	phosphoenolpyruvate__enolase__interaction
18830875-307	Inhibitory effects of <compound-id="33255">Cefazolin</compound-id> and <compound-id="5361871">Cefodizime</compound-id> on the activity of mushroom <protein-id="O42713,P06845,P07524,P33180,P55022,P55023,P55033,Q00234,Q8J130,Q92396">tyrosinase</protein-id>.	Cefodizime__tyrosinase__interaction	Cefazolin__tyrosinase__interaction
18830876-308	The order of the cytotoxicity of the compounds was; IV &gt; III &gt; II &gt; I &gt; V. <compound-id="55717">Compound IV</compound-id>, had the highest Hammett and log P values (0.23 and 4.21, respectively) and exerted both highest cytotoxicity and strongest <protein-id="O27661,O28469,O34204,O51768,O58356,O66893,O69548,O73954,O83409,P04786,P06612,P07799,P0A2I1,P0A2I2,P0A620,P0A621,P11387,P16472,P30181,P30189,P32989,P34184,P34185,P39814,P40114,P41511,P41512,P43012,P46155,P46799,P47368,P55991,P57371,P68697,P68698,P73810,P78032,P93119,Q00313,Q04750,Q07050,Q59046,Q76ZS7,Q7YR26,Q87AQ6,Q8K9P7,Q92IH1,Q9CG80,Q9CN30,Q9HM08,Q9HZJ5,Q9JN65,Q9KA23,Q9KRB2,Q9PEV8,Q9PLZ2,Q9UYS8,Q9WUL0,Q9X3X7,Q9X909,Q9YB01,Q9ZDK2,Q9ZMV7">DNA topoisomerase I</protein-id> inhibition.	Compound IV__DNA topoisomerase I__interaction
18830877-1907	Tests were carried out on cell cultures of human keratinocytes and mouse 3T3 fibroblasts incubated with radiolabeled acetate, and on homogenates prepared from yeast cells expressing human <protein-id="P38604,P48449,P48450,P84466,Q04782,Q10231,Q8BLN5,Q96WJ0">lanosterol synthase</protein-id>, incubated with radiolabeled <compound-id="5280395">oxidosqualene</compound-id>.	oxidosqualene__lanosterol synthase__no_interaction
18830880-1910	Hepatic antioxidant status viz, <compound-id="124886">reduced glutathione</compound-id> (<compound-id="124886">GSH</compound-id>), <protein-id="O15770,P06715,P11804,P23189,P41921,P43783,P48638,P48639,P70619,P78965,Q60151,Q6BPI1,Q6C5H4,Q6FRV2,Q6HA23,Q74ZK4,Q873E8,Q94655">glutathione reductase</protein-id> (GR), <protein-id="O32770,O59858,Q00277,Q9CFV1">glutathione peroxidase</protein-id> (GPx), quinone reductase (QR), <protein-id="O24339,O52762,O62839,O68146,O77229,O93662,O97492,P00432,P04040,P04762,P07145,P0A323,P0A324,P0A325,P0A326,P0A327,P11934,P17336,P24168,P24270,P25890,P29422,P30265,P30266,P32290,P42321,P44390,P45737,P45739,P55304,P55306,P55310,P55311,P55313,P77872,P81138,P90682,Q27710,Q49XC1,Q4L643,Q59296,Q59337,Q59602,Q59714,Q5HG86,Q5HPK8,Q5RF10,Q64405,Q6G9M4,Q6GH72,Q7A5T2,Q8CPD0,Q8FWU0,Q8NWV5,Q8X1P0,Q8Y3P9,Q926X0,Q99UE2,Q9AXH0,Q9KW19,Q9L4S1,Q9M5L6,Q9PT92,Q9PWF7,Q9Z598,Q9ZKX5,Q9ZN99">catalase</protein-id> (<protein-id="O62839,O97492,P00432,P00485,P00486,P00487,P04040,P06135,P07641,P11504,P20074,P22782,P25309,P25819,P26825,P26826,P32796,P36882,P36883,P43155,P47934,P49417,P52826,P58777,P62577,P62578,P62579,P62580,P90682,Q00614,Q02736,Q03058,Q5RF10,Q64405,Q704S8,Q9M5L6,Q9PWF7">CAT</protein-id> 0.001).	reduced glutathione__catalase__no_interaction	reduced glutathione__glutathione reductase__no_interaction	GSH__glutathione peroxidase__no_interaction	reduced glutathione__glutathione peroxidase__no_interaction	GSH__CAT__no_interaction	GSH__catalase__no_interaction	GSH__glutathione reductase__no_interaction	reduced glutathione__CAT__no_interaction
18830882-1911	Inhibition of rat liver <protein-id="P81494,P83205">cathepsins B</protein-id> and L by the peptide aldehyde <compound-id="107707">benzyloxycarbonyl-leucyl-leucyl-leucinal</compound-id> and its analogues.	benzyloxycarbonyl-leucyl-leucyl-leucinal__cathepsins B__interaction
18830882-1913	The concentration required for 50% inhibition (IC(50)) by <compound-id="107707">ZLLLal</compound-id> was 88 nM for <protein-id="P81494,P83205">cathepsin B</protein-id> and 163 nM for <protein-id="P09648,P25773,Q10991">cathepsin L</protein-id>.	ZLLLal__cathepsin L__interaction	ZLLLal__cathepsin B__interaction
18830885-1914	Preliminary structure-activity relationships and a molecular modeling study for 9a have revealed that the <compound-id="72304">isoflavone</compound-id> moiety plays a key role in the interaction of this series of derivatives with <protein-id="O42275,O62763,P04058,P07140,P07692,P21836,P22303,P23795,P36196,P37136,P56161,Q27677,Q29499,Q867X2,Q867X3,Q869C3,Q86GC8,Q86GC9,Q92035,Q92081,Q9DDE3">AChE</protein-id> by acting as an anchor in its peripheral anionic site.	isoflavone__AChE__interaction
18830972-1951	<protein-id="P06762,P09601,P14791,P14901,P32394,P72849,Q5E9F2">Heme oxygenase-1</protein-id> (<protein-id="P06762,P09601,P14791,P14901,P32394,Q5E9F2">HO-1</protein-id>) and <compound-id="145068">Nitric oxide</compound-id> (NO) which may play an important role in regulatory and protective processes in cells were assayed upon nickel treatment.	Nitric oxide__HO-1__no_interaction	Nitric oxide__Heme oxygenase-1__no_interaction
18831007-1971	One potential target for reducing T cell migration is inhibition of the <compound-id="271">Ca(2</compound-id>+)-activated <protein-id="P05806,P06832,P29148,P43133,P43263,P68734,P68735,P68736,Q00891">neutral protease</protein-id> <protein-id="P27730">calpain</protein-id>.	Ca(2__calpain__interaction	Ca(2__neutral protease__no_interaction
18831010-1974	A shift toward proinflammatory microglial activation is indicated by the release of <protein-id="P41693">interleukin-6</protein-id>, <protein-id="Q8JFG3">tumor necrosis factor</protein-id>-alpha, and <compound-id="145068">nitric oxide</compound-id> and the oxidative burst in rat primary microglial cells, an activation and differentiation process similar to the proinflammatory response of microglia to exposure to lipopolysaccharide.	nitric oxide__tumor necrosis factor__no_interaction	nitric oxide__interleukin-6__no_interaction
18831033-1984	<compound-id="5284583">Levetiracetam</compound-id>, a newer anticonvulsant, does not undergo <protein-id="P21568,P21569,P24525,P34887,Q26551">CYP</protein-id> metabolism and does not alter the pharmacokinetics of chemotherapy, antiemetics, and corticosteroids, which are metabolized by the liver.	Levetiracetam__CYP__interaction
18831035-1985	By combining a favorable turn sequence with a turn flanking <protein-id="P19334,P55965,Q920J4">Trp</protein-id>/<protein-id="P19334,P55965,Q920J4">Trp</protein-id> interaction and a C-terminal H-bonding interaction between a backbone amide and an i-2 <compound-id="1148,5460840">Trp</compound-id> ring, a particularly stable (DeltaG(U) &gt; 7 kJ/mol) truncated hairpin, Ac-WI-(<compound-id="8988">D-Pro</compound-id>-D-Asn)-KWTG-NH(2), results.	D-Pro__Trp__interaction	Trp__Trp__interaction
18831052-2002	The human AU <protein-id="P03526,P04487,P07940,P12002,P56958,P82866">RNA binding protein</protein-id>/enoyl-Coenzyme A hydratase (<protein-id="O42887,P60651,P60652,P60653,P60654,P60655,P60656,P60657,P70999,Q10088,Q13825,Q57K36,Q5F6R3,Q5PJH7,Q7N122,Q7P0S6,Q7VRG4,Q7X3P1,Q814Q2,Q81JT1,Q8FE36,Q90XD2,Q9BSE5,Q9K6B9">AUH</protein-id>) is a 3-hydroxy-3-methylglutaconyl-CoA dehydratase in the <compound-id="857,6106,439524">leucine</compound-id> degradation pathway.	leucine__RNA binding protein__interaction	leucine__AUH__interaction
18831980-2703	<protein-id="P19217,P49887,P49888">SULT1E1</protein-id> is responsible for the sulfation and inactivation of <compound-id="5757">beta-estradiol</compound-id> (E2) at physiological concentrations.	beta-estradiol__SULT1E1__interaction
18832050-2295	The main mechanism of resistance to <compound-id="126941">methotrexate</compound-id> was extra-chromosomal amplification of the <protein-id="O02604,O62583,O81395,P00374,P00375,P00376,P00377,P00378,P00380,P00381,P04174,P04382,P04753,P07382,P07807,P0A016,P0A017,P0A546,P0A547,P0ABQ4,P0ABQ5,P0ABQ6,P0C0P0,P0C0P1,P11045,P13922,P15093,P16126,P16184,P17719,P20712,P22906,P27498,P28019,P31073,P31074,P36591,P43791,P45350,P46103,P47470,P51820,P57243,P78028,P99079,Q05762,Q05763,Q07422,Q07801,Q23695,Q27713,Q27783,Q27793,Q27828,Q2QRX6,Q54277,Q54801,Q59487,Q5HFZ7,Q5HPB1,Q5UQG3,Q60034,Q6G9D5,Q6GGY1,Q89AV2,Q8K9Z8,Q8NWQ9,Q920D2,Q98Q32,Q9CBW1,Q9JSQ9,Q9K168,Q9PR30,Q9U8B8">dihydrofolate reductase</protein-id> gene.	methotrexate__dihydrofolate reductase__interaction
18832097-2311	In the LNCaP prostate cancer cell line, induction of apoptosis and caspase-3/7 activities by <compound-id="5279,44259,451705,5311103,5459111,6419748,6711321,9956178,44299148">staurosporine</compound-id> (STS) abolished [(3)H] <compound-id="9547243">1,25-dihydroxy vitamin D</compound-id> (3) binding and <protein-id="O13124,O42392,P11473,P13053,P48281,P49701,Q28037,Q95MH5">VDR</protein-id> protein, suggesting that the <protein-id="O13124,O42392,P11473,P13053,P48281,P49701,Q28037,Q95MH5">VDR</protein-id> may be targeted for inactivation by caspases during apoptosis.	1,25-dihydroxy vitamin D__VDR__no_interaction	staurosporine__VDR__interaction
18832102-2313	The use of lipoproteins as a substrate for <compound-id="5994">progesterone</compound-id> synthesis remains unclear, and the expression of lipoprotein receptors [very-<protein-id="P01131,P20063,Q28832">low-density lipoprotein receptor</protein-id> (<protein-id="P35953,P98155,P98165">VLDLR</protein-id>), <protein-id="P01131,P20063,Q28832">low-density lipoprotein receptor</protein-id> (<protein-id="P01130,P01131,P20063,P35950,Q28832">LDLR</protein-id>), and scavenger receptor-BI (<protein-id="O18824,P97943,Q60417,Q61009,Q8SQC1,Q8WTV0">SR-BI</protein-id> 12 h) has not been characterized.	progesterone__VLDLR__no_interaction	progesterone__low-density lipoprotein receptor__no_interaction	progesterone__SR-BI__no_interaction	progesterone__LDLR__no_interaction
18832102-2314	These data suggest that an ovulatory stimulus rapidly mobilizes stored cholesterol esters for use as a <compound-id="5994">progesterone</compound-id> substrate and that as these are depleted, new cholesterol esters are obtained through an <protein-id="P01130,P01131,P20063,P35950,Q28832">LDLR</protein-id>- and/or <protein-id="O18824,P97943,Q60417,Q61009,Q8SQC1,Q8WTV0">SR-BI</protein-id>-mediated mechanism.	progesterone__SR-BI__no_interaction	progesterone__LDLR__no_interaction
18832185-2341	The <compound-id="37034">2,2',4,4',5,5'-hexachlorobiphenyl</compound-id>-enhanced degradation of <protein-id="O57474,P08050,P14154,P16863,P17302,P18246,P23242,Q29101,Q6S9C0">connexin 43</protein-id> involves both proteasomal and lysosomal activities.	2,2',4,4',5,5'-hexachlorobiphenyl__connexin 43__interaction
18832185-2343	As this effect might be related to deregulation of <protein-id="O57474,P08050,P14154,P16863,P17302,P18246,P23242,Q29101,Q6S9C0">connexin 43</protein-id> (<protein-id="O57474,P08050,P14154,P16863,P17302,P18246,P23242,Q29101,Q6S9C0">Cx43</protein-id>) synthesis, trafficking, or degradation, we investigated the impact of <compound-id="37034">PCB 153</compound-id> on these events.	PCB 153__connexin 43__interaction	PCB 153__Cx43__interaction
18832185-2345	Inhibition of either proteasomes or lysosomes with their specific inhibitors largely restored total <protein-id="O57474,P08050,P14154,P16863,P17302,P18246,P23242,Q29101,Q6S9C0">Cx43</protein-id> protein levels, thus suggesting that both proteasomes and lysosomes may participate in the <compound-id="37034">PCB 153</compound-id>-enhanced <protein-id="O57474,P08050,P14154,P16863,P17302,P18246,P23242,Q29101,Q6S9C0">Cx43</protein-id> internalization and degradation.	PCB 153__Cx43__interaction
18832185-2346	Finally, <compound-id="37034">PCB 153</compound-id> also interfered with restoration of gap junction plaques following the inhibition of <protein-id="O57474,P08050,P14154,P16863,P17302,P18246,P23242,Q29101,Q6S9C0">Cx43</protein-id> transport to plasma membrane.	PCB 153__Cx43__interaction
18832185-2347	Taken together, multiple modes of action seem to contribute to downregulation of <protein-id="O57474,P08050,P14154,P16863,P17302,P18246,P23242,Q29101,Q6S9C0">Cx43</protein-id> in <compound-id="37034">PCB 153</compound-id>-treated rat liver epithelial cells.	PCB 153__Cx43__interaction
18832295-2399	<compound-id="6918537">Vildagliptin</compound-id> demonstrates potent inhibition of <protein-id="P97399,Q62598,Q9NZW4">DPP</protein-id>-4 activity with excellent tolerability at doses of up to and including 200 mg qd.	Vildagliptin__DPP__interaction
18832330-479	The accelerated rate of kindling was partially repressed by inhibiting N-methyl-D-aspartic acid receptor (NMDAR) with <compound-id="6442441">MK-801</compound-id> or <protein-id="P31424,P41594">mGluR5</protein-id> receptor with <compound-id="3025961">2-methyl-6-(phenylethynyl)-pyridine</compound-id> (<compound-id="3025961">MPEP</compound-id>).	MK-801__mGluR5__no_interaction	MPEP__mGluR5__interaction	2-methyl-6-(phenylethynyl)-pyridine__mGluR5__interaction
18832453-2471	Here, PCA is applied to three problems in <protein-id="P01105,P32503">GAG</protein-id> research: (i) distinguishing origins of heparin preparations, (ii) structural analysis of heparin derivatives, and (iii) classification of <compound-id="24766">chondroitin sulfates</compound-id> (CS).	chondroitin sulfates__GAG__interaction
18832454-2473	In addition, high levels of ketals of <compound-id="1060">pyruvic acid</compound-id> were found mainly at 3,4-of some terminal beta-D-<protein-id="Q9QXQ6">Galp</protein-id> units forming a five-membered ring.	pyruvic acid__Galp__interaction
18832476-2484	The CL(int) was obtained using either individual or combined cofactors for cytochrome P450 (P450) and UGT enzymes with <compound-id="16132042,16132684">alamethicin</compound-id> activation and in the presence and absence of 2% bovine <protein-id="P21847,P83517">serum albumin</protein-id> (<protein-id="P02769">BSA</protein-id>).	alamethicin__BSA__no_interaction	alamethicin__serum albumin__no_interaction
18832480-801	By using purified bovine <protein-id="P22985,P47989,P47990,P80457,Q00519,Q9MYW6">xanthine oxidase</protein-id>, the reduction was observed in the presence of <compound-id="5893">NAD</compound-id> (P)H. These results suggest that FLU-1 N-OH is involved in flutamide-induced hepatotoxicity and that cytosolic reduction of FLU-1 N-OH plays a major role in protection against flutamide-induced hepatotoxicity.	NAD__xanthine oxidase__interaction
18832589-2551	Recent studies have provided important insight into the homeoprotein <protein-id="Q25132">LIM</protein-id> homeobox transcription factor 1alpha (<protein-id="Q9JKU8">Lmx1a</protein-id>) and its role in the commitment of cells to a midbrain <compound-id="681">dopamine</compound-id> (mDA) fate in the developing mouse.	dopamine__Lmx1a__interaction	dopamine__LIM__interaction
18832593-1025	An acute increase in <compound-id="977">oxygen</compound-id> tension led to Smad activation within 30 minutes, even in the absence of exogenous <protein-id="P35855">BMP</protein-id> treatment.	oxygen__BMP__no_interaction
18832596-2558	Recognition of <compound-id="16218585,20758205">galactan</compound-id> components of pectin by <protein-id="P08699,P16110,P17931,P38486,P47845,P47953">galectin-3</protein-id>.	galactan__galectin-3__interaction
18832596-2559	By using a combination of fluorescence microscopy, flow cytometry, and force spectroscopy, it has been possible to demonstrate, for the first time, specific binding of a pectin <compound-id="16218585,20758205">galactan</compound-id> to the recombinant form of human <protein-id="Q9DG58">Gal3</protein-id>.	galactan__Gal3__interaction
18832659-2578	<protein-id="Q13586,Q58CP9">STIM1</protein-id> has been identified as an endoplasmic reticulum (ER)-resident <compound-id="271">Ca(2</compound-id>+) sensor that regulates store-operated calcium entry (SOCE) in immune cells and platelets, but the identity of the platelet SOC channel has remained elusive.	Ca(2__STIM1__interaction
18832772-2632	A sensitive and specific ELISA detects <compound-id="847">methionine sulfoxide</compound-id>-containing <protein-id="P18647">apolipoprotein A-I</protein-id> in HDL.	methionine sulfoxide__apolipoprotein A-I__interaction
18832772-2633	A wide range of reactive intermediates oxidizes methionine residues to <compound-id="847">methionine sulfoxide</compound-id> (MetO) in <protein-id="P18647">apolipoprotein A-I</protein-id> (<protein-id="O18759,O42175,O42296,O42363,P02647,P02648,P04639,P08250,P09809,P15497,P18647,P18648,P27007,P32918,P68292,P68293,Q00623,Q91488,Q9Z2L4">apoA-I</protein-id>), the major HDL protein.	methionine sulfoxide__apolipoprotein A-I__interaction	methionine sulfoxide__apoA-I__interaction
18832826-1553	The renin-angiotensin-<compound-id="5839">aldosterone</compound-id> system: approaches to guide <protein-id="Q10751">angiotensin-converting enzyme</protein-id> inhibition in patients with coronary artery disease.	aldosterone__angiotensin-converting enzyme__no_interaction
18834674-2651	It was identified as producer of extended-spectrum <protein-id="P80298,P80545,P81173">beta-lactamases</protein-id> (ESBL) by double-disk synergy test between <compound-id="33613">amoxicillin</compound-id>-<compound-id="5280980">clavulanate</compound-id> and <compound-id="5479527,5742673,6540461">cefotaxime</compound-id>, <compound-id="5479530">ceftriaxone</compound-id>, <compound-id="6321415">ceftazidime</compound-id> and <compound-id="5742832">aztreonam</compound-id>.	amoxicillin__beta-lactamases__interaction	ceftazidime__beta-lactamases__interaction	cefotaxime__beta-lactamases__interaction	ceftriaxone__beta-lactamases__interaction	aztreonam__beta-lactamases__interaction	clavulanate__beta-lactamases__interaction
18834690-355	The binding of <compound-id="3016">diazepam</compound-id> to human <protein-id="P21847,P83517">serum albumin</protein-id> was used as the model system in order to evaluate the performance of automated SPME.	diazepam__serum albumin__interaction
18834707-357	<compound-id="145068">Nitric oxide</compound-id> (NO) and interlukin-6 (<protein-id="O35736,P05231,P08505,P20607,P26892,P26893,P29455,P41323,P41683,P41693,P46650,P51494,P79341,Q25BC2,Q28319,Q28747,Q28819,Q2MH06,Q5I6E3,Q6V919,Q865W7,Q865X6,Q8MKH0,Q95181,Q9MZR1,Q9XT80">IL-6</protein-id>) are highly reactive mediators that have been shown to play different roles in a variety of different biological process.	Nitric oxide__IL-6__no_interaction
18834868-391	Mitochondrial <protein-id="O74187,P08157,P12693,P23240,P40108,P41751,P42041,P45959,Q27640,Q8VXQ2,Q9RYG9,Q9ZA11">aldehyde dehydrogenase</protein-id> (<protein-id="P17201,P22281,P80472,P80704,P80705,Q27640,Q8VXQ2">ALDH</protein-id>-2)--maker of and marker for <compound-id="943">nitrate</compound-id> tolerance in response to <compound-id="4510">nitroglycerin</compound-id> treatment.	nitroglycerin__aldehyde dehydrogenase__interaction	nitroglycerin__ALDH__interaction	nitrate__ALDH__interaction	nitrate__aldehyde dehydrogenase__interaction
18834868-392	According to the oxidative stress concept, increased vascular <compound-id="5359597">superoxide</compound-id> and <compound-id="104806">peroxynitrite</compound-id> production as well as an increased sensitivity to vasoconstrictors secondary to activation of <protein-id="P13678,Q25378">protein kinase C</protein-id> as well as vascular NADPH oxidases contribute to the development of tolerance.	superoxide__protein kinase C__no_interaction	peroxynitrite__protein kinase C__no_interaction
18834868-393	mitochondrial <protein-id="O74187,P08157,P12693,P23240,P40108,P41751,P42041,P45959,Q27640,Q8VXQ2,Q9RYG9,Q9ZA11">aldehyde dehydrogenase</protein-id> [<protein-id="P17201,P22281,P80472,P80704,P80705,Q27640,Q8VXQ2">ALDH</protein-id>-2]) and mitochondria as potential sources of reactive <compound-id="977">oxygen</compound-id> species (ROS).	oxygen__ALDH__interaction	oxygen__aldehyde dehydrogenase__interaction
18834868-395	Finally, we will address the question whether <protein-id="P17201,P22281,P80472,P80704,P80705,Q27640,Q8VXQ2">ALDH</protein-id>-2 inactivation by <compound-id="4510">nitroglycerin</compound-id> could be a useful marker for clinical <compound-id="943">nitrate</compound-id> tolerance and discuss the redox-regulation of this enzyme by oxidative stress and <compound-id="421">dihydrolipoic acid</compound-id>.	dihydrolipoic acid__ALDH__interaction	nitroglycerin__ALDH__interaction	nitrate__ALDH__interaction
18834871-397	Sex steroids enhance <protein-id="Q28516">insulin receptors</protein-id> and <compound-id="206,5793,64689,79025">glucose</compound-id> oxidation in Chang liver cells.	glucose__insulin receptors__no_interaction
18834871-398	The present study was designed to assess the effect of sex steroids (<compound-id="6013">testosterone</compound-id> and <compound-id="5757">17beta-estradiol</compound-id>) on <protein-id="Q28516">insulin receptor</protein-id> expression, <protein-id="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7">insulin</protein-id> binding and <compound-id="206,5793,64689,79025">glucose</compound-id> oxidation in human liver cell line.	glucose__insulin__no_interaction	testosterone__insulin__interaction	17beta-estradiol__insulin__interaction	testosterone__insulin receptor__interaction	glucose__insulin receptor__no_interaction	17beta-estradiol__insulin receptor__interaction
18834900-402	It is predicted to possess all the expected features of proPO members, including two putative <protein-id="O42713,P06845,P07524,P33180,P55022,P55023,P55033,Q00234,Q8J130,Q92396">tyrosinase</protein-id> copper-binding motifs with six <compound-id="773,6274">histidine</compound-id> residues and a <compound-id="519335">thiol ester</compound-id>-like motif, sharing 67% amino acid sequence identity with PmproPO1.	histidine__tyrosinase__interaction	thiol ester__tyrosinase__interaction
18834946-408	Examination of <compound-id="23973">cadmium</compound-id>-induced expression of the small heat shock protein gene, <protein-id="P19752,P40920">hsp30</protein-id>, in Xenopus laevis A6 kidney epithelial cells.	cadmium__hsp30__interaction
18834946-409	In the present study, we have characterized the effect of <compound-id="23973">cadmium</compound-id> on the accumulation of the small heat shock protein (<protein-id="P32590">HSP</protein-id>), <protein-id="P25619,P42931">HSP30</protein-id>, in Xenopus laevis A6 kidney epithelial cells.	cadmium__HSP__no_interaction	cadmium__HSP30__interaction
18834946-410	Immunocytochemical analysis of <compound-id="24633,24947">cadmium chloride</compound-id>-treated A6 cells revealed <protein-id="P25619,P42931">HSP30</protein-id> accumulation primarily in the cytoplasm in a punctate pattern supplemented with larger <protein-id="P25619,P42931">HSP30</protein-id> staining structures.	cadmium chloride__HSP30__interaction
18834946-411	Also, <protein-id="P25619,P42931">HSP30</protein-id> co-localized with the F-<protein-id="O00937,O13419,O16808,O17320,O65314,O65315,O65316,O74258,O81221,P02577,P10365,P10989,P11426,P13363,P14235,P17128,P20904,P24902,P26182,P26183,P30161,P45520,P45521,P48465,P50138,P51775,P53455,P53476,P53477,P53491,P53498,P53499,P53500,P53502,P53689,P60009,P60010,P60011,P68555,P78711,P80709,P81085,P90689,P91754,Q05214,Q11212,Q24733,Q2U7A3,Q39596,Q39758,Q6TCF2,Q75D00,Q8SWN8,Q8X119,Q92192,Q92193,Q99023,Q9P4D1,Q9UVF3,Q9UVX4,Q9UVZ8">actin</protein-id> cytoskeleton at higher <compound-id="24633,24947">cadmium chloride</compound-id> concentrations.	cadmium chloride__HSP30__interaction	cadmium chloride__actin__interaction
18834950-413	In order to suppress the emergence of such resistant variants, we introduced charged and hydrophilic amino acids, <compound-id="611,23327,33032">glutamic acid</compound-id> (E) and <compound-id="866,5962">lysine</compound-id> (K), at the solvent accessible site of <protein-id="P32910">C34</protein-id>.	glutamic acid__C34__interaction	lysine__C34__interaction
18834958-415	Cloning, expression, and characterization of <compound-id="23973">cadmium</compound-id>-induced <protein-id="O97388,P02795,P02798,P02806,P04355,P11956,P14425,P15114,P15787,P17512,P17808,P41928,P67981,P68041,P68301,P68302,P68303,P68304,P80394,Q5NVS0,Q7ZSY6,Q9I9I0,Q9XST5">metallothionein-2</protein-id> from the earthworms Metaphire posthuma and Polypheretima elongata.	cadmium__metallothionein-2__interaction
18834958-416	In this study we report the sequences of <protein-id="O97388,P02795,P02798,P02806,P04355,P11956,P14425,P15114,P15787,P17512,P17808,P41928,P43392,P55943,P67981,P68041,P68301,P68302,P68303,P68304,P80394,P94029,Q39459,Q5NVS0,Q7ZSY6,Q9I9I0,Q9VG55,Q9XST5">MT-2</protein-id> cDNA from two species of Megascoleidae earthworms, Metaphire posthuma and Polypheretima elongata, by mRNA differential display after exposure of the organisms to <compound-id="23973">cadmium</compound-id>.	cadmium__MT-2__interaction
18834958-417	Complementary (c)DNA was verified as the <protein-id="O97388,P02795,P02798,P02806,P04355,P11956,P14425,P15114,P15787,P17512,P17808,P41928,P43392,P55943,P67981,P68041,P68301,P68302,P68303,P68304,P80394,P94029,Q39459,Q5NVS0,Q7ZSY6,Q9I9I0,Q9VG55,Q9XST5">MT-2</protein-id> gene by the characteristics of its predicted translation product, namely a high <compound-id="594,5862,5360637">cysteine</compound-id> content, conserved CXC motifs, and a molecular weight of around 8 kDa.	cysteine__MT-2__interaction
18834958-420	These earthworms could be used to evaluate heavy-metal pollution in soil due to the inducible <protein-id="O97388,P02795,P02798,P02806,P04355,P11956,P14425,P15114,P15787,P17512,P17808,P41928,P43392,P55943,P67981,P68041,P68301,P68302,P68303,P68304,P80394,P94029,Q39459,Q5NVS0,Q7ZSY6,Q9I9I0,Q9VG55,Q9XST5">MT-2</protein-id> by <compound-id="23973">cadmium</compound-id> exposure.	cadmium__MT-2__interaction
18834983-429	Despite the reciprocal relationship that exists between inflammation and thrombosis, we asked whether thrombosis can develop without inflammation, and whether stress-related hormones (<protein-id="P01189,P01190,P01191,P01192,P01193,P01194,P01196,P01197,P01201,P06297,P06298,P06299,P10000,P11280,P11885,P19402,P21252,P22923,P68000,P68001,P87352,Q04617,Q04618,Q91082,Q9YGK2,Q9YGK4,Q9YGK5">ACTH</protein-id> and <compound-id="5754">cortisol</compound-id>) influence platelet-mediated thrombosis.	cortisol__ACTH__no_interaction
18835067-453	The most active compound to emerge from the in vitro and in vivo murine studies was 2b, suggesting an antimalarial activity via inhibition of <protein-id="P15160,P17724,P73925,Q03459">hemoglobin</protein-id> hydrolysis, however, not as efficient as <compound-id="2719">chloroquine</compound-id>.	chloroquine__hemoglobin__no_interaction
18835228-501	The culture medium was analyzed for pH value, concentration of free calcium and <compound-id="1061">phosphate ions</compound-id> and <protein-id="P02819,P02821,P02823,P0C225,P0C226,P15504,P28317,P39056,P81455,P83005,P83238,P83473,P83489,P84348,P84349,P84350,P84351,Q7LZI4,Q8HYY9">osteocalcin</protein-id>.	phosphate ions__osteocalcin__no_interaction
18835260-516	Surprisingly, no role of <protein-id="P27361,P28869,P42525,Q07176">ERK1</protein-id>/2 or <protein-id="P08457,P35610,Q7QDU4">STAT</protein-id>-3 was found in the protein-mediated protection of hepatocytes during <compound-id="1983">acetaminophen</compound-id> exposure.	acetaminophen__ERK1__no_interaction	acetaminophen__STAT__no_interaction
18835277-527	Mutations at M57 (M57L) and H210 (H210G, H210M, and H210N), both of which are involved in interactions with the C2 carbonyl <compound-id="977">oxygen</compound-id> in <compound-id="1174">uracil</compound-id> or <compound-id="1188">xanthine</compound-id>, cause substantial reductions in XDG and <protein-id="O51082,O74834,O84613,P04303,P09307,P0A4P3,P0A4P4,P0A4P5,P10186,P12295,P12887,P12888,P13051,P13158,P16769,P20536,P21968,P23379,P28275,P28866,P29950,P32941,P32988,P39615,P43731,P47343,P50639,P52345,P52447,P52506,P52507,P53764,P53765,P53766,P56397,P57280,P57807,P59465,P67071,P67072,P67073,P67074,P67075,P67076,P67077,P67078,P67079,P69859,P75536,P97931,Q01019,Q5FL46,Q5HI95,Q5HRG5,Q5HX80,Q5KUD0,Q5L4Q4,Q5NEP2,Q5R080,Q5UPT2,Q5WAZ9,Q5XCK3,Q65DN9,Q662W1,Q6D208,Q6F9Y2,Q6GBQ6,Q6GJ88,Q6HAN7,Q72X51,Q74K70,Q7MA00,Q7MNR0,Q7MXF6,Q7N1U8,Q7P1I1,Q7VGS1,Q7VMC0,Q7VRQ7,Q7VUM8,Q7W1Y7,Q7WQW5,Q814M9,Q81JQ4,Q821F7,Q836Z5,Q83CW4,Q879Z0,Q87SC4,Q87XE2,Q88N05,Q88YG1,Q8A5V6,Q8CQ65,Q8DEP7,Q8DPQ4,Q8DTV8,Q8EB78,Q8EPH6,Q8FF08,Q8FPQ4,Q8G3E9,Q8K7U9,Q8NQU9,Q8P1B6,Q8P4D7,Q8PFZ6,Q8R634,Q8UCM8,Q8X444,Q8XNR7,Q8XVE4,Q8ZD85,Q91UM2,Q92LU5,Q98PV4,Q9A072,Q9CBS3,Q9CIX2,Q9I5H9,Q9JUC4,Q9JZA1,Q9K682,Q9KPK8,Q9PA28,Q9PJ40,Q9PJD2,Q9PPU2,Q9RWH9,Q9Z7D3,Q9ZJN9">UDG</protein-id> activities.	xanthine__UDG__no_interaction	oxygen__UDG__no_interaction	uracil__UDG__no_interaction
18835277-528	Most interestingly, a <compound-id="614,8988,145742">proline</compound-id> substitution at the G63 position switches the <protein-id="Q51061">Gme</protein-id> <protein-id="Q53HV7,Q59I47">SMUG1</protein-id> enzyme to an exclusive <protein-id="O51082,O74834,O84613,P04303,P09307,P0A4P3,P0A4P4,P0A4P5,P10186,P12295,P12887,P12888,P13051,P13158,P16769,P20536,P21968,P23379,P28275,P28866,P29950,P32941,P32988,P39615,P43731,P47343,P50639,P52345,P52447,P52506,P52507,P53764,P53765,P53766,P56397,P57280,P57807,P59465,P67071,P67072,P67073,P67074,P67075,P67076,P67077,P67078,P67079,P69859,P75536,P97931,Q01019,Q5FL46,Q5HI95,Q5HRG5,Q5HX80,Q5KUD0,Q5L4Q4,Q5NEP2,Q5R080,Q5UPT2,Q5WAZ9,Q5XCK3,Q65DN9,Q662W1,Q6D208,Q6F9Y2,Q6GBQ6,Q6GJ88,Q6HAN7,Q72X51,Q74K70,Q7MA00,Q7MNR0,Q7MXF6,Q7N1U8,Q7P1I1,Q7VGS1,Q7VMC0,Q7VRQ7,Q7VUM8,Q7W1Y7,Q7WQW5,Q814M9,Q81JQ4,Q821F7,Q836Z5,Q83CW4,Q879Z0,Q87SC4,Q87XE2,Q88N05,Q88YG1,Q8A5V6,Q8CQ65,Q8DEP7,Q8DPQ4,Q8DTV8,Q8EB78,Q8EPH6,Q8FF08,Q8FPQ4,Q8G3E9,Q8K7U9,Q8NQU9,Q8P1B6,Q8P4D7,Q8PFZ6,Q8R634,Q8UCM8,Q8X444,Q8XNR7,Q8XVE4,Q8ZD85,Q91UM2,Q92LU5,Q98PV4,Q9A072,Q9CBS3,Q9CIX2,Q9I5H9,Q9JUC4,Q9JZA1,Q9K682,Q9KPK8,Q9PA28,Q9PJ40,Q9PJD2,Q9PPU2,Q9RWH9,Q9Z7D3,Q9ZJN9">UDG</protein-id> as demonstrated by the uniform excision of <compound-id="1174">uracil</compound-id> in both double-stranded and single-stranded DNA and the complete loss of XDG activity.	uracil__UDG__interaction	uracil__SMUG1__interaction	proline__SMUG1__interaction	uracil__Gme__interaction	proline__UDG__interaction	proline__Gme__interaction
18835344-566	<protein-id="P21847,P83517">Serum albumin</protein-id>-<compound-id="6850754">alginate</compound-id> coated microspheres: role of the inner gel in binding and release of the KRFK peptide.	alginate__Serum albumin__interaction
18835350-570	Furthermore, increased production of high inducible <protein-id="O61309,O61608,Q27571,Q9I9M2">nitric oxide synthase</protein-id> (<protein-id="O19114,O46660,O54705,O62699,P29477,P35228,P79290,Q06518,Q27995,Q28314,Q90703,Q92037,Q92091">iNOS</protein-id>) and <protein-id="O02768,O19183,O62698,O62725,P27607,P35354,P35355,P70682,P79208,Q05769">cyclooxygenase 2</protein-id> (<protein-id="O02768,O19183,O62698,O62725,P27607,P35354,P35355,P70682,P79208,Q05769">COX-2</protein-id>) expressions were detected in the hippocampus and cerebral cortex of <compound-id="23978">copper</compound-id> and cholesterol co-treated mice by immunohistochemical analysis.	copper__cyclooxygenase 2__interaction	copper__nitric oxide synthase__interaction	copper__COX-2__interaction	copper__iNOS__interaction
18835362-575	We report herein some novel phenomena between <compound-id="4971">hemin</compound-id>-H(2)O(2)-NO(2)(-) and <compound-id="5219">3-morpholinosydnonimine hydrochloride</compound-id> (SIN-1)-mediated oxidation and nitration reactions of <protein-id="O52310,O59650,O74024,P28270,P52596,P80319,P93541,P94598,P96110,Q09115,Q43260,Q47950,Q47951,Q56304,Q9YC65">glutamate dehydrogenase</protein-id> (<protein-id="O52310,O59650,O74024,O95479,P00366,P00367,P00368,P0AES2,P0AES3,P10860,P13443,P26443,P28270,P36234,P42174,P42206,P42238,P49448,P52596,P54385,P56201,P80319,P82264,P93541,P94598,P96110,Q09115,Q43260,Q47950,Q47951,Q53199,Q56304,Q59516,Q64HZ8,Q64HZ9,Q64I00,Q64I01,Q9HFR6,Q9HGU3,Q9HGU4,Q9RDE9,Q9URS1,Q9YC65">GDH</protein-id>).	hemin__GDH__interaction	3-morpholinosydnonimine hydrochloride__GDH__interaction	hemin__glutamate dehydrogenase__interaction	3-morpholinosydnonimine hydrochloride__glutamate dehydrogenase__interaction
18835442-614	After intravenous administration of either <compound-id="6437371">DOTAP</compound-id>/<compound-id="304,5997,6432564,11025495">cholesterol</compound-id> or <compound-id="6913074">DOTMA</compound-id>/<compound-id="304,5997,6432564,11025495">cholesterol</compound-id> liposomes, serum <protein-id="O35734,O77510,O77764,P01375,P04924,P06804,P13296,P16599,P19101,P23383,P23563,P29553,P33620,P36939,P48094,P51435,P51742,P51743,P59684,P59693,P59694,P59695,P79337,P79374,Q06599,Q19LH4,Q1G1A2,Q1WM27,Q2MH05,Q539C2,Q75N23,Q8HZD9,Q8JFG3,Q8MKG8,Q8WNR1,Q9BEA1">TNFalpha</protein-id> and ALT levels were normal, suggesting that liver injury as well as cytokine production was caused by lipoplexes, but not by cationic liposomes.	cholesterol__TNFalpha__no_interaction	DOTMA__TNFalpha__no_interaction	DOTAP__TNFalpha__no_interaction
18835585-659	<compound-id="6830">GTP</compound-id> was the most potent regulator of <protein-id="P15160,P17724,P73925,Q03459">hemoglobin</protein-id> affinity, with concentrations of 5 mmol L(-1) causing an increase in p(50) from 5 to 19 mm Hg at pH 7.5, while the order of potency of the other phosphates was IHP&gt;ATP&gt;BPG.	GTP__hemoglobin__interaction
18835652-693	Functional inactivation of <protein-id="P35240,P59750">NF2</protein-id>/<compound-id="84098">merlin</compound-id> in human mesothelioma.	merlin__NF2__no_interaction
18835652-694	The tumor suppressor <compound-id="84098">merlin</compound-id> is encoded by the neurofibromatosis type 2 gene (<protein-id="P35240,P59750">NF2</protein-id>) which is located on chromosome 22q12 and mutations in this gene have been found in 40% of mesothelioma.	merlin__NF2__interaction
18835662-698	No main effect of group assignment on TSST responses was found for <protein-id="O35736,P05231,P08505,P20607,P26892,P26893,P29455,P41323,P41683,P41693,P46650,P51494,P79341,Q25BC2,Q28319,Q28747,Q28819,Q2MH06,Q5I6E3,Q6V919,Q865W7,Q865X6,Q8MKH0,Q95181,Q9MZR1,Q9XT80">IL-6</protein-id>, <compound-id="5754">cortisol</compound-id> or POMS scores.	cortisol__IL-6__no_interaction
18835763-723	The objective of this study was to determine: (i) the prevalence of resistance in current clinical isolates of Streptococcus pneumoniae, Staphylococcus aureus, Haemophilus influenzae, Moraxella catarrhalis and Klebsiella pneumoniae; (ii) the prevalence of production of extended-spectrum <protein-id="P80298,P80545,P81173">beta-lactamases</protein-id> (ESBLs) and <compound-id="6087">methicillin</compound-id> resistance in S. aureus; and (iii) regional differences in the prevalence of ESBL production and clonality of K. pneumoniae isolates.	methicillin__beta-lactamases__interaction
18835829-730	<compound-id="6076">cAMP</compound-id>-induced expression of the orphan nuclear receptor <protein-id="P12813">Nur77</protein-id> in MA-10 Leydig cells involves a <protein-id="Q9P7I2">CaMKI</protein-id> pathway.	cAMP__Nur77__interaction	cAMP__CaMKI__interaction
18835829-731	In Leydig cells, androgen biosynthesis is controlled primarily by the pituitary gonadotropin luteinizing hormone (LH) acting via its receptor (LH-R), which in turn activates the <protein-id="P00936,P08678,P0A1A7,P0A1A8,P0A4Y0,P0A4Y1,P14605,P23466,P27580,P30528,P40127,P40130,P40134,P40135,P43524,P49606,P59739,Q01513,Q01631,Q05766,Q59119,Q59685,Q8FBP0,Q8XAP1,Q9WXC3">adenylate cyclase</protein-id>/<compound-id="188955">cyclic adenosine monophosphate</compound-id> (<compound-id="6076">cAMP</compound-id>) signaling pathway.	cyclic adenosine monophosphate__adenylate cyclase__interaction	cAMP__adenylate cyclase__interaction
18835829-732	Here, we report that <compound-id="6076">cAMP</compound-id>-mediated induction of <protein-id="P12813">Nur77</protein-id> expression at the protein, mRNA, and promoter levels in MA-10 cells involves different mechanisms.	cAMP__Nur77__interaction
18835829-733	In addition, our detailed analysis of the <protein-id="P12813">Nur77</protein-id> promoter in MA-10 cells revealed that distinct regulatory elements are involved in basal and <compound-id="6076">cAMP</compound-id>-induced <protein-id="P12813">Nur77</protein-id> transcription.	cAMP__Nur77__interaction
18835830-734	Expression of <protein-id="O61309,O61608,Q27571,Q9I9M2">nitric oxide synthase</protein-id> during germ cell apoptosis in testis of cynomolgus monkey after <compound-id="6013">testosterone</compound-id> and heat treatment.	testosterone__nitric oxide synthase__interaction
18835831-735	Comparing expression of <compound-id="5994">progesterone</compound-id> and <protein-id="O42132,P03372,P06211,P06212,P16058,P19785,P49884,P49885,P49886,P50240,P50241,P50242,P57717,P57753,P81559,Q29040,Q53AD2,Q91250,Q91424,Q9PVZ9,Q9QZJ5,Q9TV98,Q9YH33,Q9YHT3,Q9YHZ7">estrogen receptors</protein-id> in testicular tissue from men with obstructive and nonobstructive azoospermia.	progesterone__estrogen receptors__no_interaction
18835926-762	Together, these results provide compelling evidence that <protein-id="Q8VI82,Q9EPC2">Fgf23</protein-id> does not have a klotho-independent role in the regulation of systemic phosphate and <compound-id="5280795">vitamin D</compound-id> homeostasis.	vitamin D__Fgf23__no_interaction
18835976-780	Based on fasting <protein-id="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7">insulin</protein-id> and <compound-id="206,5793,64689,79025">glucose</compound-id>, several indices of <protein-id="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7">insulin</protein-id> sensitivity have been developed in adults.	glucose__insulin__no_interaction
18835979-782	LDL from all subjects stimulated both the basal and <protein-id="P01015,P01016,P01017,P01019,P11859,P20757,P67885,P67886,Q9GLN8,Q9GLP6,Q9TSZ0">AngII</protein-id>-induced <compound-id="5839">aldosterone</compound-id> and <compound-id="5754">cortisol</compound-id> release from adrenocortical cells.	aldosterone__AngII__interaction	cortisol__AngII__interaction
18835981-786	Here we present evidence of distinct <compound-id="5291">STI571</compound-id>-induced modulation of <protein-id="P00520,P00522">abl</protein-id> functions using high-resolution live-cell imaging approaches.	STI571__abl__interaction
18835981-787	Quantitative analysis yielded 0.81 and 1.8 microM for EC(50) values of <compound-id="5291">STI571</compound-id>-induced cell edge translocation of <protein-id="P00520,P00522">abl</protein-id>-KD-<protein-id="P42212">green fluorescent protein</protein-id> (<protein-id="P42212">GFP</protein-id>) and wild-type <protein-id="P00520,P00522">abl</protein-id>-<protein-id="P42212">GFP</protein-id>, respectively.	STI571__GFP__interaction	STI571__abl__interaction	STI571__green fluorescent protein__interaction
18836089-2732	Association of the <protein-id="P08183,P21448">ABCB1</protein-id> gene polymorphisms 2677G&gt;T/A and 3435C&gt;T with clinical outcomes of <compound-id="4666,36314,441276,5352019,6713921,6915727,44155032,53313247">paclitaxel</compound-id> monotherapy in metastatic breast cancer patients.	paclitaxel__ABCB1__interaction
18836089-2733	We evaluated the association between clinical outcome (safety and efficacy) of <compound-id="4666,36314,441276,5352019,6713921,6915727,44155032,53313247">paclitaxel</compound-id> monotherapy in metastatic breast cancer patients with <protein-id="P08183,P21448">ABCB1</protein-id> gene polymorphisms 2677G&gt;T/A or 3435C&gt;T.	paclitaxel__ABCB1__interaction
18836137-847	<protein-id="O46678,O55235,P09340,P09341,P12850,P14095">CXCL1</protein-id>/KC was detected as early as 6 hours after <compound-id="456190,5360373,5460769">bleomycin</compound-id> instillation and returned to basal levels after Day 8.	bleomycin__CXCL1__interaction
18836137-848	DF2162 treatment reduced <compound-id="456190,5360373,5460769">bleomycin</compound-id>-induced expression of <protein-id="Q62935">von Willebrand Factor</protein-id>, a marker of angiogenesis, in the lung.	bleomycin__von Willebrand Factor__interaction
18836482-927	This was prevented by pretreatment of cells with the phosphatidylinositol 3-kinase (<protein-id="O00329,O02697,O35904,P23727,P26450,P27986,P32871,P42336,P42337,P42338,P42347,P42348,P48736,P54673,P54674,P54675,P54676,Q63787,Q8BTI9,Q8UUU2,Q9JHG7,Q9Z1L0">PI3K</protein-id>) inhibitor <compound-id="3973">LY294002</compound-id> or pharmacological inhibition of <protein-id="P31749,P31750,P47196,Q01314,Q8INB9">PKB</protein-id>.	LY294002__PI3K__no_interaction	LY294002__PKB__no_interaction
18836681-1004	<compound-id="3845">Kynurenic acid</compound-id> (<compound-id="3845">KYNA</compound-id>) is an agonist of the G-protein-coupled receptor <protein-id="Q9HC97">GPR35</protein-id>, which is predominantly expressed in gastrointestinal tissues.	Kynurenic acid__GPR35__interaction	KYNA__GPR35__interaction
18836710-1021	Molecular dynamics simulation techniques have been used to study the unbinding pathways of <compound-id="22811021">1alpha,25-dihydroxyvitamin D(3</compound-id>) from the ligand-binding pocket of the vitamin D receptor (<protein-id="O13124,O42392,P11473,P13053,P48281,P49701,Q28037,Q95MH5">VDR</protein-id>).	1alpha,25-dihydroxyvitamin D(3__VDR__interaction
18836740-1043	Activation of the Na+/K+-ATPase by <protein-id="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7">insulin</protein-id> and <compound-id="206,5793,64689,79025">glucose</compound-id> as a putative negative feedback mechanism in pancreatic beta-cells.	glucose__insulin__no_interaction
18836740-1046	Inhibiting <protein-id="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7">insulin</protein-id> signalling in SUR1 (-/-) beta-cells blunted the <compound-id="206,5793,64689,79025">glucose</compound-id>-induced decrease of [Ca(2+)](c).	glucose__insulin__interaction
18836843-1091	Relaxation to <protein-id="P10286,P30880,P30881,P31888,P80511">CGRP</protein-id> (10(-8) M) was unaffected by L-NAME (3 x 10(-4) M) and <compound-id="3715">indomethacin</compound-id> (10(-6) M) suggesting no involvement of <compound-id="145068">nitric oxide</compound-id> or prostaglandins in the <protein-id="P10286,P30880,P30881,P31888,P80511">CGRP</protein-id>-induced relaxation.	nitric oxide__CGRP__no_interaction	indomethacin__CGRP__no_interaction
18836851-1099	In the mouse model of demyelination-remyelination induced by oral administration of <compound-id="9723">cuprizone</compound-id>, in situ hybridization showed an upregulation of the <protein-id="Q08345,Q7YR43">DDR1</protein-id> gene in three different white matter areas (corpus callosum, dorsal fornix, and external capsule) during the remyelination period.	cuprizone__DDR1__interaction
18836851-1100	Cells positive for <protein-id="Q08345,Q7YR43">DDR1</protein-id> mRNA were also positive for oligodendrocyte markers (<protein-id="Q13516,Q90XB3">OLIG2</protein-id>, <compound-id="9369,439224">carnosine</compound-id>, and <protein-id="P25054">APC</protein-id>) but not for markers of oligodendrocyte precursors (<protein-id="Q99942">NG2</protein-id>), myelin markers (<protein-id="P06623,P09543,P13233,P16330">CNPase</protein-id>), microglia (CD11b), or reactive glia (<protein-id="P03995,P14136,P47819,Q28115">GFAP</protein-id>).	carnosine__APC__no_interaction	carnosine__CNPase__no_interaction	carnosine__GFAP__no_interaction	carnosine__DDR1__interaction	carnosine__NG2__no_interaction	carnosine__OLIG2__no_interaction
18836996-1126	By conducting this initial screen on EMT6 cells and applying protein function and genomic structure criteria to genes identified as upregulated in response to <compound-id="451668">5-azadC</compound-id>/TSA, we were able to identify two characterized breast cancer TSGs (<protein-id="O73746,P39876,P48032">Timp3</protein-id> and Rprm) and four putative TSGs (Atp1B2, <protein-id="Q05922">Dusp2</protein-id>, <protein-id="Q5M7N6">FoxJ1</protein-id> and <protein-id="O35049,Q9JJY3">Smpd3</protein-id>) silenced in this line.	5-azadC__Dusp2__interaction	5-azadC__Timp3__interaction	5-azadC__FoxJ1__interaction	5-azadC__Smpd3__interaction
18837008-1129	Therapeutic strategy to rescue mutation-induced exon skipping in <protein-id="O16005,O16017,O16018,O16019,O16020,O18312,O18315,O18481,O18485,O18486,O18766,O42268,O42294,O42300,O42301,O42307,O42327,O42328,O42330,O42427,O42431,O42451,O42452,O42466,O42604,O62791,O62792,O62793,O62794,O62795,O62796,O62798,O93441,O93459,P02699,P02700,P08100,P09241,P15409,P22328,P22671,P24603,P28681,P29403,P31355,P31356,P32308,P32309,P35356,P35359,P35362,P35403,P41590,P41591,P49912,P51470,P51488,P51489,P52202,P56514,P56515,P56516,P79756,P79798,P79807,P79808,P79809,P79812,P79848,P79863,P79898,P79901,P79902,P79903,P79911,P79914,P87369,Q17094,Q17292,Q17296,Q28886,Q68J47,Q6W3E1,Q769E8,Q8HY69,Q90245,Q90305,Q90373,Q95KU1,Q98980,Q9DGG4,Q9YGY9,Q9YGZ0,Q9YGZ1,Q9YGZ2,Q9YGZ3,Q9YGZ4,Q9YGZ5,Q9YGZ6,Q9YGZ7,Q9YGZ8,Q9YGZ9,Q9YH00,Q9YH01,Q9YH02,Q9YH03,Q9YH04,Q9YH05">rhodopsin</protein-id> by adaptation of <compound-id="23989">U1</compound-id> snRNA.	U1__rhodopsin__interaction
18837008-1130	As a therapeutic strategy, <compound-id="23989">U1</compound-id> snRNAs were adapted to the novel <protein-id="O16005,O16017,O16018,O16019,O16020,O18312,O18315,O18481,O18485,O18486,O18766,O42268,O42294,O42300,O42301,O42307,O42327,O42328,O42330,O42427,O42431,O42451,O42452,O42466,O42604,O62791,O62792,O62793,O62794,O62795,O62796,O62798,O93441,O93459,P01122,P02699,P02700,P08100,P09241,P22328,P22671,P24603,P28681,P30403,P31355,P31356,P32308,P32309,P35356,P35403,P41590,P41591,P49912,P51470,P51488,P52202,P56514,P56515,P56516,P79756,P79798,P79807,P79808,P79809,P79812,P79848,P79863,P79898,P79901,P79902,P79903,P79911,P79914,P87369,Q17094,Q28886,Q68J47,Q6W3E1,Q769E8,Q8HY69,Q90245,Q90305,Q90373,Q95KU1,Q98980,Q9DGG4,Q9YGY9,Q9YGZ0,Q9YGZ1,Q9YGZ2,Q9YGZ3,Q9YGZ4,Q9YGZ5,Q9YGZ6,Q9YGZ7,Q9YGZ8,Q9YGZ9,Q9YH00,Q9YH01,Q9YH02,Q9YH03,Q9YH04,Q9YH05">RHO</protein-id> mutation and tested for its potential to reverse missplicing.	U1__RHO__interaction
18837469-2746	Urinary concentrations of <compound-id="176907">dihydrodaidzein</compound-id>, <compound-id="9838356">dihydrogenistein</compound-id>, <compound-id="89472">O-desmethylangolensin</compound-id>, and <compound-id="91469,382975">equol</compound-id> exceeded <protein-id="P28172,P51526">IFN</protein-id> aglycone equivalents.	dihydrodaidzein__IFN__no_interaction	equol__IFN__no_interaction	O-desmethylangolensin__IFN__no_interaction	dihydrogenistein__IFN__no_interaction
18837470-2752	Concentrations of <compound-id="206,5793,64689,79025">glucose</compound-id>, <protein-id="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7">insulin</protein-id>, C-peptide, nonesterified fatty acids, triacylglycerol, total and exogenous <compound-id="206,5793,64689,79025">glucose</compound-id> kinetics were assessed for 6 h postprandially.	glucose__insulin__no_interaction
18837470-2754	After 120 min, <compound-id="206,5793,64689,79025">glucose</compound-id> and <protein-id="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7">insulin</protein-id> responses declined, but remained higher after the Pol 0.05) in parallel to the inhibition of lipolysis.	glucose__insulin__no_interaction
18837522-1374	Keeping <compound-id="1174">uracil</compound-id> out of DNA: physiological role, structure and catalytic mechanism of <protein-id="O25536,O27642,O29157,O30931,O41033,O48500,O52597,O54134,O66592,O68992,O83855,O84294,P03195,P03370,P06968,P09254,P0A552,P0A553,P10234,P14597,P16088,P16824,P16901,P17374,P19028,P23426,P23427,P28892,P28893,P30007,P31625,P31822,P32208,P32518,P33316,P33317,P33826,P35956,P43058,P43792,P52341,P52541,P57623,P57914,P59408,P61906,P61907,P61908,P61909,P61910,P61911,P61912,P61913,P64004,P64005,P64006,P64007,P64008,P64009,P68634,P68635,P70583,P87630,Q00030,Q01034,Q06095,Q07275,Q2Y742,Q2YRG4,Q31EC7,Q31UY6,Q329L7,Q39DM5,Q39V99,Q3A499,Q3AQ75,Q3B304,Q3BNA6,Q3J0B2,Q3J6W1,Q3JV72,Q3K4M6,Q3KM70,Q3SFR7,Q3SWM9,Q3YRU2,Q3YW02,Q45920,Q47BB1,Q47NK1,Q48Q06,Q491W8,Q49992,Q4FU67,Q4JVB1,Q4K3S2,Q4QLV3,Q4ULV2,Q4UPP2,Q4ZZX9,Q57BK5,Q57IA2,Q58502,Q5F9E0,Q5FN20,Q5GST1,Q5H5L9,Q5L6D8,Q5LIH9,Q5LWD3,Q5NHX4,Q5P7Z9,Q5PAE6,Q5PC28,Q5QZB6,Q5WTW6,Q5X242,Q5YT90,Q5ZSN0,Q603M1,Q62HL1,Q63WI6,Q64ZK3,Q65R66,Q66GD8,Q68WX8,Q69151,Q6A8W1,Q6AFE0,Q6AJZ0,Q6BRN7,Q6C141,Q6CQN7,Q6DAV9,Q6E4Q0,Q6FDR0,Q6FKQ6,Q6FYR2,Q6G202,Q6MEK7,Q6MVL2,Q6RZR1,Q6TUZ4,Q74ZF0,Q76RE7,Q775Z7,Q7M9N1,Q7MAX3,Q7MBE8,Q7MVT6,Q7NKL2,Q7VJU0,Q7VN49,Q7VRK0,Q7VVR1,Q7W8Z8,Q7WKE3,Q823Q9,Q82KK4,Q82UM1,Q83G43,Q83I22,Q83PN3,Q87F19,Q88BD3,Q88C95,Q895R1,Q89662,Q8A245,Q8D2F3,Q8E9M0,Q8F729,Q8FPH9,Q8G4E8,Q8K921,Q8NPA9,Q8P458,Q8PFR5,Q8PWG1,Q8RA46,Q8RER7,Q8SRS0,Q8TGX9,Q8TV34,Q8UII1,Q8V2Y0,Q8XWL1,Q8ZJP5,Q90030,Q92I74,Q92SM6,Q97J61,Q98C10,Q9A253,Q9CJ30,Q9F7S4,Q9HMF3,Q9HTN3,Q9J5G5,Q9JUW1,Q9JZU7,Q9P6Q5,Q9PGZ6,Q9PKA2,Q9X3X5,Q9YG32,Q9YYS0,Q9Z9C2,Q9ZDD2,Q9ZKY3">dUTPases</protein-id>.	uracil__dUTPases__interaction
18837522-1375	To prevent <compound-id="1174">uracil</compound-id> incorporation into DNA, representatives of the dUTP nucleotidohydrolase (<protein-id="O25536,O27642,O29157,O30931,O41033,O48500,O52597,O54134,O66592,O68992,O83855,O84294,P03195,P03370,P06968,P09254,P0A552,P0A553,P10234,P14597,P16088,P16824,P16901,P17374,P19028,P23426,P23427,P28892,P28893,P30007,P31625,P31822,P32208,P32518,P33316,P33317,P33826,P35956,P43058,P43792,P52341,P52541,P57623,P57914,P59408,P61906,P61907,P61908,P61909,P61910,P61911,P61912,P61913,P64004,P64005,P64006,P64007,P64008,P64009,P68634,P68635,P70583,P87630,Q00030,Q01034,Q06095,Q07275,Q2Y742,Q2YRG4,Q31EC7,Q31UY6,Q329L7,Q39DM5,Q39V99,Q3A499,Q3AQ75,Q3B304,Q3BNA6,Q3J0B2,Q3J6W1,Q3JV72,Q3K4M6,Q3KM70,Q3SFR7,Q3SWM9,Q3YRU2,Q3YW02,Q45920,Q47BB1,Q47NK1,Q48Q06,Q491W8,Q49992,Q4FU67,Q4JVB1,Q4K3S2,Q4QLV3,Q4ULV2,Q4UPP2,Q4ZZX9,Q57BK5,Q57IA2,Q58502,Q5F9E0,Q5FN20,Q5GST1,Q5H5L9,Q5L6D8,Q5LIH9,Q5LWD3,Q5NHX4,Q5P7Z9,Q5PAE6,Q5PC28,Q5QZB6,Q5WTW6,Q5X242,Q5YT90,Q5ZSN0,Q603M1,Q62HL1,Q63WI6,Q64ZK3,Q65R66,Q66GD8,Q68WX8,Q69151,Q6A8W1,Q6AFE0,Q6AJZ0,Q6BRN7,Q6C141,Q6CQN7,Q6DAV9,Q6E4Q0,Q6FDR0,Q6FKQ6,Q6FYR2,Q6G202,Q6MEK7,Q6MVL2,Q6RZR1,Q6TUZ4,Q74ZF0,Q76RE7,Q775Z7,Q7M9N1,Q7MAX3,Q7MBE8,Q7MVT6,Q7NKL2,Q7VJU0,Q7VN49,Q7VRK0,Q7VVR1,Q7W8Z8,Q7WKE3,Q823Q9,Q82KK4,Q82UM1,Q83G43,Q83I22,Q83PN3,Q87F19,Q88BD3,Q88C95,Q895R1,Q89662,Q8A245,Q8D2F3,Q8E9M0,Q8F729,Q8FPH9,Q8G4E8,Q8K921,Q8NPA9,Q8P458,Q8PFR5,Q8PWG1,Q8RA46,Q8RER7,Q8SRS0,Q8TGX9,Q8TV34,Q8UII1,Q8V2Y0,Q8XWL1,Q8ZJP5,Q90030,Q92I74,Q92SM6,Q97J61,Q98C10,Q9A253,Q9CJ30,Q9F7S4,Q9HMF3,Q9HTN3,Q9J5G5,Q9JUW1,Q9JZU7,Q9P6Q5,Q9PGZ6,Q9PKA2,Q9X3X5,Q9YG32,Q9YYS0,Q9Z9C2,Q9ZDD2,Q9ZKY3">dUTPase</protein-id>) enzyme family eliminate excess dUTP.	uracil__dUTPase__interaction
18837522-1376	The <protein-id="O25536,O27642,O29157,O30931,O41033,O48500,O52597,O54134,O66592,O68992,O83855,O84294,P03195,P03370,P06968,P09254,P0A552,P0A553,P10234,P14597,P16088,P16824,P16901,P17374,P19028,P23426,P23427,P28892,P28893,P30007,P31625,P31822,P32208,P32518,P33316,P33317,P33826,P35956,P43058,P43792,P52341,P52541,P57623,P57914,P59408,P61906,P61907,P61908,P61909,P61910,P61911,P61912,P61913,P64004,P64005,P64006,P64007,P64008,P64009,P68634,P68635,P70583,P87630,Q00030,Q01034,Q06095,Q07275,Q2Y742,Q2YRG4,Q31EC7,Q31UY6,Q329L7,Q39DM5,Q39V99,Q3A499,Q3AQ75,Q3B304,Q3BNA6,Q3J0B2,Q3J6W1,Q3JV72,Q3K4M6,Q3KM70,Q3SFR7,Q3SWM9,Q3YRU2,Q3YW02,Q45920,Q47BB1,Q47NK1,Q48Q06,Q491W8,Q49992,Q4FU67,Q4JVB1,Q4K3S2,Q4QLV3,Q4ULV2,Q4UPP2,Q4ZZX9,Q57BK5,Q57IA2,Q58502,Q5F9E0,Q5FN20,Q5GST1,Q5H5L9,Q5L6D8,Q5LIH9,Q5LWD3,Q5NHX4,Q5P7Z9,Q5PAE6,Q5PC28,Q5QZB6,Q5WTW6,Q5X242,Q5YT90,Q5ZSN0,Q603M1,Q62HL1,Q63WI6,Q64ZK3,Q65R66,Q66GD8,Q68WX8,Q69151,Q6A8W1,Q6AFE0,Q6AJZ0,Q6BRN7,Q6C141,Q6CQN7,Q6DAV9,Q6E4Q0,Q6FDR0,Q6FKQ6,Q6FYR2,Q6G202,Q6MEK7,Q6MVL2,Q6RZR1,Q6TUZ4,Q74ZF0,Q76RE7,Q775Z7,Q7M9N1,Q7MAX3,Q7MBE8,Q7MVT6,Q7NKL2,Q7VJU0,Q7VN49,Q7VRK0,Q7VVR1,Q7W8Z8,Q7WKE3,Q823Q9,Q82KK4,Q82UM1,Q83G43,Q83I22,Q83PN3,Q87F19,Q88BD3,Q88C95,Q895R1,Q89662,Q8A245,Q8D2F3,Q8E9M0,Q8F729,Q8FPH9,Q8G4E8,Q8K921,Q8NPA9,Q8P458,Q8PFR5,Q8PWG1,Q8RA46,Q8RER7,Q8SRS0,Q8TGX9,Q8TV34,Q8UII1,Q8V2Y0,Q8XWL1,Q8ZJP5,Q90030,Q92I74,Q92SM6,Q97J61,Q98C10,Q9A253,Q9CJ30,Q9F7S4,Q9HMF3,Q9HTN3,Q9J5G5,Q9JUW1,Q9JZU7,Q9P6Q5,Q9PGZ6,Q9PKA2,Q9X3X5,Q9YG32,Q9YYS0,Q9Z9C2,Q9ZDD2,Q9ZKY3">dUTPase</protein-id> binding pocket is highly specific for <compound-id="1174">uracil</compound-id>.	uracil__dUTPase__interaction
18837522-1377	<compound-id="1061,167704,644102">Phosphate</compound-id> chain coordination involves Mg2+ and is analogous to that of <protein-id="O27276,O29753,O33845,O57191,O59610,O64235,O70736,O71121,O72539,O72540,P00581,P03158,P03198,P03261,P03680,P04292,P04293,P04415,P04495,P05468,P05664,P06225,P06538,P06856,P06950,P07917,P07918,P08546,P09252,P09804,P09854,P10479,P10582,P18131,P19822,P19894,P20311,P20509,P21402,P24907,P27172,P28857,P28858,P28859,P30314,P30317,P30318,P30319,P30320,P30321,P33793,P41712,P42489,P43139,P48311,P52025,P52342,P52367,P56689,P61875,P61876,P74918,P77933,P87503,P87553,Q05254,Q37882,Q37989,Q38087,Q51334,Q56366,Q58295,Q5UQR0,Q64751,Q65946,Q69025,Q6S6P1,Q83948,Q84173,Q85428,Q88469,Q90162,Q9HH05,Q9HH84,Q9YUS2,Q9YUS3">DNA polymerases</protein-id>.	Phosphate__DNA polymerases__interaction
18837522-1378	In these respective pathogens, Plasmodium falciparum and Mycobacterium tuberculosis, the biosynthesis of <compound-id="9700">dTMP</compound-id> relies exclusively on <protein-id="O25536,O27642,O29157,O30931,O41033,O48500,O52597,O54134,O66592,O68992,O83855,O84294,P03195,P03370,P06968,P09254,P0A552,P0A553,P10234,P14597,P16088,P16824,P16901,P17374,P19028,P23426,P23427,P28892,P28893,P30007,P31625,P31822,P32208,P32518,P33316,P33317,P33826,P35956,P43058,P43792,P52341,P52541,P57623,P57914,P59408,P61906,P61907,P61908,P61909,P61910,P61911,P61912,P61913,P64004,P64005,P64006,P64007,P64008,P64009,P68634,P68635,P70583,P87630,Q00030,Q01034,Q06095,Q07275,Q2Y742,Q2YRG4,Q31EC7,Q31UY6,Q329L7,Q39DM5,Q39V99,Q3A499,Q3AQ75,Q3B304,Q3BNA6,Q3J0B2,Q3J6W1,Q3JV72,Q3K4M6,Q3KM70,Q3SFR7,Q3SWM9,Q3YRU2,Q3YW02,Q45920,Q47BB1,Q47NK1,Q48Q06,Q491W8,Q49992,Q4FU67,Q4JVB1,Q4K3S2,Q4QLV3,Q4ULV2,Q4UPP2,Q4ZZX9,Q57BK5,Q57IA2,Q58502,Q5F9E0,Q5FN20,Q5GST1,Q5H5L9,Q5L6D8,Q5LIH9,Q5LWD3,Q5NHX4,Q5P7Z9,Q5PAE6,Q5PC28,Q5QZB6,Q5WTW6,Q5X242,Q5YT90,Q5ZSN0,Q603M1,Q62HL1,Q63WI6,Q64ZK3,Q65R66,Q66GD8,Q68WX8,Q69151,Q6A8W1,Q6AFE0,Q6AJZ0,Q6BRN7,Q6C141,Q6CQN7,Q6DAV9,Q6E4Q0,Q6FDR0,Q6FKQ6,Q6FYR2,Q6G202,Q6MEK7,Q6MVL2,Q6RZR1,Q6TUZ4,Q74ZF0,Q76RE7,Q775Z7,Q7M9N1,Q7MAX3,Q7MBE8,Q7MVT6,Q7NKL2,Q7VJU0,Q7VN49,Q7VRK0,Q7VVR1,Q7W8Z8,Q7WKE3,Q823Q9,Q82KK4,Q82UM1,Q83G43,Q83I22,Q83PN3,Q87F19,Q88BD3,Q88C95,Q895R1,Q89662,Q8A245,Q8D2F3,Q8E9M0,Q8F729,Q8FPH9,Q8G4E8,Q8K921,Q8NPA9,Q8P458,Q8PFR5,Q8PWG1,Q8RA46,Q8RER7,Q8SRS0,Q8TGX9,Q8TV34,Q8UII1,Q8V2Y0,Q8XWL1,Q8ZJP5,Q90030,Q92I74,Q92SM6,Q97J61,Q98C10,Q9A253,Q9CJ30,Q9F7S4,Q9HMF3,Q9HTN3,Q9J5G5,Q9JUW1,Q9JZU7,Q9P6Q5,Q9PGZ6,Q9PKA2,Q9X3X5,Q9YG32,Q9YYS0,Q9Z9C2,Q9ZDD2,Q9ZKY3">dUTPase</protein-id> activity.	dTMP__dUTPase__interaction
18837652-1413	Furthermore, NaHS enhanced inhibitory effects of <compound-id="2214">apocynin</compound-id>, <compound-id="12035">N-acetyl-l-cysteine</compound-id> (NAC), <compound-id="124886">reduced glutathione</compound-id> (<compound-id="124886">GSH</compound-id>), <protein-id="O24339,O52762,O62839,O68146,O77229,O93662,O97492,P00432,P04040,P04762,P07145,P0A323,P0A324,P0A325,P0A326,P0A327,P11934,P17336,P24168,P24270,P25890,P29422,P30265,P30266,P32290,P42321,P44390,P45737,P45739,P55304,P55306,P55310,P55311,P55313,P77872,P81138,P90682,Q27710,Q49XC1,Q4L643,Q59296,Q59337,Q59602,Q59714,Q5HG86,Q5HPK8,Q5RF10,Q64405,Q6G9M4,Q6GH72,Q7A5T2,Q8CPD0,Q8FWU0,Q8NWV5,Q8X1P0,Q8Y3P9,Q926X0,Q99UE2,Q9AXH0,Q9KW19,Q9L4S1,Q9M5L6,Q9PT92,Q9PWF7,Q9Z598,Q9ZKX5,Q9ZN99">catalase</protein-id> (<protein-id="O62839,O97492,P00432,P00485,P00486,P00487,P04040,P06135,P07641,P11504,P20074,P22782,P25309,P25819,P26825,P26826,P32796,P36882,P36883,P43155,P47934,P49417,P52826,P58777,P62577,P62578,P62579,P62580,P90682,Q00614,Q02736,Q03058,Q5RF10,Q64405,Q704S8,Q9M5L6,Q9PWF7">CAT</protein-id>), <protein-id="O50258">superoxide dismutase</protein-id> (<protein-id="O12933,O22668,O75007,P24705,P51547,P93258,Q01137,Q27666,Q9SM64">SOD</protein-id>), Nomega-nitro-<compound-id="550788">l-arginine methyl ester</compound-id> (L-NAME) on ROS production and redox enzymes levels induced by Met.	l-arginine methyl ester__CAT__no_interaction	N-acetyl-l-cysteine__SOD__no_interaction	apocynin__SOD__no_interaction	reduced glutathione__catalase__no_interaction	GSH__SOD__no_interaction	apocynin__catalase__no_interaction	reduced glutathione__SOD__no_interaction	apocynin__CAT__no_interaction	GSH__superoxide dismutase__no_interaction	apocynin__superoxide dismutase__no_interaction	reduced glutathione__superoxide dismutase__no_interaction	GSH__CAT__no_interaction	N-acetyl-l-cysteine__superoxide dismutase__no_interaction	N-acetyl-l-cysteine__catalase__no_interaction	reduced glutathione__CAT__no_interaction	l-arginine methyl ester__SOD__no_interaction	GSH__catalase__no_interaction	N-acetyl-l-cysteine__CAT__no_interaction	l-arginine methyl ester__catalase__no_interaction	l-arginine methyl ester__superoxide dismutase__no_interaction
18837698-1429	It controls the expression of a total of 11 genes, the <protein-id="P24716,Q02540">CopR</protein-id> regulon, in a <compound-id="23978">copper</compound-id>-dependent manner.	copper__CopR__interaction
18838074-1535	In this article, the intracellular signal transduction mechanisms mediating the actions of some of these regulators, including <protein-id="P47744">GTH</protein-id>-releasing hormones, <protein-id="P41585,P48144,P81039">pituitary adenylate cyclase-activating polypeptide</protein-id>, <compound-id="681">dopamine</compound-id>, <protein-id="Q6BEG6,Q6BEG7,Q9BDJ6,Q9BEF8,Q9EQX0,Q9GKY5,Q9QYH7,Q9UBU3">ghrelin</protein-id>, sex steroids, activin, and follistatin from experiments with goldfish are reviewed and discussed in relation with recent findings.	dopamine__pituitary adenylate cyclase-activating polypeptide__no_interaction	dopamine__ghrelin__no_interaction	dopamine__GTH__no_interaction
18838074-1536	Goldfish gonadotropes possess multiple pharmacologically distinct intracellular Ca2+ stores that together with voltage-sensitive Ca2+ channels, Na+/H+ exchangers, <protein-id="P13678,Q25378">protein kinase C</protein-id>, <compound-id="444899">arachidonic acid</compound-id>, NO, <protein-id="Q05608,Q9RI12">protein kinase A</protein-id>, <protein-id="P29323">ERK</protein-id>/<protein-id="O42781,P27638,Q00859">MAPK</protein-id>, and Smads allows for integrated control by different neuroendocrine factors.	arachidonic acid__MAPK__no_interaction	arachidonic acid__ERK__no_interaction	arachidonic acid__protein kinase C__no_interaction	arachidonic acid__protein kinase A__no_interaction
18838089-1541	An enzymatic reaction between <compound-id="784">hydrogen peroxide</compound-id> and <protein-id="O24339,O52762,O62839,O68146,O77229,O93662,O97492,P00432,P04040,P04762,P07145,P0A323,P0A324,P0A325,P0A326,P0A327,P11934,P17336,P24168,P24270,P25890,P29422,P30265,P30266,P32290,P42321,P44390,P45737,P45739,P55304,P55306,P55310,P55311,P55313,P77872,P81138,P90682,Q27710,Q49XC1,Q4L643,Q59296,Q59337,Q59602,Q59714,Q5HG86,Q5HPK8,Q5RF10,Q64405,Q6G9M4,Q6GH72,Q7A5T2,Q8CPD0,Q8FWU0,Q8NWV5,Q8X1P0,Q8Y3P9,Q926X0,Q99UE2,Q9AXH0,Q9KW19,Q9L4S1,Q9M5L6,Q9PT92,Q9PWF7,Q9Z598,Q9ZKX5,Q9ZN99">catalase</protein-id> produced oxygen bubbles and thus many internal pores within microsphere were naturally developed.	hydrogen peroxide__catalase__interaction
18838102-1545	The foregoing three main anatomic loci of control are regulated by intermittent time-delayed signal exchange, principally via <protein-id="P27429">gonadotropin-releasing hormone</protein-id> (<protein-id="P27429">GnRH</protein-id>), luteinizing hormone (LH) and <compound-id="6013">testosterone</compound-id>/<compound-id="5757">estradiol</compound-id> (Te/E(2)).	estradiol__GnRH__no_interaction	estradiol__gonadotropin-releasing hormone__no_interaction	testosterone__gonadotropin-releasing hormone__no_interaction	testosterone__GnRH__no_interaction
18838266-1623	We present a robust and simple method for the direct detection of multiple point mutations in the Mycobacterium tuberculosis <protein-id="O52271,O67762,O78485,O83269,O84317,O86094,O87903,P06173,P06271,P06272,P08036,P0A680,P0A681,P0A8V2,P0A8V3,P0A8V4,P0A8V5,P0C151,P11513,P11703,P12091,P16023,P19175,P21421,P22703,P23579,P27059,P29398,P30760,P31814,P36251,P36440,P37870,P41184,P41187,P41557,P41607,P43738,P46818,P47583,P47715,P47767,P47768,P48119,P49466,P50546,P51252,P56299,P56869,P57009,P57146,P59642,P59643,P60278,P60279,P60280,P60281,P60282,P60283,P77941,P77965,P78013,Q03587,Q1XDN5,Q20EX1,Q2FJ98,Q2GCD7,Q2GD90,Q2GJ68,Q2II86,Q2JFI5,Q2JJ19,Q2JX64,Q2L2M3,Q2L8Z9,Q2LQ87,Q2MIA8,Q2MIJ5,Q2NJ15,Q2NWR6,Q2NZX8,Q2RFN9,Q2RQV3,Q2S1Q5,Q2S905,Q2ST48,Q2SU19,Q2VEI4,Q2W2I1,Q2YB05,Q2YM15,Q2YSB9,Q30TP7,Q30X05,Q318Q7,Q31IY9,Q31N17,Q31U10,Q32AF9,Q32RG0,Q32RW5,Q33C46,Q38UQ2,Q39KH5,Q39Y13,Q3A6Q4,Q3A9Q7,Q3AHX5,Q3ATP5,Q3AZA4,Q3B1H7,Q3BAP8,Q3BWZ1,Q3C1G7,Q3ILP9,Q3J5T0,Q3J8Q7,Q3JMQ3,Q3K3L2,Q3K5Y1,Q3KM47,Q3M5D0,Q3SLQ6,Q3SSY0,Q3V542,Q3YST5,Q3YUZ7,Q3Z8V4,Q3ZJ93,Q3ZX01,Q46124,Q46J22,Q46WD4,Q47JB0,Q47LI5,Q47UV9,Q48D29,Q48VR1,Q492B9,Q49L06,Q49V52,Q4A5S7,Q4A7A9,Q4A969,Q4FLL2,Q4FQH3,Q4G3A7,Q4JT32,Q4K526,Q4L3K3,Q4MY95,Q4QN33,Q4UKD4,Q4URD2,Q4VZP1,Q4ZMN7,Q50388,Q51561,Q56P13,Q57CP8,Q57H69,Q589C0,Q59191,Q59622,Q5E238,Q5F5R5,Q5FFD9,Q5FM97,Q5FTX7,Q5GWS6,Q5HC05,Q5HID3,Q5HRL0,Q5HVY9,Q5L405,Q5L5I3,Q5L897,Q5LMQ5,Q5LXV3,Q5M2F5,Q5MZ23,Q5NID2,Q5NPK5,Q5P339,Q5PBG4,Q5PK93,Q5QA72,Q5QWA5,Q5SCX8,Q5WLS0,Q5WZL9,Q5X866,Q5XE97,Q5ZYQ0,Q5ZZS1,Q60A06,Q63H98,Q63Q03,Q64NJ7,Q65PB5,Q65W41,Q661M9,Q66FQ2,Q67JT3,Q68S14,Q6A6K6,Q6ACX5,Q6AP78,Q6B8R8,Q6DAN0,Q6ENI4,Q6ENX3,Q6EW56,Q6F0L7,Q6FF90,Q6GBU5,Q6GJC6,Q6HPR6,Q6KI09,Q6L3A7,Q6LLW2,Q6MDM1,Q6MJ09,Q6MRX6,Q6N4R9,Q6YQW3,Q724F0,Q727C7,Q72HM5,Q72UA8,Q73FA4,Q73JJ7,Q73SE4,Q748Y6,Q74L95,Q7MGR8,Q7MX27,Q7N9A4,Q7NIA0,Q7NQE6,Q7U8K4,Q7URW6,Q7V006,Q7V5P1,Q7VA29,Q7VKL7,Q7VRP7,Q7W0R9,Q7W2G9,Q7WRD9,Q7YJX8,Q81J48,Q81VT8,Q822J1,Q82DQ5,Q82T75,Q82Z40,Q85BW1,Q85FM7,Q85FR7,Q85X54,Q87A32,Q87KQ4,Q889X8,Q88QP2,Q88XZ3,Q890N4,Q89B20,Q89J74,Q8A469,Q8CQ84,Q8D233,Q8DD20,Q8DL55,Q8DNF0,Q8DS46,Q8E239,Q8E7J8,Q8EK74,Q8ETY8,Q8EWX1,Q8F0S2,Q8FS97,Q8G069,Q8G514,Q8GCR3,Q8GCR4,Q8GCR5,Q8GCR6,Q8HVY5,Q8K8W3,Q8KG15,Q8KWX2,Q8KWX4,Q8MA12,Q8NT26,Q8P2Y3,Q8PC56,Q8PNT0,Q8R7U6,Q8RHI6,Q8RQE9,Q8S8X9,Q8UE08,Q8WI24,Q8XUZ8,Q8YHP8,Q8Z320,Q8ZAP5,Q92F22,Q92QH7,Q932F8,Q93GF2,Q93MK7,Q93MK8,Q93MK9,Q93R88,Q97EG9,Q97NQ7,Q98N66,Q98Q23,Q9A1U1,Q9AAU2,Q9AIU3,Q9BBS9,Q9CEN6,Q9CK91,Q9F3X8,Q9KJG4,Q9KJM5,Q9KK59,Q9KV30,Q9KW14,Q9KWU7,Q9L0L0,Q9L637,Q9MTM5,Q9MUS5,Q9PA86,Q9PQV6,Q9RH41,Q9RH43,Q9RLT9,Q9RQZ7,Q9RVV9,Q9TL06,Q9TM35,Q9X6Y1,Q9XPS7,Q9Z9A0,Q9Z9M2">rpoB</protein-id> gene during the development of <compound-id="5381226">rifampin</compound-id> (RIF) resistance using an electrochemical genosensor.	rifampin__rpoB__interaction
18838482-1670	The main source of extracellular <compound-id="60961">adenosine</compound-id> stems from a coordinated two-step enzymatic conversion of precursor nucleotides via the <protein-id="O18956,O75355,O93295,P49961,P55772,P97687,Q9MYU4">ecto-apyrase</protein-id> (<protein-id="O18956,O93295,P49961,Q9MYU4">CD39</protein-id>) and the <protein-id="P21588,P21589,Q05927,Q61503">ecto-5'-nucleotidase</protein-id> (CD73).	adenosine__ecto-apyrase__interaction	adenosine__CD39__interaction	adenosine__ecto-5'-nucleotidase__interaction
18838483-2012	Critical role of <protein-id="O62664,O97554,P05979,P22437,P23219,Q63921,Q9T0N8">COX-1</protein-id> in <compound-id="5280427,5282411,6434194">prostacyclin</compound-id> production by human endothelial cells under modification of <compound-id="784">hydroperoxide</compound-id> tone.	hydroperoxide__COX-1__no_interaction	prostacyclin__COX-1__interaction
18838483-2013	We aimed at evaluating the relative contribution of cyclooxygenase (<protein-id="P11353,P36551,P36552,Q9UTE2,Q9V3D2">COX</protein-id>)-1 and <protein-id="O02768,O19183,O62698,O62725,P27607,P35354,P35355,P70682,P79208,Q05769">COX-2</protein-id> to the synthesis of <compound-id="5280427,5282411,6434194">prostacyclin</compound-id> in endothelial cells under static conditions in the presence or absence of exogenous <compound-id="444899">arachidonic acid</compound-id> and/or altered intracellular redox balance.	arachidonic acid__COX__no_interaction	arachidonic acid__COX-2__no_interaction	prostacyclin__COX-2__interaction	prostacyclin__COX__interaction
18838503-1683	In contrast, <protein-id="P10635,Q2XNC8,Q2XNC9">CYP2D6</protein-id>.24, <protein-id="P10635,Q2XNC8,Q2XNC9">CYP2D6</protein-id>.26, and <protein-id="P10635,Q2XNC8,Q2XNC9">CYP2D6</protein-id>.27 allelic isoforms all showed active drug-metabolizing activities toward both <compound-id="5284371">codeine</compound-id> and <compound-id="3008,5360696,5362449,12305042">dextromethorphan</compound-id> O-demethylation.	dextromethorphan__CYP2D6__interaction	codeine__CYP2D6__interaction
18838506-1689	Mechanism-based inactivation of <protein-id="P11712">cytochrome P450 2C9</protein-id> by <compound-id="38409">tienilic acid</compound-id> and (+/-)-<compound-id="5359">suprofen</compound-id> : a comparison of kinetics and probe substrate selection.	suprofen__cytochrome P450 2C9__interaction	tienilic acid__cytochrome P450 2C9__interaction
18838506-1690	In vitro experiments were conducted to compare k(inact), K(I) and inactivation efficiency (k(inact)/K(I)) of <protein-id="O08469">cytochrome P450</protein-id> (P450) 2C9 by <compound-id="38409">tienilic acid</compound-id> and (+/-)-<compound-id="5359">suprofen</compound-id> using (S)-flurbiprofen, diclofenac, and (S)-warfarin as reporter substrates.	tienilic acid__cytochrome P450__interaction	suprofen__cytochrome P450__interaction
18838523-1691	<protein-id="P0C081,P0C082,P0C083,P0C084,P0C085,P16462,P16535,P55117,P55118,P55123,Q7BHI8,Q9ETX2,Q9EV27,Q9EV29,Q9EV30,Q9EV31,Q9EV32,Q9EV33,Q9EV34">Leukotoxin</protein-id> activity was evaluated by measuring <compound-id="271">Ca(2</compound-id>+) entry or pore formation using spectrofluorometry or flow cytometry.	Ca(2__Leukotoxin__interaction
18838739-1780	These Ca2+-independent <protein-id="O77793,P00608,P00609,P00610,P00620,P00622,P04362,P14419,P14420,P14556,P18999,P20258,P20259,P20260,P20474,P21789,P31854,P47712,P47713,P49147,P50392,P50393,P51972,P59066,P81166,P81167,P81236,P81237,P81243,P82971,P84651,P84736,Q10756,Q7M3V3,Q7M4I5,Q7M4I6,Q99289,Q9BMK4,Q9I8F8">phospholipases A2</protein-id> display remarkable specificity for the length of the sn-2 residue, but this selectivity is lost as the residue gains <compound-id="977">oxygen</compound-id> functions.	oxygen__phospholipases A2__interaction
18839053-1886	At the end of treatment, BMI, WHR, HbA1c, fasting <compound-id="206,5793,64689,79025">glucose</compound-id>, <protein-id="O02750,O93416,Q28603,Q95189,Q95234">leptin</protein-id>, HOMA-IR, alanine aminotransferase values decreased in both groups.	glucose__leptin__no_interaction
18839067-1902	<protein-id="O08328,O66935,O84804,P05416,P0A6U8,P0A6U9,P0A6V0,P39125,P45179,P58395,Q21BQ1,Q221N9,Q255S3,Q28MN0,Q2A4U4,Q2G7S7,Q2IM81,Q2J308,Q2K485,Q2P9F6,Q2RH55,Q2RS50,Q2T6R2,Q2W5G0,Q2YB48,Q30Z13,Q31BS5,Q31IB5,Q31VJ4,Q32AV6,Q3A0B8,Q3AKK1,Q3APL6,Q3AVF9,Q3B6C3,Q3BYI1,Q3K1K2,Q3KD65,Q3KKP3,Q3SH79,Q3YW96,Q46LU1,Q47IJ4,Q48JG9,Q4KCP0,Q4QK70,Q4UZL8,Q4ZS46,Q57IU1,Q5DZC1,Q5FL65,Q5H6Q4,Q5L562,Q5N1P1,Q5NHN2,Q5NXZ7,Q5PM09,Q5SMC5,Q632H4,Q65FS7,Q65TI3,Q664I5,Q6CZK3,Q6HC18,Q6KHP2,Q6LKA1,Q6MAS9,Q6NCT7,Q729V4,Q72G68,Q72YJ6,Q73MC7,Q7MJ50,Q7NM37,Q7U7I2,Q7UPY2,Q7V275,Q7V8F0,Q7VBP0,Q7W6L5,Q7WIJ0,Q816G8,Q81K85,Q821W4,Q82SP3,Q83PV4,Q87QX5,Q880M9,Q88FN9,Q890I8,Q8CWX0,Q8DAR0,Q8DKU2,Q8DPS3,Q8E079,Q8E5V5,Q8ET54,Q8KAY6,Q8PDD2,Q8PQA3,Q8RF65,Q8XPA1,Q8XT73,Q8Z232,Q8ZA78,Q935Y7,Q97GX6,Q97QS5,Q985P2,Q9CHM9,Q9CN91,Q9EUT5,Q9I1V0,Q9KDX6,Q9KRB6,Q9PLC3,Q9RNH6,Q9RWS1,Q9WZZ7,Q9Z6V8">Glycogen synthase</protein-id> kinase-3 inhibition by 3-<compound-id="137550">anilino</compound-id>-4-phenylmaleimides: insights from 3D-QSAR and docking.	anilino__Glycogen synthase__interaction
18839068-1905	Among these indicators is <compound-id="445141,6323481,44147587">phosphatidylserine</compound-id> (PS) translocation from the inner to the outer leaflet of the plasma membrane, which can be detected by <protein-id="P08758,P14668,P17153,P48036,P70075,P81287,Q4R4H7,Q5R1W0">annexinV</protein-id> (<protein-id="P08758,P17153,P81287,Q4R4H7,Q5R1W0">ANXA5</protein-id>) conjugation.	phosphatidylserine__ANXA5__interaction	phosphatidylserine__annexinV__interaction
18839150-1938	Effects of chronic inflammation and <compound-id="5288826,5479215">morphine</compound-id> tolerance on the expression of phospho-<protein-id="P21708,P27361,Q63844">ERK 1</protein-id>/2 and phospho-<protein-id="O24473,O75791,O95433,O97628,P46108,P80350,P82869,Q01552,Q04929,Q63768,Q64010,Q9LDA4,Q9Y2S7">P38</protein-id> in the injured tissue.	morphine__P38__interaction	morphine__ERK 1__interaction
18839150-1940	The results of the present study show that <protein-id="P29323">ERKs</protein-id> phosphorylation is unaltered by inflammation or <compound-id="5288826,5479215">morphine</compound-id> tolerance, each one individually, in the plantar tissue.	morphine__ERKs__no_interaction
18839150-1941	In contrast, no significant differences in phospho-<protein-id="O24473,O75791,O95433,O97628,P46108,P80350,P82869,Q01552,Q04929,Q63768,Q64010,Q9LDA4,Q9Y2S7">p38</protein-id> expression were observed between nave and tolerant animals acutely injected with saline or <compound-id="5288826,5479215">morphine</compound-id> in presence of CFA inflammation.	morphine__p38__no_interaction
18839150-1942	These results suggest that <protein-id="P29323">ERK</protein-id> but not p38 could be implicated in the development of <compound-id="5288826,5479215">morphine</compound-id> tolerance during peripheral inflammation.	morphine__ERK__interaction
18839155-1946	The anterior pituitary gland contains five types of cells secreting specific hormones (<protein-id="O12980,O13188,O18938,O62754,O70615,O73848,O73849,O93566,P01241,P01244,P01245,P01246,P01248,P06880,P07064,P08591,P08998,P09113,P09537,P09539,P10298,P10607,P10766,P10813,P10814,P11228,P13391,P19795,P20391,P20392,P22077,P24363,P29971,P33092,P33093,P33711,P34005,P34006,P34744,P34745,P34746,P34747,P37885,P37886,P45643,P45654,P45655,P46404,P46407,P48248,P55755,P56437,P58343,P58756,P67930,P67931,P69158,P69159,P69160,P69161,P69162,P79885,P87391,Q01282,Q01283,Q05163,Q07221,Q1HFN3,Q659Q8,Q7YQB8,Q7YQD2,Q7YRR6,Q864S7,Q8HYE5,Q8MI73,Q98UF6,Q9DEV3,Q9DGG5,Q9GKA1,Q9GL60,Q9GMB2,Q9GMB3,Q9I9L5,Q9I9M4,Q9IB11,Q9IBE5,Q9JKM4,Q9PWG3,Q9W6J5,Q9W6J7,Q9W6R8">growth hormone</protein-id>, <protein-id="P01189,P01190,P01191,P01192,P01193,P01194,P01196,P01197,P01201,P06297,P06298,P06299,P10000,P11280,P11885,P19402,P21252,P22923,P68000,P68001,P87352,Q04617,Q04618,Q91082,Q9YGK2,Q9YGK4,Q9YGK5">adrenocorticotropic hormone</protein-id> (ACTH), gonadotropic hormone, <protein-id="P10765,P22393,P33089,P33090,P33091,P43001">prolactin</protein-id>, and thyroid-stimulating hormone), and the double staining results indicated that <compound-id="71080">D:-Ala</compound-id> is localized to the ACTH-secreting cells.	D: -Ala__adrenocorticotropic hormone__no_interaction	D: -Ala__prolactin__no_interaction	D: -Ala__growth hormone__no_interaction
18839173-1953	In addition to <compound-id="5381226,5388984,5458213,6243627,6842115,6913622,16043998,17753751,25141428,45356263,56947149">rifampicin</compound-id> and <compound-id="3662,441298,5288591,6426795,46835064">hyperforin</compound-id>, the anticancer drug <compound-id="4666,36314,441276,5352019,6713921,6915727,44155032,53313247">paclitaxel</compound-id> has also been shown to be an inducer of CYP3A4 via activation of the <protein-id="O54915,O75469,Q8SQ01,Q9R1A7">pregnane X receptor</protein-id> (<protein-id="O75469,Q8SQ01">PXR</protein-id>).	rifampicin__PXR__no_interaction	hyperforin__PXR__no_interaction	paclitaxel__pregnane X receptor__interaction	hyperforin__pregnane X receptor__no_interaction	rifampicin__pregnane X receptor__no_interaction	paclitaxel__PXR__interaction
18839216-1978	A comprehensive literature review of clinical studies in children evaluating s-<protein-id="O29953,O34577,P0A6J1,P0A6J2,P56858,P56861,P57497,P57702,P63889,P63890,P72940,Q5HL02,Q7MPF0,Q7UMW2,Q7UQW3,Q87SX6,Q88X60,Q8CR04,Q8DE75,Q8DJ87,Q8EB13,Q8FEJ2,Q8K9D4,Q8ZBP3,Q97MT8,Q9KP21,Q9YCR6">CysC</protein-id> or <protein-id="O29953,O34577,P0A6J1,P0A6J2,P56858,P56861,P57497,P57702,P63889,P63890,P72940,Q5HL02,Q7MPF0,Q7UMW2,Q7UQW3,Q87SX6,Q88X60,Q8CR04,Q8DE75,Q8DJ87,Q8EB13,Q8FEJ2,Q8K9D4,Q8ZBP3,Q97MT8,Q9KP21,Q9YCR6">CysC</protein-id>-based formulas and plasma <compound-id="588">creatinine</compound-id> or <compound-id="588">creatinine</compound-id>-based formulas against an exogenous reference method using receiver operating characteristics (ROC) curves or Bland-Altman plots is presented.	creatinine__CysC__no_interaction
18839216-1979	The comparison of s-<protein-id="O29953,O34577,P0A6J1,P0A6J2,P56858,P56861,P57497,P57702,P63889,P63890,P72940,Q5HL02,Q7MPF0,Q7UMW2,Q7UQW3,Q87SX6,Q88X60,Q8CR04,Q8DE75,Q8DJ87,Q8EB13,Q8FEJ2,Q8K9D4,Q8ZBP3,Q97MT8,Q9KP21,Q9YCR6">CysC</protein-id> with plasma <compound-id="588">creatinine</compound-id> indicated that s-<protein-id="O29953,O34577,P0A6J1,P0A6J2,P56858,P56861,P57497,P57702,P63889,P63890,P72940,Q5HL02,Q7MPF0,Q7UMW2,Q7UQW3,Q87SX6,Q88X60,Q8CR04,Q8DE75,Q8DJ87,Q8EB13,Q8FEJ2,Q8K9D4,Q8ZBP3,Q97MT8,Q9KP21,Q9YCR6">CysC</protein-id> was superior to plasma <compound-id="588">creatinine</compound-id> in five of 13 studies; four studies showed no difference, and, in four studies, no statistical comparison was made.	creatinine__CysC__no_interaction
18839216-1980	S-<protein-id="O29953,O34577,P0A6J1,P0A6J2,P56858,P56861,P57497,P57702,P63889,P63890,P72940,Q5HL02,Q7MPF0,Q7UMW2,Q7UQW3,Q87SX6,Q88X60,Q8CR04,Q8DE75,Q8DJ87,Q8EB13,Q8FEJ2,Q8K9D4,Q8ZBP3,Q97MT8,Q9KP21,Q9YCR6">CysC</protein-id> is most likely superior to plasma <compound-id="588">creatinine</compound-id> and at least equal to <compound-id="588">creatinine</compound-id>-based formulas.	creatinine__CysC__no_interaction
18839216-1981	<protein-id="O29953,O34577,P0A6J1,P0A6J2,P56858,P56861,P57497,P57702,P63889,P63890,P72940,Q5HL02,Q7MPF0,Q7UMW2,Q7UQW3,Q87SX6,Q88X60,Q8CR04,Q8DE75,Q8DJ87,Q8EB13,Q8FEJ2,Q8K9D4,Q8ZBP3,Q97MT8,Q9KP21,Q9YCR6">CysC</protein-id>-based prediction equations are at least as good as <compound-id="588">creatinine</compound-id>-based formulas but cannot replace exogenous methods.	creatinine__CysC__no_interaction
18839315-2028	By combining endosperm <protein-id="Q99K67,Q9SMZ4,Q9UDR5">LKR</protein-id>/<protein-id="O34607,O34635,O86564,P09367,P20132,P21801,P21912,P21914,P33073,P33074,P38997,P38998,P42630,P43065,P56072,P66773,P66774,P71349,P80212,P80213,Q02912,Q09694,Q48838,Q6FU27,Q75BV4,Q7SFX6,Q870G1,Q8LGI2,Q99K67,Q9SMZ4,Q9SQT8,Q9UDR5,Q9ZMU7">SDH</protein-id> suppression with embryo <protein-id="Q99K67,Q9SMZ4,Q9UDR5">LKR</protein-id>/<protein-id="O34607,O34635,O86564,P09367,P20132,P21801,P21912,P21914,P33073,P33074,P38997,P38998,P42630,P43065,P56072,P66773,P66774,P71349,P80212,P80213,Q02912,Q09694,Q48838,Q6FU27,Q75BV4,Q7SFX6,Q870G1,Q8LGI2,Q99K67,Q9SMZ4,Q9SQT8,Q9UDR5,Q9ZMU7">SDH</protein-id> suppression through crosses, the <compound-id="160556">saccharopine</compound-id> level in embryo was reduced and resulted in higher lysine accumulation in mature kernels.	saccharopine__LKR__interaction	saccharopine__SDH__interaction
18839328-2042	We examined the relationship between <protein-id="Q5MK86,Q9GZV9">FGF23</protein-id> and serum calcium, <compound-id="1061,167704,644102">phosphate</compound-id>, 1,25(OH)(2)D(3), and PTH levels in haemodialysis patients.	phosphate__FGF23__interaction
18839335-2050	Resistin, an adipokine-linked obesity with type 2 diabetes, impairs <compound-id="206,5793,64689,79025">glucose</compound-id>-stimulated <protein-id="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7">insulin</protein-id> secretion (GSIS) in beta-cells.	glucose__insulin__interaction
18839360-2057	Intracellular <compound-id="312">Cl</compound-id> (-) is required for the motor function of <protein-id="P58743,Q99NH7,Q9EPH0,Q9JKQ2">prestin</protein-id>, a unique plasma membrane molecular motor of these cells.	Cl__prestin__interaction
18839361-2058	<protein-id="P58743,Q99NH7,Q9EPH0,Q9JKQ2">Prestin</protein-id> was immunostained with mouse anti-FLAG primary antibody and <compound-id="18730">FITC</compound-id>-conjugated goat anti-mouse IgG secondary antibody.	FITC__Prestin__interaction
18839419-2085	Intramuscular triacylglycerol does not appear to be a ubiquitous marker of <protein-id="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7">insulin</protein-id> resistance, although specific IMCL intermediates such as long-chain fatty acyl-CoAs, ceramide, and <compound-id="6026790">diacylglycerol</compound-id> may inhibit <protein-id="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7">insulin</protein-id> signal transduction.	diacylglycerol__insulin__interaction
18840097-2250	Light stimulates <compound-id="24316">cGMP</compound-id> hydrolysis via the G-protein <protein-id="P49177">transducin</protein-id>, which directly binds to and activates phosphodiesterase.	cGMP__transducin__interaction
18840413-2365	Inhibition of gamma-glutamyl transferase (<protein-id="P19440,P20735">GGT1</protein-id>, EC 2.3.2.2)-catalyzed extracellular GSH degradation with <compound-id="294641">acivicin</compound-id> significantly blocked GSH efflux, suggesting that GSH breakdown is a driving force for GSH export.	acivicin__GGT1__no_interaction
18840446-2377	We injected females with human chorionic gonadotropin (<protein-id="Q9NFL4">HCG</protein-id>), <compound-id="5757">estradiol</compound-id>, <compound-id="5757">estradiol</compound-id> plus <compound-id="5994">progesterone</compound-id>, saline, or <protein-id="Q9NFL4">HCG</protein-id> plus <compound-id="59693">fadrozole</compound-id> (an aromatase blocker) and tested their responses to mating calls.	fadrozole__HCG__no_interaction	estradiol__HCG__no_interaction	progesterone__HCG__no_interaction
18840462-2386	Here we use an array of flow cytometric analyses to characterize silkworm hemocytes with various molecular probes, such as <compound-id="4939">propidium iodide</compound-id>, green fluorescence protein, monoclonal antibodies, and fluorescent <protein-id="P02871,P02873,P02874,P02875,P07386,P16108,P16349,P16351,P16352,P33888,P38662,P42088,P83410,P83511,P84987,Q41114">lectins</protein-id>.	propidium iodide__lectins__no_interaction
18840470-2387	Amino acid 1092 (AA1092) in <protein-id="O39831,O40980,O40981,O40983,O56129,O72620,O90369,O90371,P03314,P03315,P03316,P03590,P03591,P03598,P03601,P03602,P03605,P03607,P03641,P03642,P04866,P05070,P05072,P05673,P05674,P07566,P07699,P07931,P08491,P08563,P08564,P08767,P08768,P09502,P09592,P10468,P11333,P11642,P13890,P13897,P14340,P14849,P15100,P15406,P15892,P16486,P16489,P16596,P16653,P17529,P17782,P18027,P19725,P21368,P22056,P22116,P22172,P22955,P23627,P24147,P24264,P24402,P27284,P27285,P27334,P27335,P28899,P29165,P31798,P36329,P36330,P36331,P36332,P37991,P37993,P54087,P54088,P54089,P54090,P54635,P62406,P62683,P62684,P62685,P62690,P63117,P63126,P63128,P63130,P63145,P69466,P69467,P69470,P69471,P87889,P89946,Q00259,Q00260,Q00261,Q00467,Q00556,Q01669,Q02106,Q04542,Q04572,Q05142,Q06934,Q074N0,Q07506,Q07626,Q1X880,Q1X881,Q306W5,Q306W7,Q38041,Q4QXJ7,Q5WQY5,Q5XXP3,Q5Y388,Q66114,Q66120,Q66135,Q66138,Q66140,Q66141,Q66143,Q66154,Q6DV88,Q6J3P1,Q6X2U1,Q6X2U3,Q7LDI9,Q80QL5,Q80S27,Q83251,Q83253,Q83269,Q83271,Q86925,Q86993,Q87012,Q87019,Q88305,Q88894,Q89277,Q8JJX0,Q8JUX5,Q8QL52,Q8QZ72,Q8V987,Q8VA10,Q98803,Q99153,Q99IE6,Q9HDB9,Q9J6K8,Q9JGK8,Q9NRZ4,Q9WIJ8,Q9YNA8,Q9YRV3,Q9Z035">capsid protein</protein-id> 1 of coxsackievirus B3 (CVB3) is located in close vicinity to the central <compound-id="123143">phenoxy</compound-id> group of capsid binders (i.e.	phenoxy__capsid protein__interaction
18840474-2388	<protein-id="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7">Insulin</protein-id> is a polypeptide hormone that is present in mammals and its main function is the maintenance of adequate <compound-id="107526">blood sugar</compound-id> level.	blood sugar__Insulin__interaction
18840497-2407	In vivo assays confirmed that the three resulting genotypes differed in their ability to produce <compound-id="5754">cortisol</compound-id> in response to intravenous <protein-id="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7">insulin</protein-id> injection implicating <protein-id="O57525,O73853,P05093,P05185,P12394,P19100,P30437,P70085,P70687,Q29497,Q2XVA1,Q64410,Q8HYM9,Q8HYN0,Q8HYN1,Q92113,Q95328,Q9GLD2,Q9GMC7,Q9GMC8,Q9N0U7">CYP17</protein-id> as the primary cause of the observed hypocortisolism.	cortisol__CYP17__interaction	cortisol__insulin__interaction
18840501-434	In addition, <protein-id="O18824,P97943,Q60417,Q61009,Q8SQC1,Q8WTV0">SR-BI</protein-id> facilitates bi-directional flux of <compound-id="304,5997,6432564,11025495">cholesterol</compound-id> by modifying the phospholipid content of the plasma membrane.	cholesterol__SR-BI__interaction
18840501-435	Overall, <protein-id="O18824,P97943,Q60417,Q61009,Q8SQC1,Q8WTV0">SR-BI</protein-id> is the cell surface receptor responsible for selective uptake of lipoprotein <compound-id="304,5997,6432564,11025495">cholesterol</compound-id> and its ultimate delivery to sites of hormone synthesis in steroidogenic tissues.	cholesterol__SR-BI__interaction
18840514-2413	Susceptibility to esophageal cancer may be modified by functional polymorphisms in genes along the <compound-id="6037">folate</compound-id> metabolic pathway, such as <protein-id="P42898,Q5I598,Q60HE5,Q9WU20">methylenetetrahydrofolate reductase</protein-id> (<protein-id="P42898,Q5I598,Q60HE5">MTHFR</protein-id>).	folate__MTHFR__interaction	folate__methylenetetrahydrofolate reductase__interaction
18840516-2417	We looked at the toxicity of non-drug-containing liposomes on (3)H-<compound-id="5789">thymidine</compound-id> incorporation by <protein-id="P81460,P81461">concanavalin A</protein-id> (<protein-id="P02866,P14894,P81460,P81461">Con A</protein-id>)-stimulated human lymphocytes, splenocytes and Epstein-Barr virus (EBV)-transformed human B-cell lymphoblastoid cell line (LCL).	thymidine__concanavalin A__interaction	thymidine__Con A__interaction
18840548-2430	The anti-inflammatory effect of these compounds and a <compound-id="323,94381">coumarin</compound-id> control, <compound-id="5280460">scopoletin</compound-id>, on <protein-id="P41693">interleukin-6</protein-id> (<protein-id="O35736,P05231,P08505,P20607,P26892,P26893,P29455,P41323,P41683,P41693,P46650,P51494,P79341,Q25BC2,Q28319,Q28747,Q28819,Q2MH06,Q5I6E3,Q6V919,Q865W7,Q865X6,Q8MKH0,Q95181,Q9MZR1,Q9XT80">IL-6</protein-id>), <protein-id="Q8JFG3">tumor necrosis factor</protein-id> (<protein-id="O35734,O77510,O77764,P01375,P04924,P13296,P19101,P23383,P23563,P29553,P33620,P36939,P48094,P51435,P51742,P51743,P59684,P59693,P59694,P59695,P79337,P79374,Q06599,Q19LH4,Q1G1A2,Q1WM27,Q2MH05,Q539C2,Q75N23,Q8HZD9,Q8JFG3,Q8MKG8,Q8WNR1,Q9BEA1">TNF</protein-id>), and macrophage chemotactic protein-1 (<protein-id="P10148,P13500,P14844,P28291,P28292,P42831,P52203,P61274,P61275,Q08782,Q9TTQ3">MCP-1</protein-id>) release was studied using lipopolysaccharide (LPS)-stimulated alveolar macrophages.	coumarin__tumor necrosis factor__interaction	coumarin__interleukin-6__interaction	coumarin__MCP-1__interaction	scopoletin__TNF__interaction	coumarin__IL-6__interaction	scopoletin__tumor necrosis factor__interaction	scopoletin__interleukin-6__interaction	scopoletin__MCP-1__interaction	coumarin__TNF__interaction	scopoletin__IL-6__interaction
18840610-2455	We previously determined that <protein-id="P35804">BLIP</protein-id> Tyr51 is a canonical and Trp150 an anti-canonical <protein-id="P62593">TEM-1</protein-id>-contact residue, where canonical refers to the <compound-id="602,4580,5950,71080">alanine</compound-id> substitution resulting in a matched change in the hydrophobicity of binding free energy.	alanine__BLIP__interaction	alanine__TEM-1__no_interaction
18840610-2456	This explains the anti-canonical nature of the Trp150 to <compound-id="602,4580,5950,71080">alanine</compound-id> substitution, and also reveals a strong long distance coupling between Trp150 and Asp49 of <protein-id="P35804">BLIP</protein-id>, because these two residues are more than 25 angstroms apart.	alanine__BLIP__no_interaction
18840670-2486	This effect is independent of any change in neutrophil adhesion or adhesion molecule expression but is related to the ability of statins to reduce <compound-id="443295">fMLP</compound-id>-induced <protein-id="O51891,O67031,O83281,P03304,P0A295,P0A296,P0AG30,P0AG31,P0AG32,P0AG33,P15409,P17593,P17594,P20350,P29403,P33561,P35359,P38527,P44619,P45835,P51489,P52152,P52153,P52154,P52155,P52156,P52157,P52158,P56466,P57652,P66028,P66029,Q03222,Q06447,Q89A22,Q9ZD24,Q9ZLS9">Rho</protein-id> activity in neutrophils.	fMLP__Rho__interaction
18840670-2487	This was confirmed by the ability of the <protein-id="O51891,O67031,O83281,P03304,P0A295,P0A296,P0AG30,P0AG31,P0AG32,P0AG33,P15409,P17593,P17594,P20350,P29403,P33561,P35359,P38527,P44619,P45835,P51489,P52152,P52153,P52154,P52155,P52156,P52157,P52158,P56466,P57652,P66028,P66029,Q03222,Q06447,Q89A22,Q9ZD24,Q9ZLS9">Rho</protein-id> precursor <compound-id="447277">geranylgeranyl pyrophosphate</compound-id> to rescue the statin-mediated reduction in neutrophil transendothelial migration.	geranylgeranyl pyrophosphate__Rho__interaction
18840677-1304	Suppression of <compound-id="1388">1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine</compound-id>-induced <protein-id="O61309,O61608,Q27571,Q9I9M2">nitric-oxide synthase</protein-id> 2 expression in astrocytes by a novel <compound-id="3071">diindolylmethane</compound-id> analog protects striatal neurons against apoptosis.	1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine__nitric-oxide synthase__interaction	diindolylmethane__nitric-oxide synthase__interaction
18840759-2541	We hypothesized that conditioned medium from macrophages pretreated with palmitate or LPS would directly affect <protein-id="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7">insulin</protein-id> action and <compound-id="206,5793,64689,79025">glucose</compound-id> uptake in muscle cells.	glucose__insulin__no_interaction
18840759-2542	Surprisingly, and opposite to its effects on adipose cells, conditioned medium from LPS-treated macrophages stimulated myoblast <protein-id="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7">insulin</protein-id>-stimulated <compound-id="206,5793,64689,79025">glucose</compound-id> uptake, <protein-id="P14672,Q27994,Q9XST2,Q9XT10">GLUT4</protein-id> translocation, and <protein-id="P31750,Q8INB9">Akt</protein-id> phosphorylation without affecting stress kinases or inflammation indexes.	glucose__GLUT4__no_interaction	glucose__insulin__interaction	glucose__Akt__no_interaction
18840763-2544	The essential role of <protein-id="O12956,O42143,O42144,P01272,P01273,P01274,P01275,P04093,P05110,P06883,P07449,P09566,P09567,P09682,P09686,P0C235,P13189,P15438,P18108,P22890,P29794,P31297,P33528,P55095,P68259,P68260,P68273,P68274,P68275,P68952,P68953,P68954,P68955,P68956,P68957,P79695,P81880,Q8MJ25,Q9PRQ9">glucagon</protein-id> and <protein-id="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7">insulin</protein-id> and the importance of distributed control of <compound-id="206,5793,64689,79025">glucose</compound-id> fluxes are highlighted in this review.	glucose__insulin__interaction	glucose__glucagon__interaction
18840765-2545	Because both TCDD and HFD are associated with increased breast cancer risk, we examined their effects on metabolic syndrome-associated phenotypes in three mouse models of breast cancer: 7,12-dimethylbenz[a] <compound-id="8418">anthracene</compound-id> (<compound-id="6001">DMBA</compound-id>), Tg(MMTV-Neu)202Mul/J (<protein-id="P04626">HER2</protein-id>), and TgN(MMTV-PyMT)634Mul/J (PyMT), all on an FVB/N genetic background.	anthracene__HER2__no_interaction	DMBA__HER2__no_interaction
18840783-2553	<protein-id="O51891,O67031,O83281,P03304,P0A295,P0A296,P0AG30,P0AG31,P0AG32,P0AG33,P15409,P17593,P17594,P20350,P29403,P33561,P35359,P38527,P44619,P45835,P51489,P52152,P52153,P52154,P52155,P52156,P52157,P52158,P56466,P57652,P66028,P66029,Q03222,Q06447,Q89A22,Q9ZD24,Q9ZLS9">Rho</protein-id> kinase inhibition by <compound-id="3547">fasudil</compound-id> ameliorates diabetes-induced microvascular damage.	fasudil__Rho__interaction
18840783-2554	Involvement of the <protein-id="O51891,O67031,O83281,P03304,P0A295,P0A296,P0AG30,P0AG31,P0AG32,P0AG33,P15409,P17593,P17594,P20350,P29403,P33561,P35359,P38527,P44619,P45835,P51489,P52152,P52153,P52154,P52155,P52156,P52157,P52158,P56466,P57652,P66028,P66029,Q03222,Q06447,Q89A22,Q9ZD24,Q9ZLS9">Rho</protein-id>/<protein-id="O51891,O67031,O83281,P03304,P0A295,P0A296,P0AG30,P0AG31,P0AG32,P0AG33,P15409,P17593,P17594,P20350,P29403,P33561,P35359,P38527,P44619,P45835,P51489,P52152,P52153,P52154,P52155,P52156,P52157,P52158,P56466,P57652,P66028,P66029,Q03222,Q06447,Q89A22,Q9ZD24,Q9ZLS9">Rho</protein-id> kinase (ROCK) pathway in diabetic microvasculopathy and therapeutic potential of <compound-id="3547">fasudil</compound-id>, a selective ROCK inhibitor, are investigated.	fasudil__Rho__no_interaction
18840785-2556	This study investigated the acute effects of treatment with <compound-id="6918537">vildagliptin</compound-id> on <protein-id="P14740,P22411,P27487,P28843,P81425,Q9N2I7">dipeptidyl peptidase-4</protein-id> (<protein-id="P97399,Q62598,Q9NZW4">DPP</protein-id>-4) activity, <protein-id="O12956,P01272,P01273,P01274,P01275,P01278,P05110,P06883,P15438,P22890,P29794,P55095,P68259,Q8MJ25">glucagon-like peptide 1</protein-id> (<protein-id="O12956,P01272,P01273,P01274,P01275,P05110,P06883,P22890,P29794,P55095,P68259,Q06605,Q8MJ25">GLP-1</protein-id>) concentration, <protein-id="P01298,P01299,P01301,P01302,P06303,P06304,P06305,P06884,P10601,P11967,P13083,P15427,P18107,P31229,P33684,P37999,P39659,P41335,P41336,P41337,P41519,P68009,P68010,P68249">pancreatic hormone</protein-id> levels, and glucose metabolism.	vildagliptin__GLP-1__interaction	vildagliptin__dipeptidyl peptidase-4__interaction	vildagliptin__pancreatic hormone__interaction	vildagliptin__glucagon-like peptide 1__interaction	vildagliptin__DPP__interaction
18840785-2557	The primary aims were to determine the effects of <protein-id="P97399,Q62598,Q9NZW4">DPP</protein-id>-4 inhibition on <protein-id="O12956,P01272,P01273,P01274,P01275,P05110,P06883,P22890,P29794,P55095,P68259,Q06605,Q8MJ25">GLP-1</protein-id> clearance and on hepatic <compound-id="206,5793,64689,79025">glucose</compound-id> uptake.	glucose__DPP__interaction	glucose__GLP-1__no_interaction
18840871-2587	In the present study we determined the effect of <protein-id="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7">insulin</protein-id> on the secretome by comparing incorporation rates of (13)C-labeled <compound-id="866,5962">lysine</compound-id> in the presence and absence of <protein-id="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7">insulin</protein-id>.	lysine__insulin__no_interaction
18840995-2643	<protein-id="P33716">Chromogranin A</protein-id> as an alternative to <compound-id="1826">5-hydroxyindoleacetic acid</compound-id> in the evaluation of symptoms during treatment of patients with neuroendocrine Tumors.	5-hydroxyindoleacetic acid__Chromogranin A__interaction
18841321-2736	<protein-id="Q64279,Q922L6">Th1</protein-id> cytokine profile may be related to the risk of the vaginal erosions following placement of <compound-id="8252">polypropylene</compound-id> meshes.	polypropylene__Th1__no_interaction
18841385-2745	However, compared to osmotic stress alone, in the seedlings treated with microwave irradiation plus osmotic stress the concentration of malondialdehyde decreased, while the activities of <protein-id="O61309,O61608,Q27571,Q9I9M2">nitricoxide synthase</protein-id>, <protein-id="O24339,O52762,O62839,O68146,O77229,O93662,O97492,P00432,P04040,P04762,P07145,P0A323,P0A324,P0A325,P0A326,P0A327,P11934,P17336,P24168,P24270,P25890,P29422,P30265,P30266,P32290,P42321,P44390,P45737,P45739,P55304,P55306,P55310,P55311,P55313,P77872,P81138,P90682,Q27710,Q49XC1,Q4L643,Q59296,Q59337,Q59602,Q59714,Q5HG86,Q5HPK8,Q5RF10,Q64405,Q6G9M4,Q6GH72,Q7A5T2,Q8CPD0,Q8FWU0,Q8NWV5,Q8X1P0,Q8Y3P9,Q926X0,Q99UE2,Q9AXH0,Q9KW19,Q9L4S1,Q9M5L6,Q9PT92,Q9PWF7,Q9Z598,Q9ZKX5,Q9ZN99">catalase</protein-id>, <protein-id="P15984,P16147,P84714">peroxidase</protein-id>, <protein-id="O50258">superoxide dismutase</protein-id> and the concentration of <compound-id="145068">nitric oxide</compound-id>, <compound-id="54670067,54690394">ascorbic acid</compound-id> and <compound-id="124886">glutathione</compound-id> increased.	ascorbic acid__peroxidase__no_interaction	nitric oxide__peroxidase__no_interaction	ascorbic acid__catalase__no_interaction	nitric oxide__superoxide dismutase__no_interaction	nitric oxide__catalase__no_interaction	ascorbic acid__nitricoxide synthase__no_interaction	glutathione__nitricoxide synthase__no_interaction	ascorbic acid__superoxide dismutase__no_interaction	glutathione__superoxide dismutase__no_interaction	glutathione__peroxidase__no_interaction	nitric oxide__nitricoxide synthase__no_interaction	glutathione__catalase__no_interaction
18841409-2761	The oxidative stress in the mollusk was observed at the U site during spring and at the R site during summer and autumn according to the differences in Mn-<protein-id="O50258">superoxide dismutase</protein-id> and <protein-id="O24339,O52762,O62839,O68146,O77229,O93662,O97492,P00432,P04040,P04762,P07145,P0A323,P0A324,P0A325,P0A326,P0A327,P11934,P17336,P24168,P24270,P25890,P29422,P30265,P30266,P32290,P42321,P44390,P45737,P45739,P55304,P55306,P55310,P55311,P55313,P77872,P81138,P90682,Q27710,Q49XC1,Q4L643,Q59296,Q59337,Q59602,Q59714,Q5HG86,Q5HPK8,Q5RF10,Q64405,Q6G9M4,Q6GH72,Q7A5T2,Q8CPD0,Q8FWU0,Q8NWV5,Q8X1P0,Q8Y3P9,Q926X0,Q99UE2,Q9AXH0,Q9KW19,Q9L4S1,Q9M5L6,Q9PT92,Q9PWF7,Q9Z598,Q9ZKX5,Q9ZN99">catalase</protein-id> activities, O (2) (*-) production, lipid peroxidation, and <compound-id="124886">glutathione</compound-id> levels.	glutathione__catalase__no_interaction	glutathione__superoxide dismutase__no_interaction
18841465-2774	These results suggest that <compound-id="21576577">ugonin K</compound-id> by activation of <protein-id="P27361,P28869,P42525,Q07176">ERK1</protein-id>/2 and <protein-id="O00329,O02697,O35904,P23727,P26450,P27986,P32871,P42336,P42337,P42338,P42347,P42348,P48736,P54673,P54674,P54675,P54676,Q63787,Q8BTI9,Q8UUU2,Q9JHG7,Q9Z1L0">PI3K</protein-id>/<protein-id="P31750,Q8INB9">Akt</protein-id> signal pathways protects SH-SY5Y cells from H(2)O(2)-induced apoptosis.	ugonin K__PI3K__interaction	ugonin K__ERK1__interaction	ugonin K__Akt__interaction
18841468-2776	This decrease was not modified by <protein-id="O24339,O52762,O62839,O68146,O77229,O93662,O97492,P00432,P04040,P04762,P07145,P0A323,P0A324,P0A325,P0A326,P0A327,P11934,P17336,P24168,P24270,P25890,P29422,P30265,P30266,P32290,P42321,P44390,P45737,P45739,P55304,P55306,P55310,P55311,P55313,P77872,P81138,P90682,Q27710,Q49XC1,Q4L643,Q59296,Q59337,Q59602,Q59714,Q5HG86,Q5HPK8,Q5RF10,Q64405,Q6G9M4,Q6GH72,Q7A5T2,Q8CPD0,Q8FWU0,Q8NWV5,Q8X1P0,Q8Y3P9,Q926X0,Q99UE2,Q9AXH0,Q9KW19,Q9L4S1,Q9M5L6,Q9PT92,Q9PWF7,Q9Z598,Q9ZKX5,Q9ZN99">catalase</protein-id> or <compound-id="40634">Trolox</compound-id>, demonstrating that <compound-id="5460609">ONOO</compound-id> (-) was responsible for the effect.	Trolox__catalase__no_interaction	ONOO__catalase__no_interaction
18841470-2778	Cell viability (MTT colorimetric determination) and transmembrane mitochondrial potential (J-C1 fluorescence) were concentration-dependently reduced 24 h after NaN (3); neither nuclear fragmentation by <compound-id="2954">DAPI</compound-id>, nor <protein-id="P08758,P14668,P17153,P48036,P70075,P81287,Q4R4H7,Q5R1W0">Annexin V</protein-id> positivity by flow cytometry were detected, ruling out the occurrence of apoptosis.	DAPI__Annexin V__no_interaction
18841471-2779	Plasma <compound-id="1738">homovanillic acid</compound-id> and <protein-id="P10765,P22393,P33089,P33090,P33091,P43001">prolactin</protein-id> in Huntington's disease.	homovanillic acid__prolactin__no_interaction
18841471-2780	We assessed plasma <compound-id="1738">homovanillic acid</compound-id> (pHVA) and plasma <protein-id="P10765,P22393,P33089,P33090,P33091,P43001">prolactin</protein-id> (pPRL), two correlates of dopaminergic activity, in 116 subjects with CAG repeats expansion in the HD gene, 26 presymptomatic (18 females) and 90 with overt symptomatology (43 females).	homovanillic acid__prolactin__no_interaction
18841529-2811	Profile of serum <protein-id="P01584,P09428,P10749,P14628,P21621,P26889,P41687,P46648,P48090,P51493,P51745,P79162,P79182,Q28292,Q28386,Q2HZH0,Q2MH07,Q63264,Q6PUD2,Q6R2X3,Q865X8,Q8WNR2,Q9WVG1,Q9XS77">IL-1beta</protein-id> and <protein-id="O46673,O97798,P18893,P22301,P29456,P43480,P46651,P47965,P48411,P51496,P51497,P51746,P55029,P79338,Q0Z972,Q25BC1,Q28374,Q29055,Q29408,Q2PE73,Q5Q0V6,Q865X4,Q8MKG9,Q9JHK7,Q9TSJ4,Q9Z1Y5">IL-10</protein-id> shortly after ovariectomy and <compound-id="5757">estradiol</compound-id> replacement in rats.	estradiol__IL-1beta__interaction	estradiol__IL-10__interaction
18842264-225	A low plasma <protein-id="P81182">high-density lipoprotein</protein-id> <compound-id="304,5997,6432564,11025495">cholesterol</compound-id> (HDL-c) concentration is an important risk factor for the development of atherosclerotic cardiovascular disease.	cholesterol__high-density lipoprotein__interaction
18842297-227	A hydrogel was fabricated by chemically crosslinking alpha-<protein-id="P11547">elastin</protein-id> with <compound-id="3485">glutaraldehyde</compound-id> at high pressure CO(2).	glutaraldehyde__elastin__interaction
18842335-233	We evaluated whether inhibition of <protein-id="O44001,O61998,P24724,P40292,Q18688,Q4UDU8,Q61W58,Q69QQ6">heat shock protein 90</protein-id> (<protein-id="P40292,P41887,Q90474">hsp90</protein-id>) function by <compound-id="54675769">novobiocin</compound-id> derivatives could induce the degradation of signal transducers that drive cancer cell growth and thereby promote apoptosis.	novobiocin__heat shock protein 90__interaction	novobiocin__hsp90__interaction
18842348-234	The cancer cells could find an alternate pathway to make this protein that does not require progesterone secretion, or the cancer cells may actually utilize <compound-id="5994">progesterone</compound-id> and thus make <protein-id="Q8WXW3">PIBF</protein-id> in a similar fashion to normal pregnancy.	progesterone__PIBF__no_interaction
18842620-268	<protein-id="O08469">Cytochrome P450</protein-id> (<protein-id="P21568,P21569,P24525,P34887,Q26551">CYP</protein-id>) 1A1 and <protein-id="Q16678">CYP1B1</protein-id> are inducible by <compound-id="15625">2,3,7,8-tetrachlorodibenzo-p-dioxin</compound-id> (<compound-id="15625">dioxin</compound-id>) in the human breast cancer cell line, MCF-7.	2,3,7,8-tetrachlorodibenzo-p-dioxin__CYP1B1__interaction	dioxin__CYP__interaction	dioxin__Cytochrome P450__interaction	dioxin__CYP1B1__interaction	2,3,7,8-tetrachlorodibenzo-p-dioxin__CYP__interaction	2,3,7,8-tetrachlorodibenzo-p-dioxin__Cytochrome P450__interaction
18842620-269	<compound-id="15625">Dioxin</compound-id> treatment leads to recruitment of the <protein-id="O02747">aryl hydrocarbon receptor</protein-id> to the enhancer regions but not to the proximal promoter regions of both the <protein-id="O42231,O42430,O42457,P00185,P04798,P05176,P33616,P56590,P56591,P79716,P98181,Q00557,Q06367,Q3LFU0,Q5KQT7,Q6GUR1,Q6JZS3,Q92039,Q92095,Q92100,Q92109,Q92110,Q92116,Q92148,Q9W683,Q9YH64">CYP1A1</protein-id> and <protein-id="Q16678">CYP1B1</protein-id> genes.	Dioxin__CYP1A1__no_interaction	Dioxin__CYP1B1__no_interaction	Dioxin__aryl hydrocarbon receptor__interaction
18842620-270	These results suggest that nucleosomal remodeling is less significant for <compound-id="15625">dioxin</compound-id>-mediated induction of <protein-id="Q16678">CYP1B1</protein-id> than that of <protein-id="O42231,O42430,O42457,P00185,P04798,P05176,P33616,P56590,P56591,P79716,P98181,Q00557,Q06367,Q3LFU0,Q5KQT7,Q6GUR1,Q6JZS3,Q92039,Q92095,Q92100,Q92109,Q92110,Q92116,Q92148,Q9W683,Q9YH64">CYP1A1</protein-id> and may be related to the more modest inducibility of the former.	dioxin__CYP1B1__interaction	dioxin__CYP1A1__interaction
18842620-271	These observations provide novel insights into the functional roles of the endogenous coactivators in <compound-id="15625">dioxin</compound-id> induction of the human <protein-id="O42231,O42430,O42457,P00185,P04798,P05176,P33616,P56590,P56591,P79716,P98181,Q00557,Q06367,Q3LFU0,Q5KQT7,Q6GUR1,Q6JZS3,Q92039,Q92095,Q92100,Q92109,Q92110,Q92116,Q92148,Q9W683,Q9YH64">CYP1A1</protein-id> and <protein-id="Q16678">CYP1B1</protein-id> genes in their natural chromosomal configurations.	dioxin__CYP1B1__interaction	dioxin__CYP1A1__interaction
18842703-297	Decreased oral absorption of <compound-id="2909,5280754,5284373,5497195,6435893,49867938">cyclosporine A</compound-id> after liver ischemia-reperfusion injury in rats: the contribution of CYP3A and P-<protein-id="P08163">glycoprotein</protein-id> to the first-pass metabolism in intestinal epithelial cells.	cyclosporine A__glycoprotein__no_interaction
18842954-373	The different mechanisms might be explained by the different sensitivity of <protein-id="P21521">synaptotagmin</protein-id> isoforms to Ca2+, <compound-id="104798">Sr2</compound-id>+, and Ba2+.	Sr2__synaptotagmin__interaction
18842962-374	Each residue was modified with one to three <compound-id="206,439357">hexose</compound-id> units, and the most dominant <protein-id="O68901,P00446,P0A608,P0A609,P0AGD1,P0AGD2,P15453,P20379,P24702,P25841,P25842,P53636,P57005,P66826,P66827,P69049,Q12548,Q51853,Q59081,Q59448,Q59452,Q59623,Q59689,Q5ZT17,Q877B5,Q8X1S6,Q9AGW2,Q9CBI6,Q9RU48,Q9Y8D9">SodC</protein-id> glycoform was modified with nine <compound-id="206,439357">hexose</compound-id> units.	hexose__SodC__interaction
18843259-489	Following <compound-id="27991">dDAVP</compound-id> there was a time-dependent redistribution of total <protein-id="O62735,O77697,O77714,O77722,O77740,O93938,P34080,P41181,P56402,P79099,P79144,P79164,P79165,P79168,P79200,P79213,P79229,P79803">aquaporin-2</protein-id> from predominantly intracellular vesicles to the apical plasma membrane, clathrin-coated vesicles, early endosomal compartments, and lysosomes.	dDAVP__aquaporin-2__interaction
18843273-456	The relationships among obesity, metabolic syndrome, ED, sex hormone-binding globulin (<protein-id="P04278,P08689,P15196,P97497,Q62588">SHBG</protein-id>) and serum total and free <compound-id="6013">testosterone</compound-id> levels are complex and often confusing to the physician.	testosterone__SHBG__interaction
18843482-535	The transcription factors <protein-id="P12813">Nur77</protein-id> and retinoid X receptors participate in <compound-id="3007,5826,32893">amphetamine</compound-id>-induced locomotor activities.	amphetamine__Nur77__interaction
18843519-555	The molecular masses of TKU006 <protein-id="O41798,O89290,O89940,O91080,O93215,P03311,P03353,P03355,P03356,P03362,P03363,P03366,P03367,P03369,P03370,P04023,P04024,P04323,P04584,P04585,P04587,P04588,P04589,P05959,P05960,P05961,P05962,P07570,P0C210,P0C211,P10210,P10265,P10270,P10271,P10272,P10273,P10274,P10394,P10978,P11227,P11365,P12451,P12497,P12498,P12499,P14074,P14078,P15833,P16046,P16423,P16901,P17757,P18042,P18096,P18802,P19028,P19199,P19560,P19561,P20825,P20875,P20876,P20892,P21407,P21414,P24107,P24740,P26808,P26809,P26810,P27502,P28936,P31822,P35956,P35963,P51518,P63119,P63120,P63121,P63122,P63123,P63124,P63125,P63127,P63128,P63129,P63131,P84454,Q09SZ9,Q0R5R2,Q0R5R3,Q1A249,Q1A267,Q4U0X6,Q73368,Q74120,Q75002,Q76634,Q77373,Q79666,Q89928,Q8AII1,Q8I7P9,Q9IDV9,Q9Q720,Q9QBY3,Q9QBZ1,Q9QBZ5,Q9QSR3,Q9WC54,Q9WC63,Q9Y6I0">protease</protein-id> and <protein-id="P13656,P14529,P23472,P23473,P81241,P84754">chitinase</protein-id> determined by <compound-id="8778">sodium dodecyl sulfate</compound-id> (SDS)-polyacrylamide gel electrophoresis were approximately 39 and 35 kDa, respectively.	sodium dodecyl sulfate__chitinase__interaction	sodium dodecyl sulfate__protease__interaction
18844213-796	We now show that treatment of cells with phosphomimic <protein-id="P00749,P04185,P06869,P15120,P16227,P29598,Q05589">uPA</protein-id> (uPA138E/303E, <compound-id="5951">serine</compound-id> 138 and 303 substituted with glutamic acid) strongly inhibits matrix-induced cell migration.	serine__uPA__interaction
18844219-799	When cells were subjected to hypoxia (1% <compound-id="977,5359597">O2</compound-id>), the expression of <protein-id="P12794,P22358,P22954,P50021,Q27965,Q47XI6,Q5E3A7,Q5N1J4,Q6LS31,Q7U3C4,Q7UZG3,Q7V3T5,Q7V9G2,Q826F6,Q8DI58,Q8YW74">HSP70-2</protein-id> had a significant increase in cancer cells.	O2__HSP70-2__interaction
18844235-806	We further demonstrate that loss of <protein-id="O00937,O13419,O16808,O17320,O65314,O65315,O65316,O74258,O81221,P02577,P10365,P10989,P11426,P13363,P14235,P17128,P20904,P24902,P26182,P26183,P30161,P45520,P45521,P48465,P50138,P51775,P53455,P53476,P53477,P53491,P53498,P53499,P53500,P53502,P53689,P60009,P60010,P60011,P68555,P78711,P80709,P81085,P90689,P91754,Q05214,Q11212,Q24733,Q2U7A3,Q39596,Q39758,Q6TCF2,Q75D00,Q8SWN8,Q8X119,Q92192,Q92193,Q99023,Q9P4D1,Q9UVF3,Q9UVX4,Q9UVZ8">actin</protein-id> stress fibers is due to a <compound-id="188955">cyclic adenosine monophosphate</compound-id>, <protein-id="Q05608,Q9RI12">protein kinase A</protein-id>-mediated pathway that results in <protein-id="O51891,O67031,O83281,P03304,P0A295,P0A296,P0AG30,P0AG31,P0AG32,P0AG33,P15409,P17593,P17594,P20350,P29403,P33561,P35359,P38527,P44619,P45835,P51489,P52152,P52153,P52154,P52155,P52156,P52157,P52158,P56466,P57652,P66028,P66029,Q03222,Q06447,Q89A22,Q9ZD24,Q9ZLS9">Rho</protein-id> inhibition.	cyclic adenosine monophosphate__actin__interaction	cyclic adenosine monophosphate__protein kinase A__interaction	cyclic adenosine monophosphate__Rho__interaction
18844240-810	The nuclear NF-kappaB <protein-id="P16342,P19751,P21521,P21579,P21707,P41823,P46096,P47191,P48018,P53663,P54963,Q42920,Q49539,Q66198,Q8V439,Q8V6W7,Q91A29,Q9FJR1,Q9PYA3">p65</protein-id> expression after treatment with the SFN-<compound-id="3385">5-Fu</compound-id> combination was also evaluated by western blot analysis.	5-Fu__p65__no_interaction
18844240-812	Treatment ACCs cells with SFN and <compound-id="3385">5-Fu</compound-id> in combination, led to synergistic inhibition on cell growth and a decreased expression in nuclear NF-kappaB <protein-id="P16342,P19751,P21521,P21579,P21707,P41823,P46096,P47191,P48018,P53663,P54963,Q42920,Q49539,Q66198,Q8V439,Q8V6W7,Q91A29,Q9FJR1,Q9PYA3">p65</protein-id> protein.	5-Fu__p65__interaction
18844240-813	Our results demonstrate synergism between SFN and <compound-id="3385">5-Fu</compound-id> at higher doses against the ACC-M and ACC-2 cells, which was associated with the decreased expression of nuclear NF-kappaB <protein-id="P16342,P19751,P21521,P21579,P21707,P41823,P46096,P47191,P48018,P53663,P54963,Q42920,Q49539,Q66198,Q8V439,Q8V6W7,Q91A29,Q9FJR1,Q9PYA3">p65</protein-id> protein.	5-Fu__p65__interaction
18844290-828	In order to further analyse the protective mode of action, the <compound-id="5359597">superoxide</compound-id> anion scavenging activity of two extracts was evaluated in a <compound-id="1188">xanthine</compound-id>/<protein-id="P22985,P47989,P47990,P80457,Q00519,Q9MYW6">xanthine oxidase</protein-id> system.	xanthine__xanthine oxidase__interaction	superoxide__xanthine oxidase__interaction
18844296-833	Human genetic diseases that affect N-glycosylation result from the defective synthesis of the N-linked sugar moiety (<compound-id="871">glycan</compound-id>) of <protein-id="P08163">glycoproteins</protein-id>.	glycan__glycoproteins__interaction
18844325-840	Rats subcutaneously injected with ISO (85 mg/kg) at an interval of 24 h for 2 days resulted in a significant increase in the levels of mitochondrial lipid peroxides with a significant decrease in the activities/levels of mitochondrial antioxidants (<protein-id="O50258">superoxide dismutase</protein-id>, <protein-id="O24339,O52762,O62839,O68146,O77229,O93662,O97492,P00432,P04040,P04762,P07145,P0A323,P0A324,P0A325,P0A326,P0A327,P11934,P17336,P24168,P24270,P25890,P29422,P30265,P30266,P32290,P42321,P44390,P45737,P45739,P55304,P55306,P55310,P55311,P55313,P77872,P81138,P90682,Q27710,Q49XC1,Q4L643,Q59296,Q59337,Q59602,Q59714,Q5HG86,Q5HPK8,Q5RF10,Q64405,Q6G9M4,Q6GH72,Q7A5T2,Q8CPD0,Q8FWU0,Q8NWV5,Q8X1P0,Q8Y3P9,Q926X0,Q99UE2,Q9AXH0,Q9KW19,Q9L4S1,Q9M5L6,Q9PT92,Q9PWF7,Q9Z598,Q9ZKX5,Q9ZN99">catalase</protein-id>, <protein-id="O32770,O59858,Q00277,Q9CFV1">glutathione peroxidase</protein-id>, <protein-id="O04437,O18598,P0A9D2,P0A9D3,P30116,P44521,P46088,P46419,P46423,P46426,P46428,P46437,P48438,P80894,P81065,P82996,P82997,P82998,P82999,P83000,P83001,P83246,Q04522,Q08392,Q08393,Q0ZS46,Q7REH6,Q8ILQ7,Q8MU52,Q96324">glutathione-S-transferase</protein-id> and <compound-id="124886">reduced glutathione</compound-id>).	reduced glutathione__superoxide dismutase__no_interaction	reduced glutathione__glutathione-S-transferase__no_interaction	reduced glutathione__catalase__no_interaction	reduced glutathione__glutathione peroxidase__no_interaction
18844326-841	Antiobesity effect of <compound-id="9918693,12901617,44202122,45479443">ginsenoside Rg3</compound-id> involves the <protein-id="P54646,Q09136,Q9Y478">AMPK</protein-id> and <protein-id="O18924,O18971,O19052,O62807,O88275,P37231,P37234,P37238,P57797,Q4U3Q4">PPAR-gamma</protein-id> signal pathways.	ginsenoside Rg3__AMPK__interaction	ginsenoside Rg3__PPAR-gamma__interaction
18844326-842	This inhibitory effect of <compound-id="9918693,12901617,44202122,45479443">ginsenoside Rg3</compound-id> on adipocyte differentiation was accompanied by <protein-id="O18924,O18971,O19052,O62807,O88275,P37231,P37234,P37238,P57797,Q4U3Q4">PPAR-gamma</protein-id> inhibition in rosiglitazone-treated cells.	ginsenoside Rg3__PPAR-gamma__interaction
18844326-843	Taken together, these results suggest that the antiobesity effect of red ginseng rich constituent, <compound-id="9918693,12901617,44202122,45479443">ginsenoside Rg3</compound-id>, involves the <protein-id="P54646,Q09136,Q9Y478">AMPK</protein-id> signaling pathway and <protein-id="O18924,O18971,O19052,O62807,O88275,P37231,P37234,P37238,P57797,Q4U3Q4">PPAR-gamma</protein-id> inhibition.	ginsenoside Rg3__AMPK__interaction	ginsenoside Rg3__PPAR-gamma__interaction
18845121-1115	They can be oxidized by <protein-id="O08590,O70423,Q16853,Q5R9I0,Q9TTK6">semicarbazide-sensitive amine oxidase</protein-id> (<protein-id="O08590,O70423,Q16853,Q5R9I0,Q9TTK6">SSAO</protein-id>), leading to the production of toxic aldehydes such as <compound-id="712">formaldehyde</compound-id> and <compound-id="880">methylglyoxal</compound-id> as well as <compound-id="784">hydrogen peroxide</compound-id> and <compound-id="222">ammonia</compound-id>.	methylglyoxal__semicarbazide-sensitive amine oxidase__interaction	hydrogen peroxide__semicarbazide-sensitive amine oxidase__interaction	ammonia__semicarbazide-sensitive amine oxidase__interaction	formaldehyde__semicarbazide-sensitive amine oxidase__interaction	hydrogen peroxide__SSAO__interaction	formaldehyde__SSAO__interaction	methylglyoxal__SSAO__interaction	ammonia__SSAO__interaction
18845132-1120	Selenocystine is taken up well by the b(0,+) rBAT system, while <compound-id="152157">selenobetaine</compound-id> is a low-affinity substrate only for <protein-id="P39980,Q9Y3P8">SIT1</protein-id> and <protein-id="P25644,P34230,P43577,Q02166,Q6L8K7,Q7Z2H8,Q92624">PAT1</protein-id>.	selenobetaine__SIT1__interaction	selenobetaine__PAT1__interaction
18845148-1121	Experiments using a classical inhibitor of phosphotyrosine <protein-id="P06961,P45269,Q57JQ5,Q5E2K7,Q5F8K9,Q5P3T0,Q5PC82,Q5WT58,Q5X1E5,Q5ZRX9,Q60CQ4,Q62EU1,Q63YC3,Q65Q41,Q665U9,Q6D160,Q6FA38,Q6LV05,Q7M7K5,Q7MAZ9,Q7MBF4,Q821A6,Q82U82,Q87DS9,Q87SK9,Q88A53,Q88QU2,Q8CWL6,Q8CXX6,Q8P5D4,Q8PPG9,Q8XBL4,Q8Y395,Q8Z3M9,Q8ZI64,Q8ZLY4,Q9CP21,Q9I5V3,Q9JUB2,Q9JZ88,Q9KPC6,Q9L7A3,Q9PDL7">phosphatase</protein-id>, <compound-id="61671">sodium orthovanadate</compound-id>, also showed that the ecto-<protein-id="P06961,P45269,Q57JQ5,Q5E2K7,Q5F8K9,Q5P3T0,Q5PC82,Q5WT58,Q5X1E5,Q5ZRX9,Q60CQ4,Q62EU1,Q63YC3,Q65Q41,Q665U9,Q6D160,Q6FA38,Q6LV05,Q7M7K5,Q7MAZ9,Q7MBF4,Q821A6,Q82U82,Q87DS9,Q87SK9,Q88A53,Q88QU2,Q8CWL6,Q8CXX6,Q8P5D4,Q8PPG9,Q8XBL4,Q8Y395,Q8Z3M9,Q8ZI64,Q8ZLY4,Q9CP21,Q9I5V3,Q9JUB2,Q9JZ88,Q9KPC6,Q9L7A3,Q9PDL7">phosphatase</protein-id> activity was inhibited in a dose-dependent manner.	sodium orthovanadate__phosphatase__interaction
18845237-1144	<protein-id="P54149,Q9UJ68">MSRAs</protein-id> (methionine <compound-id="8442">sulfoxide reductases</compound-id> A) are enzymes that reverse the effects of oxidative damage by reducing <compound-id="847">methionine sulfoxide</compound-id> back to methionine and recovering protein function.	methionine sulfoxide__MSRAs__interaction	sulfoxide__MSRAs__interaction
18845237-1145	Both promoters are partially regulated by <compound-id="444795">all-trans retinoic acid</compound-id> via <protein-id="P10276,P18514,Q5FBR4,Q90966,Q9W5Z3">RARA</protein-id> and other RARs.	all-trans retinoic acid__RARA__interaction
18845277-1178	Our data suggest a developmental role of <protein-id="P16257,P30535,P30536,P50637">PBRs</protein-id> in erythropoiesis in chickens, possibly via the regulation of <compound-id="4971">heme</compound-id> availability for the assembly of functional <protein-id="P15160,P17724,P73925,Q03459">hemoglobins</protein-id>.	heme__hemoglobins__interaction	heme__PBRs__interaction
18845302-1193	Circulating <compound-id="56841713">apelin</compound-id>, adiponectin, <protein-id="O02750,O93416,Q28603,Q95189,Q95234">leptin</protein-id>, <protein-id="O35734,O77510,O77764,P01375,P04924,P06804,P13296,P16599,P19101,P23383,P23563,P29553,P33620,P36939,P48094,P51435,P51742,P51743,P59684,P59693,P59694,P59695,P79337,P79374,Q06599,Q19LH4,Q1G1A2,Q1WM27,Q2MH05,Q539C2,Q75N23,Q8HZD9,Q8JFG3,Q8MKG8,Q8WNR1,Q9BEA1">TNF-alpha</protein-id>, hsCRP and <protein-id="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7">insulin</protein-id> levels were determined both at baseline and after TLC intervention and statin treatment.	apelin__TNF-alpha__no_interaction	apelin__insulin__no_interaction	apelin__leptin__no_interaction
18845357-1202	<protein-id="P15691,P15692,P26617,P49151,P50412,P67964,P67965,Q99PS1,Q9GKR0,Q9MYV3">VEGF</protein-id>, <protein-id="O35734,O77510,O77764,P01375,P04924,P06804,P13296,P16599,P19101,P23383,P23563,P29553,P33620,P36939,P48094,P51435,P51742,P51743,P59684,P59693,P59694,P59695,P79337,P79374,Q06599,Q19LH4,Q1G1A2,Q1WM27,Q2MH05,Q539C2,Q75N23,Q8HZD9,Q8JFG3,Q8MKG8,Q8WNR1,Q9BEA1">TNF-alpha</protein-id> and <compound-id="107873">8-isoprostane</compound-id> levels in exhaled breath condensate and serum of patients with lung cancer.	8-isoprostane__TNF-alpha__no_interaction	8-isoprostane__VEGF__no_interaction
18845357-1203	The aim of the present study was to evaluate the levels of <protein-id="P15691,P15692,P26617,P49151,P50412,P67964,P67965,Q99PS1,Q9GKR0,Q9MYV3">VEGF</protein-id>, <compound-id="107873">8-isoprostane</compound-id> and <protein-id="O35734,O77510,O77764,P01375,P04924,P06804,P13296,P16599,P19101,P23383,P23563,P29553,P33620,P36939,P48094,P51435,P51742,P51743,P59684,P59693,P59694,P59695,P79337,P79374,Q06599,Q19LH4,Q1G1A2,Q1WM27,Q2MH05,Q539C2,Q75N23,Q8HZD9,Q8JFG3,Q8MKG8,Q8WNR1,Q9BEA1">TNF-alpha</protein-id> in EBC and serum of patients with primary lung cancer prior to the initiation of any treatment, in order to evaluate their possible diagnostic role.	8-isoprostane__TNF-alpha__no_interaction	8-isoprostane__VEGF__no_interaction
18845357-1204	Furthermore, associations between <protein-id="P15691,P15692,P26617,P49151,P50412,P67964,P67965,Q99PS1,Q9GKR0,Q9MYV3">VEGF</protein-id>, <compound-id="107873">8-isoprostane</compound-id> and <protein-id="O35734,O77510,O77764,P01375,P04924,P06804,P13296,P16599,P19101,P23383,P23563,P29553,P33620,P36939,P48094,P51435,P51742,P51743,P59684,P59693,P59694,P59695,P79337,P79374,Q06599,Q19LH4,Q1G1A2,Q1WM27,Q2MH05,Q539C2,Q75N23,Q8HZD9,Q8JFG3,Q8MKG8,Q8WNR1,Q9BEA1">TNF-alpha</protein-id> levels in EBC and serum with clinicopathologic factors were investigated.	8-isoprostane__TNF-alpha__no_interaction	8-isoprostane__VEGF__no_interaction
18845357-1205	<protein-id="O35734,O77510,O77764,P01375,P04924,P06804,P13296,P16599,P19101,P23383,P23563,P29553,P33620,P36939,P48094,P51435,P51742,P51743,P59684,P59693,P59694,P59695,P79337,P79374,Q06599,Q19LH4,Q1G1A2,Q1WM27,Q2MH05,Q539C2,Q75N23,Q8HZD9,Q8JFG3,Q8MKG8,Q8WNR1,Q9BEA1">TNF-alpha</protein-id>, <protein-id="P15691,P15692,P26617,P49151,P50412,P67964,P67965,Q99PS1,Q9GKR0,Q9MYV3">VEGF</protein-id> and <compound-id="107873">8-isoprostane</compound-id> levels in EBC and serum were analyzed by an immunoenzymatic method (ELISA).	8-isoprostane__TNF-alpha__no_interaction	8-isoprostane__VEGF__no_interaction
18845383-1219	Currently, adreno-corticotrophic hormone (<protein-id="P01189,P01190,P01191,P01192,P01193,P01194,P01196,P01197,P01201,P06297,P06298,P06299,P10000,P11280,P11885,P19402,P21252,P22923,P68000,P68001,P87352,Q04617,Q04618,Q91082,Q9YGK2,Q9YGK4,Q9YGK5">ACTH</protein-id>), steroids and <compound-id="5665">vigabatrin</compound-id> (VGB) form the mainstay of its treatment.	vigabatrin__ACTH__no_interaction
18845389-1221	The addition of <protein-id="P03161,P03610,P03631,P03632,P07394,P15966,P25243,P25244,P35823,P98005">a protein</protein-id> kinase C (PKC) activator, <compound-id="4792,27924,122634,22833501">phorbol 12-myristate 13-acetate</compound-id>, rescued PhIP-inhibited <protein-id="O35734,O77510,O77764,P01375,P04924,P06804,P13296,P16599,P19101,P23383,P23563,P29553,P33620,P36939,P48094,P51435,P51742,P51743,P59684,P59693,P59694,P59695,P79337,P79374,Q06599,Q19LH4,Q1G1A2,Q1WM27,Q2MH05,Q539C2,Q75N23,Q8HZD9,Q8JFG3,Q8MKG8,Q8WNR1,Q9BEA1">TNF-alpha</protein-id> expression in LTA-stimulated cells.	phorbol 12-myristate 13-acetate__TNF-alpha__interaction	phorbol 12-myristate 13-acetate__a protein__interaction
18845486-1248	Diabetes was induced in C57BL/6 Gal-3(+/+) and Gal-3 (-/-) mice and disease monitored by blood <compound-id="206,5793,64689,79025">glucose</compound-id> level, immuno-histology, <protein-id="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7">insulin</protein-id> content of islets and expression of the proinflammatory cytokines, <protein-id="O35734,O77510,O77764,P01375,P04924,P06804,P13296,P16599,P19101,P23383,P23563,P29553,P33620,P36939,P48094,P51435,P51742,P51743,P59684,P59693,P59694,P59695,P79337,P79374,Q06599,Q19LH4,Q1G1A2,Q1WM27,Q2MH05,Q539C2,Q75N23,Q8HZD9,Q8JFG3,Q8MKG8,Q8WNR1,Q9BEA1">TNF-alpha</protein-id>, <protein-id="O35497,O35735,O57571,O57603,O57608,O73915,O77763,P01579,P01580,P01581,P07353,P17773,P17803,P28333,P28341,P30123,P42160,P42161,P42162,P46402,P49708,P63309,P63310,P63311,P79154,Q1WM28,Q25BC0,Q2PE75,Q4ZH68,Q5CCK0,Q5I6S9,Q62574,Q647G2,Q7TSP4,Q865W6,Q865X1,Q865Y4,Q866Y6,Q8MKF5,Q8SPW9,Q9QXX2,Q9TTB0,Q9TV67,Q9YGB9">IFN-gamma</protein-id>, <protein-id="Q16552,Q60I29,Q61453,Q62386,Q687Y7">IL-17</protein-id>, and <protein-id="O19114,O46660,O54705,O62699,P29477,P35228,P79290,Q06518,Q27995,Q28314,Q90703,Q92037,Q92091">iNOS</protein-id> in pancreatic lymph nodes.	glucose__TNF-alpha__no_interaction	glucose__insulin__no_interaction	glucose__IL-17__no_interaction	glucose__iNOS__no_interaction	glucose__IFN-gamma__no_interaction
18845629-1303	They secreted <protein-id="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7">insulin</protein-id> in response to <compound-id="206,5793,64689,79025">glucose</compound-id> and could correct hyperglycemia in vivo when cotransplanted with vascular cells.	glucose__insulin__interaction
18845633-1305	This action was mimicked solely by 100 nm CH-275, a selective agonist at the somatostatin type 1 receptor (<protein-id="P30872">SSTR1</protein-id>), but not by 100 nm BIM-23027, L-362855, or <compound-id="5311371">NNC-269100</compound-id> ; agonists selective for the other four SSTRs known to exist in MIN6.	NNC-269100__SSTR1__no_interaction
18845634-1306	A functional <protein-id="O02750,O93416,Q28603,Q95189,Q95234">leptin</protein-id> system is essential for <compound-id="26052">sodium tungstate</compound-id> antiobesity action.	sodium tungstate__leptin__interaction
18845638-1311	Deletion of the G protein-coupled receptor 30 impairs glucose tolerance, reduces bone growth, increases blood pressure, and eliminates <compound-id="5757">estradiol</compound-id>-stimulated <protein-id="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7">insulin</protein-id> release in female mice.	estradiol__insulin__interaction
18845639-1312	The aim of this study was to assess in rats the effect of protein feeding on the: 1) distribution of endogenous <compound-id="206,5793,64689,79025">glucose</compound-id> production (EGP) among gluconeogenic organs, and 2) repercussion on the <protein-id="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7">insulin</protein-id> sensitivity of glucose metabolism.	glucose__insulin__no_interaction
18845640-1315	Transcription of <protein-id="P58864,Q9DG08">steroidogenic acute regulatory protein</protein-id> in the rodent ovary and placenta: alternative modes of <compound-id="6076">cyclic adenosine 3', 5'-monophosphate</compound-id> dependent and independent regulation.	cyclic adenosine 3', 5'-monophosphate__steroidogenic acute regulatory protein__interaction
18845640-1316	The substrate for the synthesis of all steroid hormones is cholesterol, and its conversion to the first steroid, <compound-id="8955">pregnenolone</compound-id>, by the cholesterol side-chain cleavage <protein-id="O08469">cytochrome P450</protein-id> (<protein-id="O46515,P00189,P05108,P10612,P79153,P79202,Q07217,Q28827,Q2XV99,Q92045,Q9EPT4">CYP11A1</protein-id>) enzyme complex takes place in the inner mitochondrial membranes.	pregnenolone__CYP11A1__interaction	pregnenolone__cytochrome P450__interaction
18845643-1319	Collectively, these studies identify a novel role for <compound-id="5280453">1,25-dihydroxyvitamin D</compound-id> (3) and the <protein-id="O13124,O42392,P11473,P13053,P48281,P49701,Q28037,Q95MH5">VDR</protein-id> in the control of adipocyte metabolism and lipid storage in vivo.	1,25-dihydroxyvitamin D__VDR__no_interaction
18845645-1323	Direct <protein-id="P08235,P22199,P79404,Q29131,Q3YC04,Q4JM28,Q8QHI2,Q8VII8,Q91573,Q9BDJ7,Q9IAC6,Q9N0W8">mineralocorticoid receptor</protein-id> (MR) activation with <compound-id="5952">deoxycorticosterone acetate</compound-id> has deleterious effects on the cerebral vasculature.	deoxycorticosterone acetate__mineralocorticoid receptor__interaction
18845645-1325	Therefore, we hypothesized that systemic <protein-id="O77667,P50168,P50233,P51661,P51976,P80365">11betaHSD2</protein-id> inhibition with <compound-id="21913,636403,5311038">carbenoxolone</compound-id> (CBX) would cause remodeling of the middle cerebral artery (MCA) and increase the damage caused by cerebral ischemia.	carbenoxolone__11betaHSD2__interaction
18845661-1336	In this study, we attempted to evaluate the effects of <compound-id="3821,182137,644025">ketamine</compound-id> on F-<protein-id="O00937,O13419,O16808,O17320,O65314,O65315,O65316,O74258,O81221,P02577,P10365,P10989,P11426,P13363,P14235,P17128,P20904,P24902,P26182,P26183,P30161,P45520,P45521,P48465,P50138,P51775,P53455,P53476,P53477,P53491,P53498,P53499,P53500,P53502,P53689,P60009,P60010,P60011,P68555,P78711,P80709,P81085,P90689,P91754,Q05214,Q11212,Q24733,Q2U7A3,Q39596,Q39758,Q6TCF2,Q75D00,Q8SWN8,Q8X119,Q92192,Q92193,Q99023,Q9P4D1,Q9UVF3,Q9UVX4,Q9UVZ8">actin</protein-id> and microtubular cytoskeletons in human hepatoma HepG2 cells and its possible molecular mechanisms.	ketamine__actin__interaction
18845661-1337	Consequently, <compound-id="3821,182137,644025">ketamine</compound-id>-caused cytoskeletal interruption led to suppression of <protein-id="P08684">CYP3A4</protein-id> expression and its metabolizing activity.	ketamine__CYP3A4__interaction
18845662-1339	Because many drug-drug interactions may occur at the level of drug transporting proteins, we studied interactions of <compound-id="3033">diclofenac</compound-id> with apical ATP-binding cassette (ABC) <protein-id="O31855,O82855,P37340,P45272,P58163,P58164,Q55364,Q57PL1,Q5E4Y6,Q5KZL2,Q5MZD9,Q5NYX9,Q5PH16,Q5QWR6,Q62LW6,Q63DZ4,Q63S57,Q65IG9,Q65SY9,Q66A27,Q6D5W6,Q6FEY7,Q6HLG9,Q6LQ49,Q6NB79,Q71YH0,Q73BB8,Q7MKP8,Q7N1G0,Q7N3V2,Q7NXN3,Q7UAH8,Q7VMB5,Q7WAK9,Q7WJR0,Q7WTR3,Q81G28,Q81T85,Q879Z5,Q88BA2,Q88CB9,Q89AX2,Q89W72,Q8CUL5,Q8D9N8,Q8DPQ6,Q8EES3,Q8FH68,Q8G2I1,Q8P4E6,Q8PG07,Q8UDF5,Q8Y654,Q8YFD7,Q8Z6N7,Q8ZDZ8,Q8ZPP2,Q92AG2,Q92PZ0,Q97QN5,Q98D15,Q9CMZ9,Q9F5N7,Q9HTR0,Q9I3Y3,Q9JV27,Q9K015,Q9KEJ2,Q9KRU4,Q9PA34,Q9RY44,Q9WZS2">multidrug efflux transporters</protein-id>.	diclofenac__multidrug efflux transporters__interaction
18845662-1341	Furthermore, in Sf9-<protein-id="Q9UNQ0">BCRP</protein-id> membrane vesicles <compound-id="3033">diclofenac</compound-id> inhibited transport of methotrexate in a concentration-dependent manner.	diclofenac__BCRP__interaction
18845675-1354	To test this hypothesis, we measured the effect of <protein-id="P25285,P28337,P48728,Q9TSZ7">AMT</protein-id> on <protein-id="P30957,Q92736">RyR2</protein-id> channels from mice and sheep and on intact mouse cardiomyocytes loaded with the Ca(2+) fluorescent indicator <compound-id="57054">Fura-2</compound-id> <compound-id="53627513">acetoxymethyl</compound-id> ester.	Fura-2__AMT__no_interaction	Fura-2__RyR2__no_interaction	acetoxymethyl__AMT__no_interaction	acetoxymethyl__RyR2__no_interaction
18845767-1393	Most cells contain methionine sulfoxide reductases, which catalyze a <protein-id="O14463,O17486,O22022,O30974,O51088,O51890,O83889,O84544,O96952,O97508,O97680,P00276,P08058,P08628,P08629,P09857,P0A0K4,P0A0K5,P0A0K6,P0A4L3,P0A4L4,P0A616,P0A617,P10472,P10473,P10599,P10639,P11232,P14930,P14949,P21609,P21610,P29429,P29451,P33791,P34723,P37395,P42115,P43785,P46843,P47370,P50254,P50338,P50413,P51225,P52227,P52230,P52231,P52233,P57653,P59527,P66928,P66929,P75512,P80579,P81108,P81109,P81110,P82460,P96132,P99122,P99505,Q05739,Q57755,Q5HGT9,Q5HQ29,Q5R9M3,Q6GA69,Q6GHU0,Q7KQL8,Q7M1B9,Q8CPL5,Q92JR5,Q98PL5,Q98TX1,Q9BDJ3,Q9CM49,Q9DGI3,Q9JWM8,Q9K1N8,Q9PJK3,Q9R6P9,Q9UW02,Q9X2T1,Q9Z7P5,Q9ZEE0">thioredoxin</protein-id>-dependent reduction of <compound-id="876,6137">methionine</compound-id> sulfoxide back to <compound-id="876,6137">methionine</compound-id>.	methionine__thioredoxin__interaction
18845767-1394	The intracellular free <compound-id="876,6137">methionine</compound-id> and <compound-id="34756">S-adenosylmethionine</compound-id> pools were not altered, nor was the specific activity of the key enzyme, <protein-id="O00088,O04867,O08467,O27612,O29313,O58097,O59648,O66514,P00964,P04773,P07804,P09606,P0A039,P0A040,P0A1P6,P0A1P7,P0A9C5,P0A9C6,P0A9C7,P0A9C8,P10583,P10656,P11600,P12424,P12425,P13499,P15103,P15104,P15105,P15106,P15124,P15623,P16580,P19064,P19904,P20479,P21154,P22248,P23712,P23794,P25821,P28605,P28786,P32288,P33035,P36205,P43386,P43518,P43794,P45627,P46410,P51120,P51121,P60890,P77961,P94126,P94845,P99095,Q04831,Q05650,Q05907,Q06378,Q09179,Q12613,Q4R7U3,Q5HGC3,Q5HPN2,Q60182,Q6B4U7,Q6C3E0,Q6FMT6,Q6G9Q4,Q6GHC6,Q75BT9,Q86ZF9,Q86ZU6,Q874T6,Q8CSR8,Q8HZM5,Q8J1R3,Q8X169,Q96UG9,Q96UV5,Q96V52,Q9C2U9,Q9CDL9,Q9CLP2,Q9HH09,Q9HNI2,Q9HU65,Q9KNJ2,Q9QY94,Q9UUN6,Q9UY99,Q9ZLW5">glutamine synthetase</protein-id>.	S-adenosylmethionine__glutamine synthetase__no_interaction	methionine__glutamine synthetase__no_interaction
18845781-1399	Activity of muscle <protein-id="O33915,O34002,O68883,P09948,P0ABH7,P0ABH8,P14165,P18789,P20901,P20902,P20903,P21553,P26491,P27660,P42457,P51031,P51032,P51033,P51034,P51035,P51036,P51039,P51040,P51041,P51042,P51043,P51045,P56062,P80148,P84543,P94325,Q53554,Q59136,Q59198,Q59258,Q59730,Q59732,Q59734,Q59741,Q59742,Q59748,Q59759,Q59768,Q59776,Q59778,Q59939,Q59977,Q9RWB2,Q9ZN37">citrate synthase</protein-id> and <protein-id="O49809,P07896,P21177,P28793,P51659,P51660,P55100,P77399,P97852,Q08426,Q0TAL0,Q1C2C4,Q1CN99,Q1Q8J9,Q1R466,Q32A21,Q39659,Q3K9D8,Q3YVC1,Q489W3,Q48GW3,Q4FQC6,Q4KFC4,Q4ZRA0,Q57HM6,Q57LW6,Q5E3U1,Q5E8X6,Q5PCX6,Q5PKQ2,Q5QXH7,Q5QXM1,Q668V1,Q66FR8,Q6D2L7,Q6DAP5,Q6FF68,Q6LTK3,Q6LW06,Q7MIS5,Q7MQH9,Q7MZ92,Q7N288,Q83PG1,Q83QQ0,Q87MM3,Q87TN9,Q87ZB2,Q88L02,Q8DB47,Q8DDK6,Q8ECP7,Q8EKR9,Q8FBI2,Q8FFG4,Q8W1L6,Q8X8I2,Q8XCP2,Q8Z3C6,Q8Z4Z0,Q8ZAN0,Q8ZD45,Q8ZNA7,Q93Q12,Q9AHY3,Q9DBM2,Q9F0Y7,Q9HZJ2,Q9KNI1,Q9KT58,Q9L6L5">3-hydroxyacyl-CoA dehydrogenase</protein-id>, as well as maximal <compound-id="977">oxygen</compound-id> uptake and 10-km performance time, remained unaltered in both groups.	oxygen__3-hydroxyacyl-CoA dehydrogenase__no_interaction	oxygen__citrate synthase__no_interaction
18845907-1434	MIN6 cells excreted insulin, <protein-id="O12956,O42143,O42144,P01272,P01273,P01274,P01275,P04093,P05110,P06883,P07449,P09566,P09567,P09682,P09686,P0C235,P13189,P15438,P18108,P22890,P29794,P31297,P33528,P55095,P68259,P68260,P68273,P68274,P68275,P68952,P68953,P68954,P68955,P68956,P68957,P79695,P81880,Q8MJ25,Q9PRQ9">glucagon</protein-id>, <compound-id="16129681,16129706">somatostatin</compound-id> and <protein-id="Q6BEG6,Q6BEG7,Q9BDJ6,Q9BEF8,Q9EQX0,Q9GKY5,Q9QYH7,Q9UBU3">ghrelin</protein-id>.	somatostatin__glucagon__no_interaction	somatostatin__ghrelin__no_interaction
18845907-1435	They expressed mRNAs of <protein-id="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7">insulin</protein-id> I and II, proglucagon, <compound-id="16129681,16129706">somatostatin</compound-id>, <protein-id="P01298,P01299,P01300,P01301,P01302,P06303,P06304,P06305,P06884,P10601,P11967,P13083,P15427,P18107,P31229,P33684,P37999,P39659,P41335,P41336,P41337,P41519,P68009,P68010,P68248,P68249">pancreatic polypeptide</protein-id> (PP) and <protein-id="Q6BEG6,Q6BEG7,Q9BDJ6,Q9BEF8,Q9EQX0,Q9GKY5,Q9QYH7,Q9UBU3">ghrelin</protein-id> which were shown in the mouse pancreatic islet core and periphery obtained by LCM.	somatostatin__pancreatic polypeptide__no_interaction	somatostatin__ghrelin__no_interaction	somatostatin__insulin__no_interaction
18845907-1436	<protein-id="O12956,O42143,O42144,P01272,P01273,P01274,P01275,P04093,P05110,P06883,P07449,P09566,P09567,P09682,P09686,P0C235,P13189,P15438,P18108,P22890,P29794,P31297,P33528,P55095,P68259,P68260,P68273,P68274,P68275,P68952,P68953,P68954,P68955,P68956,P68957,P79695,P81880,Q8MJ25,Q9PRQ9">Glucagon</protein-id>, <compound-id="16129681,16129706">somatostatin</compound-id> and <protein-id="Q6BEG6,Q6BEG7,Q9BDJ6,Q9BEF8,Q9EQX0,Q9GKY5,Q9QYH7,Q9UBU3">ghrelin</protein-id> were detectable in the culture medium.	somatostatin__Glucagon__no_interaction	somatostatin__ghrelin__no_interaction
18846314-1555	<protein-id="O02033,O13257,O18842,O42152,O93571,P02807,P04358,P07216,P08002,P23038,P25127,P25128,P30331,P30565,P51902,P52723,P52725,P52726,P52728,P55945,P55946,P55948,P55951,P55952,P55953,P68494,P68495,P68497,P68498,P68499,P80367,P80593,P84865,Q05890,Q6J1T3,Q6S4N8,Q6XUW5,Q708T3,Q7ZZP9,Q800D3,Q8UVY1,Q94550,Q9IB50,Q9U568">Metallothioneins</protein-id> (MTs) are <compound-id="594,5862,5360637">cysteine</compound-id>-rich, metal-binding proteins that are useful biomarkers for monitoring pollution by heavy metals.	cysteine__Metallothioneins__interaction
18846314-1558	The deduced amino acid sequence has 18 <compound-id="594,5862,5360637">cysteine</compound-id> residues, implying that S. henanense <protein-id="Q8WSW3">CdMT</protein-id> binds six equivalents of bivalent metal ions (Cd) as opposed to the seven in its mammalian counterparts.	cysteine__CdMT__interaction
18846317-1559	Their health status was assessed by medical conditions, family history, BMI, past or present clinical manifestations, 25 (OH)D, Calcium, <protein-id="O60109,P81800,P83456">alkaline phosphatase</protein-id>, <compound-id="24404,139579">phosphorus</compound-id>, HbA1C, <protein-id="O27732,O28185,O66677,O74017,O74806,O83975,O84806,O85235,P01268,P01269,P01270,P04089,P0A281,P0A282,P0A7D1,P0A7D2,P0A7D3,P15743,P37470,P38876,P44682,P47329,P47714,P49607,P52212,P56077,P57287,P57820,P59490,P61234,P61235,P61414,P65863,P65864,P65865,P65866,P65867,P65868,P65869,P78034,Q27IM2,Q57NM8,Q59989,Q5F9L4,Q5FFA3,Q5FMA9,Q5FRT7,Q5GTI9,Q5GWR6,Q5HC85,Q5HIH3,Q5HRQ3,Q5HWF9,Q5JDB8,Q5L3U7,Q5LV91,Q5M222,Q5M6L4,Q5N2J4,Q5NGZ6,Q5NL75,Q5P722,Q5P9A6,Q5PCR7,Q5QV03,Q5SHZ2,Q5V1D3,Q5WAD6,Q5WTE7,Q5X1N7,Q5XEM3,Q5YPZ6,Q5ZS66,Q601M5,Q60363,Q60A14,Q62FC1,Q63HI2,Q63XM0,Q64X30,Q65PG8,Q65V47,Q65ZY7,Q66AY1,Q67JD0,Q68WD4,Q6AAC7,Q6ADQ8,Q6AJL9,Q6D557,Q6F240,Q6F8I7,Q6G0F9,Q6G2L1,Q6GBY6,Q6GJG9,Q6HPW6,Q6KHA3,Q6LNA9,Q6MJR3,Q6MS28,Q6N1P9,Q6NI78,Q6YP15,Q6YR64,Q724K0,Q72BR1,Q72IA8,Q72RZ0,Q73FF7,Q73II8,Q73Q01,Q741V9,Q74FE6,Q74LA8,Q7M7U8,Q7MMZ2,Q7MXK9,Q7N5A1,Q7NN75,Q7NQT1,Q7U9I5,Q7UKV0,Q7V342,Q7V4V4,Q7VDT7,Q7VG29,Q7VMI1,Q7VUH3,Q7W179,Q7WNY2,Q81J96,Q81VY9,Q821W6,Q82HE5,Q82TQ6,Q839C0,Q83AP0,Q83FR1,Q83HD8,Q83LE1,Q86Y79,Q877G5,Q87A24,Q87RN9,Q888C8,Q88PX8,Q88Z39,Q899I4,Q89DJ9,Q89YZ2,Q8BW00,Q8CQU9,Q8CXP8,Q8D2K4,Q8DFF4,Q8DJ45,Q8DRQ2,Q8DWN5,Q8E2I1,Q8E7Y8,Q8EHN5,Q8EWQ8,Q8F3Q2,Q8FQV6,Q8G5I6,Q8K8Z7,Q8K9V3,Q8KD05,Q8P327,Q8PC61,Q8PNT8,Q8Q0M4,Q8R757,Q8RIJ5,Q8RLD7,Q8TKX4,Q8TV04,Q8U0N0,Q8UD97,Q8XHJ8,Q8Y2E3,Q8YAD1,Q8YYK4,Q8ZEY4,Q8ZYM4,Q92F62,Q92H41,Q92N67,Q976I0,Q97CB4,Q97E97,Q97TD1,Q980V1,Q98HV6,Q98PE2,Q9A206,Q9AAV9,Q9AEQ5,Q9CD49,Q9CJI1,Q9F8Q3,Q9GL67,Q9HLW6,Q9HVC3,Q9J5H2,Q9JV42,Q9K029,Q9K3T8,Q9KGJ3,Q9KQ21,Q9PA78,Q9PII7,Q9PR67,Q9RRW3,Q9V108,Q9X1W1,Q9XT35,Q9YBD6,Q9Z6V6,Q9ZCV4,Q9ZJC3">PTH</protein-id>, Mg and <compound-id="588">creatinine</compound-id> analysis.	phosphorus__alkaline phosphatase__no_interaction	creatinine__PTH__no_interaction	phosphorus__PTH__no_interaction	creatinine__alkaline phosphatase__no_interaction
18846318-1561	Treatment of Platelet Rich Plasma (PRP) with the dialyzed supernatant from the leucocyte suspension incubated with 80 microM <compound-id="2244">aspirin</compound-id> resulted in parallel syntheses of NO and <protein-id="P35849">IFN-alpha</protein-id> as determined by methemoglobin assay and enzyme linked immunosorbent assay respectively.	aspirin__IFN-alpha__interaction
18846383-1582	Muscular oxidative stress and inflammation induced by <compound-id="784">H2O2</compound-id> or MS were assessed by measurements of isoprostanes and <protein-id="O35736,P05231,P08505,P20607,P26892,P26893,P29455,P41323,P41683,P41693,P46650,P51494,P79341,Q25BC2,Q28319,Q28747,Q28819,Q2MH06,Q5I6E3,Q6V919,Q865W7,Q865X6,Q8MKH0,Q95181,Q9MZR1,Q9XT80">IL-6</protein-id> levels.	H2O2__IL-6__interaction
18846383-1583	In control rats, <compound-id="784">H2O2</compound-id>, <protein-id="O08677,P01042,P01044,P01045,P08934,P83055,P83060,P83856,P83857,P84697,P84825,P84895,Q7T3L1,Q90W88,Q90WZ1">bradykinin</protein-id> and MS significantly enhanced the HFV response.	H2O2__bradykinin__no_interaction
18846383-1584	Pre-treatment with <protein-id="O12933,O22668,O75007,P24705,P51547,P93258,Q01137,Q27666,Q9SM64">SOD</protein-id> abolished the post-MS-enhanced HFV response whereas <compound-id="3033">diclofenac</compound-id> lowered the peak HFV response to MS and <compound-id="784">H2O2</compound-id>.	H2O2__SOD__no_interaction	diclofenac__SOD__no_interaction
18846383-1585	<compound-id="784">H2O2</compound-id> injection and MS elicited significant and similar increases in isoprostanes and <protein-id="O35736,P05231,P08505,P20607,P26892,P26893,P29455,P41323,P41683,P41693,P46650,P51494,P79341,Q25BC2,Q28319,Q28747,Q28819,Q2MH06,Q5I6E3,Q6V919,Q865W7,Q865X6,Q8MKH0,Q95181,Q9MZR1,Q9XT80">IL-6</protein-id>.	H2O2__IL-6__interaction
18846462-1626	The decreased level of GSH as well as <protein-id="O12933,O22668,O75007,P24705,P51547,P93258,Q01137,Q27666,Q9SM64">SOD</protein-id> and GSH-Px activities in <compound-id="3559">haloperidol</compound-id>-treated mice were significantly increased by NTA pretreatment.	haloperidol__SOD__interaction
18846552-1647	In the present study, rTHS was used to stabilize penicillin <protein-id="O69768,P22984,P27765,P95896">amidase</protein-id> (PGA) in <compound-id="887,19314">methanol</compound-id>-water mixtures.	methanol__amidase__interaction
18847291-1916	In this study, fluorescence microscopy and elemental analysis were exploited to show that the 3,4-dihydroxyphenyl-L-<compound-id="602,4580,5950,71080">alanine</compound-id> (<compound-id="6047">dopa</compound-id>) residues of mussel <protein-id="Q25434,Q25460,Q27409">foot protein-1</protein-id> colocalize with Fe and Ca distributions in the cuticle of Mytilus galloprovincialis mussel byssal threads.	alanine__foot protein-1__interaction	dopa__foot protein-1__interaction
18847329-1933	We measured pain using a visual analog pain scale at five time points in 0-48 h, oxycodone use for pain, <compound-id="1983">acetaminophen</compound-id> for fever, C-reactive protein (<protein-id="O19062,P02741,P02742,P08462,P18151,P21291,P41964,P47875,P49254,P49262,P52753,P67966,P67967,P97315,Q07203">CRP</protein-id>), and total and percent gammadeltaT-cells.	acetaminophen__CRP__no_interaction
18847384-1963	Association between <protein-id="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7">insulin</protein-id> resistance, <compound-id="206,5793,64689,79025">glucose</compound-id> intolerance, and hypertension in pregnancy.	glucose__insulin__interaction
18847384-1966	These results suggest that <protein-id="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7">insulin</protein-id> resistance and relative <compound-id="206,5793,64689,79025">glucose</compound-id> intolerance are associated with an increased risk of new-onset hypertension in pregnancy, particularly preeclampsia, and support the hypothesis that <protein-id="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7">insulin</protein-id> resistance may play a role in the pathogenesis of this disorder.	glucose__insulin__interaction
18848359-2685	Serotonin transporter (5-<protein-id="P31645">HTT</protein-id>) and <protein-id="P20905,P28285,P28286,Q17239,Q25190,Q25414">5-HT receptor</protein-id> (5-HTR) involved in the neurotransmission of <compound-id="5202">5-HT</compound-id> may play an important role in the development of major depression disorder (<protein-id="P32377">MDD</protein-id>).	5-HT__5-HT receptor__interaction	5-HT__HTT__interaction	5-HT__MDD__interaction
18848532-2325	These <protein-id="P06525,P0A9Q7,P0A9Q8,P17648,P33744,P42327,P48977,P81786,Q04983,Q24803,Q24857,Q9NAR7">ADHs</protein-id> are likely to perform similar functions to those reported for other mammalian <protein-id="P06525,P0A9Q7,P0A9Q8,P17648,P33744,P42327,P48977,P81786,Q04983,Q24803,Q24857,Q9NAR7">ADHs</protein-id> in the metabolism of ingested and endogenous <compound-id="702">alcohols</compound-id> and aldehydes.	alcohols__ADHs__interaction
18848584-2351	<protein-id="O04885,O49818,P0A0T2,P0A0T3,P0A1Q2,P0A1Q3,P0AC81,P0AC82,P0AC83,P16635,P44638,P46235,P46417,P50107,P84719,Q04760,Q09751,Q39366,Q42891,Q4R5F2,Q55595,Q6P7Q4,Q8H0V3,Q948T6,Q9CPU0,Q9KT93">Glyoxalase I</protein-id> and II form a ubiquitous <compound-id="124886">glutathione</compound-id>-dependent pathway for the detoxification of reactive and mutagenic ketoaldehydes.	glutathione__Glyoxalase I__interaction
18848584-2353	<compound-id="137849">S-Acetyl</compound-id>- and S-propionyltrypanothione obtained by this spontaneous reaction proved to be excellent substrates of T. brucei <protein-id="O24495,O24496,O35952,P05446,P0AC84,P0AC85,P57336,P71374,P72933,P96981,Q05584,Q08889,Q12320,Q16775,Q26547,Q28333,Q89AN4,Q99KB8,Q9C8L4,Q9SID3">glyoxalase II</protein-id>.	S-Acetyl__glyoxalase II__interaction
18848601-2359	<protein-id="P14061,P51656,P51657,Q1WNP0">17beta-Hydroxysteroid dehydrogenase type 1</protein-id> (<protein-id="P14061,P51656,P51657,Q1WNP0">17beta-HSD1</protein-id>) is responsible for the catalytic reduction of the weak estrogen <compound-id="5870">estrone</compound-id> (E1) into the highly potent <compound-id="5757">17beta-estradiol</compound-id> (E2).	estrone__17beta-HSD1__interaction	17beta-estradiol__17beta-Hydroxysteroid dehydrogenase type 1__interaction	estrone__17beta-Hydroxysteroid dehydrogenase type 1__interaction	17beta-estradiol__17beta-HSD1__interaction
18848601-2360	3-[4-(4-Hydroxyphenyl)-1H-<compound-id="67516">1,2,3-triazol</compound-id>-1-yl]phenol (3) was the most active compound discovered in this study with an IC(50) value of 840nM and a reasonable selectivity towards <protein-id="P37059,P51658,Q62730">17beta-HSD2</protein-id>.	1,2,3-triazol__17beta-HSD2__interaction
18848620-2373	Blood was collected before and repeatedly afterward for determination of NF-kappaB activity, leukocyte subset numbers, <compound-id="5754">cortisol</compound-id>, <compound-id="951,439260">norepinephrine</compound-id>, and in vitro-stimulated <protein-id="O35736,P05231,P08505,P20607,P26892,P26893,P29455,P41323,P41683,P41693,P46650,P51494,P79341,Q25BC2,Q28319,Q28747,Q28819,Q2MH06,Q5I6E3,Q6V919,Q865W7,Q865X6,Q8MKH0,Q95181,Q9MZR1,Q9XT80">IL-6</protein-id> production.	cortisol__IL-6__no_interaction	norepinephrine__IL-6__no_interaction
18848620-2374	Higher NF-kappaB stress responses were associated with lower <compound-id="5754">cortisol</compound-id> stress responses (beta=-.37, p=.05), higher pre-stress <protein-id="O35736,P05231,P08505,P20607,P26892,P26893,P29455,P41323,P41683,P41693,P46650,P51494,P79341,Q25BC2,Q28319,Q28747,Q28819,Q2MH06,Q5I6E3,Q6V919,Q865W7,Q865X6,Q8MKH0,Q95181,Q9MZR1,Q9XT80">IL-6</protein-id> production (beta=.38, p=.043), and high chronic in combination with low acute stress, or vice versa (beta=-.61, p=.06).	cortisol__IL-6__no_interaction
18848644-2380	7-Ethoxy resorufin O-deethylase (EROD) activity is strictly related to <protein-id="Q6JZS3,Q92039,Q9YH64">CYP1A</protein-id> presence, at the same time P450-dependent oxidative metabolism leads to reactive <compound-id="977">oxygen</compound-id> species (ROS) production, thought to be an important mechanism of pollutant-mediated toxicity in aquatic organisms.	oxygen__CYP1A__no_interaction
18848646-2382	The combination of <compound-id="857,6106,439524">leucine</compound-id>-rich repeat (LRR) and immunoglobulin-like (Ig) domains is found in the domain architecture of the <protein-id="P35739,P47946,Q24155">Trk</protein-id> neurotrophin receptor protein.	leucine__Trk__interaction
18848646-2383	Given the significant biological roles of <protein-id="P35739,P47946,Q24155">Trk</protein-id> and such newly identified proteins, we have searched the public database for human proteins with LRR and Ig domains (collectively termed the <compound-id="857,6106,439524">leucine</compound-id>-rich repeat and Ig domain-containing protein, LRRIG protein, in this study), and have analyzed the mRNA expression pattern of mouse orthologs of obtained human LRRIG proteins at embryonic day 10.	leucine__Trk__no_interaction
18848727-2425	Quantum chemical studies for oxidation of <compound-id="8083">morpholine</compound-id> by <protein-id="O08469">Cytochrome P450</protein-id>.	morpholine__Cytochrome P450__interaction
18848727-2426	Since <compound-id="8083">morpholine</compound-id> oxidation has recently been shown to involve <protein-id="O08469">Cytochrome P450</protein-id>, the study on its mechanism at molecular level using quantum chemical calculations for the model of cytochrome active site is reported here.	morpholine__Cytochrome P450__interaction
18848748-2442	Pretreatment with oligonol diminished the levels of <protein-id="O01377,O02115,O16852,O82134,O82797,P04961,P12004,P15873,P17070,P17917,P17918,P18248,P22177,P24314,P31008,P53358,P57761,P61074,P61258,Q00268,Q03392,Q43124,Q43266,Q6B6N4,Q9DDF1,Q9DEA3,Q9MAY3,Q9PTP1,Q9W644">proliferating cell nuclear antigen</protein-id> and expression of <protein-id="O02768,O19183,O62698,O62725,P27607,P35354,P35355,P70682,P79208,Q05769">COX-2</protein-id> in papillomas and carcinomas, respectively, as compared to <compound-id="6001">DMBA</compound-id> plus TPA treatment alone.	DMBA__COX-2__interaction	DMBA__proliferating cell nuclear antigen__interaction
18848782-2443	TnBP (<compound-id="31357">tri-n-butyl phosphate</compound-id>) and polysorbate 20 during the manufacture of the factor VIII/<protein-id="P04275,P80012,Q28295,Q28833,Q8CIZ8">VWF</protein-id> concentrate Optivate has been investigated.	tri-n-butyl phosphate__VWF__interaction
18848797-2450	Euthyroid animals with a palpation score &gt;or=3 were significantly older, had higher body weights, lower <protein-id="O60109,P81800,P83456">alkaline phosphatase</protein-id>, alanine aminotransferase, <compound-id="1061,167704,644102">phosphate</compound-id>, and urine specific gravity, but higher <protein-id="Q7M4U7">lipase</protein-id> and <compound-id="588">creatinine</compound-id> concentrations than hyperthyroid cats.	creatinine__lipase__no_interaction	phosphate__lipase__no_interaction	phosphate__alkaline phosphatase__no_interaction	creatinine__alkaline phosphatase__no_interaction
18848818-2462	A role for <protein-id="P34972,P47936,Q9QZN9">CB2</protein-id> receptors in <compound-id="5281969">anandamide</compound-id> signalling pathways involved in the regulation of IL-12 and IL-23 in microglial cells.	anandamide__CB2__interaction
18848825-2465	<protein-id="P16104">H2AX</protein-id> phosphorylation <compound-id="31423">pyrene</compound-id> diol epoxides.	pyrene__H2AX__interaction
18848878-2491	2-Deoxyglucose decreased NADH/<compound-id="5893">NAD</compound-id> (+) and NADPH/NADP(+) ratios by 59 and 50%, respectively, and intact cell <protein-id="P15559,Q5RD31,Q8CHK7">NQO1</protein-id> activity by 74%; lactate restored NADH/<compound-id="5893">NAD</compound-id> (+), but not NADPH/NADP(+) or <protein-id="P15559,Q5RD31,Q8CHK7">NQO1</protein-id> activity.	NAD__NQO1__no_interaction
18848878-2492	The results suggest that <protein-id="P15559,Q5RD31,Q8CHK7">NQO1</protein-id> activity is more tightly coupled to the redox status of the NADPH/NADP(+) than NADH/<compound-id="5893">NAD</compound-id> (+) redox pair, and that NADPH is the endogenous <protein-id="P15559,Q5RD31,Q8CHK7">NQO1</protein-id> electron donor.	NAD__NQO1__no_interaction
18848894-880	We propose that the coordinated regulation of <protein-id="O00937,O13419,O16808,O17320,O65314,O65315,O65316,O74258,O81221,P02577,P10365,P10989,P11426,P13363,P14235,P17128,P20904,P24902,P26182,P26183,P30161,P45520,P45521,P48465,P50138,P51775,P53455,P53476,P53477,P53491,P53498,P53499,P53500,P53502,P53689,P60009,P60010,P60011,P68555,P78711,P80709,P81085,P90689,P91754,Q05214,Q11212,Q24733,Q2U7A3,Q39596,Q39758,Q6TCF2,Q75D00,Q8SWN8,Q8X119,Q92192,Q92193,Q99023,Q9P4D1,Q9UVF3,Q9UVX4,Q9UVZ8">actin</protein-id> cytoskeletal reorganization and macropinocytosis-mediated retrograde membrane trafficking may contribute to <compound-id="271">Ca(2</compound-id>+)-induced axon growth inhibition.	Ca(2__actin__interaction
18848957-982	Cocaine stimulated <protein-id="P01189,P01190,P01191,P01192,P01193,P01194,P01196,P01197,P01201,P06297,P06298,P06299,P10000,P11280,P11885,P19402,P21252,P22923,P68000,P68001,P87352,Q04617,Q04618,Q91082,Q9YGK2,Q9YGK4,Q9YGK5">ACTH</protein-id>, <compound-id="5754">cortisol</compound-id>, and LH, whereas cocaine+nalbuphine in combination produced a smaller increase in <protein-id="P01189,P01190,P01191,P01192,P01193,P01194,P01196,P01197,P01201,P06297,P06298,P06299,P10000,P11280,P11885,P19402,P21252,P22923,P68000,P68001,P87352,Q04617,Q04618,Q91082,Q9YGK2,Q9YGK4,Q9YGK5">ACTH</protein-id>, and decreased <compound-id="5754">cortisol</compound-id> and LH.	cortisol__ACTH__no_interaction
18848957-983	Thus it appears that nalbuphine attenuated cocaine's effects on <protein-id="P01189,P01190,P01191,P01192,P01193,P01194,P01196,P01197,P01201,P06297,P06298,P06299,P10000,P11280,P11885,P19402,P21252,P22923,P68000,P68001,P87352,Q04617,Q04618,Q91082,Q9YGK2,Q9YGK4,Q9YGK5">ACTH</protein-id>, <compound-id="5754">cortisol</compound-id>, and LH.	cortisol__ACTH__no_interaction
18848961-2547	In this work we show that in FaO rat hepatoma cells inhibition of the <protein-id="P55245">epidermal growth factor receptor</protein-id> (<protein-id="P00533,P13387,P55245">EGFR</protein-id>) with the tyrphostin <compound-id="2051">AG1478</compound-id> enhances TGF-beta-induced cell death, coincident with an elevated increase in ROS production and GSH depletion.	AG1478__epidermal growth factor receptor__interaction	AG1478__EGFR__interaction
18848984-2561	Membrane inlet mass spectrometry was used to observe <compound-id="145068">nitric oxide</compound-id> in the well-studied reaction of nitrite with <protein-id="P15160,P17724,P73925,Q03459">hemoglobin</protein-id>.	nitric oxide__hemoglobin__interaction
18849028-2571	Diminished levels of L-<compound-id="232,4367,6322">arginine</compound-id> and endothelial <protein-id="O61309,O61608,Q27571,Q9I9M2">nitric oxide synthase</protein-id> (<protein-id="P29473,P29474,P70313,P79209,P97270,Q28969,Q62600">eNOS</protein-id>) uncoupling through deficiency of <compound-id="44257,9816201">tetrahydrobiopterin</compound-id> (BH(4)) may contribute to endothelial dysfunction.	tetrahydrobiopterin__nitric oxide synthase__interaction	arginine__eNOS__no_interaction	tetrahydrobiopterin__eNOS__interaction	arginine__nitric oxide synthase__no_interaction
18849030-2572	Serum testosterone, <compound-id="5757">estradiol</compound-id>, sex hormone binding globulin (<protein-id="P04278,P08689,P15196,P97497,Q62588">SHBG</protein-id>), and <compound-id="5881">dehydroepiandrosterone</compound-id> levels were measured in 1947 postmenopausal women aged 45-84 years (30% White, 14% Chinese-American, 31% Black, and 25% Hispanic) and not on hormone therapy.	dehydroepiandrosterone__SHBG__no_interaction	estradiol__SHBG__no_interaction
18849030-2573	Total and bioavailable testosterone were positively associated with common cIMT independent of age, BMI, hypertension, smoking, HDL-<compound-id="304,5997,6432564,11025495">cholesterol</compound-id>, LDL-<compound-id="304,5997,6432564,11025495">cholesterol</compound-id> and <protein-id="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7">insulin</protein-id> sensitivity (p=0.009 and p=0.002, respectively).	cholesterol__insulin__no_interaction
18849055-2585	In addition to lipid peroxidation, the activities of antioxidant enzymes such as <protein-id="O50258">superoxide dismutase</protein-id>, <protein-id="O24339,O52762,O62839,O68146,O77229,O93662,O97492,P00432,P04040,P04762,P07145,P0A323,P0A324,P0A325,P0A326,P0A327,P11934,P17336,P24168,P24270,P25890,P29422,P30265,P30266,P32290,P42321,P44390,P45737,P45739,P55304,P55306,P55310,P55311,P55313,P77872,P81138,P90682,Q27710,Q49XC1,Q4L643,Q59296,Q59337,Q59602,Q59714,Q5HG86,Q5HPK8,Q5RF10,Q64405,Q6G9M4,Q6GH72,Q7A5T2,Q8CPD0,Q8FWU0,Q8NWV5,Q8X1P0,Q8Y3P9,Q926X0,Q99UE2,Q9AXH0,Q9KW19,Q9L4S1,Q9M5L6,Q9PT92,Q9PWF7,Q9Z598,Q9ZKX5,Q9ZN99">catalase</protein-id>, <protein-id="O32770,O59858,Q00277,Q9CFV1">glutathione peroxidase</protein-id>, <protein-id="O15770,P06715,P11804,P23189,P41921,P43783,P48638,P48639,P70619,P78965,Q60151,Q6BPI1,Q6C5H4,Q6FRV2,Q6HA23,Q74ZK4,Q873E8,Q94655">glutathione reductase</protein-id> and <protein-id="O04437,O18598,P0A9D2,P0A9D3,P30116,P44521,P46088,P46419,P46423,P46426,P46428,P46437,P48438,P80894,P81065,P82996,P82997,P82998,P82999,P83000,P83001,P83246,Q04522,Q08392,Q08393,Q0ZS46,Q7REH6,Q8ILQ7,Q8MU52,Q96324">glutathione S-transferase</protein-id> and two non-enzymatic antioxidants (<compound-id="54670067,54690394">ascorbic acid</compound-id> and <compound-id="124886">reduced glutathione</compound-id>) were investigated in order to understand their variation with respect to pollution status of the sampling locations.	reduced glutathione__catalase__no_interaction	reduced glutathione__glutathione reductase__no_interaction	reduced glutathione__superoxide dismutase__no_interaction	ascorbic acid__glutathione S-transferase__no_interaction	ascorbic acid__catalase__no_interaction	ascorbic acid__glutathione reductase__no_interaction	reduced glutathione__glutathione peroxidase__no_interaction	ascorbic acid__superoxide dismutase__no_interaction	ascorbic acid__glutathione peroxidase__no_interaction	reduced glutathione__glutathione S-transferase__no_interaction
18849055-2586	This study shows that changes in lipid peroxidation, <protein-id="O50258">superoxide dismutase</protein-id>, <protein-id="O24339,O52762,O62839,O68146,O77229,O93662,O97492,P00432,P04040,P04762,P07145,P0A323,P0A324,P0A325,P0A326,P0A327,P11934,P17336,P24168,P24270,P25890,P29422,P30265,P30266,P32290,P42321,P44390,P45737,P45739,P55304,P55306,P55310,P55311,P55313,P77872,P81138,P90682,Q27710,Q49XC1,Q4L643,Q59296,Q59337,Q59602,Q59714,Q5HG86,Q5HPK8,Q5RF10,Q64405,Q6G9M4,Q6GH72,Q7A5T2,Q8CPD0,Q8FWU0,Q8NWV5,Q8X1P0,Q8Y3P9,Q926X0,Q99UE2,Q9AXH0,Q9KW19,Q9L4S1,Q9M5L6,Q9PT92,Q9PWF7,Q9Z598,Q9ZKX5,Q9ZN99">catalase</protein-id>, <protein-id="O15770,P06715,P11804,P23189,P41921,P43783,P48638,P48639,P70619,P78965,Q60151,Q6BPI1,Q6C5H4,Q6FRV2,Q6HA23,Q74ZK4,Q873E8,Q94655">glutathione reductase</protein-id>, <protein-id="O04437,O18598,P0A9D2,P0A9D3,P30116,P44521,P46088,P46419,P46423,P46426,P46428,P46437,P48438,P80894,P81065,P82996,P82997,P82998,P82999,P83000,P83001,P83246,Q04522,Q08392,Q08393,Q0ZS46,Q7REH6,Q8ILQ7,Q8MU52,Q96324">glutathione S-transferase</protein-id> and <compound-id="124886">reduced glutathione</compound-id> in tissues of P. viridis can be used as molecular biomarkers in environmental monitoring programs.	reduced glutathione__superoxide dismutase__no_interaction	reduced glutathione__catalase__no_interaction	reduced glutathione__glutathione reductase__no_interaction	reduced glutathione__glutathione S-transferase__no_interaction
18849069-2591	At the same time, both types of conduits were permeable to three compounds tested including <compound-id="206,5793,64689,79025">glucose</compound-id>, <protein-id="O64362,O80288,O80292,P00720,P03706,P07540,P09963,P10439,P11187,P13656,P15057,P19385,P19386,P21270,P23472,P23473,P27359,P33486,P37715,P39046,P51771,P62692,P62693,P68920,P68921,P81241,P82174,P82175,P83673,Q27650,Q37875,Q37896,Q48603,Q7SID7,Q9CIT4,Q9T1X2,Q9ZXB7">lysozyme</protein-id> and bovine <protein-id="P21847,P83517">serum albumin</protein-id>, indicating the suitability of the conduits for free exchanges of nutrients.	glucose__serum albumin__no_interaction	glucose__lysozyme__no_interaction
18849110-2608	The inhibitory effect of <compound-id="951,439260">norepinephrine</compound-id> on the migration of ES-2 ovarian carcinoma cells involves a <protein-id="P08645,P18613,Q91VL8,Q96TL7">Rap1</protein-id>-dependent pathway.	norepinephrine__Rap1__interaction
18849110-2609	This inhibitory effect is possibly mediated by a <compound-id="6076">cAMP</compound-id>-dependent activation of the small GTPase <protein-id="P08645,P18613,Q91VL8,Q96TL7">Rap1</protein-id> via <protein-id="Q8VCC8,Q9Z1C8">Epac</protein-id>.	cAMP__Rap1__interaction	cAMP__Epac__interaction
18849120-2614	Gender differences in <protein-id="P01189,P01190,P01191,P01192,P01193,P01194,P01196,P01197,P01201,P06297,P06298,P06299,P10000,P11280,P11885,P19402,P21252,P22923,P68000,P68001,P87352,Q04617,Q04618,Q91082,Q9YGK2,Q9YGK4,Q9YGK5">corticotropin</protein-id> and <compound-id="5753">corticosterone</compound-id> secretion and <protein-id="P01142,P01143,P06296,P06850,P49188,P49926,Q8CIT0,Q95MI6,Q9PTS1">corticotropin-releasing factor</protein-id> mRNA expression in the paraventricular nucleus of the hypothalamus and the central nucleus of the amygdala in response to footshock stress or psychological stress in rats.	corticosterone__corticotropin-releasing factor__no_interaction	corticosterone__corticotropin__no_interaction
18849120-2615	Although females in both proestrus and diestrus showed significant increases in plasma <protein-id="P01189,P01190,P01191,P01192,P01193,P01194,P01196,P01197,P01201,P06297,P06298,P06299,P10000,P11280,P11885,P19402,P21252,P22923,P68000,P68001,P87352,Q04617,Q04618,Q91082,Q9YGK2,Q9YGK4,Q9YGK5">ACTH</protein-id> and <compound-id="5753">corticosterone</compound-id> and <protein-id="O75973,P01142,P01143,P06296,P06850,P49188,P49926,Q8CIT0,Q95MI6,Q9PTS1">CRF</protein-id> mRNA expression in the PVN in response to PS, no significant responses of the HPA axis to PS were found in males.	corticosterone__ACTH__no_interaction	corticosterone__CRF__no_interaction
18849121-2616	<protein-id="O18752,O18753,O18755,O70183,O97759,P14082,P21237,P23363,P23560,P25429,P25430,P25431,P25432,Q02193,Q06225,Q3SAT7,Q4L0Y3,Q5IS78,Q6LCI5,Q7YRB4,Q90322,Q95106,Q9TST3">BDNF</protein-id>, <protein-id="P21617,P34129,Q6YBR5,Q90W38">NGF</protein-id>, <protein-id="P01189,P01190,P01191,P01192,P01193,P01194,P01196,P01197,P01201,P06297,P06298,P06299,P10000,P11280,P11885,P19402,P21252,P22923,P68000,P68001,P87352,Q04617,Q04618,Q91082,Q9YGK2,Q9YGK4,Q9YGK5">adrenocorticotropic hormone</protein-id> (<protein-id="P01189,P01190,P01191,P01192,P01193,P01194,P01196,P01197,P01201,P06297,P06298,P06299,P10000,P11280,P11885,P19402,P21252,P22923,P68000,P68001,P87352,Q04617,Q04618,Q91082,Q9YGK2,Q9YGK4,Q9YGK5">ACTH</protein-id>), <compound-id="5754">cortisol</compound-id> and <protein-id="O12980,O13188,O18938,O62754,O70615,O73848,O73849,O93566,P01241,P01244,P01245,P01246,P01248,P06880,P07064,P08591,P08998,P09113,P09537,P09539,P10298,P10607,P10766,P10813,P10814,P11228,P13391,P19795,P20391,P20392,P22077,P24363,P29971,P33092,P33093,P33711,P34005,P34006,P34744,P34745,P34746,P34747,P37885,P37886,P45643,P45654,P45655,P46404,P46407,P48248,P55755,P56437,P58343,P58756,P67930,P67931,P69158,P69159,P69160,P69161,P69162,P79885,P87391,Q01282,Q01283,Q05163,Q07221,Q1HFN3,Q659Q8,Q7YQB8,Q7YQD2,Q7YRR6,Q864S7,Q8HYE5,Q8MI73,Q98UF6,Q9DEV3,Q9DGG5,Q9GKA1,Q9GL60,Q9GMB2,Q9GMB3,Q9I9L5,Q9I9M4,Q9IB11,Q9IBE5,Q9JKM4,Q9PWG3,Q9W6J5,Q9W6J7,Q9W6R8">growth hormone</protein-id> (GH) were determined at baseline on postnatal days (<protein-id="P01160">PND</protein-id>) 14, 30 and 60 by means of specific ELISA and <protein-id="P13304">RIA</protein-id> procedures.	cortisol__PND__no_interaction	cortisol__BDNF__no_interaction	cortisol__adrenocorticotropic hormone__no_interaction	cortisol__RIA__no_interaction	cortisol__NGF__no_interaction	cortisol__ACTH__no_interaction	cortisol__growth hormone__no_interaction
18849159-2635	A substrate regeneration cycle coupling <protein-id="P13006,P81156,Q92452">GOD</protein-id> with l-<compound-id="54670067,54690394">ascorbic acid</compound-id> (AsA: 0, 1.0, 3.0, 10.0 and 50.0 mmol/l; as reducing reagent system) was applied to the chemo-mechanical reaction unit in order to amplify the output signal of the tonometric biosensor.	ascorbic acid__GOD__interaction
18849171-2637	In vitro and in vivo models simulating the bee sting have been developed using live honeybees and, as the envenomation sites, pig ears and rat legs; MALDI MSI has been used to map, over time, the diffusion and distribution of three venom allergens (<compound-id="99290">Api</compound-id> m 1, <compound-id="99290">Api</compound-id> m 4, and <compound-id="99290">Api</compound-id> m 6) and two venom toxins (apamine and <protein-id="P04205,P04567">mast cell degranulating peptide</protein-id>).	Api__mast cell degranulating peptide__no_interaction
18849325-2674	The effect was lactose-inhibitable and required <protein-id="P08699,P16110,P17931,P38486,P47845,P47953">galectin-3</protein-id> affinity for <compound-id="245,439271,9800166,25203095">N-acetyllactosamine</compound-id>, a saccharide typically found on <protein-id="Q50833,Q58232">cell surface glycoproteins</protein-id>, since a mutant lacking this activity was without effect.	N-acetyllactosamine__cell surface glycoproteins__interaction	N-acetyllactosamine__galectin-3__interaction
18849352-2679	Despite widespread expression of <protein-id="P01132,P01133,P07522,Q00968,Q95ND4,Q9BEA0">epidermal growth factor</protein-id> (EGF) receptors (<protein-id="P00533,P13387,P55245">EGFRs</protein-id>) and EGF family ligands in non-small-cell lung cancer (NSCLC), EGFR-specific tyrosine kinase inhibitors (TKIs) such as <compound-id="123631">gefitinib</compound-id> exhibit limited activity in this cancer.	gefitinib__epidermal growth factor__no_interaction	gefitinib__EGFRs__no_interaction
18849352-2680	It is noteworthy that <protein-id="P03969,P09038,P20003,P48798,P48799,P48800,Q60487">FGF2</protein-id> and <protein-id="P31371">FGF9</protein-id> as well as <protein-id="P11362,P21804,Q8MY86,Q91285">FGFR1</protein-id> IIIc and/or <protein-id="P18461,P21802,Q8MY85,Q91147,Q91286">FGFR2</protein-id> IIIc mRNA and protein are frequently coexpressed in NSCLC cell lines, especially those that are insensitive to <compound-id="123631">gefitinib</compound-id>.	gefitinib__FGFR1__interaction	gefitinib__FGF2__interaction	gefitinib__FGF9__interaction	gefitinib__FGFR2__interaction
18849389-2687	Preprandial concentrations of <compound-id="206,5793,64689,79025">glucose</compound-id>, <protein-id="P80303">NEFA</protein-id>, <compound-id="612">lactate</compound-id>, and <protein-id="P05017,P07455,P08025,P10763,P16545,P17085,P17647,P18254,P33712,P51457,P51458,P51462,Q02815,Q28933,Q68LC0,Q6GUL6,Q6IVA5,Q6JLX1,Q95222">IGF-I</protein-id> fluctuated over time without significant treatment effect.	lactate__NEFA__no_interaction	glucose__IGF-I__no_interaction	lactate__IGF-I__no_interaction	glucose__NEFA__no_interaction
18849389-2688	In late gestation, the postprandial increases in <compound-id="206,5793,64689,79025">glucose</compound-id> and <protein-id="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7">insulin</protein-id> were delayed, and smaller, after a high-fiber meal than after a control meal.	glucose__insulin__no_interaction
18849389-2689	During lactation, <compound-id="206,5793,64689,79025">glucose</compound-id> and <protein-id="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7">insulin</protein-id> profiles after a standard meal did not differ between sows from treatment groups.	glucose__insulin__no_interaction
18849391-1967	Effects of gram-negative bacterial <compound-id="11970143">lipopolysaccharide</compound-id> (LPS) and supplemental dietary Met on N balance, serum hormones and <protein-id="P19006">haptoglobin</protein-id>, and plasma <compound-id="1176,265993">urea</compound-id>-N and AA were evaluated in 20 Angus-cross steers (BW = 262+/-6.3 kg).	lipopolysaccharide__haptoglobin__no_interaction	urea__haptoglobin__no_interaction
18849391-1968	Diet samples, feed refusals, feces, and urine were collected daily for 5 d. Rectal temperature and serum concentrations of <compound-id="5754">cortisol</compound-id>, <protein-id="P10765,P22393,P33089,P33090,P33091,P43001">prolactin</protein-id>, <protein-id="Q8JFG3">tumor necrosis factor</protein-id>-alpha, and <protein-id="P19006">haptoglobin</protein-id> 0.01).	cortisol__haptoglobin__no_interaction	cortisol__tumor necrosis factor__no_interaction	cortisol__prolactin__no_interaction
18849391-1969	Plasma <compound-id="1176,265993">urea</compound-id>-N was greater for+LPS than-LPS steers (LPS; P = 0.03), and serum <protein-id="Q95222">IGF-1</protein-id> was not affected (P &gt; or = 0.26) by LPS or Met.	urea__IGF-1__no_interaction
18849413-2041	Domain shape annealing is observed from branched to rounded shapes after <protein-id="P09599,P09978,P11889,P17627,P33377,P69502,Q2FWP1,Q5HEI1,Q9RLV9">SMase</protein-id> activity quenching by <compound-id="6049">EDTA</compound-id>, with a decay halftime of approximately 10 min.	EDTA__SMase__interaction
18849415-2702	We also found that the amino acid stretches of <protein-id="P02866,P14894,P81460,P81461">ConA</protein-id>, having high <compound-id="171147">B-factor</compound-id> values in the crystal structure, show relatively greater mobility in the simulations.	B-factor__ConA__interaction
18849420-2060	Using neighborhood approaches, we were able to assign seven novel functional partners in <protein-id="P08659,P13129,Q01158,Q26304,Q27757">luciferase</protein-id> synthesis, <compound-id="947,123329">nitrogen</compound-id> metabolism, and quorum sensing to BLUF domain-containing proteins (involved in light sensing).	nitrogen__luciferase__no_interaction
18849565-2744	Chondroitin lyases (or <protein-id="P34059">chondroitinases</protein-id>) are a family of enzymes that depolymerize <compound-id="24766,21873177">chondroitin sulfate</compound-id> (CS) and dermatan <compound-id="1117">sulfate</compound-id> (DS) galactosaminoglycans, which have gained prominence as important players in central nervous system biology.	sulfate__chondroitinases__interaction	chondroitin sulfate__chondroitinases__interaction
18849890-22	We have assessed the impact of the functional C-1019G variant of the <protein-id="P08908,P19327,P28285,Q64264,Q6XXX9,Q6XXY0,Q98998,Q9N296,Q9N297,Q9N298">5-HT1A</protein-id> receptor on the response to <compound-id="5073">risperidone</compound-id> or <compound-id="3559">haloperidol</compound-id> in a prospective, randomized, double-blind study.	risperidone__5-HT1A__interaction	haloperidol__5-HT1A__interaction
18850007-61	This downregulation was abolished following treatment with the histone deacetylase (HDAC) inhibitor <compound-id="444732">trichostatin A</compound-id> (TSA) and <compound-id="597">cytosine</compound-id> methylation inhibitor <compound-id="451668">5-aza-2-deoxycytidine</compound-id> (5-Aza), suggesting that an epigenetic regulatory mechanism may be involved in <protein-id="Q13761">RUNX3</protein-id> silencing by hypoxia.	cytosine__RUNX3__interaction	5-aza-2-deoxycytidine__RUNX3__interaction	trichostatin A__RUNX3__interaction
18850009-63	<compound-id="387447">Bortezomib</compound-id> overcomes cell-adhesion-mediated drug resistance through downregulation of <protein-id="P13612,Q00651,Q91687">VLA-4</protein-id> expression in multiple myeloma.	Bortezomib__VLA-4__interaction
18850074-89	<compound-id="31703">Doxorubicin</compound-id>-<protein-id="P02787,P09571,P12346,P19134,P27425,Q29443,Q921I1">transferrin</protein-id> conjugate selectively overcomes multidrug resistance in leukaemia cells.	Doxorubicin__transferrin__interaction
18850074-90	The purpose of this study was to examine the distribution and action of <compound-id="31703">doxorubicin</compound-id>-<protein-id="P02787,P09571,P12346,P19134,P27425,Q29443,Q921I1">transferrin</protein-id> conjugate (DOXTRF) in a leukaemia cell line (HL60), a multidrug-resistant leukaemia cell line (HL60ADR) and a normal tissue cell line (human fibroblasts).	doxorubicin__transferrin__interaction
18850096-105	Purification of an <protein-id="O31186,P00332,P00334,P06525,P07159,P07162,P0A9Q7,P0A9Q8,P10807,P12311,P14940,P17648,P21518,P21898,P22245,P23277,P23278,P23361,P25139,P25721,P25988,P26719,P28483,P28484,P33744,P37473,P42327,P42328,P48584,P48585,P48977,P51549,P51550,P51551,P51552,P71017,P84328,Q00669,Q00670,Q00671,Q00672,Q03384,Q05114,Q07588,Q09009,Q09010,Q24641,Q24803,Q27404,Q6LCE4,Q9GN94,Q9NAR7,Q9NG40,Q9NG42,Q9U8S9">alcohol dehydrogenase</protein-id> involved in the conversion of <compound-id="18635">methional</compound-id> to <compound-id="10448">methionol</compound-id> in Oenococcus oeni IOEB 8406.	methionol__alcohol dehydrogenase__interaction	methional__alcohol dehydrogenase__interaction
18850096-106	An <compound-id="5893">NAD</compound-id> (P)H-dependent <protein-id="P06525,P0A9Q7,P0A9Q8,P17648,P33744,P42327,P48977,P81786,Q04983,Q24803,Q24857,Q9NAR7">ADH</protein-id> involved in the reduction of <compound-id="18635">methional</compound-id> was then purified to homogeneity.	NAD__ADH__interaction	methional__ADH__interaction
18850096-107	Sequencing of the purified enzyme and amino acid sequence comparison with the database revealed the presence of a conserved sequence motif specific to the medium-chain zinc-containing <compound-id="5893">NAD</compound-id> (P)H-dependent <protein-id="P06525,P0A9Q7,P0A9Q8,P17648,P33744,P42327,P48977,P81786,Q04983,Q24803,Q24857,Q9NAR7">ADHs</protein-id>.	NAD__ADHs__interaction
18850096-108	The purified <protein-id="P06525,P0A9Q7,P0A9Q8,P17648,P33744,P42327,P48977,P81786,Q04983,Q24803,Q24857,Q9NAR7">ADH</protein-id> does not seem to be involved in the modification of buttery and lactic notes or to be involved in the specific formation of volatile <compound-id="702">alcohols</compound-id> during MLF.	alcohols__ADH__no_interaction
18850096-109	The function of the purified <protein-id="P06525,P0A9Q7,P0A9Q8,P17648,P33744,P42327,P48977,P81786,Q04983,Q24803,Q24857,Q9NAR7">ADH</protein-id> remains unclear, although the role of the <compound-id="402">sulfur atom</compound-id> in <compound-id="18635">methional</compound-id> molecules in the interaction between enzyme and substrate was evidenced.	methional__ADH__no_interaction	sulfur atom__ADH__no_interaction
18850241-169	All strains tested positive for <protein-id="P07981,P07982,P07983,P10474,P10475,P10476,P13933,P15329,P15704,P16216,P17974,P18126,P18336,P19487,P21833,P21834,P22533,P22669,P22699,P23548,P23549,P23665,P27035,P29019,P37651,P37696,P45699,P46236,P46237,P46239,P58599,P58935,P81190,P82186,P84194,P84196,Q05622,Q12622,Q12714,Q8RSY9,Q8X5L9,Q8Z289,Q8ZLB7">cellulase</protein-id> activity while none where capable of <compound-id="50909243">xylan</compound-id> degradation.	xylan__cellulase__no_interaction
18850267-174	In the present work we studied the effect of <protein-id="P05305,Q28469">endothelin-1</protein-id> and-3 on neuronal <compound-id="951,439260">norepinephrine</compound-id> release and the short-term regulation of tyrosine hydroxylase in the olfactory bulb.	norepinephrine__endothelin-1__interaction
18850267-175	Results showed that both endothelins increased tyrosine hydroxylase activity through the activation of a non-conventional endothelin G-protein coupled receptor, coupled to the stimulation of <protein-id="Q05608,Q9RI12">protein kinase A</protein-id> and C, as well as <compound-id="271">Ca(2</compound-id>+)/<protein-id="O02367,O16305,O60041,O82018,O94739,O96102,O97341,P02594,P02595,P02598,P02599,P04352,P04353,P04464,P05933,P05934,P05935,P06787,P07463,P11118,P11120,P11121,P15094,P17928,P18061,P21251,P23286,P24044,P27161,P27165,P27166,P41040,P41041,P48976,P60204,P60205,P60206,P61859,P61860,P61861,P62144,P62145,P62149,P62151,P62152,P62154,P62155,P62156,P62157,P62158,P62160,P62161,P62162,P62184,P62201,P62202,P62203,P62204,P69097,P69098,P84339,P93087,P93171,Q05055,Q39752,Q40302,Q5EHV7,Q5RAD2,Q6IT78,Q6PI52,Q6R520,Q6YNX6,Q71UH5,Q71UH6,Q7T3T2,Q7Y052,Q8STF0,Q8X187,Q95NI4,Q95NR9,Q9GRJ1,Q9HFY6,Q9U6D3,Q9UWF0">calmodulin</protein-id>-dependent <protein-id="P00513,P25848">protein kinase</protein-id> II.	Ca(2__protein kinase A__no_interaction	Ca(2__protein kinase__no_interaction	Ca(2__calmodulin__no_interaction
18850490-228	The data presented here indicate a substantial decline in antioxidant defences by actions of corticosterone, evidenced by coordinate decreases in the activities in the brain, liver and heart of free-radical scavenging enzymes <protein-id="O50258">superoxide dismutase</protein-id> (<protein-id="O12933,O22668,O75007,P24705,P51547,P93258,Q01137,Q27666,Q9SM64">SOD</protein-id>), <protein-id="O24339,O52762,O62839,O68146,O77229,O93662,O97492,P00432,P04040,P04762,P07145,P0A323,P0A324,P0A325,P0A326,P0A327,P11934,P17336,P24168,P24270,P25890,P29422,P30265,P30266,P32290,P42321,P44390,P45737,P45739,P55304,P55306,P55310,P55311,P55313,P77872,P81138,P90682,Q27710,Q49XC1,Q4L643,Q59296,Q59337,Q59602,Q59714,Q5HG86,Q5HPK8,Q5RF10,Q64405,Q6G9M4,Q6GH72,Q7A5T2,Q8CPD0,Q8FWU0,Q8NWV5,Q8X1P0,Q8Y3P9,Q926X0,Q99UE2,Q9AXH0,Q9KW19,Q9L4S1,Q9M5L6,Q9PT92,Q9PWF7,Q9Z598,Q9ZKX5,Q9ZN99">catalase</protein-id> (<protein-id="O62839,O97492,P00432,P00485,P00486,P00487,P04040,P06135,P07641,P11504,P20074,P22782,P25309,P25819,P26825,P26826,P32796,P36882,P36883,P43155,P47934,P49417,P52826,P58777,P62577,P62578,P62579,P62580,P90682,Q00614,Q02736,Q03058,Q5RF10,Q64405,Q704S8,Q9M5L6,Q9PWF7">CAT</protein-id>), <protein-id="O04437,O18598,P0A9D2,P0A9D3,P30116,P44521,P46088,P46419,P46423,P46426,P46428,P46437,P48438,P80894,P81065,P82996,P82997,P82998,P82999,P83000,P83001,P83246,Q04522,Q08392,Q08393,Q0ZS46,Q7REH6,Q8ILQ7,Q8MU52,Q96324">glutathione S-transferase</protein-id> (<protein-id="P20432,P30104,P30106,P30107,P30108,Q04522,Q0ZS46,Q7REH6,Q8ILQ7,Q8MU52">GST</protein-id>) and <protein-id="O15770,P06715,P11804,P23189,P41921,P43783,P48638,P48639,P70619,P78965,Q60151,Q6BPI1,Q6C5H4,Q6FRV2,Q6HA23,Q74ZK4,Q873E8,Q94655">glutathione reductase</protein-id> (GR), as well as the non-enzymatic antioxidants <compound-id="124886">glutathione</compound-id> (<compound-id="124886">GSH</compound-id>) and serum urate.	glutathione__CAT__no_interaction	GSH__glutathione S-transferase__no_interaction	GSH__SOD__no_interaction	glutathione__GST__no_interaction	glutathione__SOD__no_interaction	GSH__superoxide dismutase__no_interaction	glutathione__glutathione S-transferase__no_interaction	GSH__CAT__no_interaction	glutathione__superoxide dismutase__no_interaction	glutathione__glutathione reductase__no_interaction	GSH__catalase__no_interaction	GSH__glutathione reductase__no_interaction	GSH__GST__no_interaction	glutathione__catalase__no_interaction
18851707-551	<protein-id="P13900,P16604">P2X</protein-id> receptors are membrane cation channels gated by extracellular <compound-id="5957">ATP</compound-id>.	ATP__P2X__interaction
18851710-552	End-point measures were HOMA (homoeostasis model assessment)-IR, androgens, lipids, inflammatory markers [hsCRP (high-sensitivity C-reactive protein)] and endothelial function [FMD (flow-mediated dilation), <compound-id="123831">ADMA</compound-id> (<compound-id="123831">asymmetric dimethylarginine</compound-id>), PAI-1 (plasminogen activator inhibitor-1) and vWF (<protein-id="Q62935">von Willebrand factor</protein-id>)].	asymmetric dimethylarginine__von Willebrand factor__no_interaction	ADMA__von Willebrand factor__no_interaction
18851713-556	Addition of <protein-id="O12933,O22668,O75007,P24705,P51547,P93258,Q01137,Q27666,Q9SM64">SOD</protein-id> (<protein-id="O50258">superoxide dismutase</protein-id>) doubled the amount of <compound-id="83547">HOBr</compound-id> detected.	HOBr__superoxide dismutase__interaction	HOBr__SOD__interaction
18851895-635	Drug-resistant cancer cells became sensitive to <compound-id="31703">doxorubicin</compound-id> treatment when <protein-id="P06748,P07222,P13084,P16039,Q3T160,Q61937">nucleophosmin</protein-id> was expressed in cytosol.	doxorubicin__nucleophosmin__interaction
18851927-647	All the analyzed resistant mutants exhibited both increased <compound-id="3198">econazole</compound-id> efflux and increased transcription of <protein-id="P65380,P65381">mmpS5</protein-id>-<protein-id="O53784">mmpL5</protein-id> genes, encoding a hypothetical efflux system belonging to the resistance-nodulation-division (RND) family of transporters.	econazole__mmpL5__interaction	econazole__mmpS5__interaction
18851956-1598	This study investigated the effects of atorvastatin on <protein-id="P08183,P21448">ABCB1</protein-id> and <protein-id="P33527,Q5F364">ABCC1</protein-id> mRNA expression on peripheral blood mononuclear cells (PBMC) and their relationship with gene polymorphisms and lowering-<compound-id="304,5997,6432564,11025495">cholesterol</compound-id> response.	cholesterol__ABCB1__interaction	cholesterol__ABCC1__interaction
18851994-2766	While the three <protein-id="O06736,O07308,O07309,O28606,O33580,O33581,O34764,O43252,O50273,O50274,O54820,O66036,O67174,O76156,O88428,O95340,P08536,P0A951,P0A952,P0A9D4,P0A9D5,P0A9D6,P0A9D7,P13441,P13442,P21156,P21673,P23145,P23845,P28603,P28604,P29847,P32003,P43886,P52978,P52995,P56862,P56863,P56864,P56892,P56893,P57162,P57498,P57499,P59740,P65670,P65671,P65672,P65673,P67764,P67765,P67766,P71405,P72338,P72339,P74089,P74241,P77985,P78937,P84547,Q01612,Q06750,Q10600,Q12555,Q12650,Q27128,Q28999,Q3T0Q0,Q54506,Q56002,Q59967,Q5HIE6,Q5HL01,Q5HRM4,Q60967,Q60FC6,Q6GBV9,Q6GJE0,Q7MPF2,Q7MPF3,Q7N8L0,Q7NVN5,Q7UMW2,Q83JX8,Q87DG7,Q87DG8,Q87SX9,Q87SY0,Q87WW0,Q88NA9,Q89B11,Q8AAP9,Q8AXL1,Q8CR03,Q8CTU2,Q8DE72,Q8DE73,Q8EB10,Q8FEJ0,Q8FEJ1,Q8UH69,Q8X7X4,Q8X7X7,Q8Z470,Q8ZBP1,Q8ZBP2,Q8ZMF5,Q9JHW6,Q9KP19,Q9KP20,Q9PD78,Q9PD79,Q9X5U0,Q9Y872,Q9YCR4,Q9ZK14">SAT</protein-id> isotypes showed comparable Km and k(cat) for <compound-id="5951">L-serine</compound-id> and acetyl-CoA, they showed remarkable differences in their sensitivity to inhibition by <compound-id="581,5862,5460838">L-cysteine</compound-id>.	L-cysteine__SAT__interaction	L-serine__SAT__interaction
18851994-2767	We propose that multiple <protein-id="O06736,O07308,O07309,O28606,O33580,O33581,O34764,O43252,O50273,O50274,O54820,O66036,O67174,O76156,O88428,O95340,P08536,P0A951,P0A952,P0A9D4,P0A9D5,P0A9D6,P0A9D7,P13441,P13442,P21156,P21673,P23145,P23845,P28603,P28604,P29847,P32003,P43886,P52978,P52995,P56862,P56863,P56864,P56892,P56893,P57162,P57498,P57499,P59740,P65670,P65671,P65672,P65673,P67764,P67765,P67766,P71405,P72338,P72339,P74089,P74241,P77985,P78937,P84547,Q01612,Q06750,Q10600,Q12555,Q12650,Q27128,Q28999,Q3T0Q0,Q54506,Q56002,Q59967,Q5HIE6,Q5HL01,Q5HRM4,Q60967,Q60FC6,Q6GBV9,Q6GJE0,Q7MPF2,Q7MPF3,Q7N8L0,Q7NVN5,Q7UMW2,Q83JX8,Q87DG7,Q87DG8,Q87SX9,Q87SY0,Q87WW0,Q88NA9,Q89B11,Q8AAP9,Q8AXL1,Q8CR03,Q8CTU2,Q8DE72,Q8DE73,Q8EB10,Q8FEJ0,Q8FEJ1,Q8UH69,Q8X7X4,Q8X7X7,Q8Z470,Q8ZBP1,Q8ZBP2,Q8ZMF5,Q9JHW6,Q9KP19,Q9KP20,Q9PD78,Q9PD79,Q9X5U0,Q9Y872,Q9YCR4,Q9ZK14">SAT</protein-id> isotypes with different properties may play complementary roles in the regulation of the <compound-id="594,5862,5360637">cysteine</compound-id> biosynthetic pathway in E. histolytica under different conditions, e.g.	cysteine__SAT__interaction
18852015-684	At 1 min before the exposure rats were treated with one of the following: intravenous <protein-id="P00974">aprotinin</protein-id>, 4.4 mg/kg; intraperitoneal (ip) <compound-id="132519">ilomastat</compound-id>, 25mg/kg; or ip <compound-id="40634">trolox</compound-id>, 500 microg/kg.	ilomastat__aprotinin__no_interaction	trolox__aprotinin__no_interaction
18852015-685	Treatment with <protein-id="P00974">aprotinin</protein-id> or <compound-id="132519">ilomastat</compound-id> eliminated these PF changes, yielding results comparable with controls for each of these parameters.	ilomastat__aprotinin__no_interaction
18852015-686	While <protein-id="P00974">aprotinin</protein-id> and <compound-id="132519">ilomastat</compound-id> both alleviated the PF perturbations, surprisingly only <protein-id="P00974">aprotinin</protein-id> reduced the observed pathology, both grossly and histologically.	ilomastat__aprotinin__no_interaction
18852015-687	These early results indicate that treatment with <protein-id="P00974">aprotinin</protein-id> and to a lesser extent <compound-id="132519">ilomastat</compound-id> reduces some of the direct inflammatory response and damage associated with SM-induced lung injury.	ilomastat__aprotinin__no_interaction
18852059-705	Thirdly, enzyme immunoassays and ovarian follicular culture were used to determine the effect of treatment with human recombinant <protein-id="P01349,P11184,P11185,P11952,P11953">relaxin</protein-id>-3 on the production of 17beta-estradiol and <compound-id="319260">17 alpha</compound-id>, 20 beta-dihydroxy-4-pregnen-3-one in killifish ovarian follicles.	17 alpha__relaxin__interaction
18852063-706	<protein-id="Q99K82,Q9NWM0">Spermine oxidase</protein-id> (<protein-id="O42224,P56726,P97698,Q99835,Q9NWM0">SMO</protein-id>) is a FAD-containing enzyme involved in animal cell polyamines (PA) homeostasis, selectively active on <compound-id="1103">spermine</compound-id> and producing H(2)O(2), spermidine, and the 3-aminopropanal.	spermine__SMO__interaction	spermine__Spermine oxidase__interaction
18852217-740	Pretreatment with DEX abrogated <protein-id="P01258,P01259,P01260,P01262,P0C234">calcitonin</protein-id> inhibition by sst (2)-preferring analogue <compound-id="383414,448601">octreotide</compound-id> in TT.	octreotide__calcitonin__interaction
18852255-2230	<compound-id="5280492">Leukotriene B4</compound-id> enhances the activity of nuclear factor-kappaB pathway through <protein-id="Q15722">BLT1</protein-id> and BLT2 receptors in atherosclerosis.	Leukotriene B4__BLT1__interaction
18853098-1027	<protein-id="O08590,O70423,Q16853,Q5R9I0,Q9TTK6">Semicarbazide-sensitive amine oxidase</protein-id> activity and total nitrite and <compound-id="943">nitrate</compound-id> concentrations in serum: novel biochemical markers for type 2 diabetes.	nitrate__Semicarbazide-sensitive amine oxidase__no_interaction
18853098-1028	The aim of this study was to evaluate the activity of <protein-id="O08590,O70423,Q16853,Q5R9I0,Q9TTK6">semicarbazide-sensitive amine oxidase</protein-id> (<protein-id="O08590,O70423,Q16853,Q5R9I0,Q9TTK6">SSAO</protein-id>) and the total nitrite and <compound-id="943">nitrate</compound-id> (NO(x)) concentrations in serum from type 2 diabetic patients and control subjects in order to evaluate if they could be used as novel diabetic markers.	nitrate__SSAO__no_interaction	nitrate__semicarbazide-sensitive amine oxidase__no_interaction
18853099-1030	Serum lipid, <compound-id="588">creatinine</compound-id>, <compound-id="1175">uric acid</compound-id>, <protein-id="O19062,P02741,P02742,P08462,P18151,P21291,P41964,P47875,P49254,P49262,P52753,P67966,P67967,P97315,Q07203">CRP</protein-id>, HbA(1C) and urinary albumin concentration were measured.	uric acid__CRP__no_interaction	creatinine__CRP__no_interaction
18853102-1107	<compound-id="82143">Cryptolepine</compound-id> activity showed highest correlations to <protein-id="O29238,O51934,O58530,O67037,O67226,P74759,P95479,Q08582,Q58907,Q6F598,Q8R979,Q8ZXT5,Q971T7,Q975P6,Q97ZF5,Q97ZZ8,Q9UZ86,Q9YC75,Q9YCB6">topoisomerase</protein-id> II and microtubule targeting drugs.	Cryptolepine__topoisomerase__interaction
18853145-1060	Ulcerated tissues were processed to assess ulcer area, <compound-id="10964">malondialdehyde</compound-id>, <protein-id="O01377,O02115,O16852,O82134,O82797,P04961,P12004,P15873,P17070,P17917,P17918,P18248,P22177,P24314,P31008,P53358,P57761,P61074,P61258,Q00268,Q03392,Q43124,Q43266,Q6B6N4,Q9DDF1,Q9DEA3,Q9MAY3,Q9PTP1,Q9W644">proliferating cell nuclear antigen</protein-id> (<protein-id="O01377,O02115,O10308,O16852,O27367,O29912,O58398,O73947,O82134,O82797,P04961,P11038,P12004,P15873,P17070,P17917,P17918,P18248,P22177,P24314,P31008,P53358,P57761,P61074,P61258,Q00265,Q00268,Q03392,Q43124,Q43266,Q57697,Q6B6N4,Q6KZF1,Q6LWJ8,Q74MV1,Q7T6Y0,Q8PX25,Q8TUF7,Q8TWK3,Q979S2,Q9DDF1,Q9DEA3,Q9HJQ0,Q9HN45,Q9M7Q7,Q9MAY3,Q9P9H8,Q9PTP1,Q9UWR9,Q9UYX8,Q9W644">PCNA</protein-id>) and cleaved caspase-3.	malondialdehyde__proliferating cell nuclear antigen__no_interaction	malondialdehyde__PCNA__no_interaction
18853166-1068	Serum NO, <protein-id="O24339,O52762,O62839,O68146,O77229,O93662,O97492,P00432,P04040,P04762,P07145,P0A323,P0A324,P0A325,P0A326,P0A327,P11934,P17336,P24168,P24270,P25890,P29422,P30265,P30266,P32290,P42321,P44390,P45737,P45739,P55304,P55306,P55310,P55311,P55313,P77872,P81138,P90682,Q27710,Q49XC1,Q4L643,Q59296,Q59337,Q59602,Q59714,Q5HG86,Q5HPK8,Q5RF10,Q64405,Q6G9M4,Q6GH72,Q7A5T2,Q8CPD0,Q8FWU0,Q8NWV5,Q8X1P0,Q8Y3P9,Q926X0,Q99UE2,Q9AXH0,Q9KW19,Q9L4S1,Q9M5L6,Q9PT92,Q9PWF7,Q9Z598,Q9ZKX5,Q9ZN99">catalase</protein-id> and <compound-id="124886">glutathione</compound-id> were measured.	glutathione__catalase__no_interaction
18853166-1069	Serum <compound-id="124886">glutathione</compound-id> and <protein-id="O24339,O52762,O62839,O68146,O77229,O93662,O97492,P00432,P04040,P04762,P07145,P0A323,P0A324,P0A325,P0A326,P0A327,P11934,P17336,P24168,P24270,P25890,P29422,P30265,P30266,P32290,P42321,P44390,P45737,P45739,P55304,P55306,P55310,P55311,P55313,P77872,P81138,P90682,Q27710,Q49XC1,Q4L643,Q59296,Q59337,Q59602,Q59714,Q5HG86,Q5HPK8,Q5RF10,Q64405,Q6G9M4,Q6GH72,Q7A5T2,Q8CPD0,Q8FWU0,Q8NWV5,Q8X1P0,Q8Y3P9,Q926X0,Q99UE2,Q9AXH0,Q9KW19,Q9L4S1,Q9M5L6,Q9PT92,Q9PWF7,Q9Z598,Q9ZKX5,Q9ZN99">catalase</protein-id> levels were significantly lower in FM patients than controls.	glutathione__catalase__no_interaction
18853182-1073	This article discusses the physiology of proximal <compound-id="923,373840">Na</compound-id> (+)/H(+) exchange, the multiple mechanisms of <protein-id="P26432,P48764,Q28362">NHE3</protein-id> regulation, and the reciprocal relationship between <protein-id="P26432,P48764,Q28362">NHE3</protein-id> and <protein-id="Q9Y2E8">NHE8</protein-id> at the lumen of the proximal tubule.	Na__NHE3__no_interaction	Na__NHE8__no_interaction
18853185-1077	<compound-id="5754">Cortisol</compound-id> and <compound-id="12594">DHEA-sulfate</compound-id> response to rapid <protein-id="P01189,P01190,P01191,P01192,P01193,P01194,P01196,P01197,P01201,P06297,P06298,P06299,P10000,P11280,P11885,P19402,P21252,P22923,P68000,P68001,P87352,Q04617,Q04618,Q91082,Q9YGK2,Q9YGK4,Q9YGK5">adrenocorticotropic hormone</protein-id> (<protein-id="P01189,P01190,P01191,P01192,P01193,P01194,P01196,P01197,P01201,P06297,P06298,P06299,P10000,P11280,P11885,P19402,P21252,P22923,P68000,P68001,P87352,Q04617,Q04618,Q91082,Q9YGK2,Q9YGK4,Q9YGK5">ACTH</protein-id>) stimulation was inadequate.	Cortisol__ACTH__no_interaction	DHEA-sulfate__adrenocorticotropic hormone__no_interaction	DHEA-sulfate__ACTH__no_interaction	Cortisol__adrenocorticotropic hormone__no_interaction
18853207-1083	The effects of industrial storage on the changes of the cell viability and the activities of intracellular <protein-id="O31186,P00332,P00334,P06525,P07159,P07162,P0A9Q7,P0A9Q8,P10807,P12311,P14940,P17648,P21518,P21898,P22245,P23277,P23278,P23361,P25139,P25721,P25988,P26719,P28483,P28484,P33744,P37473,P42327,P42328,P48584,P48585,P48977,P51549,P51550,P51551,P51552,P71017,P84328,Q00669,Q00670,Q00671,Q00672,Q03384,Q05114,Q07588,Q09009,Q09010,Q24641,Q24803,Q27404,Q6LCE4,Q9GN94,Q9NAR7,Q9NG40,Q9NG42,Q9U8S9">alcohol dehydrogenase</protein-id> (<protein-id="P06525,P0A9Q7,P0A9Q8,P17648,P33744,P42327,P48977,P81786,Q04983,Q24803,Q24857,Q9NAR7">ADH</protein-id>) and glucose-6-phosphate dehydrogenase (<protein-id="P37830,P48826">G6PDH</protein-id>) in brewer's yeast, and the corresponding capacity for the bioconversion of <compound-id="8868">ethyl-3-oxobutanoate</compound-id> (<compound-id="9547937">EOB</compound-id>) to ethyl (<compound-id="94318">S)-3-hydroxybutanoate</compound-id> ((S)-<compound-id="46942358">EHB</compound-id>), were investigated.	EOB__ADH__interaction	S)-3-hydroxybutanoate__ADH__interaction	ethyl-3-oxobutanoate__G6PDH__interaction	ethyl-3-oxobutanoate__alcohol dehydrogenase__interaction	EHB__ADH__interaction	EHB__alcohol dehydrogenase__interaction	EOB__alcohol dehydrogenase__interaction	EHB__G6PDH__interaction	S)-3-hydroxybutanoate__G6PDH__interaction	S)-3-hydroxybutanoate__alcohol dehydrogenase__interaction	EOB__G6PDH__interaction	ethyl-3-oxobutanoate__ADH__interaction
18853207-1084	The intracellular levels of <protein-id="P06525,P0A9Q7,P0A9Q8,P17648,P33744,P42327,P48977,P81786,Q04983,Q24803,Q24857,Q9NAR7">ADH</protein-id> and <protein-id="P37830,P48826">G6PDH</protein-id> after permeabilization of these stored cells with cetyltrimetylammonium bromide (<compound-id="2681">CTAB</compound-id>) were much higher, which showed only slight decrease within 2 weeks during the industrial storage.	CTAB__ADH__no_interaction	CTAB__G6PDH__no_interaction
18853234-1098	Streptokinase (SK), <protein-id="P81156">glucose oxidase</protein-id> (GOx) and <compound-id="1014">phosphorylcholine</compound-id> (PC) were immobilized onto PGLD to obtain a blood compatible bioconjugate with <compound-id="206,5793,64689,79025">glucose</compound-id> sensing properties.	glucose__glucose oxidase__interaction	phosphorylcholine__glucose oxidase__no_interaction
18854222-1462	Treatment of RPE cells with high <compound-id="206,64689">glucose</compound-id>-induced a significant increased of <protein-id="O19114,O46660,O54705,O62699,P29477,P35228,P79290,Q06518,Q27995,Q28314,Q90703,Q92037,Q92091">iNOS</protein-id>, accompanied by an increase in cell damage, NO and nitrotyrosine levels.	glucose__iNOS__interaction
18854222-1464	High <compound-id="206,64689">glucose</compound-id> causes increased cell damage and NO generation in RPE cells by a process of <protein-id="O19114,O46660,O54705,O62699,P29477,P35228,P79290,Q06518,Q27995,Q28314,Q90703,Q92037,Q92091">iNOS</protein-id> expression that requires the activation of <protein-id="O62618">p38MAPK</protein-id> and <protein-id="P29323">ERK</protein-id>.	glucose__iNOS__interaction	glucose__ERK__interaction	glucose__p38MAPK__interaction
18854226-1467	A crude peel extract and purified fraction of Flemingia vestita, as well as a crude rhizome extract of Stephania glabra and fractions were tested with respect to the activity of <protein-id="O54705,O61309,O61608,Q26240,Q28969,Q9I9M2">NOS</protein-id>, NO efflux and <compound-id="24316">cGMP</compound-id> concentration in the cestode Raillietina echinobothrida in order to find out the possible mode of anthelmintic action of these plant-derived components.	cGMP__NOS__no_interaction
18854307-761	Our data suggest that <protein-id="P04409,P05696,P10102,P17252,P20444">PKCalpha</protein-id> translocates to the contractile system and anchors to <protein-id="P05547,P36188,Q7M3Y3">TnI</protein-id> in a <compound-id="271">Ca(2</compound-id>+)-dependent manner in the human heart, contributing to the maintenance of contractile force.	Ca(2__PKCalpha__interaction	Ca(2__TnI__no_interaction
18854368-1518	In this study, we describe the crystal structure of yeast <protein-id="O74739,Q02890,Q4R6F3,Q503I8,Q59Q38,Q5XI55,Q5ZJM3,Q6BNI6,Q6CAX5,Q6CLZ6,Q6FRU8,Q75D29,Q7KRR5,Q96IV0,Q9JI78">PNGase</protein-id> in complex with <compound-id="439544">N,N'-diacetylchitobiose</compound-id> (<compound-id="439544">chitobiose</compound-id>).	chitobiose__PNGase__interaction	N,N'-diacetylchitobiose__PNGase__interaction
18854368-1519	Mutagenesis studies confirm the critical role of the <compound-id="439544">chitobiose</compound-id>-interacting residues in substrate binding and suggest that efficient oligosaccharide binding is required for <protein-id="O74739,Q02890,Q4R6F3,Q503I8,Q59Q38,Q5XI55,Q5ZJM3,Q6BNI6,Q6CAX5,Q6CLZ6,Q6FRU8,Q75D29,Q7KRR5,Q96IV0,Q9JI78">PNGase</protein-id> activity.	chitobiose__PNGase__interaction
18854379-1521	Prediction of the effect of <compound-id="12560">erythromycin</compound-id>, <compound-id="39186">diltiazem</compound-id>, and their metabolites, alone and in combination, on <protein-id="P08684">CYP3A4</protein-id> inhibition.	diltiazem__CYP3A4__interaction	erythromycin__CYP3A4__interaction
18854401-1524	Previous studies have suggested a regulatory relationship between serum <compound-id="24404,139579">phosphorus</compound-id>, <compound-id="5280795">vitamin D</compound-id>, and fibroblast growth factor 23 (<protein-id="Q5MK86,Q9GZV9">FGF23</protein-id>), a hormone that promotes renal excretion of phosphate.	phosphorus__FGF23__interaction	vitamin D__FGF23__interaction
18854401-1525	This condition is caused by mutations in the <protein-id="O27732,O28185,O66677,O74017,O74806,O83975,O84806,O85235,P01268,P01269,P01270,P04089,P0A281,P0A282,P0A7D1,P0A7D2,P0A7D3,P15743,P37470,P38876,P44682,P47329,P47714,P49607,P52212,P56077,P57287,P57820,P59490,P61234,P61235,P61414,P65863,P65864,P65865,P65866,P65867,P65868,P65869,P78034,Q27IM2,Q57NM8,Q59989,Q5F9L4,Q5FFA3,Q5FMA9,Q5FRT7,Q5GTI9,Q5GWR6,Q5HC85,Q5HIH3,Q5HRQ3,Q5HWF9,Q5JDB8,Q5L3U7,Q5LV91,Q5M222,Q5M6L4,Q5N2J4,Q5NGZ6,Q5NL75,Q5P722,Q5P9A6,Q5PCR7,Q5QV03,Q5SHZ2,Q5V1D3,Q5WAD6,Q5WTE7,Q5X1N7,Q5XEM3,Q5YPZ6,Q5ZS66,Q601M5,Q60363,Q60A14,Q62FC1,Q63HI2,Q63XM0,Q64X30,Q65PG8,Q65V47,Q65ZY7,Q66AY1,Q67JD0,Q68WD4,Q6AAC7,Q6ADQ8,Q6AJL9,Q6D557,Q6F240,Q6F8I7,Q6G0F9,Q6G2L1,Q6GBY6,Q6GJG9,Q6HPW6,Q6KHA3,Q6LNA9,Q6MJR3,Q6MS28,Q6N1P9,Q6NI78,Q6YP15,Q6YR64,Q724K0,Q72BR1,Q72IA8,Q72RZ0,Q73FF7,Q73II8,Q73Q01,Q741V9,Q74FE6,Q74LA8,Q7M7U8,Q7MMZ2,Q7MXK9,Q7N5A1,Q7NN75,Q7NQT1,Q7U9I5,Q7UKV0,Q7V342,Q7V4V4,Q7VDT7,Q7VG29,Q7VMI1,Q7VUH3,Q7W179,Q7WNY2,Q81J96,Q81VY9,Q821W6,Q82HE5,Q82TQ6,Q839C0,Q83AP0,Q83FR1,Q83HD8,Q83LE1,Q86Y79,Q877G5,Q87A24,Q87RN9,Q888C8,Q88PX8,Q88Z39,Q899I4,Q89DJ9,Q89YZ2,Q8BW00,Q8CQU9,Q8CXP8,Q8D2K4,Q8DFF4,Q8DJ45,Q8DRQ2,Q8DWN5,Q8E2I1,Q8E7Y8,Q8EHN5,Q8EWQ8,Q8F3Q2,Q8FQV6,Q8G5I6,Q8K8Z7,Q8K9V3,Q8KD05,Q8P327,Q8PC61,Q8PNT8,Q8Q0M4,Q8R757,Q8RIJ5,Q8RLD7,Q8TKX4,Q8TV04,Q8U0N0,Q8UD97,Q8XHJ8,Q8Y2E3,Q8YAD1,Q8YYK4,Q8ZEY4,Q8ZYM4,Q92F62,Q92H41,Q92N67,Q976I0,Q97CB4,Q97E97,Q97TD1,Q980V1,Q98HV6,Q98PE2,Q9A206,Q9AAV9,Q9AEQ5,Q9CD49,Q9CJI1,Q9F8Q3,Q9GL67,Q9HLW6,Q9HVC3,Q9J5H2,Q9JV42,Q9K029,Q9K3T8,Q9KGJ3,Q9KQ21,Q9PA78,Q9PII7,Q9PR67,Q9RRW3,Q9V108,Q9X1W1,Q9XT35,Q9YBD6,Q9Z6V6,Q9ZCV4,Q9ZJC3">PTH</protein-id>/<protein-id="P12272,P13085,P17251,P22858,P52211,P58073,Q9GK30,Q9GLC7,Q9GMB7">PTHrP</protein-id> receptor that result in ligand-independent <compound-id="6076">cAMP</compound-id> accumulation, thus rendering the receptor constitutively active.	cAMP__PTHrP__interaction	cAMP__PTH__interaction
18854421-1530	Adiponectin, an adipokine secreted by the white adipose tissue, plays an important role in regulating <compound-id="206,5793,64689,79025">glucose</compound-id> and lipid metabolism and controlling energy homeostasis in <protein-id="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7">insulin</protein-id>-sensitive tissues.	glucose__insulin__no_interaction
18854429-993	<protein-id="Q8VCC8,Q9Z1C8">Epac</protein-id> is involved in <compound-id="6076">cAMP</compound-id>-stimulated proglucagon expression and hormone production but not hormone secretion in pancreatic alpha- and intestinal L-cell lines.	cAMP__Epac__interaction
18854429-994	Both <protein-id="Q8VCC8,Q9Z1C8">Epac</protein-id> and PKA are effectors of the second messenger <compound-id="6076">cAMP</compound-id>.	cAMP__Epac__interaction
18854435-1007	Since a polypeptide lacking the <compound-id="614,8988,145742">proline</compound-id>-rich region (P-region) of <protein-id="P42858,P42859,P51111,P51112">huntingtin</protein-id> (103Q) cannot form aggresomes, this domain serves as an aggresome-targeting signal.	proline__huntingtin__interaction
18854599-1421	Expression of <compound-id="1167,439185,23724461">UDP-N-acetyl-D-galactosamine</compound-id> : <protein-id="Q5EA41,Q8C7U7,Q8NCL4">polypeptide N-acetylgalactosaminyltransferase-6</protein-id> in gastric mucosa, intestinal metaplasia, and gastric carcinoma.	UDP-N-acetyl-D-galactosamine__polypeptide N-acetylgalactosaminyltransferase-6__interaction
18854599-1422	<compound-id="1167,439185,23724461">UDP-N-acetyl-d-galactosamine</compound-id> : <protein-id="Q5EA41,Q8C7U7,Q8NCL4">polypeptide N-acetylgalactosaminyltransferase-6</protein-id> (ppGalNAc-T6) is one of the enzymes responsible for the initial step in O-glycosylation.	UDP-N-acetyl-d-galactosamine__polypeptide N-acetylgalactosaminyltransferase-6__interaction
18854840-1661	In addition, SAH caused large increases in markers of inflammation, including <protein-id="O35734,O77510,O77764,P01375,P04924,P06804,P13296,P16599,P19101,P23383,P23563,P29553,P33620,P36939,P48094,P51435,P51742,P51743,P59684,P59693,P59694,P59695,P79337,P79374,Q06599,Q19LH4,Q1G1A2,Q1WM27,Q2MH05,Q539C2,Q75N23,Q8HZD9,Q8JFG3,Q8MKG8,Q8WNR1,Q9BEA1">TNFalpha</protein-id> and NFkappaB, and markers of cell injury or cell death, including IgG endocytosis and caspase-3 activation, with <compound-id="3488">glibenclamide</compound-id> significantly reducing these effects.	glibenclamide__TNFalpha__interaction
18854840-1662	We conclude that block of <protein-id="P33300,Q09428">SUR1</protein-id> by <compound-id="3488">glibenclamide</compound-id> may ameliorate several pathologic effects associated with inflammation that lead to cortical dysfunction after SAH.	glibenclamide__SUR1__interaction
18854981-1711	Intrinsic fluorescence of <compound-id="1148,6305,9060,5460840">tryptophan</compound-id>-214 in <protein-id="P24807,Q07490">HSA</protein-id> was monitored upon addition of the chemicals.	tryptophan__HSA__interaction
18854987-1716	The <protein-id="O23760,O81646,O82054,P21964,P28002,P46484,Q06509,Q06528,Q43239,Q43609,Q6ZD89,Q8GU25,Q8LL87,Q8W013,Q99028,Q9FQY8,Q9SWC2">COMT</protein-id> enzyme breaks down extracellular <compound-id="681">dopamine</compound-id> (DA) and has a particularly important role in the prefrontal cortex (PFC) where <protein-id="P23977,P27922,Q01959,Q03614,Q61327,Q9GJT6">DA transporters</protein-id> are sparse.	dopamine__DA transporters__no_interaction	dopamine__COMT__interaction
18854995-1721	The 223A&gt;G polymorphism of the <protein-id="O02750,O93416,Q28603,Q95189,Q95234">leptin</protein-id> receptor gene and lipid-lowering efficacy of <compound-id="54454,4677798">simvastatin</compound-id> in Chinese patients with coronary heart disease.	simvastatin__leptin__no_interaction
18854999-1723	CYP719A subfamily of <protein-id="O08469">cytochrome P450</protein-id> oxygenases and <compound-id="8405">isoquinoline</compound-id> alkaloid biosynthesis in Eschscholzia californica.	isoquinoline__cytochrome P450__no_interaction
18855021-1734	The metal-<compound-id="5047209">thiolate</compound-id> connectivity of recombinant Cd(7)-MT10 <protein-id="O02033,O13257,O18842,O42152,O93571,P02807,P04358,P07216,P08002,P23038,P25127,P25128,P30331,P30565,P51902,P52723,P52725,P52726,P52728,P55945,P55946,P55948,P55951,P55952,P55953,P68494,P68495,P68497,P68498,P68499,P80367,P80593,P84865,Q05890,Q6J1T3,Q6S4N8,Q6XUW5,Q708T3,Q7ZZP9,Q800D3,Q8UVY1,Q94550,Q9IB50,Q9U568">metallothionein</protein-id> from the sea mussel Mytilus galloprovincialis has been investigated for the first time by means of multinuclear, multidimensional NMR spectroscopy.	thiolate__metallothionein__interaction
18855035-1741	Radical scavenging activity of lipophilized products from <protein-id="Q7M4U7">lipase</protein-id>-catalyzed transesterification of <compound-id="5497163">triolein</compound-id> with cinnamic and ferulic acids.	triolein__lipase__interaction
18855035-1742	<protein-id="Q7M4U7">Lipase</protein-id>-catalyzed transesterification of <compound-id="5497163">triolein</compound-id> with cinnamic and ferulic acids using an immobilized <protein-id="Q7M4U7">lipase</protein-id> from Candida antarctica (E.C.	triolein__lipase__interaction	triolein__Lipase__interaction
18855107-1775	Validation of a food frequency questionnaire measurement of dietary acrylamide intake using <protein-id="P15160,P17724,P73925,Q03459">hemoglobin</protein-id> adducts of acrylamide and <compound-id="91550">glycidamide</compound-id>.	glycidamide__hemoglobin__interaction
18855190-2056	Effects of weight loss on visceral and abdominal subcutaneous adipose tissue blood-flow and <protein-id="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7">insulin</protein-id>-mediated <compound-id="206,5793,64689,79025">glucose</compound-id> uptake in healthy obese subjects.	glucose__insulin__interaction
18855521-439	The study established that <compound-id="16069453">SPZ</compound-id> attenuated myocardial I/R injury through overexpression of <protein-id="O19114,O46660,O54705,O62699,P29477,P35228,P79290,Q06518,Q27995,Q28314,Q90703,Q92037,Q92091">iNOS</protein-id>, leading to enhancement of <compound-id="145068">nitric oxide</compound-id> bioavailability and tissue oxygenation.	nitric oxide__iNOS__interaction	SPZ__iNOS__interaction
18855522-1934	Currently, <compound-id="1051">pyridoxal-5'-phosphate</compound-id> (PLP)-dependent <protein-id="P32232,P32582,P35520,P46794,Q58H57,Q91WT9,Q9N0V7,Q9YBL2">cystathionine beta-synthase</protein-id> (CBS) is thought to be the major H(2)S-producing enzyme in the brain.	pyridoxal-5'-phosphate__cystathionine beta-synthase__interaction
18855762-2063	The present study shows that extracellular Ca2+ controls cPHB [complexed poly-(<compound-id="441,92135">R)-3-hydroxybutyrate</compound-id>] biosynthesis through the <protein-id="Q06067">AtoS</protein-id>-<protein-id="Q06065">AtoC</protein-id> two-component system.	R)-3-hydroxybutyrate__AtoC__interaction	R)-3-hydroxybutyrate__AtoS__interaction
18855911-2114	A novel approach to prepare <protein-id="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7">insulin</protein-id>-loaded poly(lactic-co-<compound-id="757">glycolic acid</compound-id>) microcapsules and the protein stability study.	glycolic acid__insulin__interaction
18855911-2115	The purpose of this study was to propose a new preparation method to fabricate <protein-id="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7">insulin</protein-id>-loaded poly(lactic-coglycolic acid) (<compound-id="36797">PLGA</compound-id>) microparticles satisfying protein loading, release profiles, burst release, and particularly stability of the encapsulated protein.	PLGA__insulin__interaction
18855935-2126	A Na+/<protein-id="P00920,P27139">Ca2</protein-id>+ exchanger isoform, <protein-id="P32418,P48767">NCX1</protein-id>, is involved in retinal cell death after N-methyl-D-<compound-id="5960">aspartate</compound-id> injection and ischemia-reperfusion.	aspartate__Ca2__no_interaction	aspartate__NCX1__interaction
18855935-2127	We also examined the role of <protein-id="O43763">NCX</protein-id> in <compound-id="977">oxygen</compound-id>-<compound-id="206,5793,64689,79025">glucose</compound-id> deprivation (OGD) stress with a retinal ganglion cell line (RGC-5) cell culture in vitro.	glucose__NCX__interaction	oxygen__NCX__interaction
18855936-2128	This injury induces central sensitization leading to tactile allodynia and is mediated by activation of <compound-id="271">Ca(2</compound-id>+) permeable AMPA/kainate receptors through <protein-id="P05130,P13677,P13678,P34722">PKC</protein-id> and PKA.	Ca(2__PKC__interaction
18855942-2132	Stimulation of choline <protein-id="P16966">acetyltransferase</protein-id> by <compound-id="216416">C3d</compound-id>, a neural cell adhesion molecule ligand.	C3d__acetyltransferase__interaction
18855943-2134	Transport properties of PIs by the drug efflux transporters P-gp and <protein-id="P06795,P08183,P16875,P21448,P33449,P34712,P43245,Q06034,Q9ZR72">multidrug resistance protein 1</protein-id> (MRP1) were assessed by measuring the cellular uptake of (3)H-<compound-id="148192">atazanavir</compound-id> or (3)H-<compound-id="392622">ritonavir</compound-id> in P-gp and MRP1 overexpressing cells as well as hCMEC/D3.	atazanavir__multidrug resistance protein 1__interaction	ritonavir__multidrug resistance protein 1__interaction
18922131-2288	Incubation of L6 myotubes with palmitate (for 16 h) increases intramyocellular ceramide and reduces <protein-id="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7">insulin</protein-id>-stimulated <protein-id="P31749,P31750,P47196,Q01314,Q8INB9">PKB</protein-id> activation and <compound-id="206,5793,64689,79025">glucose</compound-id> uptake.	glucose__insulin__no_interaction	glucose__PKB__no_interaction
18922514-2447	This is the first <protein-id="O30565,P04830,P05618,P08704,P09121,P14014,P17692,P26827,P27036,P30920,P30921,P31746,P31747,P31797,P31835,P43379">cyclodextrin glycosyltransferase</protein-id> with a known primary structure and a <compound-id="738,5961">glutamine</compound-id> instead of <compound-id="750">glycine</compound-id> residue at position 179 in the highly conserved-6 subsite, shown to be involved in substrate binding.	glycine__cyclodextrin glycosyltransferase__no_interaction	glutamine__cyclodextrin glycosyltransferase__interaction
18922527-2451	Functional <protein-id="O35502,O35573,O35724,O35840,P04180,P30930,P53760,P53761,Q08758">LCAT</protein-id> is not required for macrophage <compound-id="304,5997,6432564,11025495">cholesterol</compound-id> efflux to human serum.	cholesterol__LCAT__no_interaction
18922794-2589	The AbfR/S two-component system is required to activate the expression of the suite of enzymes that remove the numerous side chains from <compound-id="50909243">xylan</compound-id>, but not the <protein-id="O43097,O59859,O60206,P07529,P09850,P17137,P23360,P23557,P29417,P40943,P45703,P48793,P56588,P81536,Q53317">xylanases</protein-id> that hydrolyze the beta1,4-linked xylose polymeric backbone of this polysaccharide.	xylan__xylanases__no_interaction
18922879-2629	In agreement with molecular modeling predictions, the inhibitory action of pPTME and PTME toward intracellular <protein-id="O22616,P00860,P07805,P08432,P09057,P11926,P14019,P27116,P27117,P27118,P27119,P27121,P40807,P40808,P41931,P43099,P49725,P50134,P78599,Q5RFB7,Q8S3N2,Q92445,Q9BQT8,Q9UQW9">ODC</protein-id> of LN229 cells exceeded that of the previous designed lead compound <compound-id="9543438">POB</compound-id>.	POB__ODC__interaction
18922958-2662	Treatment with acidified saline reduced fetal basal pH from 7.35+/-0.01 to 7.29+/-0.01 but did not alter basal cardiovascular variables, blood <compound-id="206,5793,64689,79025">glucose</compound-id>, or plasma concentrations of catecholamines, <protein-id="P01189,P01190,P01191,P01192,P01193,P01194,P01196,P01197,P01201,P06297,P06298,P06299,P10000,P11280,P11885,P19402,P21252,P22923,P68000,P68001,P87352,Q04617,Q04618,Q91082,Q9YGK2,Q9YGK4,Q9YGK5">ACTH</protein-id>, and <compound-id="5754">cortisol</compound-id>.	glucose__ACTH__no_interaction	cortisol__ACTH__no_interaction
18922958-2663	During hypoxemia, treatment with acidified saline increased the magnitude of the fetal bradycardia and femoral vasoconstriction and concomitantly increased chemoreflex function and enhanced the increments in plasma concentrations of catecholamines, <protein-id="P01189,P01190,P01191,P01192,P01193,P01194,P01196,P01197,P01201,P06297,P06298,P06299,P10000,P11280,P11885,P19402,P21252,P22923,P68000,P68001,P87352,Q04617,Q04618,Q91082,Q9YGK2,Q9YGK4,Q9YGK5">ACTH</protein-id>, and <compound-id="5754">cortisol</compound-id>.	cortisol__ACTH__no_interaction
18923065-2678	The induction of <protein-id="P06762,P09601,P14791,P14901,P32394,Q5E9F2">HO-1</protein-id> by <compound-id="5712">YC-1</compound-id> was unchanged by the sGC inhibitor, 1H-(1,2,4)oxadiazolo[4,3-alpha]quinozalin-1-one (<compound-id="1456">ODQ</compound-id>) or by the protein kinase <compound-id="68958">pyrimidin-4-ylamine</compound-id> (<compound-id="9798973">BAY 41-2272</compound-id>).	BAY 41-2272__HO-1__interaction	YC-1__HO-1__interaction	pyrimidin-4-ylamine__HO-1__interaction	ODQ__HO-1__no_interaction
18923087-1868	The endogenous brain constituent <compound-id="10596625,53394481">N-arachidonoyl L-serine</compound-id> is an activator of large conductance <protein-id="P00920,P27139">Ca2</protein-id>+-activated K+ channels.	N-arachidonoyl L-serine__Ca2__interaction
18923087-1871	The potentiation was not altered by the beta(1) subunit or mediated by ARA-S metabolites, stimulation of known cannabinoid receptors, G proteins, <protein-id="P00513,P25848">protein kinases</protein-id>, or <compound-id="271">Ca(2</compound-id>+)-dependent processes; it was lost after patch excision or after membrane <compound-id="304,5997,6432564,11025495">cholesterol</compound-id> depletion but was restored after <compound-id="304,5997,6432564,11025495">cholesterol</compound-id> reconstitution.	Ca(2__protein kinases__no_interaction	cholesterol__protein kinases__no_interaction
18923147-2705	Modulation of <protein-id="P40792,P63001,Q6RUV5">Rac1</protein-id> activity by <compound-id="123831">ADMA</compound-id>/<protein-id="O94760,O95865">DDAH</protein-id> regulates pulmonary endothelial barrier function.	ADMA__DDAH__no_interaction	ADMA__Rac1__interaction
18923157-2713	Endometriosis is associated with <compound-id="5994">progesterone</compound-id> resistance in the baboon (Papio anubis) oviduct: evidence based on the localization of <protein-id="P36718,Q12889,Q28042,Q28542,Q28990,Q60557,Q62010">oviductal glycoprotein</protein-id> 1 (<protein-id="P36718,Q12889,Q28042,Q28542,Q28990,Q60557">OVGP1</protein-id>).	progesterone__oviductal glycoprotein__interaction	progesterone__OVGP1__interaction
18923157-2714	In this study we evaluated <protein-id="P36718,Q12889,Q28042,Q28542,Q28990,Q60557">OVGP1</protein-id> and steroid receptor expression in oviducts of baboons with endometriosis during the midsecretory phase and determined whether <compound-id="5994">progesterone</compound-id> resistance associated with endometriosis also occurs in the oviduct.	progesterone__OVGP1__interaction
18923157-2715	These data imply that the normal antagonism of <compound-id="5994">progesterone</compound-id> on <protein-id="O42132,P03372,P06212,P16058,P49884,P49885,P49886,P50240,P50241,P50242,P57753,Q29040,Q53AD2,Q91250,Q91424,Q9PVZ9,Q9QZJ5,Q9TV98,Q9YH33,Q9YHZ7">ESR</protein-id> and <protein-id="P36718,Q12889,Q28042,Q28542,Q28990,Q60557">OVGP1</protein-id>, which results in their downregulation during the window of implantation, is absent in animals with endometriosis.	progesterone__OVGP1__interaction	progesterone__ESR__interaction
18923162-2718	Expression of <protein-id="P13563,Q61647,Q92839">hyaluronan synthase 1</protein-id> and distribution of <compound-id="24759">hyaluronan</compound-id> during follicular atresia in pig ovaries.	hyaluronan__hyaluronan synthase 1__no_interaction
18923162-2719	In this study, we evaluated the distribution of the principal CD44 ligand <compound-id="24759">hyaluronan</compound-id> (HA) and the expressions of <protein-id="P0C0H0,P0C0H1,Q5X9A9,Q8K5G6,Q8NKX1">HA synthases</protein-id> (HAS: <protein-id="Q03532,Q0UR48,Q1EA54,Q2GMX1,Q4IEK8,Q4P6N0,Q5AK59,Q5KMN6,Q6BH93,Q6C7D2,Q6CXB7,Q6FIL3,Q74Z73,Q92839">HAS1</protein-id>, <protein-id="O57424,O97711,Q92819">HAS2</protein-id>, and <protein-id="O00219,O57425">HAS3</protein-id>) during atresia in pig ovaries.	hyaluronan__HAS1__no_interaction	hyaluronan__HA synthases__no_interaction	hyaluronan__HAS3__no_interaction	hyaluronan__HAS2__no_interaction
18923385-2036	Chronic inhibition of <protein-id="O61309,O61608,Q27571,Q9I9M2">nitric oxide synthase</protein-id> by N(omega)-nitro-<compound-id="550788">L-arginine methyl ester</compound-id> (L-NAME) causes progressive renal injury with systemic hypertension and interstitial macrophage infiltration.	L-arginine methyl ester__nitric oxide synthase__interaction
18923387-2775	Transgenic mice that overexpress rat <protein-id="P01016,P01017,P67885,P67886">angiotensinogen</protein-id> in their proximal tubule cells were given either <compound-id="2214">apocynin</compound-id>, <compound-id="107807">perindopril</compound-id>, or <compound-id="3637">hydralazine</compound-id> while untreated or <compound-id="2214">apocynin</compound-id>-treated non-transgenic littermates served as controls.	apocynin__angiotensinogen__no_interaction	perindopril__angiotensinogen__no_interaction	hydralazine__angiotensinogen__no_interaction
18923396-2782	<protein-id="P01213,P01214,Q95104">Dynorphin</protein-id> peptides and the kappa-opioid receptor are important in the rewarding properties of cocaine, <compound-id="5462328">heroin</compound-id>, and alcohol.	heroin__Dynorphin__interaction
18923397-2783	Requirement of <protein-id="O77750,P55087,Q5I4F9,Q923J4">AQP4</protein-id> for antidepressive efficiency of <compound-id="3386">fluoxetine</compound-id> : implication in adult hippocampal neurogenesis.	fluoxetine__AQP4__interaction
18923397-2785	Collectively, these findings suggest that <protein-id="O77750,P55087,Q5I4F9,Q923J4">AQP4</protein-id> is required for the antidepressive action of <compound-id="3386">fluoxetine</compound-id> via regulating adult hippocampal neurogenesis.	fluoxetine__AQP4__interaction
18923398-2787	Although no significant change in the apparent K(m) was revealed in animals that exhibited an escalation in the rate of cocaine intake, an increased <compound-id="681">dopamine</compound-id> uptake rate was found suggesting an upregulation of <protein-id="P13483,P23977,P27922,Q01959,Q03614,Q61327,Q9GJT6">DAT</protein-id> number in response to a history of high cocaine intake.	dopamine__DAT__interaction
18923402-2788	Previous work has shown that repeated <compound-id="2995">desipramine</compound-id> treatment causes downregulation of the <protein-id="O55192,P23975,P51143">norepinephrine transporter</protein-id> (<protein-id="O55192,P23975,P41970,P51143,P54762">NET</protein-id>) and persistent antidepressant-like effects on behavior, ie effects observed 2 days after discontinuation of drug treatment when acute effects are minimized.	desipramine__NET__interaction	desipramine__norepinephrine transporter__interaction
18923402-2790	Treatment for 14 days with 70 mg/kg per day venlafaxine, which inhibits both the <protein-id="O55192,P23975,P41970,P51143,P54762">NET</protein-id> and <protein-id="P31645,Q9XT49">SERT</protein-id>, or 10 mg/kg per day <compound-id="3675">phenelzine</compound-id>, a monoamine oxidase inhibitor, produced antidepressant-like effects on behavior without altering <protein-id="O55192,P23975,P41970,P51143,P54762">NET</protein-id> or <protein-id="P31645,Q9XT49">SERT</protein-id> expression.	phenelzine__NET__no_interaction	phenelzine__SERT__no_interaction
18923405-2791	Studies in schizophrenia identify robust decreases in genes for GABA function, including glutamic acid decarboxylase, <protein-id="P49773,P62958,P80912,Q5RF69">HINT1</protein-id>, <compound-id="611,23327,33032">glutamate</compound-id> transport and GluRs, <protein-id="O18752,O18753,O18755,O70183,O97759,P14082,P21237,P23363,P23560,P25429,P25430,P25431,P25432,Q02193,Q06225,Q3SAT7,Q4L0Y3,Q5IS78,Q6LCI5,Q7YRB4,Q90322,Q95106,Q9TST3">BDNF</protein-id> and <protein-id="P45522">TrkB</protein-id>, numerous <protein-id="O96436">14-3-3 protein</protein-id> family members, and decreases in genes for CNS synaptic and metabolic functions, particularly glycolysis and <compound-id="5957">ATP</compound-id> generation.	glutamate__TrkB__no_interaction	ATP__BDNF__no_interaction	glutamate__14-3-3 protein__no_interaction	ATP__TrkB__no_interaction	ATP__HINT1__no_interaction	glutamate__HINT1__no_interaction	ATP__14-3-3 protein__no_interaction	glutamate__BDNF__no_interaction
18923405-2792	Brains from persons with major depressive disorder reveal decreased expression for genes in <compound-id="611,23327,33032">glutamate</compound-id> transport and metabolism, neurotrophic signaling (eg, <protein-id="O10284,P41444">FGF</protein-id>, <protein-id="O18752,O18753,O18755,O70183,O97759,P14082,P21237,P23363,P23560,P25429,P25430,P25431,P25432,Q02193,Q06225,Q3SAT7,Q4L0Y3,Q5IS78,Q6LCI5,Q7YRB4,Q90322,Q95106,Q9TST3">BDNF</protein-id> and <protein-id="O15240,O57166,P20494,Q86607,Q9JFH4">VGF</protein-id>), and MAP kinase pathways.	glutamate__FGF__no_interaction	glutamate__BDNF__no_interaction	glutamate__VGF__no_interaction
18923439-2805	BEZ increased prostaglandin D(2) (<protein-id="P00349,P14332,P52209">PGD</protein-id> (2)) synthesis by CLL cells, and treatment with <protein-id="P00349,P14332,P52209">PGD</protein-id> (2) and its antineoplastic derivative 15dDelta(12,14,) <compound-id="5311209">PGJ(2</compound-id>) recapitulated BEZ-induced antiproliferative and proapoptotic actions.	PGJ(2__PGD__no_interaction
18923823-499	However, detection of <compound-id="104815">Cu</compound-id> and Zn in <protein-id="O50258">superoxide dismutase</protein-id> after PAGE-LA-ICP-MS depends on the conditions of the PAGE method because possible metal losses can occur (either with SDS-PAGE or with native PAGE).	Cu__superoxide dismutase__interaction
18923827-111	Recent studies have suggested that a decrease in the specific activity of the 2-<protein-id="Q89AJ7">oxoglutarate dehydrogenase</protein-id> complex (ODHC) is important for <compound-id="611,23327,33032">glutamate</compound-id> overproduction by Corynebacterium glutamicum.	glutamate__oxoglutarate dehydrogenase__interaction
18923851-130	To evaluate the potential of using heme-containing lipocalin nitrophorin 1 (<protein-id="P47971,Q15818,Q26239,Q62443">NP1</protein-id>) as a template for protein engineering, we have replaced the native <protein-id="Q07342">axial</protein-id> heme-coordinating <compound-id="773,6274">histidine</compound-id> residue with <compound-id="750">glycine</compound-id>, <compound-id="602,4580,5950,71080">alanine</compound-id>, and <compound-id="594,5862,5360637">cysteine</compound-id>.	histidine__axial__interaction	histidine__NP1__interaction	alanine__axial__interaction	alanine__NP1__interaction	cysteine__axial__interaction	glycine__axial__interaction	glycine__NP1__interaction	cysteine__NP1__interaction
18923851-133	Two crystal structures of the H60C_ <protein-id="P47971,Q15818,Q26239,Q62443">NP1</protein-id> in complex with <compound-id="795">imidazole</compound-id> and <compound-id="774">histamine</compound-id> were solved to 1.7- and 1.96-A resolution, respectively.	imidazole__NP1__interaction	histamine__NP1__interaction
18923851-134	Both structures show that the H60C mutation is well tolerated by the protein scaffold and suggest that <compound-id="4971">heme</compound-id>-<compound-id="5047209">thiolate</compound-id> coordination in H60C_ <protein-id="P47971,Q15818,Q26239,Q62443">NP1</protein-id> requires some movement of the <compound-id="4971">heme</compound-id> within its binding cavity.	thiolate__NP1__interaction	heme__NP1__interaction
18923901-159	Anticancer effect of <compound-id="2662">celecoxib</compound-id> via <protein-id="O02768,O19183,O62698,O62725,P27607,P35354,P35355,P70682,P79208,Q05769">COX-2</protein-id> dependent and independent mechanisms in human gastric cancers cells.	celecoxib__COX-2__interaction
18924134-216	Real-time polymerase chain reaction analysis of hypoxic, NO-<compound-id="5352,1548885,1548887">sulindac</compound-id> treated PC-3 cells showed downregulation of <protein-id="P16636,P28300,P28301,P33072,P45845,Q05063">lysyl oxidase</protein-id> and <protein-id="Q16790,Q8VHB5">carbonic anhydrase IX</protein-id> mRNA expression.	sulindac__carbonic anhydrase IX__interaction	sulindac__lysyl oxidase__interaction
18925358-887	Established risk cardiovascular factors like hypertension, atherogenic dyslipidaemia, and <compound-id="206,5793,64689,79025">glucose</compound-id> intolerance occur in the setting of <protein-id="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7">insulin</protein-id> resistance and central adiposity, with genetic and environmental influences modulating the ultimate risk.	glucose__insulin__interaction
18925359-508	Despite this lack of oxidative and cytotoxic action, exposure of hepatoma cells to <compound-id="934">Ni(2</compound-id>+) resulted in a significant activation of <protein-id="P31750,Q8INB9">Akt</protein-id> that was abrogated by inhibitors of PI3K.	Ni(2__Akt__interaction
18925413-539	Gas exchange was monitored and blood samples were collected during exercise for GH, <protein-id="P01189,P01190,P01191,P01192,P01193,P01194,P01196,P01197,P01201,P06297,P06298,P06299,P10000,P11280,P11885,P19402,P21252,P22923,P68000,P68001,P87352,Q04617,Q04618,Q91082,Q9YGK2,Q9YGK4,Q9YGK5">ACTH</protein-id>, <protein-id="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7">insulin</protein-id>, and blood <compound-id="206,5793,64689,79025">glucose</compound-id> and <compound-id="612">lactate</compound-id> determination.	lactate__ACTH__no_interaction	glucose__insulin__no_interaction	lactate__insulin__no_interaction	glucose__ACTH__no_interaction
18925649-643	The chimera was at least fourfold less sensitive to inhibition by okadaic acid, but was stimulated by <compound-id="934">nickel ions</compound-id> and <compound-id="1794427">chlorogenic acid</compound-id>, characteristics of <protein-id="P07978">PP2B</protein-id> not of <protein-id="P22198,P30366,P48487,P48488,P50391,P80074,Q61041,Q63447">PP1</protein-id>.	chlorogenic acid__PP2B__no_interaction	nickel ions__PP2B__no_interaction	nickel ions__PP1__no_interaction	chlorogenic acid__PP1__no_interaction
18925653-646	Because o-quinones are very unstable, we used an oxymetric method to characterize the kinetics of this substrate, based on measurements of the <compound-id="977">oxygen</compound-id> consumed in the <protein-id="O42713,P06845,P07524,P33180,P55022,P55023,P55033,Q00234,Q8J130,Q92396">tyrosinase</protein-id> reaction.	oxygen__tyrosinase__interaction
18925655-1527	Plasma levels of <compound-id="2771,146570">citalopram</compound-id>, <compound-id="5754">cortisol</compound-id>, and <protein-id="P10765,P22393,P33089,P33090,P33091,P43001">prolactin</protein-id> were measured.	citalopram__prolactin__no_interaction	cortisol__prolactin__no_interaction
18925655-1528	An increase in <compound-id="5754">cortisol</compound-id> and <protein-id="P10765,P22393,P33089,P33090,P33091,P43001">prolactin</protein-id> concentrations was observed from the EOI until 60 min after the EOI.	cortisol__prolactin__no_interaction
18925830-712	Different lag-time of pulse-released nerve growth factor (<protein-id="P21617,P34129,Q6YBR5,Q90W38">NGF</protein-id>) from <compound-id="23340,442424,44144320">genipin</compound-id>-crosslinked gelatin within <compound-id="10401">polycaprolactone</compound-id> (PCL) conduits was evaluated in large-gap peripheral nerve repair.	polycaprolactone__NGF__interaction	genipin__NGF__interaction
18925830-713	In this study, 10% (w/v) gelatin was mixed with <protein-id="P21617,P34129,Q6YBR5,Q90W38">NGF</protein-id>, crosslinked with 0%, 0.1%, 0.5%, and 1% (w/v) <compound-id="23340,442424,44144320">genipin</compound-id>, and then sucked into the wall of PCL conduits.	genipin__NGF__interaction
18925831-716	Effect of autologous bone marrow stromal cell seeding and bone <protein-id="P07580">morphogenetic protein</protein-id>-2 delivery on ectopic bone formation in a microsphere/poly(<compound-id="8252">propylene</compound-id> <compound-id="444972">fumarate</compound-id>) composite.	fumarate__morphogenetic protein__interaction	propylene__morphogenetic protein__interaction
18925831-717	Three composites consisting of 0, 0.08, or 8 microg <protein-id="O19006,O46564,P12643,P21274,P49001,Q804S2,Q90751">BMP-2</protein-id> per mg of poly(lactic-co-<compound-id="757">glycolic acid</compound-id>) microspheres, embedded in a porous PPF scaffold, were combined with either plasma (no cells) or culture-expanded BMSCs.	glycolic acid__BMP-2__interaction
18926542-922	It was found from this group that <compound-id="54682930">4-hydroxycoumarin</compound-id> was the best alternative to warfarin for examining the interactions of drugs at Sudlow site I on <protein-id="P24807,Q07490">HSA</protein-id>.	4-hydroxycoumarin__HSA__interaction
18926547-923	Effects of <protein-id="O73810,P14416,P20288,P52702,P60026,Q6TLI9,Q9GJU1">DRD2</protein-id>/<protein-id="Q8NFD2">ANKK1</protein-id> gene variations and clinical factors on <compound-id="60795">aripiprazole</compound-id> efficacy in schizophrenic patients.	aripiprazole__DRD2__interaction	aripiprazole__ANKK1__interaction
18926641-955	The majority of patients with acute depression shows an exaggerated plasma corticotrophin (<protein-id="P01189,P01190,P01191,P01192,P01193,P01194,P01196,P01197,P01201,P06297,P06298,P06299,P10000,P11280,P11885,P19402,P21252,P22923,P68000,P68001,P87352,Q04617,Q04618,Q91082,Q9YGK2,Q9YGK4,Q9YGK5">ACTH</protein-id>) and <compound-id="5754">cortisol</compound-id> response to this test that normalizes gradually during successful antidepressant therapy.	cortisol__ACTH__no_interaction
18926641-956	We examined plasma <protein-id="P01189,P01190,P01191,P01192,P01193,P01194,P01196,P01197,P01201,P06297,P06298,P06299,P10000,P11280,P11885,P19402,P21252,P22923,P68000,P68001,P87352,Q04617,Q04618,Q91082,Q9YGK2,Q9YGK4,Q9YGK5">ACTH</protein-id> and <compound-id="5754">cortisol</compound-id> responses to the dex/CRH test in acutely depressed inpatients treated either with mirtazapine (n=55) or a monoamine reuptake inhibitor (n=105) according to doctor's choice and compared the test results with healthy controls (n=40).	cortisol__ACTH__no_interaction
18926682-975	Both extracts increased <protein-id="O24006">AMP</protein-id>-kinase phosphorylation and <protein-id="O08424,O24594,O26662,O28538,O51628,O59469,O74164,O76819,P00347,P04035,P09610,P13702,P14773,P16237,P16393,P20715,P48021,P51639,P54960,Q01237,Q01559,Q03163,Q10283,Q12577,Q12649,Q1W675,Q29512,Q58116,Q59468,Q5R6N3,Q9V1R3,Q9Y7D2,Q9YAS4">HMG-CoA reductase</protein-id> phosphorylation by 2.5-to 4-fold, but with different time courses: maximal phosphorylation with <compound-id="4630">green tea</compound-id> was evident within 30 min of treatment, whereas with black tea phosphorylation was slower to develop, with maximal phosphorylation occurring &gt; or =3 hours after treatment.	green tea__HMG-CoA reductase__interaction	green tea__AMP__interaction
18926687-978	However, the ethyl ester of commipheric acid (150 mg/kg, twice daily) lowered fasting blood <compound-id="206,5793,64689,79025">glucose</compound-id> and plasma <protein-id="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7">insulin</protein-id>, and plasma triglycerides without affecting food intake or body weight.	glucose__insulin__no_interaction
18926751-991	The sequence has also been successfully implemented for <protein-id="P03161,P03610,P03631,P03632,P07394,P15966,P25243,P25244,P35823,P98005">a protein</protein-id> at very-low concentration in interaction with a small ligand, namely the salivary IB5 protein binding the polyphenol epigallocatechine <compound-id="370">gallate</compound-id>.	gallate__a protein__interaction
18926804-1008	This finding led the authors to propose that <protein-id="Q9BPW9">RDH-E2</protein-id> may be involved in the pathogenesis of psoriasis through its potential role in <compound-id="444795">retinoic acid</compound-id> biosynthesis and stimulation of keratinocyte proliferation.	retinoic acid__RDH-E2__interaction
18926804-1010	In this study, we began the characterization of <protein-id="Q9BPW9">RDH-E2</protein-id> protein in order to determine whether it might play a role in <compound-id="444795">retinoic acid</compound-id> biosynthesis.	retinoic acid__RDH-E2__interaction
18926804-1011	The preference for NAD(+) suggests that <protein-id="Q9BPW9">RDH-E2</protein-id> is likely to function in the oxidative direction in vivo, further supporting its potential role in the oxidation of retinol to retinaldehyde for <compound-id="444795">retinoic acid</compound-id> biosynthesis in human keratinocytes.	retinoic acid__RDH-E2__interaction
18926806-1012	Identification of Aldh1a, <protein-id="O55127,O93323,P79739">Cyp26</protein-id> and RAR orthologs in protostomes pushes back the <compound-id="444795">retinoic acid</compound-id> genetic machinery in evolutionary time to the bilaterian ancestor.	retinoic acid__Cyp26__no_interaction
18926807-1160	<protein-id="P30837,P40047,P52476">ALDH5</protein-id> (aka succinic semialdehyde dehydrogenase) is a NAD(+)-dependent <protein-id="O74187,P08157,P12693,P23240,P40108,P41751,P42041,P45959,Q27640,Q8VXQ2,Q9RYG9,Q9ZA11">aldehyde dehydrogenase</protein-id> crucial for the proper removal of the <compound-id="119">GABA</compound-id> metabolite succinic semialdehyde (SSA).	GABA__aldehyde dehydrogenase__interaction	GABA__ALDH5__interaction
18926807-1161	As release of <compound-id="439153">NADH</compound-id> can be a rate-limiting step for <protein-id="P17201,P22281,P80472,P80704,P80705,Q27640,Q8VXQ2">ALDH</protein-id> activity, NADH binding was evaluated for R166wt and R166H enzymes.	NADH__ALDH__interaction
18926839-1035	We also established a significant role for functionalization-dependent <compound-id="123591">fullerene</compound-id>-regulation of the caspase <protein-id="O41798,O89290,O89940,O91080,O93215,P03311,P03353,P03355,P03356,P03362,P03363,P03366,P03367,P03369,P03370,P04023,P04024,P04323,P04584,P04585,P04587,P04588,P04589,P05959,P05960,P05961,P05962,P07570,P0C210,P0C211,P10210,P10265,P10270,P10271,P10272,P10273,P10274,P10394,P10978,P11227,P11365,P12451,P12497,P12498,P12499,P14074,P14078,P15833,P16046,P16423,P16901,P17757,P18042,P18096,P18802,P19028,P19199,P19560,P19561,P20825,P20875,P20876,P20892,P21407,P21414,P24107,P24740,P26808,P26809,P26810,P27502,P28936,P31822,P35956,P35963,P51518,P63119,P63120,P63121,P63122,P63123,P63124,P63125,P63127,P63128,P63129,P63131,P84454,Q09SZ9,Q0R5R2,Q0R5R3,Q1A249,Q1A267,Q4U0X6,Q73368,Q74120,Q75002,Q76634,Q77373,Q79666,Q89928,Q8AII1,Q8I7P9,Q9IDV9,Q9Q720,Q9QBY3,Q9QBZ1,Q9QBZ5,Q9QSR3,Q9WC54,Q9WC63,Q9Y6I0">proteases</protein-id> in the elicited responses.	fullerene__proteases__interaction
18926849-1039	<compound-id="124886">GSH</compound-id> is the most powerful intracellular antioxidant and plays a role in the detoxification of a variety of electrophilic compounds and peroxides via catalysis by <protein-id="O04437,O18598,P0A9D2,P0A9D3,P30116,P44521,P46088,P46419,P46423,P46426,P46428,P46437,P48438,P80894,P81065,P82996,P82997,P82998,P82999,P83000,P83001,P83246,Q04522,Q08392,Q08393,Q0ZS46,Q7REH6,Q8ILQ7,Q8MU52,Q96324">glutathione-S-transferases</protein-id> (<protein-id="P20432,P30104,P30106,P30107,P30108,Q04522,Q0ZS46,Q7REH6,Q8ILQ7,Q8MU52">GST</protein-id>) and <protein-id="O32770,O59858,Q00277,Q9CFV1">glutathione peroxidases</protein-id> (GPx).	GSH__GST__interaction	GSH__glutathione peroxidases__interaction	GSH__glutathione-S-transferases__interaction
18926859-1152	Peripheral <protein-id="O12956,P01272,P01273,P01274,P01275,P05110,P06883,P22890,P29794,P55095,P68259,Q06605,Q8MJ25">GLP-1</protein-id> gastroprotection against <compound-id="702">ethanol</compound-id> : the role of exendin, NO, <protein-id="P10286,P30880,P30881,P31888,P80511">CGRP</protein-id>, prostaglandins and blood flow.	ethanol__GLP-1__interaction	ethanol__CGRP__interaction
18926859-1154	<compound-id="702">Absolute ethanol</compound-id> was administered through an orogastric cannula right after the injection of <protein-id="O12956,P01272,P01273,P01274,P01275,P05110,P06883,P22890,P29794,P55095,P68259,Q06605,Q8MJ25">GLP-1</protein-id> (1, 10, 100, 1000 or 10,000 ng/kg; i.p.).	Absolute ethanol__GLP-1__interaction
18926889-1065	It inhibited Trypanosoma brucei <protein-id="O01360,O13507,O27090,O28542,O32755,O34425,O42259,O52631,O57479,O57672,O59494,O59841,O67161,O83816,O96423,P00355,P00356,P00357,P00361,P00362,P04406,P04797,P08439,P09124,P09316,P09317,P0A1P0,P0A1P1,P0C0G6,P0C0G7,P10096,P10097,P10618,P15115,P16858,P17244,P17721,P19089,P19314,P19315,P20287,P20445,P22512,P22513,P23722,P24163,P24164,P24166,P24746,P24748,P24749,P24750,P24751,P24753,P25861,P26518,P26519,P26520,P26521,P26988,P27726,P28844,P29272,P29497,P32637,P32638,P34783,P35143,P39460,P44304,P46406,P46713,P46795,P46796,P47543,P48812,P51009,P51469,P51640,P52694,P52987,P53429,P53430,P54117,P54118,P54226,P55070,P55071,P55971,P56649,P57384,P58839,P61879,P61880,P64178,P64179,P68777,P70685,P75358,P80447,P80534,P83601,P87197,P94915,Q00301,Q00584,Q00640,Q01558,Q01597,Q01651,Q01982,Q05025,Q07234,Q12552,Q1DTF9,Q27652,Q27890,Q28259,Q28554,Q2NEN0,Q3IUT3,Q46450,Q48335,Q4J940,Q4KYY3,Q58546,Q59199,Q59309,Q59800,Q59906,Q5JHB5,Q5R2J2,Q5RAB4,Q5V061,Q5XDW3,Q6BMK0,Q6CCU7,Q6L125,Q6M0E6,Q757I2,Q89AK1,Q8J1H3,Q8K8M9,Q8NK47,Q8PTD3,Q8TFJ2,Q8WZN0,Q8X1X3,Q8ZWK7,Q92211,Q92243,Q92263,Q94469,Q96US8,Q971K2,Q97BJ8,Q9HFX1,Q9HGY7,Q9HJ69,Q9HSS7,Q9N2D5,Q9N655,Q9P8C0,Q9PJN6,Q9UR38,Q9UVC0,Q9UW96,Q9V1P1,Q9Y796,Q9Y8E9,Q9YFS9,Q9Z518,Q9Z7T0,Q9ZKT0">GAPDH</protein-id> with an IC(50) value of 240 microM and has been shown to be a competitive reversible inhibitor (Ki=200+/-10 microM) of this enzyme with respect to its cofactor <compound-id="5893">NAD</compound-id> (+).	NAD__GAPDH__interaction
18926911-1076	We have also described LD between <protein-id="P17693,Q95IT1">HLA-G</protein-id> alleles and HLA class II <protein-id="Q8IUH3">DRB1</protein-id> allelic groups and found significant LD between DRB104-G01B, DRB113-G010401, DRB114-G010108, DRB115-<compound-id="750">G0103</compound-id>, DRB103-G0101A and DRB103-G01B.	G0103__HLA-G__no_interaction	G0103__DRB1__no_interaction
18927146-1139	<compound-id="5476374">Morpholino</compound-id> oligonucleotide-induced expression of truncated <protein-id="O97592,P11530,P11531,P11532,P11533,Q5GN48">dystrophin</protein-id> in the brains of mdx mice, but not in the muscle, ameliorated the abnormal freezing response to restraint.	Morpholino__dystrophin__interaction
18927216-1186	It is suggested that in this animal model, characterized by TSH elevation and low-grade inflammation, an increased expression and function of <protein-id="O19114,O46660,O54705,O62699,P29477,P35228,P79290,Q06518,Q27995,Q28314,Q90703,Q92037,Q92091">iNOS</protein-id>, resulting in <compound-id="5359597">superoxide</compound-id> generation, accounts for an impaired NO availability.	superoxide__iNOS__interaction
18927219-1190	Selective elevation of adiponectin production by the natural compounds derived from a medicinal herb alleviates <protein-id="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7">insulin</protein-id> resistance and <compound-id="206,5793,64689,79025">glucose</compound-id> intolerance in obese mice.	glucose__insulin__no_interaction
18927219-1192	These changes were associated with an alleviation of hyperglycemia, <compound-id="206,5793,64689,79025">glucose</compound-id> intolerance, and <protein-id="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7">insulin</protein-id> resistance.	glucose__insulin__no_interaction
18927241-1195	Vernakalant was metabolized rapidly via 4-O-demethylation by <protein-id="O08469">cytochrome P450</protein-id> (<protein-id="P21568,P21569,P24525,P34887,Q26551">CYP</protein-id>)2D6 to its major metabolite RSD1385, which then circulated predominantly as an inactive <compound-id="5281877">glucuronide</compound-id> conjugate.	glucuronide__cytochrome P450__no_interaction	glucuronide__CYP__no_interaction
18927268-1200	We assessed in vivo carotid sinus nerve activity (CSNA) at baseline, in response to acute hypoxia, in response to infused <compound-id="22880">NMDA</compound-id>, and in response to infused <protein-id="P05305,Q28469">endothelin-1</protein-id> (<protein-id="P05305,P09558,P13206,P17322,P22387,P22388,P29560,P97740,Q28469,Q5NRP9,Q5NRQ1,Q9BG76">ET-1</protein-id>) with and without MK-801, an NMDA receptor blocker.	NMDA__ET-1__no_interaction	NMDA__endothelin-1__no_interaction
18927347-1235	Thus, CS-mediated down-regulation of <protein-id="P56519,Q92769">HDAC2</protein-id> in human macrophages and lung epithelial cells in vitro and in mouse lung in vivo involves the induction of <compound-id="5951">serine</compound-id>/<compound-id="6288">threonine</compound-id> phosphorylation and proteasomal degradation, which may have implications for steroid resistance and abnormal inflammation caused by cigarette smoke.	serine__HDAC2__no_interaction	threonine__HDAC2__no_interaction
18927433-1257	Immunofluorescence microscopy of live human umbilical vein endothelial cells showed that <protein-id="P04275,P80012,Q28295,Q28833,Q8CIZ8">VWF</protein-id> multimers rapidly formed strings several hundred micrometers long on the cell surface after stimulation with <compound-id="774">histamine</compound-id>.	histamine__VWF__interaction
18927433-1258	Soluble P-selectin reduced the number of platelet-decorated <protein-id="P04275,P80012,Q28295,Q28833,Q8CIZ8">VWF</protein-id> strings in the absence of <compound-id="271">Ca(2</compound-id>+) and Mg(2+) but had no effect in the presence of these cations.	Ca(2__VWF__interaction
18927435-1259	To examine the relationship of functional expression of <protein-id="P13612,Q00651,Q91687">VLA-4</protein-id> to prognosis in AML, we studied marrow samples from 175 adult AML patients who underwent induction chemotherapy with anthracycline and <compound-id="6253">cytarabine</compound-id> on Southwest Oncology Group trials.	cytarabine__VLA-4__no_interaction
18928402-1632	Independent lines of research involving biochemical and behavioral approaches in normal and/or genetically modified mice provide converging evidence for an involvement of the signaling molecules <protein-id="P31750,Q8INB9">Akt</protein-id> and <protein-id="O08328,O66935,O84804,P05416,P0A6U8,P0A6U9,P0A6V0,P39125,P45179,P58395,Q21BQ1,Q221N9,Q255S3,Q28MN0,Q2A4U4,Q2G7S7,Q2IM81,Q2J308,Q2K485,Q2P9F6,Q2RH55,Q2RS50,Q2T6R2,Q2W5G0,Q2YB48,Q30Z13,Q31BS5,Q31IB5,Q31VJ4,Q32AV6,Q3A0B8,Q3AKK1,Q3APL6,Q3AVF9,Q3B6C3,Q3BYI1,Q3K1K2,Q3KD65,Q3KKP3,Q3SH79,Q3YW96,Q46LU1,Q47IJ4,Q48JG9,Q4KCP0,Q4QK70,Q4UZL8,Q4ZS46,Q57IU1,Q5DZC1,Q5FL65,Q5H6Q4,Q5L562,Q5N1P1,Q5NHN2,Q5NXZ7,Q5PM09,Q5SMC5,Q632H4,Q65FS7,Q65TI3,Q664I5,Q6CZK3,Q6HC18,Q6KHP2,Q6LKA1,Q6MAS9,Q6NCT7,Q729V4,Q72G68,Q72YJ6,Q73MC7,Q7MJ50,Q7NM37,Q7U7I2,Q7UPY2,Q7V275,Q7V8F0,Q7VBP0,Q7W6L5,Q7WIJ0,Q816G8,Q81K85,Q821W4,Q82SP3,Q83PV4,Q87QX5,Q880M9,Q88FN9,Q890I8,Q8CWX0,Q8DAR0,Q8DKU2,Q8DPS3,Q8E079,Q8E5V5,Q8ET54,Q8KAY6,Q8PDD2,Q8PQA3,Q8RF65,Q8XPA1,Q8XT73,Q8Z232,Q8ZA78,Q935Y7,Q97GX6,Q97QS5,Q985P2,Q9CHM9,Q9CN91,Q9EUT5,Q9I1V0,Q9KDX6,Q9KRB6,Q9PLC3,Q9RNH6,Q9RWS1,Q9WZZ7,Q9Z6V8">glycogen synthase</protein-id> kinase-3 (<protein-id="P38615">GSK3</protein-id>) in the regulation of behavior by <compound-id="681">dopamine</compound-id> and <compound-id="5202">serotonin</compound-id> (<compound-id="5202">5-HT</compound-id>).	5-HT__GSK3__no_interaction	serotonin__Akt__no_interaction	serotonin__GSK3__no_interaction	dopamine__Akt__no_interaction	dopamine__glycogen synthase__no_interaction	serotonin__glycogen synthase__no_interaction	5-HT__glycogen synthase__no_interaction	dopamine__GSK3__no_interaction	5-HT__Akt__no_interaction
18929413-2021	Inhibition of <protein-id="P18266,P49841,Q5YJC2,Q9WV60">GSK3beta</protein-id> by <compound-id="28486,3028194">lithium</compound-id> in vivo suppressed the inflammatory response in mice infected with F. tularensis LVS and conferred a survival advantage.	lithium__GSK3beta__interaction
18929429-2031	The capacity for osmotic adjustment, <protein-id="O50258">superoxide dismutase</protein-id> (<protein-id="O12933,O22668,O75007,P24705,P51547,P93258,Q01137,Q27666,Q9SM64">SOD</protein-id>) and ascorbate <protein-id="P15984,P16147,P84714">peroxidase</protein-id> (<protein-id="P27695,Q01613,Q42564">APX</protein-id>) activities and <compound-id="614,8988,145742">proline</compound-id> content were also elevated in the transgenic Arabidopsis plants.	proline__peroxidase__no_interaction	proline__SOD__no_interaction	proline__APX__no_interaction	proline__superoxide dismutase__no_interaction
18929477-2059	To prevent the effects of interfering anionic species, such as <compound-id="1175">uric acid</compound-id> and <compound-id="54670067,54690394">ascorbic acid</compound-id>, on the sensor response, the Pt-Ir electrode was coated with <compound-id="61890">Nafion</compound-id>, and then <protein-id="P81156">glucose oxidase</protein-id> was immobilized on the coated electrode.	Nafion__glucose oxidase__no_interaction	uric acid__glucose oxidase__no_interaction	ascorbic acid__glucose oxidase__no_interaction
18929529-2083	Cleavage of the transmembrane domain away from the <protein-id="P19334,P55965,Q920J4">Trp</protein-id> leader carrier protein was performed with <compound-id="10476">cyanogen bromide</compound-id>.	cyanogen bromide__Trp__interaction
18929530-2084	We review here molecular mechanisms leading to these vast combinatorial peptide libraries, and structural and functional properties of antimicrobial peptides of the <compound-id="16130489">dermaseptin</compound-id> and <protein-id="P31393">plasticin</protein-id> families, as well as those of <compound-id="16130489">dermaseptin</compound-id> S9, an amyloidogenic peptide with antimicrobial and chemoattractant activities.	dermaseptin__plasticin__no_interaction
18929666-2130	A naturally occurring <compound-id="750">glycine</compound-id> to <compound-id="424,5960,83887">aspartic acid</compound-id> mutation at position 169 (G169D) in the putative transmembrane domain 4 (<protein-id="Q40170">TM4</protein-id>) makes mice susceptible to Salmonella typhimurim, Leishmania donovani, and Mycobacterium bovis.	aspartic acid__TM4__interaction	glycine__TM4__interaction
18930039-2213	Serum free <compound-id="10918">L-carnitine</compound-id> in association with <protein-id="O77003,P02144,P02145,P02147,P02148,P02150,P02151,P02152,P02153,P02154,P02155,P02156,P02157,P02159,P02160,P02161,P02163,P02164,P02165,P02166,P02167,P02168,P02169,P02170,P02171,P02173,P02174,P02177,P02178,P02179,P02180,P02181,P02182,P02183,P02184,P02185,P02186,P02187,P02189,P02190,P02191,P02192,P02193,P02194,P02195,P02196,P02197,P02199,P02200,P02201,P02202,P02203,P02204,P02205,P02206,P02210,P02211,P02214,P02215,P04247,P04248,P04249,P04250,P09965,P0C227,P11343,P14393,P14396,P14397,P14398,P14399,P15160,P17724,P20856,P29287,P30562,P31331,P32428,P49672,P51535,P51537,P56208,P56532,P62734,P62735,P63113,P63114,P68080,P68081,P68082,P68083,P68084,P68085,P68086,P68189,P68190,P68276,P68277,P68278,P68279,P80721,P80722,P83682,P84997,P87497,Q01966,Q03459,Q0KIY0,Q0KIY1,Q0KIY2,Q0KIY3,Q0KIY5,Q0KIY9,Q2MJN4,Q6I7B0,Q6PL31,Q6VN46,Q701N9,Q76G09,Q7LZM1,Q7LZM2,Q7LZM3,Q7LZM4,Q7LZM5,Q7M3C1,Q7M424,Q7T044,Q9DEN8,Q9DEN9,Q9DEP0,Q9DEP1,Q9DGI8,Q9DGI9,Q9DGJ0,Q9DGJ1,Q9DGJ2,Q9QZ76">myoglobin</protein-id> as a diagnostic marker of acute myocardial infarction.	L-carnitine__myoglobin__interaction
18930039-2214	The aim of this study was to monitor the level of serum free <compound-id="10918">L-carnitine</compound-id> in combination with <protein-id="O77003,P02144,P02145,P02147,P02148,P02150,P02151,P02152,P02153,P02154,P02155,P02156,P02157,P02159,P02160,P02161,P02163,P02164,P02165,P02166,P02167,P02168,P02169,P02170,P02171,P02173,P02174,P02177,P02178,P02179,P02180,P02181,P02182,P02183,P02184,P02185,P02186,P02187,P02189,P02190,P02191,P02192,P02193,P02194,P02195,P02196,P02197,P02199,P02200,P02201,P02202,P02203,P02204,P02205,P02206,P02210,P02211,P02214,P02215,P04247,P04248,P04249,P04250,P09965,P0C227,P11343,P14393,P14396,P14397,P14398,P14399,P15160,P17724,P20856,P29287,P30562,P31331,P32428,P49672,P51535,P51537,P56208,P56532,P62734,P62735,P63113,P63114,P68080,P68081,P68082,P68083,P68084,P68085,P68086,P68189,P68190,P68276,P68277,P68278,P68279,P80721,P80722,P83682,P84997,P87497,Q01966,Q03459,Q0KIY0,Q0KIY1,Q0KIY2,Q0KIY3,Q0KIY5,Q0KIY9,Q2MJN4,Q6I7B0,Q6PL31,Q6VN46,Q701N9,Q76G09,Q7LZM1,Q7LZM2,Q7LZM3,Q7LZM4,Q7LZM5,Q7M3C1,Q7M424,Q7T044,Q9DEN8,Q9DEN9,Q9DEP0,Q9DEP1,Q9DGI8,Q9DGI9,Q9DGJ0,Q9DGJ1,Q9DGJ2,Q9QZ76">myoglobin</protein-id> (Myo) and creatine kinase (total activity and CK-MB level) for usefulness as a predictor of AMI in ICU patients.	L-carnitine__myoglobin__interaction
18930076-2223	Curcuminoids inhibited <protein-id="O42275,O62763,P04058,P07140,P07692,P21836,P22303,P23795,P36196,P37136,P56161,Q27677,Q29499,Q867X2,Q867X3,Q869C3,Q86GC8,Q86GC9,Q92035,Q92081,Q9DDE3">AChE</protein-id> in the in-vitro assay with IC(50) value of 19.67, <compound-id="5315472">bisdemethoxycurcumin</compound-id> 16.84, <compound-id="5324476">demethoxycurcumin</compound-id> 33.14 and curcumin 67.69 microM.	demethoxycurcumin__AChE__interaction	bisdemethoxycurcumin__AChE__interaction
18930084-2225	L-<compound-id="25242319">penetratin</compound-id> was the most effective promoter of <protein-id="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7">insulin</protein-id> absorption compared with others CPPs.	penetratin__insulin__interaction
18930084-2226	A dose-dependent relationship of L-<compound-id="25242319">penetratin</compound-id> and <protein-id="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7">insulin</protein-id> bioavailability was statically significant.	penetratin__insulin__interaction
18930084-2227	There was no significant difference in the release of <protein-id="P29038,P33571,P93052,Q27797,Q27888,Q95028,Q99289">LDH</protein-id> in nasal lavage fluid and the integrity of nasal respiratory epithelium when L-<compound-id="25242319">penetratin</compound-id> was present.	penetratin__LDH__no_interaction
18930085-2228	GSL-liposomes remarkably enhanced the production of <protein-id="O35497,O35735,O57571,O57603,O57608,O73915,O77763,P01579,P01580,P01581,P07353,P17773,P17803,P28333,P28341,P30123,P42160,P42161,P42162,P46402,P49708,P63309,P63310,P63311,P79154,Q1WM28,Q25BC0,Q2PE75,Q4ZH68,Q5CCK0,Q5I6S9,Q62574,Q647G2,Q7TSP4,Q865W6,Q865X1,Q865Y4,Q866Y6,Q8MKF5,Q8SPW9,Q9QXX2,Q9TTB0,Q9TV67,Q9YGB9">IFN-gamma</protein-id> from splenocytes in vitro and this enhancement depended on the content of the pH-sensitive lipid dioleoyl-<compound-id="1015">phosphoethanolamine</compound-id> (DOPE) in the liposomes.	phosphoethanolamine__IFN-gamma__interaction
18930122-2233	Osteoblasts up-regulate the expression of extracellular <protein-id="O41798,O89290,O89940,O91080,O93215,P03311,P03353,P03355,P03356,P03362,P03363,P03366,P03367,P03369,P03370,P04023,P04024,P04323,P04584,P04585,P04587,P04588,P04589,P05959,P05960,P05961,P05962,P07570,P0C210,P0C211,P10210,P10265,P10270,P10271,P10272,P10273,P10274,P10394,P10978,P11227,P11365,P12451,P12497,P12498,P12499,P14074,P14078,P15833,P16046,P16423,P16901,P17757,P18042,P18096,P18802,P19028,P19199,P19560,P19561,P20825,P20875,P20876,P20892,P21407,P21414,P24107,P24740,P26808,P26809,P26810,P27502,P28936,P31822,P35956,P35963,P51518,P63119,P63120,P63121,P63122,P63123,P63124,P63125,P63127,P63128,P63129,P63131,P84454,Q09SZ9,Q0R5R2,Q0R5R3,Q1A249,Q1A267,Q4U0X6,Q73368,Q74120,Q75002,Q76634,Q77373,Q79666,Q89928,Q8AII1,Q8I7P9,Q9IDV9,Q9Q720,Q9QBY3,Q9QBZ1,Q9QBZ5,Q9QSR3,Q9WC54,Q9WC63,Q9Y6I0">proteases</protein-id> following attachment to <compound-id="107801">Poly(beta-hydroxybutyrate-co-beta-hydroxyvalerate</compound-id>).	Poly(beta-hydroxybutyrate-co-beta-hydroxyvalerate__proteases__interaction
18930149-2366	Pharmacological stimulation of <protein-id="Q697L1,Q8NER1">TRPV1</protein-id> channels with <compound-id="1548943">capsaicin</compound-id> (10 nM) selectively enhanced the frequency of glutamate-mediated spontaneous (sEPSCs) and miniature excitatory postsynaptic currents (mEPSCs) recorded from putative striatal medium spiny neurons.	capsaicin__TRPV1__interaction
18930149-2367	Consistently, the totality of striatal neurons responded to <compound-id="1548943">capsaicin</compound-id> (10 nM or 10 microM) after prevention of desensitization of <protein-id="Q697L1,Q8NER1">TRPV1</protein-id> channels with the protein kinase C (PKC) activator <compound-id="4792,27924,122634,22833501">phorbol 12-myristate 13-acetate</compound-id> (<compound-id="27924,122634,22833501">PMA</compound-id>).	PMA__TRPV1__interaction	capsaicin__TRPV1__interaction	phorbol 12-myristate 13-acetate__TRPV1__interaction
18930149-2368	The effects of <compound-id="1548943">capsaicin</compound-id> and of <compound-id="27924,122634,22833501">PMA</compound-id> were absent after pharmacological or genetic inactivation of <protein-id="Q697L1,Q8NER1">TRPV1</protein-id> channels.	PMA__TRPV1__interaction	capsaicin__TRPV1__interaction
18930149-2369	Finally, we provided evidence for <compound-id="5281969">anandamide</compound-id> as an endovanilloid substance in the striatum, since genetic inhibition of <compound-id="5281969">anandamide</compound-id> degradation resulted in a tonic activation of <protein-id="Q697L1,Q8NER1">TRPV1</protein-id> channels modulating glutamate but not GABA release.	anandamide__TRPV1__interaction
18930474-2338	With the exception of significantly elevated serum <protein-id="P10765,P22393,P33089,P33090,P33091,P43001">prolactin</protein-id> after <compound-id="146570">escitalopram</compound-id>, no effects in the secondary outcome measures were detected.	escitalopram__prolactin__interaction
18930547-2375	The cellular response to dsRNA or its synthetic analog <compound-id="32744,274740">polyinosinic-polycytidylic acid</compound-id> (<compound-id="32744,213546,274740">poly I:C</compound-id>) results in <protein-id="P70671,Q14653,Q4JF28,Q764M6,Q90643">IRF-3</protein-id>-, <protein-id="P70434,Q92985">IRF-7</protein-id>- and NF-kB-mediated activation of type 1 IFNs and pro-inflammatory cytokines critical for innate antiviral immune responses.	polyinosinic-polycytidylic acid__IRF-7__interaction	poly I:C__IRF-3__interaction	polyinosinic-polycytidylic acid__IRF-3__interaction	poly I:C__IRF-7__interaction
18930565-2381	<compound-id="4908">Primaquine</compound-id> toxicity is aggravated in people deficient of 6-glucose phosphate dehydrogenase or <protein-id="O32463,P04425,P35667,P35668,P45480,P46413,P48637,P51855,P57612,P58578,P58579,P58580,P58581,P58582,P59495,P61396,P73493,Q08220,Q5EAC2,Q5LYY5,Q5M3J8,Q65RX0,Q6ANW2,Q71VZ1,Q7M7H8,Q7MHK1,Q7NF44,Q7NQ65,Q7TUG9,Q7TUK9,Q7TVB0,Q7U3W8,Q7VY62,Q7W910,Q7WKF5,Q82V16,Q82ZG8,Q83AL0,Q83Q91,Q87D42,Q87LK1,Q87VA4,Q88D35,Q88UW5,Q89WL0,Q8D335,Q8DCA9,Q8DKF1,Q8DW15,Q8DXM9,Q8E399,Q8EIK8,Q8FE30,Q8FXW6,Q8HXX5,Q8K931,Q8P6P1,Q8PHZ5,Q8UII5,Q8XK30,Q8Y3R3,Q8YE82,Q926X7,Q92SN3,Q98DE8,Q9ABS9,Q9CM00,Q9I697,Q9JTJ6,Q9JYJ3,Q9KUP7,Q9PC29">glutathione synthetase</protein-id>.	Primaquine__glutathione synthetase__interaction
18930648-795	Levels of <protein-id="P10145">interleukin-8</protein-id> (<protein-id="O62812,P08317,P10145,P19874,P26894,P36925,P41324,P46653,P49113,P67813,P67814,P79255,Q102R3,Q7YRB5,Q9XSX5">IL-8</protein-id>) and <compound-id="107873">8-isoprostane</compound-id> were measured in epithelial lining fluid (ELF) from central and peripheral airways separately collected using a bronchoscopic microsampling technique.	8-isoprostane__IL-8__no_interaction	8-isoprostane__interleukin-8__no_interaction
18930650-823	Fluoroimmunoassay based on the fluorescent property of quantum dot was used along with immunoassay to detect 2,4-D. CdTe capped with mercaptopropionic acid, was conjugated using N-(3-dimethylaminopropyl)-N-ethylcarbodiimide hydrochloride (EDC) and a coupling reagent like <compound-id="80170">N-hydroxysuccinimide</compound-id> (NHS) to <protein-id="O60109,P81800,P83456">alkaline phosphatase</protein-id> (<protein-id="P03973,P12547,P22298,P28296,P29118,P35211,P83610,P97430,Q03420,Q53GG5,Q9H0A0,Q9PU47,Q9Z1X0">ALP</protein-id>) which was in turn conjugated to 2,4-D molecule.	N-hydroxysuccinimide__ALP__interaction	N-hydroxysuccinimide__alkaline phosphatase__interaction
18930705-2444	The SoxN protein is proposed to harbor the heme b of lower reduction potential and the <compound-id="5326705,5942915">heme a</compound-id> (s), and <protein-id="O54088,P58029">CbsA</protein-id> the other heme b.	heme a__CbsA__no_interaction
18930712-2448	Seleno-L-methionine (SeMet) can be oxidized to L-methionine selenoxide (MetSeO) by flavin-containing monooxygenase 3 (<protein-id="P31513,P32417,Q7YS44,Q8HYJ9,Q8SPQ7,Q95LA1">FMO3</protein-id>) and rat liver microsomes in the presence of <compound-id="5884">NADPH</compound-id>.	NADPH__FMO3__interaction
18930714-667	Regulatory roles for <protein-id="Q60610">Tiam1</protein-id>, a guanine nucleotide exchange factor for <protein-id="P40792,P63001,Q6RUV5">Rac1</protein-id>, in <compound-id="206,5793,64689,79025">glucose</compound-id>-stimulated <protein-id="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7">insulin</protein-id> secretion in pancreatic beta-cells.	glucose__Rac1__no_interaction	glucose__insulin__interaction	glucose__Tiam1__interaction
18930714-668	Using various biochemical, pharmacological and molecular biological approaches, we have recently reported regulatory roles for <protein-id="P40792,P63001,Q6RUV5">Rac1</protein-id>, a <protein-id="P15153">small G-protein</protein-id>, in <compound-id="206,5793,64689,79025">glucose</compound-id>-stimulated <protein-id="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7">insulin</protein-id> secretion (GSIS).	glucose__small G-protein__no_interaction	glucose__insulin__interaction	glucose__Rac1__interaction
18930714-670	<compound-id="6830">GTP</compound-id>-bound form) and membrane association of <protein-id="P40792,P63001,Q6RUV5">Rac1</protein-id> in INS 832/13 cells and rat islets.	GTP__Rac1__interaction
18930714-671	Interestingly, however, in contrast to the inhibitory effects of <compound-id="409805">NSC23766</compound-id>, <protein-id="Q60610">Tiam1</protein-id> gene depletion potentiated GSIS in these cells; such a potentiation of GSIS was sensitive to extracellular calcium.	NSC23766__Tiam1__no_interaction
18930760-2475	This vector allows the co-expression of alpha-Hb as a fusion protein with <protein-id="O04437,O18598,P0A9D2,P0A9D3,P30116,P44521,P46088,P46419,P46423,P46426,P46428,P46437,P48438,P80894,P81065,P82996,P82997,P82998,P82999,P83000,P83001,P83246,Q04522,Q08392,Q08393,Q0ZS46,Q7REH6,Q8ILQ7,Q8MU52,Q96324">Glutathione S-Transferase</protein-id> (<protein-id="P20432,P30104,P30106,P30107,P30108,Q04522,Q0ZS46,Q7REH6,Q8ILQ7,Q8MU52">GST</protein-id>-alpha-Hb) and beta-Hb with an additional <compound-id="876,6137">methionine</compound-id> at the N-terminal extremity (rbeta-Hb).	methionine__Glutathione S-Transferase__no_interaction	methionine__GST__no_interaction
18930779-791	<protein-id="O50258">Superoxide dismutase</protein-id> (<protein-id="O12933,O22668,O75007,P24705,P51547,P93258,Q01137,Q27666,Q9SM64">SOD</protein-id>), <protein-id="O24339,O52762,O62839,O68146,O77229,O93662,O97492,P00432,P04040,P04762,P07145,P0A323,P0A324,P0A325,P0A326,P0A327,P11934,P17336,P24168,P24270,P25890,P29422,P30265,P30266,P32290,P42321,P44390,P45737,P45739,P55304,P55306,P55310,P55311,P55313,P77872,P81138,P90682,Q27710,Q49XC1,Q4L643,Q59296,Q59337,Q59602,Q59714,Q5HG86,Q5HPK8,Q5RF10,Q64405,Q6G9M4,Q6GH72,Q7A5T2,Q8CPD0,Q8FWU0,Q8NWV5,Q8X1P0,Q8Y3P9,Q926X0,Q99UE2,Q9AXH0,Q9KW19,Q9L4S1,Q9M5L6,Q9PT92,Q9PWF7,Q9Z598,Q9ZKX5,Q9ZN99">catalase</protein-id> (<protein-id="O62839,O97492,P00432,P00485,P00486,P00487,P04040,P06135,P07641,P11504,P20074,P22782,P25309,P25819,P26825,P26826,P32796,P36882,P36883,P43155,P47934,P49417,P52826,P58777,P62577,P62578,P62579,P62580,P90682,Q00614,Q02736,Q03058,Q5RF10,Q64405,Q704S8,Q9M5L6,Q9PWF7">CAT</protein-id>), and <protein-id="O32770,O59858,Q00277,Q9CFV1">glutathione peroxidase</protein-id> (GSH-Px) activities as well as <compound-id="2723628">thiobarbituric acid</compound-id> reactive substances (TBARSs) and <compound-id="145068">nitric oxide</compound-id> (NO) levels were analysed in erythrocyte and plasma of rats.	nitric oxide__Superoxide dismutase__no_interaction	nitric oxide__catalase__no_interaction	thiobarbituric acid__Superoxide dismutase__no_interaction	thiobarbituric acid__glutathione peroxidase__no_interaction	nitric oxide__glutathione peroxidase__no_interaction	thiobarbituric acid__catalase__no_interaction	nitric oxide__SOD__no_interaction	thiobarbituric acid__SOD__no_interaction	thiobarbituric acid__CAT__no_interaction	nitric oxide__CAT__no_interaction
18930779-793	The erythrocyte <protein-id="O62839,O97492,P00432,P00485,P00486,P00487,P04040,P06135,P07641,P11504,P20074,P22782,P25309,P25819,P26825,P26826,P32796,P36882,P36883,P43155,P47934,P49417,P52826,P58777,P62577,P62578,P62579,P62580,P90682,Q00614,Q02736,Q03058,Q5RF10,Q64405,Q704S8,Q9M5L6,Q9PWF7">CAT</protein-id> activity was higher in <compound-id="65632">erdosteine</compound-id> group and there was a statistically significant increase, when compared with the <compound-id="65632">erdosteine</compound-id> plus ischemia/reperfusion group.	erdosteine__CAT__interaction
18930802-2496	The ethidium bromide (EB) demyelinating model was associated with <compound-id="2116,14985,1548900,1742129">vitamin E</compound-id> (Vit E) and <compound-id="3194">ebselen</compound-id> (Ebs) treatment to evaluate <protein-id="Q867X2,Q867X3,Q86GC9,Q92081">acetylcholinesterase</protein-id> (<protein-id="O42275,O62763,P04058,P07140,P07692,P21836,P22303,P23795,P36196,P37136,P56161,Q27677,Q29499,Q867X2,Q867X3,Q869C3,Q86GC8,Q86GC9,Q92035,Q92081,Q9DDE3">AChE</protein-id>) activity in the striatum (ST), hippocampus (HP), cerebral cortex (CC) and erythrocytes.	ebselen__acetylcholinesterase__interaction	ebselen__AChE__interaction	vitamin E__acetylcholinesterase__interaction	vitamin E__AChE__interaction
18930812-868	These properties appear to depend on a specific mitochondrial signaling of melatonin which is associated with a lower generation of reactive <compound-id="977">oxygen</compound-id> species and a better control of redox-sensitive components such as the antiapoptotic protein <protein-id="P10417,P49950">Bcl-2</protein-id>.	oxygen__Bcl-2__no_interaction
18930813-875	A search of publicly available microarray data reveals that expression of mitochondrial manganese <protein-id="O50258">superoxide dismutase</protein-id> (<protein-id="O08460,P07895,P09224,P09671,P36606,P80733,Q00637,Q03301,Q07449,Q9UQX0">Sod2</protein-id>), responsible for the conversion of <compound-id="5359597">superoxide</compound-id> (O(2)(-)) to <compound-id="784">hydrogen peroxide</compound-id> (H(2)O(2)), is consistently increased in high-grade and advanced-stage bladder tumors.	hydrogen peroxide__Sod2__interaction	hydrogen peroxide__superoxide dismutase__interaction	superoxide__superoxide dismutase__interaction	superoxide__Sod2__interaction
18930826-2517	In vivo <protein-id="O14649">TASK</protein-id> blockade by <compound-id="5281969">anandamide</compound-id> significantly increased infarct volumes at 24 h in mice undergoing 30 min of transient middle cerebral artery occlusion (tMCAO).	anandamide__TASK__interaction
18930833-2520	<protein-id="O04437,O18598,P0A9D2,P0A9D3,P30116,P44521,P46088,P46419,P46423,P46426,P46428,P46437,P48438,P80894,P81065,P82996,P82997,P82998,P82999,P83000,P83001,P83246,Q04522,Q08392,Q08393,Q0ZS46,Q7REH6,Q8ILQ7,Q8MU52,Q96324">Glutathione S-transferases</protein-id> (<protein-id="P20432,P30104,P30106,P30107,P30108,Q04522,Q0ZS46,Q7REH6,Q8ILQ7,Q8MU52">GSTs</protein-id>) are multifunctional phase II detoxification enzymes that catalyze the attachment of electrophilic substrates to <compound-id="124886">glutathione</compound-id>.	glutathione__GSTs__interaction	glutathione__Glutathione S-transferases__interaction
18930846-916	It can use a dithiol-disulfide active-site to transfer reducing equivalents from <compound-id="5884">NADPH</compound-id> to <protein-id="O14463,O17486,O22022,O30974,O51088,O51890,O83889,O84544,O96952,O97508,O97680,P00276,P08058,P08628,P08629,P09857,P0A0K4,P0A0K5,P0A0K6,P0A4L3,P0A4L4,P0A616,P0A617,P10472,P10473,P10599,P10639,P11232,P14930,P14949,P21609,P21610,P29429,P29451,P33791,P34723,P37395,P42115,P43785,P46843,P47370,P50254,P50338,P50413,P51225,P52227,P52230,P52231,P52233,P57653,P59527,P66928,P66929,P75512,P80579,P81108,P81109,P81110,P82460,P96132,P99122,P99505,Q05739,Q57755,Q5HGT9,Q5HQ29,Q5R9M3,Q6GA69,Q6GHU0,Q7KQL8,Q7M1B9,Q8CPL5,Q92JR5,Q98PL5,Q98TX1,Q9BDJ3,Q9CM49,Q9DGI3,Q9JWM8,Q9K1N8,Q9PJK3,Q9R6P9,Q9UW02,Q9X2T1,Q9Z7P5,Q9ZEE0">thioredoxin</protein-id> (<protein-id="O97508,O97680,P08628,P08629,P0A4L3,P0A4L4,P0A616,P0A617,P10599,P10639,P11232,P14949,P20659,P29451,P37395,P42115,P46843,P47370,P50413,P52227,P75512,P82460,P99505,Q24742,Q57755,Q5R9M3,Q98TX1,Q9BDJ3,Q9DGI3,Q9R6P9,Q9X2T1">Trx</protein-id>), via the cofactor FAD.	NADPH__Trx__interaction	NADPH__thioredoxin__interaction
18930903-626	<protein-id="O35800,Q0PGG7,Q16665,Q309Z6,Q61221,Q98SW2,Q9I8A9,Q9XTA5,Q9YIB9">Hypoxia-inducible factor-1alpha</protein-id> (<protein-id="O35800,Q0PGG7,Q16665,Q309Z6,Q61221,Q98SW2,Q9I8A9,Q9XTA5,Q9YIB9">HIF-1alpha</protein-id>) is a transcription factor that plays an essential role in <compound-id="977">oxygen</compound-id> homeostasis.	oxygen__Hypoxia-inducible factor-1alpha__interaction	oxygen__HIF-1alpha__interaction
18930948-1088	However, <protein-id="P02787,P09571,P12346,P19134,P27425,Q29443,Q921I1">transferrin</protein-id>, <protein-id="P03161,P03610,P03631,P03632,P07394,P15966,P25243,P25244,P35823,P98005">a protein</protein-id> with no active site <compound-id="5951">serine</compound-id>, was covalently modified in vitro by 0.5mM 10-fluoroethoxyphosphinyl-N-biotinamido pentyldecanamide, chlorpyrifos oxon, diisopropylfluorophosphate, dichlorvos, sarin, and soman.	serine__a protein__no_interaction	serine__transferrin__no_interaction
18931023-1335	Ovariectomized Wistar rats consuming a high-sodium diet received one of four treatments (n=7 per group): group 1, placebo pellets; group 2, E(2) (0 x 5 mg/pellet, 21-day release); group 3, NOS inhibitor, <compound-id="4367">N(omega)-nitro-L-arginine</compound-id>-methyl-ester (L-NAME; 40 mg/kg per day for 14 days) plus <protein-id="P01015,P01016,P01017,P01019,P11859,P20757,P67885,P67886,Q9GLN8,Q9GLP6,Q9TSZ0">Ang II</protein-id> (0 x 225 mg/kg per day on days 11-14); group 4, E(2) plus L-NAME/<protein-id="P01015,P01016,P01017,P01019,P11859,P20757,P67885,P67886,Q9GLN8,Q9GLP6,Q9TSZ0">Ang II</protein-id>.	N(omega)-nitro-L-arginine__Ang II__no_interaction
18931024-1924	At the peripheral level, <compound-id="5754">cortisol</compound-id> (10(-6) M), <protein-id="P01189,P01190,P01191,P01192,P01193,P01194,P01196,P01197,P01201,P06297,P06298,P06299,P10000,P11280,P11885,P19402,P21252,P22923,P68000,P68001,P87352,Q04617,Q04618,Q91082,Q9YGK2,Q9YGK4,Q9YGK5">ACTH</protein-id> (10(-7) M), and <protein-id="P01189,P01190,P01191,P01192,P01193,P01194,P01196,P01197,P01201,P06297,P06298,P06299,P10000,P11280,P11885,P19402,P21252,P22923,P41589,P61280,P61281,P68000,P68001,P87352,Q91082,Q9YGK2,Q9YGK4,Q9YGK5">alpha-MSH</protein-id> (10(-7) M) stimulate the release of T(4) from kidney and head kidney fragments, which contain all functional thyroid follicles in carp, by two-to fourfold.	cortisol__ACTH__no_interaction	cortisol__alpha-MSH__no_interaction
18931035-2612	The mechanism of lysoPAF-mediated inhibition of neutrophils involves an elevation in the intracellular <compound-id="6076">cAMP</compound-id> level, and pharmacological blockade of <protein-id="P00936,P08678,P0A1A7,P0A1A8,P0A4Y0,P0A4Y1,P14605,P15318,P23466,P26338,P27580,P30528,P40127,P40130,P40134,P40135,P40136,P43524,P49606,P59739,Q01513,Q01631,Q03100,Q03101,Q05766,Q25263,Q26721,Q26896,Q27675,Q57506,Q59119,Q59685,Q8FBP0,Q8XAP1,Q99279,Q99280,Q99396,Q9WXC3">adenylyl cyclase</protein-id> completely reverses the inhibitory effect of lysoPAF.	cAMP__adenylyl cyclase__no_interaction
18931047-2620	Sympathetic neurogenic Ca2+ signalling in rat arteries: <compound-id="5957">ATP</compound-id>, <compound-id="951,439260">noradrenaline</compound-id> and <protein-id="P01303,P01304,P07808,P14765,P28672,P28673,P28674,P29071,P33689,P57774,P68006,P68007,P68008,P69101,P69102,P80167,Q27441,Q6RUW3,Q90WF4,Q9DGK7,Q9I8P3,Q9I9D3,Q9PTA0,Q9PW68,Q9XSW6">neuropeptide Y</protein-id>.	noradrenaline__neuropeptide Y__no_interaction	ATP__neuropeptide Y__no_interaction
18931108-2645	<protein-id="O25916,O30477,O78411,O83097,P07908,P0A1Q4,P0A1Q5,P0ACB0,P0ACB1,P45256,P46394,P47340,P49519,P51333,P57611,P59966,P71715,P75539,Q55418,Q6ABX1,Q89A52,Q8FB22,Q8K932,Q8X5V3,Q8YZA1,Q92HG8,Q9CNL6,Q9F5P4,Q9ZD08,Q9ZJM5">DnaB</protein-id> (BA) demonstrated a strong DNA <protein-id="O29238,O51934,O58530,O67037,O67226,P09395,P09498,P15095,P15402,P16342,P17779,P17965,P18458,P19751,P19811,P20951,P22168,P22591,P22657,P27327,P27328,P27407,P27409,P27410,P27411,P27920,P28726,P28897,P36286,P37987,P54634,P59641,P74759,P95479,Q04544,Q04561,Q04575,Q05002,Q06502,Q07518,Q07630,Q08582,Q3I5J6,Q58907,Q66198,Q66914,Q68772,Q69014,Q6F598,Q83017,Q86117,Q86119,Q89273,Q8B912,Q8R979,Q8V439,Q8V6W7,Q8V736,Q8ZXT5,Q91A29,Q91AV2,Q91QT2,Q96725,Q971T7,Q975P6,Q97ZF5,Q97ZZ8,Q9IW06,Q9PYA3,Q9UZ86,Q9WJB2,Q9YC75,Q9YCB6,Q9YN02">helicase</protein-id> activity that required <compound-id="5957">ATP</compound-id> or <compound-id="15993">dATP</compound-id>.	dATP__helicase__interaction	dATP__DnaB__interaction	ATP__DnaB__interaction	ATP__helicase__interaction
18931108-2646	Based on the ratio of DNA <protein-id="O29238,O51934,O58530,O67037,O67226,P09395,P09498,P15095,P15402,P16342,P17779,P17965,P18458,P19751,P19811,P20951,P22168,P22591,P22657,P27327,P27328,P27407,P27409,P27410,P27411,P27920,P28726,P28897,P36286,P37987,P54634,P59641,P74759,P95479,Q04544,Q04561,Q04575,Q05002,Q06502,Q07518,Q07630,Q08582,Q3I5J6,Q58907,Q66198,Q66914,Q68772,Q69014,Q6F598,Q83017,Q86117,Q86119,Q89273,Q8B912,Q8R979,Q8V439,Q8V6W7,Q8V736,Q8ZXT5,Q91A29,Q91AV2,Q91QT2,Q96725,Q971T7,Q975P6,Q97ZF5,Q97ZZ8,Q9IW06,Q9PYA3,Q9UZ86,Q9WJB2,Q9YC75,Q9YCB6,Q9YN02">helicase</protein-id> and ATPase activities, <protein-id="O25916,O30477,O78411,O83097,P07908,P0A1Q4,P0A1Q5,P0ACB0,P0ACB1,P45256,P46394,P47340,P49519,P51333,P57611,P59966,P71715,P75539,Q55418,Q6ABX1,Q89A52,Q8FB22,Q8K932,Q8X5V3,Q8YZA1,Q92HG8,Q9CNL6,Q9F5P4,Q9ZD08,Q9ZJM5">DnaB</protein-id> (BA) is highly efficient in DNA unwinding and its coupling to <compound-id="5957">ATP</compound-id> consumption.	ATP__DnaB__interaction	ATP__helicase__interaction
18931130-230	MerH was found to transport mercuric ions in Escherichia coli via a pair of essential <compound-id="594,5862,5360637">cysteine</compound-id> residues but only when coexpressed with the <protein-id="P00392,P08332,P08662,P0A0E4,P0A0E5,P16171,P17239,P30341,P94188,P94702,Q51772,Q52109,Q54465">mercuric reductase</protein-id>.	cysteine__mercuric reductase__no_interaction
18931136-2657	HmuY and <protein-id="Q56989">HmuR</protein-id> are <compound-id="4971">hemin</compound-id> binding proteins required for P. gingivalis growth.	hemin__HmuR__interaction
18931257-1820	The effect of <protein-id="O01673,O02389,O16127,O18416,O44119,O61379,O96764,O97162,O97192,P31816,P91958,Q02088,Q23758,Q23939,Q25145,Q25456,Q25457,Q25632,Q26503,Q26519,Q7M3Y8,Q8IT89,Q8T380,Q8T6L5,Q8WR63,Q95PU1,Q95VA8,Q9GZ69,Q9GZ70,Q9GZ71,Q9N2R3,Q9NAS5,Q9NDS0,Q9NFZ4,Q9NG56,Q9UB83">tropomyosin</protein-id> on <protein-id="O00937,O13419,O16808,O17320,O65314,O65315,O65316,O74258,O81221,P02577,P10365,P10989,P11426,P13363,P14235,P17128,P20904,P24902,P26182,P26183,P30161,P45520,P45521,P48465,P50138,P51775,P53455,P53476,P53477,P53491,P53498,P53499,P53500,P53502,P53689,P60009,P60010,P60011,P68555,P78711,P80709,P81085,P90689,P91754,Q05214,Q11212,Q24733,Q2U7A3,Q39596,Q39758,Q6TCF2,Q75D00,Q8SWN8,Q8X119,Q92192,Q92193,Q99023,Q9P4D1,Q9UVF3,Q9UVX4,Q9UVZ8">actin</protein-id> filaments was independent of ionic strength, but became stronger as the <compound-id="5462224">magnesium</compound-id> concentration increased.	magnesium__actin__interaction	magnesium__tropomyosin__interaction
18931328-2696	We showed that, compared with the untreated CF serous cells, a 24-hour pre-incubation period with 200 nM salmeterol induced an 83% increase in delF508-<protein-id="P13569,P26361,P26362,P26363,P34158,P35071,Q00552,Q00553,Q00554,Q00555,Q07DV2,Q07DW5,Q07DX5,Q07DY5,Q07DZ6,Q07E16,Q07E42,Q09YH0,Q09YJ4,Q09YK5,Q108U0,Q2IBA1,Q2IBB3,Q2IBE4,Q2IBF6,Q2QL74,Q2QL83,Q2QLA3,Q2QLB4,Q2QLC5,Q2QLE5,Q2QLF9,Q2QLH0,Q5D1Z7,Q5U820,Q6PQZ2,Q7JII7,Q7JII8,Q9TSP5,Q9TUQ2">CFTR</protein-id>-mediated <compound-id="312">chloride</compound-id> efflux.	chloride__CFTR__interaction
18931344-2072	Activation of <protein-id="P27297,Q07813,Q63690">Bax</protein-id> and <protein-id="O08734">Bak</protein-id> was demonstrated in peripheral blood mononuclear cells, and induction of apoptosis was related to overall <compound-id="11404337,45356963">obatoclax</compound-id> exposure, as monitored by the plasma concentration of oligonucleosomal DNA/histone complexes.	obatoclax__Bak__no_interaction	obatoclax__Bax__no_interaction
18931380-2724	Liver <compound-id="91550">glycidamide</compound-id> DNA adducts and <compound-id="6579">acrylamide</compound-id> and <compound-id="91550">glycidamide</compound-id> N-terminal <compound-id="6287">valine</compound-id> <protein-id="P15160,P17724,P73925,Q03459">hemoglobin</protein-id> adducts were also determined.	glycidamide__hemoglobin__no_interaction	valine__hemoglobin__interaction	acrylamide__hemoglobin__interaction
18931475-2743	The acyl <protein-id="Q6BEG6,Q6BEG7,Q9BDJ6,Q9BEF8,Q9EQX0,Q9GKY5,Q9QYH7,Q9UBU3">ghrelin</protein-id> peptide features a unique post-translational modification of O-n-octanoylation at <compound-id="5951">serine</compound-id> 3, and is the only gastrointestinal signal that increases meal size.	serine__ghrelin__interaction
18931618-2800	Tests of the blood samples obtained at the ED revealed leucocytosis (11 070.6+/-4302.5/microl), increased blood <compound-id="206,5793,64689,79025">glucose</compound-id>, <protein-id="P29038,P33571,P93052,Q27797,Q27888,Q95028,Q99289">LDH</protein-id>, CK and CK-MB levels.	glucose__LDH__no_interaction
18931836-26	Molecular and biochemical characterization of a distinct <protein-id="O42713,P06845,P07524,P33180,P55022,P55023,P55033,Q00234,Q8J130,Q92396">tyrosinase</protein-id> involved in <compound-id="6325610">melanin</compound-id> production from Aeromonas media.	melanin__tyrosinase__interaction
18931836-28	<protein-id="P07023,P20692,P43901,P43902,Q02287,Q9CET9">TyrA</protein-id> had a relatively higher affinity to <compound-id="33665">diphenol</compound-id> substrate L-<compound-id="836">dihydroxyphenylalanine</compound-id> (<compound-id="6047">L-dopa</compound-id>) than many other <protein-id="O42713,P06845,P07524,P33180,P55022,P55023,P55033,Q00234,Q8J130,Q92396">tyrosinases</protein-id>.	diphenol__tyrosinases__no_interaction	L-dopa__tyrosinases__interaction	diphenol__TyrA__no_interaction	dihydroxyphenylalanine__tyrosinases__interaction	L-dopa__TyrA__interaction	dihydroxyphenylalanine__TyrA__interaction
18931836-29	EDTA or glutathione notably inhibited the enzymatic activities of <protein-id="P07023,P20692,P43901,P43902,Q02287,Q9CET9">TyrA</protein-id>, whereas <compound-id="5590">Triton X-100</compound-id> and SDS activated them.	Triton X-100__TyrA__interaction
18931836-30	These results suggest that <protein-id="P07023,P20692,P43901,P43902,Q02287,Q9CET9">TyrA</protein-id> is the first reported distinct <protein-id="O42713,P06845,P07524,P33180,P55022,P55023,P55033,Q00234,Q8J130,Q92396">tyrosinase</protein-id> involved in <compound-id="6325610">melanin</compound-id> production in the genus Aeromonas.	melanin__TyrA__interaction	melanin__tyrosinase__no_interaction
18931932-360	<protein-id="O80452,P15274,P50998">AMP-deaminase</protein-id> from goldfish white muscle: regulatory properties and redistribution under exposure to high environmental <compound-id="977">oxygen</compound-id> level.	oxygen__AMP-deaminase__interaction
18931932-361	Both sodium and potassium ions activated goldfish <protein-id="O80452,Q84NP7">AMPD</protein-id> at low concentrations, with maximal activation at about 80 mM of each <compound-id="312">chloride</compound-id> salt, whereas higher concentrations became inhibitory.	chloride__AMPD__interaction
18931932-362	Magnesium and calcium ions also inhibited goldfish muscle <protein-id="O80452,Q84NP7">AMPD</protein-id>, as did <compound-id="1061,167704,644102">phosphate</compound-id> and <compound-id="28179">fluoride</compound-id> ; at a concentration of 8 mM, each anion reduced activity by about 66%.	fluoride__AMPD__interaction	phosphate__AMPD__interaction
18931933-364	Age-associated impairment of <protein-id="P31750,Q8INB9">Akt</protein-id> phosphorylation in primary rat hepatocytes is remediated by <compound-id="864,6112">alpha-lipoic acid</compound-id> through <protein-id="P42347,P42348,P54673,P54674,P54675,P54676">PI3 kinase</protein-id>, <protein-id="P60483,P60484">PTEN</protein-id>, and <protein-id="P23696,Q06009,Q9ZSE4">PP2A</protein-id>.	alpha-lipoic acid__Akt__interaction	alpha-lipoic acid__PTEN__interaction	alpha-lipoic acid__PI3 kinase__interaction	alpha-lipoic acid__PP2A__interaction
18931946-74	Unfolding and inactivation of abalone (Haliotis diversicolor) <protein-id="O60109,P81800,P83456">alkaline phosphatase</protein-id> during denaturation by <compound-id="3520">guanidine hydrochloride</compound-id>.	guanidine hydrochloride__alkaline phosphatase__interaction
18931946-75	Unfolding and inactivation of <protein-id="P81800">ALPase</protein-id> from abalone (Haliotis diversicolor) during denaturation by <compound-id="3520">guanidine hydrochloride</compound-id> (GuHCl) of different concentrations has first been studied.	guanidine hydrochloride__ALPase__interaction
18931948-76	We aim to study a possible benefit of a common nitrogen oxide donor, anti-anginal drug, nicorandil [N-(2-hydroxyethyl) nicotinamide nitrate ester], in managing acute gastric ulcers through studying its effect on some relevant intermediates to ulcerogenesis as lipid peroxidation, <protein-id="Q8JFG3">tumor necrosis factor</protein-id>-alpha (<protein-id="O35734,O77510,O77764,P01375,P04924,P06804,P13296,P16599,P19101,P23383,P23563,P29553,P33620,P36939,P48094,P51435,P51742,P51743,P59684,P59693,P59694,P59695,P79337,P79374,Q06599,Q19LH4,Q1G1A2,Q1WM27,Q2MH05,Q539C2,Q75N23,Q8HZD9,Q8JFG3,Q8MKG8,Q8WNR1,Q9BEA1">TNF-alpha</protein-id>), and <compound-id="145068">nitric oxide</compound-id> (NO).	nitric oxide__TNF-alpha__no_interaction	nitric oxide__tumor necrosis factor__no_interaction
18932012-101	Converting <compound-id="439153">NADH</compound-id> to <compound-id="5893">NAD</compound-id>+ by <protein-id="P11024,Q13423,Q61941">nicotinamide nucleotide transhydrogenase</protein-id> as a novel strategy against mitochondrial pathologies during aging.	NADH__nicotinamide nucleotide transhydrogenase__interaction	NAD__nicotinamide nucleotide transhydrogenase__interaction
18932012-102	<compound-id="439153">NADH</compound-id>/<compound-id="5893">NAD</compound-id> (+) ratio can be normalized by the activation or overexpression of <protein-id="P11024,Q13423,Q61941">nicotinamide nucleotide transhydrogenase</protein-id> (<protein-id="O93474,P11024,Q13423">NNT</protein-id>--&gt; <compound-id="5884">NADPH</compound-id>+ <compound-id="5893">NAD</compound-id> (+).	NADPH__NNT__interaction	NADPH__nicotinamide nucleotide transhydrogenase__interaction	NADH__NNT__interaction	NAD__NNT__interaction	NADH__nicotinamide nucleotide transhydrogenase__interaction	NAD__nicotinamide nucleotide transhydrogenase__interaction
18932024-913	An efficient electrocatalytic biosensor for sulfite detection was developed by co-immobilizing <protein-id="P07850,Q9S850">sulfite oxidase</protein-id> and <protein-id="O07091,O13393,O22642,O93863,P00002,P00003,P00004,P00007,P00008,P00011,P00012,P00013,P00014,P00017,P00018,P00019,P00020,P00021,P00022,P00024,P00025,P00027,P00028,P00029,P00030,P00031,P00032,P00035,P00036,P00037,P00038,P00039,P00040,P00041,P00042,P00043,P00046,P00047,P00048,P00049,P00051,P00052,P00053,P00054,P00055,P00056,P00057,P00058,P00059,P00060,P00061,P00062,P00063,P00064,P00065,P00066,P00067,P00068,P00069,P00070,P00071,P00072,P00073,P00074,P00075,P00076,P00077,P00078,P00079,P12831,P15451,P18822,P19681,P19974,P21665,P22342,P25400,P29380,P32556,P38091,P53698,P56205,P59218,P62772,P62773,P62894,P62895,P62896,P67881,P67882,P68096,P68097,P68098,P68099,P68100,P68517,P68518,P68519,P81280,P81459,P99998,P99999,Q41346,Q4HVX7,Q52V08,Q52V09,Q52V10,Q5RFH4,Q640U4,Q6C9Q0,Q6IQM2,Q6Q4H8,Q6QLW4,Q6WUX8,Q753F4,Q7YR71,Q96VP3">cytochrome c</protein-id> with polyaniline <compound-id="104748">sulfonic acid</compound-id> in a layer-by-layer assembly.	sulfonic acid__cytochrome c__interaction	sulfonic acid__sulfite oxidase__interaction
18932046-599	After 10 days of treatment, otomicroscopic evaluation of tympanic membranes and measurement of anti-inflammatory mediators such as <protein-id="O50258">superoxide dismutase</protein-id>, nitrite/nitrate, <protein-id="O32770,O59858,Q00277,Q9CFV1">glutathione peroxidase</protein-id> and <compound-id="10964">malondialdehyde</compound-id> were performed.	malondialdehyde__superoxide dismutase__no_interaction	malondialdehyde__glutathione peroxidase__no_interaction
18932046-600	The levels of <compound-id="10964">malondialdehyde</compound-id> and <protein-id="O50258">superoxide dismutase</protein-id> were lower in ginkgo groups but not significantly.	malondialdehyde__superoxide dismutase__no_interaction
18932201-188	These results indicate that cloned embryos have aberrant DNA methylation in the <compound-id="6804">CpG</compound-id> sites of the PE region of <protein-id="O97552,P20263,Q01860,Q9TSV5">Oct-4</protein-id>, and this may contribute directly to abnormal expression of this gene in cloned embryos.	CpG__Oct-4__interaction
18932209-190	Xenopus follicle-enclosed oocytes are endowed with <protein-id="O15547,O54803,O70397,P34996,P35383,P41231,P41232,P47824,P47900,P48042,P49650,P49651,P49652,P49653,P49654,P51575,P51576,P51577,P51578,P51579,P56373,P59902,Q64663,Q93086,Q99571,Q99572,Q9UBL9,Q9Z1M0">purinergic receptors</protein-id> located in the follicular cell membrane ; their stimulation by <compound-id="5957">ATP</compound-id> elicits an electrical response that includes generation of a fast inward current (F(Cl)) carried by Cl(-).	ATP__purinergic receptors__no_interaction
18932227-940	Moreover, the dopaminergic and glutamatergic regulation of <protein-id="Q9Z214,Q9Z2Y3">Homer1</protein-id> gene activation by <compound-id="2826,5760,439497,446220,644017,54613779">cocaine</compound-id> was investigated.	cocaine__Homer1__interaction
18932227-941	The acute <compound-id="2826,5760,439497,446220,644017,54613779">cocaine</compound-id>-mediated activation of <protein-id="Q9Z214,Q9Z2Y3">Homer1</protein-id> gene was regulated by D1 but not D2 dopamine receptors.	cocaine__Homer1__interaction
18932227-942	Activation of <protein-id="Q9Z214,Q9Z2Y3">Homer1</protein-id> gene may contribute to the <compound-id="2826,5760,439497,446220,644017,54613779">cocaine</compound-id>-mediated synaptic and behavioral plasticity.	cocaine__Homer1__interaction
18935969-1418	The reduction of WST-1 was inhibited in a concentration-dependent manner by <protein-id="O50258">superoxide dismutase</protein-id>, an enzyme that catalyzes the reduction of <compound-id="5359597">superoxide</compound-id> to <compound-id="784">peroxide</compound-id>, confirming that the reduction of WST-1 was due to the presence of <compound-id="5359597">superoxide</compound-id>.	superoxide__superoxide dismutase__interaction	peroxide__superoxide dismutase__interaction
18935970-1419	Eukaryotes plus their archaebacterial sisters form the clade neomura, which evolved from a radically modified derivative of an actinobacterial posibacterium that had replaced the ancestral eubacterial murein <compound-id="9816401">peptidoglycan</compound-id> by N-linked <protein-id="P08163">glycoproteins</protein-id>, radically modified its DNA-handling enzymes, and evolved cotranslational protein secretion, but not the isoprenoid-<compound-id="3283,5382654">ether</compound-id> lipids of archaebacteria.	ether__glycoproteins__no_interaction	peptidoglycan__glycoproteins__no_interaction
18935973-1420	<compound-id="2828334">Necrostatin-1</compound-id>, a new inhibitor of non-apoptotic death, rescued cells from death by <protein-id="P24817,P52594,P56626,Q13546,Q2TA45,Q86UA6">RIPs</protein-id>, although the effect was also partial and temporary.	Necrostatin-1__RIPs__interaction
18935985-1424	Here we show the first direct quantitative evidence for <protein-id="O32449,O43150,O74326,O74518,O83041,O96690,P09274,P0ABF1,P0ABF2,P0ABF3,P10226,P16790,P25500,P27417,P28958,P29468,P36322,P36702,P42786,P44439,P46541,P46542,P46544,P46547,P47266,P51003,P51004,P51005,P51006,P52278,P52279,P52439,P52440,P75092,P80366,P84399,P93732,P96084,Q06141,Q09131,Q10295,Q13442,Q38924,Q3UHX2,Q51D88,Q61183,Q62785,Q7SIG6,Q87DF8,Q8Z9C3,Q8ZRQ8,Q97A76,Q97UA2,Q9D0D3,Q9JUV1,Q9JZR6,Q9NVV4,Q9PD69,Q9S2L4,Q9UT49,Q9UTN3,Q9ZWQ8">PAP</protein-id> binding to the cap analog <compound-id="444378">m(7)GTP</compound-id>.	m(7)GTP__PAP__interaction
18935985-1425	van't Hoff analysis of <compound-id="444378">m(7)GTP</compound-id>-<protein-id="O32449,O43150,O74326,O74518,O83041,O96690,P09274,P0ABF1,P0ABF2,P0ABF3,P10226,P16790,P25500,P27417,P28958,P29468,P36322,P36702,P42786,P44439,P46541,P46542,P46544,P46547,P47266,P51003,P51004,P51005,P51006,P52278,P52279,P52439,P52440,P75092,P80366,P84399,P93732,P96084,Q06141,Q09131,Q10295,Q13442,Q38924,Q3UHX2,Q51D88,Q61183,Q62785,Q7SIG6,Q87DF8,Q8Z9C3,Q8ZRQ8,Q97A76,Q97UA2,Q9D0D3,Q9JUV1,Q9JZR6,Q9NVV4,Q9PD69,Q9S2L4,Q9UT49,Q9UTN3,Q9ZWQ8">PAP</protein-id> equilibrium reveals a binding reaction that is enthalpy driven and entropy favored with TDeltaS degrees contributing 15% to the overall value of DeltaG degrees.	m(7)GTP__PAP__interaction
18935985-1426	eIFiso4G was shown to enhance the interaction of <protein-id="O32449,O43150,O74326,O74518,O83041,O96690,P09274,P0ABF1,P0ABF2,P0ABF3,P10226,P16790,P25500,P27417,P28958,P29468,P36322,P36702,P42786,P44439,P46541,P46542,P46544,P46547,P47266,P51003,P51004,P51005,P51006,P52278,P52279,P52439,P52440,P75092,P80366,P84399,P93732,P96084,Q06141,Q09131,Q10295,Q13442,Q38924,Q3UHX2,Q51D88,Q61183,Q62785,Q7SIG6,Q87DF8,Q8Z9C3,Q8ZRQ8,Q97A76,Q97UA2,Q9D0D3,Q9JUV1,Q9JZR6,Q9NVV4,Q9PD69,Q9S2L4,Q9UT49,Q9UTN3,Q9ZWQ8">PAP</protein-id> with <compound-id="444378">m(7)GTP</compound-id> cap analog by 2.4-fold.	m(7)GTP__PAP__interaction
18936037-1437	In addition to activating the <protein-id="P06186,P06401,P07812,P79373,Q00175,Q28590,Q63449,Q8AYI2,Q9GLW0">progesterone receptors</protein-id> (PRs)-B and-A, members of the superfamily of ligand-dependent transcription factors, <compound-id="5994">progesterone</compound-id> also elicits a variety of rapid signalling events independently of transcriptional or genomic regulation.	progesterone__progesterone receptors__no_interaction
18936084-1443	In granulosa-lutein cells, STAR transcript abundance was not affected by <protein-id="P22004">BMP6</protein-id>, whereas <compound-id="47936">forskolin</compound-id>-induced expression of <protein-id="O46515,P00189,P05108,P10612,P79153,P79202,Q07217,Q28827,Q2XV99,Q92045,Q9EPT4">CYP11A1</protein-id>, <protein-id="P14060,Q60555">HSD3B1</protein-id>, <protein-id="O46512,P11511,P19098,P46194,P70091,P79690,P79699,Q29605,Q29624,Q5QQX7,Q69FB6,Q6QHT9,Q6YI21,Q92087,Q92111,Q92112,Q95M61,Q9XS28">CYP19A1</protein-id> and <protein-id="P01175,P01176,P01177,P01178,P01179,P13389,P32005,P35454,P69043,P69044,P69056,P69057,P69058">oxytocin</protein-id> transcripts was reduced.	forskolin__CYP19A1__interaction	forskolin__CYP11A1__interaction	forskolin__HSD3B1__interaction	forskolin__BMP6__interaction	forskolin__oxytocin__interaction
18936084-1444	In both cell types, follistatin attenuated the suppressive effect of activin A and <protein-id="P22004">BMP6</protein-id> on <compound-id="47936">forskolin</compound-id>-induced P4 secretion but had no effect alone.	forskolin__BMP6__interaction
18936109-1448	<compound-id="1367">1-Aminobenzotriazole</compound-id> (1-ABT) is generally considered to be a nonselective mechanism-based inactivator of both human and non-human <protein-id="O08469">cytochrome P450</protein-id> (P450) enzymes.	1-Aminobenzotriazole__cytochrome P450__interaction
18936140-1459	<compound-id="91474">7-Ketocholesterol</compound-id> is present in lipid deposits in the primate retina: potential implication in the induction of <protein-id="P15691,P15692,P26617,P49151,P50412,P67964,P67965,Q99PS1,Q9GKR0,Q9MYV3">VEGF</protein-id> and CNV formation.	7-Ketocholesterol__VEGF__interaction
18936181-1478	ETEC infection also caused a drastic inhibition of host <protein-id="P16397,P18773">esterase</protein-id> activity, as measured by <compound-id="65079">calcein</compound-id> fluorescence.	calcein__esterase__interaction
18936191-1737	<compound-id="11561383">HCV-796</compound-id> is a nonnucleoside inhibitor of the hepatitis C virus (HCV) <protein-id="P18571,P30890">nonstructural protein</protein-id> 5B (<protein-id="O39927,O39928,O39929,O91936,O92529,O92530,O92531,O92532,P19711,P19712,P19741,P21530,P26660,P26661,P26662,P26663,P26664,P27958,P29846,Q00269,Q01499,Q5I2N3,Q68749,Q68798,Q68801,Q69422,Q81258,Q81487,Q81495,Q81754,Q913D4,Q96662,Q99IB8,Q9DHD6,Q9QAX1,Q9WMX2">NS5B</protein-id>) polymerase, and boceprevir is an inhibitor of the NS3 serine protease.	HCV-796__NS5B__interaction	HCV-796__nonstructural protein__interaction
18936191-1738	They also exhibited resistance to <compound-id="227">anthranilate</compound-id> nonnucleoside inhibitors of NS5B but were fully sensitive to inhibitors of different mechanisms: a pyranoindole, Hsp90 inhibitors, an NS5B nucleoside inhibitor, and pegylated interferon (Peg-<protein-id="P28172,P51526">IFN</protein-id>).	anthranilate__IFN__no_interaction
18936191-1739	Mutations known to confer resistance to <compound-id="11561383">HCV-796</compound-id> (<protein-id="O39927,O39928,O39929,O91936,O92529,O92530,O92531,O92532,P19711,P19712,P19741,P21530,P26660,P26661,P26662,P26663,P26664,P27958,P29846,Q00269,Q01499,Q5I2N3,Q68749,Q68798,Q68801,Q69422,Q81258,Q81487,Q81495,Q81754,Q913D4,Q96662,Q99IB8,Q9DHD6,Q9QAX1,Q9WMX2">NS5B</protein-id> C316Y) and boceprevir (<protein-id="O71152,P06591,P15775,P15779,P29076,Q04854,Q90056">NS3</protein-id> V170A) were present in the combination-resistant replicons.	HCV-796__NS5B__interaction	HCV-796__NS3__interaction
18936517-1603	Here, we show that 12-O-tetradecanoyl-<compound-id="499953,54612241">phorbol-13-acetate</compound-id> (TPA)-induced stabilization of receptor mRNA requires the activity of <protein-id="P13678,Q25378">protein kinase C</protein-id> and is accompanied by activation of the major <protein-id="Q00859">mitogen activated protein kinase</protein-id> pathways.	phorbol-13-acetate__mitogen activated protein kinase__interaction	phorbol-13-acetate__protein kinase C__interaction
18936772-1665	Increased apoptosis of a human salivary gland (HSG) cell line occurred only in the presence of <compound-id="11970143">lipopolysaccharide</compound-id> (LPS-) and interferon (<protein-id="P28172,P51526">IFN</protein-id>)-gamma-stimulated human monocytic THP-1 cells, which was reversed when caspase-1 in THP-1 cells was targeted by siRNA.	lipopolysaccharide__IFN__no_interaction
18936912-1717	A role for <compound-id="60823">atorvastatin</compound-id> and <protein-id="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7">insulin</protein-id> combination in protecting from liver injury in a model of type 2 diabetes with hyperlipidemia.	atorvastatin__insulin__no_interaction
18936912-1718	Genetic type 2 diabetic Goto-Kakizaki rats were fed with a high-fat diet to test hepatic effects of type 2 diabetes with hyperlipidemia and the effect of <compound-id="60823">atorvastatin</compound-id> and <protein-id="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7">insulin</protein-id>, individually and in combination, in systemic and hepatic inflammatory and oxidative stress markers.	atorvastatin__insulin__no_interaction
18936912-1719	Combination of <protein-id="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7">insulin</protein-id> and <compound-id="60823">atorvastatin</compound-id> further improved glycemic and lipid profiles and decreased circulating C-reactive protein levels and liver inflammatory and oxidative stress markers.	atorvastatin__insulin__no_interaction
18936912-1720	<protein-id="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7">Insulin</protein-id> and <compound-id="60823">atorvastatin</compound-id> combination leads to better glycaemic and lipid profiles and to better protection against liver inflammation and oxidative stress, giving a superior level of liver protection in type 2 diabetic with hyperlipidemia.	atorvastatin__Insulin__no_interaction
18936931-1732	Effect of genetic polymorphisms of <protein-id="P20815">CYP3A5</protein-id> and <protein-id="P08183,P13568,P16875,P28873,P53258,Q06034,Q9LJX0,Q9ZR72">MDR1</protein-id> on <compound-id="5280754,5284373,5497195,6435893,24883466,25246316">cyclosporine</compound-id> concentration during the early stage after renal transplantation in Chinese patients co-treated with <compound-id="39186">diltiazem</compound-id>.	cyclosporine__CYP3A5__interaction	diltiazem__CYP3A5__no_interaction	diltiazem__MDR1__no_interaction	cyclosporine__MDR1__interaction
18936931-1733	The aim of this study was to assess the influence of the cytochrome (CYP450)3A5 and multidrug resistance (<protein-id="P08183,P13568,P16875,P28873,P53258,Q06034,Q9LJX0,Q9ZR72">MDR1</protein-id>) gene polymorphisms on <compound-id="2909,5280754,5284373,5497195,6435893,49867938">cyclosporine A</compound-id> (CsA) trough concentration during the early stage after renal transplantation in Chinese patients co-treated with <compound-id="39186">diltiazem</compound-id>.	cyclosporine A__MDR1__interaction	diltiazem__MDR1__no_interaction
18936963-1743	The-417- and-593 bp promoter regions were sufficient for <protein-id="P05804">GUS</protein-id> gene activation by <compound-id="6325,21159546">ethylene</compound-id> and <compound-id="62388,5281929,5319693,5367719,6432008">methyl jasmonate</compound-id> treatments, respectively.	methyl jasmonate__GUS__interaction	ethylene__GUS__interaction
18936983-1746	Reversible two-step unfolding of <compound-id="4971">heme</compound-id>-human <protein-id="P21847,P83517">serum albumin</protein-id> : a (1)H-NMR relaxometric and circular dichroism study.	heme__serum albumin__interaction
18936983-1747	Human <protein-id="P21847,P83517">serum albumin</protein-id> (<protein-id="P24807,Q07490">HSA</protein-id>) participates in <compound-id="4971">heme</compound-id> scavenging, the bound <compound-id="4971">heme</compound-id> turning out to be a reactivity center and a powerful spectroscopic probe.	heme__HSA__interaction	heme__serum albumin__interaction
18936983-1748	Here, the reversible unfolding of <compound-id="4971">heme</compound-id>-<protein-id="P24807,Q07490">HSA</protein-id> has been investigated by (1)H-NMR relaxometry, circular dichroism, and absorption spectroscopy.	heme__HSA__interaction
18936994-1754	The purified enzymes were a monomer with an apparent molecular mass of 32 kDa (Chi32) and 46 kDa (Chi46), respectively, and showed <protein-id="P13656,P14529,P23472,P23473,P81241,P84754">chitinase</protein-id> activity bands with 0.01% <compound-id="174">glycol</compound-id> chitin as a substrate after SDS-PAGE.	glycol__chitinase__no_interaction
18937061-1791	The interactions between N,N'-di(2-hydroxy-3-methyoxy-phenyl-1-methylene)-o-phenyldiamine-mone Zn(II), Nd(III) <compound-id="943">nitrate</compound-id> (2LZnNd) and bovine <protein-id="P21847,P83517">serum albumin</protein-id> (<protein-id="P02769">BSA</protein-id>) was investigated by various spectroscopic techniques under physiological conditions.	nitrate__serum albumin__interaction	nitrate__BSA__interaction
18937066-2628	In particular, expression of genes involved in N-<compound-id="871">glycan</compound-id> synthesis or in the modeling of <compound-id="53477707">chondroitin</compound-id> and <protein-id="P16070,Q60522">heparan sulfate proteoglycans</protein-id> appeared to be modulated.	glycan__heparan sulfate proteoglycans__no_interaction	chondroitin__heparan sulfate proteoglycans__no_interaction
18937073-2436	Possible relation of <compound-id="4971">hemin</compound-id>-induced <protein-id="P06762,P09601,P14791,P14901,P32394,Q5E9F2">HO-1</protein-id> expression to the upregulation of <protein-id="P15691,P15692,P26617,P49151,P50412,P67964,P67965,Q99PS1,Q9GKR0,Q9MYV3">VEGF</protein-id> and <protein-id="O18752,O18753,O18755,O70183,O97759,P14082,P21237,P23363,P23560,P25429,P25430,P25431,P25432,Q02193,Q06225,Q3SAT7,Q4L0Y3,Q5IS78,Q6LCI5,Q7YRB4,Q90322,Q95106,Q9TST3">BDNF</protein-id> mRNA levels in rat C6 glioma cells.	hemin__HO-1__interaction	hemin__VEGF__interaction	hemin__BDNF__interaction
18937073-2437	Based on this hypothetical idea, the direct effect of <compound-id="4971">hemin</compound-id> on the expression of genes encoding <protein-id="P06762,P09601,P14791,P14901,P32394,P72849,Q5E9F2">heme oxygenase-1</protein-id> (<protein-id="P06762,P09601,P14791,P14901,P32394,Q5E9F2">HO-1</protein-id>), vascular endothelial growth factor (<protein-id="P15691,P15692,P26617,P49151,P50412,P67964,P67965,Q99PS1,Q9GKR0,Q9MYV3">VEGF</protein-id>), and <protein-id="P25430,P25431,P25432,Q06225">brain-derived neurotrophic factor</protein-id> (<protein-id="O18752,O18753,O18755,O70183,O97759,P14082,P21237,P23363,P23560,P25429,P25430,P25431,P25432,Q02193,Q06225,Q3SAT7,Q4L0Y3,Q5IS78,Q6LCI5,Q7YRB4,Q90322,Q95106,Q9TST3">BDNF</protein-id>) in glial cells was examined using rat C6 glioma cells as an in vitro model system.	hemin__heme oxygenase-1__interaction	hemin__HO-1__interaction	hemin__brain-derived neurotrophic factor__interaction	hemin__VEGF__interaction	hemin__BDNF__interaction
18937079-1799	Furthermore, we study the <protein-id="P31750,Q8INB9">Akt</protein-id> activation after As(2)O(3) treatment and the HCC cells proliferation after combination of As(2)O(3) with PI3K inhibitor <compound-id="312145">Wortmannin</compound-id>.	Wortmannin__Akt__no_interaction
18937214-1831	<compound-id="2566">Carbofuran</compound-id> is a pesticide whose acute toxicity is due to inhibition of <protein-id="Q867X2,Q867X3,Q86GC9,Q92081">acetylcholinesterase</protein-id>.	Carbofuran__acetylcholinesterase__interaction
18937289-1865	The interaction of <compound-id="4932">propafenone</compound-id> (<compound-id="70387">PPF</compound-id>) enantiomers with human plasma, human <protein-id="P21847,P83517">serum albumin</protein-id> (<protein-id="P24807,Q07490">HSA</protein-id>), alpha(1)-acid <protein-id="P08163">glycoprotein</protein-id> (AGP), as well as with plasma from rat, rabbit, and cow was investigated using indirect chiral high performance liquid chromatography (HPLC) and ultrafiltration techniques.	PPF__serum albumin__interaction	propafenone__glycoprotein__interaction	PPF__glycoprotein__interaction	PPF__HSA__interaction	propafenone__HSA__interaction	propafenone__serum albumin__interaction
18937323-1876	<compound-id="6076">cAMP</compound-id>-<protein-id="Q9EQZ6,Q9Z1C7">Epac2</protein-id>-mediated activation of <protein-id="P08645,P18613,Q91VL8,Q96TL7">Rap1</protein-id> in developing male germ cells: RA-RhoGAP as a possible direct down-stream effector.	cAMP__Rap1__interaction	cAMP__Epac2__interaction
18937323-1878	Taken together, our results, obtained with endogenously expressed proteins, are consistent with a <compound-id="6076">cAMP</compound-id>/<protein-id="Q9EQZ6,Q9Z1C7">Epac2</protein-id>/<protein-id="P08645,P18613,Q91VL8,Q96TL7">Rap1</protein-id>-mediated signaling that could exert its action, among others, through RA-RhoGAP to promote the progression of spermatogenesis.	cAMP__Rap1__interaction	cAMP__Epac2__interaction
18937360-1888	Cholesterol promotes basal and <compound-id="2520">verapamil</compound-id>-induced ATPase activity of P-<protein-id="P08163">glycoprotein</protein-id> (P-gp).	verapamil__glycoprotein__interaction
18937368-1889	Elucidation of the human <protein-id="P21847,P83517">serum albumin</protein-id> (<protein-id="P24807,Q07490">HSA</protein-id>) binding site for the <compound-id="9552058">Cu-PTSM</compound-id> and <compound-id="6409958">Cu-ATSM</compound-id> radiopharmaceuticals.	Cu-ATSM__serum albumin__interaction	Cu-PTSM__serum albumin__interaction	Cu-PTSM__HSA__interaction	Cu-ATSM__HSA__interaction
18937368-1891	This study examines the structural basis for <protein-id="P24807,Q07490">HSA</protein-id> binding of <compound-id="9552058">Cu-PTSM</compound-id> and <compound-id="6409958">Cu-ATSM</compound-id> via competition with drugs having known albumin binding sites.	Cu-PTSM__HSA__interaction	Cu-ATSM__HSA__interaction
18937368-1892	<compound-id="6409958">Cu-ATSM</compound-id> from <protein-id="P24807,Q07490">HSA</protein-id>.	Cu-ATSM__HSA__interaction
18937368-1893	At 8:1 warfarin: <protein-id="P24807,Q07490">HSA</protein-id> <compound-id="6409958">Cu-ATSM</compound-id> levels increased 300-500%.	Cu-ATSM__HSA__interaction
18937368-1894	<compound-id="6409958">Cu-ATSM</compound-id> was observed except at high ibuprofen: <protein-id="P24807,Q07490">HSA</protein-id> ratios, where secondary ibuprofen binding to the IIA site may cause modest radiopharmaceutical displacement.	Cu-ATSM__HSA__no_interaction
18937538-664	This work also demonstrated that S-(+)-AF possesses the strongest effects in induction of intracellular reactive <compound-id="977">oxygen</compound-id> species, DNA damage, and upregulation of <protein-id="O09185,O12946,O57538,O93379,P02340,P04637,P10361,P19558,P19559,P56423,P56424,P61260,P79820,P79892,Q29537,Q42578,Q8SPZ3,Q92143,Q9TTA1,Q9TUB2,Q9W678,Q9W679">p53</protein-id> gene expression.	oxygen__p53__no_interaction
18937625-2531	0.05) in the overall <compound-id="206,5793,64689,79025">glucose</compound-id>-mediated <protein-id="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7">insulin</protein-id> response.	glucose__insulin__interaction
18937625-2532	<compound-id="206,5793,64689,79025">Glucose</compound-id>-stimulated <protein-id="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7">insulin</protein-id> levels were not significantly different from controls.	Glucose__insulin__interaction
18937643-2052	The inducible form of <protein-id="O61309,O61608,Q27571,Q9I9M2">nitric oxide synthase</protein-id> (<protein-id="O19114,O46660,O54705,O62699,P35228,P60321,P79290,Q27995,Q28314,Q90703,Q92037,Q92091">NOS2</protein-id>) plays an important role in sepsis incurred as a result of infection with Gram-negative bacteria that elaborate <compound-id="44268108">endotoxin</compound-id>.	endotoxin__nitric oxide synthase__interaction	endotoxin__NOS2__interaction
18937645-884	Atypical sialylated N-<compound-id="871">glycan</compound-id> structures are attached to neuronal <protein-id="P0A333,P0A334,Q9YDF8">voltage-gated potassium channels</protein-id>.	glycan__voltage-gated potassium channels__interaction
18937645-885	<compound-id="906,444885,445063">Sialic acid</compound-id> linkages were identified for <protein-id="P0A333,P0A334,Q9YDF8">voltage-gated potassium channels</protein-id>, Kv3.1, 3.3, 3.4, 1.1, 1.2 and 1.4, by evaluating their electrophoretic migration patterns in adult rat brain membranes digested with various glycosidases.	Sialic acid__voltage-gated potassium channels__interaction
18937879-2138	No regional difference in <protein-id="O73810,P14416,P20288,P52702,P60026,P61168,P61169,Q6TLI9,Q9GJU1">dopamine D2 receptor</protein-id> occupancy by the second-generation antipsychotic drug <compound-id="5073">risperidone</compound-id> in humans: a positron emission tomography study.	risperidone__dopamine D2 receptor__no_interaction
18937879-2139	In this study, regional distribution of <protein-id="O73810,P14416,P20288,P52702,P60026,P61168,P61169,Q6TLI9,Q9GJU1">dopamine D2 receptor</protein-id> occupancy by <compound-id="5073">risperidone</compound-id> was determined in order to elucidate the limbic and cortical selectivity of second-generation antipsychotics.	risperidone__dopamine D2 receptor__interaction
18937879-2140	Striatal and extrastriatal <protein-id="O73810,P14416,P20288,P52702,P60026,P61168,P61169,Q6TLI9,Q9GJU1">dopamine D2 receptor</protein-id> binding <compound-id="129497">FLB 457</compound-id>, respectively.	FLB 457__dopamine D2 receptor__interaction
18937971-2150	<protein-id="O09185,O12946,O36006,O57538,O93379,P04637,P10360,P13481,P25035,P41685,P51664,P56423,P56424,P61260,P67938,P67939,P79820,P79892,Q00366,Q29480,Q29537,Q64662,Q8SPZ3,Q92143,Q95330,Q9TTA1,Q9TUB2,Q9W678,Q9W679,Q9WUR6">TP53</protein-id>, <protein-id="Q00709">BCL-2</protein-id> and <protein-id="O02703,P55269,Q07812,Q07814,Q07815">BAX</protein-id> analysis in 199 ovarian cancer patients treated with <compound-id="108169,9548828">taxane</compound-id>-<compound-id="23939">platinum</compound-id> regimens.	taxane__BAX__interaction	platinum__BCL-2__interaction	platinum__BAX__interaction	taxane__BCL-2__interaction	platinum__TP53__interaction	taxane__TP53__interaction
18938111-2180	<protein-id="Q9HC29">NOD2</protein-id>, an intracellular sensor of bacteria-derived <compound-id="40846,451714,11620162">muramyl dipeptide</compound-id> (MDP) has been implicated as a key player in intestinal immune health and disease.	muramyl dipeptide__NOD2__interaction
18938126-2184	The end product of <protein-id="P40746,P52183,P81453,Q819L3,Q81MS1,Q8GR90,Q9K5W7">transglutaminase</protein-id> crosslinking: simultaneous quantitation of [Nepsilon-(gamma-glutamyl) <compound-id="866,5962">lysine</compound-id>] and <compound-id="866,5962">lysine</compound-id> by HPLC-MS3.	lysine__transglutaminase__interaction
18938128-2186	The <protein-id="P20432,P30104,P30106,P30107,P30108,Q04522,Q0ZS46,Q7REH6,Q8ILQ7,Q8MU52">GST</protein-id>-catalyzed formation of CA-<compound-id="124886">GSH</compound-id> occurred with both CA-AMP and CA-CoA.	GSH__GST__interaction
18938142-2192	Exposure of HEK293 cells to BK produced a concentration-dependent rise in intracellular Ca(2+) (EC(50)=36.5+/-8.0 x 10(-9)M), a rapid increase in <compound-id="1153,6057,5460803">tyrosine</compound-id> phosphorylation of <protein-id="P29323">ERK</protein-id> (EC(50)=9.8+/-0.4 x 10(-9)M), and elevation in ECAR by approximately 20%.	tyrosine__ERK__interaction
18938163-2196	<protein-id="P05017,P07455,P08025,P10763,P16545,P17085,P17647,P18254,P33712,P51457,P51458,P51462,Q02815,Q28933,Q68LC0,Q6GUL6,Q6IVA5,Q6JLX1,Q95222">IGF-I</protein-id> expression coupled with infusion of the IGF binding protein inhibitor <compound-id="54684689">NBI-31772</compound-id> significantly prevented corticospinal motor neuron death 0.05), but did not promote corticospinal axon regeneration.	NBI-31772__IGF-I__interaction
18938187-2204	A significant decrease was observed in <compound-id="119">GABA</compound-id> (A) alpha(1), <protein-id="P20228,P54767,Q04792,Q07346,Q42521,Q99259,Q9CG20">GAD</protein-id> (67), and <protein-id="O75973,P01142,P01143,P06296,P06850,P49188,P49926,Q8CIT0,Q95MI6,Q9PTS1">CRF</protein-id>, but not <protein-id="P35436,Q00959,Q12879,Q5IS45">NR2A</protein-id>, mRNAs in adult rats that consumed <compound-id="702">ethanol</compound-id> in comparison to controls.	ethanol__GAD__interaction	ethanol__NR2A__no_interaction	GABA__NR2A__no_interaction	ethanol__CRF__interaction	GABA__CRF__no_interaction	GABA__GAD__no_interaction
18938240-2219	We showed previously that activation of the <protein-id="Q10757">angiotensin</protein-id> type 1 receptor (AT1R), which belongs to the G protein-coupled receptor (GPCR) family, leads to <protein-id="P00523,P05480,P12931,Q9WUD9">c-Src</protein-id>-dependent <compound-id="1153,6057,5460803">tyrosine</compound-id> phosphorylation of beta2-adaptin, a subunit of the clathrin adaptor <protein-id="P05549,P34056,P58197,Q9N0N3">AP-2</protein-id>.	tyrosine__AP-2__interaction	tyrosine__c-Src__interaction	tyrosine__angiotensin__interaction
18939858-2823	EPL was used to incorporate d-<compound-id="602,4580,5950,71080">alanine</compound-id> and an amide-to-ester backbone modification in the selectivity filter of the <protein-id="P0A333,P0A334">KcsA</protein-id> potassium channel, providing insight into the mechanism of selectivity in ion conduction.	alanine__KcsA__interaction
18939895-2826	Genotoxic effect of 2,4,6-<compound-id="6914">trichlorophenol</compound-id> on <protein-id="O09185,O12946,O57538,O93379,P02340,P04637,P10361,P19558,P19559,P56423,P56424,P61260,P79820,P79892,Q29537,Q42578,Q8SPZ3,Q92143,Q9TTA1,Q9TUB2,Q9W678,Q9W679">p53</protein-id> gene in zebrafish liver.	trichlorophenol__p53__interaction
18940183-691	Extensive neutrophil infiltration and chemoattractant factor <protein-id="P10145">interleukin 8</protein-id> (<protein-id="O62812,P08317,P10145,P19874,P26894,P36925,P41324,P46653,P49113,P67813,P67814,P79255,Q102R3,Q7YRB5,Q9XSX5">IL-8</protein-id>) expression in IL-10 KO mice were observed after <compound-id="3562">halothane</compound-id> administration.	halothane__IL-8__interaction	halothane__interleukin 8__interaction
18940183-692	In addition, increased signal transducer and activator of transcription factors (<protein-id="P08457,P35610,Q7QDU4">STAT</protein-id>) 1 and <protein-id="P40763,P61635">STAT3</protein-id> were observed in <compound-id="3562">halothane</compound-id> treated IL-10 KO mice.	halothane__STAT__interaction	halothane__STAT3__interaction
18940187-471	Human <protein-id="O74187,P08157,P12693,P23240,P40108,P41751,P42041,P45959,Q27640,Q8VXQ2,Q9RYG9,Q9ZA11">aldehyde dehydrogenase</protein-id>-catalyzed oxidation of <compound-id="174">ethylene glycol</compound-id> <compound-id="3283,5382654">ether</compound-id> aldehydes.	ethylene glycol__aldehyde dehydrogenase__interaction	ether__aldehyde dehydrogenase__interaction
18940188-92	Interaction of <protein-id="O23970,P00435,P04041,P07203,P11352,P11909,P36014,Q4AEI1,Q4AEI2,Q4AEI3,Q865R2,Q8MJ14">glutathione peroxidase-1</protein-id> and <compound-id="6326970">selenium</compound-id> in endemic dilated cardiomyopathy.	selenium__glutathione peroxidase-1__interaction
18940188-93	We studied the gene-environment interaction in the pathogenesis of KD by assessing the association of low blood <compound-id="6326970">selenium</compound-id> and polymorphisms in <protein-id="O23970,P00435,P04041,P07203,P11352,P11909,P36014,Q4AEI1,Q4AEI2,Q4AEI3,Q865R2,Q8MJ14">glutathione peroxidase-1</protein-id> (<protein-id="P00435,P04041,P07203,P11352,P11909,Q4AEI1,Q4AEI2,Q4AEI3,Q865R2,Q8MJ14">GPx-1</protein-id>) gene.	selenium__glutathione peroxidase-1__interaction	selenium__GPx-1__interaction
18940204-495	However, under the pressure of a death stimulus such as <compound-id="1393">edelfosine</compound-id> treatment, L. infantum <protein-id="O08600,P38447,Q14249,Q95NM6">EndoG</protein-id> is released from the single mitochondrion and translocates to the nucleus, where it is thought to participate in the process of DNA degradation that is associated with programmed cell death.	edelfosine__EndoG__interaction
18940228-124	Results revealed that HCH administration lead to an increase in hepatic lipid peroxidation associated with reduction in, levels of <compound-id="124886">glutathione</compound-id> (<compound-id="124886">GSH</compound-id>), activity of <protein-id="O50258">superoxide dismutase</protein-id> (<protein-id="O12933,O22668,O75007,P24705,P51547,P93258,Q01137,Q27666,Q9SM64">SOD</protein-id>), <protein-id="O24339,O52762,O62839,O68146,O77229,O93662,O97492,P00432,P04040,P04762,P07145,P0A323,P0A324,P0A325,P0A326,P0A327,P11934,P17336,P24168,P24270,P25890,P29422,P30265,P30266,P32290,P42321,P44390,P45737,P45739,P55304,P55306,P55310,P55311,P55313,P77872,P81138,P90682,Q27710,Q49XC1,Q4L643,Q59296,Q59337,Q59602,Q59714,Q5HG86,Q5HPK8,Q5RF10,Q64405,Q6G9M4,Q6GH72,Q7A5T2,Q8CPD0,Q8FWU0,Q8NWV5,Q8X1P0,Q8Y3P9,Q926X0,Q99UE2,Q9AXH0,Q9KW19,Q9L4S1,Q9M5L6,Q9PT92,Q9PWF7,Q9Z598,Q9ZKX5,Q9ZN99">catalase</protein-id> and glucose-6-phosphate dehydrogenase.	GSH__SOD__no_interaction	glutathione__SOD__no_interaction	GSH__superoxide dismutase__no_interaction	glutathione__superoxide dismutase__no_interaction	GSH__catalase__no_interaction	glutathione__catalase__no_interaction
18940247-147	However, these events were blocked by treatment with the antioxidant, <compound-id="581">N-acetyl-cysteine</compound-id> (NAC), as well as <protein-id="P35557,Q12851,Q61161">GCK</protein-id> overexpression.	N-acetyl-cysteine__GCK__no_interaction
18940248-149	Consistently, immunoprecipitation followed by immunodetection with anti-<compound-id="68841">phosphoserine</compound-id> antibody suggest that <protein-id="Q9JL10,Q9UHV2">TRIP-Br1</protein-id> exists in a <compound-id="5951">serine</compound-id>-phosphorylated form.	phosphoserine__TRIP-Br1__interaction	serine__TRIP-Br1__interaction
18940267-156	It decreased TG levels in tyloxapol-induced hyperlipidemia and increased <protein-id="P81182">high-density lipoprotein</protein-id> <compound-id="304,5997,6432564,11025495">cholesterol</compound-id> (HDL-C) and reduced atherogenic index in normotensive rats.	cholesterol__high-density lipoprotein__interaction
18940894-262	This analysis reveals <protein-id="P25170">TRPCs</protein-id> as major and unsuspected gates of <compound-id="271">Ca(2</compound-id>+) entry that contribute, depending on context, to activation of transcription factors, apoptosis, vascular contractility, platelet activation, and cardiac hypertrophy, as well as to normal and abnormal cell proliferation.	Ca(2__TRPCs__interaction
18940938-278	A single bout of exercise increases <compound-id="206,5793,64689,79025">glucose</compound-id> uptake and fatty acid oxidation in skeletal muscle, with a corresponding activation of AMP-activated <protein-id="P00513,P25848">protein kinase</protein-id> (<protein-id="P54646,Q09136,Q9Y478">AMPK</protein-id>).	glucose__protein kinase__interaction	glucose__AMPK__interaction
18940938-280	Changes in <compound-id="977">oxygen</compound-id> consumption and the RQ ratio during sedentary and low-intensity exercise were not different between alpha(1)-<protein-id="P54646,Q09136,Q9Y478">AMPK</protein-id>-DN and WT.	oxygen__AMPK__no_interaction
18941142-329	<protein-id="O95477">ABCA1</protein-id>-mediated <compound-id="304,5997,6432564,11025495">cholesterol</compound-id> efflux generates microparticles in addition to HDL through processes governed by membrane rigidity.	cholesterol__ABCA1__interaction
18941467-423	<compound-id="10635">DHT</compound-id> treatment, in vivo or ex vivo, increased nuclear NFkappaB activation in cerebral arteries and increased levels of the proinflammatory products of NFkappaB activation, <protein-id="O02768,O19183,O62698,O62725,P27607,P35354,P35355,P70682,P79208,Q05769">cyclooxygenase-2</protein-id> (<protein-id="O02768,O19183,O62698,O62725,P27607,P35354,P35355,P70682,P79208,Q05769">COX-2</protein-id>) and inducible <protein-id="O61309,O61608,Q27571,Q9I9M2">nitric oxide synthase</protein-id> (<protein-id="O19114,O46660,O54705,O62699,P29477,P35228,P79290,Q06518,Q27995,Q28314,Q90703,Q92037,Q92091">iNOS</protein-id>).	DHT__cyclooxygenase-2__interaction	DHT__iNOS__interaction	DHT__nitric oxide synthase__interaction	DHT__COX-2__interaction
18941467-424	Effects of <compound-id="10635">DHT</compound-id> on <protein-id="O02768,O19183,O62698,O62725,P27607,P35354,P35355,P70682,P79208,Q05769">COX-2</protein-id> and <protein-id="O19114,O46660,O54705,O62699,P29477,P35228,P79290,Q06518,Q27995,Q28314,Q90703,Q92037,Q92091">iNOS</protein-id> were attenuated by <compound-id="3397">flutamide</compound-id>.	flutamide__iNOS__interaction	DHT__iNOS__interaction	flutamide__COX-2__interaction	DHT__COX-2__interaction
18941467-426	In conclusion, activation of the NFkappaB-mediated <protein-id="O02768,O19183,O62698,O62725,P27607,P35354,P35355,P70682,P79208,Q05769">COX-2</protein-id>/<protein-id="O19114,O46660,O54705,O62699,P29477,P35228,P79290,Q06518,Q27995,Q28314,Q90703,Q92037,Q92091">iNOS</protein-id> pathway by the selective androgen receptor agonist, <compound-id="10635">DHT</compound-id>, results in a state of vascular inflammation.	DHT__iNOS__interaction	DHT__COX-2__interaction
18941468-399	After MRI, one group of animals had BBB permeability measured in the WM with (14)C-<compound-id="5988">sucrose</compound-id>, and another had <compound-id="5356750,6913958,9566058">Evans blue</compound-id> (EB) injected for fluorescent microscopy for <protein-id="P08253,P33434,P33436,P50757,Q90611,Q9GLE5">MMP-2</protein-id>, <protein-id="O18733,P14780,P41245,P41246,P50282,P52176">MMP-9</protein-id>, tight junction proteins (TJPs), and in situ zymography.	sucrose__MMP-9__interaction	Evans blue__MMP-2__interaction	Evans blue__MMP-9__interaction	sucrose__MMP-2__interaction
18941714-1885	The electrons released from <compound-id="5884">NADPH</compound-id> by <protein-id="P00388,P00389,P04175,P16435,P16603,P19618,P36587,P37039,P37040,P37116,P37201,P50126,Q00141,Q05001,Q07994,Q27597,Q3SYT8,Q9EQV9,Q9HDG2,Q9JHH6">CPR</protein-id> were transferred to CTC in the reaction medium, and CTC reduction activity could be assessed spectrophotometrically and spectrofluorometrically.	NADPH__CPR__interaction
18941758-517	<compound-id="838,5816,247704">Adrenaline</compound-id>, <compound-id="4782,6041">phenylephrine</compound-id> and <protein-id="P01015,P01016,P01017,P01019,P11859,P20757,P67885,P67886,Q9GLN8,Q9GLP6,Q9TSZ0">ang II</protein-id> (<protein-id="O25424,P06608,P54420,Q9ZLB9">Asn</protein-id> (1), Val(5)) were injected into P. borchgrevinki.	phenylephrine__ang II__no_interaction	phenylephrine__Asn__no_interaction	Adrenaline__ang II__no_interaction	Adrenaline__Asn__no_interaction
18941797-421	Effects of dissolved <compound-id="977">oxygen</compound-id> tension and agitation rate on the production of heat-shock protein <protein-id="P08163">glycoprotein</protein-id> 96 by MethA tumor cell suspension culture in stirred-tank bioreactors.	oxygen__glycoprotein__interaction
18941818-549	Goldfish scales were incubated either with 20:3n-9 or with <compound-id="445639">oleic acid</compound-id> at 15 degrees C for 6 and 18 h. Both osteoblastic and osteoclastic activities in the scale were assessed by measuring <protein-id="O60109,P81800,P83456">alkaline phosphatase</protein-id> (<protein-id="P03973,P12547,P22298,P28296,P29118,P35211,P83610,P97430,Q03420,Q53GG5,Q9H0A0,Q9PU47,Q9Z1X0">ALP</protein-id>) and tartrate-resistant acid <protein-id="P06961,P45269,Q57JQ5,Q5E2K7,Q5F8K9,Q5P3T0,Q5PC82,Q5WT58,Q5X1E5,Q5ZRX9,Q60CQ4,Q62EU1,Q63YC3,Q65Q41,Q665U9,Q6D160,Q6FA38,Q6LV05,Q7M7K5,Q7MAZ9,Q7MBF4,Q821A6,Q82U82,Q87DS9,Q87SK9,Q88A53,Q88QU2,Q8CWL6,Q8CXX6,Q8P5D4,Q8PPG9,Q8XBL4,Q8Y395,Q8Z3M9,Q8ZI64,Q8ZLY4,Q9CP21,Q9I5V3,Q9JUB2,Q9JZ88,Q9KPC6,Q9L7A3,Q9PDL7">phosphatase</protein-id>, respectively.	oleic acid__ALP__no_interaction	oleic acid__alkaline phosphatase__no_interaction	oleic acid__phosphatase__no_interaction
18941818-550	MC3T3-E1 cells (an osteoblast cell line derived from the mouse) were incubated with 20:3n-9 or <compound-id="445639">oleic acid</compound-id> at 37 degrees C for 6 and 18 h. <protein-id="P03973,P12547,P22298,P28296,P29118,P35211,P83610,P97430,Q03420,Q53GG5,Q9H0A0,Q9PU47,Q9Z1X0">ALP</protein-id> activity in cell lysate was measured.	oleic acid__ALP__interaction
18941890-590	Reactive oxygen species induce phosphorylation of <compound-id="5951">serine</compound-id> 118 and 167 on <protein-id="O42132,P03372,P06211,P06212,P16058,P19785,P49884,P49885,P49886,P50240,P50241,P50242,P57717,P57753,P81559,Q29040,Q53AD2,Q91250,Q91424,Q9PVZ9,Q9QZJ5,Q9TV98,Q9YH33,Q9YHT3,Q9YHZ7">estrogen receptor</protein-id> alpha.	serine__estrogen receptor__interaction
18941890-591	Both kinases have been implicated in the phosphorylation of <compound-id="5951">serine</compound-id> 118 and <compound-id="5951">serine</compound-id> 167 on <protein-id="O42132,P03372,P06211,P06212,P16058,P19785,P49884,P49885,P49886,P50240,P50241,P50242,P57717,P57753,P81559,Q29040,Q53AD2,Q91250,Q91424,Q9PVZ9,Q9QZJ5,Q9TV98,Q9YH33,Q9YHT3,Q9YHZ7">ERalpha</protein-id>, respectively.	serine__ERalpha__interaction
18941890-592	Our data show for the first time that ROS can induce post-translational modifications of <protein-id="O42132,P03372,P06211,P06212,P16058,P19785,P49884,P49885,P49886,P50240,P50241,P50242,P57717,P57753,P81559,Q29040,Q53AD2,Q91250,Q91424,Q9PVZ9,Q9QZJ5,Q9TV98,Q9YH33,Q9YHT3,Q9YHZ7">ERalpha</protein-id> at <compound-id="5951">serine</compound-id> 118 and <compound-id="5951">serine</compound-id> 167, and may lead to <protein-id="O42132,P03372,P06211,P06212,P16058,P19785,P49884,P49885,P49886,P50240,P50241,P50242,P57717,P57753,P81559,Q29040,Q53AD2,Q91250,Q91424,Q9PVZ9,Q9QZJ5,Q9TV98,Q9YH33,Q9YHT3,Q9YHZ7">ERalpha</protein-id> down-regulation in human breast cancer cells.	serine__ERalpha__interaction
18942092-662	Therapeutic efficacy of 177Lu-CHX-A''-DTPA-hu3S193 radioimmunotherapy in prostate cancer is enhanced by <protein-id="P00533,P13387,P55245">EGFR</protein-id> inhibition or <compound-id="148124">docetaxel</compound-id> chemotherapy.	docetaxel__EGFR__no_interaction
18942097-665	Expression of the <protein-id="O22582,O49118,O97484,P02280,P02283,P14001,P17271,P19374,P21897,P23754,P27326,P27795,P27893,P30757,P35067,P37210,P40284,P48557,P59781,P59782,P69069,P69070,P78567,P82887,P83837,P83863,P93354,Q27442,Q2HH38,Q2U5A9,Q4HTT2,Q4PEF8,Q4WWC5,Q5G577,Q5KMT4,Q6C4I7,Q75VN4,Q76FD7,Q76FE5,Q76FE9,Q76FF3,Q7M400,Q7M4G7,Q7Z9J4,Q875B7,Q8I1N0,Q8J1K2,Q8SRE2,Q99285">histone H2B</protein-id>-<protein-id="P42212">GFP</protein-id> fusion protein was observed exclusively upon <compound-id="54671203">doxycycline</compound-id> induction and was uniformly distributed throughout the intestinal epithelium.	doxycycline__GFP__interaction	doxycycline__histone H2B__interaction
18942140-690	On <compound-id="12332">hexanoamide</compound-id> the <protein-id="O69768,P22984,P27765,P95896">amidase</protein-id> exhibited a K(m) value of 5.5 mM compared to 0.07 mM for <compound-id="7691">p-nitroacetanilide</compound-id>.	p-nitroacetanilide__amidase__interaction	hexanoamide__amidase__interaction
18942727-207	<protein-id="P21457,P34057,P35243">Recoverin</protein-id> is an important neuronal calcium sensor (<protein-id="P0A3R9,P0A3S0">NCS</protein-id>) protein, which have been implicated in a wide range of <compound-id="271">Ca(2</compound-id>+) signaling events in neurons and photoreceptors.	Ca(2__Recoverin__interaction	Ca(2__NCS__no_interaction
18942747-891	Activation of <protein-id="P13900,P16604">P2X</protein-id> (7)R in OPCs in response to 3'-O-(4-benzoyl) benzoyl-<compound-id="5957">ATP</compound-id> (BzATP) led to an increased mobilization of intracellular calcium [Ca(2+)]i, formation of large pores and cell death.	ATP__P2X__interaction
18942747-893	A decrease in <protein-id="P13900,P16604">P2X</protein-id> (7)R expression was observed in cultured OPCs after exposure to <compound-id="977">oxygen</compound-id>-<compound-id="206,5793,64689,79025">glucose</compound-id> deprivation (OGD) for 2 h in vitro.	oxygen__P2X__interaction	glucose__P2X__interaction
18945212-1760	Reactivity of <compound-id="145068">nitric oxide</compound-id> with the [<compound-id="6398953">4Fe-4S] cluster</compound-id> of <protein-id="O06069,O27498,O29248,O51887,O67009,O69198,P05791,P31874,P31959,P40810,P44851,P51785,P55186,P57656,P57957,P59426,P65154,P65155,P65156,P65157,P65158,P65159,P65160,P74689,Q02139,Q317H9,Q31UL3,Q329V0,Q3A3A5,Q3AER0,Q3APB9,Q3BYS5,Q3IMV2,Q3IXP4,Q3J9N3,Q3JV12,Q3K559,Q3SW60,Q3YVJ3,Q3Z888,Q3ZXH9,Q46AU2,Q46LF6,Q47JC0,Q47MS7,Q47UN7,Q48PA6,Q491Z0,Q4FM19,Q4FS54,Q4J860,Q4JUN3,Q4K498,Q4L7T6,Q4QMF8,Q4UZT2,Q4ZZ83,Q57FS2,Q57HU7,Q58672,Q5E1P2,Q5F8G6,Q5FN26,Q5GUY8,Q5HEE8,Q5HMG3,Q5HXE4,Q5KYA5,Q5L9I8,Q5LN98,Q5LYH1,Q5M334,Q5N3N2,Q5NH32,Q5NLJ4,Q5PK00,Q5SIY0,Q5V545,Q5WEM9,Q606D6,Q62LG7,Q63CV3,Q63WB9,Q64PS6,Q65IB0,Q65QD4,Q66G45,Q67KX6,Q6AEN9,Q6CZC7,Q6G543,Q6G7Q4,Q6GF19,Q6HKA0,Q6KZ30,Q6LLH7,Q6M0F3,Q6N9S5,Q6NHN6,Q71Y38,Q725Q1,Q72JA8,Q72TC0,Q73TT7,Q74BW7,Q7MAN4,Q7MGI8,Q7MYJ5,Q7NGK1,Q7NYJ7,Q7TV16,Q7U763,Q7UJ69,Q7V1T1,Q7VC95,Q7VHW3,Q7VRL8,Q81F26,Q81S26,Q82E99,Q82XY7,Q83GP9,Q83HI6,Q83PI6,Q87F63,Q87KB6,Q87V83,Q88CQ2,Q8A608,Q8CNL6,Q8DDG1,Q8DK13,Q8DRT7,Q8E9D9,Q8EN63,Q8F219,Q8FBR5,Q8G353,Q8G3H2,Q8KER4,Q8KTS9,Q8NQZ9,Q8PDJ3,Q8PQI0,Q8Q078,Q8RDJ9,Q8TW40,Q8U297,Q8UE43,Q8XAV1,Q8XWR1,Q8Y5S2,Q8YEN0,Q8YTE6,Q8Z377,Q8ZAB3,Q8ZYU6,Q92A32,Q92M28,Q96YK0,Q97EE3,Q97UB2,Q9I6E0,Q9JS61,Q9JUE0,Q9K8E4,Q9KVW0,Q9PH47,Q9PJ98,Q9RQ48,Q9RQ52,Q9RQ56,Q9RV97,Q9UZ03,Q9WZ21,Q9XBI3,Q9YG88">dihydroxyacid dehydratase</protein-id> from Escherichia coli.	nitric oxide__dihydroxyacid dehydratase__interaction	4Fe-4S] cluster__dihydroxyacid dehydratase__interaction
18945212-1763	The rate constant for the initial reaction between NO and the <protein-id="O06069,O27498,O29248,O51887,O67009,O69198,P05791,P31874,P31959,P40810,P44851,P51785,P55186,P57656,P57957,P59426,P65154,P65155,P65156,P65157,P65158,P65159,P65160,P74689,Q02139,Q317H9,Q31UL3,Q329V0,Q3A3A5,Q3AER0,Q3APB9,Q3BYS5,Q3IMV2,Q3IXP4,Q3J9N3,Q3JV12,Q3K559,Q3SW60,Q3YVJ3,Q3Z888,Q3ZXH9,Q46AU2,Q46LF6,Q47JC0,Q47MS7,Q47UN7,Q48PA6,Q491Z0,Q4FM19,Q4FS54,Q4J860,Q4JUN3,Q4K498,Q4L7T6,Q4QMF8,Q4UZT2,Q4ZZ83,Q57FS2,Q57HU7,Q58672,Q5E1P2,Q5F8G6,Q5FN26,Q5GUY8,Q5HEE8,Q5HMG3,Q5HXE4,Q5KYA5,Q5L9I8,Q5LN98,Q5LYH1,Q5M334,Q5N3N2,Q5NH32,Q5NLJ4,Q5PK00,Q5SIY0,Q5V545,Q5WEM9,Q606D6,Q62LG7,Q63CV3,Q63WB9,Q64PS6,Q65IB0,Q65QD4,Q66G45,Q67KX6,Q6AEN9,Q6CZC7,Q6G543,Q6G7Q4,Q6GF19,Q6HKA0,Q6KZ30,Q6LLH7,Q6M0F3,Q6N9S5,Q6NHN6,Q71Y38,Q725Q1,Q72JA8,Q72TC0,Q73TT7,Q74BW7,Q7MAN4,Q7MGI8,Q7MYJ5,Q7NGK1,Q7NYJ7,Q7TV16,Q7U763,Q7UJ69,Q7V1T1,Q7VC95,Q7VHW3,Q7VRL8,Q81F26,Q81S26,Q82E99,Q82XY7,Q83GP9,Q83HI6,Q83PI6,Q87F63,Q87KB6,Q87V83,Q88CQ2,Q8A608,Q8CNL6,Q8DDG1,Q8DK13,Q8DRT7,Q8E9D9,Q8EN63,Q8F219,Q8FBR5,Q8FPX6,Q8G353,Q8G3H2,Q8KER4,Q8KTS9,Q8NQZ9,Q8PDJ3,Q8PQI0,Q8Q078,Q8RDJ9,Q8TW40,Q8U297,Q8UE43,Q8XAV1,Q8XWR1,Q8Y5S2,Q8YEN0,Q8YTE6,Q8Z377,Q8ZAB3,Q8ZYU6,Q92A32,Q92M28,Q96YK0,Q97EE3,Q97UB2,Q98BZ8,Q9I6E0,Q9JUE0,Q9K8E4,Q9KVW0,Q9PH47,Q9PJ98,Q9RQ48,Q9RQ52,Q9RQ56,Q9RV97,Q9UZ03,Q9WZ21,Q9XBI3,Q9YG88">IlvD</protein-id> [<compound-id="6398953">4Fe-4S] cluster</compound-id> is estimated to be (7.0+/-2.0)x10(6) M(-2) x s(-1) at 25 degrees C, which is approx.	4Fe-4S] cluster__IlvD__interaction
18945212-1766	The results suggest that the iron-<compound-id="402">sulfur</compound-id> clusters in proteins such as <protein-id="O06069,O27498,O29248,O51887,O67009,O69198,P05791,P31874,P31959,P40810,P44851,P51785,P55186,P57656,P57957,P59426,P65154,P65155,P65156,P65157,P65158,P65159,P65160,P74689,Q02139,Q317H9,Q31UL3,Q329V0,Q3A3A5,Q3AER0,Q3APB9,Q3BYS5,Q3IMV2,Q3IXP4,Q3J9N3,Q3JV12,Q3K559,Q3SW60,Q3YVJ3,Q3Z888,Q3ZXH9,Q46AU2,Q46LF6,Q47JC0,Q47MS7,Q47UN7,Q48PA6,Q491Z0,Q4FM19,Q4FS54,Q4J860,Q4JUN3,Q4K498,Q4L7T6,Q4QMF8,Q4UZT2,Q4ZZ83,Q57FS2,Q57HU7,Q58672,Q5E1P2,Q5F8G6,Q5FN26,Q5GUY8,Q5HEE8,Q5HMG3,Q5HXE4,Q5KYA5,Q5L9I8,Q5LN98,Q5LYH1,Q5M334,Q5N3N2,Q5NH32,Q5NLJ4,Q5PK00,Q5SIY0,Q5V545,Q5WEM9,Q606D6,Q62LG7,Q63CV3,Q63WB9,Q64PS6,Q65IB0,Q65QD4,Q66G45,Q67KX6,Q6AEN9,Q6CZC7,Q6G543,Q6G7Q4,Q6GF19,Q6HKA0,Q6KZ30,Q6LLH7,Q6M0F3,Q6N9S5,Q6NHN6,Q71Y38,Q725Q1,Q72JA8,Q72TC0,Q73TT7,Q74BW7,Q7MAN4,Q7MGI8,Q7MYJ5,Q7NGK1,Q7NYJ7,Q7TV16,Q7U763,Q7UJ69,Q7V1T1,Q7VC95,Q7VHW3,Q7VRL8,Q81F26,Q81S26,Q82E99,Q82XY7,Q83GP9,Q83HI6,Q83PI6,Q87F63,Q87KB6,Q87V83,Q88CQ2,Q8A608,Q8CNL6,Q8DDG1,Q8DK13,Q8DRT7,Q8E9D9,Q8EN63,Q8F219,Q8FBR5,Q8FPX6,Q8G353,Q8G3H2,Q8KER4,Q8KTS9,Q8NQZ9,Q8PDJ3,Q8PQI0,Q8Q078,Q8RDJ9,Q8TW40,Q8U297,Q8UE43,Q8XAV1,Q8XWR1,Q8Y5S2,Q8YEN0,Q8YTE6,Q8Z377,Q8ZAB3,Q8ZYU6,Q92A32,Q92M28,Q96YK0,Q97EE3,Q97UB2,Q98BZ8,Q9I6E0,Q9JUE0,Q9K8E4,Q9KVW0,Q9PH47,Q9PJ98,Q9RQ48,Q9RQ52,Q9RQ56,Q9RV97,Q9UZ03,Q9WZ21,Q9XBI3,Q9YG88">IlvD</protein-id> and <protein-id="O04916,O08451,O13966,P09339,P16276,P19414,P20004,P21399,P28271,P34455,P37032,P49608,P49609,P63433,P63434,P70920,P82611,P99148,Q01059,Q23500,Q2A1K3,Q42669,Q59938,Q5HG69,Q5HPJ0,Q63270,Q6G9K9,Q6GH55,Q6YZX6,Q8CPC2,Q90875,Q92G90,Q99798,Q99KI0,Q9ER34,Q9ZCF4">aconitase</protein-id> B may constitute the primary targets of the NO cytotoxicity under both aerobic and anaerobic conditions.	sulfur__aconitase__interaction	sulfur__IlvD__interaction
18945214-2009	Moreover, following size-exclusion separation of <compound-id="5590">Triton X-100</compound-id>-extracted <protein-id="P16629,P24266,P28991,Q04565,Q07252">membrane proteins</protein-id>, <protein-id="P48025,Q64725">Syk</protein-id> was found only in the high-molecular-mass fraction containing oligomerized/phosphorylated band 3.	Triton X-100__membrane proteins__interaction	Triton X-100__Syk__interaction
18945215-1768	Acylcarnitines have been suggested to play a role in <protein-id="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7">insulin</protein-id> resistance, as well as other <compound-id="284">long-chain fatty acid</compound-id> metabolites.	long-chain fatty acid__insulin__interaction
18945215-1769	In the present study we investigated whether muscle long-chain acylcarnitines increase during fasting and we investigated their relationship with <compound-id="206,5793,64689,79025">glucose</compound-id>/fat oxidation and <protein-id="P01314,P01316,P01319,P01320,P01324,P01328,P01330,P01331,P01334,P01336,P01340,P07453,P09476,P09477,P0C236,P12703,P12704,P12708,P13190,P18109,P29335,P42633,P67968,P67969,P67971,P67973,P67974,P68243,P68245,P68987,P68988,P68989,P68990,P68991,P68992,P69046,P69047,P69048,P81423,P81881,Q9TQY7">insulin</protein-id> sensitivity in lean healthy humans.	glucose__insulin__no_interaction
18945217-1773	<compound-id="702">Ethanol</compound-id> attenuates the HFS-induced, <protein-id="P29323">ERK</protein-id>-mediated LTP in a dose-dependent manner in rat striatum.	Ethanol__ERK__interaction
18945429-1846	These results suggest that <protein-id="O46689,P49675,P51557,P58864,P70114,P79245,P97826,Q28918,Q28996,Q9DE06,Q9DEB4,Q9DG08,Q9DG09,Q9DG10">StAR</protein-id> delivers <compound-id="304,5997,6432564,11025495">cholesterol</compound-id> to mitochondria where regulatory oxysterols are generated.	cholesterol__StAR__interaction
18945563-2825	<protein-id="P14061,P51656,P51657,Q1WNP0">17beta-Hydroxysteroid dehydrogenase type 1</protein-id> (<protein-id="P14061,Q1WNP0">HSD17B1</protein-id>) is a key enzyme of <compound-id="5757">17beta-estradiol</compound-id> biosynthesis, which might play an important role in follicular development of the ovary.	17beta-estradiol__HSD17B1__interaction	17beta-estradiol__17beta-Hydroxysteroid dehydrogenase type 1__interaction
18945608-1920	A prototype chronoamperometric biosensor for the determination of total cholesterol was developed that consists of a homemade potentiostat and disposable strips immobilized with <compound-id="29936">Fe(3</compound-id>)O(4), cholesterol oxidase (ChOx), and <protein-id="P07882,P19835,P30122,P32947,Q64285">cholesterol esterase</protein-id> (ChE).	Fe(3__cholesterol esterase__no_interaction
18945611-1922	<protein-id="O26715,O27970,O59499,O74023,O93728,P0A2U0,P0A2U1,P0A696,P0A697,P0AFH0,P0AFH1,P11742,P16455,P24528,P26186,P26187,P26188,P29177,P44687,P52982,Q4J9C6,Q58924,Q5UNU9,Q6TDU1,Q8PY44,Q8TI34,Q8TZ11,Q8TZV2,Q973C7,Q97VW7,Q9V1N7,Q9ZET8">MGMT</protein-id> promoter hypermethylation correlates with a survival benefit from <compound-id="5394">temozolomide</compound-id> in patients with recurrent anaplastic astrocytoma but not glioblastoma.	temozolomide__MGMT__interaction
18945611-1923	To investigate the correlation between O(6)-methylguanine-DNA-<protein-id="O40976,P03588,P03589,P06011,P17769,P20122,P27752,P28726,P28931,Q00020,Q66121,Q83264,Q83270">methyltransferase</protein-id> (<protein-id="O26715,O27970,O59499,O74023,O93728,P0A2U0,P0A2U1,P0A696,P0A697,P0AFH0,P0AFH1,P11742,P16455,P24528,P26186,P26187,P26188,P29177,P44687,P52982,Q4J9C6,Q58924,Q5UNU9,Q6TDU1,Q8PY44,Q8TI34,Q8TZ11,Q8TZV2,Q973C7,Q97VW7,Q9V1N7,Q9ZET8">MGMT</protein-id>) promoter methylation and benefit from <compound-id="5394">temozolomide</compound-id> in patients with recurrent high-grade glioma.	temozolomide__methyltransferase__interaction	temozolomide__MGMT__interaction
18945624-1926	<compound-id="64971">Betulinic acid</compound-id> binding to human <protein-id="P21847,P83517">serum albumin</protein-id> : a study of protein conformation and binding affinity.	Betulinic acid__serum albumin__interaction
18945756-2007	Adenosine nucleotide translocase (<protein-id="P02723,P25083,P27080,P27081,P31691,P31692,P49382,Q09188,Q26365,Q38914">ANT</protein-id>) translocates ADP/<compound-id="5957">ATP</compound-id> across the inner mitochondrial membrane.	ATP__ANT__interaction
18945757-720	This review will focus on recent evidence that <compound-id="145068">nitric oxide</compound-id>, <protein-id="P28374">natriuretic peptides</protein-id> and <protein-id="P01303,P01304,P07808,P14765,P28672,P28673,P28674,P29071,P33689,P57774,P68006,P68007,P68008,P69101,P69102,P80167,Q27441,Q6RUW3,Q90WF4,Q9DGK7,Q9I8P3,Q9I9D3,Q9PTA0,Q9PW68,Q9XSW6">neuropeptide Y</protein-id> act by converging on neuronal cyclic nucleotide-dependent pathways to alter the autonomic phenotype in both health and disease.	nitric oxide__natriuretic peptides__no_interaction	nitric oxide__neuropeptide Y__no_interaction
18945783-756	Deletion of the first <compound-id="594,5862,5360637">cysteine</compound-id>-rich region of the varicella-zoster virus <protein-id="P18345">glycoprotein E</protein-id> ectodomain abolishes the gE and gI interaction and differentially affects cell-cell spread and viral entry.	cysteine__glycoprotein E__interaction
18945810-2026	Glucocorticoid-activated GR repressed <protein-id="O02768,O19183,O62698,O62725,P27607,P35354,P35355,P70682,P79208,Q05769">COX-2</protein-id> gene induction by <compound-id="11970143">lipopolysaccharide</compound-id> (LPS).	lipopolysaccharide__COX-2__interaction
18945821-2039	Inhibition of P-<protein-id="P08163">glycoprotein</protein-id>-mediated <compound-id="4666,5352019,6713921,6915727,44155032,53313247">paclitaxel</compound-id> resistance by reversibly linked quinine homodimers.	paclitaxel__glycoprotein__interaction
18945824-860	The data provide the first demonstration for the presence of <protein-id="O77808,P30518">V2R</protein-id> in primary cilia of renal epithelial cells, and a functional <compound-id="6076">cAMP</compound-id>-signaling pathway, which targets ciliary channel function and may help control the sensory function of the primary cilium.	cAMP__V2R__no_interaction
18945826-2045	The endothelial [<compound-id="271">Ca(2</compound-id>+)](<compound-id="597">CYT</compound-id>) response to <protein-id="O08677,P01042,P01044,P01045,P08934,P83055,P83060,P83856,P83857,P84697,P84825,P84895,Q7T3L1,Q90W88,Q90WZ1">bradykinin</protein-id> (100 nM) was significantly attenuated.	CYT__bradykinin__interaction	Ca(2__bradykinin__interaction
18945930-874	The purpose of this research was to enhance intranasal drug targeting to the CNS by incorporating a vasoconstrictor [phenylephrine (PHE)] into nasal formulations containing therapeutic <protein-id="P21259">neuropeptides</protein-id> [<protein-id="O43612,O55232,O55241,O77668,P56717,Q9GLF6">hypocretin-1</protein-id> (HC) or the dipeptide L-Tyr-D-Arg (D-<compound-id="446833">KTP</compound-id>)].	KTP__neuropeptides__no_interaction	KTP__hypocretin-1__no_interaction
18945988-1510	<compound-id="6804">CpG</compound-id> dinucleotides identified in <protein-id="O35185,O35780">Bhlhb2</protein-id>, <protein-id="O88275,P37234,P37238">Pparg</protein-id>, <protein-id="Q27368">E2f</protein-id>, and <protein-id="P08046,P08154,P26632">Egr1</protein-id> binding sites at the <protein-id="P09216,P16054">Prkce</protein-id> gene promoter were densely methylated in males and females and were unaffected by cocaine exposure.	CpG__E2f__interaction	CpG__Pparg__interaction	CpG__Prkce__interaction	CpG__Bhlhb2__interaction	CpG__Egr1__interaction
